OBO_ID (LABEL):	CHEBI_27300 (vitamin D)

IGNORANCE CATEGORY:	important_consideration

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
BMJ_2010_Apr_29_340_c1640	4/2010	S95-BMJ_2010_Apr_29_340_c1640	['maternal exposure and health of offspring\nthis report adds to other work SHOWING that maternal exposure to ambient ultraviolet radiation during Pregnancy MIGHT INFLUENCE subsequent health in the offspring.30313233in a new zealand Birth cohort, infants whose mothers were exposed to peak sunshine during the first Trimester were significantly heavier at Birth than infants whose mothers experienced trough levels of sunshine during the same trimester.30in the united kingdom, maternal ambient Ultraviolet B exposure in the third trimester HAS BEEN positively RELATED to bone Mineral density and content at age 9 in offspring.34there is now GROWING INTEREST in the ROLE of maternal Vitamin D deficiency in Pregnancy and the Development of Central Nervous System and Immune disorders, PARTICULARLY schizophrenia,33type 1 diabetes, and other disorders.35ALTHOUGH active Vitamin D3Concentrations in the mother increase substantially during Pregnancy, early fetal supplies are lower36and directly DEPENDENT on the mother.']	[('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 160), ('INCOMPLETE_EVIDENCE', 538), ('SUPERFICIAL_RELATIONSHIP', 558), ('INCOMPLETE_EVIDENCE', 639), ('SUPERFICIAL_RELATIONSHIP', 663), ('IMPORTANT_CONSIDERATION', 782), ('ANOMALY_CURIOUS_FINDING', 848), ('SUPERFICIAL_RELATIONSHIP', 991)]	10	[('GO_0007565', 'female pregnancy', 144, 'pregnancy'), ('GO_0007567', 'parturition', 230, 'birth'), ('GO_0009294', 'DNA mediated transformation', 313, 'trimester'), ('GO_0007567', 'parturition', 353, 'birth'), ('CHEBI_72754', 'bisphenol AF', 492, 'ultraviolet B'), ('CHEBI_46662', 'mineral', 574, 'mineral'), ('CHEBI_27300', 'vitamin D', 680, 'vitamin D'), ('GO_0007565', 'female pregnancy', 704, 'pregnancy'), ('GO_0008289', 'lipid binding', 722, 'development'), ('GO_0022412', 'cellular process involved in reproduction in multicellular organism', 737, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 737, 'central nervous system'), ('UBERON_0002405', 'immune system', 764, 'immune'), ('PR_000017350', 'serine/threonine-protein kinase VRK2', 866, 'vitamin D3concentrations'), ('GO_0007565', 'female pregnancy', 935, 'pregnancy')]
BMJ_2010_Apr_29_340_c1640	4/2010	S96-BMJ_2010_Apr_29_340_c1640	['by the time of Delivery, maternal and infant Cord Serum 25-Hydroxyvitamin d3concentrations are highly CORRELATED.37UNFORTUNATELY, much REMAINS UNKNOWN, leading to large international variations in maternal Vitamin D monitoring and supplementation during Pregnancy.353839\na maternal EFFECT operating Antenatally would also be CONSISTENT with the stronger maternal than paternal “parent of origin” EFFECT in familial multiple sclerosis.1340it HAS BEEN PREVIOUSLY PROPOSED14THAT maternal Vitamin D deficiency, a PROBLEM for SOME dark skinned women migrating to regions with low ambient ultraviolet radiation, such as the uk, MIGHT EXPLAIN the increase in incidence of disease SEEN among second generation migrants in such locations.41our FINDINGS are CONSISTENT with this EXPLANATION.']	[('SUPERFICIAL_RELATIONSHIP', 102), ('ANOMALY_CURIOUS_FINDING', 113), ('ANOMALY_CURIOUS_FINDING', 113), ('FULL_UNKNOWN', 135), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 325), ('SUPERFICIAL_RELATIONSHIP', 396), ('INCOMPLETE_EVIDENCE', 441), ('INCOMPLETE_EVIDENCE', 450), ('INCOMPLETE_EVIDENCE', 461), ('IMPORTANT_CONSIDERATION', 509), ('INCOMPLETE_EVIDENCE', 521), ('INCOMPLETE_EVIDENCE', 622), ('PROBABLE_UNDERSTANDING', 628), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 735), ('INCOMPLETE_EVIDENCE', 748), ('PROBABLE_UNDERSTANDING', 769)]	18	[('GO_0007567', 'parturition', 15, 'delivery'), ('UBERON_0002240', 'spinal cord', 45, 'cord'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_67376', 'dihydrooroxylin A', 56, '25-hydroxyvitamin'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy'), ('GO_0007288', 'sperm axoneme assembly', 299, 'antenatally'), ('CHEBI_27300', 'vitamin D', 485, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S99-BMJ_2010_Apr_29_340_c1640	['ultraviolet radiation exposure during the first trimester would be expected to specifically INFLUENCE Vitamin D concentrations up to early in the second trimester, given that Vitamin D has a half life of one to two months.45in RECENT australian work, higher levels of ambient ultraviolet radiation were ASSOCIATED with higher Vitamin D concentrations at the population level with a lag of one and a half months.46\n\nPOSSIBLE mechanisms\nfirst trimester Vitamin D concentrations MIGHT be particularly IMPORTANT in the development of the Central Nervous System BECAUSE during Early Embryonic Development, Vitamin D receptors are Expressed in the Neuroepithelium and later in the Subventricular Zone.15myelination occurs later; EVEN in mid-Gestation (19-24 weeks) Cortical Axonal tracts are not yet myelinated,47with major myelination of several areas occurring as late as 29-39 weeks.48in addition, the in utero Development Of Immune central Tolerance occurs in the first trimester and Vitamin D has immunomodulating properties.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 303), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 476), ('IMPORTANT_CONSIDERATION', 498), ('PROBABLE_UNDERSTANDING', 557), ('ANOMALY_CURIOUS_FINDING', 723)]	8	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 326, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 534, 'central nervous system'), ('UBERON_0019248', 'early embryo', 572, 'early embryonic'), ('GO_0009790', 'embryo development', 578, 'embryonic development'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('GO_0010467', 'gene expression', 625, 'expressed'), ('UBERON_0034705', 'developing neuroepithelium', 642, 'neuroepithelium'), ('UBERON_0004922', 'postnatal subventricular zone', 675, 'subventricular zone'), ('GO_0007565', 'female pregnancy', 735, 'gestation'), ('UBERON_0001851', 'cortex', 759, 'cortical'), ('GO_0030424', 'axon', 768, 'axonal'), ('GO_0034102', 'erythrocyte clearance', 908, 'development of ... tolerance'), ('UBERON_0002405', 'immune system', 923, 'immune'), ('CHEBI_27300', 'vitamin D', 982, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S101-BMJ_2010_Apr_29_340_c1640	['for example, Vitamin D can down-regulate Interleukin 6, an IMPORTANT mediator of the adverse EFFECT of maternal infection during Pregnancy on neural development in the fetus.505152\n\nPrenatal and Postnatal timing\nour results do not INDICATE that the POSSIBLE beneficial EFFECT of Ultraviolet radiation exposure is confined ONLY to the Prenatal period.']	[('IMPORTANT_CONSIDERATION', 59), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 231), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 269), ('INCOMPLETE_EVIDENCE', 322)]	6	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('PR_000008988', 'interleukin-1 family member 5', 41, 'interleukin 6'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007565', 'female pregnancy', 182, 'Prenatal'), ('GO_0007567', 'parturition', 195, 'postnatal'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 279, 'ultraviolet'), ('GO_0007565', 'female pregnancy', 334, 'prenatal')]
BMJ_2010_Apr_29_340_c1640	4/2010	S103-BMJ_2010_Apr_29_340_c1640	['overall, epidemiological studies SUPPORT a PROTECTIVE ROLE for Vitamin D in Autoimmune disease, PARTICULARLY in childhood and Adolescence, and Vitamin D supplementation in early Adulthood EFFECTIVELY reduces the risk of multiple sclerosis; THEREFORE, supplementation of adolescents and young Adults COULD BE effectively used for PREVENTION.6the FINDINGS HERE provide the FIRST population BASED evidence beyond month of Birth PATTERNS to INDICATE that Vitamin D supplementation for the PREVENTION of multiple sclerosis MIGHT also NEED to be CONSIDERED during in utero development.14they are CONSISTENT with a multi-hit causal cascade for multiple sclerosis, with PUTATIVE adverse environmental FACTORS, such as low Vitamin D concentrations, acting at more than one stage of Life.53\n\nwhat is already known on this topic\nin the northern hemisphere, there are more cases of multiple sclerosis in People Born in may and fewer in those Born in november\nmaternal exposure to ambient ultraviolet radiation in Pregnancy can be used as an instrumental variable for Vitamin D status during Pregnancy\nlow Vitamin D concentrations HAVE BEEN ASSOCIATED with a higher risk of multiple sclerosis\n\nwhat THIS STUDY adds\nin australia there is a reciprocal PATTERN of month of Birth and risk of multiple sclerosis, with a higher risk for those Born in november-december compared with may-june\nthis PATTERN was accounted FOR by maternal exposure to ambient ultraviolet radiation in the first trimester\nlow maternal exposure to Ultraviolet Radiation in the first trimester was inversely RELATED to risk of multiple sclerosis in the offspring after adjustment for either month of Birth or place of Birth\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 188), ('PROBABLE_UNDERSTANDING', 240), ('INCOMPLETE_EVIDENCE', 299), ('SUPERFICIAL_RELATIONSHIP', 329), ('INCOMPLETE_EVIDENCE', 345), ('QUESTION_ANSWERED_BY_THIS_WORK', 354), ('INCOMPLETE_EVIDENCE', 371), ('QUESTION_ANSWERED_BY_THIS_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 437), ('SUPERFICIAL_RELATIONSHIP', 485), ('INCOMPLETE_EVIDENCE', 518), ('FUTURE_WORK', 529), ('IMPORTANT_CONSIDERATION', 529), ('FUTURE_WORK', 540), ('IMPORTANT_CONSIDERATION', 540), ('INCOMPLETE_EVIDENCE', 590), ('SUPERFICIAL_RELATIONSHIP', 590), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 693), ('INCOMPLETE_EVIDENCE', 1118), ('SUPERFICIAL_RELATIONSHIP', 1128), ('QUESTION_ANSWERED_BY_THIS_WORK', 1186), ('SUPERFICIAL_RELATIONSHIP', 1237), ('SUPERFICIAL_RELATIONSHIP', 1378), ('QUESTION_ANSWERED_BY_THIS_WORK', 1400), ('SUPERFICIAL_RELATIONSHIP', 1565)]	31	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 76, 'autoimmune'), ('GO_0048848', 'neurohypophysis morphogenesis', 126, 'adolescence'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('UBERON_0007023', 'adult organism', 292, 'adults'), ('GO_0007567', 'parturition', 419, 'birth'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 714, 'vitamin D'), ('UBERON_0000104', 'life cycle', 773, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 892, 'people'), ('GO_0007567', 'parturition', 899, 'born'), ('GO_0007567', 'parturition', 930, 'born'), ('GO_0007565', 'female pregnancy', 1001, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1079, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007567', 'parturition', 1257, 'birth'), ('GO_0007567', 'parturition', 1324, 'born'), ('CHEBI_52927', 'To-Pro-1(2+)', 1506, 'ultraviolet radiation'), ('GO_0007567', 'parturition', 1657, 'birth'), ('GO_0007567', 'parturition', 1675, 'birth')]
PMC1168874	7/2005	S66-PMC1168874	['among Oestrogens and Retinol (Vitamin A), ONLY high dose treatments are CONSIDERED.']	[('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 72), ('INCOMPLETE_EVIDENCE', 72)]	3	[('CHEBI_50905', 'teratogenic agent', 6, 'oestrogens'), ('CHEBI_26536', 'retinoic acid', 21, 'retinol'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin A')]
PMC1168874	7/2005	S67-PMC1168874	['it is WORTH MENTIONING that we had three mothers who were treated by 50,000 and one with 100,000 iu doses of Vitamin A daily in the first and second months of Gestation, and later they Delivered newborn infants without any cas25.']	[('IMPORTANT_CONSIDERATION', 6)]	1	[('CHEBI_27300', 'vitamin D', 109, 'vitamin A'), ('GO_0007565', 'female pregnancy', 159, 'gestation'), ('GO_0007567', 'parturition', 185, 'delivered')]
PMC1168874	7/2005	S68-PMC1168874	['OUR FINDING is IN AGREEMENT with the CONCLUSION of the european network of the teratology information services, whose data set DID NOT PROVIDE EVIDENCE for an INCREASED RISK of major cas ASSOCIATED with high Vitamin A intake (10,000 iu per day or more) during the Organogenetic period of Embryo26.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 127), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 187)]	6	[('CHEBI_27300', 'vitamin D', 208, 'vitamin A'), ('GO_0048513', 'animal organ development', 264, 'organogenetic'), ('UBERON_0000922', 'embryo', 288, 'embryo26')]
PMC1361787	12/2005	S11-PMC1361787	['maternal Intake of Carbohydrates and protein [3], Fatty Acids [4], and Micronutrients such as zinc [5-7], iron [2], magnesium [8-10], Calcium [11], riboflavin [4], and Vitamin C [12]MAY also have IMPORTANT EFFECTS on fetal growth and Perinatal outcomes.']	[('INCOMPLETE_EVIDENCE', 182), ('IMPORTANT_CONSIDERATION', 196), ('SUPERFICIAL_RELATIONSHIP', 206)]	3	[('GO_0007631', 'feeding behavior', 9, 'intake'), ('CHEBI_16646', 'carbohydrate', 19, 'carbohydrates'), ('CHEBI_35366', 'fatty acid', 50, 'fatty acids'), ('CHEBI_33839', 'macromolecule', 71, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 134, 'calcium'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin C'), ('GO_0036268', 'swimming', 234, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 234, 'perinatal')]
PMC1544352	6/2006	S40-PMC1544352	['(2001), usa [19]survey, self completed questionnaire150 women in 1stto 3rdtrimesters (24% response rate)13% used Dietary Supplement during Pregnancy45 herbs used, most common: echinacea, Pregnancy tea**, ginger, Vitamin B6*, Vitamin C*, multivitamin with herbs, raspberry leaf studies specifically CONCERNED with nausea hollyer et al.']	[('IMPORTANT_CONSIDERATION', 298)]	1	[('CHEBI_23888', 'drug', 113, 'dietary'), ('CHEBI_16158', 'steroid sulfate', 121, 'supplement'), ('GO_0007565', 'female pregnancy', 139, 'pregnancy45'), ('GO_0007565', 'female pregnancy', 187, 'pregnancy'), ('CHEBI_33237', 'vitamin D4', 212, 'vitamin B6'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin C')]
PMC1888711	5/2007	S46-PMC1888711	['beneficial EFFECTS on Birth weight and the risk of Postpartum endometritis were SEEN for high-risk women" [22].moderatedietary Vitamin A deficiencyvitamin a supplementation"further EVIDENCE on biologically PLAUSIBLE mechanisms of morbidity reduction such as reduced incidence of sepsis and/or reduced MARKERS of inflammation ARE NEEDED" [60].lowdietary Micronutrient deficienciesmultiple Micronutrient supplementationone trial in tanzania showed no additional effect on markers of infection (C-Reactive Protein) compared with Iron and Folic Acid [15].lowanemia p. falciparum infectionanti-malarial Drugs"Drugs given routinely for malaria during Pregnancy reduce SEVERE Antenatal anaemia in the mother, and are ASSOCIATED with higher Birth weight in the baby and PROBABLY fewer Perinatal deaths.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 181), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 301), ('FUTURE_WORK', 325), ('IMPORTANT_CONSIDERATION', 662), ('SUPERFICIAL_RELATIONSHIP', 710), ('PROBABLE_UNDERSTANDING', 762)]	9	[('GO_0007567', 'parturition', 22, 'birth'), ('GO_0007565', 'female pregnancy', 51, 'postpartum'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 353, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 388, 'micronutrient'), ('PR_000005890', 'crooked neck-like protein 1', 492, 'C-reactive protein'), ('CHEBI_24870', 'ion', 526, 'iron'), ('CHEBI_30751', 'formic acid', 535, 'folic acid'), ('CHEBI_23888', 'drug', 598, 'drugs'), ('CHEBI_23888', 'drug', 604, 'Drugs'), ('GO_0007565', 'female pregnancy', 645, 'pregnancy'), ('GO_0007567', 'parturition', 669, 'antenatal'), ('GO_0007567', 'parturition', 733, 'birth'), ('GO_0036268', 'swimming', 777, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 777, 'perinatal')]
PMC2290997	4/2008	S16-PMC2290997	['ALTHOUGH most of the health-promoting benefits of sun exposure are THOUGHT TO occur through Vitamin D Photosynthesis, there MAY BE OTHER health benefits that have gone largely OVERLOOKED in the DEBATE over HOW much sun is NEEDED for good health [see “other sun-dependent pathways,” p. a165].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('EXPLICIT_QUESTION', 206), ('IMPORTANT_CONSIDERATION', 222)]	8	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0006654', 'phosphatidic acid biosynthetic process', 102, 'photosynthesis')]
PMC2290997	4/2008	S26-PMC2290997	['more RECENTLY, there HAS BEEN a GROWING APPRECIATION for Vitamin D’s IMPACT on bone health in Adults.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 40), ('SUPERFICIAL_RELATIONSHIP', 69)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0007023', 'adult organism', 94, 'adults')]
PMC2290997	4/2008	S29-PMC2290997	['evolution of the great solar debate\nin the 2002 book bone loss and osteoporosis in past populations: an anthropological perspective , reinhold vieth, a nutrition professor at the university of toronto, writes that early Primates PROBABLY acquired their relatively high Vitamin D REQUIREMENTS from frequent Grooming and Ingestion of oils rich in Vitamin D precursors that were Secreted by their skin onto their fur.']	[('PROBABLE_UNDERSTANDING', 229), ('IMPORTANT_CONSIDERATION', 279)]	2	[('NCBITaxon_33208', 'Metazoa', 220, 'primates'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('GO_0040007', 'growth', 306, 'grooming'), ('GO_0007631', 'feeding behavior', 319, 'ingestion'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('GO_0046903', 'secretion', 376, 'secreted')]
PMC2290997	4/2008	S32-PMC2290997	['in the july 2000 issue of the journal of Human Evolution , california academy of sciences anthropologists nina jablonski and george chaplin wrote that BECAUSE dark skin REQUIRES about five to six times more solar exposure than pale skin for equivalent Vitamin D Photosynthesis, and because the intensity of uvb radiation declines with increasing latitude, one could surmise that skin lightening was an evolutionary adaptation that allowed for optimal survival in low-uvr climes, ASSUMING a traditional diet and outdoor lifestyle.']	[('PROBABLE_UNDERSTANDING', 151), ('IMPORTANT_CONSIDERATION', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 479)]	3	[('NCBITaxon_10088', 'Mus <genus>', 41, 'Human'), ('GO_0006983', 'ER overload response', 47, 'Evolution'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('GO_0006654', 'phosphatidic acid biosynthetic process', 262, 'photosynthesis')]
PMC2290997	4/2008	S34-PMC2290997	['with shorter winter days and insufficient solar radiation in the uvb wavelengths NEEDED to stimulate Vitamin D synthesis, dietary sources such as fatty fish became increasingly IMPORTANT.']	[('FUTURE_WORK', 81), ('IMPORTANT_CONSIDERATION', 177)]	2	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 109, 'D')]
PMC2290997	4/2008	S45-PMC2290997	['NEVERTHELESS, a meta-analysis published in the february 2008 international journal of epidemiology FOUND that high Vitamin D levels reduce the RISK of active tb (i.e., tb showing clinical symptoms) by 32%.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 143)]	3	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC2290997	4/2008	S74-PMC2290997	['STILL to be resolved, HOWEVER, is the QUESTION of WHAT levels of Vitamin D are OPTIMAL for preventing the disease—and WHETHER the statistical ASSOCIATIONS REFLECT DIFFERENT Gene pools RATHER than DIFFERENT levels of 25(Oh)D. (INTERESTINGLY, holick REPORTED in the august 1988 issue of the journal of clinical endocrinology & Metabolism that no previtamin d3formed when Human skin was exposed to sunlight on cloudless days in boston, at 42.2°n, from november through february or in edmonton, at 52°n, from october through march.)']	[('IMPORTANT_CONSIDERATION', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('EXPLICIT_QUESTION', 38), ('EXPLICIT_QUESTION', 50), ('IMPORTANT_CONSIDERATION', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('EXPLICIT_QUESTION', 118), ('SUPERFICIAL_RELATIONSHIP', 142), ('SUPERFICIAL_RELATIONSHIP', 155), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('ANOMALY_CURIOUS_FINDING', 226), ('INCOMPLETE_EVIDENCE', 248)]	14	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('SO_0000704', 'gene', 173, 'gene'), ('CHEBI_71657', 'versiconol acetate', 216, '25(OH)D'), ('GO_0008152', 'metabolic process', 325, 'Metabolism'), ('NCBITaxon_9606', 'Homo sapiens', 369, 'human')]
PMC2290997	4/2008	S75-PMC2290997	['“SCIENTIFIC EVIDENCE on specific EFFECTS of Vitamin D in preventing ms or slowing its progression is not SUFFICIENT,” says alberto ascherio, a nutritional epidemiologist at the harvard school of public health.']	[('INCOMPLETE_EVIDENCE', 1), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 105)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC2290997	4/2008	S76-PMC2290997	['“NEVERTHELESS, considering the SAFETY of Vitamin D EVEN in high doses, there is NO CLEAR contraindication, and BECAUSE Vitamin D deficiency is very PREVALENT, especially among ms patients, taking Vitamin D supplements and getting moderate sun exposure is more LIKELY to be beneficial than not.”\nas with ms, there APPEARS TO be a latitudinal gradient for type 1 diabetes, with a higher incidence at higher latitudes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 1), ('IMPORTANT_CONSIDERATION', 31), ('ANOMALY_CURIOUS_FINDING', 51), ('FULL_UNKNOWN', 80), ('PROBABLE_UNDERSTANDING', 111), ('IMPORTANT_CONSIDERATION', 148), ('PROBABLE_UNDERSTANDING', 260), ('ANOMALY_CURIOUS_FINDING', 313)]	8	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC2290997	4/2008	S84-PMC2290997	['People living at higher latitudes throughout the world are at higher RISK of hypertension, and patients with Cardiovascular disease are OFTEN found to be deficient in Vitamin D, ACCORDING TO research by harvard medical school professor thomas j. wang and colleagues in the 29 january 2008 issue of circulation .']	[('IMPORTANT_CONSIDERATION', 69), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 178)]	3	[('NCBITaxon_10088', 'Mus <genus>', 0, 'People'), ('UBERON_0004535', 'cardiovascular system', 109, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC2290997	4/2008	S95-PMC2290997	['in addition, 25(Oh)D levels are inversely ASSOCIATED with the clinical status of ra patients, and greater intake of Vitamin D HAS BEEN LINKED with lower ra RISK, AS REPORTED in january 2004 in arthritis & rheumatism .']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 156), ('PROBABLE_UNDERSTANDING', 162), ('INCOMPLETE_EVIDENCE', 165)]	6	[('CHEBI_71657', 'versiconol acetate', 13, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC2290997	4/2008	S101-PMC2290997	['NEVERTHELESS, given the epidemiologic backdrop DESCRIBED above, there are now CALLS to rethink sun exposure policy OR to promote Vitamin D supplementation in HIGHER-RISK populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 78), ('IMPORTANT_CONSIDERATION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC2290997	4/2008	S102-PMC2290997	['such groups include Pregnant or breastfeeding women (these states draw upon a mother’s own reserves of Vitamin D), the elderly, and those who MUST avoid the sun.']	[('IMPORTANT_CONSIDERATION', 142)]	1	[('GO_0007565', 'female pregnancy', 20, 'pregnant'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC2290997	4/2008	S104-PMC2290997	['EVEN in the sun-rich environment of the middle east, insufficient Vitamin D is a SEVERE PROBLEM among Breast-Fed infants of women who wear a burqa (a traditional garment that covers the body from Head to Foot), as reported in the february 2003 journal of pediatrics .']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 81), ('IMPORTANT_CONSIDERATION', 88), ('PROBLEM_COMPLICATION', 88)]	4	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'breast'), ('GO_0007631', 'feeding behavior', 109, 'fed'), ('UBERON_0000033', 'head', 196, 'head'), ('UBERON_0002387', 'pes', 204, 'foot')]
PMC2290997	4/2008	S107-PMC2290997	['studies by bruce hollis, director of pediatric nutritional sciences at the medical university of south carolina, and colleagues SUGGEST that a maternal Vitamin D3Intake of 4,000 iu per day is SAFE and sufficient to ensure adequate Vitamin D status for both mother and nursing infant.']	[('INCOMPLETE_EVIDENCE', 128), ('IMPORTANT_CONSIDERATION', 192)]	2	[('CHEBI_63635', 'valganciclovir', 152, 'vitamin D3intake'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D')]
PMC2290997	4/2008	S109-PMC2290997	['holick and others ASSERT that levels of 29 ng/ml or lower CAN be considered to INDICATE a relative insufficiency of Vitamin D. using this scale and considering VARIOUS epidemiologic STUDIES, an ESTIMATED 1 billion People worldwide have Vitamin D deficiency or insufficiency, says holick, who adds, “ACCORDING TO SEVERAL STUDIES, SOME forty to one hundred percent of the u.s. and european elderly men and women STILL living in the community [that is, not in nursing homes] are Vitamin D DEFICIENT.” holick ASSERTS that a large NUMBER of infants, children, adolescents, and Postmenopausal women also are Vitamin D INSUFFICIENT.']	[('INCOMPLETE_EVIDENCE', 18), ('PROBABLE_UNDERSTANDING', 18), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 299), ('INCOMPLETE_EVIDENCE', 312), ('INCOMPLETE_EVIDENCE', 329), ('IMPORTANT_CONSIDERATION', 410), ('IMPORTANT_CONSIDERATION', 486), ('INCOMPLETE_EVIDENCE', 505), ('INCOMPLETE_EVIDENCE', 526), ('IMPORTANT_CONSIDERATION', 612)]	14	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 214, 'people'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 476, 'vitamin D'), ('GO_0007595', 'lactation', 572, 'postmenopausal'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D')]
PMC2290997	4/2008	S111-PMC2290997	['in the context of INADEQUATE sunlight or Vitamin D insufficiency, SOME scientists WORRY that the EMPHASIS on preventing skin cancers tends to obscure the much larger mortality BURDEN posed by more Life-threatening cancers such as Lung, Colon, and Breast cancers.']	[('IMPORTANT_CONSIDERATION', 18), ('INCOMPLETE_EVIDENCE', 66), ('IMPORTANT_CONSIDERATION', 82), ('IMPORTANT_CONSIDERATION', 97), ('IMPORTANT_CONSIDERATION', 176)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0000104', 'life cycle', 197, 'life'), ('UBERON_0002048', 'lung', 230, 'lung'), ('UBERON_0001155', 'colon', 236, 'colon'), ('UBERON_0000310', 'breast', 247, 'breast')]
PMC2290997	4/2008	S115-PMC2290997	['so when you ESTIMATE the number of deaths LIKELY to be attributable to uv light or Vitamin D, it does is not APPEAR TO BE the BEST policy to ADVISE People to simply keep out of the sun just to prevent skin cancer.”\nto maximize protection against cancer, grant RECOMMENDS raising 25(Oh)D levels to between 40 and 60 ng/ml.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 42), ('ANOMALY_CURIOUS_FINDING', 109), ('IMPORTANT_CONSIDERATION', 126), ('FUTURE_WORK', 141), ('FUTURE_WORK', 260)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 148, 'people'), ('CHEBI_71657', 'versiconol acetate', 279, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 279, '25(OH ... D')]
PMC2290997	4/2008	S130-PMC2290997	['“many elderly, ESPECIALLY those living in nursing homes, are Vitamin D deficient, [EVEN] those living in areas CONSIDERED to have adequate sunshine.”\nmany EXPERTS are now RECOMMENDING a middle-ground approach that focuses on modest sun exposures.']	[('IMPORTANT_CONSIDERATION', 15), ('ANOMALY_CURIOUS_FINDING', 83), ('IMPORTANT_CONSIDERATION', 111), ('PROBABLE_UNDERSTANDING', 155), ('FUTURE_WORK', 171)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC2290997	4/2008	S131-PMC2290997	['gilchrest says the american academy of dermatology and MOST dermatologists currently SUGGEST sun protection in combination with Vitamin D supplementation AS a means of minimizing the RISK of both skin cancer and internal cancers.']	[('PROBABLE_UNDERSTANDING', 55), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 154), ('IMPORTANT_CONSIDERATION', 183)]	4	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC2290997	4/2008	S136-PMC2290997	['in the near FUTURE, Vitamin D and health GUIDELINES regarding sun exposure MAY NEED TO BE revised.']	[('FUTURE_WORK', 12), ('IMPORTANT_CONSIDERATION', 41), ('INCOMPLETE_EVIDENCE', 75), ('FUTURE_WORK', 79)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC2290997	4/2008	S182-PMC2290997	['moreover, it is not at all clear WHEN, over a lifetime, sun exposure/Vitamin D is most IMPORTANT.']	[('EXPLICIT_QUESTION', 33), ('IMPORTANT_CONSIDERATION', 87)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC2330139	3/2008	S98-PMC2330139	['the FINDINGS that the most commonly used ds by teens were multivitamins (16%) and Vitamin C (6%) IS REASSURING in terms of POTENTIAL health RISKS.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 100), ('INCOMPLETE_EVIDENCE', 123), ('IMPORTANT_CONSIDERATION', 140)]	5	[('CHEBI_27300', 'vitamin D', 82, 'vitamin C')]
PMC2405769	5/2008	S13-PMC2405769	['background\nmultivitamin-Mineral supplementation is RECOMMENDED before and during Pregnancy to ensure adequate intake of several KEY Nutrients including Folate, iron, and more RECENTLY Vitamin D – all of which have IMPORTANCE among Pregnant women, women of Childbearing age, and during Fetal Development [1-6].']	[('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 128), ('INCOMPLETE_EVIDENCE', 175), ('IMPORTANT_CONSIDERATION', 214)]	4	[('CHEBI_46662', 'mineral', 24, 'mineral'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy'), ('CHEBI_33284', 'nutrient', 132, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 152, 'folate'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 231, 'pregnant'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 256, 'childbearing'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 285, 'fetal development')]
PMC2581757	11/2008	S4-PMC2581757	['THUS, we conclude that the use of Vitamins C and e SHOULD BE CONSIDERED for the Control of certain IMPORTANT biochemical indices during the development of Preeclampsia; HOWEVER, FURTHER STUDIES ARE NEEDED to develop methods for the PREVENTION of Preeclampsia in women at high RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 51), ('FUTURE_WORK', 61), ('IMPORTANT_CONSIDERATION', 61), ('IMPORTANT_CONSIDERATION', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('FUTURE_WORK', 178), ('FUTURE_WORK', 186), ('SUPERFICIAL_RELATIONSHIP', 232), ('IMPORTANT_CONSIDERATION', 276)]	10	[('CHEBI_27300', 'vitamin D', 34, 'vitamins C'), ('PR_000004900', 'complement C3', 43, 'C'), ('GO_0065007', 'biological regulation', 80, 'control'), ('GO_0007128', 'meiotic prophase I', 155, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 246, 'preeclampsia')]
PMC2581757	11/2008	S6-PMC2581757	['a significant reduction in the incidence of Preeclampsia was FOUND in women AT RISK who were taking Vitamins C and E supplements [1].']	[('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 76)]	2	[('GO_0007128', 'meiotic prophase I', 44, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 100, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 115, 'E')]
PMC2581757	11/2008	S10-PMC2581757	['the functional consequence and the POSSIBLE ROLE of the decrease in Plasma Vitamin C reserves in Preeclampsia (pe) are CONSISTENT with the fact that women who Ingested less Vitamin C than the recommended daily allowance (8.5\xa0mg) were at a 2-fold INCREASED risk of developing pe [7].']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 119), ('IMPORTANT_CONSIDERATION', 246)]	4	[('UBERON_0001969', 'blood plasma', 68, 'plasma'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin C'), ('GO_0007128', 'meiotic prophase I', 97, 'preeclampsia'), ('GO_0007631', 'feeding behavior', 159, 'ingested'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin C')]
PMC2581757	11/2008	S36-PMC2581757	['in VIEW of the CONTRADICTORY REPORTS and the SERIOUSNESS of preeclampsia, the PRESENT STUDY included the determination of the activities of catalase, sod, Gpx and Grx in the Blood of normal and Preeclamptic women with and without vitamin treatment, along-with the contents of mda, Gsh, gssg, gssg/Gsh, no and Uric Acid, TO collectively EVALUATE the ROLES of Vitamins C and e in the Regulation of these factors.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 15), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 320), ('QUESTION_ANSWERED_BY_THIS_WORK', 336), ('SUPERFICIAL_RELATIONSHIP', 349)]	8	[('PR_000008210', 'glutathione peroxidase 1', 155, 'GPx'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 163, 'GRx'), ('UBERON_0000178', 'blood', 174, 'blood'), ('GO_0007565', 'female pregnancy', 194, 'preeclamptic'), ('CHEBI_16856', 'glutathione', 281, 'GSH'), ('CHEBI_16856', 'glutathione', 297, 'GSH'), ('CHEBI_27226', 'uric acid', 309, 'uric acid'), ('CHEBI_27300', 'vitamin D', 358, 'vitamins C'), ('GO_0065007', 'biological regulation', 382, 'regulation')]
PMC2581757	11/2008	S45-PMC2581757	['group b initially consisted of a high number of patients who were viewed as being at an INCREASED RISK of preeclampsia BECAUSE of FACTORS such as preeclampsia in a preceding Pregnancy, hellp syndrome, or eclampsia in any past Pregnancy at any Gestational stage, and who were taking additional Vitamin supplement (1000\xa0mg Vitamin C plus 400\xa0iu Vitamin E per day) from the second Trimester of Pregnancy to Delivery as mentioned for the controls (placebo).']	[('IMPORTANT_CONSIDERATION', 88), ('PROBLEM_COMPLICATION', 119), ('SUPERFICIAL_RELATIONSHIP', 130)]	3	[('GO_0007565', 'female pregnancy', 174, 'pregnancy'), ('GO_0007565', 'female pregnancy', 226, 'pregnancy'), ('GO_0007565', 'female pregnancy', 243, 'gestational'), ('CHEBI_33229', 'vitamin (role)', 293, 'vitamin'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 343, 'vitamin E'), ('GO_0009294', 'DNA mediated transformation', 378, 'trimester'), ('GO_0007565', 'female pregnancy', 391, 'pregnancy'), ('GO_0007567', 'parturition', 404, 'delivery')]
PMC2581757	11/2008	S187-PMC2581757	['[1] HAVE REPORTED that a significant reduction in the incidence of Preeclampsia was FOUND in women AT RISK who were taking a Vitamins C and E supplements.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 84), ('IMPORTANT_CONSIDERATION', 99)]	3	[('GO_0007128', 'meiotic prophase I', 67, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 125, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 140, 'E')]
PMC2581757	11/2008	S200-PMC2581757	['THUS, we conclude that use of Vitamins C and E DEFINITELY Controls certain IMPORTANT biochemical indices during the development of Preeclampsia, and that FURTHER STUDIES ARE NEEDED to DEVELOP STRATEGIES for the PREVENTION of Preeclampsia in women at high RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 47), ('IMPORTANT_CONSIDERATION', 75), ('FUTURE_WORK', 154), ('FUTURE_WORK', 162), ('FUTURE_WORK', 184), ('FUTURE_WORK', 192), ('SUPERFICIAL_RELATIONSHIP', 211), ('IMPORTANT_CONSIDERATION', 255)]	9	[('CHEBI_27300', 'vitamin D', 30, 'vitamins C'), ('PR_000004900', 'complement C3', 39, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 45, 'E'), ('GO_0065007', 'biological regulation', 58, 'controls'), ('GO_0007128', 'meiotic prophase I', 131, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 225, 'preeclampsia')]
PMC2582131	11/2008	S12-PMC2582131	['conclusions\nFINDINGS from the PRESENT STUDY SUGGEST that maternal Vitamin D deficiency in early Pregnancy is significantly ASSOCIATED with an elevated RISK for gdm.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 123), ('IMPORTANT_CONSIDERATION', 151)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy')]
PMC2582131	11/2008	S14-PMC2582131	['HOWEVER, the ubiquitous distribution of Intracellular Vitamin D Receptor across diverse Tissues[1]and the EMERGING epidemiological EVIDENCE DOCUMENTING INCREASED RISKS of hypertension[2],[3], Cardiovascular disease[4]–[7], and selected cancers[1],[8]ASSOCIATED with Vitamin D deficiency underscore the pleiotropic actions of Vitamin D. evidence is also accumulating for a ROLE of Vitamin D in maintaining normal Glucose Homeostasis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 250), ('SUPERFICIAL_RELATIONSHIP', 372)]	6	[('GO_0005622', 'intracellular anatomical structure', 40, 'intracellular'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 54, 'vitamin D receptor'), ('UBERON_0000479', 'tissue', 88, 'tissues'), ('UBERON_0004535', 'cardiovascular system', 192, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_17234', 'glucose', 412, 'glucose'), ('GO_0042593', 'glucose homeostasis', 412, 'glucose homeostasis')]
PMC2582131	11/2008	S19-PMC2582131	['it HAS long BEEN KNOWN that Vitamin D deficiency is PREVALENT among Pregnant women[20]–[22].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 52)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnant')]
PMC2582131	11/2008	S84-PMC2582131	['the MAJOR sources of Vitamin D in the body are dietary Vitamin D intake and supplementation as well as Endogenous Production Of Vitamin D in the skin exposed to sunlight.']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0009790', 'embryo development', 103, 'endogenous'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 114, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC2582131	11/2008	S85-PMC2582131	['the biologically active form of Vitamin D is 1,25-[Oh] D. HOWEVER, 25-[Oh] D is REGARDED AS the BEST INDICATOR of Vitamin D status in the body because it is the substrate for the Renal and Nonrenal Production Of 1,25-[Oh] D and has a longer biological half-life and higher concentrations in circulation than 1,25-[Oh] D. Plasma 25-[Oh] D REFLECTS Vitamin D from both endogenous and exogenous sources.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('PROBABLE_UNDERSTANDING', 80), ('PROBABLE_UNDERSTANDING', 89), ('IMPORTANT_CONSIDERATION', 96), ('SUPERFICIAL_RELATIONSHIP', 101), ('PROBABLE_UNDERSTANDING', 338), ('SUPERFICIAL_RELATIONSHIP', 338)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_34300', '2-naphthoyl-CoA', 47, '25-[OH] D'), ('CHEBI_34300', '2-naphthoyl-CoA', 67, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0006260', 'DNA replication', 179, 'renal ...'), ('UBERON_0002113', 'kidney', 179, 'renal'), ('UBERON_0000970', 'eye', 189, 'nonrenal'), ('GO_0030164', 'protein denaturation', 198, 'production of ... OH] D'), ('CHEBI_84441', '13(S)-HOTrE', 212, '1,25-[OH] D'), ('CHEBI_34300', '2-naphthoyl-CoA', 310, '25-[OH] D'), ('UBERON_0001969', 'blood plasma', 321, 'Plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 328, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D')]
PMC2582131	11/2008	S93-PMC2582131	['for instance, Endogenous Production Of Vitamin D In the Skin due to sun exposure is a MAJOR source of Plasma 25-[Oh] D. sun exposure could be positively CORRELATED with outdoor physical activity, a PROTECTIVE FACTOR for Insulin resistance and gdm[32]–[34].']	[('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 153), ('SUPERFICIAL_RELATIONSHIP', 198)]	3	[('GO_0009790', 'embryo development', 14, 'endogenous'), ('GO_1902907', 'proteasome storage granule disassembly', 25, 'production of vitamin D in ... skin'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 102, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 109, '25-[OH] D'), ('PR_000045358', 'insulin family protein', 220, 'insulin')]
PMC2582131	11/2008	S118-PMC2582131	['HOWEVER, DUE TO the PREDISPOSITION of asian, black, and hispanic women for Insulin resistance and Vitamin D deficiency, IT IS POSSIBLE that adequate Vitamin D status MAY BE even more IMPORTANT in these populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 166), ('IMPORTANT_CONSIDERATION', 183)]	6	[('PR_000045358', 'insulin family protein', 75, 'insulin'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC2606998	6/2007	S14-PMC2606998	['maternal Vitamin\u2009D deficiency is SUGGESTED to cause POOR foetal and infant Skeletal growth and mineralization8with consequences for future bone mass9.']	[('INCOMPLETE_EVIDENCE', 33), ('IMPORTANT_CONSIDERATION', 52)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0004288', 'skeleton', 75, 'skeletal')]
PMC2606998	6/2007	S86-PMC2606998	['both Folate and Vitamin\u2009D are CONSIDERED to have PROFOUND EFFECTS on Pregnancy outcome, as well as on maternal health.6,7.']	[('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 49), ('SUPERFICIAL_RELATIONSHIP', 58)]	4	[('CHEBI_30863', '5-azaorotic acid', 5, 'folate'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy')]
PMC2606998	6/2007	S97-PMC2606998	['since the winter, with less light, in sweden is quite long, relatively more Vitamin\u2009D is NEEDED from Food.']	[('IMPORTANT_CONSIDERATION', 89)]	1	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_33290', 'food', 101, 'food')]
PMC2606998	6/2007	S120-PMC2606998	['ACCORDING TO the PRESENT STUDY there is a NEED to expand this FOCUS and include Selenium, Folate and Vitamin\u2009D too.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('FUTURE_WORK', 42), ('IMPORTANT_CONSIDERATION', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 62)]	5	[('CHEBI_27568', 'selenium atom', 80, 'selenium'), ('CHEBI_30863', '5-azaorotic acid', 90, 'folate'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC2642759	1/2009	S311-PMC2642759	["[87] evaluated WHETHER combined Antenatal Corticosteroid and Vitamin K administration has a BENEFIT, over and above that of Corticosteroid OR Vitamin K used alone, in reducing the frequency and the degree of Periventricular-Intraventricular haemorrhage (pivh) in premature newborns of less than 35 weeks' Gestation."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 15), ('IMPORTANT_CONSIDERATION', 92)]	2	[('GO_0007567', 'parturition', 32, 'antenatal'), ('CHEBI_36916', 'cation', 42, 'corticosteroid'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin K'), ('CHEBI_36916', 'cation', 124, 'corticosteroid'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin K'), ('UBERON_0002281', 'vestibular membrane of cochlear duct', 208, 'periventricular'), ('UBERON_0006250', 'infundibular recess of 3rd ventricle', 224, 'intraventricular'), ('GO_0007565', 'female pregnancy', 305, 'gestation')]
PMC2671168	5/2009	S214-PMC2671168	['IN FACT, supplementation with some Micronutrients, such as Vitamins C and e, was ASSOCIATED with INCREASED RISK of low Birth weight[55].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 97)]	3	[('CHEBI_33839', 'macromolecule', 35, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 59, 'vitamins C'), ('PR_000004900', 'complement C3', 68, 'C'), ('GO_0007567', 'parturition', 119, 'birth')]
PMC2679409	5/2009	S477-PMC2679409	['given the POTENTIAL Teratogenic EFFECT and toxicity of high-dose Vitamin A, a variety of Vitamin A INTERVENTIONS (daily supplementation with either low-dose Vitamin A or Β-Carotene) HAVE BEEN evaluated with assessment of SAFETY and IMPACT on maternal, newborn and infant outcomes.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 99), ('INCOMPLETE_EVIDENCE', 182), ('IMPORTANT_CONSIDERATION', 221), ('SUPERFICIAL_RELATIONSHIP', 232)]	6	[('CHEBI_50905', 'teratogenic agent', 20, 'teratogenic'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 170, 'β-carotene')]
PMC2679409	5/2009	S500-PMC2679409	['ANY FUTURE STUDIES of Vitamin A supplementation MUST FOCUS on HIGH-RISK women, assess the most APPROPRIATE Vitamin type and dosage, and show that the intervention is both SAFE for the mother and fetus, and EFFECTIVE.']	[('IMPORTANT_CONSIDERATION', 0), ('FUTURE_WORK', 4), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 62), ('IMPORTANT_CONSIDERATION', 95), ('IMPORTANT_CONSIDERATION', 171), ('SUPERFICIAL_RELATIONSHIP', 206)]	8	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 107, 'vitamin')]
PMC2685863	5/2009	S1-PMC2685863	['dietary Vitamin D intake HAS BEEN ASSOCIATED with lower ms risk, and Vitamin D deficiency HAS BEEN ASSOCIATED with INCREASED RISK, BUT direct LINKS between Vitamin D and ms have NOT BEEN IDENTIFIED.']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 99), ('IMPORTANT_CONSIDERATION', 115), ('ANOMALY_CURIOUS_FINDING', 131), ('SUPERFICIAL_RELATIONSHIP', 142), ('FULL_UNKNOWN', 178)]	8	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC2685863	5/2009	S13-PMC2685863	['the authors PROPOSE that Vitamin D supplementation at CRITICAL periods during Pregnancy and early childhood MIGHT reduce the RISK for developing ms—a VIEW endorsed by bruce hollis, a nutritional biochemist and professor of pediatrics at the medical university of south carolina.']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 54), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 125), ('INCOMPLETE_EVIDENCE', 150)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy')]
PMC2685863	5/2009	S14-PMC2685863	['WHEREAS the institute of medicine RECOMMENDS 200 international units of Vitamin D per day (iu/day) for People under age 50, including Pregnant and Lactating women and infants, hollis wrote in the december 2007 issue of the journal of bone and Mineral research that as much as 6,000 iu/day MIGHT be NEEDED to maintain adequate Blood levels of the Vitamin in these populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 34), ('INCOMPLETE_EVIDENCE', 289), ('FUTURE_WORK', 298), ('IMPORTANT_CONSIDERATION', 298)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 103, 'people'), ('GO_0007565', 'female pregnancy', 134, 'pregnant'), ('GO_0007594', 'puparial adhesion', 147, 'lactating'), ('CHEBI_46662', 'mineral', 243, 'Mineral'), ('UBERON_0000178', 'blood', 326, 'blood'), ('CHEBI_33229', 'vitamin (role)', 346, 'vitamin')]
PMC2716336	7/2009	S162-PMC2716336	['HOWEVER, because Vitamin C is Water-soluble and heat labile, RECOMMENDATIONS MUST STRESS the IMPORTANCE of the retention of Vitamin C during Food Preparation and cooking.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 61), ('IMPORTANT_CONSIDERATION', 77), ('IMPORTANT_CONSIDERATION', 93)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin C'), ('CHEBI_15377', 'water', 30, 'water'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin C'), ('CHEBI_33290', 'food', 141, 'food'), ('GO_0007631', 'feeding behavior', 141, 'food preparation')]
PMC2722583	1/2009	S117-PMC2722583	['iron deficiency is an IMPORTANT RISK FACTOR for increased maternal mortality, low Birth weight and Preterm Delivery (brabin et al 2001) and the availability of calcium, Iodine, Folate and Vitamins A and D MAY Modulate fetal development (bartley et al 2005).']	[('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 205)]	3	[('GO_0007567', 'parturition', 82, 'birth'), ('GO_0007565', 'female pregnancy', 99, 'preterm'), ('GO_0007567', 'parturition', 107, 'delivery'), ('CHEBI_24859', 'iodine atom', 169, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 177, 'folate'), ('CHEBI_27300', 'vitamin D', 188, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 203, 'D'), ('GO_0065007', 'biological regulation', 209, 'modulate')]
PMC2779500	11/2009	S44-PMC2779500	['THESE FINDINGS, among others, UNDOUBTEDLY necessitate CONCERN, and have led authors to QUESTION the benefits of universal Vitamin A supplementation for women in hiv-endemic areas [30,31].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 30), ('IMPORTANT_CONSIDERATION', 54), ('PROBLEM_COMPLICATION', 54), ('EXPLICIT_QUESTION', 87)]	5	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A')]
PMC2779500	11/2009	S118-PMC2779500	['moreover, SINCE Ascorbic Acid (Vitamin C) HAS BEEN cited as a KEY H2O2Scavenging antioxidant [40], we use it as our antioxidant for the purpose of parameter estimation.']	[('PROBLEM_COMPLICATION', 10), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 62)]	3	[('CHEBI_22652', 'ascorbic acid', 16, 'ascorbic acid'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin C'), ('CHEBI_74359', 'L-alpha-aminobutyrate zwitterion', 66, 'H2O2scavenging')]
PMC2798111	12/2010	S14-PMC2798111	['introduction\namong breastfed infants, the RISK of Vitamin D deficiency is SIGNIFICANT [1,2].']	[('IMPORTANT_CONSIDERATION', 42), ('IMPORTANT_CONSIDERATION', 74)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC2798111	12/2010	S16-PMC2798111	["Human Milk's total Vitamin D or its antirachitic activity obtained from mothers receiving 400\u2009iu/day TYPICALLY contains 33–68\u2009iu/l, far below the ESTIMATED daily infant REQUIREMENT of 400\u2009iu/l [3–5], the NECESSARY level for the PREVENTION of rickets [1]."]	[('PROBABLE_UNDERSTANDING', 101), ('INCOMPLETE_EVIDENCE', 146), ('IMPORTANT_CONSIDERATION', 169), ('IMPORTANT_CONSIDERATION', 204), ('SUPERFICIAL_RELATIONSHIP', 228)]	5	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('UBERON_0001913', 'milk', 6, 'milk'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC2798111	12/2010	S17-PMC2798111	['THEREFORE, Oral supplementation or sufficient sun exposure is NECESSARY to ensure adequate Vitamin D status for proper calcium absorption and bone mineralization [3–6].RECENT RESEARCH has also LINKED Vitamin D to Innate Immunity [7–9].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 62), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 193)]	4	[('UBERON_0000165', 'mouth', 11, 'oral'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('GO_0045087', 'innate immune response', 213, 'innate immunity')]
PMC2798111	12/2010	S19-PMC2798111	['with THIS KNOWLEDGE, IT IS CLEAR that Vitamin D supplementation of the breastfedinfant is NECESSARY and RECOMMENDED by the american academy of pediatrics and the canadian pediatrics society [5,25].']	[('PROBABLE_UNDERSTANDING', 5), ('PROBABLE_UNDERSTANDING', 21), ('IMPORTANT_CONSIDERATION', 90), ('FUTURE_WORK', 104)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC2798111	12/2010	S25-PMC2798111	['while the parent randomized clinical trial will not be completed until 2011, it is ESSENTIAL to report PRELIMINARY DATA on the EFFECTIVENESS of one drop per day dosing of Vitamin D to aid clinicians in their decision-making process concerning Vitamin D preparations for infants.']	[('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC2798111	12/2010	S90-PMC2798111	['discussion\nbecause the PRELIMINARY results of this arm of the trial are IMPORTANT for decision-making in the current clinical environment, we report HERE the interim results of an ONGOING Vitamin D supplementation TRIAL of Lactating women and their infants.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 72), ('QUESTION_ANSWERED_BY_THIS_WORK', 149), ('IMPORTANT_CONSIDERATION', 180), ('INCOMPLETE_EVIDENCE', 214)]	5	[('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 223, 'lactating')]
PMC2798111	12/2010	S95-PMC2798111	['WHILE not powered to assess SAFETY at this juncture, it is IMPORTANT TO NOTE that, thus FAR, there HAVE BEEN no increased rates of infection in the infants or adverse health EFFECTS that COULD BE ATTRIBUTED to Vitamin D supplementation in this cohort.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 28), ('IMPORTANT_CONSIDERATION', 59), ('ANOMALY_CURIOUS_FINDING', 88), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 196)]	8	[('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC2798111	12/2010	S96-PMC2798111	['another IMPORTANT finding in THIS STUDY is that the majority of infants enrolled in this cohort of exclusively Breastfed infants had Vitamin D deficiency (defined as circulating 25(Oh)D levels <20\u2009ng/ml) at one month of age.']	[('IMPORTANT_CONSIDERATION', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 29)]	2	[('GO_0007567', 'parturition', 111, 'breastfed'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 181, 'OH)D')]
PMC2798111	12/2010	S98-PMC2798111	['UNTIL it can be determined WHAT amount of Vitamin D supplementation in mothers will effectively and SAFELY increase and/or maintain the Vitamin D status in her breastfed infant, we MUST rely on Vitamin D supplementation of the infant to prevent deficiency.']	[('FUTURE_WORK', 0), ('EXPLICIT_QUESTION', 27), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 181)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC2821652	2/2010	S21-PMC2821652	['INTERESTINGLY, there APPEARS TO BE LITTLE, if ANY, RELATIONSHIP with respect to the parent Vitamin, Vitamin D [11].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 21), ('INCOMPLETE_EVIDENCE', 35), ('IMPORTANT_CONSIDERATION', 46), ('SUPERFICIAL_RELATIONSHIP', 51)]	5	[('CHEBI_33229', 'vitamin (role)', 91, 'vitamin'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC2821652	2/2010	S30-PMC2821652	['these aspects of Calcium and Vitamin D Metabolism are IMPORTANT in the understanding of Vitamin D sufficiency during Pregnancy and the PREMISE that the REQUIREMENTS of Vitamin D are stable throughout Gestation.']	[('IMPORTANT_CONSIDERATION', 54), ('INCOMPLETE_EVIDENCE', 135), ('IMPORTANT_CONSIDERATION', 152)]	3	[('GO_0051216', 'cartilage development', 17, 'calcium ...'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 29, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('GO_0007565', 'female pregnancy', 200, 'gestation')]
PMC2831604	1/2010	S79-PMC2831604	["the POTENTIAL for adverse events on medium to high dose ics is USUALLY LIMITED to a small reduction in growth velocity of approximately 1 cm in the first year of treatment which is not progressive over time and can be measured by a stadiometer.20,21\nin children who are REQUIRED to receive high dose Corticosteroids, age appropriate dietary Intake of Calcium and Vitamin D SHOULD BE reviewed with the child's care givers (evidence d) and slit lamp Eye examination and bone densitometry SHOULD BE CONSIDERED (evidence d)."]	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 270), ('FUTURE_WORK', 373), ('FUTURE_WORK', 486), ('IMPORTANT_CONSIDERATION', 486), ('FUTURE_WORK', 496)]	8	[('CHEBI_50850', 'etabonate ester', 300, 'corticosteroids'), ('GO_0007631', 'feeding behavior', 341, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 351, 'calcium'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('UBERON_0000970', 'eye', 448, 'eye')]
PMC2841444	2/2010	S11-PMC2841444	['the following are SUPPORTED by moderate- to high-quality evidence and STRONGLY RECOMMENDED for lmics:\n• two INTERVENTIONS PREVENT Preterm Births—smoking cessation and Progesterone\n• eight INTERVENTIONS PREVENT stillbirths—balanced protein energy supplementation, screening and treatment of syphilis, intermittant presumptive treatment for malaria during Pregnancy, Insecticide-treated mosquito nets, Birth preparedness, emergency obstetric care, cesarean section for breech presentation, and elective induction for post-term Delivery\n• eleven INTERVENTIONS improve survival of Preterm newborns—prophylactic Steroids in Preterm labor, Antibiotics for prom, Vitamin K supplementation at Delivery, case management of neonatal sepsis and pneumonia, delayed Cord clamping, room air (vs. 100% oxygen) for resuscitation, hospital-based kangaroo mother care, early breastfeeding, thermal care, and Surfactant therapy and application of continued distending pressure to the Lungs for Respiratory Distress syndrome\n\nconclusion\nthe research paradigm for discovery science and intervention development MUST BE BALANCED to address PREVENTION as well as improve morbidity and mortality in all settings.']	[('INCOMPLETE_EVIDENCE', 18), ('PROBABLE_UNDERSTANDING', 70), ('FUTURE_WORK', 79), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 543), ('IMPORTANT_CONSIDERATION', 1090), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1098), ('SUPERFICIAL_RELATIONSHIP', 1118)]	11	[('GO_0007565', 'female pregnancy', 130, 'preterm births'), ('CHEBI_17026', 'progesterone', 167, 'progesterone'), ('GO_0007565', 'female pregnancy', 354, 'pregnancy'), ('CHEBI_24852', 'insecticide', 365, 'insecticide'), ('GO_0007567', 'parturition', 400, 'birth'), ('GO_0007567', 'parturition', 525, 'delivery'), ('GO_0007565', 'female pregnancy', 577, 'preterm'), ('CHEBI_35341', 'steroid', 607, 'steroids'), ('GO_0007565', 'female pregnancy', 619, 'preterm'), ('CHEBI_33282', 'antibacterial agent', 634, 'antibiotics'), ('CHEBI_27300', 'vitamin D', 656, 'vitamin K'), ('GO_0007567', 'parturition', 685, 'delivery'), ('UBERON_0002240', 'spinal cord', 753, 'cord'), ('CHEBI_35195', 'surfactant', 890, 'surfactant'), ('UBERON_0002048', 'lung', 965, 'lungs'), ('UBERON_0003495', 'respiratory system arteriole', 975, 'respiratory distress')]
PMC2841444	2/2010	S481-PMC2841444	['preterm infants are deficient in Vitamin A due to INADEQUATE Hepatic stores and the inability to tolerate routine Oral supplementation [243,244].']	[('IMPORTANT_CONSIDERATION', 50)]	1	[('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('UBERON_0002107', 'liver', 61, 'hepatic'), ('UBERON_0000165', 'mouth', 114, 'oral')]
PMC2841444	2/2010	S491-PMC2841444	['antenatal and Postnatal Vitamin K supplementation in preterm infants\nVitamin K is a fat-soluble Vitamin CRUCIAL to the Production Of many Proteins INVOLVED with the Coagulation Process.']	[('IMPORTANT_CONSIDERATION', 104), ('SUPERFICIAL_RELATIONSHIP', 147)]	2	[('GO_0007567', 'parturition', 14, 'postnatal'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin K'), ('CHEBI_28384', 'vitamin K', 69, 'Vitamin K'), ('CHEBI_33229', 'vitamin (role)', 96, 'vitamin'), ('GO_0006412', 'translation', 119, 'production of ... proteins'), ('GO_0050817', 'coagulation', 165, 'coagulation process')]
PMC2841444	2/2010	S494-PMC2841444	['a cochrane review [250] evaluated five randomized or quasi-randomized trials of Vitamin K administered parenterally or orally to women AT RISK of imminent Preterm Birth, none of which were from lmics.']	[('IMPORTANT_CONSIDERATION', 135)]	1	[('CHEBI_27300', 'vitamin D', 80, 'vitamin K'), ('GO_0007565', 'female pregnancy', 155, 'preterm birth')]
PMC2841444	2/2010	S499-PMC2841444	['although the quality of the trials is variable and FURTHER STUDIES ARE NEEDED, these data SUGGEST a POSSIBLE ROLE for Antenatal maternal Vitamin K administration as a means of reducing RISKS of pvh and mortality in preterm infants.']	[('FUTURE_WORK', 51), ('FUTURE_WORK', 59), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 185)]	6	[('GO_0007567', 'parturition', 118, 'antenatal'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin K')]
PMC2841444	2/2010	S501-PMC2841444	['the STRONGEST EVIDENCE from high-income countries comes from periods in which CONCERNS about the SAFETY of Vitamin K led to its reduced use in newborns; these periods were followed by increased incidence of hemorrhagic disorders [252].']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 78), ('IMPORTANT_CONSIDERATION', 97)]	3	[('CHEBI_27300', 'vitamin D', 107, 'vitamin K')]
PMC2872349	4/2010	S146-PMC2872349	['this is an IDEAL platform on which TO INVESTIGATE epigenetic Modulation Of Placental Calcium Transport, PARTICULARLY the ROLE of Vitamin D. this SHOULD improve our understanding of the processes INVOLVED in developing osteoporosis, and POTENTIALLY provide a focus for interventions to avert DETRIMENTAL processes by INFLUENCING maternal dietary habits.']	[('IMPORTANT_CONSIDERATION', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('IMPORTANT_CONSIDERATION', 104), ('SUPERFICIAL_RELATIONSHIP', 121), ('FUTURE_WORK', 145), ('SUPERFICIAL_RELATIONSHIP', 195), ('INCOMPLETE_EVIDENCE', 236), ('IMPORTANT_CONSIDERATION', 291), ('SUPERFICIAL_RELATIONSHIP', 316)]	9	[('GO_0061724', 'lipophagy', 61, 'modulation of'), ('GO_0006813', 'potassium ion transport', 75, 'placental calcium transport'), ('UBERON_0001987', 'placenta', 75, 'placental'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC2874518	6/2010	S111-PMC2874518	['women in our cohort were receiving adequate amounts of these Micronutrients from their diet alone, as assessed by the 24-hour dietary Recall (table 2), confirming the inverse Supplement HYPOTHESIS, that women who least NEED Supplements are most LIKELY to take them.22\nOTHER STUDIES have SUGGESTED POTENTIAL adverse EFFECTS of SOME Supplements, specifically those containing antioxidant Vitamins such as Vitamins C and E, on Pregnancy outcome when taken by women with adequate dietary Micronutrient intake.']	[('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 219), ('PROBABLE_UNDERSTANDING', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 268), ('INCOMPLETE_EVIDENCE', 268), ('INCOMPLETE_EVIDENCE', 287), ('INCOMPLETE_EVIDENCE', 297), ('SUPERFICIAL_RELATIONSHIP', 315), ('INCOMPLETE_EVIDENCE', 326)]	9	[('CHEBI_33839', 'macromolecule', 61, 'micronutrients'), ('GO_0060033', 'anatomical structure regression', 134, 'recall'), ('CHEBI_16158', 'steroid sulfate', 175, 'supplement'), ('CHEBI_33341', 'titanium atom', 224, 'supplements'), ('CHEBI_33341', 'titanium atom', 331, 'supplements'), ('CHEBI_33277', 'gamma-tocotrienol', 386, 'vitamins'), ('CHEBI_27300', 'vitamin D', 403, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 418, 'E'), ('GO_0007565', 'female pregnancy', 424, 'pregnancy'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 484, 'micronutrient')]
PMC2874518	6/2010	S114-PMC2874518	['ANOTHER STUDY FOUND that use of supplements for Vitamins C and E was ASSOCIATED with an INCREASED RISK of premature rupture of membranes.24unfortunately, this information was NOT RECORDED in our study.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 69), ('IMPORTANT_CONSIDERATION', 88), ('FULL_UNKNOWN', 175)]	5	[('CHEBI_27300', 'vitamin D', 48, 'vitamins C'), ('PR_000004900', 'complement C3', 57, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 63, 'E')]
PMC2874518	6/2010	S121-PMC2874518	['the PATTERN of dietary supplement use in our cohort, with most women taking Supplements (mainly Folic Acid) in the first Trimester, is expected because there is no national RECOMMENDATION in england for routine Supplement-taking during Pregnancy apart from Folic Acid in the first trimester and Vitamin D for Pregnant women in ‘high-RISK’ groups.30there is no national RECOMMENDATION to take multivitamin and Mineral supplements at any stage during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FUTURE_WORK', 173), ('IMPORTANT_CONSIDERATION', 333), ('FUTURE_WORK', 369)]	4	[('CHEBI_33341', 'titanium atom', 76, 'supplements'), ('CHEBI_30751', 'formic acid', 96, 'folic acid'), ('GO_0009294', 'DNA mediated transformation', 121, 'trimester'), ('CHEBI_16158', 'steroid sulfate', 211, 'supplement'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy'), ('CHEBI_30751', 'formic acid', 257, 'folic acid'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D'), ('GO_0007565', 'female pregnancy', 309, 'pregnant'), ('CHEBI_46662', 'mineral', 409, 'mineral'), ('GO_0007565', 'female pregnancy', 449, 'pregnancy')]
PMC2889879	5/2010	S139-PMC2889879	['it HAS BEEN HYPOTHESISED that Vitamin D INSUFFICIENCY COULD account for SOME of the increased risk of schizophrenia OBSERVED among dark-skinned immigrants moving to countries with less sun exposure [12].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 116)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC2889879	5/2010	S141-PMC2889879	['our results of a PROTECTIVE EFFECT of Vitamin D intake MUST BE CONSIDERED AS ROUGH, SINCE we ONLY measure the dietary intake of Vitamin D. a more complete picture of the Vitamin D status COULD have been supplied through Vitamin D levels in Blood; HOWEVER, NO biological samples are AVAILABLE.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 63), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 77), ('PROBLEM_COMPLICATION', 84), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 187), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('FULL_UNKNOWN', 256)]	11	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('UBERON_0000178', 'blood', 240, 'blood')]
PMC2889879	5/2010	S146-PMC2889879	['our results of the PROTECTIVE EFFECT of fatty fish COULD IN PART be due to the content of Vitamin D. WHILE the epidemiological EVIDENCE LINKING low Prenatal Vitamin D and schizophrenia REMAINS INCONCLUSIVE, Rodent MODELS have provided COMPELLING EVIDENCE about the ROLE of Vitamin D deficiency for Brain Development like larger lateral volumes [36], subtle Memory dysfunction and altered attention processing [37] which have IMPLICATIONS for neuropsychiatric disorders.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('INCOMPLETE_EVIDENCE', 235), ('SUPERFICIAL_RELATIONSHIP', 265), ('IMPORTANT_CONSIDERATION', 425)]	13	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'prenatal'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 207, 'rodent'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('GO_0007420', 'brain development', 298, 'brain development'), ('UBERON_0000955', 'brain', 298, 'brain'), ('GO_0007613', 'memory', 357, 'memory')]
PMC2889879	5/2010	S177-PMC2889879	['in terms of GENERALISABILITY of our results it is RELEVANT TO compare the levels of dietary Intake of Pufas and Vitamin D in our cohort to other populations.']	[('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('GO_0007631', 'feeding behavior', 92, 'intake'), ('CHEBI_86926', 'S a S b S', 102, 'PUFAs'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC2889879	5/2010	S182-PMC2889879	['it is RELEVANT TO NOTE that in sweden low-fat dairy products and Margarines are fortified with Vitamin D. OTHERWISE the dietary intake of Vitamin D WOULD BE lower.']	[('IMPORTANT_CONSIDERATION', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('FUTURE_PREDICTION', 148)]	3	[('CHEBI_25140', 'maltodextrin', 65, 'margarines'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC2889879	5/2010	S196-PMC2889879	['UNFORTUNATELY, we DO NOT HAVE information about specific Vitamin D supplementation.']	[('IMPORTANT_CONSIDERATION', 0), ('FULL_UNKNOWN', 18)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC2913107	8/2010	S1-PMC2913107	['subsequently, the title of an article in scientific american RECENTLY ASKED, ‘WHAT IF Vitamin D deficiency is a cause of autism?’ (3) since then, an ARTICLE on Vitamin D and autism in acta paediatrica (4) and the accompanying COMMENTARY (5) have added to the ACCELERATING SUSPICION that Vitamin D deficiency – EITHER during Pregnancy OR early childhood – MAY BE an environmental TRIGGER for the Genetic disease of autism.']	[('INCOMPLETE_EVIDENCE', 61), ('EXPLICIT_QUESTION', 70), ('EXPLICIT_QUESTION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('EXPLICIT_QUESTION', 127), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 226), ('IMPORTANT_CONSIDERATION', 259), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 272), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 310), ('INCOMPLETE_EVIDENCE', 355), ('SUPERFICIAL_RELATIONSHIP', 379)]	12	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('SO_0000704', 'gene', 395, 'genetic')]
PMC2913107	8/2010	S8-PMC2913107	['a 2008 REVIEW DETAILED the DEVASTATING EFFECT Gestational Vitamin D deficiency has on developing Mammalian Brains (7).']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 27), ('SUPERFICIAL_RELATIONSHIP', 39)]	4	[('GO_0007565', 'female pregnancy', 46, 'gestational'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('NCBITaxon_40674', 'Mammalia', 97, 'mammalian'), ('UBERON_0000955', 'brain', 107, 'brains')]
PMC2913107	8/2010	S9-PMC2913107	['UNFORTUNATELY, the tiny 10 μg (400 iu) dose in Prenatal Vitamins is VIRTUALLY IRRELEVANT in PREVENTING the current EPIDEMIC of Gestational Vitamin D deficiency (8).']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 68), ('IMPORTANT_CONSIDERATION', 78), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 115)]	5	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 56, 'vitamins'), ('GO_0007565', 'female pregnancy', 127, 'gestational'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC2913107	8/2010	S10-PMC2913107	['FOR THIS REASON, in 2007, the canadian paediatric society CAUTIONED Pregnant women they MAY REQUIRE NOT 400 iu/day BUT 2000 iu/day, or more, to PREVENT Gestational Vitamin D deficiency (9).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 58), ('INCOMPLETE_EVIDENCE', 88), ('IMPORTANT_CONSIDERATION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('SUPERFICIAL_RELATIONSHIP', 144)]	6	[('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('GO_0007565', 'female pregnancy', 152, 'gestational'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC2913107	8/2010	S11-PMC2913107	['IF adequate amounts of Vitamin D PREVENT autism, one WOULD EXPECT children with rickets to have an INCREASED RISK of autism.']	[('FUTURE_PREDICTION', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('FUTURE_PREDICTION', 53), ('FUTURE_PREDICTION', 59), ('IMPORTANT_CONSIDERATION', 99)]	5	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC2913107	8/2010	S15-PMC2913107	['even more INTRIGUING, BOTH PAPERS REPORT that the mental condition in rickets IMPROVED with Vitamin D.\nANOTHER of the MYSTERIES of autism is the APPARENT INCREASED INCIDENCE of autism in the children of richer college-educated parents, ESPECIALLY women, a FINDING announced a few months ago (12).']	[('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('FULL_UNKNOWN', 118), ('ANOMALY_CURIOUS_FINDING', 145), ('IMPORTANT_CONSIDERATION', 154), ('ANOMALY_CURIOUS_FINDING', 236), ('INCOMPLETE_EVIDENCE', 256)]	11	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC2913107	8/2010	S37-PMC2913107	['WHILE the Omega-3 and mercury content of fish is WELL KNOWN, LESS WELL KNOWN is THE FACT THAT fish is one of the few Foods with SIGNIFICANT amounts of Vitamin D, which, as referenced earlier, PROTECTS the Genome from damage by Toxins.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 49), ('INCOMPLETE_EVIDENCE', 61), ('ANOMALY_CURIOUS_FINDING', 80), ('IMPORTANT_CONSIDERATION', 128), ('SUPERFICIAL_RELATIONSHIP', 192)]	6	[('CHEBI_79370', 'ibho#10', 10, 'omega-3'), ('CHEBI_33290', 'food', 117, 'foods'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('SO_0001026', 'genome', 205, 'genome'), ('CHEBI_27026', 'toxin', 227, 'toxins')]
PMC2913107	8/2010	S41-PMC2913107	['a comment to the authors (20) DETAILED the EVIDENCE that Antiepileptic Drugs are one of the few classes of Drugs that CONSISTENTLY and SIGNIFICANTLY INTERFERE with Vitamin D Metabolism, lowering 25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 43), ('PROBABLE_UNDERSTANDING', 118), ('IMPORTANT_CONSIDERATION', 135), ('SUPERFICIAL_RELATIONSHIP', 149)]	5	[('CHEBI_35218', 'anthocyanin cation', 57, 'antiepileptic'), ('CHEBI_23888', 'drug', 71, 'drugs'), ('CHEBI_23888', 'drug', 107, 'drugs'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0008152', 'metabolic process', 174, 'metabolism'), ('CHEBI_71657', 'versiconol acetate', 195, '25(OH)D')]
PMC2913107	8/2010	S46-PMC2913107	['indeed, without the Genetic TENDENCY for autism, i SUSPECT that SEVERE maternal or early childhood Vitamin D deficiency MAY cause bone abnormalities, as referenced above, with no evidence autism.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 64), ('FUTURE_PREDICTION', 120)]	4	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC2913107	8/2010	S47-PMC2913107	['all that the current EPIDEMIC of maternal and early childhood Vitamin D deficiency does, with its resultant neural deficiency in the pluripotent Neurosteroid Calcitriol, is to ALLOW the Genetic TENDENCY for autism to Express itself.']	[('IMPORTANT_CONSIDERATION', 21), ('FUTURE_PREDICTION', 176), ('SUPERFICIAL_RELATIONSHIP', 194)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_47838', 'nitrile oxide', 145, 'neurosteroid'), ('CHEBI_17823', 'calcitriol', 158, 'calcitriol'), ('SO_0000704', 'gene', 186, 'genetic'), ('GO_0010467', 'gene expression', 217, 'express')]
PMC2913107	8/2010	S48-PMC2913107	['IF this THEORY is TRUE, the PATH TOWARDS EFFECTIVE PREVENTION – and PERHAPS a treatment EFFECT IF ADEQUATE physiological doses of Vitamin D are given – is so SIMPLE, so SAFE, so INEXPENSIVE, so READILY AVAILABLE and so easy, that it DEFIES IMAGINATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18), ('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 95), ('IMPORTANT_CONSIDERATION', 98), ('IMPORTANT_CONSIDERATION', 158), ('IMPORTANT_CONSIDERATION', 169), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 194), ('ANOMALY_CURIOUS_FINDING', 233)]	15	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC2913107	8/2010	S49-PMC2913107	['seventeen Vitamin D EXPERTS RECENTLY STATED, ‘IN OUR OPINION, children with chronic illnesses such as autism, diabetes and/or frequent infections SHOULD BE supplemented with higher doses of sunshine or Vitamin D3, doses ADEQUATE to maintain their 25(Oh)D levels in the mid-normal of the reference range [65 ng/ml (162 nmol/l)] – and SHOULD BE so supplemented year round.’ (22)\nfinally, IF TRUE, a DARKER SIDE of the THEORY EMERGES.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 146), ('IMPORTANT_CONSIDERATION', 220), ('IMPORTANT_CONSIDERATION', 333), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 386), ('PROBABLE_UNDERSTANDING', 389), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 397), ('INCOMPLETE_EVIDENCE', 416), ('INCOMPLETE_EVIDENCE', 423)]	12	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 202, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 202, 'vitamin D3'), ('CHEBI_71657', 'versiconol acetate', 247, '25(OH)D')]
PMC2963768	10/2010	S0-PMC2963768	['Vitamin D status of infants in northeastern rural bangladesh: preliminary observations and a review of potential determinants\n\nabstract\nVitamin D deficiency is a GLOBAL PUBLIC-HEALTH CONCERN, EVEN in tropical regions where the risk of deficiency was PREVIOUSLY ASSUMED to be low due to cutaneous Vitamin D Synthesis stimulated by exposure to sun.']	[('IMPORTANT_CONSIDERATION', 162), ('ANOMALY_CURIOUS_FINDING', 192), ('INCOMPLETE_EVIDENCE', 250), ('PROBABLE_UNDERSTANDING', 261)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 136, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 296, 'vitamin D synthesis')]
PMC2963768	10/2010	S1-PMC2963768	['POOR Vitamin D status, INDICATED by low Serum concentrations of 25-Hydroxyvitamin D [25(Oh)D], HAS BEEN observed in south asian populations.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('UBERON_0001977', 'blood serum', 40, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 64, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D')]
PMC2963768	10/2010	S10-PMC2963768	['in conclusion, the Vitamin D status in young infants in rural sylhet, bangladesh, was poorer than MIGHT be expected based on geographic CONSIDERATIONS.']	[('INCOMPLETE_EVIDENCE', 98), ('IMPORTANT_CONSIDERATION', 136)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC2963768	10/2010	S12-PMC2963768	['introduction\nthroughout most of the previous century, Vitamin D deficiency and rickets were predominantly PERCEIVED as PROBLEMS of industrialized countries at northern latitudes, where insufficient exposure to sun and intake of Vitamin D were LINKED to INADEQUATE Intestinal absorption of Calcium and impaired Skeletal mineralization (1).']	[('PROBABLE_UNDERSTANDING', 106), ('IMPORTANT_CONSIDERATION', 119), ('SUPERFICIAL_RELATIONSHIP', 243), ('IMPORTANT_CONSIDERATION', 253)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('UBERON_0000160', 'intestine', 264, 'intestinal'), ('CHEBI_22313', 'alkaline earth metal atom', 289, 'calcium'), ('UBERON_0004288', 'skeleton', 310, 'skeletal')]
PMC2963768	10/2010	S13-PMC2963768	['HOWEVER, SINCE Vitamin D status has become READILY estimable BASED on Serum/Plasma 25-Hydroxyvitamin D concentration [25(Oh)D] (2), epidemiologic RESEARCH aimed at identifying PREVIOUSLY-UNCHARACTERIZED AT-risk populations and characterizing NOVEL disease ASSOCIATIONS with Vitamin D status HAS BEEN greatly facilitated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('PROBABLE_UNDERSTANDING', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('FUTURE_WORK', 146), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 187), ('IMPORTANT_CONSIDERATION', 203), ('FULL_UNKNOWN', 242), ('SUPERFICIAL_RELATIONSHIP', 256), ('INCOMPLETE_EVIDENCE', 291)]	11	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('UBERON_0001969', 'blood plasma', 76, 'plasma'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 83, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC2963768	10/2010	S14-PMC2963768	['THUS, Vitamin D deficiency has re-emerged as a GLOBAL PUBLIC-HEALTH CONCERN and is now presumptively LINKED to a range of infectious, inflammatory and neoplastic diseases throughout the Life Course and around the world (1).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 101)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0001281', 'hepatic sinusoid', 186, 'life course')]
PMC2963768	10/2010	S19-PMC2963768	["summary of studies of Vitamin D status of infants and children aged 1 month to <5 years in bangladesh, pakistan, and indiastudyparticipantslocationlatitudeseasonno.mean 25(Oh)d (nmol/l)categorical descriptions of Vitamin D statuscombs et al ., 2008 (9)aged 1-5 years; no clinical signs of ricketschakaria subdistrict, cox's bazar, bangladesh21°nunknown15868.3\n25(Oh)D <25 nmol/l in 6% (10/158)\n25(Oh)D <37.5 nmol/l in 21% (33/158)fischer et al ., 1999 (10)cases in case-control study of rickets; aged 10-120 monthschakaria subdistrict, bangladesh21°nunknown1450\nrange 17.5-162.5 nmol/l\n25(Oh)D <35 nmol/l in 2/14 (14%).controlschakaria subdistrict, bangladesh21°nunknown1362.5\nrange 55-87.5 nmol/l\nnone with 25(Oh)D <35 nmol/latiq et al ., 1998 (11)aged 6 weeks-11 months; immunization clinickarachi, pakistan25°nnovember-march2324.5\n25(Oh)D <25 nmol/l in 52% (throughout the year)april-october4840.7agarwal et al ., 2002 (12)aged 9-24 months; high-pollution areamorigate, delhi, india28°nmarch-april2631\n25(oh)d <30 nmol/l in 35%aged 9-24 months; low-pollution areagurgaon, delhi, india28°nmarch-april3168\n25(Oh)D <30 nmol/l in 0%bhalala et al ., 2007 (13)healthy breastfed infants aged 3 monthsmumbai, india18°nthroughout the year3545.5\n25(Oh)D <62.5 nmol/l in 80%tiwari and puliyel, 2004 (14)aged 9-30 months living in impoverished neighbourhoodssundernagari, delhi, india28°njanuary4796.3\n25(Oh)D <35 nmol/l in 2%rajiv colony, delhi, india28°nfebruary4923.8\n25(Oh)D <35nmol/l in 82.9%rajiv colony, delhi, india28°naugust4817.8\n25(Oh)D <35 nmol/l in 84.0%gurgaon, delhi, india28°naugust5219.2\n25(Oh)D <35 nmol/l in 82.0%wayse et al ., 2004 (15)healthy controls in case-control study; aged <5 yearsindapur, india17°nmay-june7038.4\n25(Oh)D <22.5 nmol/l in 31%\n25(Oh)D <50 nmol/l in 61%\nknowledge of the Vitamin D status of young children and infants IS NEEDED to DESIGN STUDIES targeting the aetiologic mechanisms and POTENTIAL health IMPLICATIONS of deficiency."]	[('FUTURE_WORK', 1851), ('FUTURE_WORK', 1864), ('INCOMPLETE_EVIDENCE', 1919), ('IMPORTANT_CONSIDERATION', 1936)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_37972', 'phosphorus-32 atom', 169, '25'), ('CHEBI_17792', 'organohalogen compound', 172, 'OH'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 360, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 394, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 588, '(OH)D'), ('CHEBI_71657', 'versiconol acetate', 708, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 711, 'OH ... D'), ('CHEBI_71657', 'versiconol acetate', 834, '25(OH)D'), ('PR_000006880', 'extracellular matrix protein 2', 834, '25 ... OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 1110, 'OH)D'), ('CHEBI_71657', 'versiconol acetate', 1239, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1393, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1399, 'D'), ('CHEBI_71657', 'versiconol acetate', 1462, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1531, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1596, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1733, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1761, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1804, 'vitamin D')]
PMC2963768	10/2010	S83-PMC2963768	["cement, brick, or tin)\xa0\xa0floor03 (6)0.221\xa0\xa0walls6 (25)16 (32)0.537\xa0\xa0roof20 (83)45 (90)0.411child is/was usually swaddled during the first 6 months of Life24 (100)46 (92)0.154child was deliberately exposed to sunlight before Learning to crawl/walk18 (75)36 (72)0.786mother's clothing practices when outdoors\xa0\xa0head usually covered23 (96)50 (100)0.146\xa0\xa0Face usually covered00-\xa0\xa0Arms usually covered24 (100)48 (96)0.321\xa0\xa0usually wears burka in public21 (91)47 (94)0.672number of meals at which mother reportedly Consumed Food items from Animal source during the past week (median±iqr)any type of fish13.0±514.5±120.158\xa0\xa0small fish with Bones6.0±76±80.561\xa0\xa0milk0±00±70.119\xa0\xa0meat0±0.50±20.415\xa0\xa0Eggs0±1.50±20.247\xa0\xa0Liver0±00±00.324\nfigures in parentheses indicate percentages;\niqr=interquartile range;\nsd=standard deviation\n\ndiscussion\nTHIS PRELIMINARY STUDY in sylhet during the winter dry season REVEALED that the Vitamin d status of young infants in rural bangladesh MIGHT be POOR enough to put many AT RISK of rickets and other POTENTIAL Vitamin D-RELATED health consequences."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 827), ('QUESTION_ANSWERED_BY_THIS_WORK', 832), ('QUESTION_ANSWERED_BY_THIS_WORK', 832), ('INCOMPLETE_EVIDENCE', 889), ('INCOMPLETE_EVIDENCE', 961), ('IMPORTANT_CONSIDERATION', 970), ('IMPORTANT_CONSIDERATION', 994), ('INCOMPLETE_EVIDENCE', 1023), ('SUPERFICIAL_RELATIONSHIP', 1043)]	9	[('UBERON_0008878', 'palmar part of manus', 149, 'life24'), ('GO_0007612', 'learning', 223, 'learning'), ('UBERON_0001456', 'face', 349, 'Face'), ('UBERON_0001460', 'arm', 374, 'Arms'), ('GO_0007631', 'feeding behavior', 507, 'consumed'), ('CHEBI_33290', 'food', 516, 'food'), ('NCBITaxon_33208', 'Metazoa', 532, 'animal'), ('UBERON_0001474', 'bone element', 631, 'bones6'), ('CL_0000059', 'ameloblast', 687, 'Eggs0'), ('UBERON_0001773', 'sclera', 706, 'Liver0'), ('CHEBI_33229', 'vitamin (role)', 907, 'vitamin'), ('CHEBI_27300', 'vitamin D', 1033, 'vitamin D')]
PMC2963768	10/2010	S109-PMC2963768	['THEREFORE, the MAJOR REASON that bangladeshi infants start Life with POOR Vitamin D stores is low maternal Antenatal 25(Oh)D, which HAS BEEN DOCUMENTED in urban and rural bangladeshi women of Reproductive age (27).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 15), ('PROBABLE_UNDERSTANDING', 21), ('IMPORTANT_CONSIDERATION', 69), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 141)]	6	[('UBERON_0000104', 'life cycle', 59, 'life'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007567', 'parturition', 107, 'antenatal'), ('CHEBI_71657', 'versiconol acetate', 117, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 123, 'D'), ('GO_0000003', 'reproduction', 192, 'reproductive')]
PMC2963768	10/2010	S111-PMC2963768	['RECENTLY STUDIED female workers in a garment factory in dhaka and SPECULATED that their long day-time hours in indoors, brief exposure to low-intensity sunlight in the early morning, outdoor air pollution, and widespread sunscreen use, in combination with darkly-Pigmented skin, MAY CONTRIBUTE to their POOR Vitamin D status (mean 25(Oh)D of 37 nmol/l, and 15% of the participants had 25(Oh)D <25 nmol/l) (28).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 279), ('SUPERFICIAL_RELATIONSHIP', 283), ('IMPORTANT_CONSIDERATION', 303)]	5	[('CHEBI_26130', 'biological pigment', 263, 'pigmented'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 331, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 385, '25(OH)D')]
PMC2963768	10/2010	S112-PMC2963768	['conservative dress, including almost complete skin coverage by traditional veils or cloaks, HAS BEEN EMPHASIZED as a contributor to Vitamin D deficits in muslim women in south asia and the middle east because it limits cutaneous Vitamin D Synthesis REGARDLESS OF the intensity of ambient ultraviolet b (29).']	[('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 101), ('INCOMPLETE_EVIDENCE', 249)]	3	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 229, 'vitamin D synthesis')]
PMC2963768	10/2010	S117-PMC2963768	['SINCE the concentration of Vitamin D Metabolites in Breastmilk is determined by maternal Vitamin D status, maternal Vitamin D deficiency during Lactation MAY cause ongoing deficits in Postnatal infants’ Vitamin D intake (42); YET, maternal FACTORS CANNOT ENTIRELY ACCOUNT for the persistence of low 25(Oh)D among toddlers (table 1) who experience direct exposure to sun and should BE unaffected by the conservative clothing practices of their mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226), ('ANOMALY_CURIOUS_FINDING', 226), ('SUPERFICIAL_RELATIONSHIP', 240), ('INCOMPLETE_EVIDENCE', 248), ('IMPORTANT_CONSIDERATION', 264), ('ANOMALY_CURIOUS_FINDING', 381)]	9	[('CHEBI_26871', 'terpene alkaloid', 27, 'vitamin D metabolites'), ('UBERON_0001348', 'brown adipose tissue', 52, 'breastmilk'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007595', 'lactation', 144, 'lactation'), ('GO_0007567', 'parturition', 184, 'postnatal'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 299, '25(OH)D')]
PMC2963768	10/2010	S118-PMC2963768	['THEREFORE, much remains to be learnt about the DETERMINANTS of Vitamin D status throughout infancy and childhood, PARTICULARLY where 25(Oh)D APPEARS DISCREPANT from that which would be expected BASED ON latitude.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 114), ('ANOMALY_CURIOUS_FINDING', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149), ('SUPERFICIAL_RELATIONSHIP', 194)]	6	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D')]
PMC2963768	10/2010	S122-PMC2963768	['Taurine (36)\ninadequate consumption of dietary Fatty Acid\nchronic Intestinal inflammation (37)\ncholestatic Liver disease (and reduced Bile Acid excretion)\nlow fat mass, LEADING to reduced capacity to store Vitamin Dhepatic conversion of Vitamin D to 25-Hydroyxyvitamin D\nchronic hepatitis or Hepatic dysfunction, e.g.']	[('IMPORTANT_CONSIDERATION', 169)]	1	[('CHEBI_15891', 'taurine', 0, 'taurine'), ('CHEBI_35366', 'fatty acid', 47, 'fatty acid'), ('UBERON_0000160', 'intestine', 66, 'intestinal'), ('UBERON_0002107', 'liver', 107, 'liver'), ('CHEBI_3098', 'bile acid', 134, 'bile acid'), ('UBERON_0001970', 'bile', 134, 'bile'), ('CHEBI_64980', 'gammaGluCys(IAN)Gly', 206, 'vitamin DHepatic'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 250, '25-hydroyxyvitamin D'), ('UBERON_0002107', 'liver', 292, 'hepatic')]
PMC2963768	10/2010	S125-PMC2963768	['Vitamin D Receptor, 24-hydroxylase\nDESPITE the current enthusiasm for Vitamin D supplementation in the usa (22), the EFFECTS of Vitamin D deficits during early infancy are STILL NOT FULLY UNDERSTOOD, and meaningful inflection points in 25(Oh)D-outcome RELATIONSHIPS have NOT BEEN ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('ANOMALY_CURIOUS_FINDING', 35), ('SUPERFICIAL_RELATIONSHIP', 117), ('FULL_UNKNOWN', 172), ('IMPORTANT_CONSIDERATION', 172), ('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 252), ('FULL_UNKNOWN', 271), ('ANOMALY_CURIOUS_FINDING', 275)]	9	[('CHEBI_27300', 'vitamin D', 0, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 0, 'vitamin D receptor'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 236, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 236, '25'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 239, 'OH ... D')]
PMC2963768	10/2010	S126-PMC2963768	['the most WIDELY-accepted manifestation of SEVERE Vitamin D deficiency in infancy is rickets, the classical childhood Metabolic bone disease ASSOCIATED with Skeletal hypomineralization and deformities, muscle weakness, and growth impairment (1).']	[('PROBABLE_UNDERSTANDING', 9), ('IMPORTANT_CONSIDERATION', 42), ('SUPERFICIAL_RELATIONSHIP', 140)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0008152', 'metabolic process', 117, 'metabolic'), ('UBERON_0004288', 'skeleton', 156, 'skeletal')]
PMC2963768	10/2010	S127-PMC2963768	['young infants with SEVERE congenital Vitamin D deficiency MAY present with hypocalcaemic tetany or seizures, with absent or subtle Skeletal pathology (43–45).']	[('IMPORTANT_CONSIDERATION', 19), ('INCOMPLETE_EVIDENCE', 58)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0004288', 'skeleton', 131, 'skeletal')]
PMC2963768	10/2010	S137-PMC2963768	["a PLAUSIBLE HYPOTHESIS is that Vitamin D deficiency ACTS SYNERGISTICALLY with OTHER causes of INADEQUATE bone mineralization and that an Individual's 25(Oh)D concentration below which clinical signs emerge DEPENDS ON the severity and multiplicity of OTHER Genetic and environmental FACTORS."]	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 250), ('SUPERFICIAL_RELATIONSHIP', 282)]	9	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('NCBITaxon_1', 'root', 137, 'individual'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 150, '25 ... OH ... D'), ('SO_0000704', 'gene', 256, 'genetic')]
PMC2963768	10/2010	S141-PMC2963768	['if Vitamin D deficiency is CONFIRMED AS a RISK FACTOR for pneumonia, INTERVENTIONS to improve maternal-infant Vitamin D status COULD reduce THE GLOBAL BURDEN of alri, the single most IMPORTANT cause of early childhood death in the world (58).']	[('INCOMPLETE_EVIDENCE', 27), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('FUTURE_WORK', 69), ('INCOMPLETE_EVIDENCE', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 140), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 183)]	8	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC2963768	10/2010	S146-PMC2963768	['selection of control was necessarily non-random from the perspective of age and gender and, thus, UNFORTUNATELY led to an over-representation of boys; however, there is UNLIKELY to be a gender DIFFERENTIAL in Vitamin D status during early infancy (63).']	[('IMPORTANT_CONSIDERATION', 98), ('PROBABLE_UNDERSTANDING', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193)]	3	[('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC2996405	11/2010	S30-PMC2996405	['the clinal gradation of skin colouration is CORRELATED with uv radiation levels and represents a compromising Solution to the CONFLICTING physiological REQUIREMENTS of Photoprotection and Vitamin D uv-dependent synthesis [13].']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('IMPORTANT_CONSIDERATION', 152)]	3	[('CHEBI_75958', 'solution', 110, 'solution'), ('GO_0006909', 'phagocytosis', 168, 'photoprotection'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D')]
PMC2996405	11/2010	S31-PMC2996405	['the latter is very IMPORTANT SINCE Vitamin D is INVOLVED in many health outcomes (e.g.']	[('IMPORTANT_CONSIDERATION', 19), ('PROBABLE_UNDERSTANDING', 29), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC2996405	11/2010	S49-PMC2996405	['for instance, Depigmentation is CRUCIAL for Vitamin D Synthesis at higher latitudes but it also exposes a higher RISK for skin cancer.']	[('IMPORTANT_CONSIDERATION', 32), ('IMPORTANT_CONSIDERATION', 113)]	2	[('GO_0046697', 'decidualization', 14, 'depigmentation'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 44, 'vitamin D synthesis')]
PMC2996405	11/2010	S103-PMC2996405	['an IMPORTANT factor HYPOTHESIZED to be both latitude DEPENDENT and Neural Development-RELATED is Vitamin D. we checked for an enrichment of lrgs in Vitamin D related (vdr) Genes by manually creating a list of 943 Genes that broadly comprised the most IMPORTANT processes in which it is INVOLVED, since a comprehensive list is not yet present in the literature (additional file4).']	[('IMPORTANT_CONSIDERATION', 3), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 86), ('IMPORTANT_CONSIDERATION', 251), ('SUPERFICIAL_RELATIONSHIP', 286)]	6	[('GO_0007399', 'nervous system development', 67, 'neural development'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 148, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 148, 'Vitamin'), ('SO_0000704', 'gene', 172, 'genes'), ('SO_0000704', 'gene', 213, 'genes')]
PMC2996405	11/2010	S147-PMC2996405	['searching for a mechanism that COULD CONNECT latitude and schizophrenia at a molecular level, we reasoned that a well-known phenomenon separately LINKED to both of them is Vitamin D. indeed, Vitamin D is ESSENTIAL for normal growth, calcium absorption and Skeletal Development.']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 146), ('IMPORTANT_CONSIDERATION', 204)]	4	[('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0001501', 'skeletal system development', 256, 'skeletal development'), ('UBERON_0004288', 'skeleton', 256, 'skeletal')]
PMC2996405	11/2010	S149-PMC2996405	['with the same dietary Intake, the most IMPORTANT DETERMINANT for Vitamin D levels IS CONSIDERED to be where Individuals live, because of the DEPENDENCE on geographical location of the availability of uv radiation for Vitamin D synthesis.']	[('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 141)]	4	[('GO_0007631', 'feeding behavior', 22, 'intake'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('NCBITaxon_1', 'root', 108, 'individuals'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
PMC2996405	11/2010	S152-PMC2996405	['this adaptation process was compulsory, SINCE Pelvic deformities due to Vitamin D deficiency COULD PREVENT normal Childbirth, BUT it is REASONABLE to SUGGEST that also OTHER molecular mechanisms apart from depigmentation COULD HAVE been subject to selective pressure in order to increase the levels of Vitamin D in the body.']	[('PROBABLE_UNDERSTANDING', 40), ('PROBLEM_COMPLICATION', 40), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 168), ('INCOMPLETE_EVIDENCE', 221), ('IMPORTANT_CONSIDERATION', 227)]	10	[('UBERON_0002108', 'small intestine', 46, 'pelvic'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007623', 'circadian rhythm', 114, 'childbirth'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC2996405	11/2010	S162-PMC2996405	['in addition, epidemiological data SUGGEST that Vitamin D deficiency MAY BE ASSOCIATED with INCREASED RISKS of mental health disorders such as schizophrenia [55].']	[('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 75), ('IMPORTANT_CONSIDERATION', 91)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC3004407	12/2010	S14-PMC3004407	['introduction\nmuch has happened in the world of Vitamin D RESEARCH since the 2002 centers for disease control report of the WIDESPREAD deficiency in african-american women in their Childbearing years [1].']	[('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 123)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 180, 'childbearing')]
PMC3004407	12/2010	S17-PMC3004407	["STUDIES to SUPPORT this PREMISE have increased significantly in number during the past five years [13–30], and with frequent lay press articles and featured news items about Vitamin D, PUBLIC UNDERSTANDING of Vitamin D's IMPORTANCE in maintaining health has increased."]	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 185), ('IMPORTANT_CONSIDERATION', 221)]	5	[('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC3004407	12/2010	S22-PMC3004407	['AS a result of the CONCERN regarding the prevalence of Vitamin D deficiency among Pregnant women receiving care at community health centers, and TO CLARIFY earlier scientific STUDIES which REPORTED that a majority of african-american and hispanic women are Vitamin D deficient [34–40], a cross-sectional study of Pregnant women presenting at a community health center network in south carolina at latitude 32°n was designed and implemented.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 19), ('PROBLEM_COMPLICATION', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 145), ('FUTURE_WORK', 148), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 189)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('GO_0007565', 'female pregnancy', 313, 'pregnant')]
PMC3004407	12/2010	S104-PMC3004407	['the association between RELEVANT prior and current medical conditions and present Vitamin D status is summarized intable 4.']	[('IMPORTANT_CONSIDERATION', 24)]	1	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC3004407	12/2010	S146-PMC3004407	['using both circulating 25(Oh)D and pth as MARKERS of Vitamin D deficiency, THESE FINDINGS UNDERSCORE RECENT REPORTS of widespread Vitamin D deficiency among Pregnant women, EVEN in areas of the world with ample sunlight.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 108), ('ANOMALY_CURIOUS_FINDING', 173)]	6	[('CHEBI_71657', 'versiconol acetate', 23, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnant')]
PMC3004407	12/2010	S149-PMC3004407	['infants who are Vitamin D deficient at Birth are at the highest RISK of impaired bone development [5] that APPEARS to persist in EVEN later childhood [37].']	[('IMPORTANT_CONSIDERATION', 64), ('ANOMALY_CURIOUS_FINDING', 107), ('ANOMALY_CURIOUS_FINDING', 129)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007567', 'parturition', 39, 'birth')]
PMC3004407	12/2010	S150-PMC3004407	['what is MOST CONCERNING is that use of Prenatal Vitamins containing 400\u2009iu/tablet was IRRELEVANT in AFFECTING Vitamin D status: those who took their prescribed Prenatal vitamin containing Vitamin D did not differ from those who did not.']	[('PROBABLE_UNDERSTANDING', 8), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 100)]	4	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 48, 'vitamins'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'prenatal'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D')]
PMC3004407	12/2010	S152-PMC3004407	['the STRENGTHS of the study are that a large and diverse group of women at various stages of Pregnancy were studied to: (1) ascertain their Vitamin D status at the time of presentation to a community health center and (2) find WHAT FACTORS were most PREDICTIVE of that status in a sun-rich environment where THEORETICALLY there are no LIMITATIONS to achieving an adequate Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 4), ('EXPLICIT_QUESTION', 226), ('SUPERFICIAL_RELATIONSHIP', 231), ('SUPERFICIAL_RELATIONSHIP', 249), ('INCOMPLETE_EVIDENCE', 307), ('INCOMPLETE_EVIDENCE', 334)]	6	[('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin D')]
PMC3004407	12/2010	S156-PMC3004407	['given RECENT DISCOVERIES that LINK Vitamin D with the innate Immune System [6], it is not UNREASONABLE to predict that deficiencies during fetal development COULD have lasting sequelae on the child, NOT ONLY in terms of bone mineralization, BUT ALSO in terms of Immune Development that becomes the basis for later derangements SEEN with long-latency diseases such as multiple sclerosis, rheumatoid arthritis, diabetes, and certain cancers [59].']	[('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 13), ('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 157), ('ANOMALY_CURIOUS_FINDING', 199), ('ANOMALY_CURIOUS_FINDING', 241), ('INCOMPLETE_EVIDENCE', 327)]	8	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007566', 'embryo implantation', 61, 'immune'), ('UBERON_0002405', 'immune system', 61, 'immune system'), ('GO_0001822', 'kidney development', 262, 'immune development'), ('UBERON_0002405', 'immune system', 262, 'immune')]
PMC3004407	12/2010	S158-PMC3004407	['studies TO EXAMINE the BENEFIT of higher doses of Vitamin D during Pregnancy SUGGEST that the dose of Vitamin D FOUND in MOST Prenatal Vitamins—400\u2009iu—is INADEQUATE to meet the NEEDS of the Pregnant woman and her growing fetus [11,32,34,39,60–67].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 112), ('PROBABLE_UNDERSTANDING', 121), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 177)]	7	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 135, 'vitamins'), ('GO_0007565', 'female pregnancy', 190, 'pregnant')]
PMC3004407	12/2010	S159-PMC3004407	["TAKING INTO account Vitamin D's EMERGING ROLE in Immune maintenance throughout the body and the MOUNTING EVIDENCE TO SUPPORT the IMPORTANCE of Vitamin D in maintaining good health, at the very LEAST, women who are deficient in Vitamin D SHOULD BE counseled regarding the risks of Vitamin D deficiency for themselves and their offspring and RECOMMENDED a therapy to ensure Vitamin D adequacy [60–62,68–70]."]	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 7), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 129), ('PROBABLE_UNDERSTANDING', 193), ('FUTURE_WORK', 237), ('FUTURE_WORK', 340)]	10	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0002405', 'immune system', 49, 'immune'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 372, 'vitamin D')]
PMC3032617	5/2010	S8-PMC3032617	['conclusion\nthe results of THIS STUDY SUGGEST including Vitamin C in the GUIDELINES of multivitamin PREVENTION for Pregnant women, ESPECIALLY in developing countries where seasonal availability of fruits and Vegetables COULD result in adverse clinical outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 72), ('PROBABLE_UNDERSTANDING', 72), ('SUPERFICIAL_RELATIONSHIP', 99), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 218)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin C'), ('GO_0007565', 'female pregnancy', 114, 'pregnant'), ('CHEBI_33267', 'elemental nitrogen', 207, 'vegetables')]
PMC3032617	5/2010	S13-PMC3032617	['other IMPORTANT biological functions include copper and iron reduction (which facilitates iron absorption), Carnitine Biosynthesis, Neurotransmitter Biosynthesis, reductive protection of Folic Acid and reductive regeneration of Vitamin E [3].']	[('IMPORTANT_CONSIDERATION', 6)]	1	[('CHEBI_17126', 'carnitine', 108, 'carnitine'), ('GO_0045329', 'carnitine biosynthetic process', 108, 'carnitine biosynthesis'), ('CHEBI_25512', 'neurotransmitter', 132, 'neurotransmitter'), ('GO_0042136', 'neurotransmitter biosynthetic process', 132, 'neurotransmitter biosynthesis'), ('CHEBI_30751', 'formic acid', 187, 'folic acid'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin E')]
PMC3032617	5/2010	S14-PMC3032617	['the most IMPORTANT disorder of Vitamin C deficiency is scurvy, characterized by Gingival changes, pain in the Extremities, deformed bone growth in infants, hemorrhagic manifestations, ulcerations and ultimately death [1].']	[('IMPORTANT_CONSIDERATION', 9)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin C'), ('PR_000004900', 'complement C3', 39, 'C'), ('UBERON_0001091', 'calcareous tooth', 80, 'gingival'), ('UBERON_0007614', 'extensor digiti minimi muscle', 110, 'extremities')]
PMC3032617	5/2010	S27-PMC3032617	['ON THE OTHER HAND, Oxalate is an end product of Ascorbate Catabolism and plays an IMPORTANT ROLE in Kidney Stone Formation, so excessive daily amounts of Vitamin C such as Intakes higher than 1g/day are shown to produce hyperoxaluria [1].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 82), ('SUPERFICIAL_RELATIONSHIP', 92)]	3	[('CHEBI_16162', 'o-orsellinate', 19, 'oxalate'), ('CHEBI_22651', 'ascorbate', 48, 'ascorbate'), ('GO_0009056', 'catabolic process', 58, 'catabolism'), ('GO_0016255', 'attachment of GPI anchor to protein', 100, 'kidney'), ('UBERON_0003460', 'arm bone', 100, 'kidney stone'), ('GO_0009057', 'macromolecule catabolic process', 113, 'formation'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin C'), ('GO_0007631', 'feeding behavior', 172, 'intakes')]
PMC3032617	5/2010	S30-PMC3032617	['SEVERAL randomized placebo controlled STUDIES have ATTEMPTED to repeat pauling’s experience with INCONSISTENT and variable results which to date can not provide a definite conclusion around the real extent of overall health BENEFIT brought in by Vitamin C high daily intake [16-18].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 38), ('DIFFICULT_TASK', 51), ('INCOMPLETE_EVIDENCE', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('IMPORTANT_CONSIDERATION', 224)]	6	[('CHEBI_27300', 'vitamin D', 246, 'vitamin C')]
PMC3032617	5/2010	S92-PMC3032617	['chi squared value=9.971 with 4 degrees of freedom\n\ncaption (table-wrap): table 4:\nsystolic Blood pressure (bp) variation from baseline to Delivery in the two groups of womenbaseline (median, range)Delivery*(median, range)average increase (mmhg)p Vitamin C97 (86-134)104 (92-132)8.040.0001controls98 (83-133)103 (79-129)4.50.0001\nin cases of Miscarriage or Preterm Delivery, the last Antenatal bp value was considered in the analysis\n\ncaption (fig): figure 1:\n\nstudy flow diagram\n\ncaption (fig): figure 2:\n\npatients’ distribution in the two treatment groups according to the number of times hospitalized\n\ndiscussion\nin this randomized, open label, cohort study, the daily Vitamin C supplementation provided IMPORTANT clinical signs in the group of women treated.']	[('IMPORTANT_CONSIDERATION', 706)]	1	[('UBERON_0000178', 'blood', 91, 'blood'), ('GO_0007567', 'parturition', 138, 'delivery'), ('GO_0007586', 'digestion', 197, 'Delivery'), ('CHEBI_80326', 'Neuropeptide FF', 246, 'Vitamin C97'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 246, 'Vitamin C97'), ('GO_0046660', 'female sex differentiation', 341, 'miscarriage'), ('GO_0007565', 'female pregnancy', 356, 'preterm'), ('GO_0007567', 'parturition', 364, 'delivery'), ('GO_0007567', 'parturition', 383, 'antenatal'), ('CHEBI_27300', 'vitamin D', 671, 'vitamin C')]
PMC3032617	5/2010	S107-PMC3032617	['considering the IMPORTANCE of systolic Blood pressure during Pregnancy which is a direct reflex of mother’s Blood output and THEREFORE child Nutrient provision, we compared in each group the difference from baseline to end of Pregnancy and a significant average increase was FOUND in both groups from baseline, with a higher increase in the Vitamin C group.']	[('IMPORTANT_CONSIDERATION', 16), ('PROBABLE_UNDERSTANDING', 125), ('INCOMPLETE_EVIDENCE', 275)]	3	[('UBERON_0000178', 'blood', 39, 'blood'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('UBERON_0000178', 'blood', 108, 'blood'), ('CHEBI_33284', 'nutrient', 141, 'nutrient'), ('GO_0007565', 'female pregnancy', 226, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 341, 'vitamin C')]
PMC3032617	5/2010	S109-PMC3032617	['in second place , the higher increase achieved with the Vitamin C supplementation (8mmhg vs. 4.5mmhg), with a TREND towards SIGNIFICANCE, can be INTERPRETED in two ways; as an increased Gastric absorption of iron in the presence of Ascorbic Acid that HAS BEEN DEMONSTRATED in SEVERAL STUDIES [1,3,9,22] and also, the Red Blood Cell protection from oxidation in the presence of high amounts of Ascorbic Acid which HAS BEEN DEMONSTRATED to be an Electron Donor of Glutathione, a vital antioxidant of Red Blood Cells [1,3,24].']	[('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 124), ('FULL_UNKNOWN', 145), ('INCOMPLETE_EVIDENCE', 251), ('INCOMPLETE_EVIDENCE', 260), ('INCOMPLETE_EVIDENCE', 276), ('INCOMPLETE_EVIDENCE', 413)]	7	[('CHEBI_27300', 'vitamin D', 56, 'vitamin C'), ('UBERON_0001844', 'cochlea', 186, 'gastric'), ('CHEBI_22652', 'ascorbic acid', 232, 'ascorbic acid'), ('CL_0000232', 'erythrocyte', 317, 'red blood cell'), ('UBERON_0000178', 'blood', 321, 'blood'), ('CHEBI_22652', 'ascorbic acid', 393, 'ascorbic acid'), ('CHEBI_10545', 'electron', 444, 'electron'), ('CHEBI_13193', 'hydrogen acceptor', 453, 'donor'), ('CHEBI_16856', 'glutathione', 462, 'glutathione'), ('CL_0000232', 'erythrocyte', 498, 'red blood cells'), ('UBERON_0000178', 'blood', 502, 'blood')]
PMC3032617	5/2010	S112-PMC3032617	['the choice of dosing the Vitamin C supplement 400mg daily matured after reviewing the medical literature were it was HIGHLIGHTED that at doses exceeding 1g daily the PROBABILITY of side-effects such as diarrhea and Renal colic increased greatly [1,3,13,14] on the OTHER side doses up to 500 mg daily are advised by the official statement of the linus pauling’s institute to the general population, this led us to choose this dose as the SAFEST.']	[('INCOMPLETE_EVIDENCE', 117), ('PROBABLE_UNDERSTANDING', 166), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('IMPORTANT_CONSIDERATION', 437)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin C'), ('UBERON_0002113', 'kidney', 215, 'renal')]
PMC3032617	5/2010	S116-PMC3032617	['moreover, the supplementation of a relatively cheap, clinically SAFE and health-bearing integrator as Vitamin C, PROVED to add overall BENEFITS in terms of hospitalization and several other mother-to-child outcomes RELEVANT during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 64), ('PROBABLE_UNDERSTANDING', 113), ('IMPORTANT_CONSIDERATION', 135), ('IMPORTANT_CONSIDERATION', 215)]	4	[('CHEBI_27300', 'vitamin D', 102, 'vitamin C'), ('GO_0007565', 'female pregnancy', 231, 'pregnancy')]
PMC3034879	12/2010	S15-PMC3034879	['FURTHER ATTENTION SHOULD BE PAID to improving Vitamin D status during Pregnancy.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 18), ('IMPORTANT_CONSIDERATION', 28)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy')]
PMC3034879	12/2010	S192-PMC3034879	['optimally, Vitamin D sufficiency SHOULD BE guaranteed during fetal Life AS the FINDINGS of the PRESENT STUDY SUGGEST that the CONSEQUENCES of POOR Vitamin D status during the fetal period cannot be totally reverted by Postnatal Vitamin D supplementation.']	[('FUTURE_WORK', 33), ('IMPORTANT_CONSIDERATION', 33), ('PROBABLE_UNDERSTANDING', 72), ('INCOMPLETE_EVIDENCE', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('INCOMPLETE_EVIDENCE', 109), ('PROBLEM_COMPLICATION', 126), ('IMPORTANT_CONSIDERATION', 142)]	8	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 218, 'postnatal'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC3034879	12/2010	S201-PMC3034879	['it SEEMS UNLIKELY, THEREFORE, that IMPROVING Vitamin D intake merely in infancy would revert the CONSEQUENCES of POOR Vitamin D status during the Fetal Period.']	[('ANOMALY_CURIOUS_FINDING', 3), ('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 19), ('FUTURE_WORK', 35), ('PROBLEM_COMPLICATION', 97), ('IMPORTANT_CONSIDERATION', 113)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0002375', 'cricoid cartilage', 146, 'fetal period')]
PMC3061267	2/2011	S2-PMC3061267	['adequate Vitamin D and Calcium nutrition throughout Life MAY reduce the RISK of osteoporosis, and Calcium supplementation during Pregnancy MAY reduce Preeclampsia and low Birth weight.']	[('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 72), ('INCOMPLETE_EVIDENCE', 139)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 23, 'calcium'), ('UBERON_0000104', 'life cycle', 52, 'life'), ('CHEBI_22313', 'alkaline earth metal atom', 98, 'calcium'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 150, 'preeclampsia'), ('GO_0007567', 'parturition', 171, 'birth')]
PMC3061267	2/2011	S29-PMC3061267	['nutrient deficiencies LINKED to PUBLIC HEALTH PROBLEMS in women\n\nCalcium and Vitamin D\nCalcium (1,200 mg elemental Ca/d) was found to reduce all four Premenstrual syndrome symptoms examined in an older clinical trial [7].']	[('SUPERFICIAL_RELATIONSHIP', 22), ('IMPORTANT_CONSIDERATION', 32), ('IMPORTANT_CONSIDERATION', 46)]	3	[('CHEBI_31341', 'calcium dihydroxide', 65, 'Calcium'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_31341', 'calcium dihydroxide', 87, 'Calcium'), ('CHEBI_32588', 'potassium chloride', 115, 'Ca'), ('GO_0007565', 'female pregnancy', 150, 'premenstrual')]
PMC3061267	2/2011	S33-PMC3061267	['adequate Vitamin D and calcium nutrition throughout the Life-course APPEAR to reduce the RISK of osteoporosis [10].']	[('ANOMALY_CURIOUS_FINDING', 68), ('IMPORTANT_CONSIDERATION', 89)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0000104', 'life cycle', 56, 'life')]
PMC3061267	2/2011	S40-PMC3061267	['WHILE DEFICIENCIES of several Nutrients besides iron CAN cause anemia, and SOME Nutrients like Vitamin A are OFTEN LINKED to iron status, a RECENT review FOUND no greater IMPACT of a multimicronutrient supplement on iron status THAN supplementing with iron alone [17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 171), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	10	[('CHEBI_33284', 'nutrient', 30, 'nutrients'), ('CHEBI_33284', 'nutrient', 80, 'nutrients'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin A')]
PMC3061267	2/2011	S105-PMC3061267	['maternal Vitamin C levels SEEMED PARTICULARLY IMPORTANT for Birth weight along with zinc for Birth length.']	[('ANOMALY_CURIOUS_FINDING', 26), ('ANOMALY_CURIOUS_FINDING', 33), ('IMPORTANT_CONSIDERATION', 46)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin C'), ('GO_0007567', 'parturition', 60, 'birth'), ('GO_0007567', 'parturition', 93, 'birth')]
PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]
PMC3075531	7/2010	S12-PMC3075531	['there are DIFFERENCES in OPTIMAL level of 25-Hydroxy Vitamin D BUT nowadays internationally ACCEPTED normal range is between 75 nmol/l and 200 nmol/l, and we CONSIDER Serum level below 75 nmol/l and below 2 nmol/l as insufficiency and deficiency, respectively.42325even it SEEMS to achieve the prevention of Autoimmune diseases, the Serum level of Vitamin D MUST BE higher than the level required to reduce osteoporosis (higher than 75 nmol/l).4in attention to high prevalence of ms in iran and especially in isfahan which is ABOUT 43.5/100,0002627and GIVEN that iran is located in an latitude of 32° 50’ and longitude of 51° 43’ with enough sun exposure and BECAUSE nobody INVESTIGATED the RELATIONSHIP between Vitamin D, AS an environmental agent, and ms disease in iran before, we DECIDED to compare the Serum level of 25-Hydroxy Vitamin D in ms patients and healthy control group in isfahan region.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 158), ('ANOMALY_CURIOUS_FINDING', 273), ('IMPORTANT_CONSIDERATION', 358), ('INCOMPLETE_EVIDENCE', 526), ('PROBABLE_UNDERSTANDING', 552), ('PROBABLE_UNDERSTANDING', 659), ('QUESTION_ANSWERED_BY_THIS_WORK', 674), ('SUPERFICIAL_RELATIONSHIP', 691), ('PROBABLE_UNDERSTANDING', 723), ('QUESTION_ANSWERED_BY_THIS_WORK', 784)]	14	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 42, '25-hydroxy vitamin D'), ('UBERON_0001977', 'blood serum', 167, 'serum'), ('UBERON_0001442', 'skeleton of manus', 308, 'autoimmune'), ('UBERON_0001977', 'blood serum', 333, 'serum'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 712, 'vitamin D'), ('UBERON_0001977', 'blood serum', 807, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 822, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 841, 'D')]
PMC3075531	7/2010	S43-PMC3075531	['relative to sun exposure, diet is a POOR source of Colecalciferol, providing ONLY 40-400 iu per Food serving,12WHEREAS whole-body uvb exposure for 20 min for a light-skinned Person during the summer months will produce AT LEAST 10,000 iu.713HOWEVER, increased skin pigmentation, age, use of sunscreen, built environment, and environmental FACTORS that reduce the strength of uvb reaching the earth’s surface (e.g., winter season, high latitude, pollution, cloud cover, and Ozone levels) all CONTRIBUTE to reduce skin Colecalciferol production to the point at which diet MIGHT become the primary source.7–14BECAUSE Melanin Pigment in Human skin absorbs uvb,28black People have lower 25 Hydroxyvitamin D concentrations than white People, and are OFTEN Vitamin D deficient.21HOWEVER, the risk of ms in black People is lower than in white People (BECAUSE of Genetic differences).28analyses of the RELATION between Vitamin D status and ms risk are THEREFORE BETTER done separately within each race/ethnic group.']	[('IMPORTANT_CONSIDERATION', 36), ('ANOMALY_CURIOUS_FINDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('PROBABLE_UNDERSTANDING', 219), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 241), ('SUPERFICIAL_RELATIONSHIP', 339), ('SUPERFICIAL_RELATIONSHIP', 491), ('INCOMPLETE_EVIDENCE', 570), ('PROBABLE_UNDERSTANDING', 606), ('PROBABLE_UNDERSTANDING', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 772), ('PROBABLE_UNDERSTANDING', 843), ('SUPERFICIAL_RELATIONSHIP', 893), ('PROBABLE_UNDERSTANDING', 943), ('IMPORTANT_CONSIDERATION', 953)]	15	[('CHEBI_50553', 'mancude carbobicyclic parent', 51, 'colecalciferol'), ('CHEBI_33290', 'food', 96, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 174, 'person'), ('CHEBI_25812', 'ozone', 473, 'ozone'), ('CHEBI_50553', 'mancude carbobicyclic parent', 517, 'colecalciferol'), ('CHEBI_25179', 'melanins', 614, 'melanin'), ('CHEBI_26130', 'biological pigment', 622, 'pigment'), ('NCBITaxon_9606', 'Homo sapiens', 633, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 664, 'people'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 682, '25 hydroxyvitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 728, 'people'), ('CHEBI_27300', 'vitamin D', 750, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 805, 'people'), ('NCBITaxon_10088', 'Mus <genus>', 835, 'people'), ('SO_0000704', 'gene', 854, 'genetic'), ('CHEBI_27300', 'vitamin D', 910, 'vitamin D')]
PMC3075531	7/2010	S48-PMC3075531	['the ONLY study satisfying this condition used a nested case-control design to sample an underlying prospective cohort comprising over 7 million Individuals who served in the us military and had at least two Serum samples stored in the us department of defense Serum repository.18the study CONCLUDED that Serum concentration of 25 Hydroxyvitamin D in healthy young white Adults is an IMPORTANT PREDICTOR of their risk of developing ms, INDEPENDENTLY from their place of Birth and latitude of residence during childhood.18in a prospective investigation comprising approximately 200,000 women in the usa, Vitamin D intake was measured every 4 years by a comprehensive semi-quantitative Food frequency questionnaire.37the incidence of ms during the 30-year follow-up decreased with increasing Vitamin D intake (p=0.03 for trend) and was 33% lower among women in the highest quintile of Vitamin D intake versus those in the lowest quintile.17furthermore, ms incidence was 41% lower among women taking 400 iu per day or more from Supplements compared with non-users.17ATTEMPTS to RELATE Vitamin D intake to ms risk HAVE also BEEN made in casecontrol studies.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 289), ('IMPORTANT_CONSIDERATION', 383), ('SUPERFICIAL_RELATIONSHIP', 393), ('SUPERFICIAL_RELATIONSHIP', 435), ('INCOMPLETE_EVIDENCE', 1062), ('SUPERFICIAL_RELATIONSHIP', 1074), ('INCOMPLETE_EVIDENCE', 1109)]	8	[('NCBITaxon_1', 'root', 144, 'individuals'), ('UBERON_0001977', 'blood serum', 207, 'serum'), ('UBERON_0001977', 'blood serum', 260, 'Serum'), ('UBERON_0001977', 'blood serum', 304, 'serum'), ('CHEBI_37972', 'phosphorus-32 atom', 327, '25'), ('CHEBI_67825', '17beta,21beta-epoxyhopan-3-one', 330, 'hydroxyvitamin D'), ('UBERON_0007023', 'adult organism', 370, 'adults'), ('GO_0007567', 'parturition', 469, 'birth'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D'), ('CHEBI_33290', 'food', 683, 'food'), ('CHEBI_27300', 'vitamin D', 789, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 882, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 1024, 'supplements'), ('CHEBI_27300', 'vitamin D', 1081, 'vitamin D')]
PMC3075531	7/2010	S49-PMC3075531	['in norway, a study comprising 119 ms cases and 251 controls living above the arctic circle, where Fatty Fish is a MAJOR CONTRIBUTOR to Vitamin D intake, REPORTED a lower risk of ms for Individuals who Ate fish three or more times per week at 16–20 years of age compared with those with a lower Consumption (odds ratio=0.57 [95%ci 0.33-0.93]; p=0.024).19supplementation with codliver oil was also ASSOCIATED with lower risk of ms, BUT ONLY among Individuals with low summer outdoor activity.']	[('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 396), ('ANOMALY_CURIOUS_FINDING', 430)]	5	[('CHEBI_38677', 'famphur', 98, 'fatty fish'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_1', 'root', 185, 'individuals'), ('GO_0009636', 'response to toxic substance', 201, 'ate'), ('GO_0007631', 'feeding behavior', 294, 'consumption'), ('NCBITaxon_1', 'root', 445, 'individuals')]
PMC3075531	7/2010	S55-PMC3075531	['in a pooled analysis of data from canada, uk, denmark, and sweden including more than 40,000 Individuals with ms, significantly fewer (8.5%) People with ms were Born in november and significantly more (9.1%) were Born in may.39THIS FINDING SUGGESTS that Prenatal exposures or exposures in the first months of Life COULD BE IMPORTANT in ms etiology, BUT the LINK to Vitamin D is UNCLEAR.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 314), ('IMPORTANT_CONSIDERATION', 323), ('ANOMALY_CURIOUS_FINDING', 349), ('SUPERFICIAL_RELATIONSHIP', 357), ('FULL_UNKNOWN', 378)]	8	[('NCBITaxon_1', 'root', 93, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 141, 'people'), ('GO_0007567', 'parturition', 161, 'born'), ('GO_0007567', 'parturition', 213, 'born'), ('GO_0007565', 'female pregnancy', 254, 'prenatal'), ('UBERON_0000104', 'life cycle', 309, 'life'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
PMC3075531	7/2010	S58-PMC3075531	['THEREFORE, Genetic variations in Vitamin-D-related Genes MIGHT also AFFECT ms risk, EITHER directly OR by modifying the EFFECTS of Vitamin D.40\nour IMPLICATIONS for FUTURE RESEARCH and ms prevention and ACCORDING TO the basis of the results of the ONLY longitudinal study of Serum 25-Hydroxyvitamin D and ms onset,18and ASSUM-ING that these results are unbiased and Vitamin D is TRULY PROTECTIVE against ms, over 70% of ms cases in the usa and europe COULD BE PREVENTED by increasing the Serum 25-Hydroxyvitamin D concentration of adolescents and young Adults to above 100 nmol/l.4142these concentrations are commonly FOUND ONLY in Individuals with outdoor lifestyles in sunny regions, BUT COULD BE reached in MOST People by taking 1000-4000 iu Colecalciferol daily.8254344ALTHOUGH these doses are LARGELY CONSIDERED SAFE and POTENTIALLY beneficial for other outcomes,819CONFIRMATION of SAFETY and efficacy in a LARGE randomized TRIAL is NEEDED before making general RECOMMENDATIONS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 148), ('FUTURE_WORK', 165), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 320), ('PROBABLE_UNDERSTANDING', 379), ('SUPERFICIAL_RELATIONSHIP', 385), ('INCOMPLETE_EVIDENCE', 451), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 618), ('ANOMALY_CURIOUS_FINDING', 624), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 686), ('INCOMPLETE_EVIDENCE', 690), ('PROBABLE_UNDERSTANDING', 710), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 773), ('INCOMPLETE_EVIDENCE', 798), ('INCOMPLETE_EVIDENCE', 806), ('IMPORTANT_CONSIDERATION', 817), ('INCOMPLETE_EVIDENCE', 826), ('INCOMPLETE_EVIDENCE', 871), ('IMPORTANT_CONSIDERATION', 887), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 938), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 11, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 33, 'vitamin-D'), ('SO_0000704', 'gene', 51, 'genes'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0001977', 'blood serum', 275, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 281, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 366, 'vitamin D'), ('UBERON_0001977', 'blood serum', 488, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 494, '25-hydroxyvitamin D'), ('UBERON_0007023', 'adult organism', 553, 'adults'), ('NCBITaxon_1', 'root', 632, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 715, 'people'), ('CHEBI_50553', 'mancude carbobicyclic parent', 745, 'colecalciferol')]
PMC3075531	7/2010	S61-PMC3075531	['conclusions\nin conclusion, THIS STUDY SHOWED that Serum Vitamin D deficiency MIGHT be a POTENTIAL environmental predisposing FACTOR for developing multiple sclerosis in our region, and NEED to follow FACTORS that cause THIS PROBLEM including dietary, Genetic, and other ones.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 125), ('IMPORTANT_CONSIDERATION', 185), ('SUPERFICIAL_RELATIONSHIP', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 219), ('IMPORTANT_CONSIDERATION', 224)]	9	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('SO_0000704', 'gene', 251, 'genetic')]
PMC3075531	7/2010	S62-PMC3075531	['WHEREAS FUTURE observational epidemiological studies and Genetic and molecular INVESTIGATIONS WILL be useful to strengthen and refine the HYPOTHESIS, it MIGHT be NECESSARY to do a LARGE randomized TRIAL to establish the SAFETY and efficacy NEEDED to promote large-scale Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 79), ('FUTURE_PREDICTION', 94), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 153), ('IMPORTANT_CONSIDERATION', 162), ('FUTURE_WORK', 180), ('IMPORTANT_CONSIDERATION', 220), ('FUTURE_WORK', 240)]	10	[('SO_0000704', 'gene', 57, 'genetic'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC3075531	7/2010	S63-PMC3075531	['a test of the HYPOTHESIS that Vitamin D COULD reduce ms risk WILL REQUIRE the administration of relatively high doses of Vitamin D to hundreds of thousands of young adults for several years, and careful monitoring for UNFORESEEN ADVERSE EFFECTS is MANDATORY.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 40), ('FUTURE_PREDICTION', 61), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 218), ('IMPORTANT_CONSIDERATION', 248)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC3075531	7/2010	S65-PMC3075531	['furthermore, screening of Serum 25-Hydroxyvitamin D concentrations is LIKELY to identify a large proportion of patients who are Vitamin D deficient or insufficient, and who MIGHT BENEFIT from Vitamin D supplementation for PREVENTION of osteoporosis and other complications, especially multiple sclerosis.']	[('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 173), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 222)]	4	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 32, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC3103150	3/2011	S14-PMC3103150	['Breast Milk concentration of Vitamin D is low (<20 iu/l) and is INADEQUATE for the needs of the Growing infant2.']	[('IMPORTANT_CONSIDERATION', 64)]	1	[('UBERON_0013538', 'Brodmann (1909) area 7', 0, 'Breast milk'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0040007', 'growth', 96, 'growing')]
PMC3103150	3/2011	S84-PMC3103150	['caption (table-wrap): table ii\n\nprevalence of Vitamin D deficiency and its biochemical markers in infants and mothers (n=98)parameterinfants n (%)mothers n (%)Vitamin D deficiency64 (66.7)77 (81.1)Vitamin D insufficiency19 (19.8)11 (11.6)SEVERE Vitamin D deficiency26 (27.1)22 (23.2)hypocalcemia7 (7.1)23 (24.2)raised Alp89 (91.8)92 (96.8)hyperparathyroidism47 (48.5)52 (53.7)\nalp, alkaline phosphatase; 25Ohd, 25 Hydroxyvitamin D; pth, parathormone\n\ncaption (fig): fig.']	[('IMPORTANT_CONSIDERATION', 238)]	1	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 159, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 197, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('PR_000003930', 'methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial', 318, 'ALP89'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 404, '25OHD'), ('CHEBI_67825', '17beta,21beta-epoxyhopan-3-one', 414, 'hydroxyvitamin D')]
PMC3107676	4/2011	S38-PMC3107676	['accounting for Vitamin C use when assessing the EFFECTS of Nitrosatable Drugs on Pregnancy outcomes MAY prove to be CRITICALLY IMPORTANT.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 116), ('IMPORTANT_CONSIDERATION', 127)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin C'), ('CHEBI_7496', 'nelfinavir', 59, 'nitrosatable drugs'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC3171895	9/2011	S36-PMC3171895	['methods\na number of Micronutrients and Vitamins are KNOWN to serve as antioxidants or be essential Cofactors for antioxidant enzymes; these include Selenium, copper, zinc, manganese, and Vitamins C and e. THE PRESENT PAPER summarises CURRENT UNDERSTANDING of the IMPORTANCE of these Micronutrient antioxidants in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 52), ('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('INCOMPLETE_EVIDENCE', 234), ('IMPORTANT_CONSIDERATION', 263)]	5	[('CHEBI_33839', 'macromolecule', 20, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 39, 'vitamins'), ('CHEBI_23357', 'cofactor', 99, 'cofactors'), ('CHEBI_27568', 'selenium atom', 148, 'selenium'), ('CHEBI_27300', 'vitamin D', 187, 'vitamins C'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 283, 'micronutrient'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy')]
PMC3171895	9/2011	S142-PMC3171895	['smoking HAS BEEN SHOWN to increase oxidative stress and Metabolic turnover of Vitamin C, thus the REQUIREMENT for smokers is increased by 35\u2009mg/day [79].']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 98)]	2	[('GO_0008152', 'metabolic process', 56, 'metabolic'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin C')]
PMC3171895	9/2011	S145-PMC3171895	['a CONSIDERABLE INTEREST exists regarding PREVENTION of Maternal and Perinatal Morbidity with Vitamins C and E. HOWEVER, the most RECENT meta-analysis of ten trials (6533 women) published in 2008 of antioxidant supplementation (including Vitamin C and e but also OTHER supplements such as Lycopene) SHOWED no difference in the relative risk (rr) of Preeclampsia (rr 0.73, 95% ci 0.51 to 1.06), Preterm Birth (before 37 weeks) (rr 1.10, 95% ci 0.99 to 1.22), sga infants (rr 0.83, 95% ci 0.62 to 1.11), or any baby death (rr 1.12, 95% ci 0.81 to 1.53) [7].']	[('ANOMALY_CURIOUS_FINDING', 2), ('ANOMALY_CURIOUS_FINDING', 15), ('IMPORTANT_CONSIDERATION', 15), ('SUPERFICIAL_RELATIONSHIP', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 129), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 262), ('INCOMPLETE_EVIDENCE', 298)]	8	[('GO_0007618', 'mating', 55, 'maternal ...'), ('GO_0019230', 'proprioception', 68, 'perinatal morbidity'), ('UBERON_0012101', 'perinatal stage', 68, 'perinatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamins C'), ('PR_000004900', 'complement C3', 102, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 108, 'E'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin C'), ('CHEBI_15948', 'lycopene', 288, 'lycopene'), ('GO_0007128', 'meiotic prophase I', 348, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 393, 'preterm'), ('GO_0007567', 'parturition', 401, 'birth')]
PMC3171895	9/2011	S149-PMC3171895	['FURTHER INVESTIGATIONS are REQUIRED AS the concentrations of these Vitamins REMAIN significantly reduced in women with Preeclampsia, but in the absence OF FURTHER EVIDENCE, routine supplementation with higher dose Vitamin C and E is not RECOMMENDED AS they CAN be POTENTIALLY dangerous in high concentrations.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('IMPORTANT_CONSIDERATION', 27), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 76), ('ANOMALY_CURIOUS_FINDING', 152), ('INCOMPLETE_EVIDENCE', 155), ('FUTURE_WORK', 237), ('PROBABLE_UNDERSTANDING', 249), ('INCOMPLETE_EVIDENCE', 257), ('INCOMPLETE_EVIDENCE', 264)]	11	[('CHEBI_33277', 'gamma-tocotrienol', 67, 'vitamins'), ('GO_0007128', 'meiotic prophase I', 119, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 228, 'E')]
PMC3184661	9/2006	S35-PMC3184661	['patients with UNCONTROLLED essential hypertension have elevated concentrations of Superoxide Anion (O2-*), Hydrogen Peroxide (H2O2), Lipid Peroxides, endothelin, and Transforming Growth Factor-beta (Tgf-Beta) with a simultaneous decrease in Endothelial Nitric Oxide (eno), Superoxide dismutase (sod), Vitamin E, and long-chain pufas (8).']	[('IMPORTANT_CONSIDERATION', 14)]	1	[('CHEBI_62945', 'thromboxane anion', 82, 'superoxide anion'), ('CHEBI_76710', 'EC 4.* (lyase) inhibitor', 100, 'O2-*),'), ('CHEBI_16240', 'hydrogen peroxide', 107, 'hydrogen peroxide'), ('CHEBI_16240', 'hydrogen peroxide', 126, 'H2O2'), ('CHEBI_48155', 'tetrahydrofurancarboxylic acid', 133, 'lipid peroxides'), ('PR_000000035', 'BMP receptor type-1A', 166, 'transforming growth factor-'), ('PR_000000046', 'TGF-beta', 199, 'TGF-beta'), ('UBERON_0001986', 'endothelium', 241, 'endothelial'), ('CHEBI_16480', 'nitric oxide', 253, 'nitric oxide'), ('CHEBI_18421', 'superoxide', 273, 'superoxide'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin E')]
PMC3231892	4/2011	S21-PMC3231892	['women of Reproductive age, ESPECIALLY Pregnant women, in developing countries are recognized to be AT RISK of multiple Micronutrient deficiencies, such as Iron, Folic Acid, Iodine, zinc, Vitamins A and d, riboflavin, b6 and b12, with the LIKELIHOOD of adverse EFFECTS on the mother and Pregnancy outcomes [1,6].']	[('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 99), ('PROBABLE_UNDERSTANDING', 238), ('SUPERFICIAL_RELATIONSHIP', 260)]	4	[('GO_0000003', 'reproduction', 9, 'reproductive'), ('GO_0007565', 'female pregnancy', 38, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 119, 'micronutrient'), ('CHEBI_24870', 'ion', 155, 'iron'), ('CHEBI_30751', 'formic acid', 161, 'folic acid'), ('CHEBI_24859', 'iodine atom', 173, 'iodine'), ('CHEBI_27300', 'vitamin D', 187, 'vitamins A'), ('GO_0007565', 'female pregnancy', 286, 'pregnancy')]
PMC3235789	12/2011	S99-PMC3235789	['in the case of Vitamin D deficiency, OUR FINDINGS are CONSISTENT with a RECENT cohort of Pregnant women, which FOUND a dose-response RELATIONSHIP between 25-Oh-D and the PREVALENCE of Bv during Pregnancy [29], and a nationally representative cross-sectional study of women in the united states, which found that 25-Oh-D <30\u2009ng/ml significantly increased the odds of bv during Pregnancy (aor 2.87, 95% ci: 1.13–7.28) [30].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 133), ('IMPORTANT_CONSIDERATION', 170)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnant'), ('CHEBI_17808', 'IDP', 157, 'OH-D'), ('PR_000004696', 'apoptosis facilitator Bcl-2-like protein 14', 184, 'BV'), ('GO_0007565', 'female pregnancy', 194, 'pregnancy'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 312, '25-OH-D'), ('GO_0007565', 'female pregnancy', 376, 'pregnancy')]
PMC3235789	12/2011	S104-PMC3235789	['there is EMERGING EVIDENCE that Vitamin D Regulates a KEY Antimicrobial peptide with broad Antimicrobial properties against gram-negative and gram-positive bacteria [40].']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 54)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 42, 'regulates'), ('CHEBI_65381', 'albizoside C', 58, 'antimicrobial'), ('CHEBI_65381', 'albizoside C', 91, 'antimicrobial')]
PMC3235789	12/2011	S110-PMC3235789	['also, suboptimal Vitamin D status, defined as 25-Oh-D <75\u2009nmol/l (30\u2009ng/ml), is more PREVALENT among non-hispanic black compared with non-hispanic white women (74–95% versus 46–62%) [46].']	[('IMPORTANT_CONSIDERATION', 85)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 46, '25-OH-D')]
PMC3235789	12/2011	S115-PMC3235789	['THUS, in addition to the myriad OTHER health REASONS for addressing the POOR UNDERLYING Vitamin D and Folate status of us women [48,49], decreasing the susceptibility of women of Reproductive age to bv MAY provide further RATIONALE.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('PROBABLE_UNDERSTANDING', 45), ('IMPORTANT_CONSIDERATION', 72), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 202), ('PROBABLE_UNDERSTANDING', 222)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 102, 'folate'), ('GO_0000003', 'reproduction', 179, 'reproductive')]
PMC3257641	3/2010	S4-PMC3257641	['the EVIDENCE to date SUPPORTS that women SHOULD BE monitored and treated for Vitamin D deficiency during Pregnancy BUT OPTIMAL and upper limit Serum 25(Oh)D levels during Pregnancy are NOT KNOWN.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('IMPORTANT_CONSIDERATION', 119), ('FULL_UNKNOWN', 185)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'pregnancy'), ('UBERON_0001977', 'blood serum', 143, 'serum'), ('CHEBI_71657', 'versiconol acetate', 149, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 149, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy')]
PMC3257641	3/2010	S5-PMC3257641	['1. review\nthe high PREVALENCE of Vitamin D insufficiency during Pregnancy is increasingly RECOGNIZED, amid GROWING EVIDENCE that the Intrauterine environment CAN have both immediate and long-lasting EFFECTS on health of the offspring.']	[('IMPORTANT_CONSIDERATION', 19), ('PROBABLE_UNDERSTANDING', 90), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 199)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('UBERON_0022293', 'reproductive gland secretion', 133, 'intrauterine')]
PMC3257641	3/2010	S45-PMC3257641	['NEVERTHELESS, low Vitamin D status is also PREVALENT in Pregnant caucasian populations, PARTICULARLY those not receiving supplementation (table 2).nutrients-02-00389-t002_table 2\n\ncaption (table-wrap): table 2\n\nthe prevalence of a low Vitamin D status in Pregnancy.referenceyearcountrypopulationstage Of Pregnancydefinition% n/n[127]1997iraniran women attending largest tehran hospitaldelivery<25 nmol/l80% (40/50)[128]1997-2001usaafrican american–90% receiving Prenatal Vitamins4-21 week Gestation<37.5 nmol/l44.9% (89/194)[128]1997-2001usawhite–90% receiving Prenatal Vitamins4-21 week Gestation<37.5 nmol/l2% (4/199)[128]1997-2001usaafrican–american37-42 weeks<37.5 nmol/l29.2% (54/185)[128]1997-2001usawhite37-42 weeks<37.5 nmol/l5% (10/199)[128]1997-2001usaturkish12 week Gestation<25 nmol/l83.5% (66/79)[128]1997-2001usamoroccan12 week Gestation<25 nmol/l81.2% (56/69)[128]1997-2001usaother non-western12 week Gestation<25 nmol/l59% (62/105)[129]1999irelandcaucasians in ulster–on supplements (54–55on)12 weeks<25 nmol/l4.5% (1/22)[129]1999irelandno supplements12 weeks<25 nmol/l44.2% (34/77)[129]1999irelandsupplements20 weeks<25 nmol/l22.7% (5/22)[129]1999irelandno supplements20 weeks<25 nmol/l50.6% (39/77)[129]1999irelandsupplements35 weeks<25 nmol/l0% (0/22)[129]1999irelandno supplements35 weeks<25 nmol/l20.8% (16/77)[32]1999-2000australiaveiled &/or dark skinned women attending Antenatal clinicduring Antenatal care, when a routine Blood test was ordered<22.5 nmol/l80.5% (66/82)[130]1999-2000united arab emirateskuwaitdelivery<25 nmol/l40% (86/214)[131]2002indiaattendees of queen mary’s hosptal, lucknow (26.8on) northern india – urbandelivery–full term, live<22.5 nmol/l84.3% (118/140)[131]2002indiaattendees of queen mary’s hosptal, lucknow (26.8on) northern india–urbanrural<56.3 nmol/l84%(56/67)[132]2005-2006indiaresidents of barabanki district, 26.8onsecond trimester<50 nmol/l74.1% (103/139)\n\n4.1.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 43), ('ANOMALY_CURIOUS_FINDING', 88), ('IMPORTANT_CONSIDERATION', 88)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnant'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy'), ('GO_0007308', 'oocyte construction', 301, 'of PregnancyDefinition'), ('GO_0007565', 'female pregnancy', 462, 'prenatal'), ('CHEBI_38749', 'dihydroxyflavanone', 471, 'vitamins4'), ('GO_0007565', 'female pregnancy', 489, 'gestation'), ('GO_0007565', 'female pregnancy', 561, 'prenatal'), ('CHEBI_38749', 'dihydroxyflavanone', 570, 'vitamins4'), ('GO_0007565', 'female pregnancy', 588, 'gestation'), ('GO_0007565', 'female pregnancy', 777, 'gestation'), ('GO_0007565', 'female pregnancy', 842, 'gestation'), ('GO_0007565', 'female pregnancy', 916, 'gestation'), ('GO_0007567', 'parturition', 1394, 'antenatal'), ('GO_0007567', 'parturition', 1417, 'antenatal'), ('UBERON_0000178', 'blood', 1448, 'blood')]
PMC3257641	3/2010	S78-PMC3257641	['HOWEVER, it is NOT CLEAR that the Vitamin D REQUIREMENTS of these largely nocturnal Animals REFLECT Human NEEDS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 15), ('IMPORTANT_CONSIDERATION', 44), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 84, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 100, 'human')]
PMC3257641	3/2010	S79-PMC3257641	['Human STUDIES ARE NEEDED AS inter-species variation in Vitamin D REQUIREMENTS and Metabolism MAY occur [55].']	[('FUTURE_WORK', 6), ('PROBABLE_UNDERSTANDING', 25), ('IMPORTANT_CONSIDERATION', 65), ('INCOMPLETE_EVIDENCE', 93)]	4	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0008152', 'metabolic process', 82, 'metabolism')]
PMC3257641	3/2010	S122-PMC3257641	['as Il-10 is IMPORTANT in the development of tolerance to exogenous Antigens and inhibition of Mast Cell Degranulation [57], these FINDINGS are CONSISTENT with the notion of low Vitamin D levels at Birth increasing the risk of an allergic propensity.']	[('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 143)]	3	[('PR_000001470', 'interleukin-28B', 3, 'IL-10'), ('CHEBI_59132', 'antigen', 67, 'antigens'), ('CL_0000097', 'mast cell', 94, 'mast cell'), ('GO_0030154', 'cell differentiation', 99, 'cell degranulation'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('GO_0007567', 'parturition', 197, 'birth')]
PMC3257641	3/2010	S132-PMC3257641	['this is a DIFFICULT BUT IMPORTANT AREA to research [101,102,103,104], with Animal work indicting transient Prenatal Vitamin D deficiency is ASSOCIATED with subtle alterations in Learning and Memory functions in Adult Rats [105].']	[('DIFFICULT_TASK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('IMPORTANT_CONSIDERATION', 24), ('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 140)]	5	[('NCBITaxon_33208', 'Metazoa', 75, 'animal'), ('GO_0007565', 'female pregnancy', 107, 'prenatal'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007612', 'learning', 178, 'learning'), ('GO_0007613', 'memory', 191, 'memory'), ('UBERON_0007023', 'adult organism', 211, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 217, 'rats')]
PMC3257641	3/2010	S134-PMC3257641	['OBSERVATIONAL studies provide INDIRECT EVIDENCE that low Vitamin D status during early Life MAY increase the RISK of multiple sclerosis [107,108].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 109)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0000104', 'life cycle', 87, 'life')]
PMC3257641	3/2010	S139-PMC3257641	['OTHER CANDIDATE diseases that REQUIRE FURTHER RESEARCH with regard to the POTENTIAL ROLE of Prenatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 30), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 84)]	7	[('GO_0007565', 'female pregnancy', 92, 'prenatal'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3257641	3/2010	S152-PMC3257641	['the MERIT of achieving a relatively high Vitamin D status (>100 nmol/l) has NOT BEEN FULLY ESTABLISHED, particularly in RELATION to offspring Cardiovascular or atopic disease development.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 120)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 142, 'cardiovascular')]
PMC3257641	3/2010	S153-PMC3257641	['HOWEVER, the MAJORITY of POTENTIAL adverse offspring health outcomes pertain to low Prenatal Vitamin D status and the EVOLVING EVIDENCE has provided greater IMPETUS for PUBLIC HEALTH EFFORTS to ensure mothers are not frankly Vitamin D deficient (<25 nmol/l) in Pregnancy, ALTHOUGH the value of treating relative Vitamin D insufficiency in Pregnancy is NOT clearly ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 169), ('FUTURE_WORK', 183), ('ANOMALY_CURIOUS_FINDING', 272), ('FULL_UNKNOWN', 352)]	9	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('GO_0007565', 'female pregnancy', 261, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D'), ('GO_0007565', 'female pregnancy', 339, 'pregnancy')]
PMC3257641	3/2010	S154-PMC3257641	['women AT RISK of Vitamin D deficiency SHOULD BE monitored and treated during Pregnancy for Vitamin D deficiency [22].']	[('IMPORTANT_CONSIDERATION', 6), ('FUTURE_WORK', 38)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC3257641	3/2010	S157-PMC3257641	['such trials NEED TO carefully CONSIDER the safety profile of the interventional Vitamin D administration provided.']	[('IMPORTANT_CONSIDERATION', 12), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 30)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC3257641	3/2010	S160-PMC3257641	['to examine the POTENTIAL long term EFFECTS of low Vitamin D on offspring health, randomized controlled trials STUDIES MAY NOT BE feasible, particularly for RARE diseases with later onset such as schizophrenia.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 35), ('FUTURE_WORK', 110), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 122), ('INCOMPLETE_EVIDENCE', 156)]	6	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC3257641	3/2010	S162-PMC3257641	['in this situation, the timing of low Vitamin D’s EFFECT over the Life Course will HAVE TO BE carefully determined, using specific Life Course analytic techniques [125], TO ASSESS WHETHER any low Prenatal Vitamin D status is INDEPENDENTLY ASSOCIATED with health outcomes INDEPENDENTLY of the mother’s Vitamin D status before Pregnancy and the offspring’s Vitamin D status during Postnatal Life.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('SUPERFICIAL_RELATIONSHIP', 224), ('SUPERFICIAL_RELATIONSHIP', 238), ('SUPERFICIAL_RELATIONSHIP', 270)]	7	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0001281', 'hepatic sinusoid', 65, 'life course'), ('UBERON_0001281', 'hepatic sinusoid', 130, 'life course'), ('GO_0007565', 'female pregnancy', 195, 'prenatal'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin D'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 354, 'vitamin D'), ('GO_0007567', 'parturition', 378, 'postnatal'), ('UBERON_0000104', 'life cycle', 388, 'life')]
PMC3271033	1/2012	S14-PMC3271033	['Serum 25-Hydroxyvitamin D (25(Oh)D) is ACCEPTED as the BEST MARKER of Vitamin D status ALTHOUGH it MAY serve PRIMARILY as a MARKER of exposure RATHER than clinical outcomes [2].there are FEW DATA that CORRELATE Serum 25(Oh)D levels with functional outcomes in newborns and small infants.']	[('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('INCOMPLETE_EVIDENCE', 99), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 201)]	10	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 6, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0001977', 'blood serum', 211, 'serum'), ('CHEBI_71657', 'versiconol acetate', 217, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 217, '25(OH)D')]
PMC3271033	1/2012	S116-PMC3271033	['these extremely low values are NOT COMMONLY reported in the united states, ALTHOUGH we SPECULATE that an increasing NUMBER OF cases MAY BE reported in the FUTURE DUE TO INCREASED AWARENESS of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 31), ('ANOMALY_CURIOUS_FINDING', 75), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 132), ('FUTURE_PREDICTION', 155), ('PROBABLE_UNDERSTANDING', 162), ('IMPORTANT_CONSIDERATION', 169)]	8	[('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC3271033	1/2012	S132-PMC3271033	['HOWEVER, it is LIKELY that by three months of age, Vitamin D has a KEY ROLE in calcium absorption, especially in Breast-Fed infants with a relatively low Calcium Intake COMPARED TO formula-Fed infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 15), ('IMPORTANT_CONSIDERATION', 67), ('SUPERFICIAL_RELATIONSHIP', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007567', 'parturition', 113, 'breast'), ('UBERON_0000310', 'breast', 113, 'breast'), ('GO_0007631', 'feeding behavior', 120, 'fed'), ('CHEBI_22313', 'alkaline earth metal atom', 154, 'calcium'), ('GO_0007631', 'feeding behavior', 162, 'intake'), ('GO_0007631', 'feeding behavior', 189, 'fed')]
PMC3271033	1/2012	S137-PMC3271033	['THEREFORE, in considering early Vitamin D supplementation, the QUESTION becomes WHETHER there is physiological BENEFIT to rapid replenishment with Vitamin D (e.g.']	[('PROBABLE_UNDERSTANDING', 0), ('EXPLICIT_QUESTION', 63), ('EXPLICIT_QUESTION', 80), ('IMPORTANT_CONSIDERATION', 111)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC3271033	1/2012	S147-PMC3271033	['the 30 ng/ml target is well above that LIKELY TO BE NEEDED for adequate Vitamin D status in the newborn BASED UPON the recent RECOMMENDATIONS of the institute of medicine [2].']	[('FUTURE_PREDICTION', 39), ('SUPERFICIAL_RELATIONSHIP', 104), ('IMPORTANT_CONSIDERATION', 126)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC3272870	12/2011	S42-PMC3272870	['during Pregnancy Vitamin D and Calcium Metabolism undergo significant changes to provide the calcium NEEDED for maternal Skeletal preservation and foetal Skeletal Formation.']	[('IMPORTANT_CONSIDERATION', 101)]	1	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0070583', 'spore membrane bending pathway', 17, 'vitamin D ...'), ('CHEBI_22313', 'alkaline earth metal atom', 31, 'calcium'), ('GO_0018884', 'carbazole metabolic process', 31, 'calcium metabolism'), ('UBERON_0004288', 'skeleton', 121, 'skeletal'), ('GO_0001501', 'skeletal system development', 154, 'skeletal formation'), ('UBERON_0004288', 'skeleton', 154, 'skeletal')]
PMC3272870	12/2011	S45-PMC3272870	['moreover, the usual RECOMMENDATIONS to avoid sun exposure reduces dermal Synthesis Of Vitamin D3Although Vitamin D is UNDOUBTEDLY IMPORTANT for foetal Bone Development, we KNOW that it plays a much wider ROLE in health and disease prevention.']	[('FUTURE_WORK', 20), ('ANOMALY_CURIOUS_FINDING', 96), ('PROBABLE_UNDERSTANDING', 118), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 204)]	6	[('GO_0030474', 'spindle pole body duplication', 73, 'synthesis of ... D3Although'), ('CHEBI_83701', '8-PAHSA(1-)', 86, 'vitamin D3Although'), ('PR_000027594', 'histone H3', 86, 'vitamin D3Although'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0048539', 'bone marrow development', 151, 'bone development')]
PMC3272870	12/2011	S51-PMC3272870	['Vitamin D is LIKELY SAFE during Pregnancy and Breast feeding when taken by mouth in RECOMMENDED amounts, that is 10 mcg (400 usp units) of Vitamin D daily in normal Pregnancy.']	[('PROBABLE_UNDERSTANDING', 13), ('IMPORTANT_CONSIDERATION', 20), ('FUTURE_WORK', 84)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 32, 'pregnancy'), ('UBERON_0000310', 'breast', 46, 'breast'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy')]
PMC3272870	12/2011	S54-PMC3272870	['the range between therapeutic and toxic doses is narrow, and Vitamin D toxicity, when it occurs, is a SERIOUS PROBLEM.']	[('IMPORTANT_CONSIDERATION', 102), ('IMPORTANT_CONSIDERATION', 110)]	2	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC3276988	9/2011	S92-PMC3276988	['[24] cleft palate HAS been experimentally produced in new Born Rats by Feeding diets either deficient or excessive in Vitamin A to maternal Rats during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 18)]	1	[('GO_0007567', 'parturition', 58, 'born'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 63, 'rats'), ('GO_0007631', 'feeding behavior', 71, 'feeding'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin A'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 140, 'rats'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy')]
PMC3277098	12/2011	S20-PMC3277098	['more RECENTLY variations in Vitamin D status and intake HAS BEEN IMPLICATED in Allergy Development and CONSIDERED AS one of a NUMBER OF EXPLANATIONS for epidemiological and immunological ASSOCIATIONS.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 103), ('PROBABLE_UNDERSTANDING', 114), ('INCOMPLETE_EVIDENCE', 126), ('PROBABLE_UNDERSTANDING', 136), ('SUPERFICIAL_RELATIONSHIP', 187)]	9	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0060021', 'roof of mouth development', 79, 'allergy development')]
PMC3277098	12/2011	S27-PMC3277098	['a large percentage of Human Vitamin D REQUIREMENTS are provided via sun exposure [14] (at latitudes with adequate uvb exposure) which acts through stimulating the conversion of 7-Dehydrocholesterol into d3 in the skin [15].']	[('IMPORTANT_CONSIDERATION', 38)]	1	[('NCBITaxon_9606', 'Homo sapiens', 22, 'human'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 177, '7-dehydrocholesterol')]
PMC3277098	12/2011	S50-PMC3277098	['to date, the MAJORITY of research HAS BEEN conducted using cells sourced from peripheral Blood; HOWEVER SOME authors have PROPOSED that Gut-associated lymphoid Tissue MAY be of RELEVANCE, particularly in regard to oral Vitamin D Intake and Food Allergen sensitization [33].']	[('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 122), ('INCOMPLETE_EVIDENCE', 167), ('IMPORTANT_CONSIDERATION', 177)]	7	[('UBERON_0000178', 'blood', 89, 'blood'), ('UBERON_0001555', 'digestive tract', 136, 'gut'), ('UBERON_0000479', 'tissue', 160, 'tissue'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('GO_0007631', 'feeding behavior', 229, 'intake'), ('CHEBI_33290', 'food', 240, 'food'), ('CHEBI_50904', 'allergen', 245, 'allergen')]
PMC3277098	12/2011	S111-PMC3277098	['in japan, a MAJOR source of dietary Vitamin D is fish which is a rich source of N-3 Fatty Acids, WHEREAS OTHER countries such as the us rely heavily on Vitamin D fortified Milk [51] which is relatively high in saturated, and low in polyunsaturated, Fatty Acids [52].']	[('IMPORTANT_CONSIDERATION', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_35418', 'N-acetylneuraminate', 80, 'n-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('UBERON_0001913', 'milk', 172, 'milk'), ('CHEBI_35366', 'fatty acid', 249, 'fatty acids')]
PMC3277098	12/2011	S120-PMC3277098	['HOWEVER, there was no association between maternal Vitamin D and eczema RISK at 3 years.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 72)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3277098	12/2011	S185-PMC3277098	['SUPPORTING this observation are SEVERAL STUDIES which FOUND Vitamin D supplementation to be ASSOCIATED with an INCREASED RISK of atopic dermatitis [73], allergic rhinitis [35,74], asthma, sensitisation [69,74] and Food allergy [70], HOWEVER NONE of these papers are SUPPORTED by biological measures of Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 233), ('INCOMPLETE_EVIDENCE', 241), ('INCOMPLETE_EVIDENCE', 266)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_33290', 'food', 214, 'food'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC3277098	12/2011	S187-PMC3277098	['[74] reported that supplementation with 50 µg Vitamin D/day (2000 iu) in the first year of Life was ASSOCIATED with a higher RISK of allergic rhinitis (or 1.66; 95% ci 1.1–1.6, p< 0.001) and atopy (or 1.46; 95% ci 1.4–2.0, p< 0.001).']	[('SUPERFICIAL_RELATIONSHIP', 100), ('IMPORTANT_CONSIDERATION', 125)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0000104', 'life cycle', 91, 'life')]
PMC3277098	12/2011	S189-PMC3277098	['HOWEVER, OTHER authors investigating infant Intakes in this lower dose range (closer to aap recommendations) HAVE ALSO SHOWN that atopic manifestations (particularly atopic dermatitis) were more prevalent in children with “high” (>13.1 μg/day) versus “low” (≤13.1 μg/day) intake of Vitamin D [73].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 114)]	4	[('GO_0007631', 'feeding behavior', 44, 'intakes'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC3277098	12/2011	S201-PMC3277098	['FUTURE RESEARCH MUST accurately account for the DIFFERENT sources of Vitamin D, stage of Immune Development and Genetic FACTORS in order to understand the immunological consequences of changing Vitamin d status through supplementation or lifestyle changes.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0001822', 'kidney development', 89, 'immune development'), ('UBERON_0002405', 'immune system', 89, 'immune'), ('SO_0000704', 'gene', 112, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 194, 'vitamin')]
PMC3277098	12/2011	S205-PMC3277098	['AS this early Life stage is RELEVANT TO programming of future Immune function it is CRUCIAL to understand the EFFECTS of Vitamin D and identify optimal status levels.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('UBERON_0000104', 'life cycle', 14, 'life'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC3277098	12/2011	S207-PMC3277098	['RANDOMIZED control TRIALS are ultimately REQUIRED to determine the EFFECTS of Vitamin D supplementation on the developing Immune System, and any POTENTIAL ROLE in preventing allergic disease.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 19), ('FUTURE_WORK', 41), ('IMPORTANT_CONSIDERATION', 41), ('SUPERFICIAL_RELATIONSHIP', 67), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 155)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002405', 'immune system', 122, 'immune system')]
PMC3296991	2/2012	S83-PMC3296991	['polymorphisms in the Vitamin D Receptor Gene MAY CONTRIBUTE to racial DISPARITIES in fetal growth and bone mineralization [20,21], although ADDITIONAL RESEARCH IS WARRANTED in this area.']	[('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 70), ('FUTURE_WORK', 140), ('FUTURE_WORK', 151)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 21, 'vitamin D receptor'), ('SO_0000704', 'gene', 40, 'gene')]
PMC3296991	2/2012	S98-PMC3296991	['FURTHER RESEARCH is NECESSARY to CONSIDER the behavior of OTHER BIOMARKERS in RELATIONSHIP to Vitamin D status and their POTENTIAL CONTRIBUTION to PREDICTION of neonatal wbbmc.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 20), ('FUTURE_WORK', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('SUPERFICIAL_RELATIONSHIP', 64), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 147)]	9	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3296991	2/2012	S102-PMC3296991	['because Vitamin D inadequacy during Gestation and its IMPACTS on offspring bone integrity are of PUBLIC HEALTH CONCERN, FURTHER STUDIES ARE WARRANTED to investigate the COMPLEX mechanisms LINKING in utero Vitamin D status to fetal Bone Development.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 97), ('FUTURE_WORK', 120), ('FUTURE_WORK', 128), ('DIFFICULT_TASK', 169), ('SUPERFICIAL_RELATIONSHIP', 188)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 36, 'gestation'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('GO_0048539', 'bone marrow development', 231, 'bone development')]
PMC3309463	6/2011	S43-PMC3309463	['it HAS BEEN PROPOSED that developmental Vitamin D deficiency MAY CONTRIBUTE to the increased risk of schizophrenia in dark-skinned migrants and those living in crowded urban settings.28both dark skin and urban residence are ASSOCIATED with an INCREASED risk of hypovitaminosis D.29developmental Vitamin D deficiency MAY also UNDERLIE the well-replicated season of birth EFFECT FOUND in schizophrenia (those Born in winter and spring have a small but significant increased risk of schizophrenia).30vitamin D is a potent pro-differentiation agent and CAN INFLUENCE Brain functioning via many DIFFERENT pathways.31the Vitamin D receptor and the enzyme required for the manufacture of the hormonally active form of Vitamin D have BEEN IDENTIFIED in the Human Brain,32AND THERE IS EVIDENCE from Rodent MODELS DEMONSTRATING that transient Prenatal Vitamin D deficiency results in persistent changes in Adult Brain structure, neurochemistry and behavior.33our species has evolved in settings where Vitamin D is abundant, and migration to colder climates and urban-related lifestyle factors have left modern Humans at increased risk of hypovitaminosis D.\ninspired by the conceptual framework described above, we PROPOSE that the absence of adequate Vitamin D levels during development deprives the Organism of expected instructions from the environment.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 224), ('IMPORTANT_CONSIDERATION', 243), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 325), ('SUPERFICIAL_RELATIONSHIP', 370), ('INCOMPLETE_EVIDENCE', 377), ('INCOMPLETE_EVIDENCE', 549), ('SUPERFICIAL_RELATIONSHIP', 553), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 590), ('ANOMALY_CURIOUS_FINDING', 726), ('INCOMPLETE_EVIDENCE', 731), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 761), ('INCOMPLETE_EVIDENCE', 767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 797), ('INCOMPLETE_EVIDENCE', 797), ('INCOMPLETE_EVIDENCE', 804), ('INCOMPLETE_EVIDENCE', 1204)]	21	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 277, 'D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D'), ('GO_0007567', 'parturition', 407, 'born'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 505, 'D'), ('UBERON_0000955', 'brain', 563, 'brain'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 711, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'human'), ('UBERON_0000955', 'brain', 755, 'brain'), ('NCBITaxon_33208', 'Metazoa', 790, 'rodent'), ('GO_0007565', 'female pregnancy', 833, 'prenatal'), ('CHEBI_27300', 'vitamin D', 842, 'vitamin D'), ('UBERON_0007023', 'adult organism', 896, 'adult'), ('UBERON_0000955', 'brain', 902, 'brain'), ('CHEBI_27300', 'vitamin D', 991, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1100, 'humans'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1144, 'D'), ('CHEBI_27300', 'vitamin D', 1241, 'vitamin D'), ('NCBITaxon_1', 'root', 1290, 'organism')]
PMC3309463	6/2011	S44-PMC3309463	['we SPECULATE that (a) developmental Vitamin D deficiency MAY underlie KEY features of the epidemiology of schizophrenia, (b) the Vitamin D deficiency during development decanalizes Brain Development and (c) schizophrenia is a behavioral phenotype ASSOCIATED with increased variance ASSOCIATED with this decanalization of Brain Development.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 70), ('SUPERFICIAL_RELATIONSHIP', 247), ('SUPERFICIAL_RELATIONSHIP', 282)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007420', 'brain development', 181, 'brain development'), ('UBERON_0000955', 'brain', 181, 'brain'), ('GO_0007420', 'brain development', 321, 'brain development'), ('UBERON_0000955', 'brain', 321, 'brain')]
PMC3319623	4/2012	S60-PMC3319623	['Animal MODELS of Gestational Vitamin D deficiency HIGHLIGHT the IMPORTANT ROLE of Vitamin D for correct Neurodevelopment[25].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 50), ('IMPORTANT_CONSIDERATION', 64), ('SUPERFICIAL_RELATIONSHIP', 74)]	4	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('GO_0007565', 'female pregnancy', 17, 'gestational'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007399', 'nervous system development', 104, 'neurodevelopment')]
PMC3319623	4/2012	S61-PMC3319623	['furthermore, neonatal Vitamin D levels are significantly ASSOCIATED with RISK of schizophrenia later in Life[26].']	[('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 73)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0000104', 'life cycle', 104, 'life')]
PMC3319623	4/2012	S63-PMC3319623	['SIMILAR mechanisms MAY apply to bad and rdd, BUT the EVIDENCE for Vitamin D in these disorders is much LESS STRONG and OTHER FACTORS such as maternal infections and fluctuations in diet MAY also play an IMPORTANT ROLE.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 125), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 203), ('SUPERFICIAL_RELATIONSHIP', 213)]	11	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3338544	4/2012	S10-PMC3338544	['introduction\nan INCREASING body of epidemiological EVIDENCE SUPPORTS the HYPOTHESIS that maternal Vitamin D deficiency is a risk-modifying factor for schizophrenia[1],[2].']	[('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 73)]	4	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC3338544	4/2012	S170-PMC3338544	['such DIFFERENCES HIGHLIGHT the IMPORTANCE of species and strain selection in studies of altered Vitamin D Signalling and Brain Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 31)]	3	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0048371', 'lateral mesodermal cell differentiation', 96, 'vitamin D signalling'), ('GO_0007420', 'brain development', 121, 'brain development'), ('UBERON_0000955', 'brain', 121, 'brain')]
PMC3347007	4/2012	S6-PMC3347007	['we PROPOSE that clinicians ENCOURAGE Vitamin D supplementation among Pregnant women, with SPECIAL FOCUS on vulnerable groups such as the young, smokers and multiparous women, in order to improve maternal and fetal health both during and after Pregnancy.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 27), ('IMPORTANT_CONSIDERATION', 90), ('IMPORTANT_CONSIDERATION', 98)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('GO_0007565', 'female pregnancy', 243, 'pregnancy')]
PMC3347007	4/2012	S9-PMC3347007	['the need for Vitamin D CAN be fulfilled by exposing skin to sunlight; however, in northern latitudes the sun exposure only synthesizes Vitamin D from april to october [1] and Vitamin D MUST BE obtained from OTHER sources during the winter period.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 207)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC3347007	4/2012	S15-PMC3347007	['in the unborn child, Vitamin D is IMPORTANT for fetal Bone Development through its ROLE in Regulating Calcium Homeostasis [6,7].']	[('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0048539', 'bone marrow development', 54, 'bone development'), ('GO_0065007', 'biological regulation', 91, 'regulating'), ('GO_0055073', 'cadmium ion homeostasis', 102, 'calcium homeostasis')]
PMC3347007	4/2012	S28-PMC3347007	['this information CAN HELP identify women AT RISK of insufficient Vitamin D intake and POTENTIALLY Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 21), ('IMPORTANT_CONSIDERATION', 41), ('INCOMPLETE_EVIDENCE', 86)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC3347007	4/2012	S131-PMC3347007	['none of the participants reported dietary intakes that match the RECOMMENDED intake level in Pregnancy of 10 µg per day, which underlines the NECESSITY of Vitamin D supplementation.']	[('FUTURE_WORK', 65), ('IMPORTANT_CONSIDERATION', 142)]	2	[('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC3347007	4/2012	S132-PMC3347007	['the RECOMMENDATIONS for Pregnant women in most northern countries include a Vitamin D supplement of 10 µg per day.']	[('FUTURE_WORK', 4), ('IMPORTANT_CONSIDERATION', 4)]	2	[('GO_0007565', 'female pregnancy', 24, 'pregnant'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC3347007	4/2012	S145-PMC3347007	['we FOUND Supplements to contribute substantially to Vitamin D intake, but a large group of women STILL did not reach the RECOMMENDED level of intake.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 97), ('FUTURE_WORK', 121)]	3	[('CHEBI_33341', 'titanium atom', 9, 'supplements'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC3347007	4/2012	S146-PMC3347007	['public ATTENTION MUST BE focused on Vitamin D supplementation in order to improve PUBLIC HEALTH.']	[('IMPORTANT_CONSIDERATION', 7), ('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 82)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3347007	4/2012	S156-PMC3347007	['smokers MIGHT be overall less health conscious and THEREFORE not aware of the IMPORTANCE of using Vitamin D supplements in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 78)]	3	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy')]
PMC3347007	4/2012	S166-PMC3347007	['it is QUESTIONABLE WHETHER this ASSOCIATION is random OR IF it REFLECTS a seasonal variation in dietary Vitamin D intake OR in the AWARENESS of the IMPORTANCE of Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('SUPERFICIAL_RELATIONSHIP', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('SUPERFICIAL_RELATIONSHIP', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('IMPORTANT_CONSIDERATION', 131), ('IMPORTANT_CONSIDERATION', 148)]	8	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC3347007	4/2012	S178-PMC3347007	['IT IS POSSIBLE that null value IMPUTATION has caused an UNDERESTIMATION of Vitamin D supplementation, BUT since the ESTIMATED use of Vitamin D supplements is SIMILAR TO the one SEEN in norway [17], and lower than the one in finland [27], we do not think this ISSUE is RELEVANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('PROBLEM_COMPLICATION', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 177), ('PROBLEM_COMPLICATION', 259), ('IMPORTANT_CONSIDERATION', 268)]	9	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC3347007	4/2012	S184-PMC3347007	['determinants of Vitamin D insufficiency MUST BE TAKEN INTO CONSIDERATION in making RECOMMENDATIONS on Vitamin D intake in Pregnancy, to include more vulnerable groups that MAY BE at higher risk of deficiency.']	[('IMPORTANT_CONSIDERATION', 40), ('IMPORTANT_CONSIDERATION', 48), ('FUTURE_WORK', 83), ('INCOMPLETE_EVIDENCE', 172)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy')]
PMC3347007	4/2012	S190-PMC3347007	['we PROPOSE that clinicians SHOULD ENCOURAGE Vitamin D supplementation among Pregnant women, with a SPECIAL FOCUS on vulnerable groups, such as younger, smoking and multiparous women, IN ORDER to improve maternal and fetal health both during and after Pregnancy.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 27), ('FUTURE_WORK', 34), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 107), ('QUESTION_ANSWERED_BY_THIS_WORK', 183)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnant'), ('GO_0007565', 'female pregnancy', 251, 'pregnancy')]
PMC3347028	3/2012	S2-PMC3347028	['there are clear indicators from in vitro and Animal in vivo studies that POINT to Vitamin D’s INDISPUTABLE ROLE in both Innate and Adaptive Immunity; HOWEVER, the translation of THESE FINDINGS to clinical practice, including the Care of the Pregnant woman, has not occurred.']	[('INCOMPLETE_EVIDENCE', 73), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 178)]	5	[('NCBITaxon_33208', 'Metazoa', 45, 'animal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007631', 'feeding behavior', 120, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 131, 'adaptive immunity'), ('GO_0007567', 'parturition', 229, 'care'), ('GO_0007565', 'female pregnancy', 241, 'pregnant')]
PMC3347028	3/2012	S16-PMC3347028	['it is with these CAUTIONS and confessions that we approach THIS review about Vitamin D’s ROLE during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC3347028	3/2012	S18-PMC3347028	['during this foray into the world of Vitamin D and the fetus, we MUST first define WHAT Vitamin D is, WHAT it is not, and review the Metabolic pathways LINKED with Vitamin D.\n\n2.']	[('IMPORTANT_CONSIDERATION', 64), ('EXPLICIT_QUESTION', 82), ('EXPLICIT_QUESTION', 101), ('SUPERFICIAL_RELATIONSHIP', 151)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0008152', 'metabolic process', 132, 'metabolic'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3347028	3/2012	S30-PMC3347028	['it is IMPORTANT TO NOTE that UNLIKE OTHER Steroid hormones in the body whose main substrate is Cholesterol, Vitamin D Synthesis requires the 7-Dehydrocholesterol precursor and sunlight at a specific wavelength and angle.']	[('IMPORTANT_CONSIDERATION', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36)]	3	[('CHEBI_35341', 'steroid', 42, 'steroid'), ('CHEBI_16113', 'cholesterol', 95, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0031151', 'histone methyltransferase activity (H3-K79 specific)', 116, 'D synthesis'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 141, '7-dehydrocholesterol')]
PMC3347028	3/2012	S36-PMC3347028	['general Vitamin D Metabolism\nIN ORDER TO understand the DIFFERENCES between the nonpregnant and Pregnant states and their EFFECTS on Vitamin D Metabolism, it is ESSENTIAL to understand the nonpregnant state first.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('SUPERFICIAL_RELATIONSHIP', 122), ('IMPORTANT_CONSIDERATION', 161)]	4	[('CHEBI_28384', 'vitamin K', 8, 'Vitamin D'), ('GO_0046443', 'FAD metabolic process', 8, 'Vitamin D Metabolism'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 8, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnant'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 133, 'vitamin D metabolism'), ('PR_000006444', 'diacylglycerol kinase delta', 141, 'D')]
PMC3347028	3/2012	S49-PMC3347028	['adequate Vitamin D MUST BE on hand to provide enough substrate to form 25(Oh)D, which in turn, is converted to 1,25(Oh)2D, whose half-life is 8 hours.']	[('IMPORTANT_CONSIDERATION', 19)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 116, 'OH)2D')]
PMC3347028	3/2012	S61-PMC3347028	['focusing on the innate Immune System first, a MAJOR mechanism of action of Vitamin D is via an endogenous Antimicrobial peptide called Cathelicidin (Ll-37), which is generated in response to Microbial Invasion through activation of toll-2 receptors (tlr) on Monocytes and Macrophages [19,20,21].']	[('IMPORTANT_CONSIDERATION', 46)]	1	[('GO_0007566', 'embryo implantation', 23, 'immune'), ('UBERON_0002405', 'immune system', 23, 'immune system'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_65381', 'albizoside C', 106, 'antimicrobial'), ('PR_000006009', 'alpha-catulin', 135, 'cathelicidin'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 149, 'LL-37'), ('GO_0000266', 'mitochondrial fission', 191, 'microbial invasion'), ('NCBITaxon_10088', 'Mus <genus>', 191, 'microbial'), ('CL_0000576', 'monocyte', 258, 'monocytes'), ('CL_0000235', 'macrophage', 272, 'macrophages')]
PMC3347028	3/2012	S70-PMC3347028	['[23], SHOWED that Ifn-Γ-mediated Antimicrobial activity of Human Macrophages, especially IMPORTANT in hiv and tuberculosis patients, is DEPENDENT on Vitamin D. BOTH STUDY findings have IMPLICATIONS for the Pregnant woman and her developing fetus, BUT our understanding of such processes following maternal exposure to a pathogen or maternal infection REMAINS SCANT.']	[('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 89), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 185), ('ANOMALY_CURIOUS_FINDING', 247), ('INCOMPLETE_EVIDENCE', 351), ('INCOMPLETE_EVIDENCE', 359)]	8	[('PR_000008920', 'interferon alpha-7', 18, 'IFN-γ'), ('CHEBI_65381', 'albizoside C', 33, 'antimicrobial'), ('NCBITaxon_9606', 'Homo sapiens', 59, 'human'), ('CL_0000235', 'macrophage', 65, 'macrophages'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 206, 'pregnant')]
PMC3347028	3/2012	S87-PMC3347028	['it IS NOT SURPRISING, then that during Pregnancy pth as a MARKER of Vitamin D status is a LESS RELIABLE PREDICTOR than in nonpregnant Adults [60,61,62].']	[('PROBABLE_UNDERSTANDING', 3), ('PROBABLE_UNDERSTANDING', 6), ('ANOMALY_CURIOUS_FINDING', 10), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 104)]	7	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adults')]
PMC3347028	3/2012	S105-PMC3347028	['with rickets, Bone Formation and Development is SERIOUSLY altered with SEVERE Vitamin D ( i.e.']	[('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 71)]	2	[('GO_0048539', 'bone marrow development', 14, 'bone formation ... development'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3347028	3/2012	S107-PMC3347028	['beyond childhood, SEVERE Vitamin D deficiency CAN occur in young women, including those who are Pregnant, with higher RISK with advancing age in a woman’s Lifecycle.']	[('IMPORTANT_CONSIDERATION', 18), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 118)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnant'), ('GO_0006266', 'DNA ligation', 155, 'lifecycle')]
PMC3347028	3/2012	S123-PMC3347028	['a GLOBAL PERSPECTIVE on Vitamin D status of women during Pregnancy\nwith improved laboratory techniques for the measurement of Vitamin D developed in the early 1980’s [73], investigators began to measure the Vitamin D status of Pregnant women.']	[('IMPORTANT_CONSIDERATION', 2), ('INCOMPLETE_EVIDENCE', 9)]	2	[('CHEBI_28384', 'vitamin K', 24, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('GO_0007565', 'female pregnancy', 227, 'pregnant')]
PMC3347028	3/2012	S133-PMC3347028	['women—including Pregnant women, with a bmi greater than 30 are at INCREASED RISK of Vitamin D deficiency [70].']	[('IMPORTANT_CONSIDERATION', 66)]	1	[('GO_0007565', 'female pregnancy', 16, 'pregnant'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC3347028	3/2012	S145-PMC3347028	['with SEVERE maternal Vitamin D deficiency, the fetus rarely MAY develop rickets in utero with manifestation at Birth [96].']	[('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 60)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007567', 'parturition', 111, 'birth')]
PMC3347028	3/2012	S156-PMC3347028	['BECAUSE Vitamin D status has not been a consistent CONCERN during Pregnancy, long-term DATA are SPARSE.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 87)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy')]
PMC3347028	3/2012	S158-PMC3347028	['reports of neonatal seizures due to SEVERE hypocalcemia or rickets in utero that is manifested at Birth from SEVERE maternal and THUS fetal Vitamin D deficiency are RARE and do not further our understanding of POTENTIAL epigenetic EFFECTS of Vitamin D [122,123].']	[('IMPORTANT_CONSIDERATION', 36), ('IMPORTANT_CONSIDERATION', 109), ('PROBABLE_UNDERSTANDING', 129), ('INCOMPLETE_EVIDENCE', 165), ('INCOMPLETE_EVIDENCE', 210), ('SUPERFICIAL_RELATIONSHIP', 231)]	6	[('GO_0007567', 'parturition', 98, 'birth'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D')]
PMC3347028	3/2012	S163-PMC3347028	['WHILE we await the results of numerous clinical trials now underway TO determine IF there is a discernible EFFECT of Vitamin D in altering RISK for various disease states to understand the ROLE of Vitamin D in health, it is IMPORTANT not TO discount the MOUNTING EVIDENCE from laboratory studies and prospective observation trials [103,104,105] that Vitamin D—as a preprohormone—is ESSENTIAL in maintaining the Immune System with PROFOUND IMPLICATIONS [19,138,139,140].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 139), ('SUPERFICIAL_RELATIONSHIP', 189), ('IMPORTANT_CONSIDERATION', 224), ('QUESTION_ANSWERED_BY_THIS_WORK', 238), ('INCOMPLETE_EVIDENCE', 254), ('IMPORTANT_CONSIDERATION', 382), ('IMPORTANT_CONSIDERATION', 430), ('IMPORTANT_CONSIDERATION', 439)]	12	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('UBERON_0002405', 'immune system', 411, 'immune system')]
PMC3347028	3/2012	S166-PMC3347028	['GIVES INVALUABLE INSIGHT into Vitamin D status of darker Pigmented Individuals living in a sun-rich environment in eastern africa [141].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 6), ('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 17)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 57, 'pigmented'), ('NCBITaxon_1', 'root', 67, 'individuals')]
PMC3347028	3/2012	S179-PMC3347028	['a large proportion of the younger Adult population MAY follow these guidelines, which MAY increase the RISK of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 86), ('IMPORTANT_CONSIDERATION', 103)]	3	[('UBERON_0007023', 'adult organism', 34, 'adult'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC3347028	3/2012	S180-PMC3347028	['SINCE the modern diet supplies less than 10% of one’s total Vitamin D REQUIREMENTS, IF judicious sunlight exposure is not an option, then the only alternative for the Pregnant woman is Vitamin D supplementation.']	[('PROBLEM_COMPLICATION', 0), ('IMPORTANT_CONSIDERATION', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 167, 'pregnant'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3347028	3/2012	S182-PMC3347028	['effectiveness of Vitamin D supplementation during Pregnancy\nthere HAS BEEN a PAUCITY OF studies evaluating the REQUIREMENTS and EFFECTS of Vitamin D supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 111), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_28384', 'vitamin K', 17, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 172, 'pregnancy')]
PMC3347028	3/2012	S187-PMC3347028	['results of two RECENT randomized controlled trials during Pregnancy\nin our RECENTLY completed nichd Vitamin D supplementation trial involving a diverse group of Pregnant women less than 16 weeks of Gestation, 4000 iu (100 μg) Vitamin D3/day was SUPERIOR to 400 (control)- or 2000 iu/day in achieving circulating 25(Oh)d of at least 40 ng/ml (100 nmol/l), the point at which 1,25(Oh)2D begins to be optimized (seefigure 2) [6].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 245)]	3	[('GO_0007565', 'female pregnancy', 58, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'pregnant'), ('GO_0007565', 'female pregnancy', 198, 'gestation'), ('CHEBI_33279', 'vitamin D5', 226, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 226, 'vitamin D3'), ('CHEBI_63056', 'zinc cation', 312, '25(OH'), ('CHEBI_82784', 'PVP38-Ag NP', 374, '1,25(OH)2D')]
PMC3347028	3/2012	S191-PMC3347028	['EVEN in the latter trial where women were randomized to either 2000 iu (50 μg) or 4000 iu (100 μg) Vitamin D3/day, there were no safety ISSUES surrounding Vitamin D supplementation and there was a TREND where specific health COMPLICATIONS of Pregnancy such as Preterm Birth, Preterm Labor, hypertensive orders of Pregnancy, Gestational diabetes, and infection were higher in the 400 iu-compared with the 4000 iu-group, but did not reach statistical significance [149].']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 136), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 197), ('IMPORTANT_CONSIDERATION', 225), ('PROBLEM_COMPLICATION', 225)]	6	[('CHEBI_33279', 'vitamin D5', 99, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 99, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('GO_0007565', 'female pregnancy', 260, 'preterm birth'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 275, 'preterm labor'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy'), ('GO_0007565', 'female pregnancy', 324, 'gestational')]
PMC3347028	3/2012	S215-PMC3347028	['the SIGNIFICANCE of these trials is that Vitamin D status is improved with 4000 iu vitamin D3Taken daily to achieve: (1) optimization of 1,25(Oh)2D production, and (2) improved Cord Blood 25(Oh)D concentration.']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_51469', 'butyllithium', 91, 'D3taken'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 142, 'OH)2D'), ('UBERON_0009472', 'axilla', 177, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 188, '25(OH ... D')]
PMC3347028	3/2012	S217-PMC3347028	['studies specifically designed and powered to answer the QUESTION of WHETHER OR NOT Vitamin D supplementation LEADS TO improved health outcomes—lower RISK of Preterm Birth, preeclampsia, and infection REMAIN to be done.']	[('EXPLICIT_QUESTION', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 149), ('INCOMPLETE_EVIDENCE', 200)]	5	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'preterm birth')]
PMC3347028	3/2012	S218-PMC3347028	['we can conservatively say that WHILE we do not understand completely the ROLE of 1,25(Oh)2D during Pregnancy, achieving OPTIMAL production can be done SAFELY with 4000 iu Vitamin D3/day, which APPEARS TO BE the amount of Vitamin D that would be conservatively generated by the body with adequate sunlight exposure over the duration of Gestation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 151), ('ANOMALY_CURIOUS_FINDING', 193)]	5	[('CHEBI_37958', 'dye', 81, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 83, '25(OH)2D'), ('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('CHEBI_33279', 'vitamin D5', 171, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 171, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('GO_0007565', 'female pregnancy', 335, 'gestation')]
PMC3347028	3/2012	S226-PMC3347028	['the health effects data from Vitamin D supplementation trials THUS FAR, WHILE TANTALIZING, are NOT CONCLUSIVE in SHOWING definitive “proof” for Vitamin D AS a POTENTIAL CANDIDATE in the reduction of comorbidities of Pregnancy, YET one CANNOT DISMISS the strong CORRELATION between reduced RISK with increased Serum 25(Oh)D concentrations.']	[('INCOMPLETE_EVIDENCE', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 113), ('PROBABLE_UNDERSTANDING', 154), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('ANOMALY_CURIOUS_FINDING', 227), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235), ('SUPERFICIAL_RELATIONSHIP', 261), ('IMPORTANT_CONSIDERATION', 289)]	13	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy'), ('UBERON_0001977', 'blood serum', 309, 'serum'), ('CHEBI_71657', 'versiconol acetate', 315, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 315, '25(OH)D')]
PMC3347028	3/2012	S233-PMC3347028	['looking carefully at the INCREASING NUMBER OF epidemiological STUDIES involving women with Preeclampsia: is there a LINK with Vitamin D deficiency where PERHAPS in certain women, there is loss of the Vitamin D-mediated Suppression Of T Cells that leads to a profound inflammatory reaction REMINISCENT of graft- vs. -host disease?']	[('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 153), ('ANOMALY_CURIOUS_FINDING', 289), ('EXPLICIT_QUESTION', 328)]	6	[('GO_0007128', 'meiotic prophase I', 91, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('GO_0048469', 'cell maturation', 219, 'suppression of T cells'), ('CL_0000084', 'T cell', 234, 'T cells')]
PMC3347028	3/2012	S234-PMC3347028	['in those women with a specific Genetic repertoire—affinity for Vitamin D and receptor processing—Vitamin D deficiency MAY very well be the LOST KEY to stopping the Cascade of Events.']	[('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 139), ('IMPORTANT_CONSIDERATION', 144)]	3	[('SO_0000704', 'gene', 31, 'genetic'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0055097', 'high density lipoprotein particle mediated signaling', 164, 'cascade'), ('GO_0006897', 'endocytosis', 175, 'events')]
PMC3347028	3/2012	S239-PMC3347028	['what is clear, HOWEVER, is that Vitamin D deficiency during Pregnancy is RAMPANT throughout the world, including countries such as the united states and great britain.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 15), ('IMPORTANT_CONSIDERATION', 73)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy')]
PMC3347028	3/2012	S242-PMC3347028	['a RECENT randomized controlled TRIAL with 350 women of diverse racial and ethnic backgrounds SHOWED that 4000 iu Vitamin D/day is MOST EFFECTIVE in improving the Vitamin D status of Pregnant women, attaining circulating levels of at least 40 ng/ml (100 nmol/l) for 25(Oh)D, and was NECESSARY to achieve OPTIMAL 1,25(Oh)2D production.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 130), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 282), ('IMPORTANT_CONSIDERATION', 303)]	6	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 265, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 267, '(OH ... D'), ('CHEBI_37983', 'sulfur-35 atom', 311, '1'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 313, '25(OH)2D')]
PMC3348565	4/2012	S15-PMC3348565	['two hospital-based case-control studies in ethiopia1and india2SUGGEST that Vitamin D deficiency MIGHT substantially increase the risk of SEVERE pneumonia in children.']	[('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 96), ('IMPORTANT_CONSIDERATION', 137)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC3348565	4/2012	S121-PMC3348565	['ALTHOUGH this is PROBABLY TRUE, a sufficient Serum concentrations for the immunological EFFECTS of Vitamin D is UNKNOWN and COULD BE higher or lower than that of the Skeletal system accepted concentrations.6THE NEED for a steady state is currently highly SPECULATIVE and RELATES to Vitamin D2Supplementation for negative cancer22and bone outcomes.23\nour findings are AT ODDS with SMALLER case-control hospital STUDIES that show an enhanced rate of Vitamin D deficiency or rickets in children with pneumonia and the INCREASING EVIDENCE SUGGESTING that Calcitriol, the biologically active Metabolite of Vitamin D, has an IMPORTANT ROLE in the Human Immune System.4a systematic review of the ROLE of Vitamin D supplementation in infectious diseases had MIXED findings, CONCLUDING that more rigorously designed clinical trials ARE NEEDED (panel).25NO STUDIES report the EFFECT of Vitamin D on radiologically confirmed pneumonias.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 17), ('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 112), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('INCOMPLETE_EVIDENCE', 380), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 619), ('SUPERFICIAL_RELATIONSHIP', 629), ('SUPERFICIAL_RELATIONSHIP', 689), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 750), ('PROBABLE_UNDERSTANDING', 766), ('FUTURE_WORK', 823), ('INCOMPLETE_EVIDENCE', 844), ('SUPERFICIAL_RELATIONSHIP', 866)]	21	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0004288', 'skeleton', 166, 'skeletal'), ('CHEBI_52910', 'delta-lactam ring', 282, 'vitamin D2supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 282, 'vitamin D2supplementation'), ('CHEBI_27300', 'vitamin D', 448, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 551, 'calcitriol'), ('CHEBI_39382', 'flufenoxuron', 587, 'metabolite'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 641, 'human'), ('UBERON_0002405', 'immune system', 647, 'immune system'), ('CHEBI_27300', 'vitamin D', 697, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 876, 'vitamin D')]
PMC3348565	4/2012	S133-PMC3348565	['FURTHER QUESTIONS arise with respect to the previous treatment trial in the same region of kabul, which showed that a single high-dose supplementation with 100\u2008000 iu Vitamin D3Given orally to young children, along with Antibiotic treatment at the time of diagnosis, reduced repeat episodes of pneumonia in the subsequent 3 months.3the INCONSISTENT results COULD BE RELATED to the evidence that stimulation of toll-like receptors on Macrophages and Monocytes by Bacterial Antigens is IMPORTANT in up-regulation of Cyp27B1 and the Vitamin D receptor,5which are CRUCIAL in Production Of Cathelicidins in Vitamin-D-depleted Individuals.']	[('FUTURE_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 336), ('INCOMPLETE_EVIDENCE', 357), ('SUPERFICIAL_RELATIONSHIP', 366), ('IMPORTANT_CONSIDERATION', 484), ('IMPORTANT_CONSIDERATION', 560)]	6	[('CHEBI_67916', '2alpha,3beta,23-trihydroxylup-20(29)-en-28-oic acid', 167, 'vitamin D3given'), ('PR_000001177', 'D(2) dopamine receptor', 175, 'D3given'), ('CHEBI_33282', 'antibacterial agent', 220, 'antibiotic'), ('CL_0000235', 'macrophage', 433, 'macrophages'), ('CL_0000576', 'monocyte', 449, 'monocytes'), ('CHEBI_22695', 'base', 462, 'bacterial'), ('CHEBI_59132', 'antigen', 472, 'antigens'), ('PR_000006101', 'cytochrome P450 1A1', 514, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0030154', 'cell differentiation', 571, 'production of cathelicidins'), ('CHEBI_83326', 'tedizolid phosphate', 602, 'vitamin-D'), ('NCBITaxon_1', 'root', 621, 'individuals')]
PMC3348565	4/2012	S138-PMC3348565	['ALTHOUGH Vitamin D overload is a theoretical POSSIBILITY, 100\u2008000 iu of Vitamin D3Has BEEN shown to provide the best protection against Vitamin D deficiency without overload or side-effects in high-risk infants aged 0–9 months with normal baseline ranges of Vitamin D.16furthermore, single intramuscular injection of three times this dose (300\u2008000 iu) was safe in treating nutritional rickets in 6–30-month-old children residing in lower socioeconomic regions of sunny istanbul.35higher than RECOMMENDED doses of daily supplementation of Vitamin D (500–1000 iu per day, adding up to 120\u2008000 iu over 3 months) plus additional milk fortified with Vitamin D, HAS BEEN shown not to induce an overload,13including in infants starting with normal ranges of Vitamin D, EVEN when supplementation continued during the summer (in france) and when mothers had Antenatal Vitamin D supplementation.36it is IMPORTANT to note that in our study, where community supplementation was in a population with known high rates of Vitamin D deficiency, 1% of children tested had a Calcifediol concentration greater than 375 nmol/l—THOUGHT UNDESIRABLY high.6ALTHOUGH these did not produce any clinical signs and symptoms, these measurements raise a NEED for CAUTION with doses for population supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 82), ('FUTURE_WORK', 492), ('INCOMPLETE_EVIDENCE', 656), ('ANOMALY_CURIOUS_FINDING', 762), ('IMPORTANT_CONSIDERATION', 893), ('INCOMPLETE_EVIDENCE', 1107), ('PROBLEM_COMPLICATION', 1115), ('ANOMALY_CURIOUS_FINDING', 1133), ('FUTURE_WORK', 1224), ('IMPORTANT_CONSIDERATION', 1233)]	12	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_35646', 'galanthan', 72, 'vitamin D3has'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 72, 'vitamin D3has'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 538, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 645, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 751, 'vitamin D'), ('GO_0007567', 'parturition', 849, 'antenatal'), ('CHEBI_27300', 'vitamin D', 859, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1007, 'vitamin D'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 1057, 'calcifediol')]
PMC3348565	4/2012	S141-PMC3348565	['in populations with similar characteristics, quarterly population level supplementation of Vitamin D to infants and young children IS NOT a policy OPTION for reducing THE BURDEN of pneumonia in children.']	[('DIFFICULT_TASK', 131), ('IMPORTANT_CONSIDERATION', 167)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC3355895	1/2011	S87-PMC3355895	['FINDINGS from the avon longitudinal study of parents and children (sayers and tobias,2009) FURTHER REINFORCED the IMPORTANCE of maternal 25(Oh)-Vitamin D levels, DEMONSTRATING a positive ASSOCIATION between ambient ultraviolet b radiation in Pregnancy and offspring bmc at 9 years old.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 114), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 187)]	6	[('CHEBI_63056', 'zinc cation', 137, '25(OH'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy')]
PMC3355895	1/2011	S88-PMC3355895	['in developing southern hemisphere populations where sunshine is in abundance, OFTEN calcium nutrition is a greater ISSUE than that of 25(oh)-Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 78), ('IMPORTANT_CONSIDERATION', 115)]	2	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3355895	1/2011	S91-PMC3355895	['THUS, in populations in nutritional transition, where maternal sunlight exposure is sufficient to maintain adequate Vitamin D status, the availability of calcium becomes a more CRITICAL DETERMINANT of fetal and childhood bone Mineral accrual.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 177), ('SUPERFICIAL_RELATIONSHIP', 186)]	3	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_46662', 'mineral', 226, 'mineral')]
PMC3356951	4/2012	S2-PMC3356951	['this PANDEMIC of hypovitaminosis d can MAINLY be ATTRIBUTED to lifestyle (for example, reduced outdoor activities) and environmental (for example, air pollution) FACTORS that reduce exposure to sunlight, which is REQUIRED for ultraviolet-b (uvb)-induced Vitamin D Production in the skin.']	[('IMPORTANT_CONSIDERATION', 5), ('PROBABLE_UNDERSTANDING', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 213)]	5	[('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 254, 'vitamin D production')]
PMC3356951	4/2012	S3-PMC3356951	['high prevalence of Vitamin D insufficiency is a PARTICULARLY IMPORTANT PUBLIC HEALTH ISSUE BECAUSE hypovitaminosis D is an INDEPENDENT RISK FACTOR for total mortality in the general population.']	[('ANOMALY_CURIOUS_FINDING', 48), ('IMPORTANT_CONSIDERATION', 61), ('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 85), ('PROBABLE_UNDERSTANDING', 91), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 135)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 115, 'D')]
PMC3356951	4/2012	S4-PMC3356951	['CURRENT STUDIES SUGGEST that we MAY NEED more Vitamin D than presently RECOMMENDED to prevent chronic disease.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 71)]	5	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC3356951	4/2012	S11-PMC3356951	['in THIS REVIEW, we will summarize the mechanisms that are PRESUMED to underlie the RELATIONSHIP between Vitamin D and understand its biology and clinical IMPLICATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 154)]	4	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC3356951	4/2012	S14-PMC3356951	['[1–3] this PANDEMIC of hypovitaminosis d CAN MAINLY be ATTRIBUTED to lifestyle and environmental FACTORS that reduce exposure to sunlight, which is REQUIRED for ultraviolet-b (uvb)-induced Vitamin D Production in the skin.']	[('IMPORTANT_CONSIDERATION', 11), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 45), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 97), ('IMPORTANT_CONSIDERATION', 148)]	6	[('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0006272', 'leading strand elongation', 197, 'D production')]
PMC3356951	4/2012	S15-PMC3356951	['black People Absorb more uvb in the Melanin of their skin than do white People and, THEREFORE, require more sun exposure to produce the same amount of vitamin D.[4]\nthe high prevalence of Vitamin D insufficiency is a PARTICULARLY IMPORTANT PUBLIC HEALTH ISSUE BECAUSE hypovitaminosis D is an INDEPENDENT RISK FACTOR for total mortality in the general population.']	[('PROBABLE_UNDERSTANDING', 84), ('ANOMALY_CURIOUS_FINDING', 217), ('IMPORTANT_CONSIDERATION', 230), ('IMPORTANT_CONSIDERATION', 240), ('PROBLEM_COMPLICATION', 254), ('PROBABLE_UNDERSTANDING', 260), ('SUPERFICIAL_RELATIONSHIP', 292), ('SUPERFICIAL_RELATIONSHIP', 304)]	8	[('NCBITaxon_10088', 'Mus <genus>', 6, 'people'), ('GO_0040011', 'locomotion', 13, 'absorb'), ('CHEBI_25179', 'melanins', 36, 'melanin'), ('NCBITaxon_10088', 'Mus <genus>', 72, 'people'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 159, 'D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 284, 'D')]
PMC3356951	4/2012	S19-PMC3356951	['[7] in THIS REVIEW, we will FOCUS on the biology of Vitamin D and summarize the mechanisms that are PRESUMED to underlie the RELATIONSHIP between Vitamin D and its clinical IMPLICATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('PROBABLE_UNDERSTANDING', 100), ('SUPERFICIAL_RELATIONSHIP', 125), ('IMPORTANT_CONSIDERATION', 173)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC3356951	4/2012	S26-PMC3356951	['Vitamin D that comes from the skin or diet is biologically inert and REQUIRES its first hydroxylation in the Liver by the Vitamin D-25-hydroxylase (25-ohase) to 25(Oh)D.[311] HOWEVER, 25(Oh)D requires a further hydroxylation in the Kidneys by the 25(Oh)D-1-Ohase (Cyp27B1) to form the biologically active form of Vitamin D 1,25(Oh)2D.']	[('IMPORTANT_CONSIDERATION', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ANOMALY_CURIOUS_FINDING', 175)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('UBERON_0002107', 'liver', 109, 'liver'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 161, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 184, '25(OH)D'), ('UBERON_0002113', 'kidney', 232, 'kidneys'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 250, 'OH)D'), ('CHEBI_32906', 'gibberellin A24', 257, 'OHase'), ('PR_000006101', 'cytochrome P450 1A1', 264, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin D'), ('CHEBI_17996', 'chloride', 324, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 325, '25(OH)2D')]
PMC3356951	4/2012	S36-PMC3356951	['[12425] Pregnant and Lactating women who take a Prenatal Vitamin and a Calcium supplement with Vitamin D remain at high RISK for vdd.']	[('IMPORTANT_CONSIDERATION', 120)]	1	[('GO_0007565', 'female pregnancy', 8, 'Pregnant'), ('GO_0007594', 'puparial adhesion', 21, 'lactating'), ('GO_0007565', 'female pregnancy', 48, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 57, 'vitamin'), ('CHEBI_22313', 'alkaline earth metal atom', 71, 'calcium'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC3356951	4/2012	S38-PMC3356951	['the MAJOR source of Vitamin D for children and Adults is exposure to natural sunlight.']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0007023', 'adult organism', 47, 'adults')]
PMC3356951	4/2012	S41-PMC3356951	['[36] People with a naturally dark skin tone have natural sun protection and REQUIRE AT LEAST three to five times longer exposure to make the same amount of Vitamin D as a Person with a white skin tone.']	[('IMPORTANT_CONSIDERATION', 76), ('PROBABLE_UNDERSTANDING', 84)]	2	[('NCBITaxon_10088', 'Mus <genus>', 5, 'People'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 171, 'person')]
PMC3356951	4/2012	S52-PMC3356951	['groups AT RISK of Vitamin-D inadequacy\nobtaining sufficient Vitamin D from natural Food sources alone is DIFFICULT.']	[('IMPORTANT_CONSIDERATION', 7), ('DIFFICULT_TASK', 105)]	2	[('CHEBI_83326', 'tedizolid phosphate', 18, 'vitamin-D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_33290', 'food', 83, 'food')]
PMC3356951	4/2012	S53-PMC3356951	['consumption of Vitamin D-fortified Foods and exposure to some sunlight are ESSENTIAL for maintaining a healthy Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 75)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_33290', 'food', 35, 'foods'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC3356951	4/2012	S54-PMC3356951	['dietary supplements MIGHT be REQUIRED to meet the daily need for Vitamin D in SOME group of People.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 29), ('INCOMPLETE_EVIDENCE', 78)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 92, 'people')]
PMC3356951	4/2012	S57-PMC3356951	['[52] american association of paediatricians (aap) RECOMMENDS that exclusively and partially Breastfed infants MUST BE supplemented with 400 iu of Vitamin D per day,[5253] the RECOMMENDED daily allowance for this Nutrient during infancy.']	[('FUTURE_WORK', 50), ('IMPORTANT_CONSIDERATION', 110), ('FUTURE_WORK', 175)]	3	[('GO_0007567', 'parturition', 92, 'breastfed'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('CHEBI_33284', 'nutrient', 212, 'nutrient')]
PMC3356951	4/2012	S59-PMC3356951	['their skin cannot synthesize Vitamin D as efficiently, they are LIKELY to spend more time indoors, and they MAY have INADEQUATE intakes of the Vitamin.']	[('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 117)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 143, 'vitamin')]
PMC3356951	4/2012	S61-PMC3356951	['[5455] the SIGNIFICANCE of the ROLE that sunscreen MAY play in reducing Vitamin D Synthesis is STILL UNCLEAR.']	[('IMPORTANT_CONSIDERATION', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 51), ('FULL_UNKNOWN', 95)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 72, 'vitamin D synthesis')]
PMC3356951	4/2012	S67-PMC3356951	['individuals with reduced ability to absorb dietary fat MIGHT REQUIRE Vitamin D supplements.']	[('INCOMPLETE_EVIDENCE', 55), ('IMPORTANT_CONSIDERATION', 61)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3356951	4/2012	S70-PMC3356951	['obese People MAY NEED larger than usual intakes of Vitamin D to achieve 25(Oh)D levels COMPARABLE to those of normal weight.']	[('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 17), ('INCOMPLETE_EVIDENCE', 87)]	3	[('NCBITaxon_10088', 'Mus <genus>', 6, 'people'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D')]
PMC3356951	4/2012	S73-PMC3356951	['[5859]\n\nsources of Vitamin D\na MAJOR source of Vitamin D for MOST Humans is synthesized from the exposure of the skin to sunlight typically between 1000 h and 1500 h in the spring, summer, and fall.']	[('IMPORTANT_CONSIDERATION', 31), ('PROBABLE_UNDERSTANDING', 61)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 66, 'humans')]
PMC3356951	4/2012	S94-PMC3356951	['[9]\n\ndosing\nonly a few Foods are a good source of Vitamin D. the BEST way to get additional Vitamin D is through supplementation.']	[('IMPORTANT_CONSIDERATION', 65)]	1	[('CHEBI_33290', 'food', 23, 'foods'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3356951	4/2012	S99-PMC3356951	['[7172] MANY STUDIES have SUGGESTED a LINK between low Vitamin D levels and an INCREASED RISK of cancer, with the STRONGEST EVIDENCE for Colorectal cancer.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 37), ('IMPORTANT_CONSIDERATION', 78), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0012652', 'colorectum', 136, 'colorectal')]
PMC3356951	4/2012	S101-PMC3356951	['[71] a definitive conclusion cannot yet be made about the ASSOCIATION between Vitamin D concentration and cancer RISK, BUT results from MANY STUDIES are promising.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('IMPORTANT_CONSIDERATION', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('INCOMPLETE_EVIDENCE', 136)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3356951	4/2012	S102-PMC3356951	['there is SOME EVIDENCE LINKING higher Vitamin D intake to a lower RISK for Breast cancer.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 23), ('IMPORTANT_CONSIDERATION', 66)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000310', 'breast', 75, 'breast')]
PMC3356951	4/2012	S123-PMC3356951	["RECENTLY, it HAS BEEN SUGGESTED that chronically INADEQUATE Vitamin D intake MAY play a significant ROLE in the pathogenesis of parkinson's disease."]	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3356951	4/2012	S128-PMC3356951	['[6] MANY STUDIES HAVE SHOWN an ASSOCIATION between low Vitamin D concentrations and an INCREASED RISK of fractures and falls in older Adults.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 87)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adults')]
PMC3356951	4/2012	S143-PMC3356951	['[102] among women younger than 75 years, there is a lower RISK for early amd with higher Vitamin D levels, with a threshold EFFECT at 15.22 ng/l Serum 25 (Oh)D.\n\nrecommendation guidelines: endocrine society of clinical practice\n\ndiagnostic procedure\nescp RECOMMEND screening for vdd in Individuals at risk for deficiency and not for patients who are not AT RISK.']	[('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 124), ('FUTURE_WORK', 255), ('IMPORTANT_CONSIDERATION', 354)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum'), ('CHEBI_71657', 'versiconol acetate', 151, '25 (OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 151, '25 (OH)D'), ('NCBITaxon_1', 'root', 286, 'individuals')]
PMC3356951	4/2012	S144-PMC3356951	['Serum circulating 25-Hydroxyvitamin D [25(Oh) D] level SHOULD BE measured to evaluate Vitamin D status in patients who are AT RISK for vdd.']	[('FUTURE_WORK', 55), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 123)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 18, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 39, '25(OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 46, 'D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3356951	4/2012	S146-PMC3356951	["[103]\n\nrecommended dietary intakes of Vitamin D\nescp SUGGESTS that obese children and Adults on Anticonvulsant medications, Glucocorticoids, antifungals such as Ketoconazole, and medications for aids SHOULD BE given at least two to three times more Vitamin D for their age group to satisfy their body's Vitamin D REQUIREMENT[table 1]."]	[('INCOMPLETE_EVIDENCE', 53), ('FUTURE_WORK', 200), ('IMPORTANT_CONSIDERATION', 200), ('IMPORTANT_CONSIDERATION', 313)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 86, 'adults'), ('CHEBI_35624', 'azaspiro compound', 96, 'anticonvulsant'), ('CHEBI_36597', 'phthalazine', 124, 'glucocorticoids'), ('CHEBI_47519', 'ketoconazole', 161, 'ketoconazole'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]
PMC3356951	4/2012	S147-PMC3356951	['caption (table-wrap): table 1\n\nrecommended dietary intakes of Vitamin D for patients AT RISK for Vitamin D deficiency[103]\nescp SUGGESTS that the maintenance tolerable upper limits (ul) of Vitamin D, which is not to BE exceeded without medical supervision, SHOULD BE 1000 iu/d for infants up to 6 months, 1500 iu/d for infants from 6 months to 1 year, AT LEAST 2500 iu/d for children aged 1–3 years, 3000 iu/d for children aged 4–8 years, and 4000 iu/d for everyone over 8 years.']	[('IMPORTANT_CONSIDERATION', 85), ('INCOMPLETE_EVIDENCE', 128), ('ANOMALY_CURIOUS_FINDING', 216), ('FUTURE_WORK', 257), ('PROBABLE_UNDERSTANDING', 352)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]
PMC3356951	4/2012	S151-PMC3356951	['primary hyperparathyroidism and vdd NEED treatment with Vitamin D.[103]\n\ncaption (table-wrap): table 2\n\ntreatment and prevention STRATEGIES[103]\n\nnoncalcemic benefits of Vitamin D\nescp RECOMMENDS prescribing Vitamin D supplementation for fall PREVENTION and do not RECOMMEND supplementation beyond RECOMMENDED daily NEEDS for the purpose of preventing Cardiovascular disease or death or improving quality of life.']	[('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 129), ('FUTURE_WORK', 185), ('SUPERFICIAL_RELATIONSHIP', 243), ('FUTURE_WORK', 265), ('FUTURE_WORK', 298), ('IMPORTANT_CONSIDERATION', 316)]	7	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 352, 'cardiovascular')]
PMC3356951	4/2012	S162-PMC3356951	['Dihydrotachysterol (Dht) is a synthetic form of Vitamin D that many CONSIDER SUPERIOR to natural d2and d3.']	[('INCOMPLETE_EVIDENCE', 68), ('IMPORTANT_CONSIDERATION', 77)]	2	[('CHEBI_4553', 'dihydroanhydropodorhizol', 0, 'Dihydrotachysterol'), ('CHEBI_18320', '1,4-dithiothreitol', 20, 'DHT'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 56, 'D')]
PMC3356951	4/2012	S177-PMC3356951	['MORE RESEARCH is REQUIRED to RECOMMEND screening Individuals who are not AT RISK for deficiency or to prescribe Vitamin D to attain the noncalcemic BENEFIT for Cardiovascular protection.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 17), ('FUTURE_WORK', 29), ('IMPORTANT_CONSIDERATION', 73), ('IMPORTANT_CONSIDERATION', 148)]	5	[('NCBITaxon_1', 'root', 49, 'individuals'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 160, 'cardiovascular')]
PMC3366289	7/2011	S17-PMC3366289	['DEFICIENCY of Thiamine and Vitamin A as well as a high prevalence of anemia HAS BEEN DOCUMENTED in Pregnant and Postpartum women in this population [8–10].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 76), ('INCOMPLETE_EVIDENCE', 85)]	3	[('CHEBI_26948', 'vitamin B1', 14, 'thiamine'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin A'), ('GO_0007565', 'female pregnancy', 99, 'pregnant'), ('GO_0007565', 'female pregnancy', 112, 'postpartum')]
PMC3366289	7/2011	S139-PMC3366289	['on the basis of Serum Retinol (6%\xa0<\xa01.05\xa0μmol/l) and of fat adjusted milk Retinol (5 and 16%\xa0≤\xa028\xa0μmol/kg fat), there is LITTLE EVIDENCE of SEVERE Vitamin A deficiency among Lactating mothers from maela camp.']	[('INCOMPLETE_EVIDENCE', 121), ('IMPORTANT_CONSIDERATION', 140)]	2	[('UBERON_0001977', 'blood serum', 16, 'serum'), ('CHEBI_26536', 'retinoic acid', 22, 'retinol'), ('CHEBI_26536', 'retinoic acid', 74, 'retinol'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin A'), ('GO_0007594', 'puparial adhesion', 174, 'lactating')]
PMC3366289	7/2011	S141-PMC3366289	['the intake of Β-Carotene-rich vegetables, oils and fruits is RECOMMENDED in order to meet the Vitamin A REQUIREMENT for mothers and their Breast-Fed infants whose diet excludes the Consumption of meat, Liver and eggs [41].']	[('FUTURE_WORK', 61), ('IMPORTANT_CONSIDERATION', 104)]	2	[('CHEBI_28064', 'cyanidin 3-O-rutinoside', 14, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin A'), ('GO_0007567', 'parturition', 138, 'breast'), ('UBERON_0000310', 'breast', 138, 'breast'), ('GO_0007631', 'feeding behavior', 145, 'fed'), ('GO_0007631', 'feeding behavior', 181, 'consumption'), ('UBERON_0002107', 'liver', 202, 'liver')]
PMC3376765	6/2012	S144-PMC3376765	['BECAUSE the KEY comparisons we make in our rct are between daily supplements with iron versus iron and zinc or between weekly iron supplements with iron versus iron and zinc, Vitamin B-12 is not a factor in INTERPRETING these DIFFERENCES.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('PROBABLE_UNDERSTANDING', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226)]	4	[('CHEBI_27300', 'vitamin D', 175, 'vitamin B')]
PMC3385441	2/2012	S269-PMC3385441	['caption (table-wrap): table 3\n\nchallenges to developing comprehensive fish Consumption ADVICE.viewpoint and challengesexamplestoxicological hazards: fish contaminants (e.g., mehg, Pcbs, Pesticides)multiple co-occurring contaminantssynergistic adverse EFFECTS on Neurodevelopment with Joint mehg and pcb exposureadvisories for single contaminantfarmed salmon low in mehg but can be high in pcbstoxicant levels vary within and across speciestilefish Mehg: high in gulf of mexico but low in atlanticvariable susceptibility to toxicitiesprenatal exposure: increased susceptibility to Mehg neurotoxicityconfounding by nutritional BENEFITSUNDERESTIMATION of hazard from mehg if CONFOUNDED by n‑3 lcpufasnutritional BENEFITS: fish Nutrients (e.g., n‑3 lcpufas, Vitamin D, Iodine, Selenium)multiple co-occurring nutrientsfor Neurodevelopment, fish intake more CONSISTENTLY beneficial than n‑3 lcpufa supplementsanutrient levels vary within and across specieshealth benefits associated with high n‑3 lcpufa fishaconfounding by contaminant riskunderestimation of benefit from n‑3 lcpufas if CONFOUNDED by Mehgincreased fish intake (for most populations) RECOMMENDED by nutrition GUIDELINESAVAILABLE fish insufficient to meet demand EVEN without greater intakeenvironmental sustainability: overfishing, habitat destruction, aquaculturemodern harvesting can deplete fish stocks, other aquatic wildlife, and habitatsfishing trawls plough the Seafloor, removing most, if not all, aquatic Life and structures in their pathwild fish stocks insufficient to meet projected GLOBAL demandapproximately 90% of large predatory fish stocks (e.g., bluefin Tuna, atlantic salmon) are already depletedaquaculture CAN adversely AFFECT wild fish and ecosystems; CONTAMINANTSFARMED salmon can escape and outcompete wild fish and MAY have higher Pcb levelseconomic INFLUENCES: consumer choice, industry stakeholders, fisheries managementeconomic ASSUMPTION of improved consumer welfare with more information not necessarily TRUE for fish choiceu.s.']	[('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 625), ('DIFFICULT_TASK', 672), ('IMPORTANT_CONSIDERATION', 709), ('PROBABLE_UNDERSTANDING', 852), ('DIFFICULT_TASK', 1081), ('FUTURE_WORK', 1144), ('PROBABLE_UNDERSTANDING', 1169), ('ANOMALY_CURIOUS_FINDING', 1222), ('IMPORTANT_CONSIDERATION', 1555), ('INCOMPLETE_EVIDENCE', 1687), ('SUPERFICIAL_RELATIONSHIP', 1701), ('IMPORTANT_CONSIDERATION', 1734), ('INCOMPLETE_EVIDENCE', 1800), ('SUPERFICIAL_RELATIONSHIP', 1835), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1916), ('PROBABLE_UNDERSTANDING', 1994)]	18	[('GO_0007631', 'feeding behavior', 75, 'consumption'), ('CHEBI_26199', 'polyprenol', 180, 'PCBs'), ('CHEBI_35392', 'glucarate(1-)', 186, 'pesticides'), ('GO_0007399', 'nervous system development', 262, 'neurodevelopment'), ('UBERON_0004905', 'articulation', 284, 'joint'), ('CHEBI_82056', 'Mebenil', 448, 'MeHg'), ('CHEBI_82056', 'Mebenil', 580, 'MeHg'), ('CHEBI_33284', 'nutrient', 724, 'nutrients'), ('CHEBI_27300', 'vitamin D', 754, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 765, 'iodine'), ('CHEBI_27568', 'selenium atom', 773, 'selenium'), ('GO_0007399', 'nervous system development', 817, 'neurodevelopment'), ('CHEBI_82492', 'N-Methylolacrylamide', 1095, 'MeHgIncreased'), ('UBERON_0001273', 'ilium', 1429, 'seafloor'), ('UBERON_0000104', 'life cycle', 1474, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 1632, 'tuna'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 1816, 'PCB')]
PMC3395583	7/2012	S101-PMC3395583	['it is IMPORTANT TO NOTE that our uvb and Vitamin D CORRELATION analysis DOES NOT prove causation and that, ALTHOUGH the Vitamin D HYPOTHESIS is SUPPORTED by both epidemiological and functional OBSERVATIONS, seasonality dominates many features of the global environment and OTHER seasonal factors MAY play a ROLE in determining the risk of id.']	[('IMPORTANT_CONSIDERATION', 6), ('SUPERFICIAL_RELATIONSHIP', 51), ('ANOMALY_CURIOUS_FINDING', 72), ('ANOMALY_CURIOUS_FINDING', 107), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 273), ('INCOMPLETE_EVIDENCE', 296), ('SUPERFICIAL_RELATIONSHIP', 307)]	10	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3407995	7/2012	S1-PMC3407995	['purpose: to highlight the POTENTIAL BENEFITS of maternal supplementation with Docosahexaenoic Acid (Dha) and other IMPORTANT complimentary Nutrients, including Vitamin D, Folic Acid and Iodine during Pregnancy and/or Breast feeding for Foetal and/or infant Brain Development and/or function.']	[('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 36), ('IMPORTANT_CONSIDERATION', 115)]	3	[('CHEBI_36003', 'decenoic acid', 78, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 100, 'DHA'), ('CHEBI_33284', 'nutrient', 139, 'nutrients'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_30751', 'formic acid', 171, 'folic acid'), ('CHEBI_24859', 'iodine atom', 186, 'iodine'), ('GO_0007565', 'female pregnancy', 200, 'pregnancy'), ('UBERON_0000310', 'breast', 217, 'breast'), ('GO_0000009', 'alpha-1,6-mannosyltransferase activity', 236, 'foetal ...'), ('GO_0007420', 'brain development', 257, 'brain development'), ('UBERON_0000955', 'brain', 257, 'brain')]
PMC3407995	7/2012	S16-PMC3407995	['titles and abstracts were reviewed and reports were selected for inclusion in the review if they were systematic reviews, meta-analyses, randomised controlled trials, cohort studies, cross-sectional or case-control studies and IF they reported BENEFITS and/or harms ASSOCIATED with maternal supplementation with Dha, Vitamin D, Folic Acid or Iodine during Pregnancy and/or Lactation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('IMPORTANT_CONSIDERATION', 244), ('SUPERFICIAL_RELATIONSHIP', 266)]	3	[('CHEBI_17874', 'dihydrozeatin', 312, 'DHA'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin D'), ('CHEBI_30751', 'formic acid', 328, 'folic acid'), ('CHEBI_24859', 'iodine atom', 342, 'iodine'), ('GO_0007565', 'female pregnancy', 356, 'pregnancy'), ('GO_0007595', 'lactation', 373, 'lactation')]
PMC3407995	7/2012	S18-PMC3407995	['data was reviewed and summarized to discuss the RELEVANCE of dietary Dha, Vitamin D, Folic Acid and Iodine to Foetal and infant Brain Development and function, to PRESENT EVIDENCE DEMONSTRATING dietary deficiency of these Nutrients in many populations, to highlight the POTENTIAL benefits of maternal supplementation during Pregnancy and/or Lactation on foetal and/or infant outcomes and to include SAFE Intake RECOMMENDATIONS.']	[('IMPORTANT_CONSIDERATION', 48), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 180), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 399), ('FUTURE_WORK', 411)]	6	[('CHEBI_17874', 'dihydrozeatin', 69, 'DHA'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_30751', 'formic acid', 85, 'folic acid'), ('CHEBI_24859', 'iodine atom', 100, 'iodine'), ('GO_0000009', 'alpha-1,6-mannosyltransferase activity', 110, 'foetal ...'), ('GO_0007420', 'brain development', 128, 'brain development'), ('UBERON_0000955', 'brain', 128, 'brain'), ('CHEBI_33284', 'nutrient', 222, 'nutrients'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('GO_0007595', 'lactation', 341, 'lactation'), ('GO_0007631', 'feeding behavior', 404, 'intake')]
PMC3407995	7/2012	S82-PMC3407995	['the MAJORITY of circulating Vitamin D, known as Serum 25-Hydroxyvitamin D [25(Oh)D] that is NECESSARY to maintain health and function of the Immune, Reproductive, Muscular, Skeletal and Integumentary System, originates from Vitamin D3 (Cholecalciferol) and REFLECTS endogenous synthesis from exposure to sunlight as well as Intake from the diet [46].']	[('PROBABLE_UNDERSTANDING', 4), ('IMPORTANT_CONSIDERATION', 92), ('SUPERFICIAL_RELATIONSHIP', 257)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 54, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 75, '25(OH)D'), ('UBERON_0002405', 'immune system', 141, 'immune ...'), ('GO_0000003', 'reproduction', 149, 'reproductive'), ('UBERON_0022230', 'retrohippocampal region', 149, 'reproductive ...'), ('UBERON_0004469', 'musculature of back', 163, 'muscular ...'), ('UBERON_0004288', 'skeleton', 173, 'skeletal'), ('UBERON_0002416', 'integumental system', 186, 'integumentary system'), ('CHEBI_33279', 'vitamin D5', 224, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 224, 'vitamin D3'), ('CHEBI_52550', 'theopalauamide', 236, 'cholecalciferol'), ('GO_0007631', 'feeding behavior', 324, 'intake')]
PMC3407995	7/2012	S84-PMC3407995	['the only OTHER useful sources are Eggs, fortified Margarines (REQUIRED in some countries by law to contain Vitamin D) and SOME fortified yoghurts and breakfast cereals.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('IMPORTANT_CONSIDERATION', 62), ('INCOMPLETE_EVIDENCE', 122)]	3	[('CL_0000025', 'egg cell', 34, 'eggs'), ('CHEBI_25140', 'maltodextrin', 50, 'margarines'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC3407995	7/2012	S89-PMC3407995	['approximately one billion People worldwide are ESTIMATED to be Vitamin D deficient with People living in europe, the middle east, china and japan AT PARTICULAR RISK [47,48].']	[('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 146), ('IMPORTANT_CONSIDERATION', 149)]	3	[('NCBITaxon_10088', 'Mus <genus>', 26, 'people'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 88, 'people')]
PMC3407995	7/2012	S91-PMC3407995	['in addition, Pregnant women with darker skin pigmentation are at EVEN greater RISK of low Vitamin D status as COMPARED to Pregnant women with lighter skin pigmentation [49].']	[('ANOMALY_CURIOUS_FINDING', 65), ('IMPORTANT_CONSIDERATION', 78), ('ANOMALY_CURIOUS_FINDING', 110)]	3	[('GO_0007565', 'female pregnancy', 13, 'pregnant'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnant')]
PMC3407995	7/2012	S92-PMC3407995	['Vitamin D is IMPORTANT during Pregnancy to:\nbuild strong Bones—Vitamin D ensures foetal supply of Calcium for strong Bones [45] including those of the Skull.']	[('IMPORTANT_CONSIDERATION', 13)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 30, 'pregnancy'), ('UBERON_0001474', 'bone element', 57, 'bones'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 98, 'calcium'), ('UBERON_0001474', 'bone element', 117, 'bones'), ('UBERON_0003129', 'skull', 151, 'skull')]
PMC3407995	7/2012	S100-PMC3407995	['THEREFORE at its worst, Vitamin D deficiency CAN be Life threatening to the newborn, WHILE lesser deficiency CAN weaken Skull Bones risking Brain injury during Birth and can CONTRIBUTE to a multitude of future health PROBLEMS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 174), ('IMPORTANT_CONSIDERATION', 217)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0000104', 'life cycle', 52, 'life'), ('UBERON_0003215', 'alveolus', 120, 'skull bones'), ('UBERON_0000955', 'brain', 140, 'brain'), ('GO_0007567', 'parturition', 160, 'birth')]
PMC3407995	7/2012	S249-PMC3407995	['evidence of the POTENTIAL benefits of maternal Vitamin D supplementation for foetal/infant Brain health\npublished placebo-controlled intervention trials studying the IMPACT of Vitamin D supplementation in mothers with low Serum 25(Oh)D are RARE [45] because such trials are deemed UNACCEPTABLE by ethics committees.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 240), ('IMPORTANT_CONSIDERATION', 281)]	4	[('CHEBI_28384', 'vitamin K', 47, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 47, 'Vitamin D'), ('UBERON_0000955', 'brain', 91, 'Brain'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 228, '25(OH)D')]
PMC3407995	7/2012	S250-PMC3407995	['THEREFORE, results of epidemiological studies provide MOST OF the EVIDENCE SUGGESTING the IMPORTANCE of Vitamin D for foetal/infant Brain health.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 54), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 90)]	5	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0000955', 'brain', 132, 'brain')]
PMC3407995	7/2012	S258-PMC3407995	['a recent review of studies LINKING maternal Vitamin D status during Pregnancy with maternal, foetal and Postnatal outcomes SUPPORTS a ROLE of maternal Vitamin D status, PARTICULARLY early in Pregnancy, in Modulating the risk of Pregnancy complications and in sustaining foetal growth, body composition, Skeletal Development, Immune Maturation and Respiratory health [141].']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 134), ('IMPORTANT_CONSIDERATION', 169)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0007567', 'parturition', 104, 'postnatal'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'pregnancy'), ('GO_0065007', 'biological regulation', 205, 'modulating'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0001501', 'skeletal system development', 303, 'skeletal development'), ('UBERON_0004288', 'skeleton', 303, 'skeletal'), ('GO_0050900', 'leukocyte migration', 325, 'immune maturation'), ('UBERON_0002405', 'immune system', 325, 'immune'), ('UBERON_0001004', 'respiratory system', 347, 'respiratory')]
PMC3407995	7/2012	S259-PMC3407995	['SEVERAL STUDIES have DEMONSTRATED an ASSOCIATION between POOR maternal Vitamin D status and SEVERE Preeclampsia that CAN result in Miscarriage [141].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 37), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 92), ('INCOMPLETE_EVIDENCE', 117)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 99, 'preeclampsia'), ('GO_0046660', 'female sex differentiation', 131, 'miscarriage')]
PMC3407995	7/2012	S262-PMC3407995	['polymorphisms in the Vitamin D Receptor Gene MAY CONTRIBUTE to Vitamin D-RELATED DISPARITIES in foetal growth [141].']	[('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 81)]	4	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 21, 'vitamin D receptor'), ('SO_0000704', 'gene', 40, 'gene'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC3407995	7/2012	S264-PMC3407995	['in addition, one STUDY has SUGGESTED that supplementation during Pregnancy MAY BE NECESSARY to assure adequate concentration of Vitamin D in Breast Milk during Lactation [142].']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 82)]	4	[('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 141, 'breast milk'), ('GO_0007595', 'lactation', 160, 'lactation')]
PMC3407995	7/2012	S278-PMC3407995	['DESPITE abundant sunshine and latitude CONSISTENT with year-long Vitamin D Synthesis, 65.5% of a largely low-risk Antenatal population in rural victoria, australia had insufficient Vitamin D. over 5.0% of women had Vitamin D levels that pose a significant neonatal and Adult health RISK [135].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 282)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 65, 'vitamin D synthesis'), ('GO_0007567', 'parturition', 114, 'antenatal'), ('UBERON_0001760', 'frontal sinus', 114, 'antenatal'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('UBERON_0007023', 'adult organism', 269, 'adult')]
PMC3407995	7/2012	S283-PMC3407995	['the authors CONCLUDED that Vitamin D deficiency is high among Pregnant urban pakistani women and their newborns and is a PUBLIC HEALTH PROBLEM that NEEDS URGENT ATTENTION [137].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 121), ('IMPORTANT_CONSIDERATION', 135), ('FUTURE_WORK', 148), ('IMPORTANT_CONSIDERATION', 148), ('IMPORTANT_CONSIDERATION', 154), ('FUTURE_WORK', 161)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnant')]
PMC3407995	7/2012	S302-PMC3407995	['the authors CONCLUDED that Prenatal Vitamin D supplements in women AT RISK of deficiency COULD reduce the risk of schizophrenia in their offspring [149].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 67), ('INCOMPLETE_EVIDENCE', 89)]	3	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3407995	7/2012	S312-PMC3407995	['these results SUGGEST that Vitamin D supplementation during Pregnancy would be beneficial for mothers, whose intake from diet and skin Synthesis is APPRECIABLY less than 500 iu of vitamin d daily.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 148)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('GO_0009057', 'macromolecule catabolic process', 135, 'synthesis')]
PMC3407995	7/2012	S433-PMC3407995	['independent researchers have RECOMMENDED up to 100 μg (4000 iu) daily to increase maternal and neonatal Vitamin D status to OPTIMAL levels [171].']	[('FUTURE_WORK', 29), ('IMPORTANT_CONSIDERATION', 124)]	2	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC3407995	7/2012	S435-PMC3407995	['their RECOMMENDATION was 37.5–50 μg 1500–2000 iu) per day in Pregnant and Lactating women with Vitamin D deficiency [172].table 1includes RECOMMENDATIONS from various health agencies and governments around the world.Nutrients-04-00799-t001_table 1\n\ncaption (table-wrap): table 1\n\nVitamin D intake RECOMMENDATIONS during Pregnancy and Lactation.agency/governmentrecommendationuk—for the elderly, Pregnant & Lactating women [173]dietary reference values 10 µg/day (400 iu/day)uk department of health 2007—for Pregnant and Lactating women [45]10 µg/day (400 iu/day)uk national institute of health and clinical excellence guideline review panel 2007 [45]all women SHOULD BE informed about the IMPORTANCE for their own and their baby’s health of maintaining adequate Vitamin D stores during Pregnancy and whilst Breast feeding and may choose to take 400 iu/day.canadian paediatric society [45]50 μg/day (2000 iu/day) throughout Pregnancyfederal department of health canada [45]5 μg/day (200 iu/day) for Pregnant and Breast-feeding womeneuropean commission [45]10 μg/day (400 iu/day) during Pregnancyworld health organisation 2004 [45]5 μg/day (200 iu/day) during Pregnancythe institute of medicine us 2010 [172,174]15 μg/day (600 iu/day) in Pregnant and Lactating womenus Endocrine task force on Vitamin D 2011 [174]37.5–50 μg/day (1500–2000 iu) in Pregnant and Lactating women with Vitamin D deficiency.']	[('FUTURE_WORK', 6), ('FUTURE_WORK', 138), ('FUTURE_WORK', 297), ('FUTURE_WORK', 660), ('IMPORTANT_CONSIDERATION', 689)]	5	[('GO_0007565', 'female pregnancy', 61, 'pregnant'), ('GO_0007594', 'puparial adhesion', 74, 'lactating'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_33284', 'nutrient', 216, 'nutrients'), ('CHEBI_28384', 'vitamin K', 280, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 320, 'pregnancy'), ('GO_0007595', 'lactation', 334, 'lactation'), ('GO_0007565', 'female pregnancy', 395, 'pregnant'), ('GO_0007594', 'puparial adhesion', 406, 'lactating'), ('GO_0007565', 'female pregnancy', 507, 'pregnant'), ('GO_0007594', 'puparial adhesion', 520, 'lactating'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('GO_0007565', 'female pregnancy', 786, 'pregnancy'), ('UBERON_0000310', 'breast', 807, 'breast'), ('GO_0007565', 'female pregnancy', 923, 'pregnancyFederal'), ('GO_0007565', 'female pregnancy', 998, 'pregnant'), ('UBERON_0000310', 'breast', 1011, 'breast'), ('GO_0014065', 'phosphatidylinositol 3-kinase signaling', 1085, 'pregnancyWorld'), ('GO_0036240', 'septal periplasm', 1158, 'pregnancyThe'), ('GO_0007565', 'female pregnancy', 1236, 'pregnant'), ('GO_0007594', 'puparial adhesion', 1249, 'lactating'), ('GO_0009790', 'embryo development', 1267, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1267, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 1291, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1291, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1344, 'pregnant'), ('GO_0007594', 'puparial adhesion', 1357, 'lactating'), ('CHEBI_27300', 'vitamin D', 1378, 'vitamin D')]
PMC3407995	7/2012	S436-PMC3407995	['a RECENT cochrane review ASSESSED the EFFECTS and SAFETY of Vitamin D supplementation in Pregnancy and EXAMINED WHETHER supplementation with Vitamin D alone OR in combination with Calcium and other Vitamins and Minerals given to women during Pregnancy COULD SAFELY improve Pregnancy outcomes [175].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 38), ('IMPORTANT_CONSIDERATION', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 252), ('IMPORTANT_CONSIDERATION', 258)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 180, 'calcium'), ('CHEBI_33277', 'gamma-tocotrienol', 198, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 211, 'minerals'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'pregnancy')]
PMC3407995	7/2012	S449-PMC3407995	['the authors CONCLUDED that Vitamin D supplementation of 4000 iu/day for Pregnant women is SAFE and MOST EFFECTIVE in achieving sufficiency in all women and their neonates regardless of race, WHEREAS the current ESTIMATED average REQUIREMENT is comparatively ineffective at achieving adequate circulating 25(Oh)D concentrations, especially in african americans [179].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 90), ('PROBABLE_UNDERSTANDING', 99), ('SUPERFICIAL_RELATIONSHIP', 104), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('INCOMPLETE_EVIDENCE', 211), ('IMPORTANT_CONSIDERATION', 229)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 304, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 304, '25(OH)D')]
PMC3407995	7/2012	S480-PMC3407995	['HOWEVER, common dietary DEFICIENCIES within many populations of particular Nutrients including dha, Vitamin D, Folic Acid, and Iodine, that all play CRITICAL ROLES at various developmental stages, HAVE BEEN SHOWN to CONTRIBUTE to functional abnormalities, many of which have lasting EFFECTS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 24), ('IMPORTANT_CONSIDERATION', 149), ('SUPERFICIAL_RELATIONSHIP', 158), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 216), ('SUPERFICIAL_RELATIONSHIP', 283)]	7	[('CHEBI_33284', 'nutrient', 75, 'nutrients'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_30751', 'formic acid', 111, 'folic acid'), ('CHEBI_24859', 'iodine atom', 127, 'iodine')]
PMC3407995	7/2012	S486-PMC3407995	['epidemiological studies have LINKED low maternal Vitamin D status to SEVERE Preeclampsia resulting in Miscarriage, risk of low Birth weight and small-for-Gestational age infants, neonatal hypocalcaemia with seizures and POSSIBLE INVOLVEMENT in the development of schizophrenia.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 69), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 229)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 76, 'preeclampsia'), ('GO_0046660', 'female sex differentiation', 102, 'miscarriage'), ('GO_0007567', 'parturition', 127, 'birth'), ('GO_0007565', 'female pregnancy', 154, 'gestational')]
PMC3407995	7/2012	S492-PMC3407995	['maternal supplementation with Dha, Vitamin D, Folic Acid and Iodine within RECOMMENDED SAFE intake quantities in a large segment of the population that is currently DEFICIENT in these Nutrients, COULD significantly prevent many Brain and Central Nervous System malfunctions and EVEN enhance Brain Development and function in future generations.']	[('FUTURE_WORK', 75), ('IMPORTANT_CONSIDERATION', 87), ('IMPORTANT_CONSIDERATION', 165), ('INCOMPLETE_EVIDENCE', 195), ('ANOMALY_CURIOUS_FINDING', 278)]	5	[('CHEBI_17874', 'dihydrozeatin', 30, 'DHA'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_30751', 'formic acid', 46, 'folic acid'), ('CHEBI_24859', 'iodine atom', 61, 'iodine'), ('CHEBI_33284', 'nutrient', 184, 'nutrients'), ('UBERON_0000955', 'brain', 228, 'brain'), ('UBERON_0001017', 'central nervous system', 238, 'central nervous system'), ('GO_0007420', 'brain development', 291, 'brain development'), ('UBERON_0000955', 'brain', 291, 'brain')]
PMC3415261	7/2012	S38-PMC3415261	['for example, the selection of the Animal model for studying Vitamin A supplementation is CRUCIAL because the Carotenoids are very differently absorbed DEPENDING ON the selected MODEL [7].']	[('IMPORTANT_CONSIDERATION', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 177)]	3	[('NCBITaxon_33208', 'Metazoa', 34, 'animal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('CHEBI_50815', 'norgestimate', 109, 'carotenoids')]
PMC3417531	7/2012	S66-PMC3417531	["(91)childreninfectious diseasehigh rate of simkania negevensis among canadian inuit infants hospitalized with Lower Respiratory Tract infections (92)childrennutritioniron deficiency and anaemia prevalence and ASSOCIATED etiologic RISK FACTORS in first nations and inuit communities in northern ontario and nunavut (93)childrennutritionfood insecurity among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (59)childrennutritionvitamin D status of inuit preschoolers reflects season and Vitamin D intake (56)childrenenvironment/environmental exposures; infectious diseaseeffect of Prenatal exposure to Polychlorinated Biphenyls on incidence of acute Respiratory infections in preschool inuit children (25)childrenchronic disease; interventions/programmingthe benefits of sound field amplification in classrooms of inuit students of nunavik: a pilot project (73)childrensocial DETERMINANTS of health; tobaccocultural, socioeconomic, and health indicators among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (9)childreninfectious disease; tobaccoindoor air quality and the risk of Lower Respiratory Tract infections in young canadian inuit children (41)childreninfectious disease; interventions/programmingheat recovery ventilators prevent Respiratory disorders in inuit children (40)childrengenetics; nutritionadaptation of inuit children to a low-calcium diet (83)childreninfectious disease; health care, policy, Human resourcesbronchiolitis in inuit children from a canadian central arctic community, 1995–1996 (69)youthchronic diseasecauses and CONTRIBUTIONS to differences in Life expectancy for inuit nunangat and canada, 1994–2003 (82)youthinfectious diseaseotitis media and Hearing loss among 12–16 year-old inuit of inukjuak, quebec, canada (35)youthinjuryinjury mortality risk assessment and targeting the subpopulations for prevention in the northwest territories, canada (86)youthnutritionage differences in Vitamin A intake among canadian inuit (55)youthmental health and wellbeingcompleted suicides among the inuit of northern quebec, 1982–1996: a case-control study (77)youthmental health and wellbeing; social determinants of healthsuicidality in a sample of arctic households (76)youthinfectious disease; interventions/programminghiv testing experiences of aboriginal youth in canada: service IMPLICATIONS (74)youthinfections disease; social determinants of healthdeterminants of Sexually Transmitted infections among canadian inuit adolescent populations (30)youthinfections disease; mental health and wellbeingyouth sexual health in nunavut: a needs-based survey of knowledge, attitudes and behaviour (31)maternalbirth outcomesreclaiming Birth, health, and community: midwifery in the inuit villages of nunavik, canada (68)maternalenvironment/environmental exposuresorganochlorine levels in maternal and Umbilical Cord Blood Plasma in arctic canada (49)maternalenvironment/environmental exposuresexposure of the inuit population of nunavik (arctic quebec) to lead and mercury (48)maternalnutritiondietary assessment of indigenous canadian arctic women with a focus on Pregnancy and Lactation (54)maternalnutritioncontribution of selected traditional and market Foods to the diet of nunavik inuit women (57)maternalbirth outcomes; tobaccomaternal smoking at first Prenatal visit as a MARKER of risk for adverse Pregnancy outcomes in the qikiqtaaluk (baffin) region (8)maternalnutrition; environment/environmental exposuresfish Consumption and Blood Lipids in 3 ethnic groups of quebec (canada) (51)maternalhealth care, policy, Human resources; Birth outcomesconverging epistemologies: CRITICAL ISSUES in canadian inuit Childbirth and Pregnancy (65)maternalenvironment/environmental exposures; nutritiondeterminants of Polychlorinated Biphenyls and Methylmercury exposure in inuit women of Childbearing age (50)maternalhealth care, policy, Human resources; interventions/programmingthe outcome of Perinatal Care in inukjuak, nunavik, canada 1998–2002 (70)maternalhealth care, policy, Human resources; Birth outcomesthe inuulitsivik maternities: culturally appropriate midwifery and epistemological accommodation (66)maternalinfectious disease; interventions/programmingoncogenic human papillomavirus infection and Cervical lesions in aboriginal women in nunavut, canada (94)maternalchronic disease; social determinants of health; tobacco; mental health and Wellbeingthe health of cree, inuit and southern quebec women: similarities and differences (79)maternalnutrition; social DETERMINANTS of health; environment/environmental exposuresfood insecurity among inuit women exacerbated by socioeconomic stresses and climate change (60)children; youthchronic diseasethe RELATIONSHIP between socio-economic and geographic factors and asthma among canada's aboriginal populations (81)children; youthinfectious diseasehospitalization due to pneumonia among innu, inuit and non-aboriginal communities, newfoundland and labrador, canada (24)children; maternalbirth outcomesheart defects and other malformations in the inuit in canada: a baseline study (62)children; maternalbirth outcomesbirth outcomes in the inuit-inhabited areas of canada (95)children; maternalbirth outcomesdegree of rural isolation and Birth outcomes (63)children; maternalbirth outcomesrisks of adverse Pregnancy outcomes among inuit and north american indian women in quebec, 1985–97 (64)children; maternalenvironment/environmental exposuresprenatal exposure to Methylmercury and Pcbs AFFECTS distinct stages of information processing: an event-related POTENTIAL study with inuit children (44)children; maternalenvironment/environmental exposuresthe RELATION of lead neurotoxicity to the event-related potential p3b component in inuit children from arctic quebec (47)children; maternalenvironment/environmental exposuresthyroid hormone levels of Pregnant inuit women and their infants exposed to environmental contaminants (96)children; maternalenvironment/environmental exposuresneuromotor functions in inuit preschool children exposed to Pb, Pcbs, and hg (43)children; maternalenvironment/environmental exposuresbeneficial EFFECTS of a polyunsaturated Fatty Acid on infant development: EVIDENCE from the inuit of arctic quebec (52)children; maternalenvironment/environmental exposuresthe RELATION of environmental contaminants exposure to behavioural indicators in inuit preschoolers in arctic quebec (46)children; maternalinfectious diseaseneonatal Vitamin A deficiency and its IMPACT on acute Respiratory infections among preschool inuit children (33)children; maternalnutritionanaemia and iron status in inuit infants from northern quebec (97)children; maternalbirth outcomes; nutritioncongenital Heart defects in canadian inuit: is more Folic Acid making a difference?"]	[('SUPERFICIAL_RELATIONSHIP', 209), ('SUPERFICIAL_RELATIONSHIP', 230), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1581), ('IMPORTANT_CONSIDERATION', 2342), ('SUPERFICIAL_RELATIONSHIP', 3334), ('IMPORTANT_CONSIDERATION', 3635), ('IMPORTANT_CONSIDERATION', 3644), ('SUPERFICIAL_RELATIONSHIP', 4527), ('SUPERFICIAL_RELATIONSHIP', 4715), ('SUPERFICIAL_RELATIONSHIP', 5499), ('INCOMPLETE_EVIDENCE', 5567), ('SUPERFICIAL_RELATIONSHIP', 5664), ('SUPERFICIAL_RELATIONSHIP', 6139), ('INCOMPLETE_EVIDENCE', 6202), ('SUPERFICIAL_RELATIONSHIP', 6304), ('SUPERFICIAL_RELATIONSHIP', 6495), ('EXPLICIT_QUESTION', 6787)]	18	[('UBERON_0004905', 'articulation', 110, 'lower respiratory tract'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 451, 'D'), ('CHEBI_27300', 'vitamin D', 502, 'vitamin D'), ('GO_0007565', 'female pregnancy', 596, 'prenatal'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 617, 'polychlorinated biphenyls'), ('UBERON_0001004', 'respiratory system', 665, 'respiratory'), ('UBERON_0004905', 'articulation', 1113, 'lower respiratory tract'), ('UBERON_0001004', 'respiratory system', 1272, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 1447, 'human'), ('UBERON_0000104', 'life cycle', 1613, 'life'), ('GO_0007605', 'sensory perception of sound', 1714, 'hearing'), ('CHEBI_27300', 'vitamin D', 1952, 'vitamin A'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 2429, 'sexually transmitted'), ('GO_0007567', 'parturition', 2689, 'birth'), ('UBERON_0002331', 'umbilical cord', 2855, 'umbilical cord'), ('UBERON_0000178', 'blood', 2870, 'blood'), ('UBERON_0001969', 'blood plasma', 2876, 'plasma'), ('GO_0007565', 'female pregnancy', 3119, 'pregnancy'), ('GO_0007595', 'lactation', 3133, 'lactation'), ('CHEBI_33290', 'food', 3212, 'foods'), ('GO_0007565', 'female pregnancy', 3314, 'prenatal'), ('GO_0007565', 'female pregnancy', 3361, 'pregnancy'), ('GO_0007631', 'feeding behavior', 3477, 'consumption'), ('UBERON_0000178', 'blood', 3493, 'blood'), ('CHEBI_18059', 'lipid', 3499, 'lipids'), ('NCBITaxon_9606', 'Homo sapiens', 3577, 'human'), ('GO_0007567', 'parturition', 3594, 'birth'), ('GO_0007623', 'circadian rhythm', 3669, 'childbirth'), ('GO_0007565', 'female pregnancy', 3684, 'pregnancy'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 3768, 'polychlorinated biphenyls'), ('CHEBI_33963', 'metallocene', 3798, 'methylmercury'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 3839, 'childbearing'), ('NCBITaxon_9606', 'Homo sapiens', 3889, 'human'), ('GO_0036356', 'cyclic 2,3-diphosphoglycerate synthetase activity', 3946, 'perinatal care'), ('UBERON_0012101', 'perinatal stage', 3946, 'perinatal'), ('NCBITaxon_9606', 'Homo sapiens', 4033, 'human'), ('GO_0007567', 'parturition', 4050, 'birth'), ('UBERON_0005434', 'cervical region', 4263, 'cervical'), ('GO_0035706', 'T-helper 1 cell chemotaxis', 4406, 'wellbeingThe'), ('GO_0007567', 'parturition', 5248, 'birth'), ('GO_0007565', 'female pregnancy', 5316, 'pregnancy'), ('CHEBI_33963', 'metallocene', 5476, 'methylmercury'), ('CHEBI_26199', 'polyprenol', 5494, 'PCBs'), ('GO_0007565', 'female pregnancy', 5860, 'pregnant'), ('CHEBI_37983', 'sulfur-35 atom', 6054, 'Pb'), ('CHEBI_26199', 'polyprenol', 6058, 'PCBs'), ('CHEBI_35366', 'fatty acid', 6168, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 6466, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 6511, 'respiratory'), ('UBERON_0000948', 'heart', 6716, 'heart'), ('CHEBI_30751', 'formic acid', 6757, 'folic acid')]
PMC3424155	8/2012	S0-PMC3424155	['maternal Vitamin D deficiency delays Glomerular maturity in f1 and f2 offspring\n\nabstract\n\nbackground\nthere is a high prevalence of Vitamin D INSUFFICIENCY in women of Reproductive age.']	[('IMPORTANT_CONSIDERATION', 142)]	1	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('UBERON_0000074', 'renal glomerulus', 37, 'Glomerular'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0000003', 'reproduction', 168, 'reproductive')]
PMC3424155	8/2012	S10-PMC3424155	['conclusion\nTHESE FINDINGS DEMONSTRATE that maternal Vitamin D deficiency accompanies changes in the Renal Expression of IMPORTANT FACTORS that MAY retard the Maturation Of Glomeruli by EXTENDING the period of Nephrogenesis.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('IMPORTANT_CONSIDERATION', 120), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 185)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002113', 'kidney', 100, 'renal'), ('GO_0010467', 'gene expression', 106, 'expression'), ('GO_0009902', 'chloroplast relocation', 158, 'maturation of glomeruli'), ('UBERON_0000074', 'renal glomerulus', 172, 'glomeruli'), ('GO_0001822', 'kidney development', 209, 'nephrogenesis')]
PMC3424155	8/2012	S16-PMC3424155	['HOWEVER, NEW EVIDENCE SUGGESTS that Vitamin D COULD BE VITAL to normal fetal Development and that Vitamin D restriction in this period MAY AFFECT chronic disease susceptibility post-Natal Life[8].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 139)]	7	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0008289', 'lipid binding', 77, 'development'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007567', 'parturition', 182, 'natal'), ('UBERON_0000104', 'life cycle', 188, 'life')]
PMC3424155	8/2012	S18-PMC3424155	['moreover, Vitamin D is ASSOCIATED with premature births, obesity and Renal dysfunction in Adulthood, making it more than an ESSENTIAL fat-soluble Vitamin RESPONSIBLE for calcium Metabolism[9],[10].']	[('SUPERFICIAL_RELATIONSHIP', 23), ('IMPORTANT_CONSIDERATION', 124), ('PROBABLE_UNDERSTANDING', 154)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0002113', 'kidney', 69, 'renal'), ('UBERON_0000113', 'post-juvenile adult stage', 90, 'adulthood'), ('CHEBI_33229', 'vitamin (role)', 146, 'vitamin'), ('GO_0008152', 'metabolic process', 178, 'metabolism')]
PMC3424155	8/2012	S164-PMC3424155	['discussion\nmicronutrient deficiency during development, such as maternal Vitamin D deficiency, is a subject of increasing IMPORTANCE BECAUSE of the nutritional deficiencies caused by excessive consumption of junk Food during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 133)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_33290', 'food', 213, 'food'), ('GO_0007565', 'female pregnancy', 225, 'pregnancy')]
PMC3424155	8/2012	S165-PMC3424155	['HOWEVER, Vitamin D insufficiency is STILL UNDER-RECOGNIZED and UNDER-TREATED, DESPITE its prevalence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 36), ('IMPORTANT_CONSIDERATION', 42), ('IMPORTANT_CONSIDERATION', 63), ('ANOMALY_CURIOUS_FINDING', 78)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC3424155	8/2012	S166-PMC3424155	['a RECENT STUDY of Pregnant women in europe REPORTED that ONLY 12% had an OPTIMAL level of Vitamin D[20].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 57), ('IMPORTANT_CONSIDERATION', 73)]	4	[('GO_0007565', 'female pregnancy', 18, 'pregnant'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC3424155	8/2012	S170-PMC3424155	['Vitamin D is NORMALLY stored in the Liver and Adipose Tissue, and after six weeks on a restricted diet, the Vitamin D levels were EXTREMELY reduced without alteration of calcium or Phosphate levels in the rodents[21].']	[('PROBABLE_UNDERSTANDING', 13), ('IMPORTANT_CONSIDERATION', 130)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0002107', 'liver', 36, 'liver'), ('UBERON_0001013', 'adipose tissue', 46, 'adipose tissue'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_18367', 'phosphate(3-)', 181, 'phosphate')]
PMC3424155	8/2012	S179-PMC3424155	['in Rats, it has been OBSERVED that maternal Vitamin D deficiency LEADS to a significant increase in the number of Glomeruli, which is a UNIQUE and IMPORTANT EFFECT of Vitamin D restriction during fetal development[13].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 65), ('ANOMALY_CURIOUS_FINDING', 136), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 157)]	5	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0000074', 'renal glomerulus', 114, 'glomeruli'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC3424155	8/2012	S183-PMC3424155	['research SUGGESTS that Vitamin D is IMPORTANT for differentiation and maturation during Cell Proliferation[9]and that it down-regulates Renin Gene Expression in the Kidneys[13].']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 36)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0008283', 'cell proliferation', 88, 'cell proliferation'), ('PR_000014368', 'RuvB-like 1', 136, 'renin'), ('GO_0010467', 'gene expression', 142, 'gene expression'), ('SO_0000704', 'gene', 142, 'gene'), ('UBERON_0002113', 'kidney', 165, 'kidneys')]
PMC3424155	8/2012	S208-PMC3424155	['the MAJOR AIM of the study was TO INVESTIGATE Glomerular Development and Renal structure at Birth, 10 days and Adulthood in Mice Born to mothers Fed a diet restricted in Vitamin D. ALTHOUGH, we EXAMINED OTHER variables, such as body mass and 24 h Urine, the PRESENT STUDY was NOT DESIGNED TO investigate Renal functional and Metabolic CONSEQUENCES BUT RATHER was DESIGNED TO answer the QUESTION of WHETHER there were structural, Glomerular alterations or transgenerational EFFECTS.']	[('IMPORTANT_CONSIDERATION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('QUESTION_ANSWERED_BY_THIS_WORK', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 203), ('QUESTION_ANSWERED_BY_THIS_WORK', 258), ('INCOMPLETE_EVIDENCE', 276), ('IMPORTANT_CONSIDERATION', 335), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('QUESTION_ANSWERED_BY_THIS_WORK', 363), ('EXPLICIT_QUESTION', 386), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 398), ('SUPERFICIAL_RELATIONSHIP', 473)]	15	[('GO_0032835', 'glomerulus development', 46, 'glomerular development'), ('UBERON_0000074', 'renal glomerulus', 46, 'glomerular'), ('UBERON_0002113', 'kidney', 73, 'renal'), ('GO_0007567', 'parturition', 92, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 111, 'adulthood'), ('NCBITaxon_10088', 'Mus <genus>', 124, 'mice'), ('GO_0007567', 'parturition', 129, 'born'), ('GO_0007631', 'feeding behavior', 145, 'fed'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('UBERON_0001088', 'urine', 247, 'urine'), ('UBERON_0002113', 'kidney', 304, 'renal'), ('GO_0008152', 'metabolic process', 325, 'metabolic'), ('UBERON_0000074', 'renal glomerulus', 429, 'glomerular')]
PMC3424155	8/2012	S209-PMC3424155	['FURTHER STUDIES are NECESSARY TO CLARIFY the IMPACT of maternal Vitamin D restriction on the Renal function of offspring.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 20), ('FUTURE_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0002113', 'kidney', 93, 'renal')]
PMC3427192	4/2012	S14-PMC3427192	['Vitamin D overview\nVitamin D, a fat-soluble Nutrient, is a Secosteroid Hormone which is widely recognized as a modulator of calcium absorption and bone health and further Regulates Neuromuscular function, Cellular Differentiation, Insulin secretion, and Blood pressure.25,26vitamin D also plays an IMPORTANT ROLE in Immune Regulation through interactions between 1,25-Dihydroxyvitamin D and Vitamin D receptors ( vdrs ) .']	[('IMPORTANT_CONSIDERATION', 298), ('SUPERFICIAL_RELATIONSHIP', 308)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_28384', 'vitamin K', 19, 'Vitamin D'), ('CHEBI_33284', 'nutrient', 44, 'nutrient'), ('CHEBI_26661', 'shidasterone', 59, 'secosteroid hormone'), ('GO_0065007', 'biological regulation', 171, 'regulates'), ('UBERON_0001016', 'nervous system', 181, 'neuromuscular'), ('GO_0030154', 'cell differentiation', 205, 'cellular differentiation'), ('PR_000045358', 'insulin family protein', 231, 'insulin'), ('UBERON_0000178', 'blood', 254, 'blood'), ('PR_000006444', 'diacylglycerol kinase delta', 282, 'D'), ('UBERON_0002405', 'immune system', 316, 'immune'), ('GO_0065007', 'biological regulation', 323, 'regulation'), ('CHEBI_67472', '15-epi-lupulin B', 363, '1,25-dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 391, 'vitamin D')]
PMC3427192	4/2012	S15-PMC3427192	['vdrs are Expressed on a variety of Airway Immune Cells, where they function as classic Nuclear Steroid Hormone receptors and ultimately Regulate the transcription of numerous Genes associated with inflammation and Immunomodulation.27vitamin d also plays an IMPORTANT ROLE in Respiratory infection by facilitating Toll-Like Receptor Signaling through increased Synthesis of Human Cathelicidin Antimicrobial peptide,28-30which is cleaved to generate the active Cationic peptide, Ll-37.31,32vitamin D also exerts direct EFFECTS on target cells independent of Gene transcription33and MAY THEREFORE be of relevance to Airway inflammatory disorders.34while Vitamin D can suppress il-1735and Il-4-mediated Expression of Il-13,35,36it CAN also shift the th1/th2 balance toward th2 dominance.37THESE CONTRADICTORY actions MAY BE DUE to the direct actions of Vitamin D on cd4+T Cells to promote an Il-10-secreting T-Regulatory population.38\n\nBiosynthesis Of Vitamin D\nBiosynthesis Of Vitamin D begins PRIMARILY with absorption of solar ultravoilet-b (uvb) radiation and secondarily via Consumption of Vitamin D-rich and fortified foods, such as oily fish, fortified grains and dairy products.26following exposure to uvb radiation, 7-Dehydrocholesterol within the skin is converted to Previtamin D3( fig.']	[('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267), ('SUPERFICIAL_RELATIONSHIP', 517), ('INCOMPLETE_EVIDENCE', 580), ('PROBABLE_UNDERSTANDING', 584), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 783), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 791), ('INCOMPLETE_EVIDENCE', 813), ('IMPORTANT_CONSIDERATION', 820), ('PROBABLE_UNDERSTANDING', 991)]	11	[('GO_0010467', 'gene expression', 9, 'expressed'), ('UBERON_0001005', 'respiratory airway', 35, 'airway'), ('CL_0000738', 'leukocyte', 42, 'immune cells'), ('UBERON_0002405', 'immune system', 42, 'immune'), ('GO_0005634', 'nucleus', 87, 'nuclear'), ('CHEBI_26764', 'steroid hormone', 95, 'steroid hormone'), ('GO_0065007', 'biological regulation', 136, 'regulate'), ('SO_0000704', 'gene', 175, 'genes'), ('GO_0050900', 'leukocyte migration', 214, 'immunomodulation'), ('UBERON_0001004', 'respiratory system', 275, 'respiratory'), ('GO_0002770', 'T cell inhibitory signaling pathway', 313, 'Toll-like receptor signaling'), ('GO_0009057', 'macromolecule catabolic process', 360, 'synthesis'), ('NCBITaxon_9606', 'Homo sapiens', 373, 'human'), ('PR_000006009', 'alpha-catulin', 379, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 392, 'antimicrobial'), ('CHEBI_36916', 'cation', 459, 'cationic'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 477, 'LL-37'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 496, 'D'), ('SO_0000704', 'gene', 556, 'gene'), ('UBERON_0001005', 'respiratory airway', 613, 'airway'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 685, 'IL-4'), ('GO_0010467', 'gene expression', 699, 'expression'), ('PR_000001470', 'interleukin-28B', 713, 'IL-13'), ('CHEBI_27300', 'vitamin D', 849, 'vitamin D'), ('CL_0000084', 'T cell', 866, 'T cells'), ('PR_000001470', 'interleukin-28B', 888, 'IL-10'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 904, 'T'), ('CL_0000232', 'erythrocyte', 906, 'regulatory'), ('GO_0065007', 'biological regulation', 906, 'regulatory'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 932, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 948, 'vitamin D'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 958, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 974, 'vitamin D'), ('GO_0007631', 'feeding behavior', 1076, 'consumption'), ('CHEBI_27300', 'vitamin D', 1091, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 1221, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 1274, 'previtamin D3')]
PMC3427192	4/2012	S19-PMC3427192	['Biosynthesis Of Vitamin D.\n\nVitamin D THRESHOLDS\nSerum concentrations of 25(Oh)D are CONSIDERED to be a BIOMARKER and INDICATOR of Vitamin D status.44,45ALTHOUGH Vitamin D insufficiency HAS TRADITIONALLY BEEN defined as a Serum 25(Oh)D concentration of 20 to 29 ng/ml,46a panel of experts from the institute of medicine RECENTLY SUGGESTED that Vitamin D INSUFFICIENCY be redefined AS a Serum 25(Oh)D concentration less than 20 ng/ml.47this RECOMMENDATION was based ON INCONCLUSIVE evidence for the threshold of 29 ng/ml and EVIDENCE for adverse Skeletal EFFECTS at thresholds less than 20 ng/ml.47HOWEVER, this revised definition of Vitamin D insufficiency has generated significant CONTROVERSY48,49AND THUS there is presently NO universally ACCEPTED definition for “optimal” 25(Oh)d concentrations INDEPENDENT of Musculoskeletal health.']	[('PROBABLE_UNDERSTANDING', 38), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 118), ('ANOMALY_CURIOUS_FINDING', 151), ('IMPORTANT_CONSIDERATION', 186), ('INCOMPLETE_EVIDENCE', 190), ('PROBABLE_UNDERSTANDING', 190), ('INCOMPLETE_EVIDENCE', 320), ('INCOMPLETE_EVIDENCE', 329), ('IMPORTANT_CONSIDERATION', 354), ('PROBABLE_UNDERSTANDING', 381), ('FUTURE_WORK', 440), ('ANOMALY_CURIOUS_FINDING', 465), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 468), ('INCOMPLETE_EVIDENCE', 524), ('SUPERFICIAL_RELATIONSHIP', 554), ('ANOMALY_CURIOUS_FINDING', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 683), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 697), ('PROBABLE_UNDERSTANDING', 703), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 742), ('INCOMPLETE_EVIDENCE', 742), ('SUPERFICIAL_RELATIONSHIP', 799)]	25	[('GO_0033593', 'BRCA2-MAGE-D1 complex', 0, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 28, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 49, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 228, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D'), ('UBERON_0001977', 'blood serum', 386, 'serum'), ('CHEBI_71657', 'versiconol acetate', 392, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 392, '25(OH)D'), ('UBERON_0004288', 'skeleton', 545, 'skeletal'), ('CHEBI_27300', 'vitamin D', 633, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 776, '25(OH)'), ('UBERON_0002204', 'musculoskeletal system', 814, 'musculoskeletal')]
PMC3427192	4/2012	S21-PMC3427192	['INSTEAD, a number of environmental exposures MAY also alter the rate of Asthma Development.50-54of these modifiable environmental exposures, the ROLE of diet in asthma is of PARTICULAR INTEREST13,55since RECENT STUDIES SUGGEST that the Development Of Asthma in children MAY BE DUE to in utero exposure to Nutrients from the mother’s diet.56given the ROLE of Vitamin D in inflammation and Immunomodulation, SEVERAL STUDIES have focused on in utero Vitamin D exposure and subsequent asthma in children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 145), ('ANOMALY_CURIOUS_FINDING', 174), ('ANOMALY_CURIOUS_FINDING', 185), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 219), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 277), ('SUPERFICIAL_RELATIONSHIP', 350), ('INCOMPLETE_EVIDENCE', 406)]	11	[('GO_0035801', 'adrenal cortex development', 72, 'asthma development'), ('GO_0009602', 'detection of symbiont', 236, 'development of asthma'), ('CHEBI_33284', 'nutrient', 305, 'nutrients'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0050900', 'leukocyte migration', 388, 'immunomodulation'), ('CHEBI_27300', 'vitamin D', 447, 'vitamin D')]
PMC3427192	4/2012	S23-PMC3427192	['SEVERAL of THESE STUDIES NOTED an inverse RELATIONSHIP between maternal Vitamin D intake and the RISK of subsequent wheezing in young infants and preschool children.58,61,62,64HOWEVER, Vitamin D intakes varied CONSIDERABLY between geographic locations, from 548 iu/day in the united states58and 260 iu/day in finland62to 248 and 137 iu/day in japan64and scotland,61respectively.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('ANOMALY_CURIOUS_FINDING', 25), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('ANOMALY_CURIOUS_FINDING', 210)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3427192	4/2012	S24-PMC3427192	['it is also IMPORTANT TO NOTE that ASSOCIATIONS between Prenatal Vitamin D exposure, wheezing and subsequent asthma have NOT BEEN CONSISTENT across studies.']	[('IMPORTANT_CONSIDERATION', 11), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120)]	3	[('GO_0007565', 'female pregnancy', 55, 'prenatal'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC3427192	4/2012	S32-PMC3427192	['HOWEVER, in THESE STUDIES, there were no associations between Cord-Blood 25(Oh)D concentrations and subsequent asthma at 5 y of age.59,66\ncollectively, these studies SUGGEST that the benefits of Vitamin D during early Life MAY BE LIMITED to its EFFECTS on Respiratory infections and Viral-induced wheezing and not asthma per se.17HOWEVER, ALTHOUGH Vitamin D MAY have IMPORTANT ROLES in Immune Regulation during early Life, excessive Vitamin D exposure MAY also be ASSOCIATED with adverse health outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 166), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 230), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 328), ('ANOMALY_CURIOUS_FINDING', 339), ('INCOMPLETE_EVIDENCE', 358), ('IMPORTANT_CONSIDERATION', 367), ('SUPERFICIAL_RELATIONSHIP', 377), ('INCOMPLETE_EVIDENCE', 452), ('SUPERFICIAL_RELATIONSHIP', 464)]	13	[('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('UBERON_0000104', 'life cycle', 218, 'life'), ('UBERON_0001004', 'respiratory system', 256, 'respiratory'), ('NCBITaxon_1', 'root', 283, 'viral'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('GO_0002521', 'leukocyte differentiation', 386, 'immune regulation'), ('UBERON_0002405', 'immune system', 386, 'immune'), ('UBERON_0000104', 'life cycle', 417, 'life'), ('CHEBI_27300', 'vitamin D', 433, 'vitamin D')]
PMC3427192	4/2012	S34-PMC3427192	['this finding is SIMILAR TO OTHER STUDIES where an INCREASED risk of allergic sensitization was NOTED in infants who received Vitamin D supplementation.67,68likewise, gale et al.63NOTED that maternal 25(Oh)D concentrations greater than 75\u2009nmol/l (30 ng/ml) were ASSOCIATED with 5-fold increased odds of asthma at 9 y of age in the exposed children.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 27), ('IMPORTANT_CONSIDERATION', 50), ('ANOMALY_CURIOUS_FINDING', 95), ('INCOMPLETE_EVIDENCE', 177), ('SUPERFICIAL_RELATIONSHIP', 261)]	6	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 199, '25(OH)D')]
PMC3427192	4/2012	S35-PMC3427192	['HOWEVER, it is IMPORTANT TO NOTE that a large percentage of children were lost to follow-up, and THUS the resulting sample of mothers had higher concentrations of 25(Oh)D and were older, less LIKELY to smoke during Pregnancy, and more educated.63therefore WHILE there MAY BE therapeutic window for vitamin D supplementation in early Life, FURTHER STUDIES ARE NEEDED to more clearly understand the RISKS of high Vitamin D intake and bioavailability during the early childhood years.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 15), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 192), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('INCOMPLETE_EVIDENCE', 268), ('FUTURE_WORK', 339), ('FUTURE_WORK', 347), ('IMPORTANT_CONSIDERATION', 397)]	9	[('CHEBI_71657', 'versiconol acetate', 163, '25(OH)D'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 306, 'D'), ('UBERON_0000104', 'life cycle', 333, 'life'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D')]
PMC3427192	4/2012	S37-PMC3427192	['OF PARTICULAR INTEREST is the FINDING of racial DISPARITIES in Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 48)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC3427192	4/2012	S38-PMC3427192	['due to higher levels of Melanin, african americans have the highest prevalence of Vitamin D deficiency, with the highest prevalence in those living in urban environments.43,76at the same time, asthma is also more PREVALENT in african american children.10,11only ONE STUDY TO DATE has FOCUSED on Vitamin D status in school-aged african american asthmatic children.']	[('IMPORTANT_CONSIDERATION', 213), ('INCOMPLETE_EVIDENCE', 262), ('INCOMPLETE_EVIDENCE', 272), ('QUESTION_ANSWERED_BY_THIS_WORK', 284)]	4	[('CHEBI_25179', 'melanins', 24, 'melanin'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC3427192	4/2012	S40-PMC3427192	['HOWEVER, 25(Oh)D concentrations in the non-asthmatic group were significantly higher than PREVIOUSLY-REPORTED average values in african american children.21the childhood asthma management program study, which consisted of a racially diverse population, also FOUND that 24% of Vitamin D deficient subjects were african american, compared with only 7% in the Vitamin D sufficient group.69the FACTORS responsible for the racial DISPARITY in Vitamin D status are UNCLEAR and WARRANT FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 425), ('FULL_UNKNOWN', 459), ('FUTURE_WORK', 471), ('FUTURE_WORK', 479)]	10	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 357, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 438, 'vitamin D')]
PMC3427192	4/2012	S53-PMC3427192	['Vitamin D in Adults with asthma\nin Adults, the RECOMMENDED dietary intake for Vitamin D ranges from 600 to 800 iu daily.47HOWEVER, DESPITE the large variety of Foods supplemented with Vitamin D, a large proportion of the Adult population remains Vitamin D deficient,77,78perhaps DUE IN PART to INADEQUATE sun exposure and the rising PREVALENCE of obesity which CAN LEAD TO decreased Vitamin D bioavailability.79SIMILAR to the studies in school age children, a NUMBER OF cross-sectional studies in Adults have also DEMONSTRATED ASSOCIATIONS between Vitamin D status and asthma Control (table 3).']	[('FUTURE_WORK', 47), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 279), ('INCOMPLETE_EVIDENCE', 283), ('IMPORTANT_CONSIDERATION', 294), ('IMPORTANT_CONSIDERATION', 333), ('INCOMPLETE_EVIDENCE', 361), ('SUPERFICIAL_RELATIONSHIP', 365), ('INCOMPLETE_EVIDENCE', 409), ('INCOMPLETE_EVIDENCE', 460), ('INCOMPLETE_EVIDENCE', 514), ('SUPERFICIAL_RELATIONSHIP', 527)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0007023', 'adult organism', 13, 'Adults'), ('UBERON_0007023', 'adult organism', 35, 'adults'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33290', 'food', 160, 'foods'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0007023', 'adult organism', 221, 'adult'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D'), ('UBERON_0007023', 'adult organism', 497, 'adults'), ('CHEBI_27300', 'vitamin D', 548, 'vitamin D'), ('GO_0065007', 'biological regulation', 576, 'control')]
PMC3427192	4/2012	S55-PMC3427192	['furthermore, in those subjects with current asthma, lower 25(Oh)D concentrations were ASSOCIATED with increased odds of asthma exacerbations and healthcare utilization in the preceding year.81OTHER STUDIES have also NOTED ASSOCIATIONS between decreased Serum 25(Oh)D concentrations and decreased Lung function, increased Airway hyperresponsiveness to Methacholine, and blunted Glucocorticoid responsiveness.80,82,84HOWEVER, in a RECENT case-control STUDY of obese subjects with and without asthma, no associations between Vitamin D status and asthma prevalence were NOTED.83the cross-sectional nature of these studies SHOULD again BE EMPHASIZED SINCE causation CANNOT BE determined DUE TO potential CONFOUNDING of the study results.']	[('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 190), ('ANOMALY_CURIOUS_FINDING', 216), ('SUPERFICIAL_RELATIONSHIP', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('INCOMPLETE_EVIDENCE', 429), ('ANOMALY_CURIOUS_FINDING', 566), ('FUTURE_WORK', 618), ('ANOMALY_CURIOUS_FINDING', 631), ('IMPORTANT_CONSIDERATION', 634), ('PROBLEM_COMPLICATION', 645), ('DIFFICULT_TASK', 661), ('PROBLEM_COMPLICATION', 682), ('PROBLEM_COMPLICATION', 699)]	14	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('UBERON_0001977', 'blood serum', 253, 'serum'), ('CHEBI_71657', 'versiconol acetate', 259, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 259, '25 ... OH ... D'), ('UBERON_0002048', 'lung', 296, 'lung'), ('UBERON_0001005', 'respiratory airway', 321, 'airway'), ('CHEBI_6805', 'methacycline', 351, 'methacholine'), ('CHEBI_24261', 'glucocorticoid', 377, 'glucocorticoid'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D')]
PMC3427250	8/2012	S11-PMC3427250	['in conclusion, Vitamin D deficiency is highly prevalent among Pregnant women in belgium and this RAISES CONCERNS about the health consequences for the mother and the offspring.']	[('IMPORTANT_CONSIDERATION', 97)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnant')]
PMC3427250	8/2012	S31-PMC3427250	['there is a GROWING CONCERN about the health CONSEQUENCES of the high prevalence of Vitamin D deficiency worldwide among the general population, including Pregnant women.']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 19), ('PROBLEM_COMPLICATION', 44)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnant')]
PMC3427250	8/2012	S118-PMC3427250	['as those authors recognize that the EVIDENCE to propose such Intakes IS SCARCE and as long as the health benefits of having Serum 25(Oh)D levels higher than 30 ng/ml are NOT clearly ESTABLISHED particularly in Pregnant women, the belgian superior health council STILL RECOMMENDS a Vitamin D supplement of 20 µg/day or 800 iu during Pregnancy[58].']	[('INCOMPLETE_EVIDENCE', 36), ('FULL_UNKNOWN', 170), ('IMPORTANT_CONSIDERATION', 262), ('FUTURE_WORK', 268)]	4	[('GO_0007631', 'feeding behavior', 61, 'intakes'), ('UBERON_0001977', 'blood serum', 124, 'serum'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 132, '(OH ... D'), ('GO_0007565', 'female pregnancy', 210, 'pregnant'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('GO_0007565', 'female pregnancy', 332, 'pregnancy')]
PMC3427250	8/2012	S126-PMC3427250	['THEREFORE, there is an URGENT NEED of randomised controlled trials of Vitamin D supplementation to investigate the maternal and neonatal health benefits of correcting Vitamin D deficiency during Pregnancy[24].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 23), ('FUTURE_WORK', 30)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy')]
PMC3432839	8/2012	S24-PMC3432839	['HOWEVER, they MAY BE an INDICATOR of increased risk of arthritis in Adulthood, SINCE it HAS BEEN SHOWN that children with Limb pains are more LIKELY to have parents and/or grandparents with a history of arthritis COMPARED TO the general population.1among SMALL STUDIES of selected groups of children, recurrent Limb pains HAVE BEEN REPORTED to be PARTICULARLY PREVALENT in obese children,4and in those with some Vitamin D deficiency,5THOUGH this WAS NOT FOUND in a SMALL STUDY in new mexico.6other POSSIBILITIES HAVE BEEN summarised by evans and scutter.7\nAdult arthritis HAS long BEEN CONSIDERED to be a condition that COULD BE ameliorated or prevented by dietary manipulation, with SUGGESTIONS of different components of the diet being IMPORTANT—particularly Ω-3 Fatty Acids.8TO OUR KNOWLEDGE the ONLY specific dietary factor that has BEEN CONSIDERED in regard to childhood Limb pain concerns a study of 532 greek children aged 4–12.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 79), ('INCOMPLETE_EVIDENCE', 88), ('PROBABLE_UNDERSTANDING', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('INCOMPLETE_EVIDENCE', 255), ('INCOMPLETE_EVIDENCE', 322), ('INCOMPLETE_EVIDENCE', 332), ('ANOMALY_CURIOUS_FINDING', 347), ('IMPORTANT_CONSIDERATION', 360), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 433), ('INCOMPLETE_EVIDENCE', 446), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 454), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 512), ('INCOMPLETE_EVIDENCE', 572), ('INCOMPLETE_EVIDENCE', 586), ('INCOMPLETE_EVIDENCE', 620), ('INCOMPLETE_EVIDENCE', 684), ('IMPORTANT_CONSIDERATION', 738), ('PROBABLE_UNDERSTANDING', 777), ('INCOMPLETE_EVIDENCE', 799), ('ANOMALY_CURIOUS_FINDING', 837), ('INCOMPLETE_EVIDENCE', 842)]	27	[('UBERON_0000113', 'post-juvenile adult stage', 68, 'adulthood'), ('UBERON_0002101', 'limb', 122, 'limb'), ('UBERON_0002101', 'limb', 311, 'limb'), ('CHEBI_27300', 'vitamin D', 412, 'vitamin D'), ('UBERON_0007023', 'adult organism', 556, 'Adult'), ('CHEBI_18320', '1,4-dithiothreitol', 761, 'ω-3'), ('CHEBI_35366', 'fatty acid', 765, 'fatty acids'), ('UBERON_0002101', 'limb', 876, 'limb')]
PMC3458940	9/2012	S11-PMC3458940	['introduction\nAll- Trans Retinoic Acid (Tra) is the primary Bioactive form of endogenous Retinoids derived from dietary Vitamin A and plays IMPORTANT ROLES in Regulating a myriad of physiological events[1].']	[('IMPORTANT_CONSIDERATION', 139), ('SUPERFICIAL_RELATIONSHIP', 149)]	2	[('CHEBI_80638', '3-Oxovalproic acid', 13, 'All- trans retinoic acid'), ('CHEBI_37972', 'phosphorus-32 atom', 39, 'tRA'), ('CHEBI_51870', 'boryl group', 59, 'bioactive'), ('CHEBI_26537', 'retinoid', 88, 'retinoids'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin A'), ('GO_0065007', 'biological regulation', 158, 'regulating')]
PMC3458940	9/2012	S160-PMC3458940	['THUS, the ROLES for the tra/rar target Genes IDENTIFIED in THIS STUDY in the aforementioned Renal anomalies ASSOCIATED to post-Natal Vitamin A deficiency DESERVE FURTHER studies.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('SUPERFICIAL_RELATIONSHIP', 108), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 154), ('FUTURE_WORK', 162)]	8	[('SO_0000704', 'gene', 39, 'genes'), ('UBERON_0002113', 'kidney', 92, 'renal'), ('GO_0007567', 'parturition', 127, 'natal'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A')]
PMC3465343	10/2012	S28-PMC3465343	['ra, an active form of Vitamin A, plays ESSENTIAL ROLES in many physiological functions, including Vision, Immunity, and Cell Differentiation[15]–[17].']	[('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('GO_0007601', 'visual perception', 98, 'vision'), ('GO_0007566', 'embryo implantation', 106, 'immunity'), ('GO_0030154', 'cell differentiation', 120, 'cell differentiation')]
PMC3465343	10/2012	S29-PMC3465343	['ra signaling is tightly Controlled by the opposing actions of Retinaldehyde dehydrogenases (raldhs), which are ESSENTIAL for the generation of Embryonic ra from Vitamin A, and cyp26 members, which Catabolize ra[18].']	[('IMPORTANT_CONSIDERATION', 111)]	1	[('GO_0065007', 'biological regulation', 24, 'controlled'), ('CHEBI_17173', 'D-ribulose', 62, 'retinaldehyde'), ('UBERON_0000922', 'embryo', 143, 'embryonic'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin A'), ('GO_0009953', 'dorsal/ventral pattern formation', 197, 'catabolize')]
PMC3465343	10/2012	S40-PMC3465343	['ra is a derivative of Vitamin A and is REQUIRED for synchronous left-right Development Of Somites, either maternal vad during Pregnancy or an Embryonic defect in Metabolism from Vitamin A to ra MIGHT be ASSOCIATED with increased risk of Human vertebral defects.']	[('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 194), ('SUPERFICIAL_RELATIONSHIP', 203)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('GO_0042461', 'photoreceptor cell development', 75, 'development of somites'), ('UBERON_0002329', 'somite', 90, 'somites'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('UBERON_0000922', 'embryo', 142, 'embryonic'), ('GO_0008152', 'metabolic process', 162, 'metabolism'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('NCBITaxon_9606', 'Homo sapiens', 237, 'human')]
PMC3465343	10/2012	S67-PMC3465343	['vad induced Skeletal abnormalities in neonatal Rats\nbecause Vitamin A is REQUIRED for Skeletal Development during Embryo Development, we also exmined the OTHER Skeletal System of neonatal Rats by the same anteroposterior radiography.']	[('IMPORTANT_CONSIDERATION', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 154)]	2	[('UBERON_0004288', 'skeleton', 12, 'skeletal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 47, 'rats'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('GO_0001501', 'skeletal system development', 86, 'skeletal development'), ('UBERON_0004288', 'skeleton', 86, 'skeletal'), ('GO_0009790', 'embryo development', 114, 'embryo development'), ('UBERON_0000922', 'embryo', 114, 'embryo'), ('UBERON_0001434', 'skeletal system', 160, 'skeletal system'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 188, 'rats')]
PMC3465343	10/2012	S142-PMC3465343	['vitamin a supplies MUST BE Regulated to avoid Teratogenic consequences from deficiency or over-Intake and adequate maternal Vitamin A level is IMPORTANT for newborn.']	[('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 143)]	2	[('GO_0065007', 'biological regulation', 27, 'regulated'), ('CHEBI_50905', 'teratogenic agent', 46, 'teratogenic'), ('GO_0031649', 'heat generation', 46, 'teratogenic'), ('GO_0007631', 'feeding behavior', 95, 'intake'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin A')]
PMC3465343	10/2012	S154-PMC3465343	['ra is the active form of Vitamin A and plays a CRUCIAL ROLE in stimulating Nuclear receptor signaling during development.']	[('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 55)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('GO_0005634', 'nucleus', 75, 'nuclear')]
PMC3465343	10/2012	S177-PMC3465343	['GIVEN that vad is STILL a SERIOUS and PREVALENT PUBLIC HEALTH PROBLEM in the world especially among Pregnant women and children and dietary Vitamin A is ONLY available from limited sources, including vegetables in the form of Β-Carotene or meat as Retinyl Esters, vad MAY BE an IMPORTANT cause of Human congenital Spinal deformities[43].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 18), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 38), ('IMPORTANT_CONSIDERATION', 48), ('PROBLEM_COMPLICATION', 62), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 268), ('IMPORTANT_CONSIDERATION', 278)]	9	[('GO_0007565', 'female pregnancy', 100, 'pregnant'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 226, 'β-carotene'), ('CHEBI_26523', 'reactive oxygen species', 248, 'retinyl esters'), ('NCBITaxon_9606', 'Homo sapiens', 297, 'human'), ('UBERON_0001130', 'vertebral column', 314, 'spinal')]
PMC3470091	9/2012	S0-PMC3470091	['the EFFICACY and SAFETY of a high dose of Vitamin D in mothers with Gestational diabetes mellitus: a randomized controlled clinical TRIAL\n\nabstract\nbackground: during Pregnancy and Lactation outstanding changes occur in mother’s Vitamin D Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 132)]	3	[('CHEBI_28384', 'vitamin K', 42, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 42, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'Gestational'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy'), ('GO_0007595', 'lactation', 181, 'lactation'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 229, 'vitamin D metabolism')]
PMC3470091	9/2012	S12-PMC3470091	['conclusions: the single 300,000 im dose of Vitamin D is REGARDED AS an EFFECTIVE and SAFE to promptly improve Vitamin D status in gdm.']	[('PROBABLE_UNDERSTANDING', 56), ('PROBABLE_UNDERSTANDING', 65), ('SUPERFICIAL_RELATIONSHIP', 71), ('IMPORTANT_CONSIDERATION', 85)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC3470091	9/2012	S15-PMC3470091	['these changes occur ACCORDING TO the needs for the mineralization of the fetus Bones as well as adequate secretion of Vitamin D in mother’s Milk.1\nDUE TO rapid fetal development, PARTICULARLY bone Calcification at the terminal stages of Pregnancy, there is a POSSIBILITY of Vitamin D deficiency to occur in mothers.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('PROBABLE_UNDERSTANDING', 147), ('IMPORTANT_CONSIDERATION', 179), ('INCOMPLETE_EVIDENCE', 259)]	4	[('UBERON_0001474', 'bone element', 79, 'bones'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0001913', 'milk', 140, 'milk'), ('GO_0051301', 'cell division', 197, 'calcification'), ('GO_0007565', 'female pregnancy', 237, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC3470091	9/2012	S16-PMC3470091	['SINCE, fetus and baby are both DEPENDENT upon mother for Blood and milk respectively, mother’s Vitamin D supplementation is highly VITAL.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 131)]	3	[('UBERON_0000178', 'blood', 57, 'blood'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC3470091	9/2012	S19-PMC3470091	['such a RELATION HAS BEEN ATTRIBUTED to special receptors for Vitamin D in Pancreatic Betacells.9moreover, Vitamin D WAS SHOWN to have positive EFFECTS on Insulin sensitivity, and its deficiency to have negative EFFECTS on the function of Betacells.11IN AGREEMENT with this, cohort studies REVEALED that Vitamin D had a PROTECTIVE EFFECT against diabetes type Ii.8,11also, Serum concentration of Vitamin D during 24-29thweek of Pregnancy in women suffering from Gestational diabetes mellitus (gdm) was lower than that in women without the disease.12\nthe study of Vitamin D status and improving it in the Lactating mothers with previous gdm is of CONSPICUOUS VALUE.4,13\ndue to the limited exposure to sunshine and inadequate Intake, the level of Vitamin D is reduced in the milk of Lactating mothers.']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 143), ('SUPERFICIAL_RELATIONSHIP', 211), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 289), ('SUPERFICIAL_RELATIONSHIP', 319), ('SUPERFICIAL_RELATIONSHIP', 330), ('IMPORTANT_CONSIDERATION', 645)]	11	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CL_0000169', 'type B pancreatic cell', 74, 'pancreatic betacells'), ('UBERON_0001264', 'pancreas', 74, 'pancreatic'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('PR_000045358', 'insulin family protein', 154, 'insulin'), ('CL_0000365', 'animal zygote', 238, 'betacells'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('CL_0002212', 'type II muscle cell', 359, 'II'), ('UBERON_0001977', 'blood serum', 372, 'serum'), ('CHEBI_27300', 'vitamin D', 395, 'vitamin D'), ('GO_0007565', 'female pregnancy', 427, 'pregnancy'), ('GO_0007565', 'female pregnancy', 461, 'gestational'), ('CHEBI_27300', 'vitamin D', 562, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 603, 'lactating'), ('GO_0007631', 'feeding behavior', 723, 'intake'), ('CHEBI_27300', 'vitamin D', 744, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 780, 'lactating')]
PMC3470091	9/2012	S21-PMC3470091	['a dose of 600,000 iu Vitamin D resulted in hypercalcemia, THEREFORE, it can not be REGARDED a SAFE dose.17there is NO STUDY to evaluate Vitamin D status in mothers with previous gdm, and present oral Vitamin D products are not fully EFFECTIVE,16THEREFORE, THIS STUDY was DESIGNED TO EVALUATE the EFFECT of intramuscular injection of 300,000 iu during a three-month period.']	[('PROBABLE_UNDERSTANDING', 58), ('PROBABLE_UNDERSTANDING', 83), ('IMPORTANT_CONSIDERATION', 94), ('FULL_UNKNOWN', 115), ('SUPERFICIAL_RELATIONSHIP', 233), ('PROBABLE_UNDERSTANDING', 245), ('QUESTION_ANSWERED_BY_THIS_WORK', 256), ('QUESTION_ANSWERED_BY_THIS_WORK', 271), ('QUESTION_ANSWERED_BY_THIS_WORK', 280), ('SUPERFICIAL_RELATIONSHIP', 296)]	10	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC3470091	9/2012	S94-PMC3470091	['conclusion\nthe FINDINGS of the study INDICATE that intramuscular administration of a single dose of 300,000 iu of Vitamin D is EFFECTIVE and SAFE to improve Vitamin D status, and to ameliorate the FACTORS RELATED to the health of mothers and infants, PARTICULARLY in the regions with SEVERE Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 127), ('IMPORTANT_CONSIDERATION', 141), ('SUPERFICIAL_RELATIONSHIP', 197), ('SUPERFICIAL_RELATIONSHIP', 205), ('ANOMALY_CURIOUS_FINDING', 251), ('IMPORTANT_CONSIDERATION', 284)]	8	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D')]
PMC3471827	10/2012	S2-PMC3471827	['ttp and Vitamin E are ESSENTIAL for Productive Pregnancy in rodents, but their precise physiological ROLE in Embryogenesis is UNKNOWN.']	[('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 101), ('FULL_UNKNOWN', 126)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin E'), ('GO_0007128', 'meiotic prophase I', 36, 'productive'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('GO_0009790', 'embryo development', 109, 'embryogenesis')]
PMC3471827	10/2012	S11-PMC3471827	['ALTHOUGH the fetal-resorption test is STILL used to define the international units for Vitamin E[2], the cause of the Embryonic failure has never been characterized.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 38)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin E'), ('UBERON_0000922', 'embryo', 118, 'embryonic')]
PMC3471827	10/2012	S15-PMC3471827	['PREVIOUSLY, we utilized the Zebrafish MODEL to separate the maternal and Embryonic REQUIREMENTS, and to characterize the molecular defect of Embryonic Vitamin E deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 83)]	3	[('NCBITaxon_7955', 'Danio rerio', 28, 'zebrafish'), ('UBERON_0000922', 'embryo', 73, 'embryonic'), ('UBERON_0000922', 'embryo', 141, 'embryonic'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin E')]
PMC3471827	10/2012	S116-PMC3471827	['the Mammalian maternal Vitamin E REQUIREMENTS occur prior to the developmental stage in which ttp is REQUIRED in the Zebrafish, creating a BARRIER to the study of ttp in Placental MODELS.']	[('IMPORTANT_CONSIDERATION', 33), ('IMPORTANT_CONSIDERATION', 101), ('DIFFICULT_TASK', 139), ('INCOMPLETE_EVIDENCE', 180)]	4	[('NCBITaxon_40674', 'Mammalia', 4, 'mammalian'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin E'), ('NCBITaxon_7955', 'Danio rerio', 117, 'zebrafish'), ('UBERON_0001987', 'placenta', 170, 'placental')]
PMC3471827	10/2012	S129-PMC3471827	['we PREVIOUSLY DEMONSTRATED the REQUIREMENT of Vitamin E during Zebrafish development using diet-induced Vitamin E deficient Embryos[7].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 31)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin E'), ('NCBITaxon_7955', 'Danio rerio', 63, 'zebrafish'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin E'), ('UBERON_0000922', 'embryo', 124, 'embryos')]
PMC3472720	8/2012	S0-PMC3472720	['Prenatal Vitamin D deficiency INDUCES an early and more SEVERE experimental Autoimmune encephalomyelitis in the second generation\n\nabstract\nin a PREVIOUS STUDY, we DEMONSTRATED that Mouse Adult f1offspring, exposed to a Vitamin D deficiency during Pregnancy, developed a less SEVERE and delayed experimental Autoimmune encephalomyelitis (eae), when compared with control offspring.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 56), ('INCOMPLETE_EVIDENCE', 145), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 276)]	5	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('UBERON_0005445', 'segment of pes', 76, 'Autoimmune'), ('NCBITaxon_10088', 'Mus <genus>', 182, 'mouse'), ('UBERON_0007023', 'adult organism', 188, 'adult'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 248, 'pregnancy'), ('UBERON_0005445', 'segment of pes', 308, 'Autoimmune')]
PMC3472720	8/2012	S3-PMC3472720	['UNEXPECTEDLY, we OBSERVED that the Vitamin D deficiency AFFECTING the f0pregnant Mice induced a precocious and more SEVERE eae in the f2generation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 116)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 81, 'mice')]
PMC3472720	8/2012	S11-PMC3472720	['this season of Birth EFFECT, combined with an OBSERVED latitude gradient in incidence (higher risk at higher latitude) [10], SUGGEST that an environmental FACTOR, POSSIBLY Vitamin D exposure, MAY BE IMPORTANT in PREDICTING ms risk.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 192), ('IMPORTANT_CONSIDERATION', 199), ('SUPERFICIAL_RELATIONSHIP', 212)]	8	[('GO_0007567', 'parturition', 15, 'birth'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC3472720	8/2012	S14-PMC3472720	['BASED ON findings from epidemiology, we predicted that offspring exposed to low Prenatal Vitamin D would be at INCREASED RISK of ms.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 111)]	3	[('GO_0007565', 'female pregnancy', 80, 'prenatal'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC3472720	8/2012	S29-PMC3472720	['PARADOXICALLY, we OBSERVED that the Vitamin D deficiency AFFECTING the f0pregnant Mice induced a precocious and more SEVERE eae in the f2generation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 117)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 82, 'mice')]
PMC3472720	8/2012	S69-PMC3472720	['it is THEREFORE LIKELY that his/her Immune and Nervous Systems BENEFITED from Vitamin D’s WELL-DESCRIBED anti-inflammatory actions [23].']	[('PROBABLE_UNDERSTANDING', 6), ('PROBABLE_UNDERSTANDING', 16), ('IMPORTANT_CONSIDERATION', 63), ('FUTURE_WORK', 90), ('INCOMPLETE_EVIDENCE', 95)]	5	[('UBERON_0002405', 'immune system', 36, 'immune'), ('UBERON_0001016', 'nervous system', 47, 'nervous systems'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3476426	8/2012	S18-PMC3476426	['long-lasting depletion of Vitamin D causes rickets and osteomalacia, with Skeletal deformities in children and bone pain and INCREASED RISK of fractures in Adults, respectively [3].']	[('IMPORTANT_CONSIDERATION', 125)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0004288', 'skeleton', 74, 'skeletal'), ('UBERON_0007023', 'adult organism', 156, 'adults')]
PMC3476426	8/2012	S96-PMC3476426	['THESE STUDIES COULD classify them as being ‘Vitamin D INADEQUATE’, which LENDS SUPPORT to the HYPOTHESIS that autism is a Vitamin D deficiency disorder [31,32].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 54), ('PROBABLE_UNDERSTANDING', 73), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 94)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC3476426	8/2012	S99-PMC3476426	['Genetic polymorphisms of Cytochrome P450 enzymes HAVE also BEEN LINKED to autism, specifically Cyp27B1 that is ESSENTIAL for proper Vitamin D Metabolism.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 64), ('IMPORTANT_CONSIDERATION', 111)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_38557', 'cytochrome c2', 25, 'cytochrome P450'), ('PR_000006101', 'cytochrome P450 1A1', 95, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 132, 'vitamin D metabolism')]
PMC3476426	8/2012	S104-PMC3476426	['Calcitriol, the active Vitamin D, AFFECTS numerous Neurotransmitters and neurotrophic factors, RELEVANT for mental disorders [34].']	[('SUPERFICIAL_RELATIONSHIP', 34), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_17823', 'calcitriol', 0, 'Calcitriol'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_25512', 'neurotransmitter', 51, 'neurotransmitters')]
PMC3476426	8/2012	S105-PMC3476426	['in addition, Vitamin D plays IMPORTANT ROLES in Repairing Dna Damage and protecting against oxidative stress which is a KEY cause of dna damage.']	[('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 120)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0033197', 'response to vitamin E', 48, 'repairing DNA damage')]
PMC3476426	8/2012	S109-PMC3476426	['autism was MORE COMMON among children of the mothers who took Antiepileptic Drugs AS these Drugs are one of the few classes of Drugs that CONSISTENTLY and SIGNIFICANTLY INTERFERE with Vitamin D Metabolism [39].']	[('PROBABLE_UNDERSTANDING', 11), ('PROBABLE_UNDERSTANDING', 82), ('PROBABLE_UNDERSTANDING', 138), ('IMPORTANT_CONSIDERATION', 155), ('SUPERFICIAL_RELATIONSHIP', 169)]	5	[('CHEBI_35218', 'anthocyanin cation', 62, 'antiepileptic'), ('CHEBI_23888', 'drug', 76, 'drugs'), ('CHEBI_23888', 'drug', 91, 'drugs'), ('CHEBI_23888', 'drug', 127, 'drugs'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 184, 'vitamin D metabolism'), ('PR_000006444', 'diacylglycerol kinase delta', 192, 'D')]
PMC3476426	8/2012	S110-PMC3476426	['UNFORTUNATELY, the tiny 10 μg (400 iu) dose in Prenatal Vitamins is VIRTUALLY IRRELEVANT in PREVENTING Gestational Vitamin D deficiency [40].']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 68), ('IMPORTANT_CONSIDERATION', 78), ('SUPERFICIAL_RELATIONSHIP', 92)]	4	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 56, 'vitamins'), ('GO_0007565', 'female pregnancy', 103, 'gestational'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3476426	8/2012	S142-PMC3476426	['indeed, without the Genetic TENDENCY for autism, SEVERE maternal or early childhood Vitamin D deficiency MAY cause bone abnormalities with no EVIDENCE autism.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 105), ('INCOMPLETE_EVIDENCE', 142)]	4	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC3476426	8/2012	S145-PMC3476426	['basic, Genetic, and epidemiological studies INDICATE a POTENTIAL ROLE of Vitamin D in the PREVENTION of Autoimmune diseases, BUT randomized and controlled TRIALS ARE NECESSARY to establish the clinical efficacy of Vitamin D supplementation in ill or at-RISK subjects [48].']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125), ('FUTURE_WORK', 155), ('FUTURE_WORK', 166), ('IMPORTANT_CONSIDERATION', 166), ('IMPORTANT_CONSIDERATION', 253)]	9	[('SO_0000704', 'gene', 7, 'genetic'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 104, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3485340	10/2012	S0-PMC3485340	['maternal vitamin c deficiency during Pregnancy persistently impairs hippocampal Neurogenesis in offspring of guinea pigs\n\nabstract\nwhile having the highest Vitamin C (vitc) concentrations in the body, specific functions of Vitc in the Brain HAVE ONLY RECENTLY BEEN acknowledged.']	[('IMPORTANT_CONSIDERATION', 241), ('INCOMPLETE_EVIDENCE', 246), ('INCOMPLETE_EVIDENCE', 251)]	3	[('GO_0007565', 'female pregnancy', 37, 'Pregnancy'), ('GO_0001822', 'kidney development', 80, 'Neurogenesis'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin C'), ('PR_000017299', 'VIP peptides', 223, 'VitC'), ('UBERON_0000955', 'brain', 235, 'brain')]
PMC3488410	10/2012	S5-PMC3488410	['we will specifically discuss the Vitamin D deficiency MODEL, the poly i:c MODEL, the Ketamine MODEL, and the Postnatal Ventral Hippocampal lesion MODEL, all of which REFLECT core Neurodevelopmental ISSUES UNDERLYING schizophrenia onset.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 166), ('IMPORTANT_CONSIDERATION', 198), ('PROBLEM_COMPLICATION', 198), ('SUPERFICIAL_RELATIONSHIP', 205)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_6121', 'ketamine', 85, 'ketamine'), ('GO_0007567', 'parturition', 109, 'postnatal'), ('UBERON_0000218', 'vertebral arch of axis', 119, 'ventral hippocampal'), ('GO_0007399', 'nervous system development', 179, 'neurodevelopmental')]
PMC3488410	10/2012	S114-PMC3488410	['INTERESTINGLY, SOME of the Vitamin D deficiency EFFECTS COULD BE RELATED to later Gestational periods THUS POSSIBLY expanding the HAZARDOUS time window for the neurobiological development of schizophrenia [129].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 102), ('INCOMPLETE_EVIDENCE', 107), ('IMPORTANT_CONSIDERATION', 130)]	8	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'gestational')]
PMC3488410	10/2012	S136-PMC3488410	['AS hippocampal Neurogenesis plays an IMPORTANT ROLE in Learning and Memory processes [74], we SPECULATE that the PREVIOUSLY DEMONSTRATED normalization of a Vitamin D deficiency-induced Habituation deficit in the hole board by Haloperidol [136] COULD result from an AT LEAST partially restored mitotic activity.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 37), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 244), ('PROBABLE_UNDERSTANDING', 265)]	8	[('GO_0022008', 'neurogenesis', 15, 'neurogenesis'), ('GO_0007612', 'learning', 55, 'learning'), ('GO_0007613', 'memory', 68, 'memory'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0046959', 'habituation', 185, 'habituation'), ('CHEBI_5613', 'haloperidol', 226, 'haloperidol')]
PMC3501517	11/2012	S2-PMC3501517	['since Treg Cells are IMPORTANT in acute Lung injury resolution, we HYPOTHESIZED that Vitamin D deficiency increases the severity of injury and delays injury resolution in Lipopolysaccharide (Lps) induced acute Lung injury.']	[('IMPORTANT_CONSIDERATION', 21), ('INCOMPLETE_EVIDENCE', 67)]	2	[('CL_0000960', 'T3 B cell', 6, 'Treg cells'), ('UBERON_0002048', 'lung', 40, 'lung'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 171, 'lipopolysaccharide'), ('CHEBI_16412', 'lipopolysaccharide', 191, 'LPS'), ('UBERON_0002048', 'lung', 210, 'lung')]
PMC3501517	11/2012	S23-PMC3501517	['MULTIPLE STUDIES have IDENTIFIED a CORRELATION between SEVERE Vitamin D deficiency in children and Lower Respiratory Tract infections such as influenza[23],[24],[25],[26],[27].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 35), ('IMPORTANT_CONSIDERATION', 55)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0004905', 'articulation', 99, 'lower respiratory tract')]
PMC3501517	11/2012	S24-PMC3501517	['RECENT STUDIES have also CORRELATED low Cord-Blood Vitamin D levels with infant wheezing[28]and RISK for Rsv infection[29].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('IMPORTANT_CONSIDERATION', 96)]	3	[('UBERON_0002240', 'spinal cord', 40, 'cord'), ('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 105, 'RSV')]
PMC3501517	11/2012	S194-PMC3501517	['these data SUGGEST that SOME PROTECTIVE BENEFIT MAY BE derived from Vitamin D supplementation in the setting of radiation-induced Lung injury; HOWEVER, the POTENTIAL physiological relevance of these differences is DIFFICULT to ascertain given the absence of systematic sampling or the LACK OF DATA on the magnitude of the differences.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 156), ('DIFFICULT_TASK', 214), ('INCOMPLETE_EVIDENCE', 285)]	9	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002048', 'lung', 130, 'lung')]
PMC3501517	11/2012	S212-PMC3501517	['THESE FINDINGS FURTHER SUGGEST that acute Vitamin D replacement therapy for patients with underlying Vitamin D deficiency MAY have LIMITED clinical BENEFIT in the setting of acute Lung injury from noninfectious causes.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 122), ('INCOMPLETE_EVIDENCE', 131), ('IMPORTANT_CONSIDERATION', 148)]	6	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0002048', 'lung', 180, 'lung')]
PMC3501517	11/2012	S217-PMC3501517	['THEREFORE, WHILE Vitamin D MAY not play a ROLE in the acute inflammatory Response or resolution of inflammation, it MAY STILL be IMPORTANT in Controlling infections in the Lung.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 116), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 129)]	7	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0060033', 'anatomical structure regression', 73, 'response'), ('GO_0065007', 'biological regulation', 142, 'controlling'), ('UBERON_0002048', 'lung', 172, 'lung')]
PMC3501517	11/2012	S228-PMC3501517	['Mice do utilize uv exposure to produce Vitamin D3[45], but IT IS POSSIBLE that Vitamin D MAY BE more RELEVANT and active in Humans.']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 101)]	3	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Mice'), ('CHEBI_33279', 'vitamin D5', 39, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 39, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 124, 'humans')]
PMC3501517	11/2012	S232-PMC3501517	['HOWEVER, the IMPACT of these DIFFERENCES on overall clinical RELEVANCE of Vitamin D deficiency is LIKELY minimal.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('IMPORTANT_CONSIDERATION', 61), ('PROBABLE_UNDERSTANDING', 98)]	5	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC3504157	11/2012	S23-PMC3504157	['MANY health providers NOW RECOMMEND nhps including Prenatal Vitamins, iron supplementation, calcium, and Vitamin D for a range of RECOGNIZED indications including deficiency states such as rickets and anemia, as well as illnesses such as multiple sclerosis.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 22), ('FUTURE_WORK', 26), ('PROBABLE_UNDERSTANDING', 130)]	4	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 60, 'vitamins'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC3509518	11/2012	S11-PMC3509518	['IN SUMMARY, THIS STUDY SUGGESTS that maternal diet of fresh Foods rich in Vitamin C is ASSOCIATED with reduced risk of infant wheeze, and that copper intake is ASSOCIATED with reduced RISK of several allergic outcomes.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 87), ('SUPERFICIAL_RELATIONSHIP', 160), ('IMPORTANT_CONSIDERATION', 184)]	6	[('CHEBI_33290', 'food', 60, 'foods'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin C')]
PMC3509518	11/2012	S131-PMC3509518	['we could not confirm PREVIOUS FINDINGS that reduced maternal Vitamin E intakes were ASSOCIATED with increased risk of developing childhood wheeze [9,10,11,12] DESPITE the fact that almost 50% of Pregnant mothers did not meet the rdi when intakes from diet alone were TAKEN INTO ACCOUNT, and 20% of the mothers did not meet the rdi when total Vitamin E intakes were analysed [18].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('ANOMALY_CURIOUS_FINDING', 159), ('IMPORTANT_CONSIDERATION', 267)]	6	[('CHEBI_27300', 'vitamin D', 61, 'vitamin E'), ('GO_0007565', 'female pregnancy', 195, 'pregnant'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin E')]
PMC3515553	12/2012	S7-PMC3515553	['OUR FINDINGS SUGGEST that maternal Vitamin B-12 MAY not have an IMPORTANT EFFECT on offspring Cognitive ability.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 64), ('SUPERFICIAL_RELATIONSHIP', 74)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin B'), ('PR_000004770', 'Polycomb complex protein BMI-1', 43, 'B-12'), ('GO_0050890', 'cognition', 94, 'cognitive')]
PMC3515553	12/2012	S14-PMC3515553	['BECAUSE of the transfer from mother to offspring of Vitamin B-12 during Pregnancy and Lactation, maternal REQUIREMENTS during these periods are increased and deficiency CAN occur[5].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 106), ('INCOMPLETE_EVIDENCE', 169)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 52, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('GO_0007595', 'lactation', 86, 'lactation')]
PMC3515553	12/2012	S15-PMC3515553	['DESPITE the IMPORTANCE of Vitamin B-12 to Neuronal Development and the dependency of the developing foetus and infant on maternal Vitamin B-12 status, it is UNKNOWN WHETHER variation in maternal Pregnancy Vitamin B-12, across the normal range, INFLUENCES offspring Neurodevelopment.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('FULL_UNKNOWN', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('SUPERFICIAL_RELATIONSHIP', 244)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 26, 'vitamin B-12'), ('CL_0000540', 'neuron', 42, 'neuronal'), ('GO_0007399', 'nervous system development', 42, 'neuronal development'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 130, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 205, 'vitamin B-12'), ('GO_0007399', 'nervous system development', 265, 'neurodevelopment')]
PMC3515553	12/2012	S80-PMC3515553	['for example, POOR absorption COULD BE more RELEVANT for Individuals with reduced Vitamin B-12 intake.']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 43), ('SUPERFICIAL_RELATIONSHIP', 43)]	4	[('NCBITaxon_1', 'root', 56, 'individuals'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 81, 'vitamin B-12')]
PMC3515553	12/2012	S153-PMC3515553	['it HAS been PREVIOUSLY SHOWN that maternal cobalamin status is a strong PREDICTOR of Vitamin B-12 in breastfed infants up to AT LEAST 6 months of age[35].']	[('IMPORTANT_CONSIDERATION', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 72), ('PROBABLE_UNDERSTANDING', 125)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 85, 'vitamin B-12')]
PMC3515553	12/2012	S171-PMC3515553	['NONETHELESS, the fact that our OBSERVATIONAL ASSOCIATION of maternal dietary Intake attenuated NOTICEABLY with adjustment for CONFOUNDING FACTORS and that the Genetic ASSOCIATIONS are not very strong SUGGESTS that maternal Vitamin B-12 MAY not have an IMPORTANT causal EFFECT on offspring iq.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 95), ('PROBLEM_COMPLICATION', 126), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 200), ('INCOMPLETE_EVIDENCE', 236), ('IMPORTANT_CONSIDERATION', 252), ('SUPERFICIAL_RELATIONSHIP', 269)]	10	[('GO_0007631', 'feeding behavior', 77, 'intake'), ('SO_0000704', 'gene', 159, 'genetic'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 223, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 233, '12')]
PMC3521768	12/2012	S27-PMC3521768	['pertaining Vitamin A, a meta-analysis CONCLUDED that Prenatal Vitamin A supplementation does not significantly reduce RISK of lbw[16].']	[('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 118)]	2	[('CHEBI_27300', 'vitamin D', 11, 'vitamin A'), ('GO_0007565', 'female pregnancy', 53, 'prenatal'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin A')]
PMC3532199	11/2012	S25-PMC3532199	['a NUMBER OF SUBSEQUENT STUDIES reviewed by czeizel [9] and munger [10] have CONTINUED to SUGGEST that Folic Acid and/or OTHER Micronutrients or vitamins, including Vitamin A and Vitamin B6, MAY BE IMPORTANT in the etiology of clefts as well.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('FUTURE_WORK', 76), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120), ('INCOMPLETE_EVIDENCE', 190), ('IMPORTANT_CONSIDERATION', 197)]	7	[('CHEBI_30751', 'formic acid', 102, 'folic acid'), ('CHEBI_33839', 'macromolecule', 126, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin A'), ('CHEBI_33237', 'vitamin D4', 178, 'vitamin B6')]
PMC3552819	12/2012	S12-PMC3552819	['there is considerable SPECULATION regarding the POTENTIAL EFFECTS of Vitamin D on both Skeletal and Extra-Skeletal aspects of Reproductive physiology and Fetal Development, YET it REMAINS UNKNOWN WHETHER there are benefits to improving maternal Antenatal Vitamin D status beyond the correction of SEVERE deficiency [2,3].']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 173), ('FULL_UNKNOWN', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('IMPORTANT_CONSIDERATION', 297)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0004288', 'skeleton', 87, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 100, 'extra-skeletal'), ('GO_0000003', 'reproduction', 126, 'reproductive'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 154, 'fetal development'), ('GO_0007567', 'parturition', 245, 'antenatal'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
PMC3552819	12/2012	S13-PMC3552819	['clinical trials employing Vitamin D dose regimens that SAFELY optimize maternal-fetal Vitamin D status will enable testing of these HYPOTHESES [4].']	[('IMPORTANT_CONSIDERATION', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3552819	12/2012	S14-PMC3552819	['HOWEVER, VERY FEW STUDIES have rigorously addressed Vitamin D supplementation during Pregnancy, and the single-dose Vitamin D3 Pregnancy trials published to date have provided LITTLE insight into pharmacokinetics or SAFETY [5,6].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 9), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 176), ('IMPORTANT_CONSIDERATION', 216)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy'), ('CHEBI_33279', 'vitamin D5', 116, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 116, 'vitamin D3'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy')]
PMC3552819	12/2012	S26-PMC3552819	['HOWEVER, to enhance the assessment of 25(Oh)D response and SAFETY during the first week of follow-up, an additional cohort of participants who continued to receive weekly Vitamin D doses beginning on day 7 (“weekly-dose group”) contributed biochemical data to the present analysis for the first 7 days after the 70,000 iu dose (i.e., up to the time preceding their 2nd dose).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 59)]	2	[('CHEBI_71657', 'versiconol acetate', 38, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 38, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC3552819	12/2012	S208-PMC3552819	['THEREFORE, upward deflections in the Serum and Urine BIOMARKERS of Calcium Homeostasis signaled a NEED TO BE cautious about the transient EFFECTS of large sudden influxes of Vitamin D, and the risk of dose-dependent toxicity.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('FUTURE_WORK', 98), ('IMPORTANT_CONSIDERATION', 103), ('SUPERFICIAL_RELATIONSHIP', 138)]	5	[('UBERON_0001977', 'blood serum', 37, 'serum'), ('UBERON_0001088', 'urine', 47, 'urine'), ('GO_0055073', 'cadmium ion homeostasis', 67, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC3552819	12/2012	S222-PMC3552819	['HOWEVER, the unpredictability of the 25(Oh)D response at the individual level, PREVIOUS REPORTS of adverse EFFECTS of large single doses [23], and the THEORETICAL DISADVANTAGES of excessive fluctuations in Vitamin D status [29] SUGGEST that the use of large single or infrequent intermittent doses of Vitamin D3 MAY BE physiologically DISADVANTAGEOUS DESPITE its practical APPEAL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 151), ('IMPORTANT_CONSIDERATION', 163), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 312), ('IMPORTANT_CONSIDERATION', 335), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 351), ('ANOMALY_CURIOUS_FINDING', 351), ('IMPORTANT_CONSIDERATION', 373)]	12	[('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 301, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 301, 'vitamin D3')]
PMC3599191	1/2013	S200-PMC3599191	['high levels of maternal Vitamin D CAN reduce the RISK of asthma and wheezing in children by up to 60% [108,109].']	[('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 49)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC3599191	1/2013	S201-PMC3599191	['the average dose of Vitamin D to be taken is ABOUT 600 ui/day [110], but MANY STUDIES INDICATE that a higher dose of Vitamin D during Pregnancy and Lactation, up to 1000 ui/day, is NECESSARY to achieve a good level of Vitamin D assets [111].']	[('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 86), ('IMPORTANT_CONSIDERATION', 181)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('GO_0007595', 'lactation', 148, 'lactation'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC3613945	2/2013	S0-PMC3613945	['common variants of the Vitamin D Binding Protein Gene and adverse health outcomes\n\nabstract\nthe Vitamin D Binding protein (dbp) is the MAJOR Plasma carrier for Vitamin D and its Metabolites, BUT it is also an actin scavenger, and is the precursor to the immunomodulatory protein, gc-maf.']	[('IMPORTANT_CONSIDERATION', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 23, 'vitamin D binding protein'), ('SO_0000704', 'gene', 49, 'gene'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('PR_000017299', 'VIP peptides', 96, 'vitamin D binding'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_25212', 'metabolite', 178, 'metabolites')]
PMC3613945	2/2013	S8-PMC3613945	['in VIEW of the HEIGHTENED INTEREST in Vitamin D as a PUBLIC HEALTH TARGET, well-DESIGNED STUDIES that look simultaneously at Vitamin D and its carrier in RELATION to genotypes and adverse health outcome SHOULD BE ENCOURAGED.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 15), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 53), ('FUTURE_WORK', 67), ('FUTURE_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 154), ('FUTURE_WORK', 203), ('FUTURE_WORK', 213)]	9	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC3613945	2/2013	S58-PMC3613945	['the population-wide IMPLICATIONS of these FINDINGS for Vitamin D in PUBLIC HEALTH are substantial, given that the 436\u2009k Allele is less PREVALENT in africans (15%) than in caucasians (23%), hispanics (20%) or asians (29%)45.']	[('IMPORTANT_CONSIDERATION', 20), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 68), ('IMPORTANT_CONSIDERATION', 135)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('SO_0001023', 'allele', 120, 'allele')]
PMC3613945	2/2013	S187-PMC3613945	['REPORTED no association between ultraviolet radiation (uvr) or Vitamin D Serum levels; YET, cod Liver oil supplementation earlier in Life was ASSOCIATED with an INCREASED risk of asthma112.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 87), ('SUPERFICIAL_RELATIONSHIP', 142), ('IMPORTANT_CONSIDERATION', 161)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001977', 'blood serum', 73, 'serum'), ('UBERON_0002107', 'liver', 96, 'liver'), ('UBERON_0000104', 'life cycle', 133, 'life')]
PMC3613945	2/2013	S207-PMC3613945	['cancer\nseveral OBSERVATIONAL STUDIES have DEMONSTRATED an inverse RELATIONSHIP between uvb irradiance (REQUIRED for the cutaneous Synthesis Of Vitamin D) or Vitamin D status [Serum 25(Oh)D concentrations] and the incidence of mortality from Endometrial126, Lung127,128, Breast127,129–133, Prostate134–137, Ovarian138,139and Colorectal cancer140–149.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 103)]	4	[('GO_0030474', 'spindle pole body duplication', 130, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('UBERON_0001977', 'blood serum', 175, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 184, 'OH)D'), ('UBERON_0004167', 'orbitofrontal cortex', 241, 'endometrial126'), ('UBERON_0002048', 'lung', 257, 'lung127'), ('UBERON_0013550', 'Brodmann (1909) area 19', 270, 'breast127'), ('UBERON_0003820', 'prostate bud', 289, 'prostate134'), ('UBERON_0008231', 'dorsal thoracic segment of trunk', 306, 'ovarian138'), ('UBERON_0012652', 'colorectum', 324, 'colorectal')]
PMC3613945	2/2013	S208-PMC3613945	['the UNDERLYING mechanism by which Vitamin D status AFFECTS cancer RISK is UNKNOWN, HOWEVER, 1,25(Oh)2D3Has BEEN SHOWN to Modulate Cell Proliferation and Differentiation Of both normal and malignant Cells.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 51), ('IMPORTANT_CONSIDERATION', 66), ('FULL_UNKNOWN', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 107)]	7	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_76957', 'N-2-hydroxytetracosenoylsphingosine', 92, '1,25(OH)2D3has'), ('GO_0065007', 'biological regulation', 121, 'modulate'), ('GO_0008283', 'cell proliferation', 130, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 153, 'differentiation of ... cells')]
PMC3613945	2/2013	S210-PMC3613945	['Breast cancer\necological case-control studies INDICATE an inverse CORRELATION between Vitamin D status and Breast cancer RISK, HOWEVER, the RELATIONSHIP is LESS CLEAR in longitudinal studies150,151.']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('SUPERFICIAL_RELATIONSHIP', 140), ('FULL_UNKNOWN', 156)]	7	[('UBERON_0000310', 'breast', 0, 'Breast'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000310', 'breast', 107, 'breast')]
PMC3613945	2/2013	S314-PMC3613945	['conclusion\nthere is GROWING EVIDENCE that dbp plays a ROLE in Immune modulation, EITHER directly through gc-maf, OR indirectly by INFLUENCING Serum levels of Vitamin D. it is TEMPTING to SPECULATE that dbp operates as a molecular switch between pro- and anti-inflammation and intervention STRATEGIES designed to modify this switch MAY be IMPORTANT in the Control and prevention Of chronic and Infectious Diseases.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 187), ('FUTURE_WORK', 289), ('INCOMPLETE_EVIDENCE', 331), ('IMPORTANT_CONSIDERATION', 338)]	9	[('UBERON_0002405', 'immune system', 62, 'immune'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0001715', 'ectodermal cell fate specification', 355, 'control ... of ... infectious diseases')]
PMC3613945	2/2013	S320-PMC3613945	['IT IS BECOMING CLEAR that dbp is indeed a multifunctional protein with an IMPORTANT auxiliary ROLE in the RELATIONSHIP between Vitamin D and Innate Immunity.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 106)]	4	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0045087', 'innate immune response', 141, 'innate immunity')]
PMC3616124	4/2013	S13-PMC3616124	['hp phenotype does not influence Preeclampsia RISK, or identify a subset of women who MAY BENEFIT from Vitamin C and E supplementation to prevent Preeclampsia.']	[('IMPORTANT_CONSIDERATION', 45), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 89)]	3	[('GO_0007128', 'meiotic prophase I', 32, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 116, 'E'), ('GO_0007128', 'meiotic prophase I', 145, 'preeclampsia')]
PMC3616124	4/2013	S173-PMC3616124	['THEREFORE, we EXAMINED the POTENTIAL for hp phenotype to INFLUENCE the effectiveness of Vitamin C and E in preventing Preeclampsia and SERIOUS COMPLICATIONS of pah.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 135), ('IMPORTANT_CONSIDERATION', 143)]	6	[('CHEBI_27300', 'vitamin D', 88, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 102, 'E'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia')]
PMC3616124	4/2013	S174-PMC3616124	['daily Vitamin C and E did not prevent Preeclampsia or SERIOUS COMPLICATIONS of pah in low risk primiparous women of any hp phenotype.']	[('IMPORTANT_CONSIDERATION', 54), ('PROBLEM_COMPLICATION', 62)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 20, 'E'), ('GO_0007128', 'meiotic prophase I', 38, 'preeclampsia')]
PMC3616124	4/2013	S203-PMC3616124	['conclusions\nIN CONTRAST TO our HYPOTHESIS, our secondary analysis of a large rct INDICATES that hp phenotype does not influence preeclampsia risk, or identify a subset of nulligravidas for whom Vitamins C and E would reduce Preeclampsia RISK in white, black or hispanic women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 81), ('IMPORTANT_CONSIDERATION', 237)]	4	[('CHEBI_27300', 'vitamin D', 194, 'vitamins C'), ('PR_000004900', 'complement C3', 203, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 209, 'E'), ('GO_0007128', 'meiotic prophase I', 224, 'preeclampsia')]
PMC3629265	4/2013	S0-PMC3629265	['SEVERE Vitamin D deficiency in 6 canadian first nation formula-Fed infants\n\nabstract\n\nbackground\nrickets was first described in the 17th century and Vitamin D deficiency was recognized as the UNDERLYING cause in the early 1900s.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 192)]	2	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('GO_0007631', 'feeding behavior', 63, 'fed'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC3629265	4/2013	S1-PMC3629265	['DESPITE this long history, Vitamin D deficiency REMAINS a significant health CONCERN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 77)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC3629265	4/2013	S4-PMC3629265	['objective\nthe OBJECTIVE of THIS report is to bring ATTENTION to the risk of SEVERE Vitamin D deficiency in high risk, formula Fed infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('IMPORTANT_CONSIDERATION', 51), ('IMPORTANT_CONSIDERATION', 76)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007631', 'feeding behavior', 126, 'fed')]
PMC3629265	4/2013	S8-PMC3629265	["while these infants had several RISK FACTORS for Vitamin D deficiency, they were all receiving Cow's milk based formula supplemented with 400 iu/l of vitamin D.\n\nconclusion\nTHIS report SUGGESTS that CURRENT practice with regards to Vitamin D supplementation MAY BE INADEQUATE, especially for high-risk infants."]	[('SUPERFICIAL_RELATIONSHIP', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 173), ('INCOMPLETE_EVIDENCE', 185), ('INCOMPLETE_EVIDENCE', 199), ('INCOMPLETE_EVIDENCE', 258), ('IMPORTANT_CONSIDERATION', 265), ('PROBLEM_COMPLICATION', 265)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 95, 'cow'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]
PMC3629265	4/2013	S12-PMC3629265	['HOWEVER, it was not until the early 1900s that Vitamin D deficiency was recognised as the UNDERLYING cause, and that the IMPORTANCE of sunlight to maintain adequate vitamin d levels was appreciated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 90), ('IMPORTANT_CONSIDERATION', 121)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC3629265	4/2013	S16-PMC3629265	['DESPITE the long history of recognition of this PROBLEM, Vitamin D deficiency continues to remain a SIGNIFICANT health ISSUE (4–12).']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 119)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC3629265	4/2013	S58-PMC3629265	['there HAVE BEEN several recent REPORTS of SEVERE Vitamin D deficiency presenting with hypocalcaemic seizures in Breast Fed infants.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 42)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 112, 'breast fed'), ('UBERON_0000310', 'breast', 112, 'breast')]
PMC3629265	4/2013	S66-PMC3629265	['in an ATTEMPT to address the CONCERNING frequency of Vitamin D deficiency in aboriginal infants, the canadian paediatric society advocates for an increase to 800 iu/day in northern native communities during the winter months (23).']	[('DIFFICULT_TASK', 6), ('IMPORTANT_CONSIDERATION', 29)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC3629265	4/2013	S68-PMC3629265	['it SEEMS UNLIKELY that infants in the first few months of Life would drink 2 l of formula/day, the volume NECESSARY to receive 800 iu/day of Vitamin D. four of our cases presented during the autumn and winter months, the other two infants presented during the early spring.']	[('ANOMALY_CURIOUS_FINDING', 3), ('PROBABLE_UNDERSTANDING', 9), ('IMPORTANT_CONSIDERATION', 106)]	3	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3629265	4/2013	S75-PMC3629265	['maternal Vitamin D deficiency REMAINS a common CONCERN (27).']	[('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 47)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC3629265	4/2013	S82-PMC3629265	['given the young age of the cases presented (mean age 30 days), maternal Vitamin D deficiency is LIKELY a MAJOR contributing FACTOR in all the cases presented.']	[('PROBABLE_UNDERSTANDING', 96), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 124)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC3629265	4/2013	S88-PMC3629265	['it is LIKELY that other asymptomatic infants with Vitamin D deficiency remain undiagnosed from this high-RISK population.']	[('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 104)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC3629265	4/2013	S89-PMC3629265	['this RAISES the QUESTION of WHETHER 400 iu of Vitamin D per litre of formula is SUFFICIENT.']	[('EXPLICIT_QUESTION', 5), ('EXPLICIT_QUESTION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('EXPLICIT_QUESTION', 28), ('IMPORTANT_CONSIDERATION', 80)]	5	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC3629265	4/2013	S92-PMC3629265	['conclusion\nwe SUGGEST that the amount of Vitamin D supplementation NEEDED to prevent deficiency in infants residing in communities in the temperate region SHOULD BE REVISITED, PARTICULARLY for those at high risk for Prenatal deficiency.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 67), ('IMPORTANT_CONSIDERATION', 67), ('FUTURE_WORK', 155), ('FUTURE_WORK', 165), ('IMPORTANT_CONSIDERATION', 176)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'prenatal')]
PMC3635901	4/2013	S35-PMC3635901	['this ROLE of Vitamin D SEEMS to be so IMPORTANT that ads show seasonality (due TO DIFFERENT levels of uv exposure), and EVEN the month of Birth MAY INFLUENCE the risk of onset of an ad, as SHOWN by disanto et al .']	[('SUPERFICIAL_RELATIONSHIP', 5), ('ANOMALY_CURIOUS_FINDING', 23), ('IMPORTANT_CONSIDERATION', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('ANOMALY_CURIOUS_FINDING', 120), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 148), ('INCOMPLETE_EVIDENCE', 189)]	9	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007567', 'parturition', 138, 'birth')]
PMC3635901	4/2013	S38-PMC3635901	["[22], in their review, EMPHASIZED that patients AFFECTED with sjögren's syndrome (ss) who have low levels of Vitamin D are at a higher risk of developing SEVERE COMPLICATIONS such as lymphoma and peripheral neuropathy [23,24]."]	[('IMPORTANT_CONSIDERATION', 23), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 154), ('PROBLEM_COMPLICATION', 161)]	4	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC3641012	4/2013	S0-PMC3641012	['randomized placebo-controlled trial of high-dose Prenatal third-Trimester Vitamin D3 supplementation in bangladesh: the avidd trial\n\nabstract\n\nbackground\nantenatal Vitamin D status MAY be ASSOCIATED with the RISK of adverse Pregnancy and neonatal outcomes; HOWEVER, the benefits of Vitamin D supplementation during Pregnancy remain UNKNOWN.']	[('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 188), ('IMPORTANT_CONSIDERATION', 208), ('ANOMALY_CURIOUS_FINDING', 257), ('FULL_UNKNOWN', 332)]	5	[('GO_0007565', 'female pregnancy', 49, 'prenatal'), ('GO_0009294', 'DNA mediated transformation', 64, 'trimester'), ('CHEBI_33279', 'vitamin D5', 74, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 74, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D'), ('GO_0007565', 'female pregnancy', 315, 'pregnancy')]
PMC3641012	4/2013	S12-PMC3641012	['the MAJOR circulating vitamin d metabolite, 25-Hydroxyvitamin D (25(Oh)D), crosses the Placenta from the maternal to the fetal circulation, thereby establishing fetal-neonatal Vitamin D stores [5].']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 44, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('UBERON_0001987', 'placenta', 87, 'placenta'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D')]
PMC3641012	4/2013	S15-PMC3641012	['moreover, the SAFETY of high-dose Prenatal Vitamin D regimens (i.e., doses that substantially exceed the conventional Prenatal intake of 400 to 600\xa0iu/day) has yet to be established [6].']	[('IMPORTANT_CONSIDERATION', 14)]	1	[('GO_0007565', 'female pregnancy', 34, 'prenatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 118, 'prenatal')]
PMC3641012	4/2013	S18-PMC3641012	['uncertainty surrounding Vitamin D REQUIREMENTS in Pregnancy has LED TO DIVERGENT dose RECOMMENDATIONS; for example, the unicef Antenatal Micronutrient formulation contains 200\xa0iu/day [11], the canadian paediatric society has SUGGESTED 2000\xa0iu/day [12], and hollis et al.']	[('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('FUTURE_WORK', 86), ('INCOMPLETE_EVIDENCE', 225)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0007567', 'parturition', 127, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 137, 'micronutrient')]
PMC3641012	4/2013	S21-PMC3641012	['determination of the Vitamin D intake level (and corresponding Serum 25(Oh)D concentration) that SAFELY optimizes Vitamin D-responsive maternal-infant health outcomes would have GLOBAL IMPLICATIONS, but MAY be particularly RELEVANT to resource-poor communities in south asia, where a relatively low Prenatal Vitamin D status OVERLAPS with a HIGH BURDEN of morbidity and mortality ASSOCIATED with adverse Birth and early infant health outcomes [15].']	[('IMPORTANT_CONSIDERATION', 97), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 185), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 223), ('SUPERFICIAL_RELATIONSHIP', 325), ('IMPORTANT_CONSIDERATION', 341), ('SUPERFICIAL_RELATIONSHIP', 380)]	8	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 69, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007565', 'female pregnancy', 299, 'prenatal'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('GO_0007567', 'parturition', 404, 'birth')]
PMC3641012	4/2013	S25-PMC3641012	['these data MAY serve to design larger rcts to measure the EFFECTS of Antenatal Vitamin D supplementation on functional outcomes of clinical and PUBLIC HEALTH IMPORTANCE.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 58), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 158)]	4	[('GO_0007567', 'parturition', 69, 'antenatal'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3641012	4/2013	S135-PMC3641012	['2mean difference [95% ci] in the change for Vitamin D versus Placebo group (difference in the slope) using generalized estimation equations (gee) to ACCOUNT for within-subject correlations.']	[('IMPORTANT_CONSIDERATION', 149)]	1	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 61, 'placebo')]
PMC3641012	4/2013	S226-PMC3641012	['in comparison to the lc-ms/ms method used HERE, the immunoassay used in the pilot study (diasorin liaison total) MAY have UNDER-estimated 25(Oh)D because of raised dbp concentrations in Pregnancy [29] OR relative imprecision at the higher 25(Oh)D range attained in the Vitamin D group [30,31].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 42), ('INCOMPLETE_EVIDENCE', 113), ('IMPORTANT_CONSIDERATION', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 201)]	4	[('CHEBI_71657', 'versiconol acetate', 138, '25(OH)D'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 239, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC3641012	4/2013	S236-PMC3641012	['FURTHER clinical DATA are REQUIRED before conclusive statements can be made regarding the APPROPRIATENESS of high-dose Antenatal Vitamin D supplementation.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 90)]	3	[('GO_0007567', 'parturition', 119, 'antenatal'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3651971	5/2013	S17-PMC3651971	["DEFICIENCY of essential Nutrients CAN harm the fetus; NO RESEARCH to date has examined the long-term EFFECT of early Vitamin A deficiency on children's cognitive or motor skills."]	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 101)]	4	[('CHEBI_33284', 'nutrient', 24, 'nutrients'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin A')]
PMC3651971	5/2013	S80-PMC3651971	["further, children whose mother's histories of Gestational night blindness during the trial were missing (n=31) were excluded from the sampling frame because night blindness is an INDICATOR of Vitamin A deficiency and was CONSIDERED an ESSENTIAL exposure of interest for other research questions in this study."]	[('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 221), ('IMPORTANT_CONSIDERATION', 235)]	3	[('GO_0007565', 'female pregnancy', 46, 'gestational'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin A')]
PMC3651971	5/2013	S89-PMC3651971	['comparisons between participants of the randomised Supplement group\nthe Vitamin A and placebo groups of tested children were similar on measures of socioeconomic and nutritional status assessed during the original nnips-2 trial, the one IMPORTANT and expected difference being that a higher proportion of children whose mothers had been night blind during Pregnancy were in the placebo vs Vitamin A group (15.5% vs 8.2%, p=0.02).']	[('IMPORTANT_CONSIDERATION', 237)]	1	[('CHEBI_16158', 'steroid sulfate', 51, 'supplement'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin A'), ('GO_0007565', 'female pregnancy', 356, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin A')]
PMC3659910	1/2013	S2-PMC3659910	['RESEARCH INDICATES that adequate Vitamin D intake in Pregnancy is OPTIMAL for maternal, fetal and child health.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 66)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 53, 'pregnancy')]
PMC3659910	1/2013	S7-PMC3659910	['THEREFORE, PREVENTION of Vitamin D deficiency among Pregnant women is ESSENTIAL.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 11), ('IMPORTANT_CONSIDERATION', 70)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnant')]
PMC3659910	1/2013	S8-PMC3659910	['the CURRENTLY RECOMMENDED supplementation amount of Vitamin D is NOT SUFFICIENT to maintain a value of 25 Hydroxy Vitamin D above 30 ng/ml, during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_WORK', 14), ('IMPORTANT_CONSIDERATION', 65)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_45557', 'sec-butyl group', 103, '25 hydroxy'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 122, 'D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy')]
PMC3659910	1/2013	S10-PMC3659910	['clearly, FURTHER INVESTIGATION is REQUIRED into the EFFECTS of Vitamin D, of Vitamin D supplementation, and of Vitamin D analogs for IMPROVEMENT in Human health generally and mothers and children specifically.']	[('FUTURE_WORK', 9), ('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 52), ('FUTURE_WORK', 133)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 148, 'human')]
PMC3659910	1/2013	S11-PMC3659910	['THIS REVIEW discusses Vitamin D Metabolism, dietary REQUIREMENTS and RECOMMENDATIONS and IMPLICATIONS of Vitamin D deficiency during Pregnancy and Lactation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 52), ('FUTURE_WORK', 69), ('IMPORTANT_CONSIDERATION', 89)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 22, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy'), ('GO_0007595', 'lactation', 147, 'lactation')]
PMC3659910	1/2013	S13-PMC3659910	['CONCERNS about Vitamin D have RESURFACED in medical and scientific literature OWING TO its multiple EFFECTS on Human health.']	[('IMPORTANT_CONSIDERATION', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 100)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 111, 'human')]
PMC3659910	1/2013	S17-PMC3659910	['[2] also the media has been taking increasing INTEREST, and public EXPECTATIONS have been RAISED regarding the enhanced ROLES for Vitamin D in Pregnancy.']	[('IMPORTANT_CONSIDERATION', 46), ('FUTURE_PREDICTION', 67), ('EXPLICIT_QUESTION', 90), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 143, 'pregnancy')]
PMC3659910	1/2013	S19-PMC3659910	['[2] there are increasing STUDIES worldwide reporting POOR Vitamin D status, including those in tropical countries.']	[('INCOMPLETE_EVIDENCE', 25), ('IMPORTANT_CONSIDERATION', 53)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC3659910	1/2013	S20-PMC3659910	['the PREVALENCE of Vitamin D deficiency has been REPORTED to range from 15% to 80%.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 48)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC3659910	1/2013	S21-PMC3659910	['[34] it is now RECOGNIZED that everyone is AT RISK for Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 15), ('IMPORTANT_CONSIDERATION', 43)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3659910	1/2013	S24-PMC3659910	['modern day cosmetology and our urbanization has eclipsed the sunlight and it is IMPOSSIBLE is to fulfill daily Intake via diet AS a large amount of Vitamin D NEEDS to be Consumed.']	[('DIFFICULT_TASK', 80), ('PROBABLE_UNDERSTANDING', 127), ('IMPORTANT_CONSIDERATION', 158)]	3	[('GO_0007631', 'feeding behavior', 111, 'intake'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('GO_0007631', 'feeding behavior', 170, 'consumed')]
PMC3659910	1/2013	S27-PMC3659910	['[5] the increasing PREVALENCE of disorders LINKED to Vitamin D deficiency is REFLECTED in the several hundred children with rickets treated each year.']	[('IMPORTANT_CONSIDERATION', 19), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC3659910	1/2013	S36-PMC3659910	['BECAUSE of its Steroid structure and function, Vitamin D plays an IMPORTANT ROLE in priming cells for other hormones to do their action.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 66), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('CHEBI_35341', 'steroid', 15, 'steroid'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC3659910	1/2013	S44-PMC3659910	['the REQUIREMENT for Vitamin D in maintaining normal Calcium Metabolism throughout Pregnancy and Lactation in mothers, fetuses and newborn infants is STILL CONTROVERSIAL.']	[('IMPORTANT_CONSIDERATION', 4), ('IMPORTANT_CONSIDERATION', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0018884', 'carbazole metabolic process', 52, 'calcium metabolism'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0007595', 'lactation', 96, 'lactation')]
PMC3659910	1/2013	S45-PMC3659910	['IT IS CLEAR, HOWEVER, that Vitamin D REQUIREMENTS are increased in mothers during Pregnancy and Lactation.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('IMPORTANT_CONSIDERATION', 37)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0007595', 'lactation', 96, 'lactation')]
PMC3659910	1/2013	S55-PMC3659910	['[12] Vitamin D deficiency CAN result in lower bone Mineral density and an INCREASED RISK of bone loss (osteoporosis) or bone fracture BECAUSE a lack of Vitamin D alters Mineral Metabolism in the body.']	[('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 74), ('PROBABLE_UNDERSTANDING', 134)]	3	[('CHEBI_28384', 'vitamin K', 5, 'Vitamin D'), ('CHEBI_46662', 'mineral', 51, 'mineral'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('CHEBI_46662', 'mineral', 169, 'mineral'), ('GO_0008152', 'metabolic process', 177, 'metabolism')]
PMC3659910	1/2013	S56-PMC3659910	["sources of Vitamin D\nthe most IMPORTANT source of Vitamin D is the skin's Synthesis Of the Vitamin from sunlight."]	[('IMPORTANT_CONSIDERATION', 30)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0034209', 'sterol acetylation', 74, 'synthesis of ... vitamin'), ('CHEBI_33229', 'vitamin (role)', 91, 'vitamin')]
PMC3659910	1/2013	S64-PMC3659910	["although Liver and cod Liver oil contain Vitamin D, they are not recommended in Pregnancy as they also contain too much Vitamin A.\nVitamin D is a unique Nutrient BECAUSE its REQUIREMENT can be met by both endogenous production from sunlight as well as exogenous dietary sources, which COMPLICATES determining the body's daily nutritional REQUIREMENTS."]	[('PROBABLE_UNDERSTANDING', 162), ('IMPORTANT_CONSIDERATION', 174), ('DIFFICULT_TASK', 285), ('IMPORTANT_CONSIDERATION', 338)]	4	[('UBERON_0002107', 'liver', 9, 'liver'), ('UBERON_0002107', 'liver', 23, 'liver'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('CHEBI_28384', 'vitamin K', 131, 'Vitamin D'), ('CHEBI_33284', 'nutrient', 153, 'nutrient')]
PMC3659910	1/2013	S65-PMC3659910	['methods are CURRENTLY available to quantify the CONTRIBUTION of Endogenous Vitamin D Synthesis resulting from sun exposure, BUT SERIOUS LIMITATIONS REMAIN in ACCURATELY ESTIMATING dietary Vitamin D intake BECAUSE of the INCOMPLETENESS of Nutrient databases for both Vitamin D-fortified Food and Vitamin D supplements.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBLEM_COMPLICATION', 124), ('IMPORTANT_CONSIDERATION', 128), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 158), ('INCOMPLETE_EVIDENCE', 169), ('PROBLEM_COMPLICATION', 205), ('INCOMPLETE_EVIDENCE', 220)]	10	[('GO_0009790', 'embryo development', 64, 'endogenous'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 75, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_33284', 'nutrient', 238, 'nutrient'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_33290', 'food', 286, 'food'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC3659910	1/2013	S66-PMC3659910	["THUS, increasing Vitamin D intake from Vitamin D fortified foods, and Vitamin D supplements, in combination with SENSIBLE sun exposure, maximize a Person's vitamin d status to promote good health."]	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 113)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'person')]
PMC3659910	1/2013	S73-PMC3659910	["women who have Intestinal Malabsorption diseases like celiac disease and crohn's disease or partial removal or bypass of the Stomach or Intestines absorb less of both dietary and supplemental Vitamin D are at INCREASED RISK of deficiency."]	[('IMPORTANT_CONSIDERATION', 209)]	1	[('UBERON_0000160', 'intestine', 15, 'intestinal'), ('GO_0046693', 'sperm storage', 26, 'malabsorption'), ('UBERON_0000945', 'stomach', 125, 'stomach'), ('UBERON_0000160', 'intestine', 136, 'intestines'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC3659910	1/2013	S77-PMC3659910	['for Vitamin D, there are STILL underlying QUESTIONS: HOW much is the daily REQUIREMENT and HOW much is too much?']	[('IMPORTANT_CONSIDERATION', 25), ('EXPLICIT_QUESTION', 42), ('EXPLICIT_QUESTION', 53), ('IMPORTANT_CONSIDERATION', 75), ('EXPLICIT_QUESTION', 91), ('EXPLICIT_QUESTION', 111)]	6	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
PMC3659910	1/2013	S78-PMC3659910	['[17] NEW RESEARCH SUGGESTS that women who take high doses of Vitamin D during Pregnancy have a greatly reduced RISK of COMPLICATIONS, including Gestational diabetes, preterm Birth, and infection.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 111), ('IMPORTANT_CONSIDERATION', 119)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0007565', 'female pregnancy', 144, 'gestational'), ('GO_0007567', 'parturition', 174, 'birth')]
PMC3659910	1/2013	S92-PMC3659910	['[1819] to attain circulating 25(Oh) D concentrations that exceed 250 nmol/l (100 ng/ml), a daily Vitamin D intake well in excess of 10,000 iu/d (250 μg/d) for several months WOULD BE REQUIRED.']	[('FUTURE_PREDICTION', 174), ('IMPORTANT_CONSIDERATION', 183)]	2	[('CHEBI_71657', 'versiconol acetate', 29, '25(OH) D'), ('PR_000008838', 'serine protease HTRA1', 29, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC3659910	1/2013	S96-PMC3659910	['ROLE of Vitamin D in Pregnant women\nadequate Vitamin D intake is ESSENTIAL for maternal and fetal health during Pregnancy, and PREVENTION of adverse outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 21, 'pregnant'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy')]
PMC3659910	1/2013	S97-PMC3659910	['RECENT work EMPHASIZES the IMPORTANCE of NON-CLASSICAL ROLES of Vitamin D in Pregnancy and the Placenta.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 12), ('IMPORTANT_CONSIDERATION', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 55)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('UBERON_0001987', 'placenta', 95, 'placenta')]
PMC3659910	1/2013	S101-PMC3659910	['a NEW STUDY FINDS that women who develop SEVERE Preeclampsia TEND to have lower Blood levels of Vitamin D than healthy Pregnant women raising the POSSIBILITY that the vitamin plays a ROLE in the COMPLICATION.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 41), ('PROBABLE_UNDERSTANDING', 61), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 183), ('IMPORTANT_CONSIDERATION', 195)]	7	[('GO_0007128', 'meiotic prophase I', 48, 'preeclampsia'), ('UBERON_0000178', 'blood', 80, 'blood'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnant')]
PMC3659910	1/2013	S122-PMC3659910	['CONVERSELY, Vitamin D deficiency results in proximal muscle weakness and decreased Lower Extremity muscle function PERHAPS CONTRIBUTING TO the RISK for cesarean section.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 123), ('IMPORTANT_CONSIDERATION', 143)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0002103', 'hindlimb', 83, 'lower extremity')]
PMC3659910	1/2013	S124-PMC3659910	['the cochrane review CONCLUDED that there is NOT ENOUGH EVIDENCE TO EVALUATE the REQUIREMENTS and EFFECTS of Vitamin D supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 55), ('FUTURE_WORK', 64), ('IMPORTANT_CONSIDERATION', 80), ('SUPERFICIAL_RELATIONSHIP', 97)]	6	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'pregnancy')]
PMC3659910	1/2013	S126-PMC3659910	['Animal MODELS of Vitamin D deficiency HAVE SHOWN just how IMPORTANT adequate nutritional intakes of Vitamin D are to Skeletal, Cardiovascular, and Neurologic Development in experimental Animals.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 58)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0001501', 'skeletal system development', 117, 'skeletal ...'), ('UBERON_0001442', 'skeleton of manus', 117, 'skeletal ...'), ('GO_0002026', 'regulation of the force of heart contraction', 127, 'cardiovascular ...'), ('UBERON_0004535', 'cardiovascular system', 127, 'cardiovascular'), ('GO_0007399', 'nervous system development', 147, 'neurologic development'), ('UBERON_0001016', 'nervous system', 147, 'neurologic'), ('NCBITaxon_33208', 'Metazoa', 186, 'animals')]
PMC3659910	1/2013	S127-PMC3659910	['[27] weishaar and simpson[28] SHOWED that lengthy periods of Vitamin D deficiency in Rats are ASSOCIATED with PROFOUND changes in Cardiovascular function, including increases in Cardiac and vascular muscle Contractile function.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 94), ('IMPORTANT_CONSIDERATION', 110)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 85, 'rats'), ('UBERON_0004535', 'cardiovascular system', 130, 'cardiovascular'), ('UBERON_0000948', 'heart', 178, 'cardiac'), ('GO_0006936', 'muscle contraction', 206, 'contractile')]
PMC3659910	1/2013	S128-PMC3659910	['a RECENT STUDY provides EVIDENCE with reference to the CONSEQUENCES of Vitamin D deficiency on the Neurodevelopment Of the Fetus during Pregnancy in a Rat MODEL.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 155)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0001503', 'ossification', 99, 'neurodevelopment of ... fetus'), ('GO_0007565', 'female pregnancy', 136, 'pregnancy'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 151, 'rat')]
PMC3659910	1/2013	S129-PMC3659910	['[28] a study on rodents SHOWED that hypovitaminosis D Trabecular Bone loss, and CONCLUDED that Vitamin D is INDISPENSABLE for normal bone mineralization during the Reproductive period in Rats.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 80), ('IMPORTANT_CONSIDERATION', 108)]	3	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 52, 'D'), ('UBERON_0002483', 'trabecular bone tissue', 54, 'trabecular bone'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0000003', 'reproduction', 164, 'reproductive'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 187, 'rats')]
PMC3659910	1/2013	S132-PMC3659910	['while there is INTEREST in the ROLE of Vitamin D in the PREVENTION of multiple sclerosis, following epidemiological STUDIES DEMONSTRATING an ASSOCIATION between Vitamin D supplementation and reduced PREVALENCE of the disease, FUTURE RESEARCH, including randomized controlled trials in Pregnant or nonpregnant Individuals, is AWAITED TO CONFIRM OR REFUTE such BENEFIT.']	[('IMPORTANT_CONSIDERATION', 15), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 141), ('IMPORTANT_CONSIDERATION', 199), ('FUTURE_WORK', 226), ('FUTURE_WORK', 325), ('FUTURE_WORK', 333), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 344), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('IMPORTANT_CONSIDERATION', 359)]	13	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 285, 'pregnant'), ('NCBITaxon_1', 'root', 309, 'individuals')]
PMC3659910	1/2013	S133-PMC3659910	['BECAUSE the POOR Vitamin D stores of the mother MAY impair Vitamin D state in the infant, it is IMPORTANT to know WHETHER rickets can be PREVENTED in breast Fed infants by supplementation of the mother.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 96), ('EXPLICIT_QUESTION', 114), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007631', 'feeding behavior', 157, 'fed')]
PMC3659910	1/2013	S139-PMC3659910	['[32]\n\nROLE of Vitamin D in newborn and infant\nadequate maternal Vitamin D levels are also IMPORTANT for fetal and child health.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('IMPORTANT_CONSIDERATION', 90)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC3659910	1/2013	S141-PMC3659910	['Vitamin D-deficiency in mothers have significantly INCREASED RISK of infantile rickets DUE TO INADEQUATE Maternal–fetal transfer of 25-Hydroxyvitamin D.[32] RECENT retrospective STUDIES FOUND a significant and PREVIOUSLY UNDETECTED ASSOCIATION of maternal Vitamin D deficiency with rickets-ASSOCIATED infant Heart Failure and with acute Lower Respiratory Tract infection,[33] a SERIOUS COMPLICATION OFTEN ASSOCIATED with sepsis without clinical signs of rickets.']	[('IMPORTANT_CONSIDERATION', 51), ('PROBABLE_UNDERSTANDING', 87), ('IMPORTANT_CONSIDERATION', 94), ('INCOMPLETE_EVIDENCE', 157), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 186), ('INCOMPLETE_EVIDENCE', 210), ('ANOMALY_CURIOUS_FINDING', 221), ('SUPERFICIAL_RELATIONSHIP', 232), ('SUPERFICIAL_RELATIONSHIP', 290), ('IMPORTANT_CONSIDERATION', 378), ('IMPORTANT_CONSIDERATION', 386), ('PROBABLE_UNDERSTANDING', 399), ('SUPERFICIAL_RELATIONSHIP', 405)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007618', 'mating', 105, 'maternal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 132, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('UBERON_0002081', 'cardiac atrium', 308, 'heart failure'), ('UBERON_0004905', 'articulation', 337, 'lower respiratory tract')]
PMC3659910	1/2013	S142-PMC3659910	['while Vitamin D supplementation in Pregnancy has PREVIOUSLY been ASSOCIATED with reduced RISK of wheezing and type 1 diabetes.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 89)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0007565', 'female pregnancy', 35, 'pregnancy')]
PMC3659910	1/2013	S146-PMC3659910	['[34] INTERESTINGLY, Vitamin D deficiency during Pregnancy is also ASSOCIATED with RISKS of health PROBLEMS later in childhood, including improper Bone Development at 9 yrs of age, asthma,[36] Dental Cavities, schizophrenia, and type i diabetes.']	[('ANOMALY_CURIOUS_FINDING', 5), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 82), ('IMPORTANT_CONSIDERATION', 98)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'pregnancy'), ('GO_0048539', 'bone marrow development', 146, 'bone development'), ('UBERON_0001076', 'neural spine', 192, 'dental cavities')]
PMC3659910	1/2013	S149-PMC3659910	['women of indian origin, ESPECIALLY Pregnant women, are KNOWN to have a high PREVALENCE of Vitamin D deficiency.']	[('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 55), ('IMPORTANT_CONSIDERATION', 76)]	3	[('GO_0007565', 'female pregnancy', 35, 'pregnant'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC3659910	1/2013	S155-PMC3659910	['testing and treatment for Vitamin D deficiency\nwomen of Reproductive age are ASSUMED TO BE able to obtain the RECOMMENDED intake for ALMOST ALL Vitamins without the use of supplements, and no national organization RECOMMENDS routine Vitamin D supplementation during Pregnancy unless a woman is at nutritional RISK.']	[('PROBABLE_UNDERSTANDING', 77), ('FUTURE_PREDICTION', 85), ('FUTURE_WORK', 110), ('PROBABLE_UNDERSTANDING', 133), ('FUTURE_WORK', 214), ('IMPORTANT_CONSIDERATION', 309)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0000003', 'reproduction', 56, 'reproductive'), ('CHEBI_33277', 'gamma-tocotrienol', 144, 'vitamins'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('GO_0007565', 'female pregnancy', 266, 'pregnancy')]
PMC3659910	1/2013	S157-PMC3659910	['one approach is to CONSIDER Serum testing in patients at high RISK for Vitamin D deficiency BUT treating without testing those at lower RISK.']	[('FUTURE_WORK', 19), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('IMPORTANT_CONSIDERATION', 136)]	4	[('UBERON_0001977', 'blood serum', 28, 'serum'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3659910	1/2013	S159-PMC3659910	['[4142] endocrine society issues practice guideline on Vitamin D and the GUIDELINE RECOMMEND that clinicians screen for Vitamin D deficiency in People AT RISK for deficiency, including obese Individuals, blacks, Pregnant and Lactating women, and patients with malabsorption syndromes.']	[('PROBABLE_UNDERSTANDING', 72), ('FUTURE_WORK', 82), ('IMPORTANT_CONSIDERATION', 150)]	3	[('CHEBI_28384', 'vitamin K', 54, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 143, 'people'), ('NCBITaxon_1', 'root', 190, 'individuals'), ('GO_0007565', 'female pregnancy', 211, 'pregnant'), ('GO_0007594', 'puparial adhesion', 224, 'lactating')]
PMC3659910	1/2013	S160-PMC3659910	['[43] IF electing to test Vitamin D status, Serum 25-Hydroxyvitamin D is the ACCEPTED BIOMARKER to be offered early in Pregnancy.']	[('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 49, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]
PMC3659910	1/2013	S166-PMC3659910	['[44] CONTROVERSY exists regarding the optimum concentration of Serum 25-Hydroxyvitamin D for DEFINING Vitamin D deficiency, ESPECIALLY in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 93), ('IMPORTANT_CONSIDERATION', 124)]	3	[('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 69, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 138, 'pregnancy')]
PMC3659910	1/2013	S169-PMC3659910	['as was RECENTLY POINTED out in a cochrane review, the topic of maternal Vitamin D REQUIREMENTS during Pregnancy HAS BEEN POORLY studied.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 112), ('PROBLEM_COMPLICATION', 121)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy')]
PMC3659910	1/2013	S170-PMC3659910	['the reality is that the actual Vitamin D REQUIREMENT during Pregnancy is NOT KNOWN.']	[('IMPORTANT_CONSIDERATION', 41), ('FULL_UNKNOWN', 73)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy')]
PMC3659910	1/2013	S173-PMC3659910	['HOWEVER this RECOMMENDED level, which was LARGELY ARBITRARILY set, SEEMS TO BE LESS HELPFUL to improve the nutritional Vitamin D status of Pregnant women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 13), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50), ('ANOMALY_CURIOUS_FINDING', 67), ('FUTURE_PREDICTION', 73), ('IMPORTANT_CONSIDERATION', 79)]	7	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007565', 'female pregnancy', 139, 'pregnant')]
PMC3659910	1/2013	S177-PMC3659910	["current nice GUIDANCE STATES clearly that Pregnant women are informed, at their first Antenatal booking, of the IMPORTANCE of adequate Vitamin D during Pregnancy and after, to maintain their own and their baby's health."]	[('FUTURE_WORK', 13), ('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 112)]	3	[('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('GO_0007567', 'parturition', 86, 'antenatal'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy')]
PMC3659910	1/2013	S186-PMC3659910	['also women are ENCOURAGED to continue to take Vitamin D supplements after Pregnancy to HELP PROTECT against health PROBLEMS such as osteoporosis.']	[('IMPORTANT_CONSIDERATION', 15), ('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 115)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy')]
PMC3659910	1/2013	S187-PMC3659910	['it was RECENTLY SHOWN that a maternal supplementation of 2100 iu Vitamin D/day was NEEDED, when administered during the period of Lactation, in order to observe an increase in Serum levels of 25(Oh) D in the Breast-Fed infants comparable to that observed in children given 400 iu/day.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 83)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007595', 'lactation', 130, 'lactation'), ('UBERON_0001977', 'blood serum', 176, 'serum'), ('CHEBI_71657', 'versiconol acetate', 192, '25(OH) D'), ('PR_000010220', 'mannose-binding protein C', 194, '('), ('PR_000006444', 'diacylglycerol kinase delta', 199, 'D'), ('GO_0007567', 'parturition', 208, 'breast'), ('UBERON_0000310', 'breast', 208, 'breast'), ('GO_0007631', 'feeding behavior', 215, 'fed')]
PMC3659910	1/2013	S189-PMC3659910	['the current LACK OF EVIDENCE of benefit for women at lower RISK of Vitamin D deficiency points to the NEED FOR FURTHER RESEARCH into Vitamin D supplementation in Pregnant women with clinical neonatal and infant end-points under SCRUTINY.']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 59), ('FUTURE_WORK', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	4	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007565', 'female pregnancy', 162, 'pregnant')]
PMC3659910	1/2013	S191-PMC3659910	['FURTHER RESEARCH is REQUIRED, PARTICULARLY to establish the dose NEEDED to supplement Pregnant women with pre-existing deficiency and the OPTIMAL Gestation at which Vitamin D supplementation SHOULD BE started.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 20), ('IMPORTANT_CONSIDERATION', 30), ('IMPORTANT_CONSIDERATION', 65), ('IMPORTANT_CONSIDERATION', 138), ('IMPORTANT_CONSIDERATION', 191)]	6	[('GO_0007565', 'female pregnancy', 86, 'pregnant'), ('GO_0007565', 'female pregnancy', 146, 'gestation'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]
PMC3659910	1/2013	S192-PMC3659910	['RECOMMENDATIONS SHOULD BE made on informing women of the IMPORTANCE of maintaining adequate Vitamin D stores in Pregnancy, PARTICULARLY for those at greatest RISK of Vitamin D deficiency.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 123), ('IMPORTANT_CONSIDERATION', 158)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC3659910	1/2013	S193-PMC3659910	["SENSIBLE sun exposure and education of the public about the beneficial EFFECTS of some limited sun exposure to satisfy their body's Vitamin D REQUIREMENTS SHOULD BE implemented."]	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 71), ('IMPORTANT_CONSIDERATION', 142), ('FUTURE_WORK', 155)]	4	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3659910	1/2013	S194-PMC3659910	['FUTURE STUDIES are ESSENTIAL to determine the true Vitamin D REQUIREMENT during Pregnancy NOT ONLY for maternal Skeletal preservation and fetal Skeletal Formation, BUT ALSO for fetal “Imprinting" that MAY AFFECT Neurodevelopment, Immune function and chronic disease SUSCEPTIBILITY soon after Birth as well as later in Life.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 61), ('ANOMALY_CURIOUS_FINDING', 90), ('FUTURE_PREDICTION', 201), ('SUPERFICIAL_RELATIONSHIP', 205), ('IMPORTANT_CONSIDERATION', 266)]	7	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('UBERON_0004288', 'skeleton', 112, 'skeletal'), ('GO_0001501', 'skeletal system development', 144, 'skeletal formation'), ('UBERON_0004288', 'skeleton', 144, 'skeletal'), ('GO_0071514', 'genetic imprinting', 184, 'imprinting'), ('GO_0007399', 'nervous system development', 212, 'neurodevelopment'), ('UBERON_0002405', 'immune system', 230, 'immune'), ('GO_0007567', 'parturition', 292, 'birth'), ('UBERON_0000104', 'life cycle', 318, 'life')]
PMC3660281	5/2013	S27-PMC3660281	['regarding to Vitamin D, both an excess and a deficiency HAVE BEEN ASSOCIATED with an INCREASED RISK of asthma.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 85)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC3660294	5/2013	S199-PMC3660294	['exclusively breastfed infants living in canada who do not take Vitamin D supplements are at greater RISK of Vitamin D deficiency and insufficiency as well as rickets [21,65,66].']	[('IMPORTANT_CONSIDERATION', 100)]	1	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC3668200	5/2013	S0-PMC3668200	['comparison of the Serum Vitamin D level between breastfed and formula-Fed infants: several FACTORS which CAN AFFECT Serum Vitamin D concentration\nit is COMMON KNOWLEDGE among pediatricians that exclusively breastfed infants SHOULD BE supplemented with Vitamin D (400 iu/day) BECAUSE Human Breast Milk contains an INADEQUATE amount of Vitamin D. accordingly, choi et al.1)REPORTED a vitamin deficiency in early infants in a comparative study between Breastfed and formula-Fed infants in this issue.']	[('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 152), ('FUTURE_WORK', 159), ('FUTURE_WORK', 224), ('PROBABLE_UNDERSTANDING', 275), ('IMPORTANT_CONSIDERATION', 313), ('INCOMPLETE_EVIDENCE', 371)]	9	[('UBERON_0001977', 'blood serum', 18, 'serum'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007631', 'feeding behavior', 70, 'fed'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 283, 'human'), ('UBERON_0001348', 'brown adipose tissue', 289, 'breast milk'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin D'), ('GO_0007567', 'parturition', 449, 'breastfed'), ('GO_0007631', 'feeding behavior', 471, 'fed')]
PMC3668200	5/2013	S1-PMC3668200	['ALTHOUGH the authors STATED SOME exclusion criteria, the study lacks SOME guidelines for CONSIDERATIONS in the evaluation of Vitamin D deficiency, especially those pertaining to FACTORS that can AFFECT the Vitamin concentration in the body.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 69), ('FUTURE_WORK', 89), ('IMPORTANT_CONSIDERATION', 89), ('SUPERFICIAL_RELATIONSHIP', 178), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 206, 'vitamin')]
PMC3668200	5/2013	S9-PMC3668200	['MOST physicians consider 1,25-Oh2-D as a KEY substance to the assessment of Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 41)]	2	[('CHEBI_82627', '15(R)-HPETE', 25, '1,25-OH2-D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC3668200	5/2013	S14-PMC3668200	['at high-latitude areas, conditions of low uv-b radiation EFFECTIVELY facilitate Vitamin D Production in Humans with light skin color, THEREBY PREVENTING Vitamin D deficiency7).']	[('IMPORTANT_CONSIDERATION', 57), ('PROBABLE_UNDERSTANDING', 134), ('SUPERFICIAL_RELATIONSHIP', 142)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 80, 'vitamin D production'), ('NCBITaxon_9606', 'Homo sapiens', 104, 'humans'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3668200	5/2013	S15-PMC3668200	['a light skin color MAY BE REQUIRED in women to produce relatively high amounts of Vitamin D NECESSARY for Pregnancy and Lactation8).']	[('INCOMPLETE_EVIDENCE', 19), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 92)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('GO_0007595', 'lactation', 120, 'lactation8')]
PMC3668200	5/2013	S21-PMC3668200	['although an infant is formula Fed, it cannot be automatically ASSUMED that the infant is adequately supplied with Vitamin D. the daily amount of formula Feeding SHOULD BE taken INTO CONSIDERATION.']	[('PROBABLE_UNDERSTANDING', 62), ('FUTURE_WORK', 161), ('IMPORTANT_CONSIDERATION', 177)]	3	[('GO_0007631', 'feeding behavior', 30, 'fed'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007631', 'feeding behavior', 153, 'feeding')]
PMC3668200	5/2013	S24-PMC3668200	['all the infant formulas in korea contain the minimum REQUIRED Vitamin D concentration of 40 iu/100 kcal (258 iu/l in a 20-kcal/oz formula).']	[('IMPORTANT_CONSIDERATION', 53)]	1	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 70, 'D')]
PMC3668200	5/2013	S28-PMC3668200	['Breast Milk ALONE can meet the Nutrient REQUIREMENT during the first 6 months of Life, with the POSSIBLE EXCEPTION of Vitamin D. the Vitamin A and Vitamin E contents of the Breast Milk are CORRELATED with the amount of the Vitamins in the dietary intake of Lactating mothers.']	[('ANOMALY_CURIOUS_FINDING', 12), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 96), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 189)]	5	[('UBERON_0013538', 'Brodmann (1909) area 7', 0, 'Breast milk'), ('CHEBI_33284', 'nutrient', 31, 'nutrient'), ('UBERON_0000104', 'life cycle', 81, 'life'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin E'), ('UBERON_0001348', 'brown adipose tissue', 173, 'breast milk'), ('CHEBI_33277', 'gamma-tocotrienol', 223, 'vitamins'), ('GO_0007594', 'puparial adhesion', 257, 'lactating')]
PMC3668200	5/2013	S29-PMC3668200	['ON the CONTRARY, Vitamin D content of the Breast Milk does not meet the REQUIRED daily amount for the infants DESPITE adequate dietary supplementation of Vitamin D12), because this supplementing does not substantially increase the Vitamin D concentration in Human milk13).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('IMPORTANT_CONSIDERATION', 72), ('ANOMALY_CURIOUS_FINDING', 110)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 42, 'breast milk'), ('CHEBI_33279', 'vitamin D5', 154, 'vitamin D12'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 258, 'human')]
PMC3668200	5/2013	S37-PMC3668200	['in addition, women with increased skin pigmentation or those with little sunlight exposure are AT RISK of Vitamin D deficiency and MAY NEED additional Vitamin D supplementation, especially during Pregnancy and Lactation.']	[('IMPORTANT_CONSIDERATION', 95), ('INCOMPLETE_EVIDENCE', 131), ('IMPORTANT_CONSIDERATION', 135)]	3	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 196, 'pregnancy'), ('GO_0007595', 'lactation', 210, 'lactation')]
PMC3668200	5/2013	S39-PMC3668200	['DESPITE SEVERE maternal Vitamin D deficiency, fetal rickets MAY RARELY develop.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 8), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 64)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC3668200	5/2013	S50-PMC3668200	['with respect to Prenatal supplementation, the GENERALLY prescribed daily intake of 400 iu of Vitamin D is NOT sufficient to achieve the OPTIMAL Vitamin D status in newborns18).']	[('PROBABLE_UNDERSTANDING', 46), ('ANOMALY_CURIOUS_FINDING', 106), ('IMPORTANT_CONSIDERATION', 136)]	3	[('GO_0007565', 'female pregnancy', 16, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC3668200	5/2013	S51-PMC3668200	['MANY RESEARCH REPORTS on Vitamin D, which is IMPORTANT for Bony Metabolism and immunity, and has beneficial EFFECTS on diverse Organs, HAVE BEEN published RECENTLY.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 45), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0001461', 'elbow', 59, 'bony'), ('GO_0008152', 'metabolic process', 64, 'metabolism'), ('UBERON_0000062', 'organ', 127, 'organs')]
PMC3672018	5/2013	S0-PMC3672018	['the INFLUENCE of early exposure to Vitamin D for development of Diseases later in Life\n\nabstract\n\nbackground\nVitamin D deficiency is common among otherwise healthy Pregnant women and MAY have CONSEQUENCES for them as well as the early Development and long-term health Of their Children.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 183), ('IMPORTANT_CONSIDERATION', 192)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007586', 'digestion', 64, 'diseases'), ('UBERON_0000104', 'life cycle', 82, 'life'), ('CHEBI_28384', 'vitamin K', 109, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 164, 'pregnant'), ('GO_0001709', 'cell fate determination', 235, 'development ... - ... of ... children')]
PMC3672018	5/2013	S1-PMC3672018	['HOWEVER, the IMPORTANCE of maternal Vitamin D status on offspring health later in Life has not been widely studied.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 13)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 82, 'life')]
PMC3672018	5/2013	S3-PMC3672018	['methods/design\nthe study is based on the fact that in 1961 fortifying Margarine with Vitamin D became MANDATORY in denmark and in 1972 low fat milk fortification was allowed.']	[('IMPORTANT_CONSIDERATION', 102)]	1	[('CHEBI_6784', 'mestranol', 70, 'margarine'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC3672018	5/2013	S4-PMC3672018	['apart from determining the INFLUENCES of exposure prior to Conception and during Prenatal Life, we will EXAMINE the IMPORTANCE of Vitamin D exposure during specific seasons and trimesters, by comparing disease incidence among Individuals Born before and after fortification.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 104), ('IMPORTANT_CONSIDERATION', 116)]	3	[('GO_0007620', 'copulation', 59, 'conception'), ('GO_0007565', 'female pregnancy', 81, 'prenatal'), ('UBERON_0000104', 'life cycle', 90, 'life'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('NCBITaxon_1', 'root', 226, 'individuals'), ('GO_0007567', 'parturition', 238, 'born')]
PMC3672018	5/2013	S7-PMC3672018	['discussion\nthe results of the study will contribute to our CURRENT understanding of the SIGNIFICANCE of supplementation with Vitamin D. more specifically, they will enable new RESEARCH in related fields, including interventional research designed to assess supplementation NEEDS for different subgroups of Pregnant women.']	[('INCOMPLETE_EVIDENCE', 59), ('IMPORTANT_CONSIDERATION', 88), ('FUTURE_WORK', 176), ('IMPORTANT_CONSIDERATION', 273)]	4	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('GO_0007565', 'female pregnancy', 306, 'pregnant')]
PMC3672018	5/2013	S12-PMC3672018	['THE PRESENT STUDY addresses these ISSUES in RELATION to Vitamin D.\n\nVitamin D\nvitamin D is a fat-soluble Vitamin that is NECESSARY for the Human body.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('PROBLEM_COMPLICATION', 34), ('SUPERFICIAL_RELATIONSHIP', 44), ('IMPORTANT_CONSIDERATION', 121)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 68, 'Vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 86, 'D'), ('CHEBI_33229', 'vitamin (role)', 105, 'vitamin'), ('NCBITaxon_9606', 'Homo sapiens', 139, 'human')]
PMC3672018	5/2013	S19-PMC3672018	['furthermore, as PROPOSED in 2001, a CRITICAL window MAY exist during which Vitamin D levels have a persisting IMPACT on health outcomes [5].']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 36), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC3672018	5/2013	S20-PMC3672018	['low Vitamin D during Gestation and in early Life MAY THEREFORE play an IMPORTANT ROLE for susceptibility to bone fragility, obesity and Autoimmune diseases later in Life [6].']	[('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 53), ('IMPORTANT_CONSIDERATION', 71), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 21, 'gestation'), ('UBERON_0000104', 'life cycle', 44, 'life'), ('UBERON_0001442', 'skeleton of manus', 136, 'autoimmune'), ('UBERON_0000104', 'life cycle', 165, 'life')]
PMC3672018	5/2013	S24-PMC3672018	['ALTHOUGH adequate exposure to uvb sunlight is PARAMOUNT to an ample supply of Vitamin D, Oral Intake, augmented by both fortification and supplementation, is NECESSARY to maintain baseline stores in populations at high latitudes were the sun can only drive dermal Synthesis Of Vitamin D from april to october [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 46), ('IMPORTANT_CONSIDERATION', 158)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000165', 'mouth', 89, 'oral'), ('GO_0007631', 'feeding behavior', 94, 'intake'), ('GO_0030474', 'spindle pole body duplication', 264, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 285, 'D')]
PMC3672018	5/2013	S27-PMC3672018	['importance of fetal Vitamin D on health later in Life\nVitamin D insufficiency is highly PREVALENT in both developed and developing societies.']	[('IMPORTANT_CONSIDERATION', 88)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0000104', 'life cycle', 49, 'life'), ('CHEBI_28384', 'vitamin K', 54, 'Vitamin D')]
PMC3672018	5/2013	S31-PMC3672018	['Pregnancy is a time of particular SUSCEPTIBILITY to Vitamin D deficiency, AS both maternal and fetal demands for the Vitamin NEED to be met [11,12].']	[('IMPORTANT_CONSIDERATION', 34), ('PROBABLE_UNDERSTANDING', 74), ('IMPORTANT_CONSIDERATION', 125)]	3	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 117, 'vitamin')]
PMC3672018	5/2013	S47-PMC3672018	['to study the INFLUENCE of seasonal variation and timing of fetal exposure in RELATION to later EFFECTS of Vitamin D on health outcomes, one REQUIRES EVEN larger numbers of subjects to be followed over long time.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('FUTURE_WORK', 140), ('IMPORTANT_CONSIDERATION', 140), ('ANOMALY_CURIOUS_FINDING', 149)]	6	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC3672018	5/2013	S54-PMC3672018	['the main HYPOTHESIS is that low levels of Vitamin D during CRITICAL phases of development have adverse EFFECTS on the long term risk of developing the above mentioned disease outcomes, and that exposure to extra Vitamin D from Food fortification has beneficial EFFECTS PREVENTING the mentioned diseases.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 59), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 261), ('SUPERFICIAL_RELATIONSHIP', 269)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_33290', 'food', 227, 'food')]
PMC3672018	5/2013	S56-PMC3672018	['the Vitamin D fortification of low fat milk was not mandatory and THEREFORE not all low fat Milk distributed in denmark in the time period was fortified with Vitamin D. UNFORTUNATELY, there are no national statistics INDICATING the proportion of Milk Consumed that was fortified with Vitamin D. NEVERTHELESS, the two well-defined time periods of Vitamin D fortification provide a natural framework for comparing the EFFECTS of early exposure to Vitamin D on the Development Of Diseases later in Life amongst exposed and non-exposed adjacent Birth cohorts (figure\xa01).']	[('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 169), ('INCOMPLETE_EVIDENCE', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('SUPERFICIAL_RELATIONSHIP', 416)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0001913', 'milk', 92, 'milk'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0001913', 'milk', 246, 'milk'), ('GO_0007631', 'feeding behavior', 251, 'consumed'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0009603', 'detection of symbiotic fungus', 462, 'development of diseases'), ('UBERON_0000104', 'life cycle', 495, 'life'), ('GO_0007567', 'parturition', 541, 'birth')]
PMC3672018	5/2013	S100-PMC3672018	['WHETHER OR NOT exposure to Vitamin D fortification in different Gestational trimesters is IMPORTANT will be examined.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 90)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'gestational')]
PMC3672018	5/2013	S101-PMC3672018	['for instance, INFLUENCE of low Vitamin D on obesity and Adipose Tissues MAY BE particularly IMPORTANT for children whose third Gestation periods occur during winter, WHILE INFLUENCE of low Vitamin D on Autoimmune diseases MAY BE particularly IMPORTANT for children whose first Gestational trimester occurs during winter.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 72), ('IMPORTANT_CONSIDERATION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('SUPERFICIAL_RELATIONSHIP', 172), ('INCOMPLETE_EVIDENCE', 222), ('IMPORTANT_CONSIDERATION', 242)]	7	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 56, 'adipose tissues'), ('GO_0007565', 'female pregnancy', 127, 'gestation'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 202, 'autoimmune'), ('GO_0007565', 'female pregnancy', 277, 'gestational')]
PMC3672018	5/2013	S165-PMC3672018	['implications\nUNLIKE many OTHER nutritional deficiencies, low Vitamin D status is PREVALENT among industrialized populations, and, ACCORDING TO danish health authorities, about half of all adults have Vitamin D insufficiency (below 50\u2009nmol/l) [32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('IMPORTANT_CONSIDERATION', 81), ('INCOMPLETE_EVIDENCE', 130)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC3672018	5/2013	S166-PMC3672018	['adequate exposure to uvb sunlight is PARAMOUNT IMPORTANCE for supply of Vitamin D, BUT Oral Intake, augmented by fortification and supplementation, is NECESSARY to maintain baseline stores, particularly in winter when sunlight is limited [8,33,34].']	[('IMPORTANT_CONSIDERATION', 37), ('IMPORTANT_CONSIDERATION', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('IMPORTANT_CONSIDERATION', 151)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0000165', 'mouth', 87, 'oral'), ('GO_0007631', 'feeding behavior', 92, 'intake')]
PMC3672018	5/2013	S169-PMC3672018	['our results will significantly increase current understanding of the IMPORTANCE of early Vitamin D intake for long-term health and the occurrence of diseases.']	[('IMPORTANT_CONSIDERATION', 69)]	1	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC3672018	5/2013	S173-PMC3672018	['Human intervention studies to determine the level of Vitamin D supplementation NECESSARY to reduce susceptibility to diseases later in Life and concomitant basic research exploring the biological mechanisms that may be INVOLVED.']	[('IMPORTANT_CONSIDERATION', 79), ('SUPERFICIAL_RELATIONSHIP', 219)]	2	[('NCBITaxon_9606', 'Homo sapiens', 0, 'human'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0000104', 'life cycle', 135, 'life')]
PMC3672018	5/2013	S179-PMC3672018	['results from this study are LIKELY to CONSIDERABLY increase our current understanding of the SIGNIFICANCE of early Vitamin D intake in RELATION to later health.']	[('PROBABLE_UNDERSTANDING', 28), ('ANOMALY_CURIOUS_FINDING', 38), ('IMPORTANT_CONSIDERATION', 93), ('SUPERFICIAL_RELATIONSHIP', 135)]	4	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3672018	5/2013	S180-PMC3672018	['besides IMPLICATIONS for research in the field, it MAY also inform the current DEBATE in denmark on WHETHER to resume Vitamin D Food fortification.']	[('IMPORTANT_CONSIDERATION', 8), ('INCOMPLETE_EVIDENCE', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('EXPLICIT_QUESTION', 100)]	5	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_33290', 'food', 128, 'food')]
PMC3679329	6/2013	S7-PMC3679329	['among Pregnant women, the proportion of women with an Intake of Vitamin C (from diet alone) below the ESTIMATED average REQUIREMENTS (ear) was lower among supplement users [users (44%) vs. non-users (68%)], and the proportion of Lactating women with intakes of iron (from diet alone) below the ear was lower among Supplement users [usesr (17%) vs. non-users (38%)].']	[('INCOMPLETE_EVIDENCE', 102), ('IMPORTANT_CONSIDERATION', 120)]	2	[('GO_0007565', 'female pregnancy', 6, 'pregnant'), ('GO_0007631', 'feeding behavior', 54, 'intake'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin C'), ('GO_0007594', 'puparial adhesion', 229, 'lactating'), ('CHEBI_16158', 'steroid sulfate', 314, 'supplement')]
PMC3679329	6/2013	S8-PMC3679329	['these results SUGGEST that among Pregnant and Lactating women, those who do not use dietary supplements TEND to have a lower intake of healthy Foods, such as beans and vegetables, as well as a lower intake of dietary fiber and Β-Carotene, which are abundant in these Foods, and non-users are more LIKELY than users to have INADEQUATE Intake of micro-Nutrient such as Vitamin C and iron.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 104), ('PROBABLE_UNDERSTANDING', 297), ('IMPORTANT_CONSIDERATION', 323), ('PROBLEM_COMPLICATION', 323)]	5	[('GO_0007565', 'female pregnancy', 33, 'pregnant'), ('GO_0007594', 'puparial adhesion', 46, 'lactating'), ('CHEBI_33290', 'food', 143, 'foods'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 227, 'β-carotene'), ('CHEBI_33290', 'food', 267, 'foods'), ('GO_0007631', 'feeding behavior', 334, 'intake'), ('CHEBI_33284', 'nutrient', 350, 'nutrient'), ('CHEBI_27300', 'vitamin D', 367, 'vitamin C')]
PMC3679329	6/2013	S79-PMC3679329	['a population based cohort study of Adults in the us DEMONSTRATED that supplement users, COMPARED TO non-users, GENERALLY had higher average Intakes of Foods which are IMPORTANT sources of Vitamin C and Carotenoids (i.e., fruits and certain vegetables) [12].']	[('INCOMPLETE_EVIDENCE', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('PROBABLE_UNDERSTANDING', 111), ('IMPORTANT_CONSIDERATION', 167)]	4	[('UBERON_0007023', 'adult organism', 35, 'adults'), ('GO_0007631', 'feeding behavior', 140, 'intakes'), ('CHEBI_33290', 'food', 151, 'foods'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin C'), ('CHEBI_50815', 'norgestimate', 202, 'carotenoids')]
PMC3685533	6/2013	S15-PMC3685533	['circulating 25Ohd is the MAJOR circulating form of Vitamin D and is CONSIDERED AS the primary INDICATOR of Vitamin D status [1].']	[('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 68), ('PROBABLE_UNDERSTANDING', 79), ('SUPERFICIAL_RELATIONSHIP', 94)]	4	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 12, '25OHD'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC3685533	6/2013	S26-PMC3685533	['population studies in europe HAVE SHOWN that immigrants from asia, the middle east or africa have a greater RISK of low Vitamin D levels [10-12].']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 108)]	2	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3685533	6/2013	S29-PMC3685533	['country of origin, Genetic traits and cultural behaviour are IMPORTANT FACTORS in determining Vitamin D levels [17].']	[('IMPORTANT_CONSIDERATION', 61), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('SO_0000704', 'gene', 19, 'genetic'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3685533	6/2013	S31-PMC3685533	['data SUGGESTS that doses exceeding 1000 iu of Vitamin D per day are NECESSARY to achieve sufficienct 25Ohd concentrations in Pregnant women [18].']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 68)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 101, '25OHD'), ('GO_0007565', 'female pregnancy', 125, 'pregnant')]
PMC3685533	6/2013	S75-PMC3685533	['in newborns, Vitamin D levels were deficient (<20 ng/dl) in 75.6% of cases, with a SEVERE deficiency (<10 ng/ml) in 46.3% and a mild deficiency (10–20 ng/ml) in 29.3%.']	[('IMPORTANT_CONSIDERATION', 83)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC3685533	6/2013	S78-PMC3685533	['when CONSIDERING the maternal multivitamin Intake during Pregnancy, all mothers supplemented with Vitamin D DEMONSTRATED higher 25Ohd values in both Cord Blood (24.5\u2009±\u200911.9 vs 17.2\u2009±\u20099.2 ng/ml; p\u2009<\u20090.01) and in neonatal Serum (17.7\u2009±\u20099.3 vs 11.1\u2009±\u20096 ng/ml; p\u2009<\u20090.001).']	[('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 108)]	2	[('GO_0007631', 'feeding behavior', 43, 'intake'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 128, '25OHD'), ('UBERON_0002240', 'spinal cord', 149, 'cord'), ('UBERON_0000178', 'blood', 154, 'blood'), ('UBERON_0001977', 'blood serum', 220, 'serum')]
PMC3685533	6/2013	S101-PMC3685533	['PREVIOUS STUDIES HAVE SHOWN a high prevalence of Vitamin D deficiency among neonates and their mothers, PARTICULARLY in united states, australia, south asia, the united kingdom, greece and in other european countries [24-29].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 104)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3685533	6/2013	S126-PMC3685533	['ALTHOUGH SEVERAL STUDIES are AVAILABLE on Vitamin D supplementation during Pregnancy, its APPROPRIATE dose is NOT CLEAR [19-21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 90), ('FULL_UNKNOWN', 110)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy')]
PMC3685533	6/2013	S137-PMC3685533	['identifying Vitamin D deficiency at Birth is ESSENTIAL for the development of public policy for PREVENTION and supplementation.']	[('IMPORTANT_CONSIDERATION', 45), ('SUPERFICIAL_RELATIONSHIP', 96)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007567', 'parturition', 36, 'birth')]
PMC3691177	6/2013	S13-PMC3691177	['trial registration\ncontrolled-trials.comisrctn68645785\n\nintroduction\nseveral observational studies have SUGGESTED a PROTECTIVE EFFECT of higher maternal Vitamin D intake during Pregnancy on RISK of wheezing[1]–[3], asthma and allergic rhinitis[4], and eczema[3]in offspring.']	[('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 127), ('IMPORTANT_CONSIDERATION', 190)]	4	[('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy')]
PMC3691177	6/2013	S117-PMC3691177	['the 95% confidence interval for our primary outcome measure was 0.49 to 1.50, so we are UNABLE TO confidently exclude EFFECTS of Prenatal vitamin D supplementation on RISK of wheezing, or on the development of atopy especially in mothers treated with daily Vitamin D. third, we DID NOT assess Vitamin D receptor polymorphisms or OTHER POTENTIALLY IMPORTANT genotypic variations.']	[('DIFFICULT_TASK', 88), ('SUPERFICIAL_RELATIONSHIP', 118), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 278), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('INCOMPLETE_EVIDENCE', 335), ('IMPORTANT_CONSIDERATION', 347)]	7	[('GO_0007565', 'female pregnancy', 129, 'prenatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 146, 'D'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D')]
PMC3691177	6/2013	S127-PMC3691177	['it HAS RECENTLY BEEN SHOWN that doses of 4000 iu of Vitamin D daily are SAFE and effective for short term treatment of Vitamin D deficiency during Pregnancy[30], ALTHOUGH the long term EFFECTS on child health have NOT BEEN STUDIED.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 72), ('ANOMALY_CURIOUS_FINDING', 162), ('SUPERFICIAL_RELATIONSHIP', 185), ('FULL_UNKNOWN', 214)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy')]
PMC3691177	6/2013	S132-PMC3691177	['the results of our randomised controlled trial do not SUPPORT a strong causal RELATIONSHIP between low Prenatal Vitamin D status within the deficient/insufficient range and INCREASED RISK of Allergic sensitization or wheezing in early childhood.']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 78), ('IMPORTANT_CONSIDERATION', 173)]	3	[('GO_0007565', 'female pregnancy', 103, 'prenatal'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0040011', 'locomotion', 191, 'allergic')]
PMC3691177	6/2013	S139-PMC3691177	['given the modest EFFECTS on Cord Blood Vitamin D achieved by these INTERVENTIONS, the SAFETY and efficacy of higher dose Prenatal Vitamin D supplementation STRATEGIES NEED TO BE explored.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 86), ('FUTURE_WORK', 156), ('FUTURE_WORK', 167)]	5	[('UBERON_0002240', 'spinal cord', 28, 'cord'), ('UBERON_0000178', 'blood', 33, 'blood'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007565', 'female pregnancy', 121, 'prenatal'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3695234	7/2013	S0-PMC3695234	['CORRELATION between Serum Vitamin D level and the severity of atopic dermatitis ASSOCIATED with Food sensitization\n\nabstract\n\npurpose\na GROWING BODY of LITERATURE has LINKED Vitamin D deficiency with allergic diseases, particularly atopic dermatitis (ad).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 80), ('IMPORTANT_CONSIDERATION', 136), ('INCOMPLETE_EVIDENCE', 136), ('SUPERFICIAL_RELATIONSHIP', 167)]	5	[('UBERON_0001977', 'blood serum', 20, 'Serum'), ('CHEBI_28384', 'vitamin K', 26, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 26, 'Vitamin'), ('CHEBI_33290', 'food', 96, 'Food'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC3695234	7/2013	S17-PMC3695234	['ANOTHER STUDY REPORTED regional DIFFERENCES in the number of prescriptions of epipens within the united states; the highest rates were FOUND in new england, and the lowest in the southern states.2THESE results MAY provide IMPORTANT etiologic CLUES and INDICATE the POTENTIAL ROLE of Vitamin D in atopic disease susceptibility.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 135), ('PROBABLE_UNDERSTANDING', 195), ('PROBABLE_UNDERSTANDING', 195), ('INCOMPLETE_EVIDENCE', 210), ('IMPORTANT_CONSIDERATION', 222), ('INCOMPLETE_EVIDENCE', 242), ('INCOMPLETE_EVIDENCE', 252), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 275)]	12	[('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
PMC3695234	7/2013	S19-PMC3695234	['there has also been increasing AWARENESS of the IMPORTANCE of one POTENTIAL FACTOR-Vitamin D-in the development and progress of atopic Diseases.']	[('IMPORTANT_CONSIDERATION', 31), ('IMPORTANT_CONSIDERATION', 48), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007586', 'digestion', 135, 'diseases')]
PMC3695234	7/2013	S20-PMC3695234	['a GROWING body of LITERATURE has LINKED decreased Serum Vitamin D levels with allergic diseases, PARTICULARLY ad.2-4HOWEVER, large-scale prospective and randomized studies are LACKING.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 97), ('IMPORTANT_CONSIDERATION', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('FULL_UNKNOWN', 176)]	6	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC3695234	7/2013	S50-PMC3695234	['a PROTECTIVE EFFECT for Vitamin D against wheezing and asthma was found to be strongest for non-atopic and older subjects, SUGGESTING that Vitamin D modifies the risk of allergic and Respiratory disease through multiple mechanisms.7\nalthough Vitamin D deficiency is DEFINED AS a Serum level <20 ng/ml of 25(Oh)d3, there is also an increasing CONCERN about Vitamin D INSUFFICIENCY, which is characterized by levels of 25(Oh)D3Between 20 and 29 ng/ml.8in THIS STUDY, we FOUND that most participants with ad COULD BE categorized as having Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 123), ('PROBABLE_UNDERSTANDING', 266), ('PROBABLE_UNDERSTANDING', 274), ('IMPORTANT_CONSIDERATION', 342), ('IMPORTANT_CONSIDERATION', 366), ('QUESTION_ANSWERED_BY_THIS_WORK', 453), ('INCOMPLETE_EVIDENCE', 468), ('INCOMPLETE_EVIDENCE', 505)]	10	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 183, 'respiratory'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('UBERON_0001977', 'blood serum', 279, 'serum'), ('CHEBI_30778', 'gallic acid', 304, '25(OH)'), ('CHEBI_27300', 'vitamin D', 356, 'vitamin D'), ('CHEBI_52744', 'fort orange 600', 417, '25(OH)D3between 20'), ('CHEBI_27300', 'vitamin D', 536, 'vitamin D')]
PMC3695234	7/2013	S54-PMC3695234	['THEREFORE, the RELATIONSHIP between Vitamin D and ad HAS been INVESTIGATED both HERE and in PREVIOUS STUDIES.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('IMPORTANT_CONSIDERATION', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('INCOMPLETE_EVIDENCE', 92)]	6	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3695234	7/2013	S75-PMC3695234	['BASED ON the identification of Vitamin D receptors in RELEVANT Immune Cells, it HAS BEEN SUGGESTED that the Vitamin D pathway plays a ROLE in asthma and atopy.19,20using Single Nucleotide Polymorphism selection and genotyping, poon et al.20found six variants that are strongly ASSOCIATED with asthma and four with atopy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 54), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 134), ('SUPERFICIAL_RELATIONSHIP', 277)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CL_0000738', 'leukocyte', 63, 'immune cells'), ('UBERON_0002405', 'immune system', 63, 'immune'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('SO_0000694', 'SNP', 170, 'single nucleotide polymorphism')]
PMC3702245	6/2013	S1-PMC3702245	['WHILE Vitamin D is IMPORTANT for Calcium and Phosphorus Homeostasis and for bone health, it also plays IMPORTANT ROLES in many OTHER physiologic functions in the body.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 103), ('SUPERFICIAL_RELATIONSHIP', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 33, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 45, 'phosphorus'), ('GO_0042592', 'homeostatic process', 56, 'homeostasis')]
PMC3702245	6/2013	S3-PMC3702245	['THEREFORE, an overview of the CURRENT understanding of Vitamin D nutrition in Pregnancy and a review of the results of studies to optimize Vitamin D status during Pregnancy and in the offspring is of PUBLIC HEALTH IMPORTANCE and timely.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 200), ('IMPORTANT_CONSIDERATION', 214)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 163, 'pregnancy')]
PMC3702245	6/2013	S4-PMC3702245	['introduction\nVitamin D deficiency in Pregnancy is widespread in many parts of the world,1and there is an ASSOCIATION between low Vitamin D status and multiple POTENTIAL adverse outcomes of Pregnancy.2–5therefore, Vitamin D nutrition in Pregnancy SHOULD BE of GLOBAL HEALTH INTEREST.']	[('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 159), ('FUTURE_WORK', 246), ('IMPORTANT_CONSIDERATION', 259)]	4	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 37, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy')]
PMC3702245	6/2013	S6-PMC3702245	['in addition, it is now known to be INVOLVED in Immunomodulation, Cell Proliferation, and Cell Differentiation, and in other physiologic functions in diverse Tissues and Organs, including the Brain, Pancreas, and Heart.6despite the REPORTED high prevalence of Vitamin D deficiency and its POSSIBLE consequences, the criteria for defining an optimal level in the body, and HENCE the amount of Vitamin D intake REQUIRED to maintain adequate levels, is CONTROVERSIAL.3,7,8this overview addresses the CURRENT INFORMATION about Vitamin D function, the GLOBAL BURDEN and POTENTIAL consequences of low Vitamin D status in Pregnancy, and current STRATEGIES to optimize Vitamin D status in Pregnant mothers and their offspring.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 231), ('INCOMPLETE_EVIDENCE', 288), ('PROBABLE_UNDERSTANDING', 371), ('IMPORTANT_CONSIDERATION', 408), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 449), ('INCOMPLETE_EVIDENCE', 496), ('IMPORTANT_CONSIDERATION', 546), ('INCOMPLETE_EVIDENCE', 564), ('FUTURE_WORK', 637)]	10	[('GO_0050900', 'leukocyte migration', 47, 'immunomodulation'), ('GO_0008283', 'cell proliferation', 65, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 89, 'cell differentiation'), ('UBERON_0000479', 'tissue', 157, 'tissues'), ('UBERON_0000062', 'organ', 169, 'organs'), ('UBERON_0000955', 'brain', 191, 'brain'), ('UBERON_0001264', 'pancreas', 198, 'pancreas'), ('UBERON_0000948', 'heart', 212, 'heart'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 391, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 594, 'vitamin D'), ('GO_0007565', 'female pregnancy', 614, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('GO_0007565', 'female pregnancy', 680, 'pregnant')]
PMC3702245	6/2013	S9-PMC3702245	['SEVERAL REPORTS in the literature HAVE SHOWN that INADEQUATE or lack of sunlight exposure without appropriate corrective Vitamin D intake or supplements accounts FOR the high prevalence of Vitamin D deficiency in women.11–18\nafter synthesis in the skin, Vitamin D attaches to Vitamin D-binding protein and is transported to the Liver, where it undergoes a process of hydroxylation to form 25-Hydroxyvitamin D [25(Oh)D].9the Serum concentration of 25(Oh)D is the MOST reliable MARKER of Vitamin D nutritional status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 162), ('PROBABLE_UNDERSTANDING', 462), ('SUPERFICIAL_RELATIONSHIP', 476)]	7	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 284, 'D'), ('UBERON_0002107', 'liver', 328, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 389, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 410, '25(OH)D'), ('UBERON_0001977', 'blood serum', 424, 'serum'), ('CHEBI_71657', 'versiconol acetate', 447, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 486, 'vitamin D')]
PMC3702245	6/2013	S10-PMC3702245	['a second hydroxylation takes place in the Kidney, which converts 25(Oh)D to the most biologically active Metabolite, 1,25-Dihydroxyvitamin D, the major classical physiologic function of which is to increase calcium and Phosphorus absorption from the Gut in order to maintain Calcium Homeostasis and promote mineralization of Osteoid bone.9\nalthough the Renal 1-alpha hydroxylase (Cytochrome P450 [Cyp]27B1) enzyme is a MAJOR DETERMINANT of Synthesis of 1,25-Dihydroxyvitamin D, IT IS KNOWN that Cyp27B1 is Expressed in Nonrenal Tissues to produce 1,25 Dihydroxyvitamin D.6,19in addition, Vitamin D receptors are also Expressed in a variety of Organs, Tissues, and cells (seefigure 1).20the 1,25-Dihydroxyvitamin D locally produced in Extrarenal Tissues, such as immune cells, Pancreatic Beta Cells, the Intestine, Prostate, Breast, and other Organs, Controls multiple Vitamin D-responsive Genes, and THUS plays an important physiologic ROLE in Cardiovascular health,21,22the Adaptive and Innate Immune Responses,23,24insulin secretion,25,26regulation of Cell Proliferation, Differentiation, and Apoptosis, and inhibition of Angiogenesis.27\n\nVitamin D Homeostasis and functions during Pregnancy\nthe classical function of Vitamin D is to maintain calcium Homeostasis.']	[('IMPORTANT_CONSIDERATION', 419), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 478), ('PROBABLE_UNDERSTANDING', 900), ('SUPERFICIAL_RELATIONSHIP', 936)]	5	[('UBERON_0002113', 'kidney', 42, 'kidney'), ('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('CHEBI_39382', 'flufenoxuron', 105, 'metabolite'), ('CHEBI_67472', '15-epi-lupulin B', 117, '1,25-dihydroxyvitamin D'), ('CHEBI_35885', 'secondary phosphine', 219, 'phosphorus'), ('UBERON_0001555', 'digestive tract', 250, 'gut'), ('GO_0055073', 'cadmium ion homeostasis', 275, 'calcium homeostasis'), ('UBERON_0008883', 'osteoid', 325, 'osteoid'), ('UBERON_0002113', 'kidney', 353, 'renal'), ('CHEBI_4056', 'cytochrome', 380, 'cytochrome'), ('PR_000006100', 'aromatase', 380, 'cytochrome P450'), ('PR_000006138', 'cytochrome P450 4F11', 397, 'CYP ... 27B1'), ('GO_0009057', 'macromolecule catabolic process', 440, 'synthesis'), ('CHEBI_67472', '15-epi-lupulin B', 453, '1,25-dihydroxyvitamin D'), ('PR_000006101', 'cytochrome P450 1A1', 495, 'CYP27B1'), ('GO_0010467', 'gene expression', 506, 'expressed'), ('UBERON_0002481', 'bone tissue', 519, 'nonrenal tissues'), ('CHEBI_67469', '15-hydroxyajubractin C', 547, '1,25 dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 588, 'vitamin D'), ('GO_0010467', 'gene expression', 617, 'expressed'), ('UBERON_0000062', 'organ', 643, 'organs'), ('UBERON_0000479', 'tissue', 651, 'tissues'), ('CHEBI_67472', '15-epi-lupulin B', 690, '1,25-dihydroxyvitamin D'), ('UBERON_0005292', 'extraembryonic tissue', 734, 'extrarenal tissues'), ('CL_0000169', 'type B pancreatic cell', 776, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 776, 'pancreatic'), ('UBERON_0000160', 'intestine', 803, 'intestine'), ('UBERON_0002367', 'prostate gland', 814, 'prostate'), ('UBERON_0000310', 'breast', 824, 'breast'), ('UBERON_0000062', 'organ', 842, 'organs'), ('GO_0065007', 'biological regulation', 850, 'controls'), ('CHEBI_27300', 'vitamin D', 868, 'vitamin D'), ('SO_0000704', 'gene', 889, 'genes'), ('UBERON_0004535', 'cardiovascular system', 944, 'cardiovascular'), ('GO_0051886', 'negative regulation of timing of anagen', 975, 'adaptive ...'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 988, 'innate immune responses'), ('UBERON_0002405', 'immune system', 995, 'immune'), ('GO_0030154', 'cell differentiation', 1054, 'cell proliferation ... differentiation'), ('GO_0006915', 'apoptotic process', 1095, 'apoptosis'), ('GO_0001525', 'angiogenesis', 1124, 'angiogenesis'), ('CHEBI_28384', 'vitamin K', 1141, 'Vitamin D'), ('GO_0042592', 'homeostatic process', 1151, 'homeostasis'), ('GO_0007565', 'female pregnancy', 1184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1220, 'vitamin D'), ('GO_0042592', 'homeostatic process', 1253, 'homeostasis')]
PMC3702245	6/2013	S13-PMC3702245	['HOWEVER, sustained Vitamin D deficiency results in rickets in children and osteomalacia in Adults.28the COMMONLY evaluated BIOMARKERS of Vitamin D nutrition include Serum 25(Oh)D concentrations, the inverse RELATIONSHIP between 25(Oh)D and Parathyroid hormone, Intestinal calcium absorption, and assessment of Skeletal integrity.29WHILE there is an inverse RELATIONSHIP between Serum Parathyroid hormone and 25(Oh)D in nonpregnant states, this RELATIONSHIP HAS BEEN SHOWN in RECENT STUDIES to be weak during Pregnancy,6,18,30,31INDICATING that Serum Parathyroid hormone MAY BE a LESS RELIABLE BIOMARKER of maternal Vitamin D status during Pregnancy than Serum 25(Oh)d.32the maternal 25(Oh)D level does not vary significantly during Pregnancy unless there is a change in Vitamin D intake or Endogenous Synthesis.2,33,34HOWEVER, Serum 1,25(Oh)2D levels increase by 100%–200% starting in the first trimester in both the mother and the fetus.35–37the increase in maternal 1,25(Oh)2D, which originates mostly from the Kidneys, accounts for increased Intestinal calcium absorption during Pregnancy.38,39the increase in fetal 1,25(Oh)2D level SEEMS to BE RELATED to synthesis in Placental and Fetal Tissues.39,40\nan IMPORTANT aspect of Vitamin D nutrition in Pregnancy is that the Vitamin D status of the infant at Birth and in early infancy DEPENDS ON the vitamin d status of the mother during Pregnancy.41vitamin D stores in the infant start with transplacental Transfer of 25(Oh)D in early Pregnancy from mother to fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('SUPERFICIAL_RELATIONSHIP', 357), ('SUPERFICIAL_RELATIONSHIP', 444), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 526), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 579), ('IMPORTANT_CONSIDERATION', 584), ('SUPERFICIAL_RELATIONSHIP', 593), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 816), ('ANOMALY_CURIOUS_FINDING', 1136), ('ANOMALY_CURIOUS_FINDING', 1145), ('SUPERFICIAL_RELATIONSHIP', 1148), ('IMPORTANT_CONSIDERATION', 1209), ('SUPERFICIAL_RELATIONSHIP', 1335)]	20	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0007023', 'adult organism', 91, 'adults'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 177, 'D'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 240, 'parathyroid'), ('UBERON_0000160', 'intestine', 261, 'intestinal'), ('UBERON_0004288', 'skeleton', 310, 'skeletal'), ('UBERON_0001977', 'blood serum', 378, 'serum'), ('UBERON_0001132', 'parathyroid gland', 384, 'parathyroid'), ('CHEBI_71657', 'versiconol acetate', 408, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 411, 'OH ... D'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy'), ('UBERON_0001977', 'blood serum', 544, 'serum'), ('UBERON_0001132', 'parathyroid gland', 550, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('GO_0007565', 'female pregnancy', 639, 'pregnancy'), ('UBERON_0001977', 'blood serum', 654, 'serum'), ('CHEBI_30778', 'gallic acid', 660, '25(OH)'), ('CHEBI_71657', 'versiconol acetate', 683, '25(OH)D'), ('GO_0007565', 'female pregnancy', 732, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 770, 'vitamin D'), ('GO_0042400', 'ectoine catabolic process', 790, 'endogenous synthesis'), ('UBERON_0001977', 'blood serum', 827, 'serum'), ('CHEBI_37958', 'dye', 833, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 835, '25(OH)2D'), ('CHEBI_37958', 'dye', 968, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 970, '25(OH)2D'), ('UBERON_0002113', 'kidney', 1013, 'kidneys'), ('UBERON_0000160', 'intestine', 1045, 'intestinal'), ('GO_0007565', 'female pregnancy', 1082, 'pregnancy'), ('CHEBI_37958', 'dye', 1119, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 1121, '25(OH)2D'), ('UBERON_0001987', 'placenta', 1172, 'placental'), ('UBERON_0005291', 'embryonic tissue', 1186, 'fetal tissues'), ('CHEBI_27300', 'vitamin D', 1229, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1252, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1274, 'vitamin D'), ('GO_0007567', 'parturition', 1308, 'birth'), ('GO_0007565', 'female pregnancy', 1388, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1408, 'D'), ('GO_0006412', 'translation', 1457, 'transfer'), ('CHEBI_71657', 'versiconol acetate', 1469, '25(OH)D'), ('GO_0007565', 'female pregnancy', 1486, 'pregnancy')]
PMC3702245	6/2013	S15-PMC3702245	['IN GENERAL, Cord Blood 25(Oh)D concentrations are APPROXIMATELY 60%–89% of the maternal value.11,17,35,41–47THEREFORE, maintaining optimum Vitamin D nutrition during Pregnancy is ESSENTIAL for PREVENTION of hypovitaminosis D in the fetus and Vitamin D deficiency at Birth and in early infancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 50), ('ANOMALY_CURIOUS_FINDING', 106), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('UBERON_0002240', 'spinal cord', 12, 'cord'), ('UBERON_0000178', 'blood', 17, 'blood'), ('CHEBI_71657', 'versiconol acetate', 23, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 23, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 223, 'D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('GO_0007567', 'parturition', 266, 'birth')]
PMC3702245	6/2013	S19-PMC3702245	['there is a high prevalence of Vitamin D deficiency [Serum 25(Oh) D <50 nmol/l], and as shown intable 1, most women studied (>80%) have Serum 25(Oh)D concentrations <75 nmol/l, which are CONSIDERED “INSUFFICIENT”.8mean Serum 25(Oh)D concentrations are highest and the prevalence of Vitamin D deficiency is lowest in sun-enriched populations,51,57WHILE the lowest mean Serum 25(Oh)d and the highest prevalence of Vitamin D deficiency are REPORTED in sunshine-deprived populations.16,17,50,55,56the high prevalence of low Vitamin D ASSOCIATED with sunshine deprivation and INADEQUATE corrective Vitamin D intake SHOULD RAISE PUBLIC HEALTH CONCERN about the INCREASED RISK of adverse health EFFECTS of low Vitamin D status for the mother and fetus and poor Vitamin D nutrition in the infant at Birth.']	[('INCOMPLETE_EVIDENCE', 186), ('PROBLEM_COMPLICATION', 198), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('INCOMPLETE_EVIDENCE', 436), ('SUPERFICIAL_RELATIONSHIP', 529), ('IMPORTANT_CONSIDERATION', 570), ('FUTURE_WORK', 609), ('IMPORTANT_CONSIDERATION', 616), ('IMPORTANT_CONSIDERATION', 622), ('IMPORTANT_CONSIDERATION', 654), ('SUPERFICIAL_RELATIONSHIP', 687)]	11	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH) D'), ('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_71657', 'versiconol acetate', 141, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 141, '25(OH)D'), ('UBERON_0001977', 'blood serum', 218, 'serum'), ('CHEBI_30778', 'gallic acid', 224, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 230, 'D'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('UBERON_0001977', 'blood serum', 367, 'serum'), ('CHEBI_30778', 'gallic acid', 373, '25(OH)'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 519, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 592, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 702, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 753, 'vitamin D'), ('GO_0007567', 'parturition', 790, 'birth')]
PMC3702245	6/2013	S21-PMC3702245	['a Serum 25(Oh)D concentration <25 nmol/l (10 ng/ml), which is ASSOCIATED with INCREASED RISK of osteomalacia in Adults,7is common during Pregnancy, AS INDICATED by RECENT REPORTS from many parts of the world.1for example, Serum 25(Oh)D < 25 nmol/l during Pregnancy HAS BEEN REPORTED in 17%–18% of the caucasian population in the uk,48,4961% of a mixed population in new zealand,5432%–42% in the indian population,15,4559%–84% of a nonwestern population in the netherlands,1441% of the kuwaiti population,1680% of the iranian population,17and 75% of the arab population in the united arab emirates.1HOWEVER, there are LIMITED STUDIES on the ASSOCIATION between such low levels of Vitamin D status and Skeletal integrity in Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 78), ('PROBABLE_UNDERSTANDING', 148), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 265), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 597), ('INCOMPLETE_EVIDENCE', 617), ('SUPERFICIAL_RELATIONSHIP', 640)]	10	[('UBERON_0001977', 'blood serum', 2, 'serum'), ('CHEBI_71657', 'versiconol acetate', 8, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 8, '25(OH)D'), ('UBERON_0007023', 'adult organism', 112, 'adults'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 228, '25(OH)D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 679, 'vitamin D'), ('UBERON_0004288', 'skeleton', 700, 'skeletal'), ('GO_0007565', 'female pregnancy', 722, 'pregnant')]
PMC3702245	6/2013	S30-PMC3702245	['maternal 25(Oh)D concentrations during Pregnancy was SHOWN in ONE uk STUDY48TO AFFECT childhood bone mass at nine years of age, but this WAS NOT confirmed in a larger more RECENT STUDY from the uk.61in populations where Vitamin D deficiency is very SEVERE, maternal Vitamin D deficiency during Pregnancy HAS BEEN ASSOCIATED with neonatal craniotabes62and congenital rickets.63–65taken TOGETHER, the results from OBSERVATIONAL studies SUGGEST a POSSIBLE EFFECT of low maternal 25(Oh)D during Pregnancy on Fetal Bone Development, BUT the ASSOCIATION with lower childhood bone mass is UNPROVEN.']	[('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 137), ('INCOMPLETE_EVIDENCE', 172), ('IMPORTANT_CONSIDERATION', 249), ('INCOMPLETE_EVIDENCE', 304), ('SUPERFICIAL_RELATIONSHIP', 313), ('INCOMPLETE_EVIDENCE', 385), ('INCOMPLETE_EVIDENCE', 412), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 444), ('SUPERFICIAL_RELATIONSHIP', 453), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 528), ('ANOMALY_CURIOUS_FINDING', 528), ('SUPERFICIAL_RELATIONSHIP', 536), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 582), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 582)]	19	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 9, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 476, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 479, 'OH ... D'), ('GO_0007565', 'female pregnancy', 491, 'pregnancy'), ('GO_0007631', 'feeding behavior', 504, 'fetal'), ('GO_0048539', 'bone marrow development', 510, 'bone development')]
PMC3702245	6/2013	S32-PMC3702245	['SEVERE hypocalcemia occasionally presenting as neonatal seizures is a known COMPLICATION of maternal Vitamin D deficiency during Pregnancy.66,67\n\nextraskeletal and noncalcemic COMPLICATIONS of Vitamin D deficiency during Pregnancy\nseveral Extraskeletal COMPLICATIONS of Vitamin D deficiency during Pregnancy HAVE BEEN REPORTED in the mother, fetus, and infant.']	[('IMPORTANT_CONSIDERATION', 0), ('PROBLEM_COMPLICATION', 76), ('PROBLEM_COMPLICATION', 176), ('PROBLEM_COMPLICATION', 253), ('INCOMPLETE_EVIDENCE', 308)]	5	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy'), ('UBERON_0001431', 'distal carpal bone 2', 239, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('GO_0007565', 'female pregnancy', 298, 'pregnancy')]
PMC3702245	6/2013	S45-PMC3702245	['CONSISTENT with THIS report, a systematic review and meta-analysis of seven observational studies performed between 2008 and 2011 FOUND Serum 25(Oh)D < 50 nmol/l to be ASSOCIATED with Gestational diabetes BUT with an overall lower odds ratio of 1.61 (ci 1.19–2.17).86another meta-analysis of maternal Vitamin D status and Pregnancy outcomes,87which included 24 studies up to 2012, FOUND an overall INCREASED RISK of Preeclampsia (odds ratio 2.09; ci 1.50–2.90) and Gestational diabetes (odds ratio 1.38; ci 1.12–1.70).']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 205), ('INCOMPLETE_EVIDENCE', 381), ('IMPORTANT_CONSIDERATION', 398)]	7	[('UBERON_0001977', 'blood serum', 136, 'serum'), ('CHEBI_71657', 'versiconol acetate', 142, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 142, '25(OH)D'), ('GO_0007565', 'female pregnancy', 184, 'gestational'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('GO_0007565', 'female pregnancy', 322, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 416, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 465, 'gestational')]
PMC3702245	6/2013	S51-PMC3702245	['further, there is a SUGGESTION of an ASSOCIATION between Vitamin D and Periodontal disease,90and maternal Serum 25(Oh)D < 75 nmol/l during Early Pregnancy HAS BEEN ASSOCIATED with a two-fold INCREASED risk of Periodontal disease.91in a RECENT randomized controlled TRIAL of Vitamin D supplementation from south carolina, Vitamin D supplementation of 4000 iu/day during Pregnancy was ASSOCIATED with a reduction in the risk of combined morbidities, such as Maternal infection, Preterm labor, and Preterm Birth.92\nIN VIEW of the POSSIBLE ASSOCIATION between maternal Vitamin D status and the pattern of fetal growth, pre-eclampsia, Gestational diabetes mellitus, and maternal infection, and the significant POTENTIAL for Perinatal morbidities ASSOCIATED with these conditions, evaluation of Vitamin D nutrition in early Pregnancy and the EFFECT of appropriate supplementation SEEMS WARRANTED.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 164), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 512), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 527), ('SUPERFICIAL_RELATIONSHIP', 536), ('INCOMPLETE_EVIDENCE', 705), ('SUPERFICIAL_RELATIONSHIP', 741), ('SUPERFICIAL_RELATIONSHIP', 836), ('ANOMALY_CURIOUS_FINDING', 874), ('FUTURE_WORK', 874)]	16	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001758', 'periodontium', 71, 'periodontal'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_71657', 'versiconol acetate', 112, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 112, '25(OH ... D'), ('GO_0051318', 'G1 phase', 139, 'early'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('UBERON_0001758', 'periodontium', 209, 'periodontal'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D'), ('GO_0007565', 'female pregnancy', 369, 'pregnancy'), ('GO_0007618', 'mating', 456, 'maternal'), ('GO_0007565', 'female pregnancy', 476, 'preterm'), ('GO_0007565', 'female pregnancy', 495, 'preterm'), ('GO_0007567', 'parturition', 503, 'birth'), ('CHEBI_27300', 'vitamin D', 565, 'vitamin D'), ('GO_0007565', 'female pregnancy', 630, 'gestational'), ('GO_0036268', 'swimming', 719, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 719, 'perinatal'), ('CHEBI_27300', 'vitamin D', 789, 'vitamin D'), ('GO_0007565', 'female pregnancy', 818, 'pregnancy')]
PMC3702245	6/2013	S54-PMC3702245	['Monocytes cultured in Vitamin D-deficient Plasma (Serum 25(Oh)D < 30 nmol/l) SHOWED significantly decreased Tolllike Receptor-mediated Expression of Cathelicidin (p < 0.05) compared with those conditioned in Vitamin D-sufficient Plasma (Serum 25(Oh)D > 75 nmol/l).93CONSISTENT with these in vitro FINDINGS, OBSERVATIONAL clinical DATA FOUND an ASSOCIATION between Vitamin D status in Cord Blood and the RISK of Lower Respiratory Tract infection in the first year of Life.94the risk of Respiratory syncytial Virus bronchiolitis in the first year of Life is increased by six-fold (ci 1.6–24.9) in infants with Cord Blood 25(Oh)D < 50 nmol/l compared with infants with 25(Oh)D > 75 nmol/l.']	[('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('INCOMPLETE_EVIDENCE', 297), ('INCOMPLETE_EVIDENCE', 307), ('FUTURE_WORK', 330), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 344), ('IMPORTANT_CONSIDERATION', 403)]	9	[('CL_0000576', 'monocyte', 0, 'Monocytes'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 42, 'plasma'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('PR_000001660', 'prostaglandin F2-alpha receptor', 108, 'tolllike receptor'), ('GO_0010467', 'gene expression', 135, 'expression'), ('PR_000006009', 'alpha-catulin', 149, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 229, 'plasma'), ('UBERON_0001977', 'blood serum', 237, 'serum'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 243, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 384, 'cord'), ('UBERON_0000178', 'blood', 389, 'blood'), ('UBERON_0004905', 'articulation', 411, 'lower respiratory tract'), ('UBERON_0000104', 'life cycle', 466, 'life'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory'), ('NCBITaxon_1', 'root', 507, 'virus'), ('UBERON_0000104', 'life cycle', 548, 'life'), ('UBERON_0002240', 'spinal cord', 608, 'cord'), ('UBERON_0000178', 'blood', 613, 'blood'), ('CHEBI_71657', 'versiconol acetate', 619, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 619, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 666, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 666, '25(OH)D')]
PMC3702245	6/2013	S56-PMC3702245	['IN CONTRAST, an OBSERVATIONAL study REPORTED an increased RISK of infantile eczema and pneumonia in ASSOCIATION with maternal Serum 25(Oh)D > 75 nmol/l in the last trimester.76HOWEVER, another RECENT STUDY with a larger sample size from the same institution DID NOT FIND an ASSOCIATION between maternal 25(Oh)d > 75 nmol/l in late Pregnancy and eczema or asthma at 12 months and three and six years of age.97there was no report on the ASSOCIATION between maternal Vitamin D status and Respiratory infections in the latter study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 435)]	10	[('UBERON_0001977', 'blood serum', 126, 'serum'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 303, '25(OH)'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 303, '25(OH'), ('GO_0007565', 'female pregnancy', 331, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory')]
PMC3702245	6/2013	S57-PMC3702245	['regarding Neurocognitive Development, WHILE ONE STUDY FOUND no association between maternal Vitamin D status during Pregnancy and Neurocognitive function,76a RECENT larger-sized STUDY LINKED maternal Serum 25(Oh)D levels during Pregnancy with Language Development in the offspring.98the results of the above studies SUGGEST that childhood infections, atopy, and Neurocognitive development NEED TO BE included as outcomes of interest following Vitamin D supplementation in Pregnancy, and that clinical trials SHOULD include a RELEVANT group of subjects CONSIDERED to be replete for Vitamin D.\ntaken TOGETHER, the high prevalence of Vitamin D deficiency in Pregnancy and the POSSIBLE multiple POTENTIAL adverse EFFECTS on mother and offspring IDENTIFIED in SEVERAL epidemiologic STUDIES UNDERSCORE the URGENT NEED FOR large randomized controlled TRIALS to identify the amount of Vitamin D supplementation that optimizes Vitamin D status during Pregnancy, and to DETERMINE the EFFECT of supplementation on POTENTIAL adverse conditions ASSOCIATED with Vitamin D deficiency and any POSSIBLE Vitamin D excess.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 184), ('INCOMPLETE_EVIDENCE', 316), ('FUTURE_WORK', 389), ('FUTURE_WORK', 508), ('IMPORTANT_CONSIDERATION', 525), ('IMPORTANT_CONSIDERATION', 552), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 691), ('SUPERFICIAL_RELATIONSHIP', 709), ('INCOMPLETE_EVIDENCE', 741), ('INCOMPLETE_EVIDENCE', 755), ('IMPORTANT_CONSIDERATION', 785), ('IMPORTANT_CONSIDERATION', 800), ('FUTURE_WORK', 807), ('INCOMPLETE_EVIDENCE', 807), ('FUTURE_WORK', 844), ('QUESTION_ANSWERED_BY_THIS_WORK', 960), ('SUPERFICIAL_RELATIONSHIP', 974), ('INCOMPLETE_EVIDENCE', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1077)]	26	[('GO_0007399', 'nervous system development', 10, 'neurocognitive development'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('GO_0050905', 'neuromuscular process', 130, 'neurocognitive'), ('UBERON_0001977', 'blood serum', 200, 'serum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 206, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 243, 'language development'), ('GO_0050905', 'neuromuscular process', 362, 'neurocognitive'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D'), ('GO_0007565', 'female pregnancy', 472, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 581, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 631, 'vitamin D'), ('GO_0007565', 'female pregnancy', 655, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 877, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 918, 'vitamin D'), ('GO_0007565', 'female pregnancy', 942, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1048, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1086, 'vitamin D')]
PMC3702245	6/2013	S58-PMC3702245	['Vitamin D REQUIREMENT during Pregnancy\nin ORDER TO DETERMINE the Vitamin D REQUIREMENT during Pregnancy, one NEEDS to define the target Serum 25(Oh)D concentration considered as “normal” or “optimal”.']	[('IMPORTANT_CONSIDERATION', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 42), ('IMPORTANT_CONSIDERATION', 75), ('FUTURE_WORK', 109), ('IMPORTANT_CONSIDERATION', 109)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 29, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy'), ('UBERON_0001977', 'blood serum', 136, 'serum'), ('CHEBI_71657', 'versiconol acetate', 142, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 148, 'D')]
PMC3702245	6/2013	S60-PMC3702245	['HOWEVER, a committee of Vitamin D EXPERTS99AND the Endocrine society8recommend a target Serum concentration >75 nmol/l BASED ON the AVAILABLE EVIDENCE in order to achieve optimal benefits for Skeletal health as well as POTENTIAL nonskeletal BENEFITS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 34), ('INCOMPLETE_EVIDENCE', 119), ('PROBABLE_UNDERSTANDING', 119), ('SUPERFICIAL_RELATIONSHIP', 119), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 219), ('IMPORTANT_CONSIDERATION', 241)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 51, 'Endocrine'), ('UBERON_0001977', 'blood serum', 88, 'serum'), ('UBERON_0004288', 'skeleton', 192, 'skeletal')]
PMC3702245	6/2013	S62-PMC3702245	['these RECOMMENDATIONS are based MOSTLY ON STUDIES from the us and MAY not be applicable worldwide DUE TO DIFFERENCES in baseline Vitamin D status,100particularly in populations where severe Vitamin D deficiency is PREVALENT.']	[('FUTURE_WORK', 6), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 32), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 66), ('PROBLEM_COMPLICATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('IMPORTANT_CONSIDERATION', 214)]	8	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC3702245	6/2013	S63-PMC3702245	['a review of the FEW previous randomized controlled TRIALS of Vitamin D supplementation during Pregnancy INDICATES that doses of 400–1600 iu/day were INSUFFICIENT in achieving a mean Serum 25(Oh)D concentration ≥50 nmol/l in most of the studies.41in a RECENT Vitamin D supplementation TRIAL from the uk, a multiethnic group of 180 Pregnant women were randomized at 27 weeks’ Gestation to receive a single Oral dose of 200,000 iu of Vitamin D, daily supplementation of 800 iu, or no treatment.33the median Serum 25(Oh)D concentration in the 800 iu/day group at study entry was 26 nmol/l (interquartile range 22–37), and the median 25(Oh)D concentration at delivery following supplementation was 42 nmol/l (interquartile range 31–76).']	[('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 51), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 149), ('PROBLEM_COMPLICATION', 149), ('INCOMPLETE_EVIDENCE', 251), ('INCOMPLETE_EVIDENCE', 284)]	7	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy'), ('UBERON_0001977', 'blood serum', 182, 'serum'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 188, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('GO_0007565', 'female pregnancy', 330, 'pregnant'), ('GO_0007565', 'female pregnancy', 374, 'gestation'), ('UBERON_0000165', 'mouth', 404, 'oral'), ('CHEBI_27300', 'vitamin D', 431, 'vitamin D'), ('UBERON_0001977', 'blood serum', 504, 'serum'), ('CHEBI_71657', 'versiconol acetate', 510, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 510, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 629, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 629, '25(OH)D')]
PMC3702245	6/2013	S68-PMC3702245	['these two studies and older RESEARCH41INDICATE that, in populations with a high prevalence of SEVERE Vitamin D sufficiency, supplementation up to 1600 iu/day MAY BE inadequate to achieve the RECOMMENDED target Serum 25(Oh)D concentration of 50 nmol/l.7in two RECENT STUDIES from india, which used large single-dose supplementation of 120,000 iu at the fifth and seventh month of Gestation15Or at the second and third trimester,69only 25% and 62%, respectively, achieved a Serum 25(Oh)D concentration >50 nmol/l.']	[('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 94), ('INCOMPLETE_EVIDENCE', 158), ('FUTURE_WORK', 191), ('INCOMPLETE_EVIDENCE', 259)]	5	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0001977', 'blood serum', 210, 'serum'), ('CHEBI_71657', 'versiconol acetate', 216, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 216, '25(OH)D'), ('GO_0007565', 'female pregnancy', 379, 'gestation15or'), ('UBERON_0001977', 'blood serum', 472, 'serum'), ('CHEBI_71657', 'versiconol acetate', 478, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 478, '25(OH)D')]
PMC3702245	6/2013	S70-PMC3702245	['OF NOTE, in two of the five studies, the mean concentration of 25(Oh)D after supplementation was <50 nmol/l,33,78and Serum 25(Oh)D WAS NOT MEASURED in ONE STUDY.73all these STUDIES underscore the uncertainty about the amount of Vitamin D supplementation REQUIRED to optimize Vitamin D status in Pregnancy and which would be generalizable worldwide.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 131), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 173), ('IMPORTANT_CONSIDERATION', 254)]	5	[('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 123, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('GO_0007565', 'female pregnancy', 295, 'pregnancy')]
PMC3702245	6/2013	S73-PMC3702245	['WHILE the DEBATE and studies to identify OPTIMAL Serum 25(Oh)D concentration CONTINUE, it is PRUDENT to monitor Vitamin D status and develop STRATEGIES to ensure AT LEAST a minimum Serum 25(Oh)D concentration of 50 nmol/l in Pregnant women, especially in an environment where Vitamin D deficiency is endemic.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 41), ('FUTURE_WORK', 77), ('FUTURE_WORK', 93), ('IMPORTANT_CONSIDERATION', 93), ('FUTURE_WORK', 141), ('PROBABLE_UNDERSTANDING', 162)]	8	[('UBERON_0001977', 'blood serum', 49, 'serum'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 55, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0001977', 'blood serum', 181, 'serum'), ('CHEBI_71657', 'versiconol acetate', 187, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 187, '25(OH)D'), ('GO_0007565', 'female pregnancy', 225, 'pregnant'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D')]
PMC3702245	6/2013	S74-PMC3702245	['in studies of Adults and nonpregnant women, a Vitamin D intake of up to 10,000 iu/day is ASSOCIATED with achievement of a Serum 25(Oh)D concentration ≥80 nmol/l without Vitamin D toxicity.103,104from a review of PREVIOUS STUDIES, an additional daily intake of 100 iu of Vitamin D increases the Serum 25(Oh)D concentration by 1–2 nmol/l.7,105THEREFORE, knowing the population baseline Serum 25(Oh)D concentration, IT IS POSSIBLE to ESTIMATE the Vitamin D intake REQUIRED to replete body stores and achieve an expected target Serum 25(Oh)d concentration.']	[('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 212), ('PROBABLE_UNDERSTANDING', 338), ('INCOMPLETE_EVIDENCE', 413), ('INCOMPLETE_EVIDENCE', 431), ('IMPORTANT_CONSIDERATION', 461)]	6	[('UBERON_0007023', 'adult organism', 14, 'adults'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001977', 'blood serum', 122, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 131, 'OH)D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('UBERON_0001977', 'blood serum', 294, 'serum'), ('CHEBI_71657', 'versiconol acetate', 300, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 300, '25(OH)D'), ('UBERON_0001977', 'blood serum', 384, 'serum'), ('CHEBI_33010', 'chromide(1-)', 392, '(OH)D'), ('CHEBI_27300', 'vitamin D', 444, 'vitamin D'), ('UBERON_0001977', 'blood serum', 524, 'serum'), ('CHEBI_30778', 'gallic acid', 530, '25(OH)')]
PMC3702245	6/2013	S75-PMC3702245	['because of CONTROVERSY surrounding Vitamin D REQUIREMENTS during Pregnancy, investigators from south carolina performed a comprehensive, large, randomized controlled study of Vitamin D supplementation in Pregnancy to achieve optimal Vitamin D status, DEFINED as a Serum 25(Oh)D concentration ≥80 nmol/l at Delivery.18BASED on the pharmacokinetics of Vitamin d, the authors INVESTIGATED the SAFETY and EFFECTIVENESS of high-dose Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('IMPORTANT_CONSIDERATION', 45), ('PROBABLE_UNDERSTANDING', 251), ('PROBABLE_UNDERSTANDING', 315), ('QUESTION_ANSWERED_BY_THIS_WORK', 373), ('IMPORTANT_CONSIDERATION', 390), ('SUPERFICIAL_RELATIONSHIP', 401)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('UBERON_0001977', 'blood serum', 264, 'serum'), ('CHEBI_71657', 'versiconol acetate', 270, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 270, '25(OH)D'), ('GO_0007567', 'parturition', 306, 'delivery'), ('CHEBI_33229', 'vitamin (role)', 350, 'vitamin'), ('CHEBI_27300', 'vitamin D', 428, 'vitamin D')]
PMC3702245	6/2013	S76-PMC3702245	['they HYPOTHESIZED that daily Vitamin D3Supplementation of 4000 iu/day would be more effective than 2000 iu and a standard dosing regimen of 400 iu in achieving a Serum 25(Oh)D concentration of >80 nmol/l without any safety ISSUES referable to Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 223), ('PROBLEM_COMPLICATION', 223)]	3	[('CHEBI_52915', 'phosphatediyl group', 29, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 29, 'vitamin D3supplementation'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 168, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC3702245	6/2013	S91-PMC3702245	['based on this protocol, the authors CONCLUDED that 4000 iu/day of Vitamin D3Supplementation is SAFE and MOST EFFECTIVE in achieving Vitamin D sufficiency in mothers and adequate Vitamin D status in their offspring, irrespective of ethnicity.']	[('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 95), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 109)]	4	[('CHEBI_52915', 'phosphatediyl group', 66, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 66, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC3702245	6/2013	S93-PMC3702245	['another RECENT STUDY from the united arab emirates among Pregnant arab women with a high prevalence of Vitamin D deficiency also CONFIRMED that 4000 iu/day of Vitamin D supplementation was SAFE and more EFFECTIVE than 2000 iu/day and 400 iu/day in optimizing Vitamin D status during Pregnancy and in achieving Vitamin D sufficiency at Birth in mothers and offspring.106in the united arab emirates study, the increment from baseline to Delivery was about four-fold higher than expected BASED ON previous pharmacokinetic STUDIES, POSSIBLY RELATED to low baseline Vitamin D status.100this INDICATES that baseline Vitamin D status SHOULD BE taken INTO CONSIDERATION when evaluating Vitamin D supplementation.100,107\nthe FINDINGS of these RECENT intervention STUDIES INDICATE an URGENT NEED for more randomized controlled trials in diverse geographic locations with large sample sizes to identify the Vitamin D intake REQUIRED to optimize Vitamin D status, and TO ASSESS the EFFECT on Pregnancy-related and infant-related COMPLICATIONS.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 189), ('SUPERFICIAL_RELATIONSHIP', 203), ('PROBABLE_UNDERSTANDING', 485), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 528), ('SUPERFICIAL_RELATIONSHIP', 537), ('INCOMPLETE_EVIDENCE', 586), ('FUTURE_WORK', 627), ('IMPORTANT_CONSIDERATION', 643), ('FUTURE_WORK', 648), ('INCOMPLETE_EVIDENCE', 716), ('INCOMPLETE_EVIDENCE', 734), ('INCOMPLETE_EVIDENCE', 762), ('IMPORTANT_CONSIDERATION', 774), ('FUTURE_WORK', 781), ('IMPORTANT_CONSIDERATION', 913), ('QUESTION_ANSWERED_BY_THIS_WORK', 956), ('SUPERFICIAL_RELATIONSHIP', 970), ('PROBLEM_COMPLICATION', 1017)]	21	[('GO_0007565', 'female pregnancy', 57, 'pregnant'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('GO_0007565', 'female pregnancy', 283, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D'), ('GO_0007567', 'parturition', 335, 'birth'), ('GO_0007567', 'parturition', 435, 'delivery'), ('CHEBI_27300', 'vitamin D', 561, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 610, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 896, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 934, 'vitamin D'), ('GO_0007565', 'female pregnancy', 980, 'pregnancy')]
PMC3702245	6/2013	S96-PMC3702245	['in VIEW of the high prevalence of low Vitamin D status in Pregnancy worldwide, INTERVENTION trials to identify optimal Vitamin D status and the REQUIRED SAFE Vitamin D intake COULD BE an IMPORTANT part of PUBLIC HEALTH STRATEGY to improve the health of mothers, and the short-term and long-term outcomes for their offspring.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 79), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 153), ('INCOMPLETE_EVIDENCE', 175), ('IMPORTANT_CONSIDERATION', 187), ('IMPORTANT_CONSIDERATION', 205), ('FUTURE_WORK', 219)]	8	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC3704911	7/2013	S24-PMC3704911	['additionally, Prenatal DEFICIENCIES in Vitamins D and E HAVE BEEN ASSOCIATED with increased incidences of Respiratory difficulties, including wheezing and asthma, in the offspring [7], and maternal Vitamin D deficiencies HAVE BEEN RELATED to observed hyper-Locomotion in the Adult Rat [8].']	[('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 221), ('SUPERFICIAL_RELATIONSHIP', 231)]	5	[('GO_0007565', 'female pregnancy', 14, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamins D'), ('PR_000006444', 'diacylglycerol kinase delta', 48, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 54, 'E'), ('UBERON_0001004', 'respiratory system', 106, 'respiratory'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0040011', 'locomotion', 257, 'locomotion'), ('UBERON_0007023', 'adult organism', 275, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 281, 'rat')]
PMC3705146	5/2013	S195-PMC3705146	['ALTHOUGH sunlight-induced Vitamin D is not an IMPORTANT source of Vitamin D for lower Animals, it HAS BEEN SHOWN that Prenatal dietary Vitamin D in sprague-dawley Rats has significant EFFECTS on Postnatal anxiety and social behaviors (pan et al.,2013).']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 86, 'animals'), ('GO_0007565', 'female pregnancy', 118, 'prenatal'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 163, 'rats'), ('GO_0007567', 'parturition', 195, 'postnatal')]
PMC3705146	5/2013	S217-PMC3705146	['the need for Vitamin D MAY have played an IMPORTANT ROLE in selecting for polymorphisms in a variety of light-responsive Genes, including the melanotropins.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 42), ('SUPERFICIAL_RELATIONSHIP', 52)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('SO_0000704', 'gene', 121, 'genes')]
PMC3705146	5/2013	S219-PMC3705146	['it is WELL KNOWN that a lack of Vitamin D causes rickets, which would have had a negative IMPACT the ability to perform the physical work NECESSARY to survive in historical times, BUT more IMPORTANTLY, frequently caused fatal outcomes during Delivery BECAUSE of the improper configuration of Pelvis in SEVERE rickets (harrison,1966; cruickshank,1967; konje and ladipo,2000).']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 90), ('IMPORTANT_CONSIDERATION', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 180), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 189), ('PROBLEM_COMPLICATION', 251), ('IMPORTANT_CONSIDERATION', 302)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 242, 'delivery'), ('UBERON_0002355', 'pelvic region of trunk', 292, 'pelvis')]
PMC3705146	5/2013	S226-PMC3705146	['HOWEVER, mcgrath and colleagues have ALSO SHOWN that the RELATIONSHIP between Vitamin D in Gestation and subsequent schizophrenia MAY BE COMPLEX, in that those with low maternal vitamin d are at INCREASED RISK of bearing offspring who become schizophrenic as are those with overly high Vitamin D (mcgrath et al.,2010a).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 130), ('DIFFICULT_TASK', 137), ('IMPORTANT_CONSIDERATION', 195)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'gestation'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D')]
PMC3705320	3/2013	S17-PMC3705320	['the POSSIBLE ASSOCIATION between maternal-fetal Vitamin D status and infant health outcomes MAY be particularly relevant to south asian countries such as bangladesh, where adverse Perinatal outcomes and infant mortality are PUBLIC HEALTH PRIORITIES [10], and where Vitamin D deficiency HAS BEEN observed among women of Reproductive age [11] and young infants [12].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 224), ('IMPORTANT_CONSIDERATION', 238), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0036268', 'swimming', 180, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 180, 'perinatal'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('GO_0000003', 'reproduction', 319, 'reproductive')]
PMC3705320	3/2013	S180-PMC3705320	['HOWEVER, SINCE the ROLE of pth as a Vitamin D status BIOMARKER during Pregnancy is UNCLEAR [26], the clinical significance of the APPARENT dose-response EFFECT of Vitamin D on pth REQUIRES FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 53), ('FULL_UNKNOWN', 83), ('ANOMALY_CURIOUS_FINDING', 130), ('SUPERFICIAL_RELATIONSHIP', 153), ('IMPORTANT_CONSIDERATION', 180), ('FUTURE_WORK', 189)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3705320	3/2013	S193-PMC3705320	['first, precision of ESTIMATES of Pharmacokinetic parameters and between-group comparisons, as well as the generalizability of inferences regarding maternal-fetal SAFETY of high-dose Vitamin D supplementation, were LIMITED by the SMALL number of participants, stringent inclusion/exclusion criteria, and enrolment of Pregnant and non-Pregnant participants at one clinic site.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 162), ('INCOMPLETE_EVIDENCE', 214), ('INCOMPLETE_EVIDENCE', 229)]	4	[('CHEBI_87163', 'dihydroisopentenyldehydrorhodopin', 33, 'pharmacokinetic'), ('GO_0006909', 'phagocytosis', 33, 'pharmacokinetic'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('GO_0007565', 'female pregnancy', 316, 'pregnant'), ('GO_0007565', 'female pregnancy', 333, 'pregnant')]
PMC3705320	3/2013	S204-PMC3705320	['the most direct application of the present OBSERVATIONS is to guide the design of FUTURE TRIALS of Vitamin D3 (at doses up to 35,000 iu per week) AIMED at CONFIRMING SAFETY and establishing the health benefits of Antenatal Vitamin D supplementation in south asia, where many POTENTIALLY Vitamin D-responsive outcomes (e.g., infant growth and infectious disease morbidity) are MAJOR PUBLIC HEALTH PRIORITIES.']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 146), ('PROBABLE_UNDERSTANDING', 155), ('IMPORTANT_CONSIDERATION', 166), ('INCOMPLETE_EVIDENCE', 275), ('IMPORTANT_CONSIDERATION', 376), ('IMPORTANT_CONSIDERATION', 382), ('IMPORTANT_CONSIDERATION', 396)]	9	[('CHEBI_33279', 'vitamin D5', 99, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 99, 'vitamin D3'), ('GO_0007567', 'parturition', 213, 'antenatal'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D')]
PMC3713405	7/2013	S29-PMC3713405	['EVIDENCE CONTINUES to mount from both epidemiological and pre-clinical studies to INDICATE that developmental Vitamin D (Dvd) deficiency MAY BE also an IMPORTANT developmental RISK factor for schizophrenia.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 137), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 121, 'DVD')]
PMC3713405	7/2013	S40-PMC3713405	['• schizophrenia\nNeurodevelopmental disorder ASSOCIATED with altered Dopamine function both prior to and during disease onset\n• developmental Vitamin D (Dvd) deficiency\nASSOCIATED with INCREASED susceptibility to schizophrenia\n• Dvd Rat MODEL\nDvd-deficiency in the Rat LEADS to a pattern of altered developmental and Adult Dopaminergic function\n• Vitamin D and Dopamine\nearly Vitamin D signaling is intrinsically LINKED with the developing Dopamine system\n• Animal MODELS of schizophrenia\nmultiple Animal MODELS of schizophrenia SHOW alterations in Dopamine Development prior to post-adolescent alterations in behavior\n• Dopamine and schizophrenia\nALTHOUGH FOCUS REMAINS TIED to Dopamine as a common endpoint in schizophrenia, understanding common Dopaminergic origins MAY BE\n\nthe epidemiology of vitamin d and schizophrenia\nnumerous pieces of epidemiological EVIDENCE IMPLICATE low levels of maternal Vitamin D AS a POTENTIAL risk factor for schizophrenia.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 184), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 268), ('SUPERFICIAL_RELATIONSHIP', 412), ('INCOMPLETE_EVIDENCE', 464), ('INCOMPLETE_EVIDENCE', 504), ('INCOMPLETE_EVIDENCE', 528), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 647), ('ANOMALY_CURIOUS_FINDING', 647), ('IMPORTANT_CONSIDERATION', 656), ('INCOMPLETE_EVIDENCE', 662), ('SUPERFICIAL_RELATIONSHIP', 670), ('INCOMPLETE_EVIDENCE', 768), ('INCOMPLETE_EVIDENCE', 859), ('SUPERFICIAL_RELATIONSHIP', 868), ('PROBABLE_UNDERSTANDING', 911), ('INCOMPLETE_EVIDENCE', 916)]	19	[('GO_0007285', 'primary spermatocyte growth', 16, 'Neurodevelopmental'), ('CHEBI_18243', 'dopamine', 68, 'dopamine'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 152, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 228, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 232, 'rat'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 242, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 264, 'rat'), ('UBERON_0007023', 'adult organism', 316, 'adult'), ('CHEBI_18243', 'dopamine', 322, 'dopaminergic'), ('CHEBI_28384', 'vitamin K', 346, 'Vitamin D'), ('CHEBI_18243', 'dopamine', 360, 'dopamine'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D'), ('CHEBI_18243', 'dopamine', 439, 'dopamine'), ('NCBITaxon_33208', 'Metazoa', 457, 'Animal'), ('NCBITaxon_33208', 'Metazoa', 497, 'animal'), ('CHEBI_18243', 'dopamine', 548, 'dopamine'), ('GO_0048597', 'post-embryonic camera-type eye morphogenesis', 548, 'dopamine development'), ('CHEBI_18243', 'dopamine', 620, 'Dopamine'), ('CHEBI_18243', 'dopamine', 678, 'dopamine'), ('CHEBI_18243', 'dopamine', 747, 'dopaminergic'), ('CHEBI_27300', 'vitamin D', 901, 'vitamin D')]
PMC3713405	7/2013	S49-PMC3713405	['most RECENTLY, and most IMPORTANTLY, a danish population-based case-control study (423 cases and 423 control) that directly assessed Vitamin D levels in Blood Spots from NEW born infants provided SOLID EVIDENCE SHOWING that low Prenatal Vitamin D levels are ASSOCIATED with an INCREASED RISK of schizophrenia (mcgrath et al., 2010).']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 24), ('FULL_UNKNOWN', 170), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 258), ('IMPORTANT_CONSIDERATION', 277)]	7	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 153, 'blood spots'), ('GO_0007565', 'female pregnancy', 228, 'prenatal'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC3713405	7/2013	S50-PMC3713405	['taken TOGETHER, these data SUPPORT the HYPOTHESIS that an absence of Vitamin D during development MAY lead to an INCREASED RISK of schizophrenia.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 98), ('IMPORTANT_CONSIDERATION', 113)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3713405	7/2013	S51-PMC3713405	['to establish the biological PLAUSIBILITY of WHETHER Dvd deficiency COULD BE RELATED to schizophrenia, our group ESTABLISHED a Dvd-deficient Rat MODEL which HAS SHOWN that low Prenatal Vitamin D adversely AFFECTS Brain Development and Adult behavior, ESPECIALLY da development and da-RELATED behaviors.']	[('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 204), ('IMPORTANT_CONSIDERATION', 250), ('SUPERFICIAL_RELATIONSHIP', 283)]	10	[('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 52, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 126, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 140, 'rat'), ('GO_0007565', 'female pregnancy', 175, 'prenatal'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007420', 'brain development', 212, 'brain development'), ('UBERON_0000955', 'brain', 212, 'brain'), ('UBERON_0007023', 'adult organism', 234, 'adult')]
PMC3713405	7/2013	S126-PMC3713405	['Vitamin D deficiency in the later portion of Gestation is REQUIRED to elicit this behavioral sensitivity WHEREAS Vitamin D deficiency during the early portion of Gestation has no IMPACT (o’loan et al., 2007).']	[('IMPORTANT_CONSIDERATION', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('SUPERFICIAL_RELATIONSHIP', 179)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 45, 'gestation'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007565', 'female pregnancy', 162, 'gestation')]
PMC3713405	7/2013	S211-PMC3713405	['in addition, it also SUGGESTS that FURTHER STUDY on the temporal window of Vitamin D deficiency would be EXTREMELY INFORMATIVE.']	[('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 35), ('IMPORTANT_CONSIDERATION', 105), ('INCOMPLETE_EVIDENCE', 115)]	4	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC3717170	5/2013	S2-PMC3717170	['HOWEVER, the biological significance of the Expression of the vdr in different Tissues is not FULLY understood, and the ROLE of Vitamin D in Extraskeletal health HAS been a matter of DEBATE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 94), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183)]	5	[('GO_0010467', 'gene expression', 44, 'expression'), ('UBERON_0000479', 'tissue', 79, 'tissues'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 141, 'extraskeletal')]
PMC3717170	5/2013	S13-PMC3717170	['nonclassical EFFECTS of Vitamin D\n\nVitamin D: beyond bone\nsylvia christakos (umdnj-new jersey medical school) began the meeting by summarizing the Metabolism and activity of Vitamin D and introducing the EMERGING AWARENESS of ROLES for Vitamin D beyond Calcium Homeostasis and Bone Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 204), ('IMPORTANT_CONSIDERATION', 213), ('SUPERFICIAL_RELATIONSHIP', 226)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 35, 'Vitamin D'), ('GO_0008152', 'metabolic process', 147, 'metabolism'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 253, 'calcium homeostasis'), ('GO_0006768', 'biotin metabolic process', 277, 'bone metabolism')]
PMC3717170	5/2013	S18-PMC3717170	['IN ORDER TO DETERMINE mechanisms INVOLVED in inhibition of Breast tumor growth, christakos’ lab SHOWED that C/Ebpα, a transcription factor that HAS BEEN SHOWN to play a CRITICAL ROLE in growth arrest of other cell types, is induced by 1,25(Oh)2D3In mcf-7 Human Breast cancer cells.2c/Ebpα was found to induce transcription of the Vitamin D receptor in mcf-7 cells.2since the levels of the vdr CORRELATE with the antiproliferative effects of 1,25(Oh)2D3, and since it HAS BEEN SUGGESTED that C/Ebpα CAN be considered a POTENTIAL tumor suppressor, these FINDINGS SUGGEST mechanisms whereby 1,25(Oh)2D3May act to inhibit Growth Of Breast cancer Cells.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 144), ('IMPORTANT_CONSIDERATION', 169), ('SUPERFICIAL_RELATIONSHIP', 178), ('SUPERFICIAL_RELATIONSHIP', 393), ('INCOMPLETE_EVIDENCE', 467), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 518), ('INCOMPLETE_EVIDENCE', 552), ('INCOMPLETE_EVIDENCE', 561)]	13	[('UBERON_0000310', 'breast', 59, 'breast'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 108, 'C/EBPα'), ('CHEBI_37958', 'dye', 235, '1,'), ('CHEBI_45409', 'ritonavir', 237, '25(OH)2D3in'), ('NCBITaxon_9606', 'Homo sapiens', 255, 'human'), ('UBERON_0000310', 'breast', 261, 'breast'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 284, 'EBPα'), ('CHEBI_27300', 'vitamin D', 330, 'vitamin D'), ('CHEBI_37983', 'sulfur-35 atom', 441, '1'), ('CHEBI_17996', 'chloride', 442, ','), ('CHEBI_73394', 'Ala-Ser', 443, '25(OH)2D3'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 491, 'C/EBPα'), ('CHEBI_37958', 'dye', 588, '1,'), ('CHEBI_83462', 'metolachlor OXA', 590, '25(OH)2D3may'), ('GO_0048468', 'cell development', 618, 'growth of ... cells'), ('UBERON_0000310', 'breast', 628, 'breast')]
PMC3717170	5/2013	S20-PMC3717170	['the mechanism of 1,25(Oh)2D3Suppression of Il-17 was found to be transcriptional and to involve blocking of Nuclear factor for Activated T Cells (Nfat, which is IMPORTANT for T Cell receptor–mediated transcriptional Regulation of Il-17), recruitment of Histone deacetylase to the Il-17 Promoter, and Sequestration of Runt-Related Transcription Factor 1 (runx1) by the vdr.31,25(Oh)2D3Was also FOUND to have a direct EFFECT on the induction of Foxp3, a transcription factor that ASSOCIATES with Nfat and runx1 for transcriptional repression.3THESE results DESCRIBE NOVEL mechanisms and new CONCEPTS with regard to Vitamin D and the Immune System and SUGGEST THERAPEUTIC TARGETS for the Control of Autoimmune diseases.']	[('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 393), ('SUPERFICIAL_RELATIONSHIP', 416), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 540), ('INCOMPLETE_EVIDENCE', 555), ('FULL_UNKNOWN', 564), ('INCOMPLETE_EVIDENCE', 589), ('FUTURE_WORK', 649), ('INCOMPLETE_EVIDENCE', 649), ('FUTURE_WORK', 657), ('FUTURE_WORK', 669)]	12	[('CHEBI_42976', 'L-glycero-alpha-D-manno-heptopyranose', 17, '1,25(OH)2D3suppression'), ('PR_000001470', 'interleukin-28B', 43, 'IL-17'), ('GO_0005634', 'nucleus', 108, 'nuclear'), ('CL_0002129', 'regular atrial cardiac myocyte', 127, 'activated T cells'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 146, 'NFAT'), ('CL_0000084', 'T cell', 175, 'T cell'), ('GO_0065007', 'biological regulation', 216, 'regulation'), ('PR_000001470', 'interleukin-28B', 230, 'IL-17'), ('CHEBI_15358', 'histone', 253, 'histone'), ('PR_000043452', 'core histone', 253, 'histone'), ('PR_000001470', 'interleukin-28B', 280, 'IL-17'), ('SO_0000167', 'promoter', 286, 'promoter'), ('GO_0051235', 'maintenance of location', 300, 'sequestration'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 317, 'Runt-related transcription factor 1'), ('CHEBI_73386', 'Ala-Val-Asp-Ser', 375, '25(OH)2D3was'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 443, 'Foxp3'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 494, 'NFAT'), ('CHEBI_27300', 'vitamin D', 613, 'vitamin D'), ('UBERON_0002405', 'immune system', 631, 'immune system'), ('GO_0065007', 'biological regulation', 685, 'control'), ('UBERON_0001442', 'skeleton of manus', 696, 'autoimmune')]
PMC3717170	5/2013	S40-PMC3717170	['HOWEVER, it is IMPORTANT TO RECOGNIZE that similar antibacterial responses to Vitamin D HAVE also BEEN REPORTED for OTHER cell types within Tissues, such as the skin, Lungs, Gi Tract, and Placenta, that MAY broadly be termed barrier sites .']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 15), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 203)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000479', 'tissue', 140, 'tissues'), ('UBERON_0002048', 'lung', 167, 'lungs'), ('UBERON_0000993', 'oviduct', 174, 'GI tract'), ('UBERON_0001987', 'placenta', 188, 'placenta')]
PMC3717170	5/2013	S41-PMC3717170	['THUS, IT IS POSSIBLE that Vitamin D deficiency has a generalized DETRIMENTAL IMPACT on antibacterial responses and MAY THEREFORE play a ROLE in many types of infectious diseases.5an IMPORTANT NOTE by hewison is that current data SUGGEST that this particular Immune Response to Vitamin D is restricted to Primates, UNDERLINING a POTENTIAL ROLE for Vitamin D in the evolution of Primate Immunity, BUT also LIMITING the scope of FURTHER in vivo STUDIES to explore this activity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('SUPERFICIAL_RELATIONSHIP', 136), ('IMPORTANT_CONSIDERATION', 182), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 229), ('PROBABLE_UNDERSTANDING', 314), ('INCOMPLETE_EVIDENCE', 328), ('SUPERFICIAL_RELATIONSHIP', 338), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 395), ('INCOMPLETE_EVIDENCE', 404), ('FUTURE_WORK', 426)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0006955', 'immune response', 258, 'immune response'), ('UBERON_0002405', 'immune system', 258, 'immune'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 304, 'primates'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 377, 'primate'), ('GO_0007566', 'embryo implantation', 385, 'immunity')]
PMC3717170	5/2013	S45-PMC3717170	['the extent to which Vitamin D deficiency is a cause of Immune disease has yet to be demonstrated and will REQUIRE new prospective clinical trials of Vitamin D supplementation.']	[('FUTURE_WORK', 106), ('IMPORTANT_CONSIDERATION', 106)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0002405', 'immune system', 55, 'immune'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC3717170	5/2013	S46-PMC3717170	['hewison STATED that it will be IMPORTANT to define WHETHER enhanced Vitamin D–mediated immunity prevents Immune disease OR WHETHER it CAN be used as therapy for these diseases.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('INCOMPLETE_EVIDENCE', 134)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002405', 'immune system', 105, 'immune')]
PMC3717170	5/2013	S48-PMC3717170	['these and OTHER facets of Vitamin D and Immune function will be IMPORTANT research challenges for the Vitamin D community.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 64)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0002405', 'immune system', 40, 'immune'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC3717170	5/2013	S50-PMC3717170	['WHILE the Heart and Vasculature have ONLY RECENTLY been identified as POTENTIAL targets of Vitamin D action, a GROWING body of EVIDENCE SUGGESTS that the activated vdr plays an IMPORTANT ROLE in Regulating Cardiovascular function.8first, the vdr and the ligand-generating 25-Hydroxyvitamin D31-α-hydroxylase HAVE BEEN SHOWN to be present in Cardiac Myocytes, Cardiac Fibroblasts, Vascular Smooth Muscle Cells, and Vascular Endothelial Cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 136), ('IMPORTANT_CONSIDERATION', 177), ('SUPERFICIAL_RELATIONSHIP', 187), ('INCOMPLETE_EVIDENCE', 308)]	9	[('UBERON_0000948', 'heart', 10, 'heart'), ('UBERON_0002049', 'vasculature', 20, 'vasculature'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0065007', 'biological regulation', 195, 'regulating'), ('UBERON_0004535', 'cardiovascular system', 206, 'cardiovascular'), ('CHEBI_67376', 'dihydrooroxylin A', 272, '25-hydroxyvitamin'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 290, 'D31'), ('CL_0000746', 'cardiac muscle cell', 341, 'cardiac myocytes'), ('UBERON_0000948', 'heart', 341, 'cardiac'), ('CL_0002548', 'fibroblast of cardiac tissue', 359, 'cardiac fibroblasts'), ('UBERON_0000948', 'heart', 359, 'cardiac'), ('CL_0000359', 'vascular associated smooth muscle cell', 380, 'vascular smooth muscle cells'), ('UBERON_0001135', 'smooth muscle tissue', 389, 'smooth muscle'), ('CL_0000071', 'blood vessel endothelial cell', 414, 'vascular endothelial cells'), ('UBERON_0001986', 'endothelium', 423, 'endothelial')]
PMC3717170	5/2013	S66-PMC3717170	['collectively, these data DEMONSTRATE that the Vitamin D system—specifically, the ligand-bound vdr—plays an IMPORTANT ROLE in the maintenance of Cardiovascular health and SUGGEST that Vitamin D repletion MAY have IMPORTANT PUBLIC HEALTH IMPLICATIONS in Controlling the prevalence of, and morbidity ASSOCIATED with, Cardiovascular disease.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('IMPORTANT_CONSIDERATION', 107), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 203), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 222), ('SUPERFICIAL_RELATIONSHIP', 297)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 144, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('GO_0065007', 'biological regulation', 252, 'controlling'), ('UBERON_0004535', 'cardiovascular system', 314, 'cardiovascular')]
PMC3717170	5/2013	S67-PMC3717170	['of equivalent IMPORTANCE, therapy with high potency Vitamin D Metabolites or their analogs MAY subserve an IMPORTANT ROLE in the management of these diseases.']	[('IMPORTANT_CONSIDERATION', 14), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 107), ('SUPERFICIAL_RELATIONSHIP', 117)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_25212', 'metabolite', 62, 'metabolites')]
PMC3717170	5/2013	S69-PMC3717170	["in addition, FEW randomized controlled trials HAVE BEEN conducted in Pregnant women to determine optimal Vitamin D status.13–15\ncarol l. wagner (medical university of south carolina) DISCUSSED two RECENT STUDIES performed by her group in collaboration with bruce hollis's group—the national institute of child health and Human development (nichd) Vitamin D Pregnancy trial12and the thrasher research fund Vitamin D community-based supplementation trial16—that INDICATE that 400 iu Vitamin D, the amount found in MOST Prenatal Vitamins, is INADEQUATE and that 4000 iu/day is NECESSARY to optimize 1,25(Oh)2D3Production, achieved when total circulating 25(Oh)d3is at least 40 ng/ml (fig."]	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 460), ('PROBABLE_UNDERSTANDING', 512), ('IMPORTANT_CONSIDERATION', 539), ('PROBLEM_COMPLICATION', 539), ('IMPORTANT_CONSIDERATION', 574)]	9	[('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 321, 'Human'), ('CHEBI_28384', 'vitamin K', 347, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 357, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 405, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 405, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 481, 'vitamin D'), ('GO_0007565', 'female pregnancy', 517, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 526, 'vitamins'), ('CHEBI_37983', 'sulfur-35 atom', 596, '1'), ('CHEBI_74151', 'S-palmitoyl-L-cysteine residue', 597, ',25(OH)2D3production'), ('PR_000029121', 'leucine-rich repeat and guanylate kinase domain-containing protein', 604, '2D3production'), ('CHEBI_33310', 'neon atom', 653, '(OH)')]
PMC3717170	5/2013	S73-PMC3717170	['YET, before such FINDINGS are fully EMBRACED, the mechanism(s) of action of Vitamin D and its PROTECTIVE EFFECT during Pregnancy MUST BE BETTER delineated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 105), ('IMPORTANT_CONSIDERATION', 129), ('INCOMPLETE_EVIDENCE', 137)]	8	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy')]
PMC3717170	5/2013	S74-PMC3717170	['ADDITIONAL RESEARCH that addresses the IMPACT of Vitamin D on Immune Homeostasis during Pregnancy and its EFFECTS during early infancy and later childhood becomes ESSENTIAL.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 106), ('IMPORTANT_CONSIDERATION', 163)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0055090', 'acylglycerol homeostasis', 62, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('GO_0007565', 'female pregnancy', 88, 'pregnancy')]
PMC3717170	5/2013	S76-PMC3717170	['it WAS THOUGHT for decades that Human Milk was minimally sufficient in Vitamin D;17yet, PRELIMINARY results of the RECENTLY COMPLETED nichd Vitamin D supplementation trial during Lactation SHOW that when a mother is Vitamin D replete, with an Intake of 6400 iu Vitamin D3/day, Breast Milk is replete and a breastfeeding infant has excellent Vitamin D status without infant supplementation that is COMPARABLE to combined maternal and infant supplementation of 400 iu Vitamin D3/day.18the IMPLICATIONS of SAFELY achieving vitamin d SUFFICIENCY for both mother and breastfeeding infant solely through maternal supplementation is just BEGINNING TO BE UNDERSTOOD and will LIKELY CHALLENGE researchers for decades to come.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 397), ('IMPORTANT_CONSIDERATION', 487), ('IMPORTANT_CONSIDERATION', 503), ('IMPORTANT_CONSIDERATION', 530), ('INCOMPLETE_EVIDENCE', 631), ('PROBABLE_UNDERSTANDING', 667), ('DIFFICULT_TASK', 674)]	12	[('NCBITaxon_9606', 'Homo sapiens', 32, 'human'), ('UBERON_0001913', 'milk', 38, 'milk'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007595', 'lactation', 179, 'lactation'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0007631', 'feeding behavior', 243, 'intake'), ('CHEBI_33279', 'vitamin D5', 261, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 261, 'vitamin D3'), ('UBERON_0000310', 'breast', 277, 'breast'), ('UBERON_0001913', 'milk', 284, 'milk'), ('CHEBI_27300', 'vitamin D', 341, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 466, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 466, 'vitamin D3')]
PMC3717170	5/2013	S82-PMC3717170	['the EFFECTS of the hormonal form of Vitamin D, 1,25(Oh)2D3, on Apoptotic Cell Death are MEDIATED via multiple signaling pathways that involve common regulators and Effectors CONVERGING on cellular Ca2+.19,21sergeev and colleagues HAVE SHOWN that the CRITICAL characteristic of the apoptotic Ca2+signal is a sustained increase in the concentration of Intracellular Ca2+, reaching elevated BUT NOT cytotoxic levels.22HOWEVER, 1,25(Oh)2D3-Regulated, Ca2+-dependent apoptotic molecular targets HAVE NOT BEEN IDENTIFIED in Adipose Tissue.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 230), ('IMPORTANT_CONSIDERATION', 250), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('ANOMALY_CURIOUS_FINDING', 392), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('FULL_UNKNOWN', 490)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_72779', '11-trans-LTE4', 47, '1,25(OH)2D3'), ('CL_0000445', 'apoptosis fated cell', 63, 'apoptotic cell'), ('GO_0006915', 'apoptotic process', 63, 'apoptotic cell death'), ('CHEBI_35224', 'effector', 164, 'effectors'), ('CHEBI_29108', 'calcium(2+)', 197, 'Ca2+.'), ('CHEBI_29108', 'calcium(2+)', 291, 'Ca2+'), ('GO_0005622', 'intracellular anatomical structure', 350, 'intracellular'), ('CHEBI_3312', 'calcium dichloride', 364, 'Ca2+,'), ('CHEBI_17996', 'chloride', 425, ','), ('CHEBI_73394', 'Ala-Ser', 426, '25(OH)2D3'), ('GO_0065007', 'biological regulation', 436, 'regulated'), ('CHEBI_81233', 'Schizonepetoside B', 447, 'Ca2+-'), ('UBERON_0001013', 'adipose tissue', 518, 'adipose tissue')]
PMC3717170	5/2013	S92-PMC3717170	['ADDITIONAL STUDIES ARE WARRANTED to evaluate this approach from a safety POINT OF VIEW and to identify the OPTIMAL levels of Calcium and Vitamin D intakes in obesity.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 73), ('IMPORTANT_CONSIDERATION', 107)]	4	[('CHEBI_22313', 'alkaline earth metal atom', 125, 'calcium'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC3717170	5/2013	S115-PMC3717170	['IMPACT of Cholecalciferol repletion on Erythropoietin requirements in Hemodialysis patients\nlily li (cleveland clinic lerner college of medicine of case western reserve university and mount sinai school of medicine) presented pilot data from a randomized control trial investigating the IMPACT of Cholecalciferol repletion on Erythropoietin REQUIREMENTS in Vitamin D–deficient hemodialysis patients.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 287), ('IMPORTANT_CONSIDERATION', 341)]	3	[('CHEBI_52550', 'theopalauamide', 10, 'cholecalciferol'), ('CHEBI_24009', 'eumelanin', 39, 'erythropoietin'), ('GO_0030097', 'hemopoiesis', 70, 'hemodialysis'), ('CHEBI_52550', 'theopalauamide', 297, 'cholecalciferol'), ('CHEBI_24009', 'eumelanin', 326, 'erythropoietin'), ('CHEBI_27300', 'vitamin D', 357, 'vitamin D')]
PMC3717170	5/2013	S125-PMC3717170	['they have INITIATED a randomized controlled trial of 25(Oh)D3Repletion in Vitamin D–deficient hemodialysis patients TO EVALUATE efficacy and SAFETY and the EFFECTS on inflammation and esa REQUIREMENTS.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 116), ('IMPORTANT_CONSIDERATION', 141), ('SUPERFICIAL_RELATIONSHIP', 156), ('IMPORTANT_CONSIDERATION', 188)]	5	[('CHEBI_76706', 'EC 6.1.* (C-O bond-forming ligase) inhibitor', 53, '25(OH)D3repletion'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 53, '25(OH'), ('PR_000006494', 'disrupted in schizophrenia 1 protein', 59, 'D3repletion'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC3717170	5/2013	S132-PMC3717170	['translating epidemiological data into policy and clinical applications\n\nVitamin D for diabetes\nanastassios g. pittas (tufts medical center) HIGHLIGHTED the POTENTIALLY IMPORTANT ROLE of Vitamin D in a variety of non-Skeletal medical conditions, including type 2 diabetes.']	[('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 156), ('IMPORTANT_CONSIDERATION', 168), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('CHEBI_28384', 'vitamin K', 72, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('UBERON_0004288', 'skeleton', 216, 'skeletal')]
PMC3717170	5/2013	S136-PMC3717170	['in Humans, the ROLE of Vitamin D in type 2 diabetes is SUGGESTED by a large NUMBER OF cross-sectional STUDIES that have CONSISTENTLY FOUND an inverse ASSOCIATION between Vitamin D status and prevalent hyperglycemia, including a REPORTED seasonal variation in the Control Of Glycemia in patients with diabetes, being worse in the winter when hypovitaminosis d is more prevalent.35in the MAJORITY of longitudinal OBSERVATIONAL studies, lower Vitamin D status is also ASSOCIATED with INCREASED RISK of incident type 2 diabetes.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 120), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 150), ('INCOMPLETE_EVIDENCE', 228), ('PROBABLE_UNDERSTANDING', 386), ('INCOMPLETE_EVIDENCE', 411), ('SUPERFICIAL_RELATIONSHIP', 465), ('IMPORTANT_CONSIDERATION', 481)]	11	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('GO_0006936', 'muscle contraction', 263, 'control of glycemia'), ('CHEBI_27300', 'vitamin D', 440, 'vitamin D')]
PMC3717170	5/2013	S139-PMC3717170	['HOWEVER, pittas CAUTIONED that one SHOULD RESIST making inferences on the basis of OBSERVATIONAL studies BECAUSE of the POSSIBILITY of CONFOUNDING ISSUES, which MAY BE especially TRUE when assessing Vitamin D status, BECAUSE WHILE 25(Oh)D3Concentration is an excellent MARKER of good health many of the VARIABLES that CONTRIBUTE to 25(Oh)d3concentration (e.g., skin pigmentation, physical inactivity, Aging, unhealthy dietary patterns) are also RISK FACTORS for the development of diabetes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 83), ('PROBLEM_COMPLICATION', 105), ('INCOMPLETE_EVIDENCE', 120), ('PROBLEM_COMPLICATION', 135), ('PROBLEM_COMPLICATION', 147), ('INCOMPLETE_EVIDENCE', 161), ('PROBABLE_UNDERSTANDING', 179), ('PROBABLE_UNDERSTANDING', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('SUPERFICIAL_RELATIONSHIP', 269), ('SUPERFICIAL_RELATIONSHIP', 303), ('SUPERFICIAL_RELATIONSHIP', 318), ('SUPERFICIAL_RELATIONSHIP', 445)]	18	[('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 231, '25(OH)D3concentration'), ('CHEBI_30778', 'gallic acid', 332, '25(OH)'), ('GO_0007568', 'aging', 401, 'aging')]
PMC3717170	5/2013	S140-PMC3717170	['THEREFORE, EVIDENCE from intervention studies—which is the most DIRECT EVIDENCE—is CRITICALLY IMPORTANT before one can conclude that Vitamin D has a ROLE in the prevention or treatment of diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 83), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 149)]	7	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC3717170	5/2013	S141-PMC3717170	['the results from SMALL clinical trials and post hoc analyses of larger trials on the EFFECT of Vitamin D supplementation on diabetes-related parameters HAVE BEEN INCONCLUSIVE, although Vitamin D APPEARS to have beneficial EFFECTS in Persons AT RISK for diabetes.36–39HOWEVER, no firm conclusions can be drawn from the available intervention studies BECAUSE of several LIMITATIONS: (1) NEARLY ALL studies were UNDERPOWERED; (2) the MINORITY of studies were designed specifically for Glycemic outcomes; (3) MOST STUDIES DID NOT REPORT use of diabetes medications at baseline or during the study; (4) SOME TRIALS used large infrequent doses of Vitamin D, which MAY BE Metabolized DIFFERENTLY compared to daily doses and MAY provide EITHER no benefit OR result in an UNFAVORABLE benefit/risk ratio.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('ANOMALY_CURIOUS_FINDING', 195), ('SUPERFICIAL_RELATIONSHIP', 222), ('IMPORTANT_CONSIDERATION', 241), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('PROBLEM_COMPLICATION', 349), ('INCOMPLETE_EVIDENCE', 368), ('PROBLEM_COMPLICATION', 368), ('PROBABLE_UNDERSTANDING', 385), ('PROBLEM_COMPLICATION', 409), ('INCOMPLETE_EVIDENCE', 431), ('INCOMPLETE_EVIDENCE', 505), ('INCOMPLETE_EVIDENCE', 518), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 658), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 677), ('INCOMPLETE_EVIDENCE', 717), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 729), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 747), ('IMPORTANT_CONSIDERATION', 763)]	23	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'persons'), ('GO_0006096', 'glycolytic process', 482, 'glycemic'), ('CHEBI_27300', 'vitamin D', 641, 'vitamin D'), ('GO_0008152', 'metabolic process', 665, 'metabolized')]
PMC3717170	5/2013	S142-PMC3717170	['pittas CONCLUDED that ALTHOUGH the OBSERVATION studies STRONGLY SUGGEST an IMPORTANT ROLE for Vitamin D in type 2 diabetes, and such a ROLE is biologically PLAUSIBLE, there is LACK OF EVIDENCE from intervention studies to SUPPORT the CONTENTION that type 2 diabetes CAN be improved or PREVENTED by raising 25(Oh)D3Concentration.']	[('INCOMPLETE_EVIDENCE', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 55), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 85), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 156), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('INCOMPLETE_EVIDENCE', 266), ('SUPERFICIAL_RELATIONSHIP', 285)]	16	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 306, '25(OH)D3concentration'), ('PR_000005058', 'extracellular calcium-sensing receptor', 306, '25(OH ... D3concentration')]
PMC3717170	5/2013	S143-PMC3717170	['on numerous earlier occasions, encouraging findings from observational studies were NOT CONFIRMED by well-designed clinical trials (e.g., hormone replacement therapy, β-Carotene, Vitamins C and E, and Folic Acid) and prevailing clinical practice was OVERTURNED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('IMPORTANT_CONSIDERATION', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 250)]	3	[('CHEBI_23042', 'carotene', 169, 'carotene'), ('CHEBI_27300', 'vitamin D', 179, 'vitamins C'), ('PR_000004900', 'complement C3', 188, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 194, 'E'), ('CHEBI_30751', 'formic acid', 201, 'folic acid')]
PMC3717170	5/2013	S146-PMC3717170	['this is a topic of clinical significance BECAUSE myopathy characterized by proximal muscle weakness and atrophy is a common symptom in Vitamin D deficiency states.40the loss of muscular strength and a reduction in muscle mass increases the RISK of falls and LEADS to fractures.']	[('PROBABLE_UNDERSTANDING', 41), ('IMPORTANT_CONSIDERATION', 240), ('SUPERFICIAL_RELATIONSHIP', 258)]	3	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D')]
PMC3717170	5/2013	S155-PMC3717170	['alterations in these mechanisms during Vitamin D deficiency states MAY account for Skeletal muscle weakness, in VIEW of the KEY ROLE that Ca2+plays in the Regulation of Contractility.']	[('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 112), ('IMPORTANT_CONSIDERATION', 124), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0004288', 'skeleton', 83, 'skeletal'), ('CHEBI_29108', 'calcium(2+)', 138, 'Ca2+'), ('GO_0065007', 'biological regulation', 155, 'regulation'), ('GO_0006936', 'muscle contraction', 169, 'contractility')]
PMC3717170	5/2013	S164-PMC3717170	['indeed, beyond its ROLES in bone health and Calcium Homeostasis, Vitamin D AFFECTS many OTHER physiological domains that are CRITICALLY modified by Aging.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('IMPORTANT_CONSIDERATION', 125)]	4	[('GO_0055073', 'cadmium ion homeostasis', 44, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007568', 'aging', 148, 'aging')]
PMC3717170	5/2013	S165-PMC3717170	['UNFORTUNATELY, the QUESTION of WHETHER Vitamin D PREVENTS OR slows Aging cannot be easily tested.']	[('IMPORTANT_CONSIDERATION', 0), ('EXPLICIT_QUESTION', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58)]	5	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007568', 'aging', 67, 'aging')]
PMC3717170	5/2013	S171-PMC3717170	['there is STRONG EVIDENCE that obesity is ASSOCIATED with POOR Vitamin D status due to fat sequestration.48in fact, compared with the non-obese, higher doses of Vitamin D are REQUIRED in obese Individuals.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 174)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('NCBITaxon_1', 'root', 192, 'individuals')]
PMC3717170	5/2013	S174-PMC3717170	['the IMPORTANCE of Vitamin D for muscle HAS BEEN discussed at length.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 39)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC3717170	5/2013	S182-PMC3717170	["low Vitamin D levels HAVE BEEN ASSOCIATED with accelerated Cognitive decline in epidemiological studies, and low Vitamin D dietary intake is ASSOCIATED with INCREASED risk of alzheimer's disease and depression.53,54mechanisms SUGGESTED for this ASSOCIATION include β-Amyloid formation/aggregation, Dysregulation of Gabaergic activity and nmda receptor, and increased calcium Entry Into Neurons."]	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 141), ('IMPORTANT_CONSIDERATION', 157), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 245)]	6	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0050890', 'cognition', 59, 'cognitive'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_60425', 'amyloid fibril', 267, 'amyloid'), ('GO_0060233', 'oenocyte delamination', 298, 'dysregulation'), ('CHEBI_86629', 'G b H', 315, 'GABAergic'), ('GO_0046897', 'N-terminal peptidyl-tyrosine methylation', 375, 'entry into neurons'), ('CL_0000540', 'neuron', 386, 'neurons')]
PMC3717170	5/2013	S186-PMC3717170	['RECOMMENDATIONS for the appropriate amount of Vitamin D to be taken for OPTIMAL health—BE it for Musculoskeletal strength OR for the numerous nonskeletal presumptive benefits of Vitamin D—remain contentious.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 72), ('ANOMALY_CURIOUS_FINDING', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 97, 'musculoskeletal'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC3717170	5/2013	S187-PMC3717170	['there is GENERAL CONSENSUS that the earlier RECOMMENDATION of 400 iu of Vitamin D/day was INSUFFICIENT.']	[('PROBABLE_UNDERSTANDING', 9), ('FUTURE_WORK', 44), ('IMPORTANT_CONSIDERATION', 90), ('PROBLEM_COMPLICATION', 90)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC3717170	5/2013	S191-PMC3717170	['the iom EXPERT panel CONCLUDED that MOST americans (97.5%) had adequate levels of Vitamin D, BASED ON their CONCLUSION that a 25(Oh)d3of 20 ng/ml or greater was sufficient, RAISING the QUESTION of WHETHER supplementation was EVEN NEEDED.']	[('PROBABLE_UNDERSTANDING', 8), ('INCOMPLETE_EVIDENCE', 21), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 93), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 173), ('EXPLICIT_QUESTION', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('EXPLICIT_QUESTION', 197), ('ANOMALY_CURIOUS_FINDING', 225), ('IMPORTANT_CONSIDERATION', 230)]	12	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 126, '25(OH)')]
PMC3717170	5/2013	S206-PMC3717170	['conclusions\nthe conference “Vitamin D: beyond bone” explo-red a considerable range of functions for Vitamin D and POTENTIAL therapeutic IMPLICATIONS outside of Calcium Homeostasis and bone health, HIGHLIGHTING the INCREASED UNDERSTANDING of Vitamin D, as well as HOW much is yet to be Learned.']	[('INCOMPLETE_EVIDENCE', 114), ('IMPORTANT_CONSIDERATION', 136), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 214), ('EXPLICIT_QUESTION', 263)]	5	[('CHEBI_28384', 'vitamin K', 28, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 28, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 160, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('GO_0007612', 'learning', 285, 'learned')]
PMC3717170	5/2013	S207-PMC3717170	['the scope of Vitamin D research and its therapeutic POSSIBILITIES, as presented by researchers across many different disciplines, generated enthusiasm TEMPERED with SOME SKEPTICISM.']	[('INCOMPLETE_EVIDENCE', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 165), ('IMPORTANT_CONSIDERATION', 170)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC3717170	5/2013	S208-PMC3717170	['CONTINUING RESEARCH IS NEEDED to BETTER UNDERSTAND the RELATIONSHIPS between Vitamin D and Extraskeletal health and to determine the OPTIMAL dose of Vitamin D for Individuals BASED ON age, health conditions, and other FACTORS.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 133), ('SUPERFICIAL_RELATIONSHIP', 175), ('SUPERFICIAL_RELATIONSHIP', 218)]	8	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 91, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('NCBITaxon_1', 'root', 163, 'individuals')]
PMC3717763	8/2013	S9-PMC3717763	['this scheme provides low-income families in the uk with fixed-value Food vouchers and vitamin coupons for eligible women and young children.1vitamin coupons can be exchanged for branded hs vitamin tablets for women (70\u2005mg Vitamin C, 10\u2005µg Vitamin D and 400\u2005µg Folic Acid daily during Pregnancy, and one year Postpartum) and drops for children (233\u2005µg Vitamin A, 20\u2005µg Vitamin C, and 7.5\u2005µg Vitamin D3 daily between\n\ncaption (boxed-text)\nwhat is already known on THIS topic\ncurrent uk GUIDANCE is that vulnerable groups of Pregnant and breastfeeding women and young children SHOULD take Vitamin Supplements (including Vitamins A, c and d) to protect against the greater RISK of Birth defects and poor health outcomes in later Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 462), ('FUTURE_WORK', 484), ('FUTURE_WORK', 574), ('IMPORTANT_CONSIDERATION', 669)]	4	[('CHEBI_33290', 'food', 68, 'food'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('CHEBI_30751', 'formic acid', 260, 'folic acid'), ('GO_0007565', 'female pregnancy', 284, 'pregnancy'), ('GO_0007565', 'female pregnancy', 308, 'postpartum'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin C'), ('CHEBI_33279', 'vitamin D5', 390, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 390, 'vitamin D3'), ('GO_0007565', 'female pregnancy', 522, 'pregnant'), ('CHEBI_33229', 'vitamin (role)', 586, 'vitamin'), ('CHEBI_33341', 'titanium atom', 594, 'supplements'), ('CHEBI_27300', 'vitamin D', 617, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 626, 'A'), ('GO_0007567', 'parturition', 677, 'birth'), ('UBERON_0000104', 'life cycle', 725, 'life')]
PMC3717763	8/2013	S18-PMC3717763	["in RECENT YEARS, there HAS BEEN particular CONCERN about Vitamin D levels among children in the uk, and the rise in Vitamin D deficiency disease, presenting as rickets, symptomatic hypocalcaemia and motor delay.5–12vitamin d is hard to source through diet alone; 90% comes from exposure to sunlight.13if the mother's Vitamin D status is low during Pregnancy, the infant will also have low levels.14estimates CONSISTENTLY SHOW that the MAJORITY of uk children aged between 1.5 and 3\u2005years do not get their daily reference Nutrient intake of Vitamin D.15–18one RECENT STUDY REPORTS that supplying hs Vitamins to all Pregnant women and young children resulted in a substantial reduction in symptomatic Vitamin D deficiency in children in one primary care trust (pct), where 75% of the population were from ethnic minority groups PARTICULARLY AT RISK of Vitamin D deficiency.19\nTHIS PAPER reports on research with parents and professionals with the AIM of understanding WHY the provision of free hs Vitamins has not resulted in higher levels of use among low income families in england."]	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 43), ('PROBABLE_UNDERSTANDING', 408), ('INCOMPLETE_EVIDENCE', 421), ('PROBABLE_UNDERSTANDING', 435), ('INCOMPLETE_EVIDENCE', 559), ('INCOMPLETE_EVIDENCE', 572), ('IMPORTANT_CONSIDERATION', 826), ('IMPORTANT_CONSIDERATION', 839), ('QUESTION_ANSWERED_BY_THIS_WORK', 874), ('QUESTION_ANSWERED_BY_THIS_WORK', 945), ('EXPLICIT_QUESTION', 966)]	13	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin D'), ('GO_0007565', 'female pregnancy', 348, 'pregnancy'), ('CHEBI_33284', 'nutrient', 521, 'nutrient'), ('CHEBI_27300', 'vitamin D', 540, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 598, 'vitamins'), ('GO_0007565', 'female pregnancy', 614, 'pregnant'), ('CHEBI_27300', 'vitamin D', 699, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 850, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 995, 'vitamins')]
PMC3717763	8/2013	S109-PMC3717763	['reports SUGGEST that less than half the midwives and health visitors are aware of the current uk Vitamin D GUIDELINES for ages under 5 years, and RECOMMEND supplementation to parents.29–31additionally, THIS STUDY INDICATES that workload pressures and infrequent contact with mothers CAN also discourage them from promoting hs Vitamins.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 107), ('FUTURE_WORK', 146), ('QUESTION_ANSWERED_BY_THIS_WORK', 202), ('INCOMPLETE_EVIDENCE', 213), ('INCOMPLETE_EVIDENCE', 283)]	6	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 105, 'D'), ('CHEBI_33277', 'gamma-tocotrienol', 326, 'vitamins')]
PMC3728489	7/2013	S164-PMC3728489	['fat-soluble Vitamins A and D play IMPORTANT ROLES in both Cell-Mediated and humoral Immune Responses (wintergerst et al.,2007).']	[('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 27, 'D'), ('GO_0000911', 'cytokinesis by cell plate formation', 58, 'cell-mediated ... immune responses'), ('UBERON_0002405', 'immune system', 84, 'immune')]
PMC3728489	7/2013	S311-PMC3728489	['Vitamin D\nwe have DESCRIBED earlier HOW Vitamin D is PIVOTAL in early Immune Development and it is also known to be CRUCIAL for early Skeletal Development.']	[('INCOMPLETE_EVIDENCE', 18), ('EXPLICIT_QUESTION', 36), ('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 116)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0001822', 'kidney development', 70, 'immune development'), ('UBERON_0002405', 'immune system', 70, 'immune'), ('GO_0001501', 'skeletal system development', 134, 'skeletal development'), ('UBERON_0004288', 'skeleton', 134, 'skeletal')]
PMC3728489	7/2013	S312-PMC3728489	['it HAS BEEN PROPOSED, THOUGH NOT PROVEN, that low levels of Vitamin D during Pregnancy and infancy COULD increase the RISK of Neurodevelopmental disorders, and that supplementation COULD play a ROLE in prevention.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 118), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 194)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0007399', 'nervous system development', 126, 'neurodevelopmental')]
PMC3728489	7/2013	S317-PMC3728489	['NOTABLY, breastfed infants are at ESPECIALLY high RISK of Vitamin D deficiency DUE TO POOR penetrance of Vitamin D Metabolites in milk (kovacs,2013; thiele et al.,2013).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 34), ('IMPORTANT_CONSIDERATION', 50), ('PROBABLE_UNDERSTANDING', 79), ('IMPORTANT_CONSIDERATION', 86), ('PROBLEM_COMPLICATION', 86)]	7	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_25212', 'metabolite', 115, 'metabolites')]
PMC3734354	7/2013	S43-PMC3734354	['WHILE many Nutrients have a ROLE to play in Brain Development, certain ones SEEM TO BE of particular IMPORTANCE during fetal and neonatal life: protein, iron, zinc, Selenium, Iodine, Folate, Vitamin A, Choline, and Long-Chain polyunsaturated Fatty Acids (lcpufas) (georgieff,2007).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 76), ('IMPORTANT_CONSIDERATION', 101)]	4	[('CHEBI_33284', 'nutrient', 11, 'nutrients'), ('GO_0007420', 'brain development', 44, 'brain development'), ('UBERON_0000955', 'brain', 44, 'brain'), ('CHEBI_27568', 'selenium atom', 165, 'selenium'), ('CHEBI_24859', 'iodine atom', 175, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 183, 'folate'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin A'), ('CHEBI_15354', 'choline', 202, 'choline'), ('CHEBI_28911', 'cob(III)alamin', 215, 'long-chain'), ('CHEBI_35366', 'fatty acid', 242, 'fatty acids')]
PMC3739737	8/2013	S14-PMC3739737	['introduction\nVitamin D deficiency is PREVALENT in the Adult population[1]and there is a GROWING body of EVIDENCE SHOWING that Vitamin D has an IMPACT on Brain function[2],[3].']	[('IMPORTANT_CONSIDERATION', 37), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 143)]	4	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0007023', 'adult organism', 54, 'adult'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('UBERON_0000955', 'brain', 153, 'brain')]
PMC3739737	8/2013	S145-PMC3739737	['FUTURE RESEARCH SHOULD investigate the POTENTIAL ROLE of Vitamin D-deficiency on Gaba, and POSSIBLE IMPLICATIONS on Cognition.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100)]	6	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_16865', 'gamma-aminobutyric acid', 81, 'GABA'), ('GO_0050890', 'cognition', 116, 'cognition')]
PMC3739737	8/2013	S160-PMC3739737	['the lack of a marked behavioural phenotype in the avd MODEL in the male sprague-dawley Rat MAY have IMPORTANT IMPLICATIONS for FUTURE Animal models exploring the biological mechanisms that MAY underpin the epidemiological ASSOCIATIONS between low Vitamin D and adverse Brain outcomes.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 110), ('FUTURE_WORK', 127), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 222)]	7	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 87, 'rat'), ('NCBITaxon_33208', 'Metazoa', 134, 'animal'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('UBERON_0000955', 'brain', 269, 'brain')]
PMC3739737	8/2013	S176-PMC3739737	['FURTHER REFINEMENTS to the MODEL, such as combined with second hit exposures, MAY BE NECESSARY to MORE adequately MODEL the EFFECTS of Vitamin D deficiency in Human populations.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 85), ('ANOMALY_CURIOUS_FINDING', 98), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 124)]	8	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 159, 'human')]
PMC3742894	7/2013	S27-PMC3742894	['to improve the nutritional status (the MAJOR cause of anemia in Pregnancy) of ethiopian women, there HAVE BEEN several interventions by the ministry of health through its essential nutrition action plan (ena), consisting of supplementation of three major Nutrients (Vitamin A, Iron, and Iodine) and other promotive activities to improve maternal and child nutrition (18).']	[('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 101)]	2	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('CHEBI_33284', 'nutrient', 255, 'nutrients'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin A'), ('CHEBI_24870', 'ion', 277, 'iron'), ('CHEBI_24859', 'iodine atom', 287, 'iodine')]
PMC3760821	9/2013	S16-PMC3760821	['introduction\nit is WELL ESTABLISHED that Vitamin D plays a primary ROLE in bone health, with SEVERE Vitamin D deficiency KNOWN to cause rickets in children and osteomalacia in Adults[1].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 93), ('INCOMPLETE_EVIDENCE', 121)]	4	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0007023', 'adult organism', 176, 'adults')]
PMC3760821	9/2013	S28-PMC3760821	['this APPARENT rise in 1,25(Oh)2D has LED TO the SUGGESTION that Pregnant women MAY REQUIRE higher cellular exposure to active Vitamin D during the second and third trimesters, and HAS BEEN interpreted by SOME as PROVIDING EVIDENCE for its POTENTIAL ROLE in obstetric well-Being[8].']	[('ANOMALY_CURIOUS_FINDING', 5), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 79), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 180), ('INCOMPLETE_EVIDENCE', 204), ('PROBABLE_UNDERSTANDING', 212), ('INCOMPLETE_EVIDENCE', 222), ('INCOMPLETE_EVIDENCE', 239), ('SUPERFICIAL_RELATIONSHIP', 249)]	11	[('CHEBI_17996', 'chloride', 23, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 24, '25(OH)2D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0016441', 'posttranscriptional gene silencing', 271, '-being')]
PMC3760821	9/2013	S35-PMC3760821	['IMPORTANTLY, this cohort was largely of white european origin and THEREFORE, less AT RISK of Vitamin D deficiency[15]; furthermore, the authors counselled that their FINDINGS SHOULD NOT BE taken to mean that individual 25Ohd concentrations are not an IMPORTANT DETERMINANT of bone health, and, moreover, that their study WAS NOT designed to examine non-bone health outcomes[14].']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 166), ('FUTURE_WORK', 175), ('ANOMALY_CURIOUS_FINDING', 186), ('IMPORTANT_CONSIDERATION', 251), ('SUPERFICIAL_RELATIONSHIP', 261), ('INCOMPLETE_EVIDENCE', 321), ('ANOMALY_CURIOUS_FINDING', 325)]	10	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 219, '25OHD')]
PMC3760821	9/2013	S42-PMC3760821	['women with t1dm have an INCREASED RISK of Pregnancy complications including; Miscarriage, congenital malformations, macrosomia, still Birth, pre-term Birth and pre-eclampsia[22], SOME of which HAVE BEEN REPORTED to be ASSOCIATED with Vitamin D deficiency in Pregnancy.']	[('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 218)]	4	[('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 77, 'miscarriage'), ('GO_0007567', 'parturition', 134, 'birth'), ('GO_0007567', 'parturition', 150, 'birth'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('GO_0007565', 'female pregnancy', 258, 'pregnancy')]
PMC3760821	9/2013	S112-PMC3760821	['SIMILAR TO maternal Vitamin D levels, the neonates had a high incidence of 25Ohd deficiency at Birth, with 28–32% exhibiting SEVERE deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 125)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 75, '25OHD'), ('GO_0007567', 'parturition', 95, 'birth')]
PMC3760821	9/2013	S155-PMC3760821	['the FINDINGS of THE CURRENT STUDY that, in women with t1dm, low Vitamin D levels are EVIDENCED throughout Gestation are IN AGREEMENT with PREVIOUS GROUPS who HAVE reported compromised Vitamin D status in Pregnancy[5].']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 138), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'gestation'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy')]
PMC3760821	9/2013	S160-PMC3760821	['EVEN given the LACK OF EVIDENCE SUPPORTING a causal LINK between low Vitamin D and a range of non-bone health outcomes, assessment and supplementation are ESSENTIAL with respect to the optimal bone health of both mother and off-spring.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 52), ('IMPORTANT_CONSIDERATION', 155)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3760821	9/2013	S165-PMC3760821	['in 2011, the uk scientific advisory committee on nutrition decided, based on NEW DATA, including the iom report of dietary reference values, that there is now SUFFICIENT evidence for an update on Vitamin D, which is expected june 2014[3].']	[('FULL_UNKNOWN', 77), ('FUTURE_WORK', 81), ('IMPORTANT_CONSIDERATION', 159), ('IMPORTANT_CONSIDERATION', 159)]	4	[('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC3760821	9/2013	S173-PMC3760821	['a KEY FINDING of THE CURRENT STUDY is that in t1dm Pregnancy, maternal Vitamin D levels EXHIBIT an INDEPENDENT inverse RELATIONSHIP with hba1clevels.']	[('IMPORTANT_CONSIDERATION', 2), ('INCOMPLETE_EVIDENCE', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ANOMALY_CURIOUS_FINDING', 88), ('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 119)]	6	[('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3760821	9/2013	S181-PMC3760821	['clearly, prospective clinical randomised controlled trials of Vitamin D supplementation ARE REQUIRED TO evaluate and CLARIFY the ASSOCIATION between Vitamin D status and Glycaemic Control in t1dm Pregnancy.']	[('FUTURE_WORK', 88), ('IMPORTANT_CONSIDERATION', 92), ('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('FUTURE_WORK', 117), ('SUPERFICIAL_RELATIONSHIP', 129)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0051162', 'L-arabitol metabolic process', 170, 'glycaemic control'), ('GO_0007565', 'female pregnancy', 196, 'pregnancy')]
PMC3760821	9/2013	S185-PMC3760821	['GIVEN the SAFETY of Vitamin D, the low cost of supplementation and its REQUIREMENT for OPTIMAL bone health (and POTENTIALLY other health outcomes) in both the mother and off-spring, the FINDINGS of THE CURRENT STUDY SUPPORT the case for determining Vitamin D status and, IF NECESSARY, administering Vitamin D in t1dm pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('IMPORTANT_CONSIDERATION', 71), ('IMPORTANT_CONSIDERATION', 87), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 186), ('QUESTION_ANSWERED_BY_THIS_WORK', 198), ('INCOMPLETE_EVIDENCE', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 271), ('IMPORTANT_CONSIDERATION', 274)]	10	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC3773018	4/2013	S19-PMC3773018	['HOWEVER, FINDINGS regarding the combined EFFECTS of Prenatal and Postnatal Vitamin D status on fs, two of the most CRITICAL periods for Immune System Development (19,20), are UNCLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 175)]	5	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('GO_0007567', 'parturition', 65, 'postnatal'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0002520', 'immune system development', 136, 'immune system development'), ('UBERON_0002405', 'immune system', 136, 'immune system')]
PMC3773018	4/2013	S59-PMC3773018	['INTERESTINGLY, when low Vitamin D at Birth was followed by sufficient Vitamin D in early childhood, children carrying the c Allele were not at an INCREASED RISK for fs (or=1.26, 95%ci: 0.65–2.43).']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 146)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007567', 'parturition', 37, 'birth'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('SO_0001023', 'allele', 124, 'allele')]
PMC3773018	4/2013	S63-PMC3773018	['OUR FINDINGS SUGGEST that both Prenatal and early Postnatal Vitamin D levels APPEAR TO play an IMPORTANT ROLE in the development of fs, ESPECIALLY among those with specific genotypes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('ANOMALY_CURIOUS_FINDING', 77), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 136)]	6	[('GO_0007565', 'female pregnancy', 31, 'prenatal'), ('GO_0007567', 'parturition', 50, 'postnatal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3773018	4/2013	S64-PMC3773018	['the MAJORITY of the Vitamin D REQUIREMENT for MOST People in the u.s. is achieved through both sun exposure and fortified Food or Vitamin D nutritional supplements.']	[('PROBABLE_UNDERSTANDING', 4), ('IMPORTANT_CONSIDERATION', 30), ('PROBABLE_UNDERSTANDING', 46)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 51, 'people'), ('CHEBI_33290', 'food', 122, 'food'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3773018	4/2013	S71-PMC3773018	['insufficient Vitamin D status is UNDESIRABLE from many viewpoints, ESPECIALLY BECAUSE of its IMPACT on bone health and Immune function.']	[('IMPORTANT_CONSIDERATION', 33), ('IMPORTANT_CONSIDERATION', 67), ('PROBLEM_COMPLICATION', 78), ('SUPERFICIAL_RELATIONSHIP', 93)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0002405', 'immune system', 119, 'immune')]
PMC3773018	4/2013	S74-PMC3773018	['the FINDINGS from THIS extended STUDY EMPHASIZE the IMPORTANT ROLE of Postnatal Vitamin D status in the development of fs.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('IMPORTANT_CONSIDERATION', 38), ('IMPORTANT_CONSIDERATION', 52), ('SUPERFICIAL_RELATIONSHIP', 62)]	6	[('GO_0007567', 'parturition', 70, 'postnatal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC3773018	4/2013	S75-PMC3773018	['children who had very low Vitamin D status at Birth but had sufficient Vitamin D during their early Life had no risk or a lower RISK of fs; WHILE children who were exposed to persistently low Vitamin D both pre- and post-Natally had the highest risk of fa (table 3).']	[('IMPORTANT_CONSIDERATION', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('GO_0007567', 'parturition', 221, 'natally')]
PMC3773018	4/2013	S82-PMC3773018	['OF NOTE, OUR FINDINGS from the stratified analyses SUGGESTED stronger ASSOCIATIONS between low Vitamin D status and high RISK of fs among children Born Preterm, which NEEDS to be FURTHER explored in a larger sample.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 70), ('IMPORTANT_CONSIDERATION', 121), ('IMPORTANT_CONSIDERATION', 167), ('FUTURE_WORK', 179), ('INCOMPLETE_EVIDENCE', 179)]	8	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007567', 'parturition', 147, 'born'), ('GO_0007565', 'female pregnancy', 152, 'preterm')]
PMC3773018	4/2013	S84-PMC3773018	['among subjects carrying the c Allele of rs2243250, persistently low Vitamin D status dramatically increased the RISK of fs, WHILE sufficient Vitamin D status during early childhood attenuated the risk of Perinatal Vitamin D deficiency on fs to null.']	[('IMPORTANT_CONSIDERATION', 112), ('ANOMALY_CURIOUS_FINDING', 124)]	2	[('SO_0001023', 'allele', 30, 'allele'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0036268', 'swimming', 204, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 204, 'perinatal'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3773018	4/2013	S86-PMC3773018	['it SHOULD BE NOTED that four Snps SHOWED significant INTERACTION EFFECTS with Vitamin D deficiency at Birth on fs in our PREVIOUS report (18).']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 121)]	6	[('SO_0000694', 'SNP', 29, 'SNPs'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'birth')]
PMC3773018	4/2013	S103-PMC3773018	['FUTURE laboratory STUDIES also SHOULD BE SERIOUSLY CONSIDERED to help BETTER UNDERSTAND the molecular basis UNDERLYING HOW the immunomodulatory EFFECT of Vitamin D and Regulatory EFFECT of the Il4 Gene on Ige Production JOINTLY INFLUENCE the risk of fs.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 41), ('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 108), ('EXPLICIT_QUESTION', 119), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 179), ('SUPERFICIAL_RELATIONSHIP', 220), ('SUPERFICIAL_RELATIONSHIP', 228)]	12	[('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0065007', 'biological regulation', 168, 'regulatory'), ('PR_000008989', 'interleukin-1 family member 7', 193, 'IL4'), ('SO_0000704', 'gene', 197, 'gene'), ('GO_0032631', 'interleukin-27 production', 205, 'IgE production'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 205, 'IgE')]
PMC3773018	4/2013	S105-PMC3773018	['overall, THIS STUDY UNDERSCORES THE NEED to simultaneously CONSIDER both Cord Blood and Postnatal Vitamin D levels, along with Genetic susceptibility, in the development of fs and Food allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 32), ('FUTURE_WORK', 36), ('FUTURE_WORK', 59), ('IMPORTANT_CONSIDERATION', 59)]	6	[('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('GO_0007567', 'parturition', 88, 'postnatal'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('SO_0000704', 'gene', 127, 'genetic'), ('CHEBI_33290', 'food', 180, 'food')]
PMC3798907	8/2013	S16-PMC3798907	['BASED ON these FINDINGS, there HAVE BEEN CALLS FOR trials of Vitamin E based intervention during Pregnancy [14].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 41)]	8	[('CHEBI_27300', 'vitamin D', 61, 'vitamin E'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy')]
PMC3798907	8/2013	S17-PMC3798907	['ALTHOUGH keen to conduct such an intervention trial we considered it IMPORTANT to conduct PRELIMINARY work to justify/REFUTE the use of Vitamin E supplements for several reasons.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 69), ('INCOMPLETE_EVIDENCE', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118)]	4	[('CHEBI_27300', 'vitamin D', 136, 'vitamin E')]
PMC3798907	8/2013	S65-PMC3798907	['significant p values for differences in responses between paired samples in cultures with or without Vitamin E supplementation are shown on the RELEVANT panels.nutrients-05-03337-t001_table 1\n\ncaption (table-wrap): table 1\n\nsummary table representing the mean responses of cbmc and Peripheral Blood Mononuclear Cell (Pbmc) samples to control stimuli and Allergens, after supplementation with Vitamin E or Vitamin C. the mean change in response is shown for 70 cbmc samples and 18 pbmc samples, after supplementation with Vitamin E, and for 51 cbmc and 18 pbmc samples, after supplementation with Vitamin C. significant p values for differences in responses between paired samples in cultures with or without Vitamin E/Vitamin C supplementation are shown on the RELEVANT panels.Vitamin eprolififn-γil-4il-10Tgf-βvitamin cprolififn-γil-4il-10tgf-β cordcord tg↑ p< 0.05↓ p< 0.05↓↓↑tg↑↑↑ p< 0.05↓↓hdm↓↓↓↓↑hdm↓↑↑↓ p< 0.05↓con a↓↑↓↓↑con a↓ p< 0.05↑↑↓↓ppd↓ p< 0.001↓↑↓↑ppd↓↑ p< 0.05↑ p< 0.05↓ p< 0.05↓klh↓ p< 0.001↓↓↓↑klh↓↑↑ p< 0.05↓↓ adultadult tg↓↑↑↑↑tg↑ p< 0.05↑↑↓↑hdm↓↑↑↑↑ p< 0.05hdm↓↑↑↓↑con a↓↓↑↓↑ p< 0.05con a↑↓ p< 0.05↑↓ p< 0.05↑ppd↑↓↑↓↑ppd↓↑↑↓↑klh↓↓↑↑↑klh↓↑↑ p< 0.05↓↑\noverall, there was a TREND for Antigen or allergen cbmc cultures supplemented with Vitamin E to exhibit decreased secretion of the cytokines Ifn-Γ, il-10 and Il-4 (figure 1andtable 1), ALTHOUGH Production Of Tgf-Β did NOT fit this pattern and was GENERALLY increased.']	[('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 1191), ('ANOMALY_CURIOUS_FINDING', 1355), ('ANOMALY_CURIOUS_FINDING', 1388), ('PROBABLE_UNDERSTANDING', 1417)]	6	[('CHEBI_27300', 'vitamin D', 101, 'vitamin E'), ('CL_0000111', 'peripheral neuron', 282, 'peripheral blood mononuclear cell'), ('UBERON_0012101', 'perinatal stage', 282, 'peripheral blood'), ('GO_0031097', 'medial cortex', 299, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 317, 'PBMC'), ('CHEBI_33663', 'cyclic hydrocarbon', 354, 'allergens'), ('CHEBI_27300', 'vitamin D', 392, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 405, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 521, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 596, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 708, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 718, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 777, 'Vitamin'), ('PR_000000037', 'BMP receptor type-2', 803, '-10TGF'), ('CHEBI_59132', 'antigen', 1201, 'antigen'), ('CHEBI_27300', 'vitamin D', 1253, 'vitamin E'), ('PR_000008920', 'interferon alpha-7', 1311, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 1328, 'IL-4'), ('GO_0036309', 'protein localization to M-band', 1364, 'production of TGF-β'), ('PR_000000046', 'TGF-beta', 1378, 'TGF-β')]
PMC3798907	8/2013	S78-PMC3798907	['significant p values for differences in responses between paired samples in cultures with or without Vitamin E supplementation are shown on the RELEVANT panels.']	[('IMPORTANT_CONSIDERATION', 144)]	1	[('CHEBI_27300', 'vitamin D', 101, 'vitamin E')]
PMC3798907	8/2013	S81-PMC3798907	['significant p values for differences in responses between paired samples in cultures with or without Vitamin C supplementation are shown on the RELEVANT panels.']	[('IMPORTANT_CONSIDERATION', 144)]	1	[('CHEBI_27300', 'vitamin D', 101, 'vitamin C')]
PMC3798907	8/2013	S89-PMC3798907	['significant p values for differences in responses between paired samples in cultures with or without Vitamin C supplementation are shown on the RELEVANT panels.']	[('IMPORTANT_CONSIDERATION', 144)]	1	[('CHEBI_27300', 'vitamin D', 101, 'vitamin C')]
PMC3798907	8/2013	S107-PMC3798907	['this is an IMPORTANT differential result because, together with the between-subject variation and the COMPLEX EFFECTS on Cytokine Production, it INDICATES that the observed in vivo epidemiological ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc responses and childhood asthma/wheeze cannot be EXPLAINED by a direct and CONSISTENT EFFECT on overall th-cell responsiveness, as originally HYPOTHESISED [22].']	[('IMPORTANT_CONSIDERATION', 11), ('DIFFICULT_TASK', 102), ('SUPERFICIAL_RELATIONSHIP', 110), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 197), ('PROBABLE_UNDERSTANDING', 317), ('INCOMPLETE_EVIDENCE', 343), ('SUPERFICIAL_RELATIONSHIP', 354), ('INCOMPLETE_EVIDENCE', 410)]	9	[('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 121, 'cytokine production'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin E'), ('GO_0007565', 'female pregnancy', 250, 'pregnancy')]
PMC3798907	8/2013	S110-PMC3798907	['this CONCERN is SUPPORTED by the RECENT report that high-dose Antenatal Vitamin C and E supplementation is ASSOCIATED with increased infant healthcare utilisation and cost of care [23].']	[('IMPORTANT_CONSIDERATION', 5), ('PROBLEM_COMPLICATION', 5), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 107)]	5	[('GO_0007567', 'parturition', 62, 'antenatal'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 86, 'E')]
PMC3798907	8/2013	S129-PMC3798907	['the single supplemental Vitamin E dose was chosen because it would be representative, in a general population, of a clinically RELEVANT Vitamin E intervention resulting in a minimal twofold increase in Cord Blood Α-Tocopherol.']	[('IMPORTANT_CONSIDERATION', 127)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin E'), ('UBERON_0002240', 'spinal cord', 202, 'cord'), ('UBERON_0000178', 'blood', 207, 'blood'), ('CHEBI_27725', 'butin', 213, 'α-tocopherol')]
PMC3798907	8/2013	S153-PMC3798907	['this DISPARITY, in conjunction with RECENT Antenatal intervention DATA [21] EMPHASISES the COMPLEX nature of ASSOCIATIONS between Nutrients and disease and the NEED carefully to CONSIDER the nature of any Vitamin E based Antenatal intervention intended to reduce the LIKELIHOOD of childhood asthma.']	[('ANOMALY_CURIOUS_FINDING', 5), ('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 76), ('DIFFICULT_TASK', 91), ('SUPERFICIAL_RELATIONSHIP', 109), ('FUTURE_WORK', 160), ('FUTURE_WORK', 178), ('PROBABLE_UNDERSTANDING', 267)]	10	[('GO_0007567', 'parturition', 43, 'antenatal'), ('CHEBI_33284', 'nutrient', 130, 'nutrients'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin E'), ('GO_0007567', 'parturition', 221, 'antenatal')]
PMC3809191	1/2013	S53-PMC3809191	['THIS EVIDENCE is CONSISTENT with low Vitamin D levels in either Pregnant or non-Pregnant Individuals in our country as in the rest of the world.11,12HOWEVER we did not FIND significant association of low levels of Serum 25 (Oh) D with elevated RISK for gdm EVEN after adjustment for conventional risk FACTORS for diabetes.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 168), ('IMPORTANT_CONSIDERATION', 244), ('ANOMALY_CURIOUS_FINDING', 257), ('SUPERFICIAL_RELATIONSHIP', 301)]	8	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('GO_0007565', 'female pregnancy', 80, 'pregnant'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('UBERON_0001977', 'blood serum', 214, 'serum'), ('CHEBI_71657', 'versiconol acetate', 220, '25 (OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 220, '25 (OH) D')]
PMC3809191	1/2013	S54-PMC3809191	['data RELATING Vitamin D status to gdm RISK are INCONSISTENT and LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('IMPORTANT_CONSIDERATION', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 64)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D')]
PMC3809191	1/2013	S55-PMC3809191	['in ONE cross-sectional STUDY, Serum 25(Oh) D levels during 24-28 weeks of Gestation were lower in gdm women than in nondiabetic Pregnant women.9in ANOTHER STUDY, maternal Serum 25 (Oh) D concentrations measured at the time of gdm screening test were significantly and inversely ASSOCIATED with fasting glucose, ALTHOUGH the ASSOCIATION of Vitamin D with gdm risk was not statistically significant.8our FINDINGS are also CONSISTENT with a study in an indian population, SHOWING no significant ASSOCIATION between 25 (Oh) D concentrations (at 30 weeks of Gestation) and gdm risk.6\ndeficiency of Vitamin D was shown to be ASSOCIATED with fetal and Brain growth deficiency and type 1 diabetes in children.13significantly reduced risk of type 1 Diabetes Mellitus Development was FOUND when high doses of Vitamin D supplementation (up to 2000 iu/d) were given during infancy in a Birth-cohort study.14\nVitamin D deficiency was also ASSOCIATED with INCREASED risk for Pregnancy complications and SERIOUS health PROBLEMS in the offspring.5,15-17higher risks of Preeclampsia and cesarean section ratios were shown in Pregnants with low levels of Vitamin D.16,17moreover supplementation of Vitamin D HAS BEEN DEMONSTRATED to decrease the RISK of Preeclampsia by 27% in a STUDY.18\n\ncaption (fig): fig.1\n\nthe correlation between Serum Vitamin D and pth levels\n\ncaption (fig): fig.2\n\nSerum Vitamin D levels in veiled and nonveiled Pregnant\n\ncaption (fig): fig.3\n\nVitamin D levels and the frequency of muscle cramps (x²=3.57, p=0.05).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 278), ('ANOMALY_CURIOUS_FINDING', 311), ('SUPERFICIAL_RELATIONSHIP', 324), ('INCOMPLETE_EVIDENCE', 402), ('INCOMPLETE_EVIDENCE', 420), ('INCOMPLETE_EVIDENCE', 469), ('SUPERFICIAL_RELATIONSHIP', 492), ('SUPERFICIAL_RELATIONSHIP', 619), ('INCOMPLETE_EVIDENCE', 774), ('SUPERFICIAL_RELATIONSHIP', 926), ('IMPORTANT_CONSIDERATION', 942), ('IMPORTANT_CONSIDERATION', 989), ('IMPORTANT_CONSIDERATION', 1004), ('INCOMPLETE_EVIDENCE', 1190), ('IMPORTANT_CONSIDERATION', 1228), ('INCOMPLETE_EVIDENCE', 1261)]	19	[('UBERON_0001977', 'blood serum', 30, 'serum'), ('CHEBI_71657', 'versiconol acetate', 36, '25(OH) D'), ('PR_000008838', 'serine protease HTRA1', 36, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('GO_0007565', 'female pregnancy', 128, 'pregnant'), ('UBERON_0001977', 'blood serum', 171, 'serum'), ('CHEBI_71657', 'versiconol acetate', 177, '25 (OH) D'), ('PR_000009880', 'Lon protease, mitochondrial', 177, '25 ... OH ... D'), ('CHEBI_28384', 'vitamin K', 339, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 339, 'Vitamin'), ('CHEBI_71657', 'versiconol acetate', 512, '25 (OH) D'), ('GO_0007565', 'female pregnancy', 553, 'gestation'), ('CHEBI_27300', 'vitamin D', 593, 'vitamin D'), ('UBERON_0000955', 'brain', 645, 'brain'), ('GO_1903709', 'uterine gland development', 740, 'diabetes mellitus development'), ('CHEBI_27300', 'vitamin D', 799, 'vitamin D'), ('GO_0007567', 'parturition', 874, 'birth'), ('CHEBI_28384', 'vitamin K', 896, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 961, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 1053, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 1108, 'pregnants'), ('CHEBI_28384', 'vitamin K', 1137, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 1180, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 1236, 'preeclampsia'), ('UBERON_0001977', 'blood serum', 1317, 'serum'), ('CHEBI_28384', 'vitamin K', 1323, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1323, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 1371, 'Serum'), ('CHEBI_28384', 'vitamin K', 1377, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1377, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1418, 'pregnant'), ('CHEBI_28384', 'vitamin K', 1450, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1450, 'Vitamin D')]
PMC3809191	1/2013	S64-PMC3809191	['ALTHOUGH there is NO CONSENSUS for routine Vitamin D screening in Pregnancy, being ALERT about the vitamin\xa0d deficiency and its symptoms and optimising when NECESSARY by replacement and/or through taking lifestyle measures MAY BE RECOMMENDED to prevent the Birth of Vitamin D-deficient infants from Vitamin D-deficient mothers.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('IMPORTANT_CONSIDERATION', 83), ('IMPORTANT_CONSIDERATION', 157), ('INCOMPLETE_EVIDENCE', 223), ('FUTURE_WORK', 230)]	7	[('CHEBI_28384', 'vitamin K', 43, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('GO_0007567', 'parturition', 257, 'birth'), ('CHEBI_28384', 'vitamin K', 266, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 266, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC3814422	10/2013	S10-PMC3814422	['introduction\nVitamin D MAY play an IMPORTANT ROLE in normal fetal Lung and Immune System Development1And there is increasing SPECULATION that maternal Vitamin D status in Pregnancy MIGHT be causally LINKED to the development of asthma and atopy in the offspring.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0006266', 'DNA ligation', 66, 'lung ...'), ('UBERON_0002048', 'lung', 66, 'lung'), ('GO_0002415', 'immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor', 75, 'immune system development1and'), ('UBERON_0002405', 'immune system', 75, 'immune system'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy')]
PMC3814422	10/2013	S11-PMC3814422	['it HAS BEEN ARGUED that maternal Vitamin D deficiency MIGHT, AT LEAST IN PART, EXPLAIN the rising PREVALENCE of asthma and allergic disease in SOME countries2.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 61), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 79), ('IMPORTANT_CONSIDERATION', 98), ('INCOMPLETE_EVIDENCE', 143)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3814422	10/2013	S12-PMC3814422	['HOWEVER, an OPPOSING argument holds that the increasing PREVALENCE of asthma and atopy MAY BE PARTLY a consequence of the fortification of childhood Foods with Vitamin D and HENCE high Vitamin D status in early childhood3–7.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('IMPORTANT_CONSIDERATION', 56), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 94), ('PROBABLE_UNDERSTANDING', 174)]	6	[('CHEBI_33290', 'food', 149, 'foods'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3814422	10/2013	S14-PMC3814422	['HOWEVER, a MAJOR LIMITATION of these studies is that diet makes a relatively minor CONTRIBUTION to total Vitamin D status, which is derived largely from Photosynthesis in the skin.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 11), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0006654', 'phosphatidic acid biosynthetic process', 153, 'photosynthesis')]
PMC3814422	10/2013	S15-PMC3814422	['HENCE, the value of analysing dietary Vitamin D intake alone AS a means of EFFECTIVELY establishing the INFLUENCE of Vitamin D on outcomes HAS BEEN QUESTIONED as it leads to considerable MISCLASSIFICATION of total exposure.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 61), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 139), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('PROBLEM_COMPLICATION', 187)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC3814422	10/2013	S119-PMC3814422	['furthermore, from a PUBLIC HEALTH perspective Maternal Pregnancy Vitamin D as a risk FACTOR for future offspring atopy or Respiratory health would only be of MAJOR IMPORTANCE IF it was relevant to most of the population and not ONLY those members at the extremes.']	[('IMPORTANT_CONSIDERATION', 20), ('SUPERFICIAL_RELATIONSHIP', 85), ('IMPORTANT_CONSIDERATION', 158), ('IMPORTANT_CONSIDERATION', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ANOMALY_CURIOUS_FINDING', 228)]	6	[('GO_0007618', 'mating', 46, 'maternal'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 122, 'respiratory')]
PMC3814422	10/2013	S121-PMC3814422	['IT IS POSSIBLE that this is a POOR MARKER of Vitamin D levels over Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 30), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy')]
PMC3814422	10/2013	S133-PMC3814422	['HOWEVER, given that Vitamin D intake is a POOR PROXY for total Vitamin D status11, APPARENT ASSOCIATIONS with dietary Vitamin D MAY HAVE BEEN CONFOUNDED by OTHER dietary or non-dietary factors which had not been controlled for in those Birth cohort studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 42), ('PROBLEM_COMPLICATION', 42), ('SUPERFICIAL_RELATIONSHIP', 47), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 132), ('DIFFICULT_TASK', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	11	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007567', 'parturition', 236, 'birth')]
PMC3820434	12/2012	S377-PMC3820434	['a POSSIBLE EXPLANATION MAY BE that upon Oral Consumption, circulating and Intracellular levels of Resveratrol in Humans are much lower than that of OTHER IMPORTANT Antioxidants, such as Vitamin C, Uric Acid, Vitamin E, and Glutathione.']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('IMPORTANT_CONSIDERATION', 154)]	5	[('UBERON_0000165', 'mouth', 40, 'oral'), ('GO_0007631', 'feeding behavior', 45, 'consumption'), ('GO_0005622', 'intracellular anatomical structure', 74, 'intracellular'), ('CHEBI_27881', 'resveratrol', 98, 'resveratrol'), ('NCBITaxon_9606', 'Homo sapiens', 113, 'humans'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 164, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin C'), ('CHEBI_27226', 'uric acid', 197, 'uric acid'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin E'), ('CHEBI_16856', 'glutathione', 223, 'glutathione')]
PMC3821254	4/2013	S66-PMC3821254	['[10] Ascorbic Acid (Vitamin C) is an IMPORTANT Intracellular Reducing Agent.']	[('IMPORTANT_CONSIDERATION', 37)]	1	[('CHEBI_2874', 'Asimicin', 5, 'Ascorbic acid'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin C'), ('GO_0005622', 'intracellular anatomical structure', 47, 'intracellular'), ('CHEBI_63247', 'reducing agent', 61, 'reducing agent')]
PMC3827489	10/2013	S6-PMC3827489	['in conclusion, given the IMPORTANT ROLE of Vitamin D in childhood health, more time spent in outdoor activity (for sunlight exposure) and Vitamin D supplementation MAY be NECESSARY for optimal health in infants, children, and adolescents.']	[('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 171)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC3827489	10/2013	S8-PMC3827489	['DEFICIENCY of Vitamin D causes osteomalacia, leading to growth retardation and Skeletal deformities in children and osteoporosis in Adults1).']	[('IMPORTANT_CONSIDERATION', 0)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0004288', 'skeleton', 79, 'skeletal'), ('UBERON_0007023', 'adult organism', 132, 'adults1')]
PMC3827489	10/2013	S13-PMC3827489	['in the Liver, vitamin d3is converted to 25-Hydroxyvitamin D (25[Oh]D), the MAJOR circulating form and BEST INDICATOR of Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 75), ('IMPORTANT_CONSIDERATION', 102), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('UBERON_0002107', 'liver', 7, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 40, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 61, '25[OH]D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3827489	10/2013	S21-PMC3827489	['the wide variety of nonskeletal diseases in which Vitamin D is IMPORTANT include Cardiovascular diseases3), obesity4), Metabolic syndrome5), Insulin resistance6), infection7), allergy8,9), some forms of cancers10-12), and Autoimmune diseases13).']	[('IMPORTANT_CONSIDERATION', 63)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 81, 'cardiovascular'), ('GO_0008152', 'metabolic process', 119, 'metabolic'), ('PR_000045358', 'insulin family protein', 141, 'insulin'), ('UBERON_0001442', 'skeleton of manus', 222, 'autoimmune')]
PMC3827489	10/2013	S24-PMC3827489	['there are SEVERAL epidemiologic STUDIES SUGGESTING that Vitamin D plays an IMPORTANT ROLE in the prevention and management of various pediatric diseases.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 40), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 85)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC3827489	10/2013	S25-PMC3827489	['THUS, given the IMPORTANT ROLE of Vitamin D in childhood health, THIS REVIEW will FOCUS on the IMPACT of Vitamin D on health and disease in childhood and Adolescence.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('SUPERFICIAL_RELATIONSHIP', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('SUPERFICIAL_RELATIONSHIP', 95)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 154, 'adolescence')]
PMC3827489	10/2013	S33-PMC3827489	['IN LINE WITH THESE data, a study FOCUSING on adolescents aged 12-13 years REPORTED that 98.9% of boys and 100% of girls showed Vitamin D insufficiency or deficiency; 5.3% had 25(Oh)D insufficiency (20.0-29.9 ng/ml), 94.2% had deficient concentrations (<20.0 ng/ml), and ONLY 1 boy (1.1%) had OPTIMAL concentrations of 25(Oh)d6).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('INCOMPLETE_EVIDENCE', 74), ('ANOMALY_CURIOUS_FINDING', 270), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 292)]	7	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 175, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 318, '25(OH')]
PMC3827489	10/2013	S39-PMC3827489	['seasonal variability has an IMPORTANT IMPACT on Vitamin D status24); the Vitamin D levels are lowest in winter, compared with spring, summer, and autumn20)BECAUSE MOST Vitamin D is produced following exposure to sunlight.']	[('IMPORTANT_CONSIDERATION', 28), ('SUPERFICIAL_RELATIONSHIP', 38), ('PROBABLE_UNDERSTANDING', 155), ('PROBABLE_UNDERSTANDING', 163)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC3827489	10/2013	S44-PMC3827489	['girls are at particular RISK for low Vitamin D status, which HAS BEEN ASCRIBED to lifestyle factors such as frequent use of sunscreen or coverage of skin by clothing that COULD AFFECT cutaneous Synthesis Of Vitamin D6).']	[('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 61), ('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0034205', 'amyloid-beta formation', 194, 'synthesis of ... D6'), ('CHEBI_33237', 'vitamin D4', 207, 'vitamin D6'), ('PR_000017299', 'VIP peptides', 207, 'vitamin D6')]
PMC3827489	10/2013	S50-PMC3827489	['Vitamin D insufficiency/deficiency and childhood bone health\nthe CRITICAL ROLE of Vitamin D in Skeletal mineralization was the FIRST of its physiological functions to be IDENTIFIED.']	[('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 170)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0001501', 'skeletal system development', 95, 'skeletal'), ('UBERON_0004288', 'skeleton', 95, 'skeletal')]
PMC3827489	10/2013	S53-PMC3827489	['the MAJOR ROLE of Vitamin D in maintaining bone health is to ensure normal calcium and phosphate levels in the Blood.']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 10)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000178', 'blood', 111, 'blood')]
PMC3827489	10/2013	S61-PMC3827489	['THUS, it is IMPORTANT to maintain sufficient Serum Vitamin D levels in order to enhance normal Calcification of the Growth Plate and bone mineralization.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 12)]	2	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0051301', 'cell division', 95, 'calcification'), ('UBERON_0002516', 'epiphyseal plate', 116, 'growth plate')]
PMC3827489	10/2013	S63-PMC3827489	['Vitamin D insufficiency/deficiency and Respiratory diseases\nemerging EVIDENCE SUGGESTS that Vitamin D plays an ESSENTIAL ROLE in the Modulation Of the Immune Responses.']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 111), ('SUPERFICIAL_RELATIONSHIP', 121)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001004', 'respiratory system', 39, 'respiratory'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0006880', 'intracellular sequestering of iron ion', 133, 'modulation of ... immune responses'), ('UBERON_0002405', 'immune system', 151, 'immune')]
PMC3827489	10/2013	S65-PMC3827489	['THUS, the QUESTION has BEEN RAISED as to WHETHER Vitamin D status INFLUENCES the RISK of Respiratory Tract infections such as common Viral infections or Pulmonary tuberculosis in children.']	[('PROBABLE_UNDERSTANDING', 0), ('EXPLICIT_QUESTION', 10), ('ANOMALY_CURIOUS_FINDING', 23), ('EXPLICIT_QUESTION', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('EXPLICIT_QUESTION', 41), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 81)]	8	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 89, 'respiratory tract'), ('NCBITaxon_1', 'root', 133, 'viral'), ('UBERON_0002048', 'lung', 153, 'pulmonary')]
PMC3827489	10/2013	S68-PMC3827489	['SEVERAL STUDIES conducted in DIFFERENT ethnic groups have FOUND a close ASSOCIATION between Vitamin D deficiency and an INCREASED RISK of tuberculosis43-45).']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 120)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3827489	10/2013	S69-PMC3827489	['in addition, a RECENT meta-analysis FOUND that low Serum levels of Vitamin D were ASSOCIATED with a high RISK of active tuberculosis46).']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 82), ('IMPORTANT_CONSIDERATION', 105)]	4	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC3827489	10/2013	S73-PMC3827489	['another RECENT STUDY SHOWED that lower Vitamin D levels in 86 children with SEVERE, therapy-resistant asthma in the united kingdom were ASSOCIATED with worsened asthma Control and Lung function49).']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 76), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0065007', 'biological regulation', 168, 'control'), ('UBERON_0002048', 'lung', 180, 'lung')]
PMC3827489	10/2013	S79-PMC3827489	['SOME obesity-related health consequences HAVE BEEN CORRELATED with Vitamin D deficiency or insufficiency5,52-54), and RECENT reports have SUGGESTED that Vitamin D supplementation MAY reduce these RISKS, ALTHOUGH the data are INCONSISTENT55,56).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 179), ('IMPORTANT_CONSIDERATION', 196), ('ANOMALY_CURIOUS_FINDING', 203), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225)]	9	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3827489	10/2013	S82-PMC3827489	['OTHER EVIDENCE SUGGESTS that low dietary Vitamin D and decreased sun exposure DUE to fewer outdoor activities are RISK FACTORS for the low Vitamin D levels OBSERVED in obese subjects4,20).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 78), ('SUPERFICIAL_RELATIONSHIP', 114), ('INCOMPLETE_EVIDENCE', 156)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC3827489	10/2013	S87-PMC3827489	['taken TOGETHER, THESE FINDINGS SUGGEST that PUBLIC HEALTH INTERVENTIONS such as outdoor activity and Vitamin D supplementation, which enhance Vitamin D status, MAY improve the health of adolescents with Metabolic PROBLEMS.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 44), ('FUTURE_WORK', 58), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 213)]	7	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0008152', 'metabolic process', 203, 'metabolic')]
PMC3827489	10/2013	S90-PMC3827489	['THEREFORE, adequate Vitamin D levels in the mother during Pregnancy promote BETTER bone health in the offspring65).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 76)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy')]
PMC3827489	10/2013	S100-PMC3827489	['it is NOT KNOWN, however, HOW much amount of Vitamin D supplementation is NEEDED for korean children and Pregnant women in order to maintain adequate concentrations of vitamin D. CONSIDERING the high prevalence of Vitamin D insufficiency or deficiency in koreans, ESPECIALLY children and adolscents6,22-24), this ISSUE NEEDS TO BE addressed URGENTLY by FUTURE STUDIES.']	[('FULL_UNKNOWN', 6), ('EXPLICIT_QUESTION', 26), ('IMPORTANT_CONSIDERATION', 74), ('INCOMPLETE_EVIDENCE', 179), ('IMPORTANT_CONSIDERATION', 264), ('PROBLEM_COMPLICATION', 313), ('IMPORTANT_CONSIDERATION', 319), ('IMPORTANT_CONSIDERATION', 341), ('FUTURE_WORK', 353)]	9	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'pregnant'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 176, 'D'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3827489	10/2013	S103-PMC3827489	['from a perspective of integrative childhood care, it MAY BE advantageous to RECOMMEND more time spent in outdoor activity for sunlight exposure and increased Vitamin D supplementation to achieve OPTIMAL health in children and adolescents.']	[('INCOMPLETE_EVIDENCE', 53), ('FUTURE_WORK', 76), ('IMPORTANT_CONSIDERATION', 195)]	3	[('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC3829803	11/2013	S163-PMC3829803	['IN FACT, both Vitamin A supplementation and therapy APPEAR TO have SIGNIFICANT clinical BENEFIT in natural Mev infection [16]–[19,21].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 52), ('IMPORTANT_CONSIDERATION', 67), ('IMPORTANT_CONSIDERATION', 88)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 107, 'MeV')]
PMC3829803	11/2013	S165-PMC3829803	['ALTHOUGH reduced mortality from diarrheal disease is ASSOCIATED with Vitamin A supplements in children of the developing world this BENEFIT APPEARS TO BE due largely to milder bacterial infections [14,62,63].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 132), ('ANOMALY_CURIOUS_FINDING', 140)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin A')]
PMC3829803	11/2013	S174-PMC3829803	['using the paramyxovirus most closely RELATED to Measles, our group has DEMONSTRATED that canine distemper virus (cdv)-infected ferrets treated with Vitamin A develop less SEVERE disease [78].']	[('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 171)]	3	[('NCBITaxon_33208', 'Metazoa', 48, 'measles'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin A')]
PMC3829803	11/2013	S175-PMC3829803	['in aggregate, these OBSERVATIONS SUGGEST that Vitamin A and its derivatives MAY play an IMPORTANT ROLE in Antiviral Responses BUT demonstrate clearly that mechanistic studies are ESSENTIAL to fully UNDERSTAND and exploit this POTENTIAL.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 88), ('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('IMPORTANT_CONSIDERATION', 179), ('FUTURE_WORK', 198), ('INCOMPLETE_EVIDENCE', 226)]	9	[('CHEBI_27300', 'vitamin D', 46, 'vitamin A'), ('GO_0002901', 'mature B cell apoptotic process', 106, 'antiviral responses')]
PMC3829803	11/2013	S208-PMC3829803	['in this context, it is PLAUSIBLE that the modest reduction in the rate of Muv Replication that we OBSERVED with Retinoid ‘treatment’ in vitro COULD translate into clinical BENEFIT during natural disease, AS occurs with Vitamin A treatment in natural Mev infection.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 142), ('IMPORTANT_CONSIDERATION', 172), ('PROBABLE_UNDERSTANDING', 204)]	5	[('NCBITaxon_10088', 'Mus <genus>', 74, 'MuV'), ('PR_000010775', 'PWWP domain-containing DNA repair factor 3A', 74, 'MuV'), ('GO_0006260', 'DNA replication', 78, 'replication'), ('CHEBI_26537', 'retinoid', 112, 'retinoid'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 250, 'MeV')]
PMC3873449	12/2013	S11-PMC3873449	['Pregnant women in beijing are at very high RISK of Vitamin D deficiency in winter.']	[('IMPORTANT_CONSIDERATION', 43)]	1	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3873449	12/2013	S12-PMC3873449	['duration of sun exposure and the use of multivitamin were the most IMPORTANT DETERMINANTS for Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 67), ('SUPERFICIAL_RELATIONSHIP', 77)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3873449	12/2013	S17-PMC3873449	['adequate 25(Oh)D levels are particularly IMPORTANT for women who Become Pregnant, BECAUSE mothers HAVE to sustain their own Vitamin D stores as well as those of their fetuses [2,3].']	[('IMPORTANT_CONSIDERATION', 41), ('PROBABLE_UNDERSTANDING', 82), ('IMPORTANT_CONSIDERATION', 98)]	3	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('GO_0007567', 'parturition', 65, 'become'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC3873449	12/2013	S24-PMC3873449	['HOWEVER, data are CONFLICTED on the IMPACT of Vitamin D on the RISK of allergic conditions.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 63)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC3873449	12/2013	S33-PMC3873449	['these FACTORS MAY LEAD TO an increase in the RISK of Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 18), ('IMPORTANT_CONSIDERATION', 45)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC3873449	12/2013	S44-PMC3873449	['the results SHOULD provide a BETTER UNDERSTANDING of the maternal FACTORS that INFLUENCE Vitamin D status during Pregnancy and help in raising AWARENESS as well as SUGGESTING STRATEGIES to prevent Vitamin D deficiency in china.']	[('FUTURE_WORK', 12), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 143), ('FUTURE_WORK', 164), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 175)]	8	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC3873449	12/2013	S92-PMC3873449	['the prevalence of Vitamin D deficiency (25(Oh)D < 50 nmol/l ) was 96.8% and no women had Serum 25(Oh)D concentrations ≥ 75 nmol/l which is CONSIDERED AS an OPTIMAL level.10.1371/journal.pone.0085081.t001\n\ncaption (table-wrap): table 1\nprevalence of Vitamin D deficiency and insufficiency in Pregnant women.25(Oh)D levelsnumber%severe deficiency5644.8(< 25 nmol/l )mild deficiency6552.0(25- < 50 nmol/l)insufficiency43.2(50 - < 75 nmol/l)sufficiency00.0(≥75 nmol/l)total125100.0\n\nmaternal characteristics and Vitamin D status\nmaternal characteristics, stratified by Vitamin D status, are shown intable 2.']	[('IMPORTANT_CONSIDERATION', 139), ('PROBABLE_UNDERSTANDING', 150), ('IMPORTANT_CONSIDERATION', 156)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 40, '25('), ('PR_000006444', 'diacylglycerol kinase delta', 46, 'D'), ('UBERON_0001977', 'blood serum', 89, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 98, 'OH)D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('GO_0007565', 'female pregnancy', 291, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 306, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 508, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 565, 'vitamin D')]
PMC3873449	12/2013	S118-PMC3873449	['these STUDIES SUGGEST that Pregnant women in beijing are at very high RISK of Vitamin D deficiency in either winter or spring.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 70)]	3	[('GO_0007565', 'female pregnancy', 27, 'pregnant'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3873449	12/2013	S124-PMC3873449	['it SEEMS, HOWEVER, that all Pregnant women are at a high RISK of Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 57)]	3	[('GO_0007565', 'female pregnancy', 28, 'pregnant'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC3873449	12/2013	S127-PMC3873449	['THUS, keeping enough sunlight exposure is IMPORTANT to prevent Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 42)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC3873449	12/2013	S135-PMC3873449	['THEREFORE it is NECESSARY to educate People about the knowledge of Vitamin D, ESPECIALLY for Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('IMPORTANT_CONSIDERATION', 78)]	3	[('NCBITaxon_10088', 'Mus <genus>', 37, 'people'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnant')]
PMC3873449	12/2013	S140-PMC3873449	['PREVIOUS experiments SUGGEST that indians REQUIRE about three times the uv exposure as white caucasians to produce the same amount of Vitamin D [24].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 42)]	3	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3873449	12/2013	S156-PMC3873449	['DEMONSTRATED that a uv-b irradiation threshold of 18 mj/cm2was REQUIRED to induce Vitamin D-3 Production for healthy white subjects [30].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 63)]	2	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 82, 'vitamin D-3'), ('GO_0001555', 'oocyte growth', 94, '... production')]
PMC3873449	12/2013	S169-PMC3873449	['it HAS BEEN REPORTED that Vitamin D supplementation CAN EFFECTIVELY improve Vitamin D status [36].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 52), ('IMPORTANT_CONSIDERATION', 56)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC3873449	12/2013	S173-PMC3873449	['appropriate dose of Vitamin D supplementation for women MAY BE REQUIRED.']	[('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 63)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC3873449	12/2013	S177-PMC3873449	['higher amounts of Vitamin D MAY BE REQUIRED, THOUGH the precise dose REMAINS UNKNOWN.']	[('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 35), ('ANOMALY_CURIOUS_FINDING', 45), ('FULL_UNKNOWN', 69)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC3873449	12/2013	S189-PMC3873449	['FURTHER high quality randomized TRIALS ARE REQUIRED to evaluate the SAFETY and effectiveness of Vitamin D supplementation in Pregnancy.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 68)]	2	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnancy')]
PMC3873449	12/2013	S191-PMC3873449	['a survey REVEALED CONSIDERABLE ignorance and confusion about the function of Vitamin D and sources of Vitamin D in chinese women [44].']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 18)]	2	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC3873449	12/2013	S214-PMC3873449	['measures MAY HAVE TO BE taken to improve Vitamin D status in Pregnant women in china.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 13)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnant')]
PMC3888066	12/2012	S14-PMC3888066	['methodologies used in this study HAVE BEEN CRITICIZED, including aggregating Heart defects as Neural Crest defects, ESTIMATING missing information on Retinol supplementation and DEMONSTRATING the Vitamin A threshold of >10,000 iu/day.9SUBSEQUENT STUDIES have DISPUTED the 10,000 iu/day THRESHOLD BASED ON Non-Human Primate STUDIES and SMALL clinical trials in Humans.10\n\nEVIDENCE to SUPPORT the NOTION that a Toxin is responsible for SOME Neurodevelopmental disorders\na Toxin that MAY cause Neurodevelopmental disorders MUST BE able to cross NOT ONLY the Placenta, BUT ALSO the Blood Brain Barrier (bbb).']	[('INCOMPLETE_EVIDENCE', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('INCOMPLETE_EVIDENCE', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 259), ('PROBABLE_UNDERSTANDING', 286), ('INCOMPLETE_EVIDENCE', 296), ('PROBABLE_UNDERSTANDING', 296), ('INCOMPLETE_EVIDENCE', 323), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 371), ('INCOMPLETE_EVIDENCE', 383), ('INCOMPLETE_EVIDENCE', 395), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 481), ('IMPORTANT_CONSIDERATION', 520), ('ANOMALY_CURIOUS_FINDING', 542)]	19	[('UBERON_0000948', 'heart', 77, 'heart'), ('UBERON_0002342', 'neural crest', 94, 'neural crest'), ('CHEBI_26536', 'retinoic acid', 150, 'retinol'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 305, 'non'), ('NCBITaxon_9606', 'Homo sapiens', 309, 'human'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 315, 'primate'), ('NCBITaxon_9606', 'Homo sapiens', 360, 'humans'), ('CHEBI_27026', 'toxin', 409, 'toxin'), ('GO_0007399', 'nervous system development', 439, 'neurodevelopmental'), ('CHEBI_27026', 'toxin', 470, 'toxin'), ('GO_0007399', 'nervous system development', 491, 'neurodevelopmental'), ('UBERON_0001987', 'placenta', 555, 'placenta'), ('UBERON_0000120', 'blood brain barrier', 578, 'blood brain barrier')]
PMC3888066	12/2012	S19-PMC3888066	['finally, neonatal levels of 13-Cis Retinoic Acid are proportionately higher than All-Trans Retinoic Acid levels when compared to maternal levels, SUGGESTING that, in newborns, the equilibrium of cis and trans isomers is shifted toward the more Teratogenic 13-cis Isomer.12this is an IMPORTANT FINDING and POINTS to a deficit in studies that DO NOT demonstrate an association between excess Vitamin A and Birth defects, AS most DO NOT measure levels of Retinoic Acid Isomers in the fetus or newborn.']	[('INCOMPLETE_EVIDENCE', 146), ('IMPORTANT_CONSIDERATION', 283), ('INCOMPLETE_EVIDENCE', 293), ('INCOMPLETE_EVIDENCE', 305), ('INCOMPLETE_EVIDENCE', 341), ('PROBABLE_UNDERSTANDING', 419), ('INCOMPLETE_EVIDENCE', 427)]	7	[('CHEBI_61206', '2-hexenoic acid', 28, '13-cis retinoic acid'), ('CHEBI_16553', 'UDP-4-dehydro-6-deoxy-D-glucose', 81, 'all-trans retinoic acid'), ('CHEBI_50905', 'teratogenic agent', 244, 'teratogenic'), ('GO_0031649', 'heat generation', 244, 'teratogenic'), ('SO_0001017', 'silent_mutation', 263, 'isomer'), ('CHEBI_27300', 'vitamin D', 390, 'vitamin A'), ('GO_0007567', 'parturition', 404, 'birth'), ('CHEBI_26536', 'retinoic acid', 452, 'retinoic acid'), ('SO_0001060', 'sequence_variant', 466, 'isomers')]
PMC3888066	12/2012	S35-PMC3888066	['brief survey of potential maternal sources of Vitamin A\n\nexplanation of rda for Vitamin A in foods\nthe RECOMMENDED daily allowance (rda) for Vitamin A in foods is defined as the amount needed to provide 97% or more of all groups with a sufficient quantity of Vitamin A to stay healthy.33since male Adults have the highest REQUIREMENT for Vitamin A, which is 3,000 iu, the rda is calculated to this group (table 2).']	[('FUTURE_WORK', 103), ('IMPORTANT_CONSIDERATION', 322)]	2	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 46, 'Vitamin A'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin A'), ('UBERON_0007023', 'adult organism', 298, 'adults'), ('CHEBI_27300', 'vitamin D', 338, 'vitamin A')]
PMC3888066	12/2012	S52-PMC3888066	['conclusion and implications for care\nhigh levels of fetal Retinoic Acid, a Metabolite of Vitamin A, are KNOWN to be Teratogenic and MAY BE ASSOCIATED with developmental defects of the Central Nervous System, PARTICULARLY involving the Cerebellum, resulting in Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 139), ('IMPORTANT_CONSIDERATION', 208)]	4	[('CHEBI_26536', 'retinoic acid', 58, 'retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 75, 'metabolite'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_50905', 'teratogenic agent', 116, 'teratogenic'), ('UBERON_0001017', 'central nervous system', 184, 'central nervous system'), ('UBERON_0002037', 'cerebellum', 235, 'cerebellum'), ('GO_0007399', 'nervous system development', 260, 'neurodevelopmental')]
PMC3888066	12/2012	S58-PMC3888066	['this author BELIEVES that AWARENESS and simple monitoring of all POTENTIAL sources of Retinoic Acid during the first Trimester of Pregnancy, including nutritional supplements, dietary Vitamin A from Animal sources, and Beta Carotene, MAY decrease the incidence of Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 26), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 234)]	4	[('CHEBI_26536', 'retinoic acid', 86, 'retinoic acid'), ('GO_0009294', 'DNA mediated transformation', 117, 'trimester'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 199, 'animal'), ('CHEBI_86157', 'cadmium sulfate hydrate', 219, 'beta'), ('CHEBI_23042', 'carotene', 224, 'carotene'), ('GO_0007399', 'nervous system development', 264, 'neurodevelopmental')]
PMC3901983	1/2013	S90-PMC3901983	['the next IMPORTANT consideration is Vitamin A deficiency.']	[('IMPORTANT_CONSIDERATION', 9)]	1	[('CHEBI_27300', 'vitamin D', 36, 'vitamin A')]
PMC3901983	1/2013	S94-PMC3901983	['the adequate level of the Vitamin A is NECESSARY especially in the second and third Pregnancy trimesters for normal Fetal Lung Development and Maturation.']	[('IMPORTANT_CONSIDERATION', 39)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin A'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('GO_0007631', 'feeding behavior', 116, 'fetal'), ('GO_0030324', 'lung development', 122, 'lung development'), ('UBERON_0002048', 'lung', 122, 'lung'), ('GO_0007618', 'mating', 143, 'maturation')]
PMC3901983	1/2013	S95-PMC3901983	['SEVERAL STUDIES have presented an INCREASED RISK of bronchopulmonary dysplasia (bpd) in preterm infants with insufficient Vitamin A status [17].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 34)]	2	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A')]
PMC3901983	1/2013	S102-PMC3901983	['an additional CONCERNING ISSUE is Vitamin K deficiency.']	[('IMPORTANT_CONSIDERATION', 14), ('PROBLEM_COMPLICATION', 14), ('PROBLEM_COMPLICATION', 25)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin K')]
PMC3901983	1/2013	S106-PMC3901983	['reported on five cases with SEVERE Intracranial bleeding and Skeletal malformations similar TO Warfarin fetopathy ( rhizomelic chondrodysplasia punctata ), which were caused by Vitamin K deficiency of mothers following bariatric surgery.']	[('IMPORTANT_CONSIDERATION', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 92)]	2	[('UBERON_2000442', 'supraneural bone', 35, 'intracranial'), ('UBERON_0004288', 'skeleton', 61, 'skeletal'), ('CHEBI_10033', 'warfarin', 95, 'warfarin'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin K')]
PMC3901983	1/2013	S107-PMC3901983	['it is the FIRST well-DOCUMENTED REPORT RELATING to maternal Vitamin K deficiency and following COMPLICATIONS.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 95)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin K')]
PMC3901983	1/2013	S108-PMC3901983	['to avoid SEVERE malnutrition and Vitamin K depletion, the authors of THIS PAPER RECOMMEND close followup with specialized team.']	[('IMPORTANT_CONSIDERATION', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('FUTURE_WORK', 80)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin K')]
PMC3901983	1/2013	S162-PMC3901983	['it is ESSENTIAL to maintain Micronutrients supplementation also after Delivery and during breastfeeding, to ensure appropriate Vitamins and Minerals intake to neonate and to prevent Vitamin B deficiency, which CAN INDICATE SEVERE COMPLICATIONS including failure in thriving, megaloblastic anemia, and development delays [3,14].']	[('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 214), ('IMPORTANT_CONSIDERATION', 223), ('PROBLEM_COMPLICATION', 230)]	5	[('CHEBI_33839', 'macromolecule', 28, 'micronutrients'), ('GO_0007567', 'parturition', 70, 'delivery'), ('CHEBI_33277', 'gamma-tocotrienol', 127, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 140, 'minerals'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin B')]
PMC3926113	1/2014	S1-PMC3926113	['the Brain is one of the Organs containing the highest concentration of Vitamin C (Vitc) and Vitc deficiency during Foetal Development MAY place the Brain AT RISK of redox status imbalance.']	[('INCOMPLETE_EVIDENCE', 134), ('IMPORTANT_CONSIDERATION', 154)]	2	[('UBERON_0000955', 'brain', 4, 'brain'), ('UBERON_0000062', 'organ', 24, 'organs'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin C'), ('PR_000017299', 'VIP peptides', 82, 'VitC'), ('PR_000017299', 'VIP peptides', 92, 'VitC'), ('GO_0060324', 'face development', 115, 'foetal development'), ('UBERON_0000955', 'brain', 148, 'brain')]
PMC3933171	3/2014	S12-PMC3933171	['introduction\nlow Vitamin D (vitd) status is a risk FACTOR for rickets and HAS BEEN ASSOCIATED with INCREASED prevalence of Respiratory infections and other adverse health outcomes in infants and children.12in response to the CONCERN about widespread childhood vitd deficiency, professional bodies have RECOMMENDED vitd intake of 400\u2005iu/ day for all infants.13the european society for paediatrics gastroenterology, hepatology and nutrition RECOMMENDS 800–1000\u2005iu/day for preterm infants.4based on BIOMARKERS of vitd status MOSTLY in adults, Serum 25-Hydroxyvitamin-D [25(Oh)D] concentration ≥50\u2005nmol/l was also RECOMMENDED.13HOWEVER, the functional benefit of this level is CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 225), ('FUTURE_WORK', 302), ('FUTURE_WORK', 439), ('SUPERFICIAL_RELATIONSHIP', 496), ('PROBABLE_UNDERSTANDING', 522), ('FUTURE_WORK', 610), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 622), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 673)]	12	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 123, 'respiratory'), ('UBERON_0001977', 'blood serum', 540, 'serum'), ('CHEBI_67320', 'majusculamide A', 546, '25-hydroxyvitamin-D'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D')]
PMC3991049	11/2013	S2-PMC3991049	['the current GUIDELINES for Vitamin D intake during Pregnancy of 200–400 iu has LITTLE scientific SUPPORT and HAS BEEN RECENTLY CHALLENGED.']	[('IMPORTANT_CONSIDERATION', 12), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy')]
PMC3991049	11/2013	S22-PMC3991049	['Vitamin D supplementation during Pregnancy REMAINS CONTROVERSIAL and the current RECOMMENDED REQUIREMENT for Vitamin D during Pregnancy (200–400 iu/d) has LITTLE scientific SUPPORT.']	[('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('FUTURE_WORK', 81), ('IMPORTANT_CONSIDERATION', 93), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 173)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy')]
PMC3991049	11/2013	S24-PMC3991049	["a RECENT STUDY SHOWED that a daily supplement of 4000 iu of Vitamin D was REQUIRED to sustain normal Metabolism in Pregnancy and this dose was EFFECTIVE and SAFE.9\nin THIS STUDY we EVALUATED the prevalence of Vitamin D deficiency in Pregnant women and EVALUATED the EFFECT of weekly Oral 50,000 iu of Vitamin D on mothers' and newborn's level of Vitamin D.\n\nmethods\nTHIS is a prospective observational study conducted at a single center at hamad medical corporation in doha, qatar."]	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 143), ('IMPORTANT_CONSIDERATION', 157), ('QUESTION_ANSWERED_BY_THIS_WORK', 167), ('QUESTION_ANSWERED_BY_THIS_WORK', 181), ('QUESTION_ANSWERED_BY_THIS_WORK', 252), ('SUPERFICIAL_RELATIONSHIP', 266), ('QUESTION_ANSWERED_BY_THIS_WORK', 366)]	10	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0008152', 'metabolic process', 101, 'metabolism'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('GO_0007565', 'female pregnancy', 233, 'pregnant'), ('UBERON_0000165', 'mouth', 283, 'oral'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D')]
PMC3991049	11/2013	S32-PMC3991049	['to ensure compliance, the research nurse called each participant monthly and reminded them of the IMPORTANCE of taking the Vitamin D and Calcium and tablets for their next appointment.']	[('IMPORTANT_CONSIDERATION', 98)]	1	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 137, 'calcium')]
PMC3991049	11/2013	S67-PMC3991049	['the IMPORTANCE of Vitamin D for fetal and infant Skeletal Development HAS LONG BEEN RECOGNIZED.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 74)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0001501', 'skeletal system development', 49, 'skeletal development'), ('UBERON_0004288', 'skeleton', 49, 'skeletal')]
PMC3991049	11/2013	S70-PMC3991049	['all of this SUPPORTS that 400 iu of Vitamin D MAY BE INADEQUATE to raise the maternal Vitamin D level to optimum level PARTICULARLY for women living in northern latitude, women with darker skin or covered women, as well as for women who are not exposed to sunlight, not on dietary supplements or have absorption and metabolic PROBLEMS.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 53), ('PROBLEM_COMPLICATION', 53), ('ANOMALY_CURIOUS_FINDING', 119), ('PROBLEM_COMPLICATION', 326)]	6	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3991049	11/2013	S71-PMC3991049	['we used a 50,000 iu dose, AS per our PREVIOUS STUDIES, which DEMONSTRATED no toxicity when Vitamin D deficient rheumatology outpatient and health care professional were supplemented this dose.31–32\nthe CONCERN of using higher doses of Vitamin D MIGHT cause hypercalcemia, hypercalciuria, Renal calculi and soft Tissue and vascular calcification toxicity is LIKELY to worsen with Calcium supplementation.']	[('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 202), ('PROBLEM_COMPLICATION', 202), ('INCOMPLETE_EVIDENCE', 245), ('PROBABLE_UNDERSTANDING', 357)]	7	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('UBERON_0002113', 'kidney', 288, 'renal'), ('UBERON_0000479', 'tissue', 311, 'tissue'), ('CHEBI_22313', 'alkaline earth metal atom', 379, 'calcium')]
PMC3991049	11/2013	S72-PMC3991049	['hypercalcemia, which is the most WORRYING toxicity, occurs with Vitamin D levels of more than 80 or 100\xa0ng/ml; and in OUR STUDY no one reached this level through out Pregnancy and in newborns with normal levels of calcium IN SPITE of supplementation.']	[('IMPORTANT_CONSIDERATION', 33), ('QUESTION_ANSWERED_BY_THIS_WORK', 118), ('ANOMALY_CURIOUS_FINDING', 222)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy')]
PMC3991049	11/2013	S81-PMC3991049	['studies are UNDERWAY in the us to establish Vitamin D REQUIREMENTS during Pregnancy (http://clinicaltrials.gov#r01hd043921).']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 54)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy')]
PMC4034700	5/2014	S6-PMC4034700	['ALTHOUGH clinical trials on the use of antioxidant Vitamins in Pregnancy proved largely UNSUCCESSFUL, the scope for their use STILL exists GIVEN the beneficial cardioprotective EFFECTS of antioxidant-rich mediterranean diet, periconceptual Vitamin use and the synergistic EFFECT of Vitamin C andl-Arginine.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 88), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 177), ('SUPERFICIAL_RELATIONSHIP', 272)]	6	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 240, 'vitamin'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin C'), ('CHEBI_15511', 'trans-feruloyl-CoA', 296, '-arginine')]
PMC4034700	5/2014	S137-PMC4034700	['HOWEVER, DESPITE encouraging in vitro DATA and cohort trials, clinical trials aimed to treat women AT RISK of Preeclampsia with Vitamins C and E (poston et al., 2006;rumbold et al., 2006) SHOWED no reduction in the incidence of the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('FUTURE_WORK', 38), ('IMPORTANT_CONSIDERATION', 99), ('INCOMPLETE_EVIDENCE', 188)]	5	[('GO_0007128', 'meiotic prophase I', 110, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 128, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 143, 'E')]
PMC4034700	5/2014	S258-PMC4034700	['ALTHOUGH clinical trials on the use of antioxidant Vitamins in Pregnancy proved largely UNSUCCESSFUL, the scope for their use STILL exists GIVEN the beneficial cardioprotective EFFECTS of antioxidant-rich mediterranean diet, periconceptual Vitamin use and the synergistic EFFECT of Vitamin C andl-Arginine.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 88), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 177), ('SUPERFICIAL_RELATIONSHIP', 272)]	6	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 240, 'vitamin'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin C'), ('CHEBI_15511', 'trans-feruloyl-CoA', 296, '-arginine')]
PMC4045304	2/2014	S4-PMC4045304	['there is also a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK for autism.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 119)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0000104', 'life cycle', 105, 'life')]
PMC4045304	2/2014	S5-PMC4045304	['in this communication, CONTROVERSIES regarding increase in ESTIMATE of prevalence, IMPLICATIONS of changes in definition, and POSSIBLE ASSOCIATION between SOME modifiable nutritional risk factors such as Folic Acid and Vitamin D and asd will be discussed.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 59), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 155)]	7	[('CHEBI_5054', 'Fibrin', 204, 'folic'), ('CHEBI_37527', 'acid', 210, 'acid'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D')]
PMC4045304	2/2014	S184-PMC4045304	['there is a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK of autism.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('INCOMPLETE_EVIDENCE', 105), ('IMPORTANT_CONSIDERATION', 114)]	6	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life')]
PMC4045304	2/2014	S219-PMC4045304	["ANOTHER PROPOSED HYPOTHESIS for the ROLE of Vitamin D in development of autism HAS TO do with Vitamin D's function in the Dna Repair and maintenance [95]."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 79)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 94, 'Vitamin D'), ('GO_0006281', 'DNA repair', 122, 'DNA repair')]
PMC4045304	2/2014	S224-PMC4045304	['the EFFECT of a Genetically impaired Vitamin D system combined with INADEQUATE amounts of Vitamin D MAY BE ASSOCIATED with de novo mutations REPORTED in autism.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 68), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 141)]	5	[('SO_0000704', 'gene', 16, 'genetically'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4045304	2/2014	S243-PMC4045304	['these studies INDICATE that maternal mcs, particularly diabetes, MAY BE ASSOCIATED with Neurodevelopmental PROBLEMS in children and Vitamin D supplementation early in childhood SHOULD BE given further CONSIDERATION in treatment of asd [103–105].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 107), ('FUTURE_WORK', 177), ('FUTURE_WORK', 201)]	6	[('GO_0007399', 'nervous system development', 88, 'neurodevelopmental'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4045304	2/2014	S272-PMC4045304	['POOR maternal Vitamin D status or early childhood Vitamin deficiency or low activity of various Vitamin D RELATED enzymes MAY result in deficient activity in the Vitamin D system crucial for Brain Development.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 122)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 50, 'vitamin'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007420', 'brain development', 191, 'brain development'), ('UBERON_0000955', 'brain', 191, 'brain')]
PMC4071151	6/2014	S64-PMC4071151	['RISK factors MAY include preoperative malnutrition (e.g., Vitamin D, iron), decreased Food Intake (dumping syndrome, reduced hunger and increased satiety, Food intolerances), inadequate Nutrient supplementation (POOR compliance with multivitamin/multimineral regimen, insufficient amounts of Vitamins and/or Minerals in supplements) and/or nutritional support (lack of follow-up, INSUFFICIENT monitoring, DIFFICULTY in recognizing symptoms of deficiency), Nutrient malabsorption (reduced absorptive Gastro-Intestinal area) [18,19].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 212), ('PROBLEM_COMPLICATION', 380), ('DIFFICULT_TASK', 405)]	5	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_33290', 'food', 86, 'food'), ('GO_0007631', 'feeding behavior', 86, 'food intake'), ('CHEBI_33290', 'food', 155, 'food'), ('CHEBI_33284', 'nutrient', 186, 'nutrient'), ('CHEBI_33277', 'gamma-tocotrienol', 292, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 308, 'minerals'), ('CHEBI_33284', 'nutrient', 456, 'nutrient'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 499, 'gastro-intestinal')]
PMC4071151	6/2014	S96-PMC4071151	['when no deficits are detected, a complete Blood count and measurement of iron, ferritin, Folic Acid, Vitamin B12, Vitamin A, 25-Hydroxyvitamin D, calcium, and Parathyroid hormone levels SHOULD BE performed every trimester.']	[('FUTURE_WORK', 186), ('IMPORTANT_CONSIDERATION', 186)]	2	[('UBERON_0000178', 'blood', 42, 'blood'), ('CHEBI_30751', 'formic acid', 89, 'folic acid'), ('CHEBI_33279', 'vitamin D5', 101, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin A'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 125, '25-hydroxyvitamin D'), ('UBERON_0001132', 'parathyroid gland', 159, 'parathyroid')]
PMC4072587	6/2014	S1-PMC4072587	['it has an IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System and YET the IMPACT of Antenatal Vitamin D deficiency on infant outcomes is POORLY UNDERSTOOD.']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 104), ('SUPERFICIAL_RELATIONSHIP', 112), ('FULL_UNKNOWN', 175), ('PROBABLE_UNDERSTANDING', 182)]	6	[('GO_0055064', 'chloride ion homeostasis', 28, 'bone homeostasis'), ('GO_0007420', 'brain development', 46, 'brain development'), ('UBERON_0000955', 'brain', 46, 'brain'), ('GO_0002022', 'detection of dietary excess', 68, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 86, 'immune system'), ('GO_0007567', 'parturition', 122, 'antenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4072587	6/2014	S12-PMC4072587	['IMPORTANT biological functions involving growth and developmental outcomes HAVE BEEN ATTRIBUTED to Vitamin D, and deficiency during Pregnancy MAY result in IMPORTANT health CONSEQUENCES for both mother and child[3],[4],[5].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 142), ('IMPORTANT_CONSIDERATION', 156), ('IMPORTANT_CONSIDERATION', 173)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007565', 'female pregnancy', 132, 'pregnancy')]
PMC4072587	6/2014	S14-PMC4072587	['the MAJOR supply of Vitamin D is through synthesis in the skin, following exposure to ultraviolet light.']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC4072587	6/2014	S20-PMC4072587	['adverse maternal and neonatal outcomes HAVE previously BEEN DESCRIBED in ASSOCIATION with Antenatal Vitamin D deficiency, including INCREASED risk of pre-eclampsia, Gestational diabetes, caesarean section, as well as low Birth weight and small for Gestational age infants[15],[16],[17],[18],[19].']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 132)]	4	[('GO_0007567', 'parturition', 90, 'antenatal'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'gestational'), ('GO_0007567', 'parturition', 221, 'birth'), ('GO_0007565', 'female pregnancy', 248, 'gestational')]
PMC4072587	6/2014	S22-PMC4072587	['more RECENTLY, maternal Vitamin D deficiency HAS BEEN ASSOCIATED with impaired infant Language Development in school-aged children[24], and HAS BEEN SUGGESTED as a possible environmental risk FACTOR for autism spectrum disorder, HIGHLIGHTING the IMPORTANT ROLE of Vitamin D in Brain Development, Neuronal function and Gene Regulation[10],[25],[26].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 229), ('IMPORTANT_CONSIDERATION', 246), ('SUPERFICIAL_RELATIONSHIP', 256)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0060132', 'prolactin secreting cell development', 86, 'language development'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D'), ('GO_0007420', 'brain development', 277, 'brain development'), ('UBERON_0000955', 'brain', 277, 'brain'), ('CL_0000540', 'neuron', 296, 'neuronal'), ('SO_0000704', 'gene', 318, 'gene'), ('GO_0065007', 'biological regulation', 323, 'regulation')]
PMC4072587	6/2014	S23-PMC4072587	['Vitamin D insufficiency in vietnam HAS PREVIOUSLY been REPORTED to be as high as 46%[27],[28],[29], HOWEVER, there is LIMITED DATA on the BURDEN and CONSEQUENCES of Vitamin D deficiency during Pregnancy in this setting[17]and FEW STUDIES have followed Infants past the Neonatal Period.']	[('IMPORTANT_CONSIDERATION', 35), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 138), ('IMPORTANT_CONSIDERATION', 149), ('INCOMPLETE_EVIDENCE', 226)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy'), ('UBERON_0002397', 'maxilla', 252, 'infants'), ('UBERON_0007221', 'neonate stage', 269, 'neonatal period')]
PMC4072587	6/2014	S24-PMC4072587	['the ROLE of Vitamin D deficiency during Pregnancy on longer term infant outcomes, PARTICULARLY with regard to early Childhood development is UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 82), ('FULL_UNKNOWN', 141)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('UBERON_0013628', 'pollical pad', 116, 'childhood')]
PMC4072587	6/2014	S122-PMC4072587	['the OBSERVED ASSOCIATION between Antenatal Vitamin D concentration and infant development is PLAUSIBLE AS Vitamin D has an IMPORTANT ROLE in Neurodevelopment through Cell Differentiation, cytokine Regulation, neurotransmitter synthesis and anti-oxidant activity, and it is HAS BEEN SUGGESTED that in utero exposure to Vitamin D deficiency during the second and third trimesters MAY AFFECT the development of the perisylvian structures, which are responsible for Language in children[24],[39].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 103), ('IMPORTANT_CONSIDERATION', 123), ('SUPERFICIAL_RELATIONSHIP', 133), ('INCOMPLETE_EVIDENCE', 273), ('INCOMPLETE_EVIDENCE', 378), ('SUPERFICIAL_RELATIONSHIP', 382)]	9	[('GO_0007567', 'parturition', 33, 'antenatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007399', 'nervous system development', 141, 'neurodevelopment'), ('GO_0030154', 'cell differentiation', 166, 'cell differentiation'), ('GO_0065007', 'biological regulation', 197, 'regulation'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('GO_0006266', 'DNA ligation', 462, 'language')]
PMC4072587	6/2014	S127-PMC4072587	['SEVERAL STUDIES have FOUND an ASSOCIATION between maternal Vitamin D status and post-Natal growth, BUT results are INCONSISTENT and the majority are OBSERVATIONAL studies that HAVE been carried out in developed countries.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('INCOMPLETE_EVIDENCE', 149), ('IMPORTANT_CONSIDERATION', 176)]	7	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007567', 'parturition', 85, 'natal')]
PMC4072587	6/2014	S130-PMC4072587	['we FOUND increasing maternal Vitamin D concentration SHOWED a TREND towards a reduced RISK of Preterm Delivery.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 86)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'preterm'), ('GO_0007567', 'parturition', 102, 'delivery')]
PMC4072587	6/2014	S148-PMC4072587	['SOME authors have also SUGGESTED that the cut off for sufficient Vitamin D levels during Pregnancy SHOULD BE as high as 100–150 nmo/l[10],[11], and THEREFORE the PROBLEM of Vitamin D deficiency in vietnam and OTHER south east asian countries MAY BE EVEN more widespread than PREVIOUSLY THOUGHT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 99), ('PROBABLE_UNDERSTANDING', 148), ('IMPORTANT_CONSIDERATION', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 209), ('INCOMPLETE_EVIDENCE', 242), ('ANOMALY_CURIOUS_FINDING', 249), ('INCOMPLETE_EVIDENCE', 275), ('INCOMPLETE_EVIDENCE', 286)]	10	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC4072587	6/2014	S156-PMC4072587	['our results STRENGTHEN the EVIDENCE for giving Vitamin D supplementation during Pregnancy and HIGHLIGHT the NEED FOR FURTHER RESEARCH to explore the IMPACT of supplementation on longer term child growth and developmental outcomes, PARTICULARLY with regard to language.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 108), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 149), ('IMPORTANT_CONSIDERATION', 231)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy')]
PMC4106226	7/2014	S32-PMC4106226	['most People are AWARE from media REPORTS that Vitamin D deficiency CAN predispose to the occurrence of atopic diseases.']	[('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 67)]	3	[('NCBITaxon_10088', 'Mus <genus>', 5, 'people'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4106226	7/2014	S39-PMC4106226	['RECENT STUDIES SUGGEST that Vitamin D deficiency MAY increase the RISK of developing Autoimmune diseases including type 1 diabetes (t1dm), by Modulating the Immune and inflammatory reactions.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 49), ('IMPORTANT_CONSIDERATION', 66)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 85, 'autoimmune'), ('GO_0065007', 'biological regulation', 142, 'modulating'), ('UBERON_0002405', 'immune system', 157, 'immune')]
PMC4106226	7/2014	S45-PMC4106226	['the authors conclude that PUBLIC HEALTH MESSAGE on the IMPORTANCE of Vitamin D status especially in diabetic children and adolescents, SHOULD BE disseminated to the public.']	[('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 40), ('IMPORTANT_CONSIDERATION', 55), ('FUTURE_WORK', 135)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4113768	7/2014	S11-PMC4113768	['the existence of a u-shaped RELATIONSHIP between Vitamin D status and RISK of certain health outcomes was ANOTHER area of discussion.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4113768	7/2014	S17-PMC4113768	['sex-specific ASSOCIATIONS between 25-Hydroxy Vitamin D3And Serum Lipids in elderly german subjects without intake of Lipid-modifying Drugs\n\njungert, a.; neuhäuser-berthold, m.\nbackground: ALTHOUGH EMERGING EVIDENCE INDICATES an ASSOCIATION between Vitamin D and Serum Lipids, the data are STILL INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 188), ('ANOMALY_CURIOUS_FINDING', 188), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 289), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295)]	8	[('CHEBI_668', '1-Phenyl-5-heptene-1,3-diyne', 34, '25-Hydroxy Vitamin D3and'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 45, 'Vitamin D3and'), ('UBERON_0001977', 'blood serum', 59, 'Serum'), ('CHEBI_18059', 'lipid', 65, 'Lipids'), ('CHEBI_18059', 'lipid', 117, 'Lipid'), ('CHEBI_23888', 'drug', 133, 'Drugs'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('UBERON_0001977', 'blood serum', 262, 'serum'), ('CHEBI_18059', 'lipid', 268, 'lipids')]
PMC4113768	7/2014	S141-PMC4113768	['background: both Vitamin D deficiency and Insomnia are PREVALENT clinical PROBLEMS in western societies.']	[('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 74)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007631', 'feeding behavior', 42, 'insomnia')]
PMC4113768	7/2014	S174-PMC4113768	['higher Vitamin D status (per 25 nmol/l increase in Serum/Plasma 25(Oh)D) was ASSOCIATED with IMPROVED Colorectal cancer specific survival (adjusted hr = 0.92 (95% ci: 0.86–0.98, p< 0.001) and overall survival (pooled adjusted hr = 0.87 (95% ci: 0.79–0.95, p< 0.001) in pooled estimates of 5 prospective studies.']	[('SUPERFICIAL_RELATIONSHIP', 77), ('IMPORTANT_CONSIDERATION', 93)]	2	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('UBERON_0001977', 'blood serum', 51, 'serum'), ('UBERON_0001969', 'blood plasma', 57, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 64, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 64, '25(OH ... D'), ('UBERON_0012652', 'colorectum', 102, 'colorectal')]
PMC4113768	7/2014	S211-PMC4113768	['CONSEQUENTLY, AS uvb penetration Of the Skin is REQUIRED for Vitamin D Production, citizens are AT RISK of Vitamin D deficiency in winter.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 14), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 96)]	4	[('GO_0001503', 'ossification', 33, 'of ... skin'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 71, 'production'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC4113768	7/2014	S228-PMC4113768	['current EVIDENCE SUGGESTS that immunomodulatory properties of Vitamin D MAY INFLUENCE lrti RISK.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 76), ('IMPORTANT_CONSIDERATION', 91)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4113768	7/2014	S244-PMC4113768	['conclusions: OUR FINDINGS SUGGEST that Vitamin D deficiency at Birth is ASSOCIATED with INCREASED RISK of lrti PARTICULARLY in infants Born to mothers without allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 88), ('ANOMALY_CURIOUS_FINDING', 111)]	5	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007567', 'parturition', 63, 'birth'), ('GO_0007567', 'parturition', 135, 'born')]
PMC4113768	7/2014	S246-PMC4113768	['strategies aimed at improving maternal Vitamin D status during Pregnancy, especially in the winter months, ARE NEEDED and MIGHT decrease the RISK of lrti in early childhood.']	[('FUTURE_WORK', 107), ('INCOMPLETE_EVIDENCE', 122), ('IMPORTANT_CONSIDERATION', 141)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy')]
PMC4113768	7/2014	S356-PMC4113768	['DUE TO the unavailability of subsidized daily doses of Vitamin D and the unaffordability of Vitamin D testing in new zealand we have established a less than IDEAL process for treating and PREVENTING Vitamin D deficiency in our IDENTIFIED high risk women and children, using monthly doses of 50,000 iu Cal-D forte for women and Vitadol-c (multivitamin) for breast feeding babies.']	[('PROBLEM_COMPLICATION', 0), ('IMPORTANT_CONSIDERATION', 157), ('SUPERFICIAL_RELATIONSHIP', 188), ('INCOMPLETE_EVIDENCE', 227)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_17789', 'dihydrochelirubine', 301, 'Cal-D'), ('PR_000004968', 'calretinin', 301, 'Cal-D'), ('CHEBI_27355', 'xylulose phosphate', 327, 'vitadol')]
PMC4113768	7/2014	S357-PMC4113768	['we have decreased the incidence of rickets in our community but with limited subsidised treatment options in a poor and AT RISK community we are STILL CONCERNED about the IMPACT of Vitamin D deficiency on our vulnerable children.']	[('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 145), ('IMPORTANT_CONSIDERATION', 151), ('SUPERFICIAL_RELATIONSHIP', 171)]	4	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4113768	7/2014	S368-PMC4113768	['conclusion: we have decreased the incidence of rickets in our community and RAISED AWARENESS of the need for Vitamin D supplementation in AT RISK communities in nz.']	[('IMPORTANT_CONSIDERATION', 76), ('IMPORTANT_CONSIDERATION', 138)]	2	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC4113768	7/2014	S371-PMC4113768	['HOW HARD should we fight for improved affordable access to daily Vitamin D supplementation?']	[('EXPLICIT_QUESTION', 0), ('IMPORTANT_CONSIDERATION', 4), ('EXPLICIT_QUESTION', 90)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 73, 'D')]
PMC4113768	7/2014	S377-PMC4113768	['background: INTERACTIONS between dietary Calcium and Vitamin D MAY have IMPLICATIONS for the Regulation of Serum 25-Hydroxy Vitamin D (25(Oh)D) and its Catabolism, and CONSEQUENTLY for the dietary REQUIREMENT for Vitamin D ((iom) institute of medicine.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 63), ('IMPORTANT_CONSIDERATION', 72), ('SUPERFICIAL_RELATIONSHIP', 93), ('PROBABLE_UNDERSTANDING', 168), ('IMPORTANT_CONSIDERATION', 197)]	6	[('CHEBI_22313', 'alkaline earth metal atom', 41, 'calcium'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0065007', 'biological regulation', 93, 'regulation'), ('UBERON_0001977', 'blood serum', 107, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 113, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 135, '25(OH)D'), ('GO_0009056', 'catabolic process', 152, 'catabolism'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC4113768	7/2014	S386-PMC4113768	['THUS, RECENT dietary Vitamin D REQUIREMENT ESTIMATES will cover the Vitamin D NEEDS of EVEN those in the population who do not have adequate Calcium intakes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 78), ('ANOMALY_CURIOUS_FINDING', 87)]	6	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 141, 'calcium')]
PMC4113768	7/2014	S461-PMC4113768	['background: ligand-bound Vitamin D: Retinol-x receptor heterodimers are IMPORTANT Vitamin D Effectors.']	[('IMPORTANT_CONSIDERATION', 72)]	1	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_26536', 'retinoic acid', 36, 'retinol'), ('CHEBI_26871', 'terpene alkaloid', 82, 'vitamin D effectors')]
PMC4113768	7/2014	S462-PMC4113768	['Retinol-x receptors heterodimerize with Retinol-A receptors and the availability of rxr falls in the presence of excessive Vitamin A. westernized populations OFTEN ingest more Vitamin a than is ADVISABLE and up to 30% have circulating concentrations above the recommended maximum level (e.g., in nhanes111).']	[('PROBABLE_UNDERSTANDING', 158), ('FUTURE_WORK', 194), ('IMPORTANT_CONSIDERATION', 194)]	3	[('CHEBI_27810', 'resorcinol', 0, 'Retinol'), ('CHEBI_26536', 'retinoic acid', 40, 'retinol'), ('PR_000004370', 'asialoglycoprotein receptor 2', 48, 'A'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 176, 'vitamin')]
PMC4113768	7/2014	S463-PMC4113768	['populations in developing countries are OFTEN deficient in Vitamin A. u or j shaped curves for benefits of increases in Vitamin D supplementation in are a GROWING CONCERN, as REPORTED in the western world.']	[('PROBABLE_UNDERSTANDING', 40), ('IMPORTANT_CONSIDERATION', 155), ('INCOMPLETE_EVIDENCE', 155), ('IMPORTANT_CONSIDERATION', 163), ('INCOMPLETE_EVIDENCE', 175)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4113768	7/2014	S466-PMC4113768	['2 large randomized controlled trials (rcts) of Vitamin A have HAD TO BE stopped DUE TO an increased incidence of Lung cancer and in Cardiac deaths.']	[('IMPORTANT_CONSIDERATION', 62), ('PROBLEM_COMPLICATION', 80)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin A'), ('UBERON_0002048', 'lung', 113, 'lung'), ('UBERON_0000948', 'heart', 132, 'cardiac')]
PMC4113768	7/2014	S476-PMC4113768	['overall reductions in Lung cancer RISKS in never-smokers in the women’s health initiative (1771 cases in 128,779 women) were seen with vitamin D intakes >400 iu/day (or = 0.37, 95% ci: 0.18–0.77); HOWEVER, rct data for the 12% of women given Vitamin D supplements SHOWED lower Lung cancer risk ONLY in those with low intakes of Retinol (or = 0.69, 95% ci, 0.5–0.96).']	[('IMPORTANT_CONSIDERATION', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('ANOMALY_CURIOUS_FINDING', 197), ('INCOMPLETE_EVIDENCE', 264), ('ANOMALY_CURIOUS_FINDING', 294), ('INCOMPLETE_EVIDENCE', 294)]	6	[('UBERON_0002048', 'lung', 22, 'lung'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 143, 'D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('UBERON_0002048', 'lung', 277, 'lung'), ('CHEBI_26536', 'retinoic acid', 328, 'retinol')]
PMC4113768	7/2014	S479-PMC4113768	['conclusions: (1) SINCE the use of supplements containing Vitamin A as well as Vitamin D is common, WHETHER in Cod Liver oil OR multi-vitamins, especially in developed countries, Vitamin A status is LIKELY to CONFOUND rcts of Vitamin D in westernized populations; (2) in particular, high Vitamin A Intakes COULD ACCOUNT for j or inverse u shaped curves for outcomes in rcts, AS COULD Gene polymorphisms increasing circulating Retinol/Retinoids; (3) CONVERSELY, poor Vitamin D status MAY BE expected to CONFOUND rcts of Vitamin A in developing countries; (4) as well as Vitamin A intakes, other lifestyle factors that are POTENTIAL CONFOUNDERS of the EFFECTS of Vitamin D SHOULD BE CONSIDERED in the PLANNING of FUTURE rcts of supplemental Vitamin D, including intakes of other Nutrients, tobacco usage, and also betel-chewing which MAY increase Catabolism Of Vitamin D and is a habit used by 10% of the world population.']	[('PROBABLE_UNDERSTANDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('PROBABLE_UNDERSTANDING', 198), ('PROBLEM_COMPLICATION', 208), ('INCOMPLETE_EVIDENCE', 305), ('IMPORTANT_CONSIDERATION', 311), ('PROBABLE_UNDERSTANDING', 374), ('INCOMPLETE_EVIDENCE', 377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 448), ('INCOMPLETE_EVIDENCE', 482), ('PROBLEM_COMPLICATION', 501), ('INCOMPLETE_EVIDENCE', 620), ('PROBLEM_COMPLICATION', 630), ('SUPERFICIAL_RELATIONSHIP', 649), ('FUTURE_WORK', 670), ('FUTURE_WORK', 680), ('FUTURE_WORK', 698), ('FUTURE_WORK', 710), ('INCOMPLETE_EVIDENCE', 831)]	19	[('CHEBI_27300', 'vitamin D', 57, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'cod'), ('UBERON_0002107', 'liver', 114, 'liver'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A'), ('GO_0007631', 'feeding behavior', 297, 'intakes'), ('SO_0000704', 'gene', 383, 'gene'), ('CHEBI_26536', 'retinoic acid', 425, 'retinol'), ('CHEBI_26537', 'retinoid', 433, 'retinoids'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 518, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 738, 'vitamin D'), ('CHEBI_33284', 'nutrient', 776, 'nutrients'), ('GO_0044851', 'hair cycle phase', 844, 'catabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 858, 'vitamin D')]
PMC4113768	7/2014	S485-PMC4113768	['in addition, an ASSOCIATION between INADEQUATE Vitamin D levels and impaired Lung function COULD BE EXPLAINED by an INCREASED RISK of Respiratory infections or a negative INFLUENCE on muscle function.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 36), ('INCOMPLETE_EVIDENCE', 91), ('PROBABLE_UNDERSTANDING', 100), ('IMPORTANT_CONSIDERATION', 116), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002048', 'lung', 77, 'lung'), ('UBERON_0001004', 'respiratory system', 134, 'respiratory')]
PMC4113768	7/2014	S625-PMC4113768	['these prospective data SUPPORT the HYPOTHESIS that maternal Vitamin D status and child season of Birth CONTRIBUTE to RISK of childhood p/tn allergy.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 103), ('IMPORTANT_CONSIDERATION', 117)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007567', 'parturition', 97, 'birth')]
PMC4113768	7/2014	S668-PMC4113768	['; dyall, l.; kepa, m.\nbackground: POSSIBLE CONSEQUENCES of low Vitamin D status include osteoporosis, falls, Cardiovascular disease, cancer, and diabetes, all of which are LIKELY to be more SERIOUS for men and women of advanced age (>80 years) compared to younger Adults.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBLEM_COMPLICATION', 43), ('PROBABLE_UNDERSTANDING', 172), ('IMPORTANT_CONSIDERATION', 190)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 109, 'cardiovascular'), ('UBERON_0007023', 'adult organism', 264, 'adults')]
PMC4113768	7/2014	S747-PMC4113768	['25(Oh)D assay standardization is, THEREFORE, ESSENTIAL to the development of EVIDENCED-BASED clinical and PUBLIC HEALTH guidelines for Vitamin D.\nmethods: Vitamin D standardization program (vdsp) is an international program designed to promote the standardized laboratory measurement of 25(Oh)D. it was established in 2010 by the us nih office of dietary supplements in collaboration with us national institute of standards and technology (nist), cdc, and ghent university.']	[('PROBABLE_UNDERSTANDING', 34), ('IMPORTANT_CONSIDERATION', 45), ('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 106)]	4	[('CHEBI_71657', 'versiconol acetate', 0, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 6, 'D'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 155, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 287, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 287, '25(OH)D')]
PMC4113768	7/2014	S760-PMC4113768	['this is a multi-year effort, which NEEDS to the support of Vitamin D researchers around the world.']	[('FUTURE_WORK', 35), ('IMPORTANT_CONSIDERATION', 35)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC4113768	7/2014	S782-PMC4113768	['RANDOMIZED controlled trials of Vitamin D supplementation MAY BE WARRANTED for infants with low 25(Oh)D during the initial months of Life, BUT careful selection of the regimen with close monitoring of safety for those who reach high 25(Oh)D levels will be NECESSARY.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 58), ('FUTURE_WORK', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('IMPORTANT_CONSIDERATION', 256)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 102, 'D'), ('UBERON_0000104', 'life cycle', 133, 'life'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 233, '25(OH ... D')]
PMC4113768	7/2014	S788-PMC4113768	['the Respiratory Epithelium is VITAL in the Defence Against such Infections, and THUS MAY BE an IMPORTANT FOCUS as to where Vitamin D has its immunomodulatory actions.']	[('IMPORTANT_CONSIDERATION', 30), ('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 95)]	4	[('UBERON_0004802', 'respiratory tract epithelium', 4, 'respiratory epithelium'), ('GO_0002235', 'detection of unfolded protein', 43, 'defence against'), ('GO_0007567', 'parturition', 64, 'infections'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4113768	7/2014	S817-PMC4113768	['the CORRELATIONS between dbp levels and several amino acid transporters SUGGEST that Vitamin D Delivery MAY BE IMPORTANT for Placental function, but FURTHER WORK is now REQUIRED to establish WHETHER these ASSOCIATIONS are causal.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 111), ('FUTURE_WORK', 149), ('IMPORTANT_CONSIDERATION', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('SUPERFICIAL_RELATIONSHIP', 205)]	8	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007567', 'parturition', 95, 'delivery'), ('UBERON_0001987', 'placenta', 125, 'placental')]
PMC4113768	7/2014	S827-PMC4113768	['the audit was based on two standards: (1) antenatal standard nice 62- at booking women SHOULD BE given information and advice on the IMPORTANCE of taking a 10 microgram Vitamin D supplement per day during Pregnancy and whilst breastfeeding.']	[('FUTURE_WORK', 87), ('IMPORTANT_CONSIDERATION', 133)]	2	[('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy')]
PMC4113768	7/2014	S828-PMC4113768	['health professionals SHOULD ensure that women at greatest RISK of Vitamin D deficiency are asked about Vitamin D supplementation; (2) nice public health GUIDELINE 11- all infants and young children aged 6 months to 5 years SHOULD take a daily supplement containing Vitamin D.\nwe surveyed 20 mothers and 15 health professionals on the Postnatal wards.']	[('FUTURE_WORK', 21), ('IMPORTANT_CONSIDERATION', 21), ('IMPORTANT_CONSIDERATION', 58), ('PROBABLE_UNDERSTANDING', 153), ('FUTURE_WORK', 223)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('GO_0007567', 'parturition', 334, 'postnatal')]
PMC4113768	7/2014	S829-PMC4113768	['the staff were asked WHETHER they knew WHY Vitamin D is IMPORTANT, WHO should BE offered Vitamin D supplementation and at WHAT dose.']	[('EXPLICIT_QUESTION', 21), ('EXPLICIT_QUESTION', 39), ('IMPORTANT_CONSIDERATION', 56), ('EXPLICIT_QUESTION', 67), ('ANOMALY_CURIOUS_FINDING', 78), ('EXPLICIT_QUESTION', 122)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4113768	7/2014	S830-PMC4113768	['the patients were asked similar questions to ascertain their knowledge of Vitamin D and the level of information they had been given, whether they were taking or plan to take Supplements, whether any other young children in their family take Supplements and their AT-RISK status.']	[('IMPORTANT_CONSIDERATION', 264), ('IMPORTANT_CONSIDERATION', 267)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 175, 'supplements'), ('CHEBI_33341', 'titanium atom', 242, 'supplements')]
PMC4113768	7/2014	S835-PMC4113768	['only 40% women could give a REASON WHY Vitamin D supplements were IMPORTANT- all of them had taken Supplements.']	[('PROBABLE_UNDERSTANDING', 28), ('EXPLICIT_QUESTION', 35), ('IMPORTANT_CONSIDERATION', 66)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 99, 'supplements')]
PMC4113768	7/2014	S838-PMC4113768	['staff: only 67% staff were able to answer WHY Vitamin D was IMPORTANT.']	[('EXPLICIT_QUESTION', 42), ('IMPORTANT_CONSIDERATION', 60)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4113768	7/2014	S843-PMC4113768	['knowledge levels APPEAR TO CORRELATE with use of Vitamin D supplementation, SUGGESTING that APPROPRIATE information provision is VITAL.']	[('ANOMALY_CURIOUS_FINDING', 17), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 92), ('IMPORTANT_CONSIDERATION', 129)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4113768	7/2014	S896-PMC4113768	['those patients REQUIRING frequent admissions for painful crises, together with Vitamin D deficiency, CAN develop vertebral changes.']	[('IMPORTANT_CONSIDERATION', 15), ('INCOMPLETE_EVIDENCE', 101)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC4113768	7/2014	S914-PMC4113768	['conclusions: early work with dietary manipulations in a Dog MODEL together with trials in institutionalized children SUGGESTED that Vitamin D is an IMPORTANT PROTECTIVE factor against Dental decay.']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 148), ('SUPERFICIAL_RELATIONSHIP', 158)]	4	[('NCBITaxon_33208', 'Metazoa', 56, 'dog'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 184, 'dental')]
PMC4113768	7/2014	S917-PMC4113768	['what is LESS CLEAR is the RELEVANT SIGNIFICANCE of Vitamin D deficiency to Tooth Development, at a population level, in the uk at present.']	[('FULL_UNKNOWN', 8), ('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 35)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0048538', 'thymus development', 75, 'tooth development'), ('UBERON_0001091', 'calcareous tooth', 75, 'tooth')]
PMC4113768	7/2014	S942-PMC4113768	['methods: to EXAMINE this VIEW reports of fractures at less than two years of age in rickets due to Vitamin D deficiency HAVE been reviewed.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 25), ('IMPORTANT_CONSIDERATION', 120)]	3	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4113768	7/2014	S951-PMC4113768	['conclusions: it is IMPORTANT to include Vitamin D deficiency rickets in the differential diagnosis of fractures in young children.']	[('IMPORTANT_CONSIDERATION', 19)]	1	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4113768	7/2014	S971-PMC4113768	['Genetic variants in the Vitamin D pathway that HAVE PREVIOUSLY BEEN shown to ASSOCIATE with risk of Vitamin D deficiency in healthy Adult populations were not associated with deficiency in this patient group.']	[('IMPORTANT_CONSIDERATION', 47), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0007023', 'adult organism', 132, 'adult')]
PMC4113768	7/2014	S983-PMC4113768	['apart from its well-DOCUMENTED ROLE in Bone mineralisation, Vitamin D is IMPLICATED in muscle strength and SEVERE Vitamin D deficiency CAN delay gross motor Development, such as walking in children (agarwal, a., et al .']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 107), ('INCOMPLETE_EVIDENCE', 135)]	5	[('GO_0007567', 'parturition', 39, 'bone'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0008289', 'lipid binding', 157, 'development')]
PMC4113768	7/2014	S1026-PMC4113768	['maternal Vitamin D supplementation reduces the risk of infection and pre-term Birth: a population study on 36,181 Pregnancies\n\nhyppönen, e.; cavadino, a.; williams, d.; czeizel, e.\nbackground: adequate Vitamin D nutrition HAS BEEN SUGGESTED to be ESSENTIAL for the successful maintenance of Pregnancy, with increasing interest on its EFFECTS on Placental function, infection risk and inflammatory responses.']	[('INCOMPLETE_EVIDENCE', 222), ('IMPORTANT_CONSIDERATION', 247), ('SUPERFICIAL_RELATIONSHIP', 334)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 9, 'Vitamin D'), ('GO_0007567', 'parturition', 78, 'Birth'), ('GO_0007565', 'female pregnancy', 114, 'Pregnancies'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('GO_0007565', 'female pregnancy', 291, 'pregnancy'), ('UBERON_0001987', 'placenta', 345, 'placental')]
PMC4113768	7/2014	S1037-PMC4113768	['conclusions: maternal Vitamin D supplementation during Pregnancy was ASSOCIATED with NOTABLE reductions in the risk of infections and pre-term Birth.']	[('SUPERFICIAL_RELATIONSHIP', 69), ('ANOMALY_CURIOUS_FINDING', 85), ('IMPORTANT_CONSIDERATION', 85)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('GO_0007567', 'parturition', 143, 'birth')]
PMC4113768	7/2014	S1038-PMC4113768	['these data SUGGEST that the RELATED EFFECTS are strong and CONSISTENT across DIFFERENT types of infections, HIGHLIGHTING THE NEED to PREVENT Vitamin D deficiency in Pregnant mothers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('IMPORTANT_CONSIDERATION', 108), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 121), ('FUTURE_WORK', 125), ('SUPERFICIAL_RELATIONSHIP', 133)]	11	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'pregnant')]
PMC4113768	7/2014	S1044-PMC4113768	['moreover clinical practice guidelines EMPHASIZE the IMPORTANCE of Vitamin D in bone health.']	[('IMPORTANT_CONSIDERATION', 38), ('IMPORTANT_CONSIDERATION', 52)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4113768	7/2014	S1084-PMC4113768	['background: reports SUGGEST that Vitamin D deficiency (vdd), and its clinical COMPLICATIONS, have increased in prevalence among children in the uk.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 78), ('PROBLEM_COMPLICATION', 78)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4113768	7/2014	S1118-PMC4113768	['background: approximately one billion People worldwide have low Serum levels of Vitamin D. the AIM of THIS STUDY was TO EVALUATE the dose-response EFFECT in order TO DETERMINE the level of supplementation of Vitamin D REQUIRED in patients with deficiency in Vitamin D concentration (≤20 ng/ml).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('SUPERFICIAL_RELATIONSHIP', 147), ('QUESTION_ANSWERED_BY_THIS_WORK', 163), ('IMPORTANT_CONSIDERATION', 218)]	6	[('NCBITaxon_10088', 'Mus <genus>', 38, 'people'), ('UBERON_0001977', 'blood serum', 64, 'serum'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC4113768	7/2014	S1158-PMC4113768	['THIS STUDY AIMED to develop a risk profile that CAN be used to easily identify older Individuals at high RISK for Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 105)]	4	[('NCBITaxon_1', 'root', 85, 'individuals'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4113768	7/2014	S1169-PMC4113768	['these risk scores MAY BE useful in clinical practice to identify Persons AT RISK for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 73)]	2	[('NCBITaxon_10088', 'Mus <genus>', 65, 'persons'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4113768	7/2014	S1329-PMC4113768	['it is HYPOTHESISED that transient changes in Serum calcium MAY BE responsible for Remineralisation of marginally under-mineralised bone; and this MIGHT EXPLAIN WHY Vitamin D most benefits those who are AT RISK of deficiency.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 146), ('PROBABLE_UNDERSTANDING', 152), ('EXPLICIT_QUESTION', 160), ('IMPORTANT_CONSIDERATION', 202)]	6	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('GO_0031147', '1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one metabolic process', 82, 'remineralisation'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4113768	7/2014	S1374-PMC4113768	['low Vitamin D concentrations are ASSOCIATED with an INCREASED RISK of type 2 diabetes mellitus (dm), as shown in longitudinal and cross-sectional studies.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 52)]	2	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
PMC4113768	7/2014	S1393-PMC4113768	['the AIM of THIS STUDY was THEREFORE TO INVESTIGATE the EFFECTS of Vitamin D on the Gene Expression of IMPORTANT enzymes INVOLVED in Brain Steroidogenesis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 102), ('SUPERFICIAL_RELATIONSHIP', 120)]	7	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0010467', 'gene expression', 83, 'gene expression'), ('SO_0000704', 'gene', 83, 'gene'), ('UBERON_0000955', 'brain', 132, 'brain'), ('GO_0001501', 'skeletal system development', 138, 'steroidogenesis')]
PMC4113768	7/2014	S1407-PMC4113768	['to COMPLICATE the picture, Genetic DIFFERENCES in the Vitamin D receptor (vdr) MAY also be of IMPORTANCE.']	[('DIFFICULT_TASK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('INCOMPLETE_EVIDENCE', 79), ('IMPORTANT_CONSIDERATION', 94)]	4	[('SO_0000704', 'gene', 27, 'genetic'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4113768	7/2014	S1444-PMC4113768	['background: epidemiological studies SUGGEST an ASSOCIATION between Vitamin D status and Cardiovascular disease (cvd) RISK.']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 117)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 88, 'cardiovascular')]
PMC4113768	7/2014	S1445-PMC4113768	['suboptimal Vitamin D status APPEARS TO increase an Individual’s RISK of developing cvd, ALTHOUGH the OPTIMAL level REQUIRED is UNCLEAR and the results of intervention studies REMAIN HETEROGENEOUS and INCONCLUSIVE.']	[('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 64), ('ANOMALY_CURIOUS_FINDING', 88), ('IMPORTANT_CONSIDERATION', 101), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 127), ('INCOMPLETE_EVIDENCE', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('DIFFICULT_TASK', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('NCBITaxon_1', 'root', 51, 'individual')]
PMC4113768	7/2014	S1460-PMC4113768	['this study SUPPORTS a POTENTIAL ROLE for Vitamin D in cvd development, HOWEVER FURTHER RESEARCH IS REQUIRED to establish causality.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('FUTURE_WORK', 79), ('IMPORTANT_CONSIDERATION', 99)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4113768	7/2014	S1461-PMC4113768	['there is a NEED for randomised controlled Human intervention trials to investigate WHETHER improving Vitamin D status in men ameliorates vasculogenic ed and reduces the RISK of cvd.']	[('FUTURE_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('IMPORTANT_CONSIDERATION', 169)]	3	[('NCBITaxon_9606', 'Homo sapiens', 42, 'human'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4113768	7/2014	S1519-PMC4113768	['THUS, Genetic FACTORS MAY help to identify who is MOST AT RISK of developing low Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 55)]	5	[('SO_0000704', 'gene', 6, 'genetic'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4113768	7/2014	S1534-PMC4113768	['carriers of a high grs MAY NEED a higher amount of Vitamin D supplementation to achieve adequate s-25(Oh)D concentrations.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 27)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('PR_000000036', 'BMP receptor type-1B', 98, '-25'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 105, 'D')]
PMC4113768	7/2014	S1536-PMC4113768	['in the FUTURE, Genetic FACTORS MIGHT be taken into ACCOUNT when RECOMMENDING Vitamin D supplementation or Food fortification.']	[('FUTURE_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 51), ('FUTURE_WORK', 64)]	5	[('SO_0000704', 'gene', 15, 'genetic'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_33290', 'food', 106, 'food')]
PMC4113768	7/2014	S1571-PMC4113768	['there is also EVIDENCE that Vitamin D plays an IMPORTANT ROLE in OTHER aspects of health, including infection and immunity.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4113768	7/2014	S1632-PMC4113768	['conclusions: standardization of 25(Oh)D measurements is IMPORTANT for accurate and consistent identification of INADEQUATE and/or deficient Vitamin D levels and RELATED health consequences in Individuals and populations.']	[('IMPORTANT_CONSIDERATION', 56), ('IMPORTANT_CONSIDERATION', 112), ('SUPERFICIAL_RELATIONSHIP', 161)]	3	[('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 32, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('NCBITaxon_1', 'root', 192, 'individuals')]
PMC4113768	7/2014	S1641-PMC4113768	['background: meta-analysis of clinical trials of Vitamin D supplementation for the PREVENTION of acute Respiratory infection (ari) SHOWS a PROTECTIVE EFFECT in the general population, BUT there is CONTROVERSY regarding the OPTIMAL dosing regimen.']	[('SUPERFICIAL_RELATIONSHIP', 82), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 138), ('SUPERFICIAL_RELATIONSHIP', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('IMPORTANT_CONSIDERATION', 222)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 102, 'respiratory')]
PMC4113768	7/2014	S1691-PMC4113768	['background: MANY epidemiological STUDIES in RECENT years SUGGEST that Vitamin D is ASSOCIATED with a high RISK of osteoporotic fractures, malignancy of Breast, Colon, Prostate and many Respiratory diseases.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0000310', 'breast', 152, 'breast'), ('UBERON_0001155', 'colon', 160, 'colon'), ('UBERON_0002367', 'prostate gland', 167, 'prostate'), ('GO_0045333', 'cellular respiration', 185, 'respiratory'), ('UBERON_0001004', 'respiratory system', 185, 'respiratory')]
PMC4113768	7/2014	S1718-PMC4113768	['the MAJOR DETERMINANTS of Vitamin D status were season of sampling, sun-seeking behaviour, use of Vitamin D supplements and bmi.']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 10)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4113768	7/2014	S1747-PMC4113768	['background: the public continues to receive the advice that sustaining a high level of Serum Vitamin D is IMPORTANT in maintaining good health, regardless OF the presence of an illness.']	[('IMPORTANT_CONSIDERATION', 106), ('ANOMALY_CURIOUS_FINDING', 155)]	2	[('UBERON_0001977', 'blood serum', 87, 'serum'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4113768	7/2014	S1783-PMC4113768	['the epidemiological data INDICATE that Vitamin D deficiency is relatively COMMON, AT LEAST in SOME parts of the united states and europe, and that INADEQUATE Serum levels of the Vitamin D are ASSOCIATED with an INCREASED RISK and POOR prognosis of several types of cancer.']	[('INCOMPLETE_EVIDENCE', 25), ('PROBABLE_UNDERSTANDING', 74), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 94), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 192), ('IMPORTANT_CONSIDERATION', 211), ('IMPORTANT_CONSIDERATION', 230)]	8	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0001977', 'blood serum', 158, 'serum'), ('CHEBI_28384', 'vitamin K', 178, 'Vitamin D')]
PMC4113768	7/2014	S1805-PMC4113768	['conclusions: OUR STUDY DEMONSTRATES that in east germany region (latitude: 51.3667) the Vitamin D status of one year old children is sufficient DUE to a general rickets prophylaxis, WHEREAS levels of two years old infants drop back to levels similar SEEN for Pregnant mothers.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('IMPORTANT_CONSIDERATION', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 250)]	6	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 259, 'pregnant')]
PMC4113768	7/2014	S1810-PMC4113768	['DUE to pleiotropic Vitamin D EFFECTS it INFLUENCES NOT ONLY physical and mental health status BUT ALSO the quality of Life.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 51), ('ANOMALY_CURIOUS_FINDING', 94)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0000104', 'life cycle', 118, 'life')]
PMC4113768	7/2014	S1835-PMC4113768	['methods: IN ORDER TO ASSESS the POTENTIAL health EFFECTS of Consuming Vitamin D fortified Foods, we performed a registry based study, taking advantage of the extensive danish PUBLIC HEALTH registries.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 175)]	5	[('GO_0007631', 'feeding behavior', 60, 'consuming'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_33290', 'food', 90, 'foods')]
PMC4113768	7/2014	S1840-PMC4113768	['this is of particular IMPORTANCE DUE TO the seasonal DEPENDENCE on dietary sources of Vitamin D in denmark.']	[('IMPORTANT_CONSIDERATION', 22), ('PROBLEM_COMPLICATION', 33), ('SUPERFICIAL_RELATIONSHIP', 53)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4113768	7/2014	S1844-PMC4113768	['specifically, in regards to children Born after the cessation of Vitamin D fortification, children Born from may–july have an INCREASED RISK, (hazard ratio 1.40 (1.05,1.85)), of developing schizophrenia compared to children Born between november and january.']	[('IMPORTANT_CONSIDERATION', 126)]	1	[('GO_0007567', 'parturition', 37, 'born'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007567', 'parturition', 99, 'born'), ('GO_0007567', 'parturition', 224, 'born')]
PMC4113768	7/2014	S1849-PMC4113768	['; parr, t.\nbackground: it is WELL KNOWN that Calcitriol, the active form of Vitamin D, is ESSENTIAL for Bone development and maintenance.']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 90)]	2	[('CHEBI_17823', 'calcitriol', 45, 'calcitriol'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007567', 'parturition', 104, 'bone')]
PMC4113768	7/2014	S1866-PMC4113768	['; lanham-new, s.\nbackground: maintaining a healthy Vitamin D status is PROBLEMATIC within the uk, largely DUE TO a combination of two FACTORS: required uv exposure for dermal Production Of Vitamin D is limited by seasonality and there are few Vitamin D-rich foods readily available within the diet.']	[('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 71), ('PROBABLE_UNDERSTANDING', 106), ('PROBLEM_COMPLICATION', 106), ('SUPERFICIAL_RELATIONSHIP', 134)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 175, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4113768	7/2014	S1867-PMC4113768	['with the IMPLICATIONS of a low Vitamin D status KNOWN to include POOR bone and muscle function, establishing STRATEGIES to improve the availability of Vitamin D sources to the population is VITAL.']	[('IMPORTANT_CONSIDERATION', 9), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 65), ('FUTURE_WORK', 109), ('IMPORTANT_CONSIDERATION', 190)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D')]
PMC4113768	7/2014	S1868-PMC4113768	['WHILST Food fortification is a sustainable solution for the PREVENTION of Vitamin D deficiency, the Food industry NEEDS to determine SUITABLE means of carriage IF it is to maximise the effectiveness of fortification.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 60), ('FUTURE_WORK', 114), ('IMPORTANT_CONSIDERATION', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160)]	5	[('CHEBI_33290', 'food', 7, 'food'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_33290', 'food', 100, 'food')]
PMC4113768	7/2014	S1879-PMC4113768	['conclusions: THIS STUDY has IMPORTANT IMPLICATIONS for the FUTURE of Food fortification in helping to raise the Vitamin D status of the population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('IMPORTANT_CONSIDERATION', 28), ('IMPORTANT_CONSIDERATION', 38), ('FUTURE_WORK', 59)]	4	[('CHEBI_33290', 'food', 69, 'food'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4113768	7/2014	S1969-PMC4113768	['BECAUSE of the IMPORTANCE of Vitamin D for many functions in the Human body and the limited Vitamin D synthesis in the skin between october and april; it is IMPORTANT to have another source of Vitamin D during these months.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 15), ('IMPORTANT_CONSIDERATION', 157)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 65, 'human'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D')]
PMC4113768	7/2014	S1979-PMC4113768	['THEREFORE, we SHOULD PAY more ATTENTION to Food as a natural source of Vitamin D.\n\n2.90.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 14), ('IMPORTANT_CONSIDERATION', 14), ('IMPORTANT_CONSIDERATION', 21), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 30)]	6	[('CHEBI_33290', 'food', 43, 'food'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4113768	7/2014	S1994-PMC4113768	['THIS STUDY adds NEW EVIDENCE to the research body of Vitamin D deficiency in RELATION to INCREASED RISKS of clrd, cvd and all-cause mortality.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 77), ('IMPORTANT_CONSIDERATION', 89)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4113768	7/2014	S2000-PMC4113768	['this RAISES the HYPOTHESIS that low Vitamin D is RELATED to POOR mental health in the Adult general population.']	[('EXPLICIT_QUESTION', 5), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 60)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0007023', 'adult organism', 86, 'adult')]
PMC4113768	7/2014	S2041-PMC4113768	['despite these INTERVENTIONS, a substantial portion of our population is AT-RISK of suboptimal Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('IMPORTANT_CONSIDERATION', 72)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC4113768	7/2014	S2049-PMC4113768	['conclusions: Vitamin D status in ireland has improved immensely in ireland over the past 40 years, but TARGETED PUBLIC HEALTH policies of low-dose supplementation ARE NEEDED TO address AT-RISK groups, and mandated fortification to SAFE levels SHOULD maintain Vitamin D adequacy in the population.']	[('FUTURE_WORK', 103), ('IMPORTANT_CONSIDERATION', 112), ('FUTURE_WORK', 163), ('QUESTION_ANSWERED_BY_THIS_WORK', 174), ('IMPORTANT_CONSIDERATION', 185), ('IMPORTANT_CONSIDERATION', 231), ('FUTURE_WORK', 243)]	7	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
PMC4113768	7/2014	S2066-PMC4113768	['conclusions: the results of THIS STUDY SUGGEST an IMPORTANT ROLE for Vitamin D in the modulation of Immune response in children with Lower Respiratory Tract infections.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('UBERON_0004905', 'articulation', 133, 'lower respiratory tract')]
PMC4113768	7/2014	S2072-PMC4113768	['in VIEW of the concerns that unsubstantiated claims were being made concerning the levels of Vitamin D intake NEEDED for health, the governments of us and canada commissioned a report by the iom.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 110)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4113768	7/2014	S2073-PMC4113768	['the 2011 iom report CONCLUDED (i) that the ESTIMATED average Vitamin D REQUIREMENT from all dietary sources is 10 µg (400 iu) daily in those with minimal sunlight exposure, corresponding to a median Serum 25Ohd level of 40 nmol/l; (ii) that a 25Ohd level below 30 nmol/l indicated risk of deficiency; (iii) that a 25ohd level above 50 nmol/l INDICATED sufficiency in 97.5%; and (iv) that 25ohd levels in excess of 125 nmol/l COULD BE ASSOCIATED with harm.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 71), ('INCOMPLETE_EVIDENCE', 342), ('INCOMPLETE_EVIDENCE', 425), ('SUPERFICIAL_RELATIONSHIP', 434)]	6	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001977', 'blood serum', 199, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 205, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 243, '25OHD')]
PMC4113768	7/2014	S2074-PMC4113768	['ireland’s high northerly latitude, which prevents skin production for 6 months of the year, places our population AT RISK of Vitamin D deficiency.']	[('IMPORTANT_CONSIDERATION', 114)]	1	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4113768	7/2014	S2086-PMC4113768	['conclusions: groups AT RISK of hypovitaminosis D NEED to consume Vitamin D-rich or fortified Foods and would BENEFIT from taking a daily low dose Vitamin D supplement of 5–10 µg (200–400 iu) IN KEEPING WITH the iom specifications for total daily Vitamin D intake.']	[('IMPORTANT_CONSIDERATION', 20), ('IMPORTANT_CONSIDERATION', 49), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 191)]	4	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 47, 'D'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_33290', 'food', 93, 'foods'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
PMC4113768	7/2014	S2088-PMC4113768	['the ESTIMATED average Vitamin D REQUIREMENT from all dietary sources is STRONGLY EVIDENCE-BASED and SHOULD represent the target total daily amount for everyone including Supplement users.']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 32), ('PROBABLE_UNDERSTANDING', 72), ('INCOMPLETE_EVIDENCE', 81), ('FUTURE_WORK', 100), ('IMPORTANT_CONSIDERATION', 100)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 170, 'supplement')]
PMC4113768	7/2014	S2104-PMC4113768	['conclusions: low Vitamin D levels were ASSOCIATED with an INCREASED RISK of stroke in this prospective cohort study of older primary care patients.this ASSOCIATION was INDEPENDENT of several IMPORTANT CONFOUNDERS and ONLY PARTLY EXPLAINED by conventional risk factors and Cardiovascular disease AS POTENTIAL causal intermediates.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 191), ('PROBLEM_COMPLICATION', 201), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 222), ('PROBABLE_UNDERSTANDING', 229), ('PROBABLE_UNDERSTANDING', 295), ('INCOMPLETE_EVIDENCE', 298)]	11	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 272, 'cardiovascular')]
PMC4113768	7/2014	S2110-PMC4113768	['a main REASON is the INADEQUATE uvb radiation during fall and winter in northern latitudes, which limits the endogenous Vitamin D production.']	[('PROBABLE_UNDERSTANDING', 7), ('IMPORTANT_CONSIDERATION', 21)]	2	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4113768	7/2014	S2295-PMC4113768	['IT IS CLEAR that general female public FACES an IMMINENT THREAT of Vitamin D deficiency-RELATED diseases UNLESS aggressive public AWARENESS is conducted.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 39), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 57), ('SUPERFICIAL_RELATIONSHIP', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('IMPORTANT_CONSIDERATION', 130)]	7	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4113768	7/2014	S2311-PMC4113768	['the ASSOCIATION between pth and Cholesterol levels as well as the inverse ASSOCIATION between Vitamin D status and Ft3 NEEDS TO BE reassessed prospectively on a larger scale to confirm THESE FINDINGS.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 119), ('INCOMPLETE_EVIDENCE', 185)]	4	[('CHEBI_16113', 'cholesterol', 32, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 115, 'FT3')]
PMC4113768	7/2014	S2357-PMC4113768	['background: seasonal variations in circulating Vitamin D levels provide VITAL INFORMATION as to the most APPROPRIATE time to either start or increase Vitamin D supplementation in order to maintain OPTIMAL Vitamin D levels.']	[('IMPORTANT_CONSIDERATION', 72), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 105), ('IMPORTANT_CONSIDERATION', 197)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
PMC4113768	7/2014	S2367-PMC4113768	['increased Vitamin D supplementation is THUS RECOMMENDED to maintain OPTIMAL Serum 25(Oh) Vitamin D levels during the summer season.']	[('PROBABLE_UNDERSTANDING', 39), ('FUTURE_WORK', 44), ('IMPORTANT_CONSIDERATION', 68)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_30778', 'gallic acid', 82, '25(OH)'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4113768	7/2014	S2385-PMC4113768	['OUR FINDINGS implicate that Vitamin D supplementation becomes more IMPORTANT in older age groups and during wintertime.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 67)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4113768	7/2014	S2398-PMC4113768	['eligible studies included Pregnant women and their offspring, and one or more RELEVANT exposures (either assessment of Vitamin D status (dietary intake, sunlight exposure, circulating 25(Oh)D) or supplementation of participants with Vitamin D or Vitamin D containing Food e.g., oily fish) and outcomes (offspring birth weight, Birth length, Head circumference, bone mass, anthropometry and body composition, risk of asthma and atopy, small for Gestational dates, Preterm Birth, type 1 diabetes, low Birth weight, Serum calcium concentration, Blood pressure and rickets).']	[('IMPORTANT_CONSIDERATION', 78)]	1	[('GO_0007565', 'female pregnancy', 26, 'pregnant'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 184, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 184, '25(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 190, 'D'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_33290', 'food', 267, 'food'), ('GO_0007567', 'parturition', 327, 'birth'), ('UBERON_0000033', 'head', 341, 'head'), ('GO_0007565', 'female pregnancy', 444, 'gestational'), ('GO_0007565', 'female pregnancy', 463, 'preterm birth'), ('GO_0007567', 'parturition', 499, 'birth'), ('UBERON_0001977', 'blood serum', 513, 'serum'), ('UBERON_0000178', 'blood', 542, 'blood')]
PMC4113768	7/2014	S2413-PMC4113768	['; cooper, c.\nbackground: Rxra is an IMPORTANT part of the binding and Nuclear action of several Molecules, including Vitamin D, Thyroxin, Glucocorticoids and ppar.']	[('IMPORTANT_CONSIDERATION', 36)]	1	[('PR_000014373', 'retinoic acid receptor RXR-beta', 25, 'RXRa'), ('GO_0005634', 'nucleus', 70, 'nuclear'), ('CHEBI_36357', 'polyatomic entity', 96, 'molecules'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_71941', 'tolmetin', 128, 'thyroxin'), ('CHEBI_36597', 'phthalazine', 138, 'glucocorticoids')]
PMC4113768	7/2014	S2424-PMC4113768	['contemporary and historical EVIDENCE INDICATES the VALUE of Vitamin D in treating tb and Genetic variation in Vitamin D receptors HAS BEEN LINKED to ethnic variations in tb.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 139)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('SO_0000704', 'gene', 89, 'genetic'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4113768	7/2014	S2441-PMC4113768	['healthcare providers SHOULD BE AWARE that Vitamin D deficiency is LIKELY to be currently under-diagnosed in tb patients.']	[('FUTURE_WORK', 21), ('IMPORTANT_CONSIDERATION', 21), ('IMPORTANT_CONSIDERATION', 31), ('PROBABLE_UNDERSTANDING', 66)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC4113768	7/2014	S2443-PMC4113768	['FURTHER STUDIES to identify the UNDERLYING mechanisms RELATING to the very high levels of Vitamin D deficiency in tb patients from the horn of africa and indian subcontinent will have IMPLICATIONS for understanding the ROLE of Vitamin D in tb aetiology as well as for the prevention and treatment of active tuberculous disease in these patients.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 184), ('SUPERFICIAL_RELATIONSHIP', 219)]	5	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC4113768	7/2014	S2448-PMC4113768	['HOWEVER it is BECOMING CLEAR that subgroups of the population are AT RISK of Vitamin D deficiency because of INADEQUATE sunlight exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 14), ('IMPORTANT_CONSIDERATION', 66), ('IMPORTANT_CONSIDERATION', 109)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC4113768	7/2014	S2463-PMC4113768	['as participants with higher Pigmented skin require a longer period of sunlight exposure to synthesise the same amount of Vitamin D as lighter skins, the former group will have produced less Vitamin D. diet provided 70–90 iu Vitamin D per day (median) across the seasons and sunlight exposure was the MAJOR CONTRIBUTOR (accounting for 70%) to total Vitamin D in summer as shown below (median (iqr)).']	[('IMPORTANT_CONSIDERATION', 300), ('SUPERFICIAL_RELATIONSHIP', 306)]	2	[('CHEBI_26130', 'biological pigment', 28, 'pigmented'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D')]
PMC4113768	7/2014	S2465-PMC4113768	['of the participants who did not take Supplements, none achieved the current uk RECOMMENDED dietary intake of 400 iu Vitamin D per day for those AT RISK of deficiency; and for the supplement users the RECOMMENDATION was ONLY achieved by one Person in spring and 2 People in summer and autumn.']	[('FUTURE_WORK', 79), ('IMPORTANT_CONSIDERATION', 144), ('FUTURE_WORK', 200), ('INCOMPLETE_EVIDENCE', 219)]	4	[('CHEBI_33341', 'titanium atom', 37, 'supplements'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 240, 'person'), ('NCBITaxon_10088', 'Mus <genus>', 263, 'people')]
PMC4113768	7/2014	S2498-PMC4113768	['KEY modifiable DETERMINANTS of achievement of peak bone mass are calcium intake, physical activity and Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 15)]	2	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4113768	7/2014	S2499-PMC4113768	['female ballet dancers and gymnasts are known to have POOR Vitamin D status POSSIBLY DUE TO heavy indoor training schedules limiting sun exposure, however it is LIKELY that their high levels of physical activity ameliorate the DETRIMENTAL EFFECTS of low Vitamin D and dietary Calcium.']	[('IMPORTANT_CONSIDERATION', 53), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 160), ('IMPORTANT_CONSIDERATION', 226), ('SUPERFICIAL_RELATIONSHIP', 238)]	7	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 275, 'calcium')]
PMC4113768	7/2014	S2517-PMC4113768	['THESE FINDINGS SUGGEST that; (1) there is no additional BENEFIT to calcium absorption or bone mineralisation from a Blood level for 25(Oh)D above ~75 nmol/l; (2)DESPITE adequate Vitamin D and regular physical activity lower dietary Calcium intake is STILL a PREDICTOR of lower total body bmd and bmc; and (3) in certain population groups with baseline 25(Oh)D > 75 nmol/l, Vitamin D supplementation of 50,000 iu/month does not significantly increase 25(Oh)D concentrations over a 12 month period, but POSSIBLY PREVENTS seasonal decline.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 56), ('ANOMALY_CURIOUS_FINDING', 161), ('IMPORTANT_CONSIDERATION', 250), ('SUPERFICIAL_RELATIONSHIP', 258), ('INCOMPLETE_EVIDENCE', 501), ('SUPERFICIAL_RELATIONSHIP', 510)]	8	[('UBERON_0000178', 'blood', 116, 'blood'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 232, 'calcium'), ('CHEBI_71657', 'versiconol acetate', 352, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 352, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 450, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 450, '25(OH)D')]
PMC4113768	7/2014	S2521-PMC4113768	['background: understanding of the EFFECT of Vitamin D supplementation on Plasma 25(Oh)D levels is ESSENTIAL to optimizing nutritional status and health.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 97)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 72, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 79, '25 ... OH ... D')]
PMC4113768	7/2014	S2543-PMC4113768	['background: AS Vitamin D is ESSENTIAL to calcium Regulation, the concern HAS BEEN RAISED that high levels of Vitamin D MAY lead TO hypercalcemia (Plasma levels exceeding 2.6 mmol/l) that, in turn, MAY increase the RISK of adverse health events such as Cardiac arrest, Renal failure, and Hepatic injuries.']	[('PROBABLE_UNDERSTANDING', 12), ('IMPORTANT_CONSIDERATION', 28), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 73), ('EXPLICIT_QUESTION', 82), ('INCOMPLETE_EVIDENCE', 119), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('INCOMPLETE_EVIDENCE', 197), ('IMPORTANT_CONSIDERATION', 214)]	9	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0065007', 'biological regulation', 49, 'regulation'), ('CHEBI_28384', 'vitamin K', 109, 'Vitamin D'), ('UBERON_0001969', 'blood plasma', 146, 'plasma'), ('UBERON_0000948', 'heart', 252, 'cardiac'), ('UBERON_0002113', 'kidney', 268, 'renal'), ('UBERON_0002107', 'liver', 287, 'hepatic')]
PMC4113768	7/2014	S2544-PMC4113768	['our OBJECTIVE is TO EXAMINE the INFLUENCE of Vitamin D supplementation on Serum calcium levels and the RISK for hypercalcimia in healthy volunteers in the pure north health program.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 32), ('IMPORTANT_CONSIDERATION', 103)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001977', 'blood serum', 74, 'serum')]
PMC4113768	7/2014	S2552-PMC4113768	['conclusion: these FINDING CONFIRM that healthy subjects supplementing with Vitamin D at modest levels are not at INCREASED RISK for hypercalcemia and SUGGEST that the same applies for supplementation levels as high as 20,000 iu per day.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 113), ('INCOMPLETE_EVIDENCE', 150)]	4	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC4113768	7/2014	S2560-PMC4113768	['background: SUBOPTIMAL Vitamin D status MAY BE ASSOCIATED with a variety of adverse health outcomes.']	[('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC4113768	7/2014	S2582-PMC4113768	['low Vitamin D status is PREVALENT among industrialized populations.']	[('IMPORTANT_CONSIDERATION', 24)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
PMC4113768	7/2014	S2587-PMC4113768	['in denmark, THEREFORE, national programs for Food fortification with Vitamin D are CONSIDERED.']	[('PROBABLE_UNDERSTANDING', 12), ('FUTURE_WORK', 83), ('IMPORTANT_CONSIDERATION', 83)]	3	[('CHEBI_33290', 'food', 45, 'food'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4113768	7/2014	S2593-PMC4113768	['THUS, OUR STUDY AIMED TO ASSESS IF Intake of Foods fortified with Vitamin D during Gestation had an EFFECT on the RISK of t1d later in Life.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 100), ('IMPORTANT_CONSIDERATION', 114)]	7	[('GO_0007631', 'feeding behavior', 35, 'intake'), ('CHEBI_33290', 'food', 45, 'foods'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'gestation'), ('UBERON_0000104', 'life cycle', 135, 'life')]
PMC4113768	7/2014	S2662-PMC4113768	['there is ACCUMULATING EVIDENCE from meta-analyses of cohort studies that Vitamin D deficiency, AS measured by low Serum levels of 25-Hydroxy Vitamin D (25(Oh)D), PREDICTS INCREASED RISK of all-cause mortality, Cardiovascular disease and hypertension.']	[('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 171)]	4	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001977', 'blood serum', 114, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 130, '25-hydroxy vitamin D'), ('CHEBI_33010', 'chromide(1-)', 154, '(OH)D'), ('UBERON_0004535', 'cardiovascular system', 210, 'cardiovascular')]
PMC4113768	7/2014	S2878-PMC4113768	['RECENTLY, Vitamin D status during icu admission HAS BEEN shown to be ASSOCIATED with the RISK of short-term (30-, 60-, and 90-day) and long-term (1-year) mortality in critically ill patients.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 69), ('IMPORTANT_CONSIDERATION', 89)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC4113768	7/2014	S2918-PMC4113768	['epidemiologic studies INDICATE that there is an inverse RELATIONSHIP between Vitamin D and the RISK and prognosis of Lung cancer.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 95)]	3	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0002048', 'lung', 117, 'lung')]
PMC4113768	7/2014	S2936-PMC4113768	['background: adequate Vitamin D status is an IMPORTANT modulator of Immunity against mycobacterium tb.']	[('IMPORTANT_CONSIDERATION', 44)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007566', 'embryo implantation', 67, 'immunity')]
PMC4113768	7/2014	S3096-PMC4113768	['ALTHOUGH Vitamin D HAS BEEN ASSOCIATED with the development of tb in Adults, LITTLE RESEARCH has EXAMINED the IMPORTANCE of Vitamin D levels in children.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 97), ('IMPORTANT_CONSIDERATION', 110)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 69, 'adults'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4113768	7/2014	S3097-PMC4113768	['THE CURRENT STUDY was DESIGNED TO IDENTIFY the EFFECT of Vitamin D insufficiency and deficiency (vdid) and host Genetic Single Nucleotide Polymorphisms (Snps) that alter Vitamin d receptor Expression on the RISK for tb in hiv-infected and –exposed infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 207)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('SO_0000704', 'gene', 112, 'genetic'), ('SO_0000694', 'SNP', 120, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 153, 'SNPs'), ('CHEBI_33229', 'vitamin (role)', 170, 'Vitamin'), ('GO_0010467', 'gene expression', 189, 'expression')]
PMC4113768	7/2014	S3177-PMC4113768	['intervention STUDIES ARE REQUIRED to more fully explore the EFFECTS on Vitamin D on Intestinal inflammation in cd.']	[('FUTURE_WORK', 13), ('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0000160', 'intestine', 84, 'intestinal')]
PMC4113768	7/2014	S3180-PMC4113768	['background: there are FEW STUDIES that look AT Vitamin D status in children living in sunny climates AS it is ASSUMED that they receive adequate Vitamin D from sun exposure.']	[('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 44), ('PROBABLE_UNDERSTANDING', 101), ('PROBABLE_UNDERSTANDING', 110)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC4113768	7/2014	S3189-PMC4113768	['knowing that modernization is bringing about a change in Vitamin D CAN inform policy-makers in ethiopia and other tropical countries about the need to implement PUBLIC HEALTH measures to prevent escalation of Vitamin D deficiency and its ASSOCIATED health outcomes.']	[('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 161), ('SUPERFICIAL_RELATIONSHIP', 238)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 65, 'D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC4113768	7/2014	S3194-PMC4113768	['; pearce, s.; rasvi, s.; jagger, c.\nbackground: DESPITE RECENT concerns about the high prevalence of low Vitamin D status in much of the british Adult and pediatric population, there is a dearth of data on Vitamin D status and its PREDICTORS in very old Adults, a sub-group of the population which is at INCREASED RISK of POOR Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('ANOMALY_CURIOUS_FINDING', 48), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 231), ('IMPORTANT_CONSIDERATION', 304), ('IMPORTANT_CONSIDERATION', 322)]	6	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 145, 'adult'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('UBERON_0007023', 'adult organism', 254, 'adults'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D')]
PMC4113768	7/2014	S3267-PMC4113768	['Vitamin D Metabolites SUPPORT anti-Viral activity in vitro , and a single-centre TRIAL in patients with predominantly SEVERE copd has REPORTED that Vitamin D supplementation reduced exacerbation RISK in patients with baseline Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 81), ('IMPORTANT_CONSIDERATION', 118), ('INCOMPLETE_EVIDENCE', 134), ('IMPORTANT_CONSIDERATION', 195)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_25212', 'metabolite', 10, 'metabolites'), ('NCBITaxon_1', 'root', 35, 'viral'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC4113768	7/2014	S3268-PMC4113768	['multi-centre trials of Vitamin D supplementation for PREVENTION of exacerbation and uri in patients with less SEVERE copd are LACKING.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 110), ('FULL_UNKNOWN', 126)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC4113768	7/2014	S3300-PMC4113768	['there are many mechanisms whereby Vitamin D CAN reduce the RISK of cvd including reduced risk of diabetes mellitus and Metabolic syndrome, EFFECTS on Blood pressure, Cholesterol, cytokines, Endothelial disruption, Glucose Regulation, Insulin resistance, muscle strength, Respiratory infections, and vascular calcification.']	[('INCOMPLETE_EVIDENCE', 44), ('IMPORTANT_CONSIDERATION', 59), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0008152', 'metabolic process', 119, 'metabolic'), ('UBERON_0000178', 'blood', 150, 'blood'), ('CHEBI_16113', 'cholesterol', 166, 'cholesterol'), ('UBERON_0001986', 'endothelium', 190, 'endothelial'), ('CHEBI_17234', 'glucose', 214, 'glucose'), ('GO_0006094', 'gluconeogenesis', 214, 'glucose regulation'), ('PR_000045358', 'insulin family protein', 234, 'insulin'), ('UBERON_0001004', 'respiratory system', 271, 'respiratory')]
PMC4113768	7/2014	S3333-PMC4113768	['when they are, they, too, will add to the UNDERSTANDING of the ROLE of Vitamin D in reducing the RISK of many types of disease and adverse health outcomes.']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 63), ('IMPORTANT_CONSIDERATION', 97)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4113768	7/2014	S3366-PMC4113768	['background: Peripheral Leukocytes, which Express Vitamin D receptor (vdr) and are capable of locally yielding active Vitamin D, play an IMPORTANT ROLE in inflammatory responses.']	[('IMPORTANT_CONSIDERATION', 136), ('SUPERFICIAL_RELATIONSHIP', 146)]	2	[('CL_0002481', 'peritubular myoid cell', 12, 'Peripheral leukocytes'), ('GO_0010467', 'gene expression', 41, 'express'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC4113768	7/2014	S3372-PMC4113768	['results: the Genome-wide methylation scan REVEALED that african americans with SEVERE Vitamin D deficiency had reduced levels of methylation compared with controls.']	[('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 79)]	2	[('SO_0001026', 'genome', 13, 'genome'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4113768	7/2014	S3379-PMC4113768	['conclusion: SEVERE Vitamin D deficiency is ASSOCIATED with methylation changes in Leukocyte dna in young african americans, which MAY BE INVOLVED in systemic inflammation.']	[('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 137)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CL_0000738', 'leukocyte', 82, 'leukocyte')]
PMC4155147	4/2007	S79-PMC4155147	['the recommended dosage originally on the package was one tablet “every three hours.” HOWEVER, it was RECENTLY changed to add “up to three times per day as NECESSARY,” BECAUSE the 15,000 units of Vitamin A from three tablets is enough to cause POSSIBLE Liver damage, dizziness, and blurred Vision.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 155), ('PROBABLE_UNDERSTANDING', 167), ('INCOMPLETE_EVIDENCE', 243)]	5	[('CHEBI_27300', 'vitamin D', 195, 'vitamin A'), ('UBERON_0002107', 'liver', 252, 'liver'), ('GO_0007601', 'visual perception', 289, 'vision')]
PMC4161853	8/2014	S214-PMC4161853	['HENCE, Vitamin A plays an IMPORTANT ROLE in the Intestinal Immune System as a source of Retinoic Acid (Ra), a Gut-homing factor for Iga Secreting cells in Intestinal Mucosa [117,118].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 36)]	3	[('CHEBI_27300', 'vitamin D', 7, 'vitamin A'), ('UBERON_0000160', 'intestine', 48, 'intestinal'), ('GO_0007566', 'embryo implantation', 59, 'immune'), ('UBERON_0002405', 'immune system', 59, 'immune system'), ('CHEBI_26536', 'retinoic acid', 88, 'retinoic acid'), ('CHEBI_36927', 'carbon-14 atom', 103, 'RA'), ('UBERON_0001555', 'digestive tract', 110, 'gut'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 132, 'IgA'), ('GO_0046903', 'secretion', 136, 'secreting'), ('UBERON_0001242', 'intestinal mucosa', 155, 'intestinal mucosa'), ('CL_0000187', 'muscle cell', 166, 'mucosa')]
PMC4161853	8/2014	S218-PMC4161853	['AS SEVERE malnutrition is one of the risk FACTORS to develop malaria-ibi co-infection, it is IMPORTANT TO evaluate the IMPACT of Vitamin A administration in the clinical management of children with malaria and ibi-co-infection in africa, EITHER as a therapeutic and/OR prophylactic measure, ESPECIALLY due to recent EVIDENCE of the positive IMPACT of Vitamin A and zinc supplementation on malaria morbidity in a study conducted in ghana [121,122].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 3), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('IMPORTANT_CONSIDERATION', 291), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 341)]	10	[('CHEBI_27300', 'vitamin D', 129, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin A')]
PMC4161853	8/2014	S219-PMC4161853	['HOWEVER, in Man, the ROLE of Vitamin A in malaria pathogenesis is multifaceted, and p. falciparum clearly BENEFITS from normal to high Vitamin A Hepatic stores, POSSIBLY depending on scavenged Vitamin A Metabolites to destabilize host Rbc Membranes facilitating invasion [123].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 106), ('INCOMPLETE_EVIDENCE', 161)]	4	[('NCBITaxon_40674', 'Mammalia', 12, 'man'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('UBERON_0002107', 'liver', 145, 'hepatic'), ('CHEBI_26871', 'terpene alkaloid', 193, 'vitamin A metabolites'), ('CL_0000232', 'erythrocyte', 235, 'RBC'), ('GO_0016020', 'membrane', 239, 'membranes')]
PMC4169453	9/2014	S16-PMC4169453	['Vitamin D supplementation in Lactating women MAY ensure APPROPRIATE maternal Vitamin D status in cases of low Vitamin D dietary consumption and restricted synthesis in the skin[7].']	[('INCOMPLETE_EVIDENCE', 45), ('IMPORTANT_CONSIDERATION', 56)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007594', 'puparial adhesion', 29, 'lactating'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4169453	9/2014	S17-PMC4169453	['most of the RECENTLY PUBLISHED rct in Lactating women HAVE BEEN focused on maternal supplementation as a method of achieving APPROPRIATE Vitamin D status in both, mothers and their Breastfed offspring[8]–[11].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 125)]	3	[('GO_0007594', 'puparial adhesion', 38, 'lactating'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007567', 'parturition', 181, 'breastfed')]
PMC4169453	9/2014	S19-PMC4169453	['HOWEVER, the OPTIMAL Vitamin D intake as well as OPTIMAL 25(Oh)D level for Lactating women (BASED ON ESTIMATED maternal NEEDS) STILL REMAINS NOT fully ESTABLISHED, or AT LEAST not accepted worldwide.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 127), ('FULL_UNKNOWN', 133), ('PROBABLE_UNDERSTANDING', 167)]	10	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('GO_0007594', 'puparial adhesion', 75, 'lactating')]
PMC4169453	9/2014	S20-PMC4169453	['the RECOMMENDED Vitamin D intake VARIES from 400 iu/d to 2000 iu/d[7],[12]–[16], BUT supplementation using less than 1000 iu/d MAY BE INADEQUATE for maintaining an “optimal” 25(Oh)D level[17].']	[('FUTURE_WORK', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 127), ('IMPORTANT_CONSIDERATION', 134), ('PROBLEM_COMPLICATION', 134)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 174, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 180, 'D')]
PMC4169453	9/2014	S88-PMC4169453	['sample size calculation\nto detect a statistically significant difference in Serum 25(Oh)D level (primary outcome) by 4 ng/ml between the intervention groups after Vitamin D supplementation at least 64 mother-infant pairs per group were REQUIRED at 80% power using a two-sided t-test at α\u200a=\u200a0.05.']	[('IMPORTANT_CONSIDERATION', 236)]	1	[('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_71657', 'versiconol acetate', 82, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 82, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC4169453	9/2014	S142-PMC4169453	['a CORRELATION between maternal and breastfed infants’ 25(Oh)D levels was STILL significant after 3 and 6 months of Vitamin D supplementation BUT APPEARED weaker than the Postpartum CORRELATION: in the 400 iu/d group at v3 r\u200a=\u200a0.35 ( p \u200a=\u200a0.003) and at v6 r\u200a=\u200a0.4 ( p \u200a=\u200a0.0009), and in the 1200 iu/d group at v3 r\u200a=\u200a0.3 ( p \u200a=\u200a0.01) and at v6 r\u200a=\u200a0.39 ( p \u200a=\u200a0.0007), respectively.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('ANOMALY_CURIOUS_FINDING', 73), ('IMPORTANT_CONSIDERATION', 73), ('ANOMALY_CURIOUS_FINDING', 141), ('ANOMALY_CURIOUS_FINDING', 145), ('SUPERFICIAL_RELATIONSHIP', 181)]	6	[('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 60, 'D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'postpartum')]
PMC4169453	9/2014	S183-PMC4169453	['in CONSEQUENCE, fundamental QUESTIONS of: a) HOW much Vitamin D is enough to reach and maintain OPTIMAL 25(Oh)D level, and b) what is the OPTIMAL range for 25(Oh)D levels, REMAIN an ISSUE of DEBATE[32],[33].']	[('PROBABLE_UNDERSTANDING', 3), ('EXPLICIT_QUESTION', 28), ('EXPLICIT_QUESTION', 45), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 138), ('INCOMPLETE_EVIDENCE', 172), ('PROBLEM_COMPLICATION', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191)]	8	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 106, '(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 156, '25(OH)D')]
PMC4169453	9/2014	S186-PMC4169453	['the studies performed in healthy Individuals INDICATE that Vitamin D supplementation at a dose of 3000–7000 iu/d MIGHT be NECESSARY to achieve a Serum 25(Oh)D level of at least 30 ng/ml in 97.5% of that population[17],[35]–[37].']	[('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 113), ('IMPORTANT_CONSIDERATION', 122)]	3	[('NCBITaxon_1', 'root', 33, 'individuals'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 154, 'OH)D')]
PMC4169453	9/2014	S188-PMC4169453	['KEEPING IN MIND RECENT LITERATURE, TO address the QUESTION of the lowest EFFECTIVE and SAFE Vitamin D dose NEEDED to observe health BENEFITS for both Lactating mother and Breastfed offspring, a higher Vitamin D doses would be chosen and evaluated in our rct (1500 iu/d vs. 2000 iu/d vs. 3000 iu/d).']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('EXPLICIT_QUESTION', 50), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 87), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 132)]	8	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 150, 'lactating'), ('GO_0007567', 'parturition', 171, 'breastfed'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC4169453	9/2014	S197-PMC4169453	['taking into account the maternal REQUIREMENT, 1200 iu/d of Vitamin D MAY PROTECT against Vitamin D deficiency, but SEEMS TOO low TO fully replenish Vitamin D insufficiency (20 ng/ml<25(Oh)D <30 ng/ml).']	[('IMPORTANT_CONSIDERATION', 33), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 73), ('ANOMALY_CURIOUS_FINDING', 115), ('DIFFICULT_TASK', 121)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 182, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 182, '25 ... OH ... D')]
PMC4169453	9/2014	S200-PMC4169453	['though supplementation at a dose of 2000 iu/d was PREVIOUSLY REPORTED to increase maternal 25(Oh)D to 30–39 ng/ml[35],[38],[39], it STILL MIGHT be insufficient for Vitamin D-deficient women[40],[41].']	[('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 132), ('INCOMPLETE_EVIDENCE', 138)]	4	[('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 91, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4169453	9/2014	S203-PMC4169453	['it is JUSTIFIED to RECOMMEND Vitamin D supplementation in breastfeeding women BASED ON their NEEDS and separately in Breastfed infants.']	[('IMPORTANT_CONSIDERATION', 6), ('FUTURE_WORK', 19), ('SUPERFICIAL_RELATIONSHIP', 78), ('IMPORTANT_CONSIDERATION', 93)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007567', 'parturition', 117, 'breastfed')]
PMC4169453	9/2014	S205-PMC4169453	['THEREFORE, breastfeeding infants NEED additional Vitamin D supplementation when maternal intake is 1200 iu/d.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 33)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4169453	9/2014	S206-PMC4169453	['NEVERTHELESS, we SHOULD KEEP IN MIND that each 400 iu/d of Vitamin D MAY increase Serum 25(Oh)D level by 2.8 ng/ml[17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 69)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0001977', 'blood serum', 82, 'serum'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 88, '25(OH)D')]
PMC4169453	9/2014	S211-PMC4169453	['in the light of the aforementioned studies, Vitamin D supplements SEEMS to be more effective as a source of Vitamin D in many contemporary industrialized populations SUFFERING from changing lifestyles (restricted sun exposure, obesity, unhealthy diet).']	[('ANOMALY_CURIOUS_FINDING', 66), ('IMPORTANT_CONSIDERATION', 166)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4169453	9/2014	S221-PMC4169453	['keeping IN MIND the diminutive DIFFERENCES in 25(Oh)D levels among the study groups, we ASSUMED that the Vitamin D status in nursing women had no IMPACT on bone mass and body composition.']	[('IMPORTANT_CONSIDERATION', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 146)]	4	[('CHEBI_71657', 'versiconol acetate', 46, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 52, 'D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4169453	9/2014	S223-PMC4169453	['the INFLUENCE of Vitamin D status and bone mass in nursing women MIGHT BE evaluated FURTHER BUT higher Vitamin D doses are NECESSARY.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 71), ('FUTURE_WORK', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('IMPORTANT_CONSIDERATION', 123)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4169453	9/2014	S238-PMC4169453	['HOWEVER, diet is not an IMPORTANT source of Vitamin D in poland[5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 24)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4169453	9/2014	S241-PMC4169453	['Vitamin D3 supplementation at a dose of 1200 iu/d is more EFFECTIVE at improving Vitamin D status of nursing women, but STILL SEEMS TOO low TO fully replenish Vitamin D deficiency/insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 120), ('IMPORTANT_CONSIDERATION', 120), ('ANOMALY_CURIOUS_FINDING', 126), ('DIFFICULT_TASK', 132)]	5	[('CHEBI_33237', 'vitamin D4', 0, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4169453	9/2014	S243-PMC4169453	['FURTHER STUDIES of Vitamin D supplementation during Lactation are NECESSARY to determine the OPTIMAL dosing for nursing women when taking into account maternal NEEDS.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 66), ('IMPORTANT_CONSIDERATION', 93), ('IMPORTANT_CONSIDERATION', 160)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007595', 'lactation', 52, 'lactation')]
PMC4171568	9/2014	S135-PMC4171568	['Vitamin D as a risk factor for the development of schizophrenia\nit HAS BEEN HYPOTHESIZED that low Prenatal Vitamin D is a risk factor for the incidence of Adult-onset schizophrenia AS the lack of this fat-soluble Vitamin and Steroid Hormone MAY DETRIMENTALLY IMPACT on the developing foetal Brain [102].']	[('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 181), ('INCOMPLETE_EVIDENCE', 241), ('IMPORTANT_CONSIDERATION', 245), ('SUPERFICIAL_RELATIONSHIP', 259)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'prenatal'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0007023', 'adult organism', 155, 'adult'), ('CHEBI_33229', 'vitamin (role)', 213, 'vitamin'), ('CHEBI_26764', 'steroid hormone', 225, 'steroid hormone'), ('UBERON_0000955', 'brain', 291, 'brain')]
PMC4172095	8/2014	S134-PMC4172095	['nutritional guidelines for Pregnancy tend to HIGHLIGHT the IMPORTANCE of ensuring sufficient Intake of a range of Micronutrients, including Iron, Folic Acid, b vitamins, zinc, magnesium, Iodine, Vitamin A, and Calcium (kaiser et al., 2002).']	[('INCOMPLETE_EVIDENCE', 45), ('IMPORTANT_CONSIDERATION', 59)]	2	[('GO_0007565', 'female pregnancy', 27, 'pregnancy'), ('GO_0007631', 'feeding behavior', 93, 'intake'), ('CHEBI_33839', 'macromolecule', 114, 'micronutrients'), ('CHEBI_24870', 'ion', 140, 'iron'), ('CHEBI_30751', 'formic acid', 146, 'folic acid'), ('CHEBI_24859', 'iodine atom', 187, 'iodine'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin A'), ('CHEBI_22313', 'alkaline earth metal atom', 210, 'calcium')]
PMC4188019	1/2010	S12-PMC4188019	['conclusion: low Vitamin D levels SEEM TO BE frequent and covered woman are at a higher RISK of deficiency.']	[('ANOMALY_CURIOUS_FINDING', 33), ('IMPORTANT_CONSIDERATION', 87)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC4188019	1/2010	S17-PMC4188019	['25-Oh Vitamin D deficiency is ASSOCIATED with an INCREASED RISK of developing preeclampsia (bodnar et al., 2007; haugen et al., 2009), multiple sclerosis (hayes et al., 1997; pierrot-deseilligny, 2009) and schizophrenia (mcgrath, 1999; mcgrath et al., 2003).']	[('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 49)]	2	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 0, '25-OH'), ('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC4188019	1/2010	S63-PMC4188019	['this SUGGESTS a widespread SHORTAGE of Vitamin D in our population, 1,75% was suffering from SEVERE deficiency, 9,9% had moderate deficiency and 18,1% had mild deficiency.']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 93)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4188019	1/2010	S66-PMC4188019	['with NEW date on the ROLE of Vitamin D besides bone Metabolism, SOME authors are PLEADING for higher cut-off values to determine deficiency (norman et al., 2007; sachan et al., 2005; wagner et al., 2008).']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 81), ('IMPORTANT_CONSIDERATION', 81)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0008152', 'metabolic process', 52, 'metabolism')]
PMC4188019	1/2010	S80-PMC4188019	['AS this was a pilot STUDY, we ONLY measured 25-Oh Vitamin D. in the FUTURE, we will start including other RELEVANT parameters such as medical history, Serum levels of calcium and Parathyroid hormone.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 30), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 44, '25-OH'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0001977', 'blood serum', 151, 'serum'), ('UBERON_0001132', 'parathyroid gland', 179, 'parathyroid')]
PMC4192458	9/2014	S201-PMC4192458	['fruit and vegetables are low in fat and calories, and are IMPORTANT sources of Nutrients RELATED to hypertension in non-Pregnant populations including dietary fiber, calcium, Magnesium, Potassium, and Vitamins C [67].']	[('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 89)]	2	[('CHEBI_33284', 'nutrient', 79, 'nutrients'), ('GO_0007565', 'female pregnancy', 120, 'pregnant'), ('CHEBI_22313', 'alkaline earth metal atom', 175, 'magnesium'), ('CHEBI_22314', 'alkali metal atom', 186, 'potassium'), ('CHEBI_27300', 'vitamin D', 201, 'vitamins C')]
PMC4210927	10/2014	S14-PMC4210927	['in Preconception nutrition care, besides Folic Acid supplementation [3], it is IMPORTANT to have an adequate intake of Iron, Iodine, Calcium, Vitamins A and d, essential Fatty-Acids and dietary supplements, when NECESSARY [4,5].']	[('IMPORTANT_CONSIDERATION', 79), ('IMPORTANT_CONSIDERATION', 212)]	2	[('GO_0007565', 'female pregnancy', 3, 'preconception'), ('CHEBI_30751', 'formic acid', 41, 'folic acid'), ('CHEBI_24870', 'ion', 119, 'iron'), ('CHEBI_24859', 'iodine atom', 125, 'iodine'), ('CHEBI_22313', 'alkaline earth metal atom', 133, 'calcium'), ('CHEBI_27300', 'vitamin D', 142, 'vitamins A'), ('CHEBI_35366', 'fatty acid', 170, 'fatty-acids')]
PMC4210927	10/2014	S20-PMC4210927	['IN GENERAL, Pregnant women in developed countries are AT RISK of SUBOPTIMAL intakes of Folate, Iron and Vitamin D [20].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 54), ('IMPORTANT_CONSIDERATION', 65)]	3	[('GO_0007565', 'female pregnancy', 12, 'pregnant'), ('CHEBI_30863', '5-azaorotic acid', 87, 'folate'), ('CHEBI_24870', 'ion', 95, 'iron'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4216020	10/2014	S72-PMC4216020	['a larger prospective study, HOWEVER, DID NOT demonstrate an ASSOCIATED RISK between maternal smoking and jia.92\nOTHER Perinatal exposures and Pregnancy-related FACTORS HAVE BEEN investigated.47,92an australian study that reviewed 262 cases and matched controls IDENTIFIED a TREND towards a PROTECTIVE EFFECT with Prenatal Nutritional Supplements.47the mothers of children that eventually developed jia were less LIKELY to receive supplementation with Prenatal multivitamins (24.9% versus 30.8%), Vitamin D (3.3% versus 7.8%), Fish Oil (2.9% versus 6.4%), Calcium (10.2% versus 14.9%), Iron (35.4% versus 40.3%), and Folate (61.4% versus 64.8%) while Pregnant compared to controls.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 160), ('INCOMPLETE_EVIDENCE', 168), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 274), ('SUPERFICIAL_RELATIONSHIP', 290), ('SUPERFICIAL_RELATIONSHIP', 301), ('PROBABLE_UNDERSTANDING', 412)]	12	[('GO_0036268', 'swimming', 118, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 118, 'perinatal'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy'), ('GO_0007565', 'female pregnancy', 313, 'prenatal'), ('CHEBI_7495', 'nefazodone hydrochloride', 322, 'nutritional'), ('CHEBI_33341', 'titanium atom', 334, 'supplements'), ('GO_0007565', 'female pregnancy', 451, 'prenatal'), ('CHEBI_27300', 'vitamin D', 496, 'vitamin D'), ('CHEBI_34766', 'Furamizole', 526, 'fish oil'), ('CHEBI_22313', 'alkaline earth metal atom', 555, 'calcium'), ('CHEBI_24870', 'ion', 585, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 616, 'folate'), ('GO_0007565', 'female pregnancy', 650, 'pregnant')]
PMC4221707	11/2014	S11-PMC4221707	['AS they also had a low intake (below the nordic nutritional recommendations) of Folate, Vitamin D, and Iron from foods, some of these women and their unborn children are POSSIBLY AT RISK for adverse EFFECTS on the Pregnancy and Birth outcome.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 170), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 199)]	4	[('CHEBI_30863', '5-azaorotic acid', 80, 'folate'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_24870', 'ion', 103, 'iron'), ('GO_0007565', 'female pregnancy', 214, 'pregnancy'), ('GO_0007567', 'parturition', 228, 'birth')]
PMC4221707	11/2014	S178-PMC4221707	['IN GENERAL, this 2009 report FOUND that the intake of Folate and Vitamin D from foods was not sufficient to cover the nutritional demands during Pregnancy, and supplements were USUALLY REQUIRED before and during Pregnancy [37,38].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 177), ('IMPORTANT_CONSIDERATION', 185)]	4	[('CHEBI_30863', '5-azaorotic acid', 54, 'folate'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('GO_0007565', 'female pregnancy', 212, 'pregnancy')]
PMC4231606	10/2013	S16-PMC4231606	['conclusion\nchildren with s-ecc APPEAR to have relatively POOR nutritional health COMPARED TO caries-free controls, and were significantly more LIKELY to have low Vitamin D, calcium, and albumin concentrations and elevated pth levels.']	[('ANOMALY_CURIOUS_FINDING', 31), ('IMPORTANT_CONSIDERATION', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('PROBABLE_UNDERSTANDING', 143)]	4	[('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC4231606	10/2013	S27-PMC4231606	['it is PLAUSIBLE that those with s-ecc are also DEFICIENT in IMPORTANT Vitamins and Nutrients, including Vitamin D [14].']	[('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 47), ('IMPORTANT_CONSIDERATION', 60)]	3	[('CHEBI_33277', 'gamma-tocotrienol', 70, 'vitamins'), ('CHEBI_33284', 'nutrient', 83, 'nutrients'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4231606	10/2013	S30-PMC4231606	['it has a CRITICAL ROLE in Enamel, Dentin, and Oral Bone formation AS Ameloblasts and Odontoblasts are target cells for 1,25-Dihydroxyvitamin D, the active form of Vitamin D [17].']	[('IMPORTANT_CONSIDERATION', 9), ('SUPERFICIAL_RELATIONSHIP', 18), ('PROBABLE_UNDERSTANDING', 66)]	3	[('UBERON_0001752', 'enamel', 26, 'enamel'), ('UBERON_0001751', 'dentine', 34, 'dentin'), ('UBERON_0000165', 'mouth', 46, 'oral'), ('GO_0007567', 'parturition', 51, 'bone'), ('CL_0000059', 'ameloblast', 69, 'ameloblasts'), ('CL_0000060', 'odontoblast', 85, 'odontoblasts'), ('CHEBI_67472', '15-epi-lupulin B', 119, '1,25-dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC4231606	10/2013	S31-PMC4231606	['DEFICIENCY in Vitamin D during periods of Tooth Development MAY also result in developmental defects [17] including Enamel hypoplasia, a SIGNIFICANT RISK FACTOR for s-ecc.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 60), ('IMPORTANT_CONSIDERATION', 137), ('SUPERFICIAL_RELATIONSHIP', 149)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0048538', 'thymus development', 42, 'tooth development'), ('UBERON_0001091', 'calcareous tooth', 42, 'tooth'), ('UBERON_0001752', 'enamel', 116, 'enamel')]
PMC4231606	10/2013	S117-PMC4231606	['RECENTLY, a meta-analysis REPORTED that Vitamin D supplementation in childhood CAN help PREVENT caries [30], and it HAS also BEEN SUGGESTED that concentrations of 25(Oh)D between 75–100\xa0nmol/l MAY reduce the RISK for Caries [22].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 88), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 193), ('IMPORTANT_CONSIDERATION', 208)]	8	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 165, '(OH)D'), ('CHEBI_23042', 'carotene', 217, 'caries')]
PMC4231606	10/2013	S121-PMC4231606	['regular milk drinkers had BETTER Vitamin D concentrations, a FINDING SUPPORTED by A large-scale clinical STUDY OBSERVING an ASSOCIATION between frequent Milk Consumption and increased 25(Oh)D [33].']	[('IMPORTANT_CONSIDERATION', 26), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001913', 'milk', 153, 'milk'), ('GO_0007631', 'feeding behavior', 158, 'consumption'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 187, 'OH)D')]
PMC4231606	10/2013	S132-PMC4231606	['a DEFICIENCY in this protein IN CONJUNCTION WITH UNDESIRABLE Vitamin D, pth, and calcium levels MAY SUGGEST that children with s-ecc have nutritional DEFICIENCIES.']	[('IMPORTANT_CONSIDERATION', 2), ('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 150)]	6	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC4231606	10/2013	S157-PMC4231606	['specifically, RECOMMENDING Vitamin D supplementation for children AT RISK of Dental caries MAY result in a decrease in the overall PREVALENCE of s-ecc and, ULTIMATELY, reduce THE BURDEN on pediatric day surgery centres.']	[('FUTURE_WORK', 14), ('IMPORTANT_CONSIDERATION', 66), ('FUTURE_PREDICTION', 91), ('IMPORTANT_CONSIDERATION', 131), ('FUTURE_PREDICTION', 156), ('IMPORTANT_CONSIDERATION', 175)]	6	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 77, 'dental')]
PMC4251419	12/2014	S1-PMC4251419	['the active form of Vitamin D has an IMPORTANT ROLE in Calcium Metabolism and in bone mineralisation, BUT the EVIDENCE for OTHER health outcomes is MIXED, with the strongest EFFECTS SEEN in the weakest epidemiological study designs.']	[('IMPORTANT_CONSIDERATION', 36), ('SUPERFICIAL_RELATIONSHIP', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('SUPERFICIAL_RELATIONSHIP', 173), ('INCOMPLETE_EVIDENCE', 181)]	8	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0018884', 'carbazole metabolic process', 54, 'calcium metabolism')]
PMC4251419	12/2014	S6-PMC4251419	['over the last 10-15 years, INCREASED RISK of a WIDE RANGE of health outcomes HAS BEEN LINKED to Vitamin D deficiency, ALTHOUGH in many cases the LINKS REMAIN rather weak.']	[('IMPORTANT_CONSIDERATION', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 86), ('ANOMALY_CURIOUS_FINDING', 118), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 151)]	7	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC4251419	12/2014	S7-PMC4251419	['after the UNDISPUTED IMPORTANCE of Vitamin D for bone health, the STRONGEST EVIDENCE is PROBABLY for an increased RISK of Immune disorders in ASSOCIATION with Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 10), ('IMPORTANT_CONSIDERATION', 21), ('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 88), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4251419	12/2014	S73-PMC4251419	['LIMITED SUCCESS in Vitamin D supplementation trials SUGGESTS that Vitamin D-INDEPENDENT EFFECTS MAY CONTRIBUTE more strongly to disease RISK.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 88), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 100), ('IMPORTANT_CONSIDERATION', 136)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4251419	12/2014	S86-PMC4251419	['ALTHOUGH childhood Vitamin D levels and sun exposure APPEAR TO BE IMPORTANT DETERMINANTS of the risk of disease onset, higher 25(Oh)D levels early in the disease course MAY PREDICT the rate of disease progression in multiple sclerosis [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 53), ('IMPORTANT_CONSIDERATION', 66), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 169), ('SUPERFICIAL_RELATIONSHIP', 173)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D')]
PMC4251419	12/2014	S116-PMC4251419	['we ANTICIPATE that a deeper understanding of HOW Vitamin D Modulates the microbiomes of the skin and other Tissues will come through ONGOING Vitamin D supplementation trials [74].']	[('IMPORTANT_CONSIDERATION', 3), ('IMPORTANT_CONSIDERATION', 3), ('EXPLICIT_QUESTION', 45), ('IMPORTANT_CONSIDERATION', 133)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0065007', 'biological regulation', 59, 'modulates'), ('UBERON_0000479', 'tissue', 107, 'tissues'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC4251419	12/2014	S122-PMC4251419	["WHY doesn't Vitamin D supplementation decrease disease RISKS?"]	[('EXPLICIT_QUESTION', 0), ('IMPORTANT_CONSIDERATION', 55), ('EXPLICIT_QUESTION', 60)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC4251419	12/2014	S123-PMC4251419	["in the face of SUPPORTIVE OBSERVATIONAL and mechanistic EVIDENCE, WHY doesn't Vitamin D supplementation decrease disease RISKS?"]	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 56), ('EXPLICIT_QUESTION', 66), ('IMPORTANT_CONSIDERATION', 121), ('EXPLICIT_QUESTION', 126)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4251419	12/2014	S130-PMC4251419	['in addition, with respect to an ability of supplemental Vitamin D to alter the course of Autoimmune diseases, there is DEBATE about the VALIDITY of biochemical OR cellular markers from Blood AS TRULY representative of disease status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('IMPORTANT_CONSIDERATION', 136), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160), ('PROBABLE_UNDERSTANDING', 191), ('PROBABLE_UNDERSTANDING', 194)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 89, 'autoimmune'), ('UBERON_0000178', 'blood', 185, 'blood')]
PMC4251419	12/2014	S134-PMC4251419	['Vitamin D supplementation STUDIES take ACCOUNT ONLY of Vitamin D, without the POSSIBLY NECESSARY additional benefits of sun exposure.']	[('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 87)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4251419	12/2014	S149-PMC4251419	['most RECENT Vitamin D supplementation TRIALS use Vitamin D3, SUGGESTING that any DIFFERENCES between d2and d3do NOT ACCOUNT for the DIFFERENT findings from OBSERVATIONAL and Vitamin D supplementation trials.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('ANOMALY_CURIOUS_FINDING', 112), ('IMPORTANT_CONSIDERATION', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('INCOMPLETE_EVIDENCE', 156)]	8	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 49, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 49, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC4251419	12/2014	S152-PMC4251419	['the study participants were not Vitamin D deficient at baseline\nif there is a causal ASSOCIATION between Vitamin D and disease risks, INCREASED risk occurs in ASSOCIATION with vitamin d deficiency [92].']	[('SUPERFICIAL_RELATIONSHIP', 85), ('IMPORTANT_CONSIDERATION', 134), ('SUPERFICIAL_RELATIONSHIP', 159)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4251419	12/2014	S155-PMC4251419	['SIMILARLY, in ONE rct of high-dose Vitamin D supplementation there was an INCREASED RISK of falls and fractures [93].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('IMPORTANT_CONSIDERATION', 74)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4251419	12/2014	S159-PMC4251419	['this DISCREPANCY in timing MAY CONTRIBUTE to the failure of Vitamin D supplementation trials to decrease the RISK of disease onset.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 109)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4251419	12/2014	S160-PMC4251419	['conclusion\nthe jury is STILL out on the IMPORTANCE of Vitamin D for Immune function: both for Vitamin D deficiency increasing the RISK of Autoimmune diseases and Viral infections through loss of Regulatory Adaptive Immune functions, as well as for high Vitamin D levels decreasing the risks of tuberculosis and infections with other Intracellular pathogens through upregulation of Innate Immunity.']	[('IMPORTANT_CONSIDERATION', 23), ('IMPORTANT_CONSIDERATION', 40), ('IMPORTANT_CONSIDERATION', 130)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 138, 'autoimmune'), ('NCBITaxon_1', 'root', 162, 'viral'), ('GO_0008016', 'regulation of heart contraction', 195, 'regulatory adaptive immune'), ('UBERON_0002405', 'immune system', 215, 'immune'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('GO_0005622', 'intracellular anatomical structure', 333, 'intracellular'), ('GO_0045087', 'innate immune response', 381, 'innate immunity')]
PMC4251419	12/2014	S161-PMC4251419	['EFFECTS MAY not be direct, but COULD work through alterations in the microbiome, OR be ONLY PARTLY Vitamin D-MEDIATED, with exposure to uvr itself also IMPORTANT.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 152)]	8	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4256222	12/2014	S17-PMC4256222	['Vitamin D plays a MAJOR ROLE in the REGULATION of calcium homeostasis[3],[4], and studies have FOUND that children Born to women with low Vitamin D status had lower Birth weight, Birth length, and lower bone Mineral content (bmc) at Birth[2].']	[('IMPORTANT_CONSIDERATION', 18), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 95)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007567', 'parturition', 115, 'born'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0007567', 'parturition', 165, 'birth'), ('GO_0007567', 'parturition', 179, 'birth'), ('CHEBI_46662', 'mineral', 208, 'mineral'), ('GO_0007567', 'parturition', 233, 'birth')]
PMC4256222	12/2014	S110-PMC4256222	['[6]were UNABLE TO detect any RELEVANT ASSOCIATION between maternal Vitamin D status and bmc and bmd shortly after Birth, ALTHOUGH they did indeed find a positive CORRELATION between maternal Vitamin D status and fetal Femur volume measured by three-dimensional ultrasound.']	[('DIFFICULT_TASK', 8), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 121), ('SUPERFICIAL_RELATIONSHIP', 162)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 114, 'birth'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('UBERON_0000981', 'femur', 218, 'femur')]
PMC4256222	12/2014	S113-PMC4256222	['[8]in the same cohort FOUND no RELEVANT association between maternal Vitamin D status in Pregnancy and bmc in 3960 offspring at 9–10 years of age.']	[('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 31)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy')]
PMC4256222	12/2014	S138-PMC4256222	['THUS, we cannot preclude that early Vitamin D supplementation IMPACTED offspring bone fracture RISK in our data and has blurred an ASSOCIATION with maternal Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 131)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4256222	12/2014	S140-PMC4256222	['in this context, a POTENTIAL negative IMPACT of maternal Vitamin D deficiency MAY have been BLURRED in our data, SINCE data are lacking on POTENTIALLY IMPORTANT CONFOUNDERS.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('PROBABLE_UNDERSTANDING', 113), ('PROBLEM_COMPLICATION', 113), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 151), ('PROBLEM_COMPLICATION', 161)]	9	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4256222	12/2014	S145-PMC4256222	['FURTHER STUDIES on this subject ARE NEEDED, BUT such STUDIES MUST BE conducted in study populations large enough to allow for INVESTIGATION of seasonal variation, subdivision of fractures and further stratification of study participants by Vitamin D status.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('FUTURE_WORK', 53), ('IMPORTANT_CONSIDERATION', 61), ('ANOMALY_CURIOUS_FINDING', 66), ('FUTURE_WORK', 126)]	8	[('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC4258799	11/2014	S310-PMC4258799	['HOWEVER, subsequent observational studies in men with POOR Sperm dna integrity showed that supplementation with both Vitamins E and C resulted in fewer Spermatozoa with fragmented dna [107,108], as well as higher Implantation and clinical Pregnancy rates [108].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 54)]	2	[('CL_0000019', 'sperm', 59, 'sperm'), ('CHEBI_27300', 'vitamin D', 117, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 132, 'C'), ('CL_0000019', 'sperm', 152, 'spermatozoa'), ('GO_0007566', 'embryo implantation', 213, 'implantation'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy')]
PMC4263713	12/2014	S2-PMC4263713	['the PRESENT STUDY AIMS TO TEST WHETHER Vitamin A supplementation CAN restore Lymphocyte pools in Vitamin A-deficient Rats and thereby improve the function of their Intestinal Mucosa; furthermore, the study AIMED TO IDENTIFY the BEST time frame for Vitamin A supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('INCOMPLETE_EVIDENCE', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 206), ('QUESTION_ANSWERED_BY_THIS_WORK', 212), ('IMPORTANT_CONSIDERATION', 228)]	8	[('CHEBI_27300', 'vitamin D', 39, 'vitamin A'), ('CL_0000542', 'lymphocyte', 77, 'lymphocyte'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 117, 'rats'), ('UBERON_0001242', 'intestinal mucosa', 164, 'intestinal mucosa'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin A')]
PMC4263713	12/2014	S9-PMC4263713	['in conclusion, the BEST recovery of a subset of Lymphocytes in the offspring of Gestational Vitamin A-deficient Rats and the greatest improvement in the Intestinal Mucosal immune response are achieved when Vitamin A supplementation occurs during the early Postnatal period.']	[('IMPORTANT_CONSIDERATION', 19)]	1	[('CL_0000542', 'lymphocyte', 48, 'lymphocytes'), ('GO_0007565', 'female pregnancy', 80, 'gestational'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin A'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 112, 'rats'), ('UBERON_0001262', 'wall of intestine', 153, 'intestinal mucosal'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin A'), ('GO_0007567', 'parturition', 256, 'postnatal')]
PMC4268639	11/2014	S29-PMC4268639	['caption (table-wrap): table 1\n\nEMPHASIS of nutrition education classesnutrientspreconception1st trimester2nd trimester3rd trimesterpostnatal protein adequatecomplete, Carnitine, methionine, cysteine, 0.8 g/kgcomplete, adequate 1.1 g/kgcomplete, adequate 1.1 g/kgcomplete, adequate fat essential Fatty Acidsomega 3omega 3omega 3omega 3 Carbohydrate complexcomplexcomplex,fiber complexcomplex Minerals Iodine, iron, magnesium, zinc, calcium, Seleniumiodine, Seleniumiron, magnesium, calciumiron, zinc, magnesiumiron, calcium Vitamins methylation factorsvitamins d, b6, b12, folatevitamins e, D, cvitamins C, ab Vitamins, Vitamin D Phytonutrients full range of colors of fruits and vegetablescolors: oxidative reservecolors: Organ growthcolors: newborn preferencecolors: oxidant balance Probiotics immune balanceimmune balanceimmune balance\n\ncaption (table-wrap): table 2\n\nPrenatal supplements adjusted to levels of Hemoglobin, hematocrit, mean corpuscular volume, Vitamin D, Zinc, Carnitine, and mthfr statusvitamin a Mixed Carotenoids5000 iumethylcobalamin800 µgchromium (Chromium Niacinate)200 µgvitamin c250 mgbiotin100 µgmolybdenum (Molybdenum Glycinate)25 µgvitamin d32000 iupantothenic Acid (D-Calcium Pantothenate)25 mgomega-3 Fatty Acids620 mgvitamin E (Mixed)110 iuiron (iron Bisglycinate)25 mgepa400 mgthiamine (Mononitrate)5 mgiodine (Potassium Iodide)150 µgdha200 mgriboflavin (5 phosphate)5 mgzinc (Zinc Citrate)25 mgother omega-320 mgniacinamide25 mgselenium (l Selenomethionine)100 µgl-Carnitine as 1492 mg l-Carnitine tartrate1000 mgb6(Pyridoxal 5 Phosphate)15 mgcopper (Copper Gluconate)1.5 mgprobiotic blend: lactobacillus acidophilus 60 b cful-5-Methylfolate1000 µgmanganese (manganese gluconate)5 mg bifidobacterium lectis, lactobacillus plantarum, lactobacillus salivarius, streptococcus thermophilus\nabbreviations: cfu, colony-forming unit; Dha, Docosahexaenoic Acid; Epa, Eicosapentaenoic Acid; mthfr, Methylenetetrahydrofolate reductase.']	[('IMPORTANT_CONSIDERATION', 31)]	1	[('CHEBI_17126', 'carnitine', 167, 'carnitine'), ('CHEBI_39327', '(1S)-cis-(alphaR)-cyhalothrin', 295, 'fatty acidsOmega'), ('CHEBI_16646', 'carbohydrate', 335, 'Carbohydrate'), ('CHEBI_25468', 'naphthaldehydes', 391, 'Minerals'), ('CHEBI_31719', 'ipriflavone', 400, 'Iodine'), ('CHEBI_9107', 'senecionine', 440, 'seleniumIodine'), ('CHEBI_30483', 'trihydridotellurate(1-)', 456, 'seleniumIron'), ('CHEBI_28371', 'vitamin K epoxide', 523, 'Vitamins'), ('PR_000006444', 'diacylglycerol kinase delta', 590, 'D'), ('PR_000004900', 'complement C3', 603, 'C'), ('CHEBI_33277', 'gamma-tocotrienol', 609, 'vitamins'), ('CHEBI_27300', 'vitamin D', 619, 'vitamin D'), ('CHEBI_36961', 'chalcocarbonic acid', 629, 'Phytonutrients'), ('UBERON_0000062', 'organ', 722, 'organ'), ('CHEBI_8474', 'propane-2-thiol', 784, 'Probiotics'), ('GO_0007565', 'female pregnancy', 870, 'Prenatal'), ('CHEBI_5679', 'herniarin', 913, 'Hemoglobin'), ('CHEBI_28384', 'vitamin K', 962, 'Vitamin D'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 973, 'Zinc'), ('CHEBI_17126', 'carnitine', 979, 'Carnitine'), ('CHEBI_60004', 'mixture', 1016, 'mixed'), ('CHEBI_77957', 'm-fluoro-L-phenylalanine', 1022, 'carotenoids5000'), ('CHEBI_53471', 'chromium(III) sulfate', 1071, 'chromium niacinate'), ('UBERON_0002365', 'exocrine gland', 1135, 'molybdenum'), ('CHEBI_32508', 'glycinate', 1146, 'glycinate'), ('CHEBI_37527', 'acid', 1190, 'acid'), ('CHEBI_38294', 'dicarba-nido-undecaborane(11)', 1196, 'd-calcium pantothenate'), ('CHEBI_78128', 'fatty acid anion 24:0', 1232, 'fatty acids620'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1257, 'E'), ('CHEBI_60004', 'mixture', 1260, 'mixed'), ('CHEBI_32499', 'amineptine', 1283, 'bisglycinate'), ('CHEBI_29440', 'methanuidyl', 1320, 'mononitrate'), ('CHEBI_8346', 'potassium iodide', 1344, 'potassium iodide'), ('CHEBI_46916', 'vinyl acetate', 1410, 'zinc citrate'), ('CHEBI_26630', 'selenocystathionine', 1474, 'selenomethionine'), ('CHEBI_17126', 'carnitine', 1499, 'carnitine'), ('CHEBI_17126', 'carnitine', 1522, 'carnitine'), ('CHEBI_16462', 'glycylpeptide', 1550, 'Pyridoxal 5 phosphate'), ('CHEBI_23401', 'coumaric acid', 1585, 'copper gluconate'), ('CHEBI_82350', '5-Nitroacenaphthene', 1661, '5-Methylfolate1000'), ('CHEBI_17874', 'dihydrozeatin', 1861, 'DHA'), ('CHEBI_36003', 'decenoic acid', 1866, 'docosahexaenoic acid'), ('CHEBI_34733', 'EPN', 1888, 'EPA'), ('CHEBI_36003', 'decenoic acid', 1893, 'eicosapentaenoic acid'), ('CHEBI_38725', 'mevinphos', 1923, 'methylenetetrahydrofolate')]
PMC4275593	9/2014	S45-PMC4275593	['the supply of free or cheap Vitamin A and D tablets, milk, orange juice and cod Liver oil to expectant mothers and children through the wartime vitamin welfare scheme, with their perceived ROLE in the decline of maternal mortality, consolidated the IMPORTANCE of dietary supplements in Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 189), ('IMPORTANT_CONSIDERATION', 249)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 42, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 42, 'D'), ('UBERON_0002107', 'liver', 80, 'liver'), ('GO_0007565', 'female pregnancy', 286, 'pregnancy')]
PMC4275595	9/2014	S127-PMC4275595	['a green ration book issued to Pregnant women on the production of a medical certificate entitled them to receive orange juice, cod Liver oil, Vitamin A and d tablets, an extra pint of Milk a day, an extra half ration of meat a week, and an extra Egg per allocation.64women were urged by a ministry of Food advertisement ‘welcome little stranger’, that ‘the very best welcome you can give your baby is a beautiful body, a contented disposition—and a healthy, happy mother.’ another advertisement WARNED them against giving these extra Foods to other family members, telling them, ‘don’t let dad get all the meat.’65\nthe interviewees had differing stories to tell about their Antenatal care.']	[('IMPORTANT_CONSIDERATION', 495)]	1	[('GO_0007565', 'female pregnancy', 30, 'pregnant'), ('UBERON_0002107', 'liver', 131, 'liver'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin A'), ('UBERON_0001913', 'milk', 184, 'milk'), ('CL_0000025', 'egg cell', 246, 'egg'), ('CHEBI_33290', 'food', 301, 'Food'), ('CHEBI_33290', 'food', 534, 'foods'), ('GO_0007567', 'parturition', 674, 'antenatal')]
PMC4289064	1/2015	S26-PMC4289064	['we FOCUSED our analyses on children and women in developing countries, where high rates of malnutrition and limited access to Nutrient Supplements MAY make Individuals more susceptible to the EFFECTS of pollinator declines, and analyzed five of the most IMPORTANT Nutrients to global nutrition: Vitamin A, zinc, iron, Folate, and Calcium[14],[15](data on Iodine, another globally IMPORTANT Nutrient, were not available in the datasets we analyzed).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 192), ('IMPORTANT_CONSIDERATION', 254), ('IMPORTANT_CONSIDERATION', 380)]	5	[('CHEBI_33284', 'nutrient', 126, 'nutrient'), ('CHEBI_33341', 'titanium atom', 135, 'supplements'), ('NCBITaxon_1', 'root', 156, 'individuals'), ('CHEBI_33284', 'nutrient', 264, 'nutrients'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 318, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 330, 'calcium'), ('CHEBI_24859', 'iodine atom', 355, 'iodine'), ('CHEBI_33284', 'nutrient', 390, 'nutrient')]
PMC4289064	1/2015	S133-PMC4289064	['“other” refers to oils, flavorings, drinks, candy, honey, and other items that do not fit into other Food groups.10.1371/journal.pone.0114805.t001\n\ncaption (table-wrap): table 1\naverage proportion of total Nutrient Intake by percent yield due to pollinators and country for children 1 to 3 years old.% yield due to pollinatorsenergyvitamin acalciumfolateironzinc bangladesh 00.740.380.550.480.620.6850.050.190.080.140.080.07250.080.100.130.170.110.10650.040.090.090.120.070.04950.080.250.160.100.120.12total1.001.001.001.001.001.00 mozambique 00.570.290.540.300.370.4950.140.130.190.290.200.16250.130.020.160.240.250.19650.140.270.080.150.120.13950.020.300.040.020.050.03total1.001.001.001.001.001.00 uganda 00.680.490.530.400.520.5550.140.090.140.300.130.16250.100.090.240.140.210.17650.040.020.010.080.020.05950.040.320.070.080.120.07total1.001.001.001.001.001.00 zambia 00.480.380.410.300.510.5150.170.110.170.350.210.24250.060.020.140.100.080.10650.120.210.130.180.070.03950.070.270.110.050.110.101000.090.000.040.020.030.02total1.001.001.001.001.001.00\nBASED ON these results, we HYPOTHESIZED that pollinators would be most IMPORTANT for nutritional health ASSOCIATED with Vitamin A, BUT less IMPORTANT for nutritional health ASSOCIATED with all other Nutrients.']	[('PROBABLE_UNDERSTANDING', 1058), ('INCOMPLETE_EVIDENCE', 1085), ('IMPORTANT_CONSIDERATION', 1129), ('SUPERFICIAL_RELATIONSHIP', 1162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1189), ('IMPORTANT_CONSIDERATION', 1198), ('SUPERFICIAL_RELATIONSHIP', 1231)]	7	[('CHEBI_33290', 'food', 101, 'food'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('GO_0007631', 'feeding behavior', 215, 'intake'), ('CHEBI_27300', 'vitamin D', 1178, 'vitamin A'), ('CHEBI_33284', 'nutrient', 1257, 'nutrients')]
PMC4289064	1/2015	S135-PMC4289064	['we found that if pollinators were removed, 2 to 56%, 0 to 2%, 0 to 23%, 1 to 5%, and 0.1 to 3% of children in the populations surveyed would become newly AT RISK of Vitamin A, calcium, Folate, iron, and zinc deficiencies, respectively (table 2).']	[('IMPORTANT_CONSIDERATION', 154)]	1	[('CHEBI_27300', 'vitamin D', 165, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 185, 'folate')]
PMC4289064	1/2015	S154-PMC4289064	['WHILE the risk of Nutrient deficiency did not change substantially for most Nutrients when pollinators were removed, the increased risk we ESTIMATED for Vitamin A carries concerning PUBLIC HEALTH IMPLICATIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 182), ('IMPORTANT_CONSIDERATION', 196)]	5	[('CHEBI_33284', 'nutrient', 18, 'nutrient'), ('CHEBI_33284', 'nutrient', 76, 'nutrients'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin A')]
PMC4289552	12/2014	S141-PMC4289552	['Vitamin D is ESSENTIAL for calcium homeostatis and now recognized as an IMPORTANT Nutrient for bone health including modest SUPPORT for maternal Vitamin D status and increased offspring bone mass among [50].']	[('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 72), ('INCOMPLETE_EVIDENCE', 124)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_33284', 'nutrient', 82, 'nutrient'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC4292819	1/2015	S29-PMC4292819	['fish is a MAJOR source of Epa and Dha [13] and an IMPORTANT source of Vitamin D and Selenium, but is a small contributor of calories [12].']	[('IMPORTANT_CONSIDERATION', 10), ('IMPORTANT_CONSIDERATION', 50)]	2	[('CHEBI_34733', 'EPN', 26, 'EPA'), ('CHEBI_17874', 'dihydrozeatin', 34, 'DHA'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27568', 'selenium atom', 84, 'selenium')]
PMC4292819	1/2015	S277-PMC4292819	['HOWEVER, as fish and shellfish are IMPORTANT CONTRIBUTORS of Fatty Acids, Vitamin D, proteins, and minerals, it is ADVISABLE that women of child-Bearing age receive proper GUIDANCE to choose the right types of fish from nonpolluted waters.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 45), ('FUTURE_WORK', 115), ('IMPORTANT_CONSIDERATION', 115), ('FUTURE_WORK', 172)]	6	[('CHEBI_35366', 'fatty acid', 61, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007567', 'parturition', 145, 'bearing')]
PMC4302429	1/2015	S8-PMC4302429	['conclusion\nour OBSERVATIONS SUGGEST a DETRIMENTAL ROLE of Vitamin D deficiency in bacterial Central Nervous System infections.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 38), ('SUPERFICIAL_RELATIONSHIP', 50)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 92, 'central nervous system')]
PMC4302429	1/2015	S27-PMC4302429	['cells of the Immune System possess Vitamin D receptors and are capable of Metabolizing the active form of Vitamin D (1,25(Oh)2D3) [15], SUGGESTING Vitamin D as an IMPORTANT FACTOR in the Immune Response to Infection [16].']	[('INCOMPLETE_EVIDENCE', 136), ('IMPORTANT_CONSIDERATION', 163), ('SUPERFICIAL_RELATIONSHIP', 173)]	3	[('UBERON_0002405', 'immune system', 13, 'immune system'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0008152', 'metabolic process', 74, 'metabolizing'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_72779', '11-trans-LTE4', 117, '1,25(OH)2D3'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0006955', 'immune response', 187, 'immune response'), ('UBERON_0002405', 'immune system', 187, 'immune'), ('GO_0007586', 'digestion', 206, 'infection')]
PMC4302429	1/2015	S29-PMC4302429	['epidemiological studies have ESTABLISHED that Vitamin D deficiency plays an IMPORTANT ROLE in susceptibility to tuberculosis [18].']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 76), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4302429	1/2015	S125-PMC4302429	['high Vitamin D3 concentrations inhibited the Production of proinflammatory cytokine Il-6 and increased production of anti-inflammatory cytokine Il-10, WHILE Ifn-Γ production in the Cns stayed unaffected\nPREVIOUS investigations REVEALED that Vitamin D plays IMPORTANT ROLES in signaling in both the Adaptive and Innate Immune Response To Viral and bacterial Infection [16,25].']	[('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 227), ('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267)]	5	[('CHEBI_33279', 'vitamin D5', 5, 'vitamin D3'), ('GO_0007128', 'meiotic prophase I', 45, 'production'), ('PR_000001470', 'interleukin-28B', 84, 'IL-6'), ('PR_000001470', 'interleukin-28B', 144, 'IL-10'), ('PR_000008920', 'interferon alpha-7', 157, 'IFN-γ'), ('UBERON_0001017', 'central nervous system', 181, 'CNS'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('GO_0051886', 'negative regulation of timing of anagen', 298, 'adaptive ...'), ('GO_0045048', 'protein insertion into ER membrane', 311, 'innate immune response to ... infection'), ('UBERON_0002405', 'immune system', 318, 'immune'), ('NCBITaxon_1', 'root', 337, 'viral')]
PMC4302429	1/2015	S168-PMC4302429	['the IMPORTANCE of Vitamin D for the resistance to infections HAS long BEEN appreciated but POORLY UNDERSTOOD.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 61), ('FULL_UNKNOWN', 91), ('PROBABLE_UNDERSTANDING', 98)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC4302429	1/2015	S172-PMC4302429	['a randomized double-blind intervention study SHOWED that supplementation with Vitamin D MAY reduce disease BURDEN in patients with frequent Respiratory Tract infections [33].']	[('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 88), ('IMPORTANT_CONSIDERATION', 107)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 140, 'respiratory tract')]
PMC4302429	1/2015	S206-PMC4302429	['conclusions\nour experiments IDENTIFIED for the FIRST TIME a DETRIMENTAL in-vivo EFFECT of Vitamin D deficiency on survival in experimental E. Coli meningoencephalitis.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 60), ('SUPERFICIAL_RELATIONSHIP', 80)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 139, 'E. coli')]
PMC4302429	1/2015	S209-PMC4302429	['our results emphasize the NECESSITY of an adequate Vitamin D supply to prevent Cns infection.']	[('IMPORTANT_CONSIDERATION', 26)]	1	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 79, 'CNS')]
PMC4303849	1/2015	S0-PMC4303849	['Regulation Of Calcitriol Biosynthesis and activity: focus on Gestational Vitamin D deficiency and adverse Pregnancy outcomes\n\nabstract\nVitamin D has garnered a great deal of ATTENTION in RECENT years DUE TO a GLOBAL prevalence of Vitamin D deficiency ASSOCIATED with an INCREASED RISK of a variety of Human diseases.']	[('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 187), ('PROBABLE_UNDERSTANDING', 200), ('IMPORTANT_CONSIDERATION', 209), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 270)]	6	[('GO_1900952', 'positive regulation of 18-methylnonadec-1-ene biosynthetic process', 0, 'Regulation of Calcitriol Biosynthesis'), ('CHEBI_17823', 'calcitriol', 14, 'Calcitriol'), ('PR_000004909', 'complement component C8 beta chain', 14, 'Calcitriol'), ('GO_0007565', 'female pregnancy', 61, 'Gestational'), ('CHEBI_28384', 'vitamin K', 73, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 73, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 135, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 135, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 301, 'human')]
PMC4303849	1/2015	S2-PMC4303849	['THEREFORE, factors that Regulate Vitamin D Metabolism are of main IMPORTANCE, especially during Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 66)]	2	[('GO_0065007', 'biological regulation', 24, 'regulate'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 33, 'vitamin D metabolism'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy')]
PMC4303849	1/2015	S13-PMC4303849	['Calcidiol is the major Vitamin D Metabolite present in the circulation and the BEST INDICATOR of vd nutritional status.']	[('IMPORTANT_CONSIDERATION', 79), ('SUPERFICIAL_RELATIONSHIP', 84)]	2	[('CHEBI_17933', 'calcidiol', 0, 'Calcidiol'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 33, 'metabolite')]
PMC4329404	10/2014	S18-PMC4329404	['a RECENT unselected cohort of over 2000 children OBSERVED no association between Serum Vitamin D and asthma or Lung function; HOWEVER, higher Serum Vitamin D was ASSOCIATED with a greater RISK of wheeze (11).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('ANOMALY_CURIOUS_FINDING', 126), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 188)]	6	[('UBERON_0001977', 'blood serum', 81, 'serum'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002048', 'lung', 111, 'lung'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4329404	10/2014	S32-PMC4329404	['we HYPOTHESIZED that pups experiencing in utero and early-Life Vitamin D deficiency would develop more SEVERE hdm-induced Airway hyper-responsiveness (ahr), Eosinophilic inflammation and remodelling due to a reduction in Regulatory T Cells in the Lung.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 103)]	2	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 122, 'airway'), ('CL_0000771', 'eosinophil', 157, 'eosinophilic'), ('CL_0000815', 'regulatory T cell', 221, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 221, 'regulatory'), ('UBERON_0002048', 'lung', 247, 'lung')]
PMC4329404	10/2014	S147-PMC4329404	['this highlights the IMPORTANCE of age and Vitamin D status on Lung function in Adults COMPARED TO in utero and early-Life deficiency.']	[('IMPORTANT_CONSIDERATION', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002048', 'lung', 62, 'lung'), ('UBERON_0007023', 'adult organism', 79, 'adults'), ('UBERON_0000104', 'life cycle', 117, 'life')]
PMC4329404	10/2014	S149-PMC4329404	['overall, GIVEN OUR FINDINGS in a neonatal Mouse MODEL, and PREVIOUS REPORTS of Vitamin D deficiency in utero through Adulthood not resulting in significantly WORSE ahr, it SEEMS LIKELY that in the context of asthma in early Life, Vitamin D deficiency modifies Immunological Responses To Allergen by the induction of an exaggerated th2 skewed response and eosinophilia.']	[('INCOMPLETE_EVIDENCE', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 68), ('IMPORTANT_CONSIDERATION', 158), ('ANOMALY_CURIOUS_FINDING', 172), ('PROBABLE_UNDERSTANDING', 172), ('PROBABLE_UNDERSTANDING', 178)]	10	[('NCBITaxon_10088', 'Mus <genus>', 42, 'mouse'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 117, 'adulthood'), ('UBERON_0000104', 'life cycle', 224, 'life'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 260, 'immunological responses to allergen'), ('CHEBI_50904', 'allergen', 287, 'allergen')]
PMC4329404	10/2014	S152-PMC4329404	['children with SEVERE asthma on high-dose Steroid therapy have worse clinical features with lower Serum Vitamin D levels (12).']	[('IMPORTANT_CONSIDERATION', 14)]	1	[('CHEBI_35341', 'steroid', 41, 'steroid'), ('UBERON_0001977', 'blood serum', 97, 'serum'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4329404	10/2014	S154-PMC4329404	['an IMPORTANT finding from our data is the partial PROTECTION from disease severity SEEN in pups that were Born to mothers on a Vitamin D-deficient diet, but were weaned onto a Vitamin D-replete diet.']	[('IMPORTANT_CONSIDERATION', 3), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 83)]	3	[('GO_0007567', 'parturition', 106, 'born'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D')]
PMC4329404	10/2014	S162-PMC4329404	['a mechanism for this FINDING was NOT REPORTED, but IN AGREEMENT with OUR FINDINGS, Vitamin D supplementation in that MODEL also ONLY SHOWED an improvement in allergic inflammation, BUT NOT a complete resolution down to levels in nonallergic Mice, and THUS, the authors conclude Vitamin D supplementation is LIKELY an IMPORTANT adjunct in the treatment of asthma, RATHER than a candidate that will achieve a cure.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('PROBABLE_UNDERSTANDING', 251), ('PROBABLE_UNDERSTANDING', 307), ('IMPORTANT_CONSIDERATION', 317), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 363)]	12	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 241, 'mice'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D')]
PMC4329404	10/2014	S163-PMC4329404	['SIMILAR FINDINGS HAVE not been REPORTED from trials of Vitamin D supplementation in Humans as they ONLY include patients that have deficient or insufficient levels prior to an intervention with Vitamin D or placebo.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 17), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 99)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 84, 'humans'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4329745	10/2014	S9-PMC4329745	['background\nthere is INCREASING EVIDENCE for the CRUCIAL ROLE of Vitamin D in maintaining Human health (1).']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 56)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 89, 'human')]
PMC4329745	10/2014	S11-PMC4329745	['SEVERAL STUDIES HAVE SHOWN a high prevalence of Vitamin D deficiency in middle east countries (3); the figures for SUBOPTIMAL levels from several countries in this region were REPORTED between 20% and 80% (4).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 115), ('INCOMPLETE_EVIDENCE', 176)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC4329745	10/2014	S12-PMC4329745	['IN ORDER to obtain a better estimation of the Vitamin D status in iran, STUDIES encompassing different populations in various age and sex groups ARE REQUIRED.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('FUTURE_WORK', 72), ('FUTURE_WORK', 145), ('IMPORTANT_CONSIDERATION', 149)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4329745	10/2014	S65-PMC4329745	['Serum 25-Ohd level is the BEST INDICATOR of Vitamin D status in Individuals (7).']	[('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 31)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_72765', 'verruculogen', 6, '25-OHD'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('NCBITaxon_1', 'root', 64, 'individuals')]
PMC4329745	10/2014	S66-PMC4329745	['insufficient Vitamin D MAY increase the RISK of Colon, Prostate, Breast and skin cancer as well as diabetes types i, multiple sclerosis and Arterial diseases.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 40)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0001155', 'colon', 48, 'colon'), ('UBERON_0002367', 'prostate gland', 55, 'prostate'), ('UBERON_0000310', 'breast', 65, 'breast'), ('UBERON_0001637', 'artery', 140, 'arterial')]
PMC4329745	10/2014	S67-PMC4329745	['the RISK of rickets and other complications in infants increased with low Vitamin D levels in the mother (4).']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC4329745	10/2014	S92-PMC4329745	['at first glance, it SEEMS that the MAJOR cause for these very low levels of Vitamin D in iranian women is the highly covered type of dressing in iran, BUT this would not rationalize the low vitamin status in iranian men (8,9).']	[('ANOMALY_CURIOUS_FINDING', 20), ('IMPORTANT_CONSIDERATION', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4340999	3/2015	S93-PMC4340999	['INCONSISTENT findings and MIXED explanations of underlying mechanism HAVE BEEN REPORTED, including SPECULATION that early temperature exposure is ASSOCIATED with physiological Regulation Of Birth Weight or that extremely low ambient temperature INFLUENCES the Conceived Embryo or the selection of the Sperm that fuses with the Ovum.19–21HOWEVER, the findings from the current study APPEARED to more strongly SUGGEST the POSSIBLE etiological ROLE of Prenatal maternal exposure to ultraviolet b radiation (uvb) and Vitamin D status in Adult chronic diseases.29–31\nsun exposure provides one of the MAJOR ways to meet Vitamin D REQUIREMENTS during Pregnancy, ESPECIALLY for those of older generations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 176), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 334), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 335), ('ANOMALY_CURIOUS_FINDING', 382), ('INCOMPLETE_EVIDENCE', 408), ('INCOMPLETE_EVIDENCE', 420), ('SUPERFICIAL_RELATIONSHIP', 441), ('IMPORTANT_CONSIDERATION', 595), ('IMPORTANT_CONSIDERATION', 624), ('IMPORTANT_CONSIDERATION', 655)]	16	[('GO_0009937', 'regulation of gibberellic acid mediated signaling pathway', 176, 'regulation of birth weight'), ('GO_0070268', 'cornification', 260, 'conceived'), ('UBERON_0000922', 'embryo', 270, 'embryo'), ('CL_0000019', 'sperm', 301, 'sperm'), ('UBERON_0000978', 'leg', 327, 'ovum'), ('GO_0007565', 'female pregnancy', 449, 'prenatal'), ('CHEBI_27300', 'vitamin D', 513, 'vitamin D'), ('UBERON_0007023', 'adult organism', 533, 'adult'), ('CHEBI_27300', 'vitamin D', 614, 'vitamin D'), ('GO_0007565', 'female pregnancy', 644, 'pregnancy')]
PMC4340999	3/2015	S94-PMC4340999	['for latitudes with distinct seasonal changes in availability of uvb, there is a WELL-DOCUMENTED seasonal cycle in Vitamin D status, with a maximum in late summer and a minimum in late winter.32low Vitamin D during Gestation MAY STRONGLY INFLUENCE susceptibility to obesity later in Life.33\nhowever, relatively LITTLE IS KNOWN about the critical period of fetal growth at which low Vitamin D is of particular IMPORTANCE.']	[('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 224), ('PROBABLE_UNDERSTANDING', 228), ('SUPERFICIAL_RELATIONSHIP', 237), ('FULL_UNKNOWN', 310), ('IMPORTANT_CONSIDERATION', 408)]	7	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('GO_0007565', 'female pregnancy', 214, 'gestation'), ('UBERON_0000104', 'life cycle', 282, 'life'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D')]
PMC4340999	3/2015	S102-PMC4340999	['ll in the PRESENT STUDY followed an opposite seasonal TREND to that of Adult adiposity measures, for which maternal uvb exposure (and HENCE Vitamin D status) is STILL a reasonable EXPLANATION.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 134), ('IMPORTANT_CONSIDERATION', 161), ('PROBABLE_UNDERSTANDING', 180)]	5	[('UBERON_0007023', 'adult organism', 71, 'adult'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC4340999	3/2015	S113-PMC4340999	['Vitamin D insufficiency during Pregnancy is highly PREVALENT in a diverse range of populations living at various latitudes and in both developed and developing societies.29,33the adverse EFFECTS of Vitamin D insufficiency on offspring during development and later in Life HAVE also BEEN extended greatly.29–31from a PUBLIC HEALTH perspective, the POTENTIAL to PREVENT common chronic diseases via low-cost, simple, and SAFE Food fortification is an attractive option.33\nsome POTENTIAL limitations of this study WARRANT CONSIDERATION.']	[('IMPORTANT_CONSIDERATION', 51), ('SUPERFICIAL_RELATIONSHIP', 187), ('INCOMPLETE_EVIDENCE', 272), ('IMPORTANT_CONSIDERATION', 316), ('INCOMPLETE_EVIDENCE', 347), ('SUPERFICIAL_RELATIONSHIP', 360), ('IMPORTANT_CONSIDERATION', 418), ('INCOMPLETE_EVIDENCE', 474), ('FUTURE_WORK', 510), ('FUTURE_WORK', 518)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 31, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0000104', 'life cycle', 267, 'life'), ('CHEBI_33290', 'food', 423, 'food')]
PMC4340999	3/2015	S125-PMC4340999	['this is also the FIRST-ever population-BASED EVIDENCE LINKING low Prenatal sun-RELATED uvb exposure (and lower Vitamin D by PROXY) to ll and the susceptibility to obesity later in Life and also SUGGESTING that late second and early third trimesters MIGHT be a CRITICAL period for the above-mentioned EFFECTS ALTHOUGH such EVIDENCE is non-specific, it WARRANTS FURTHER STUDIES in this AREA.']	[('INCOMPLETE_EVIDENCE', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 79), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 249), ('IMPORTANT_CONSIDERATION', 260), ('SUPERFICIAL_RELATIONSHIP', 300), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('INCOMPLETE_EVIDENCE', 322), ('FUTURE_WORK', 351), ('FUTURE_WORK', 360), ('FUTURE_WORK', 384)]	15	[('GO_0007565', 'female pregnancy', 66, 'prenatal'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0000104', 'life cycle', 180, 'life')]
PMC4352208	2/2015	S25-PMC4352208	['seafood is also an IMPORTANT source of other Nutrients including Vitamin D and Selenium (Se).']	[('IMPORTANT_CONSIDERATION', 19)]	1	[('CHEBI_33284', 'nutrient', 45, 'nutrients'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27568', 'selenium atom', 79, 'selenium'), ('CHEBI_37972', 'phosphorus-32 atom', 89, 'Se')]
PMC4368185	3/2015	S13-PMC4368185	['Folic Acid (Fa), a Water-soluble Vitamin B, is an ESSENTIAL Nutrient during Gestation for Dna Methylation, Synthesis and Repair, and it is well KNOWN to reduce the RISK of Neural Tube defect (ntd) in the new-born [1,2].']	[('IMPORTANT_CONSIDERATION', 50), ('INCOMPLETE_EVIDENCE', 144), ('IMPORTANT_CONSIDERATION', 164)]	3	[('CHEBI_30751', 'formic acid', 0, 'Folic acid'), ('CHEBI_30751', 'formic acid', 12, 'FA'), ('CHEBI_15377', 'water', 19, 'water'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin B'), ('CHEBI_33284', 'nutrient', 60, 'nutrient'), ('GO_0007565', 'female pregnancy', 76, 'gestation'), ('GO_0019277', 'UDP-N-acetylgalactosamine biosynthetic process', 90, 'DNA methylation ... synthesis'), ('GO_0006281', 'DNA repair', 121, 'repair'), ('UBERON_0001049', 'neural tube', 172, 'neural tube')]
PMC4377870	3/2015	S88-PMC4377870	['DESPITE the OBSERVATIONAL data LINKING Vitamin C to Lung health, supplementation with Vitamin C has not been shown to reduce the RISK of asthma [66] which MAY be RELATED to the interdependence of Nutrients found in Foods, resulting in lack OF efficacy when supplementing with isolated Nutrients.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 129), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 162), ('ANOMALY_CURIOUS_FINDING', 240)]	7	[('CHEBI_27300', 'vitamin D', 39, 'vitamin C'), ('UBERON_0002048', 'lung', 52, 'lung'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin C'), ('CHEBI_33284', 'nutrient', 196, 'nutrients'), ('CHEBI_33290', 'food', 215, 'foods'), ('CHEBI_33284', 'nutrient', 285, 'nutrients')]
PMC4377870	3/2015	S94-PMC4377870	['THUS, in SUMMARY, WHILE OBSERVATIONAL data has SUGGESTED that Vitamin C is IMPORTANT for Lung health, intervention trials SHOWING efficacy are lacking and it APPEARS that supplementation with Vitamin C-rich whole foods, such as fruit and vegetables MAY BE more EFFECTIVE.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 75), ('INCOMPLETE_EVIDENCE', 122), ('ANOMALY_CURIOUS_FINDING', 158), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 261)]	10	[('CHEBI_27300', 'vitamin D', 62, 'vitamin C'), ('UBERON_0002048', 'lung', 89, 'lung'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin C')]
PMC4377870	3/2015	S104-PMC4377870	['as a result, meta-analysis of Vitamin E EFFECTS on asthma outcomes is EQUIVOCAL; it is LIKELY that supplementation with physiological concentrations of Α-Tocopherol in the context of a background diet low in Γ-Tocopherol, MAY BE MOST beneficial in asthma and FURTHER RESEARCH testing this HYPOTHESIS IS REQUIRED.']	[('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('PROBABLE_UNDERSTANDING', 87), ('INCOMPLETE_EVIDENCE', 222), ('PROBABLE_UNDERSTANDING', 229), ('FUTURE_WORK', 259), ('INCOMPLETE_EVIDENCE', 289), ('FUTURE_WORK', 300), ('IMPORTANT_CONSIDERATION', 303)]	9	[('CHEBI_27300', 'vitamin D', 30, 'vitamin E'), ('CHEBI_27725', 'butin', 152, 'α-tocopherol'), ('CHEBI_27725', 'butin', 208, 'γ-tocopherol')]
PMC4377870	3/2015	S108-PMC4377870	['dietary intake of Vitamin E lower than RECOMMENDED dietary intakes HAS BEEN REPORTED in Pregnant women with a family history of allergic disease [88] and RECENT work in Animal MODELS has HIGHLIGHTED Α-Tocopherol MAY BE IMPORTANT for allergic mothers in Pregnancy.']	[('FUTURE_WORK', 39), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 187), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 219)]	7	[('CHEBI_27300', 'vitamin D', 18, 'vitamin E'), ('GO_0007565', 'female pregnancy', 88, 'pregnant'), ('NCBITaxon_33208', 'Metazoa', 169, 'animal'), ('CHEBI_27725', 'butin', 199, 'α-tocopherol'), ('GO_0007565', 'female pregnancy', 253, 'pregnancy')]
PMC4377870	3/2015	S157-PMC4377870	['experimental data SUGGEST that Vitamin D MAY BE IMPORTANT in copd for its EFFECT on normal Lung growth and Development, though Human data to support this is not available.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 41), ('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 74)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0030324', 'lung development', 91, 'lung ... development'), ('UBERON_0002048', 'lung', 91, 'lung'), ('NCBITaxon_9606', 'Homo sapiens', 127, 'human')]
PMC4377870	3/2015	S178-PMC4377870	['a SMALL STUDY in sweden FOUND that in older subjects with SEVERE copd, Intakes of Folic Acid and Selenium were below recommended levels, and although intake of calcium was adequate, Serum calcium levels were low, LIKELY RELATED to their Vitamin D status AS Intake was lower than recommended [141].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 58), ('PROBABLE_UNDERSTANDING', 213), ('SUPERFICIAL_RELATIONSHIP', 220), ('PROBABLE_UNDERSTANDING', 254)]	6	[('GO_0007631', 'feeding behavior', 71, 'intakes'), ('CHEBI_30751', 'formic acid', 82, 'folic acid'), ('CHEBI_27568', 'selenium atom', 97, 'selenium'), ('UBERON_0001977', 'blood serum', 182, 'serum'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('GO_0007631', 'feeding behavior', 257, 'intake')]
PMC4377870	3/2015	S251-PMC4377870	['it APPEARS that Vitamin D is IMPORTANT in Respiratory diseases and infections, HOWEVER the temporal ROLE of Vitamin D deficiency in disease onset, pathogenesis and exacerbations and WHETHER supplementation is indicated is yet to be clarified.']	[('ANOMALY_CURIOUS_FINDING', 3), ('IMPORTANT_CONSIDERATION', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ANOMALY_CURIOUS_FINDING', 79), ('SUPERFICIAL_RELATIONSHIP', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 42, 'respiratory'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4377879	3/2015	S87-PMC4377879	['DESPITE its IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System, the IMPACT of Antenatal Vitamin D is STILL poorly understood [40], not LEAST BECAUSE of uncertainties with appropriate BIOMARKERS and cut-off points.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 22), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 140), ('PROBABLE_UNDERSTANDING', 174), ('PROBABLE_UNDERSTANDING', 180), ('PROBLEM_COMPLICATION', 180), ('SUPERFICIAL_RELATIONSHIP', 222)]	9	[('GO_0055064', 'chloride ion homeostasis', 30, 'bone homeostasis'), ('GO_0007420', 'brain development', 48, 'brain development'), ('UBERON_0000955', 'brain', 48, 'brain'), ('GO_0002022', 'detection of dietary excess', 70, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 88, 'immune system'), ('GO_0007567', 'parturition', 117, 'antenatal'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4377879	3/2015	S89-PMC4377879	['a cochrane review FOUND a significant RELATIONSHIP between an increase in Serum Vitamin D concentrations at term and borderline reduction in low Birthweight [42] but there is yet NOT ENOUGH EVIDENCE for policy AS the NUMBER OF high-quality trials IS THOUGHT TO be currently too SMALL to draw conclusions on its usefulness and SAFETY [18].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 179), ('PROBABLE_UNDERSTANDING', 210), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 247), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 278), ('IMPORTANT_CONSIDERATION', 326)]	9	[('UBERON_0001977', 'blood serum', 74, 'serum'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007596', 'blood coagulation', 145, 'birthweight')]
PMC4377879	3/2015	S90-PMC4377879	['OTHER Vitamins : DEFICIENCIES of YET OTHER Vitamins such as Vitamin B12 and PERHAPS Vitamin A MAY BE IMPORTANT BUT EVIDENCE IS SPARSE OR CONFLICTING [22,43].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 17), ('ANOMALY_CURIOUS_FINDING', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 76), ('INCOMPLETE_EVIDENCE', 94), ('IMPORTANT_CONSIDERATION', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	11	[('CHEBI_33277', 'gamma-tocotrienol', 6, 'vitamins'), ('CHEBI_33277', 'gamma-tocotrienol', 43, 'vitamins'), ('CHEBI_33279', 'vitamin D5', 60, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 60, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A')]
PMC4377879	3/2015	S92-PMC4377879	['AS Pregnancy does not require additional Vitamin E and it is common in MOST diets, additional Vitamin E is UNLIKELY to be REQUIRED [21].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 71), ('PROBABLE_UNDERSTANDING', 107), ('IMPORTANT_CONSIDERATION', 122)]	4	[('GO_0007565', 'female pregnancy', 3, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin E')]
PMC4377879	3/2015	S181-PMC4377879	['oral supplementation of urban indian women with Vitamin B-12 throughout Pregnancy and early Lactation significantly increased Vitamin B-12 status of both mothers and infants [9] and so WORTH CONSIDERING where Vitamin B12 intakes are marginal.']	[('IMPORTANT_CONSIDERATION', 185), ('FUTURE_WORK', 191)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 48, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('GO_0007595', 'lactation', 92, 'lactation'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 126, 'vitamin B-12'), ('CHEBI_33279', 'vitamin D5', 209, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 217, 'B12')]
PMC4377879	3/2015	S292-PMC4377879	['Micronutrients LIKELY to be IMPORTANT for maternal, infant and child outcomes include iron, Iodine, Folate, Vitamin B12, Vitamin D, Calcium, and Selenium, PROBABLY zinc and MAYBE others, along with appropriate dietary energy intakes.']	[('PROBABLE_UNDERSTANDING', 15), ('IMPORTANT_CONSIDERATION', 28), ('PROBABLE_UNDERSTANDING', 155), ('INCOMPLETE_EVIDENCE', 173)]	4	[('CHEBI_34850', 'milrinone lactate', 0, 'Micronutrients'), ('CHEBI_24859', 'iodine atom', 92, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 100, 'folate'), ('CHEBI_33279', 'vitamin D5', 108, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 132, 'calcium'), ('CHEBI_27568', 'selenium atom', 145, 'selenium')]
PMC4377896	3/2015	S12-PMC4377896	['introduction\nfish is a source of several Nutrients that are IMPORTANT during Pregnancy for healthy Foetal Development including Iodine, Long Chain Omega-3 polyunsaturated Fatty Acids (lc n- 3pufas), and Vitamins A, D and B12 [1].']	[('IMPORTANT_CONSIDERATION', 60)]	1	[('CHEBI_33284', 'nutrient', 41, 'nutrients'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0060324', 'face development', 99, 'foetal development'), ('CHEBI_24859', 'iodine atom', 128, 'iodine'), ('CHEBI_77190', 'CDP-dipalmitoyl-sn-glycerol(2-)', 136, 'long chain omega-3'), ('CHEBI_35366', 'fatty acid', 171, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 203, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 203, 'vitamins A'), ('PR_000006444', 'diacylglycerol kinase delta', 215, 'D'), ('CHEBI_27778', 'abequose', 221, 'B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 221, 'B12')]
PMC4377896	3/2015	S148-PMC4377896	['this MAY BE attributable to the synergistic EFFECTS of Food [34] and ASSOCIATED with fish being a source of OTHER Nutrients which are IMPORTANT for infant development such as Iodine and Vitamin D. presently, there HAVE BEEN NO randomised control TRIALS examining Neurocognitive outcomes ASSOCIATED with Prenatal multivitamin use and infant Neurodevelopment, and these are UNLIKELY to occur given ethical IMPLICATIONS of such [35].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('IMPORTANT_CONSIDERATION', 134), ('INCOMPLETE_EVIDENCE', 214), ('FULL_UNKNOWN', 224), ('SUPERFICIAL_RELATIONSHIP', 287), ('PROBABLE_UNDERSTANDING', 372), ('IMPORTANT_CONSIDERATION', 404)]	10	[('CHEBI_33290', 'food', 55, 'food'), ('CHEBI_33284', 'nutrient', 114, 'nutrients'), ('CHEBI_24859', 'iodine atom', 175, 'iodine'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0050905', 'neuromuscular process', 263, 'neurocognitive'), ('GO_0007565', 'female pregnancy', 303, 'prenatal'), ('GO_0007399', 'nervous system development', 340, 'neurodevelopment')]
PMC4380518	9/2014	S0-PMC4380518	['Prenatal Vitamin use and Vitamin D status during Pregnancy, differences by race and overweight status\n\nabstract\n\nobjective\nwe AIMED TO STUDY WHETHER Prenatal Vitamin (pnv) use PROTECTS against low 25(Oh)D levels in all women and PARTICULARLY in obese and black women who are both AT RISK of Vitamin D deficiency and poor pregnancy outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 176), ('IMPORTANT_CONSIDERATION', 229), ('IMPORTANT_CONSIDERATION', 280)]	6	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_33229', 'vitamin (role)', 9, 'Vitamin'), ('CHEBI_28384', 'vitamin K', 25, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 49, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 149, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 158, 'vitamin'), ('CHEBI_71657', 'versiconol acetate', 197, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 203, 'D'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D')]
PMC4380518	9/2014	S7-PMC4380518	['introduction\nPerinatal health outcomes VARY dramatically by race in the united states.1african american women develop Preeclampsia more OFTEN than their white counterparts2and are more LIKELY to develop preterm labor.3the result is that black infants are 60% more LIKELY BE preterm and four times more LIKELY to die due to prematurity than white infants.1BECAUSE of less efficient Vitamin D Synthesis in the skin of darker Pigmented Individuals, african americans are at higher RISK than white americans of Vitamin D deficiency.4,5black women are also more LIKELY than white women to be overweight or obese6which is of CONCERN BECAUSE obesity is another RISK FACTOR for Vitamin D deficiency5,7and poor Perinatal outcomes.8in OBSERVATIONAL studies, 25-Hydroxyvitamin D (25[Oh]D) levels HAVE BEEN SHOWN to be ASSOCIATED with higher risk of several adverse Perinatal outcomes including Gestational diabetes9,10, preeclampsia,11preterm Birth12And small-for-Gestational age status.13,14,15,16,17BECAUSE of the PAUCITY of Vitamin D trial data with respect to Perinatal outcomes, WHETHER DIFFERENCES in Vitamin D status during Pregnancy explains or partially explains Perinatal DISPARITIES is PLAUSIBLE18but REMAINS UNKNOWN.']	[('DIFFICULT_TASK', 39), ('PROBABLE_UNDERSTANDING', 136), ('PROBABLE_UNDERSTANDING', 185), ('PROBABLE_UNDERSTANDING', 264), ('PROBABLE_UNDERSTANDING', 302), ('PROBABLE_UNDERSTANDING', 355), ('IMPORTANT_CONSIDERATION', 478), ('PROBABLE_UNDERSTANDING', 557), ('PROBLEM_COMPLICATION', 619), ('PROBABLE_UNDERSTANDING', 627), ('SUPERFICIAL_RELATIONSHIP', 654), ('INCOMPLETE_EVIDENCE', 725), ('INCOMPLETE_EVIDENCE', 785), ('SUPERFICIAL_RELATIONSHIP', 807), ('PROBABLE_UNDERSTANDING', 990), ('INCOMPLETE_EVIDENCE', 1005), ('EXPLICIT_QUESTION', 1073), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('IMPORTANT_CONSIDERATION', 1171), ('INCOMPLETE_EVIDENCE', 1186), ('FULL_UNKNOWN', 1201)]	21	[('GO_0036268', 'swimming', 13, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 13, 'Perinatal'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 381, 'vitamin D synthesis'), ('CHEBI_26130', 'biological pigment', 423, 'pigmented'), ('NCBITaxon_1', 'root', 433, 'individuals'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D'), ('GO_0036268', 'swimming', 702, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 702, 'perinatal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 748, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 769, '25[OH]D'), ('GO_0036268', 'swimming', 854, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 854, 'perinatal'), ('GO_0007565', 'female pregnancy', 883, 'gestational'), ('GO_0007594', 'puparial adhesion', 932, 'birth12and'), ('GO_0007565', 'female pregnancy', 953, 'gestational'), ('CHEBI_27300', 'vitamin D', 1016, 'vitamin D'), ('GO_0036268', 'swimming', 1053, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1053, 'perinatal'), ('CHEBI_27300', 'vitamin D', 1096, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1120, 'pregnancy'), ('GO_0036268', 'swimming', 1161, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1161, 'perinatal')]
PMC4380518	9/2014	S8-PMC4380518	['furthermore, WHILE multivitamin intake HAS BEEN SHOWN to VARY by race,19it REMAINS UNKNOWN WHETHER multivitamin intake improves Vitamin D status among the HIGHEST RISK groups (african americans and overweight/obese) during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 39), ('DIFFICULT_TASK', 57), ('FULL_UNKNOWN', 75), ('EXPLICIT_QUESTION', 91), ('IMPORTANT_CONSIDERATION', 155)]	6	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
PMC4380518	9/2014	S63-PMC4380518	['the OPTIMAL method of Vitamin D measurement REMAINS CONTROVERSIAL, BUT our laboratory uses u.s. national institute of standards and technology level 1 and this method is COMMONLY used clinically and in the literature.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67), ('PROBABLE_UNDERSTANDING', 170)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4380518	9/2014	S65-PMC4380518	['IN CONTRAST, our data SUPPORT INVESTIGATION into higher doses of Vitamin D in subgroups at high RISK IF BENEFITS are demonstrated by ONGOING TRIALS in Pregnancy of achieving higher 25(Oh)D levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 96), ('FUTURE_PREDICTION', 101), ('IMPORTANT_CONSIDERATION', 104), ('INCOMPLETE_EVIDENCE', 133)]	7	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 181, '25(OH)D')]
PMC4380518	9/2014	S68-PMC4380518	['IN LIGHT OF two RECENT meta-analyses/systematic reviews CONCLUDING that low 25(Oh)D levels during Pregnancy are ASSOCIATED with SEVERAL morbidities in Pregnancy15,16, optimizing Vitamin D status during Pregnancy MAY BE IMPORTANT.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 219)]	7	[('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 76, '25 ... OH ... D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy15'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy')]
PMC4383226	2/2015	S11-PMC4383226	["many also receive Vitamin A supplements, which HAVE BEEN LINKED not ONLY to the protection of a child's Vision, but also to a lower RISK of death and an improved ability to Fight off infections."]	[('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 57), ('ANOMALY_CURIOUS_FINDING', 68), ('IMPORTANT_CONSIDERATION', 132)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin A'), ('GO_0007601', 'visual perception', 104, 'vision'), ('GO_0007631', 'feeding behavior', 173, 'fight')]
PMC4383226	2/2015	S43-PMC4383226	['the underlying mechanisms of these EFFECTS are UNCLEAR, ALTHOUGH it HAS BEEN THEORIZED that Vitamin A MAY act as Adjuvant to dtp, which is POSTULATED to cause DETRIMENTAL EFFECTS (jorgensen et al., 2011).']	[('SUPERFICIAL_RELATIONSHIP', 35), ('FULL_UNKNOWN', 47), ('ANOMALY_CURIOUS_FINDING', 56), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 77), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 171)]	10	[('CHEBI_27300', 'vitamin D', 92, 'vitamin A'), ('CHEBI_60809', 'adjuvant', 113, 'adjuvant')]
PMC4383226	2/2015	S100-PMC4383226	['STILL, it CONTRADICTS SUGGESTIONS that when combined with dtp (jorgensen et al., 2011), Vitamin A MAY increase the RISK of malaria infection.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 0), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 98), ('IMPORTANT_CONSIDERATION', 115)]	8	[('CHEBI_27300', 'vitamin D', 88, 'vitamin A')]
PMC4383226	2/2015	S106-PMC4383226	['all of the epidemiological EVIDENCE TO SUPPORT the DETRIMENTAL gender-BASED EFFECTS from Vitamin A and dtp on child mortality comes from guinea bissau (benn et al., 2009a,b2009b;fisker et al., 2013).']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('SUPERFICIAL_RELATIONSHIP', 76)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin A')]
PMC4383226	2/2015	S108-PMC4383226	["Placental malaria and Vitamin A\ndifferences in the IMPACT of Vitamin A on malaria infection by Birth weight, and having a mother who used Antimalarials during the child's Gestational period SUGGESTS exposure to Placental malaria MAY play a CRITICAL ROLE in Vitamin A's PROTECTIVE EFFECT mechanisms later on in childhood."]	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 190), ('INCOMPLETE_EVIDENCE', 229), ('IMPORTANT_CONSIDERATION', 240), ('SUPERFICIAL_RELATIONSHIP', 249), ('SUPERFICIAL_RELATIONSHIP', 269), ('SUPERFICIAL_RELATIONSHIP', 280)]	7	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('GO_0007567', 'parturition', 95, 'birth'), ('CHEBI_22580', 'anthraquinone', 138, 'antimalarials'), ('GO_0007565', 'female pregnancy', 171, 'gestational'), ('UBERON_0001987', 'placenta', 211, 'placental'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin A')]
PMC4383226	2/2015	S132-PMC4383226	['this includes FURTHER CLARIFICATION regarding OPTIMAL dosages and the time sequence in which Vitamin A is administered in relation to other vaccines, as well as more accurate measures with regard to hbs and G6Pdd Allele frequency.']	[('FUTURE_WORK', 14), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 46)]	3	[('CHEBI_27300', 'vitamin D', 93, 'vitamin A'), ('PR_000007897', 'glutamate--cysteine ligase catalytic subunit', 207, 'G6PDd'), ('SO_0001023', 'allele', 213, 'allele')]
PMC4383575	1/2015	S238-PMC4383575	['OTHER POTENTIAL LIMITATIONS of OUR STUDY were the INABILITY to assess the intake of IMPORTANT dietary variables (i.e., Vitamins E, A, and C) (ragin et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 50), ('IMPORTANT_CONSIDERATION', 84)]	6	[('CHEBI_27300', 'vitamin D', 119, 'vitamins E'), ('PR_000024090', 'sensor protein TorS', 119, 'vitamins E'), ('PR_000004370', 'asialoglycoprotein receptor 2', 131, 'A'), ('PR_000004900', 'complement C3', 138, 'C')]
PMC4392531	3/2015	S97-PMC4392531	["it is DOCUMENTED that limiting Milk Intake during Pregnancy COULD reduce the absorption of protein, calcium, and Vitamin D, which COULD THREATEN the infant's health through reducing the Birth weight."]	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 130), ('IMPORTANT_CONSIDERATION', 136)]	4	[('GO_0007614', 'short-term memory', 31, 'milk'), ('GO_0007631', 'feeding behavior', 36, 'intake'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007567', 'parturition', 186, 'birth')]
PMC4392531	3/2015	S130-PMC4392531	['bread and cereals play an ESSENTIAL ROLE in the supplying calories for women and are rich in Vitamin B, iron, zinc, and fiber.']	[('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 36)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin B')]
PMC4392553	3/2015	S431-PMC4392553	["[140]\nsamsel and seneff[248249] PROPOSED that the current Vitamin D deficiency EPIDEMIC is caused by Glyphosate, due TO Glyphosate's interference with cyp enzymes."]	[('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 117)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_17754', 'glycerol', 101, 'glyphosate'), ('CHEBI_17754', 'glycerol', 120, 'glyphosate')]
PMC4392553	3/2015	S432-PMC4392553	['the Metabolite that is USUALLY measured, 25-Hydroxy Vitamin D, is the product of activation in the Liver by a cyp enzyme that is also CRITICAL in Bile Acid Formation.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 134)]	2	[('CHEBI_39382', 'flufenoxuron', 4, 'metabolite'), ('CHEBI_43141', '3-hydroxypropoxy group', 41, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002107', 'liver', 99, 'liver'), ('CHEBI_3098', 'bile acid', 146, 'bile acid'), ('GO_0006699', 'bile acid biosynthetic process', 146, 'bile acid formation'), ('UBERON_0001970', 'bile', 146, 'bile')]
PMC4396835	1/2015	S0-PMC4396835	['autism spectrum disorder and low Vitamin D at Birth: a sibling control study\n\nabstract\n\nbackground\ninsufficient Vitamin D activity has attracted increasing INTEREST AS a POSSIBLE UNDERLYING RISK factor in disorders of the Central Nervous System, including autism.']	[('IMPORTANT_CONSIDERATION', 156), ('INCOMPLETE_EVIDENCE', 156), ('PROBABLE_UNDERSTANDING', 165), ('INCOMPLETE_EVIDENCE', 170), ('SUPERFICIAL_RELATIONSHIP', 179), ('SUPERFICIAL_RELATIONSHIP', 190)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 222, 'central nervous system')]
PMC4396835	1/2015	S8-PMC4396835	['FUTURE RESEARCH SHOULD study WHETHER OR NOT adequate supplementation of Vitamin D to Pregnant women MIGHT lower the RISK for asd in the offspring.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 116)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnant')]
PMC4396835	1/2015	S17-PMC4396835	['low Vitamin D availability has attracted increasing INTEREST as an aetiological FACTOR in disorders of the Central Nervous System.']	[('IMPORTANT_CONSIDERATION', 52), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 107, 'central nervous system')]
PMC4396835	1/2015	S18-PMC4396835	['the INITIAL DISCOVERY that Rodent Brains contain Vitamin D receptors, targeted by Calcitriol, the hormonally active form of Vitamin D, was CRUCIAL for this research [14].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 139)]	3	[('NCBITaxon_33208', 'Metazoa', 27, 'rodent'), ('UBERON_0000955', 'brain', 34, 'brains'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 82, 'calcitriol'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4396835	1/2015	S23-PMC4396835	['Prenatal Vitamin D deficiency HAS now been PROPOSED as a risk factor for Neurodevelopmental disorders such as schizophrenia [22] and autism [23–27].']	[('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 43)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007399', 'nervous system development', 73, 'neurodevelopmental')]
PMC4396835	1/2015	S26-PMC4396835	['this is RELEVANT SINCE the Synthesis Of Vitamin D In Skin is impaired by Melanin [32].']	[('IMPORTANT_CONSIDERATION', 8), ('PROBABLE_UNDERSTANDING', 17)]	2	[('GO_0019915', 'lipid storage', 27, 'synthesis of vitamin D in skin'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_25179', 'melanins', 73, 'melanin')]
PMC4396835	1/2015	S30-PMC4396835	['season of Birth findings constitute another LINK between autism and Vitamin D. in europe a MAJOR proportion of the population have CONSIDERABLY lower 25(Oh)D in winter and spring compared TO summer and autumn [36,41].']	[('SUPERFICIAL_RELATIONSHIP', 44), ('IMPORTANT_CONSIDERATION', 91), ('ANOMALY_CURIOUS_FINDING', 131), ('QUESTION_ANSWERED_BY_THIS_WORK', 188)]	4	[('GO_0007567', 'parturition', 10, 'birth'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D')]
PMC4396835	1/2015	S36-PMC4396835	['the AIM of the PRESENT STUDY was TO ADDRESS the EMERGING HYPOTHESIS that low levels of Vitamin D at Birth increase the RISK for asd.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 119)]	6	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007567', 'parturition', 100, 'birth')]
PMC4396835	1/2015	S168-PMC4396835	['conclusion\nOUR FINDINGS of a low Vitamin D level in a group of newborn children, who later developed asd, provide SUPPORT for the HYPOTHESIS that developmental Vitamin D deficiency during late Pregnancy MAY carry an INCREASED risk of asd in the child, along with several other RISK FACTORS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 203), ('IMPORTANT_CONSIDERATION', 216), ('SUPERFICIAL_RELATIONSHIP', 277)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy')]
PMC4396835	1/2015	S171-PMC4396835	['FUTURE RESEARCH SHOULD include a larger cohort followed prospectively and also study WHETHER OR NOT adequate supplementation of Vitamin D to Pregnant women MIGHT lower the RISK for asd in the offspring.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 156), ('IMPORTANT_CONSIDERATION', 172)]	5	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'pregnant')]
PMC4396888	3/2015	S105-PMC4396888	['the MAJORITY of pw and rdw had an INADEQUATE Nutrient adequacy ratio nar (<0.66) with respect to protein, and Micronutrients like iron, calcium, Vitamin A, Vitamin C, Thiamine, riboflavin, niacin, zinc and Vitamin B12.']	[('PROBABLE_UNDERSTANDING', 4), ('IMPORTANT_CONSIDERATION', 34)]	2	[('CHEBI_33284', 'nutrient', 45, 'nutrient'), ('CHEBI_33839', 'macromolecule', 110, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin C'), ('CHEBI_26948', 'vitamin B1', 167, 'thiamine'), ('CHEBI_33279', 'vitamin D5', 206, 'vitamin B12')]
PMC4405493	4/2015	S16-PMC4405493	['certain HIGH risk groups for Vitamin D deficiency in Pregnancy HAVE BEEN IDENTIFIED, including vegetarians, women with limited sun exposure (e.g., those who live in cold climates, northern latitudes, or wear sun and winter protective clothing), and ethnic minorities, especially those with darker skin [2].']	[('IMPORTANT_CONSIDERATION', 8), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 73)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 53, 'pregnancy')]
PMC4405493	4/2015	S19-PMC4405493	['HOWEVER, the EFFECT of less SEVERE Vitamin D deficiency and insufficiency on maternal and fetal outcomes during Pregnancy is LESS CLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 28), ('FULL_UNKNOWN', 125)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy')]
PMC4405493	4/2015	S24-PMC4405493	['THUS, we SOUGHT TO DETERMINE IF Vitamin D deficiency in the first trimester of nulliparous patients is ASSOCIATED with clinical outcomes MOST ASSOCIATED with SIGNIFICANT maternal and fetal morbidity and mortality: Preeclampsia, Gestational diabetes, Preterm Delivery, spontaneous abortion, and growth restriction.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('SUPERFICIAL_RELATIONSHIP', 103), ('PROBABLE_UNDERSTANDING', 137), ('SUPERFICIAL_RELATIONSHIP', 142), ('IMPORTANT_CONSIDERATION', 158)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 214, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 228, 'gestational'), ('GO_0007565', 'female pregnancy', 250, 'preterm'), ('GO_0007567', 'parturition', 258, 'delivery')]
PMC4405493	4/2015	S113-PMC4405493	['these women did not have preexisting hypertension, diabetes, or other medical problems that would increase their RISK for Pregnancy complications or Vitamin D deficiency.']	[('IMPORTANT_CONSIDERATION', 113)]	1	[('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4405493	4/2015	S118-PMC4405493	['RISK FACTORS for Vitamin D deficiency include INADEQUATE sun or uv light exposure, physiologic factors (such as dark skin pigmentation, obesity, Pregnancy, certain medical problems), and low Vitamin D intake [2–3].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 46)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4405493	4/2015	S119-PMC4405493	['the PREVALENCE of Vitamin D deficiency in Reproductive aged women APPEARS TO BE increasing worldwide over the past two decades.1,3,13recent STUDIES INDICATE the prevalence of Vitamin D insufficiency and deficiency in nulliparous women, a result CORROBORATED by our study [40].']	[('IMPORTANT_CONSIDERATION', 4), ('ANOMALY_CURIOUS_FINDING', 66), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 245)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0000003', 'reproduction', 42, 'reproductive'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC4405493	4/2015	S121-PMC4405493	['UNFORTUNATELY, the increasing use of multivitamins and Mineral dietary supplements in younger to older Adults DOES NOT APPEAR TO BE ASSOCIATED with a corresponding increase in Serum 25-oh Vitamin D concentrations [3,19,41].']	[('IMPORTANT_CONSIDERATION', 0), ('ANOMALY_CURIOUS_FINDING', 110), ('ANOMALY_CURIOUS_FINDING', 119), ('SUPERFICIAL_RELATIONSHIP', 132)]	4	[('CHEBI_46662', 'mineral', 55, 'mineral'), ('UBERON_0007023', 'adult organism', 103, 'adults'), ('UBERON_0001977', 'blood serum', 176, 'serum'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D')]
PMC4405493	4/2015	S126-PMC4405493	['BECAUSE Vitamin D deficiency is so widespread, determining WHETHER Vitamin D deficiency is ASSOCIATED with adverse Pregnancy outcomes is an area of MAJOR PUBLIC HEALTH CONCERN.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('SUPERFICIAL_RELATIONSHIP', 91), ('IMPORTANT_CONSIDERATION', 148), ('IMPORTANT_CONSIDERATION', 154)]	5	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy')]
PMC4405493	4/2015	S127-PMC4405493	['it is UNCLEAR WHETHER Vitamin D deficiency is causal in the DISPARITIES in adverse Pregnancy outcomes between caucasians and african americans.']	[('FULL_UNKNOWN', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('IMPORTANT_CONSIDERATION', 60)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC4405493	4/2015	S148-PMC4405493	['for example, there is SOME EVIDENCE Vitamin D AFFECTS transcription and function of Genes responsible for Trophoblast invasion and Angiogenesis, two factors CRITICAL for Placenta Development.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 46), ('IMPORTANT_CONSIDERATION', 157)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('SO_0000704', 'gene', 84, 'genes'), ('UBERON_0000088', 'trophoblast', 106, 'trophoblast'), ('GO_0001525', 'angiogenesis', 131, 'angiogenesis'), ('GO_0001890', 'placenta development', 170, 'placenta development'), ('UBERON_0001987', 'placenta', 170, 'placenta')]
PMC4405493	4/2015	S150-PMC4405493	['maternal Vitamin D deficiency MAY also PREDISPOSE women to an increased inflammatory response that characterizes preeclampsia, ESPECIALLY SEVERE, early onset disease (reviewed in christesen [2012] and wei [2013]) [13,39].']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 127), ('IMPORTANT_CONSIDERATION', 138)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4405493	4/2015	S178-PMC4405493	['ALTHOUGH OUR STUDY DID NOT DEMONSTRATE an association of Vitamin D Plasma concentration with select clinical outcomes, the prevalence of sub-optimal Vitamin D concentrations in patient plasma EMPHASIZES THE NEED for CONTINUED RESEARCH on hypovitaminosis d in Pregnancy and Reproductive health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 192), ('INCOMPLETE_EVIDENCE', 203), ('FUTURE_WORK', 207), ('FUTURE_WORK', 216)]	10	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 67, 'plasma'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 259, 'pregnancy'), ('GO_0000003', 'reproduction', 273, 'reproductive')]
PMC4408096	4/2015	S14-PMC4408096	['WHILE iron deficiency IS CONSIDERED the LEADING cause of anemia, OTHER causes include deficiencies in Micronutrients such as Folate, Vitamin B12, and Vitamin A, infestations with parasites such as helminths or malaria, Genetically-inherited hemoglobinopathies, hiv/aids, and chronic inflammation [3,4].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65)]	4	[('CHEBI_33839', 'macromolecule', 102, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 125, 'folate'), ('CHEBI_33279', 'vitamin D5', 133, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin A'), ('SO_0000704', 'gene', 219, 'genetically')]
PMC4417995	4/2015	S2-PMC4417995	['HOWEVER, OBSERVATIONS LINKING high Vitamin D levels to an INCREASED RISK of developing ad HAVE also BEEN published, EFFECTIVELY creating a CONTROVERSY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 22), ('IMPORTANT_CONSIDERATION', 58), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4417995	4/2015	S4-PMC4417995	['as of today, the ROLE of Vitamin D in ad is FAR FROM CLEAR; ADDITIONAL STUDIES ARE PARTICULARLY NEEDED in order to confirm the PROMISING therapeutic ROLE of Vitamin D supplementation in childhood ad.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('FULL_UNKNOWN', 44), ('FUTURE_WORK', 60), ('FUTURE_WORK', 71), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 127), ('PROBABLE_UNDERSTANDING', 127), ('SUPERFICIAL_RELATIONSHIP', 149)]	8	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4417995	4/2015	S26-PMC4417995	['as a matter of fact, Vitamin D deficiency has become a PUBLIC HEALTH ISSUE.']	[('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 69)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC4417995	4/2015	S28-PMC4417995	['both children and Pregnant/Lactating women are identified as groups PARTICULARLY vulnerable to Vitamin D deficiency [15].']	[('IMPORTANT_CONSIDERATION', 68)]	1	[('GO_0007565', 'female pregnancy', 18, 'pregnant'), ('GO_0007594', 'puparial adhesion', 27, 'lactating'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC4417995	4/2015	S79-PMC4417995	['SINCE sun/uvb exposure increases Vitamin D Serum levels, SOME authors have logically HYPOTHESIZED that ad clinical improvement by sun/uvb MIGHT be MEDIATED at a molecular level by Vitamin D.\nthis is SUPPORTED by the observation that Vitamin D deficiency is ASSOCIATED with more SEVERE skin lesions localized on body sites that are not exposed to sun [37].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 199), ('SUPERFICIAL_RELATIONSHIP', 257), ('IMPORTANT_CONSIDERATION', 278)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D')]
PMC4417995	4/2015	S102-PMC4417995	['[48], who DEMONSTRATED that, for each 4\u2009ng/ml increase in Cord Blood Vitamin D levels, the RISK of eczema diminished by 13.3%.']	[('INCOMPLETE_EVIDENCE', 10), ('IMPORTANT_CONSIDERATION', 91)]	2	[('UBERON_0002240', 'spinal cord', 58, 'cord'), ('UBERON_0000178', 'blood', 63, 'blood'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4417995	4/2015	S116-PMC4417995	['HOWEVER, data on Vitamin D dietary intake and higher prevalence of ad MUST BE assessed CRITICALLY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 70), ('IMPORTANT_CONSIDERATION', 87)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC4417995	4/2015	S163-PMC4417995	['[67] reported a case of Vitamin D deficiency rickets in an adolescent with SEVERE ad.']	[('IMPORTANT_CONSIDERATION', 75)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC4417995	4/2015	S167-PMC4417995	["'s [66] observation, SUGGESTS that improvement MAY BE more evident in case of SEVERE Vitamin D deficiency."]	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 78)]	3	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4427001	4/2015	S0-PMC4427001	['Vitamin D status in women with Gestational diabetes mellitus during Pregnancy and Postpartum\n\nabstract\nof many Vitamin D Extraskeletal functions, its modulatory ROLE in Insulin secretion and action is ESPECIALLY RELEVANT for Gestational diabetes mellitus (gdm).']	[('SUPERFICIAL_RELATIONSHIP', 161), ('IMPORTANT_CONSIDERATION', 201), ('SUPERFICIAL_RELATIONSHIP', 212)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 31, 'Gestational'), ('GO_0007565', 'female pregnancy', 68, 'Pregnancy'), ('GO_0007567', 'parturition', 82, 'Postpartum'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 121, 'extraskeletal'), ('PR_000045358', 'insulin family protein', 169, 'insulin'), ('GO_0007565', 'female pregnancy', 225, 'gestational')]
PMC4427001	4/2015	S26-PMC4427001	['the MAJOR source of Vitamin D is skin after sunlight exposure.']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC4427001	4/2015	S29-PMC4427001	["circulating Plasma concentration of 25(Oh)D IS CONSIDERED the MOST RELIABLE INDICATOR of Individual's Vitamin D status."]	[('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 62), ('IMPORTANT_CONSIDERATION', 67), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('UBERON_0001969', 'blood plasma', 12, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 36, '25(OH)D'), ('NCBITaxon_1', 'root', 89, 'individual'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4427001	4/2015	S94-PMC4427001	['in addition, Vitamin D MAY also be NEEDED to ensure a normal rate of Calcium Flux Across Cell Membranes and maintenance of an adequate Cytosolic calcium pool, which is IMPORTANT for Insulin-mediated Intracellular Signalling in Insulin-responsive Tissues [35].']	[('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 35), ('IMPORTANT_CONSIDERATION', 168)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_1990171', 'SCF complex disassembly in response to cadmium stress', 69, 'calcium flux across cell membranes'), ('GO_0005886', 'plasma membrane', 89, 'cell membranes'), ('GO_0005829', 'cytosol', 135, 'cytosolic'), ('PR_000045358', 'insulin family protein', 182, 'insulin'), ('GO_0005622', 'intracellular anatomical structure', 199, 'intracellular'), ('GO_0035556', 'intracellular signal transduction', 199, 'intracellular signalling'), ('PR_000045358', 'insulin family protein', 227, 'insulin'), ('UBERON_0000479', 'tissue', 246, 'tissues')]
PMC4427001	4/2015	S109-PMC4427001	['CONTRADICTORY results COULD BE EXPLAINED by seasonal, geographical, or ethnic Vitamin D variation; the paper does NOT UNFORTUNATELY mention in WHAT season women were included in the study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 31), ('ANOMALY_CURIOUS_FINDING', 114), ('IMPORTANT_CONSIDERATION', 118), ('EXPLICIT_QUESTION', 143)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4427001	4/2015	S126-PMC4427001	['[43] DID NOT FIND association between maternal Vitamin D status in 559 nondiabetic Pregnant women from south india and the RISK of gdm.']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 123)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnant')]
PMC4427001	4/2015	S153-PMC4427001	['POTENTIALLY beneficial EFFECT of Vitamin D supplementation and the PLAUSIBLE pathogenic ROLE of 25(Oh)D deficiency in the subsequent development of diabetes mellitus type 2 in women with gdm history HAS to be FURTHER explored considering the ROLE of Vitamin D in Modulating Insulin sensitivity and Glucose Metabolism.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 199), ('FUTURE_WORK', 209), ('SUPERFICIAL_RELATIONSHIP', 242)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('GO_0065007', 'biological regulation', 263, 'modulating'), ('PR_000045358', 'insulin family protein', 274, 'insulin'), ('CHEBI_17234', 'glucose', 298, 'glucose'), ('GO_0006006', 'glucose metabolic process', 298, 'glucose metabolism')]
PMC4448820	5/2015	S68-PMC4448820	['phase i of the bond program included an evaluation of 6 Nutrients— zinc, iron, Folic Acid, Vitamin B-12, Vitamin A, and Iodine—chosen for their PUBLIC HEALTH IMPORTANCE and BECAUSE they represent the range of ISSUES confronting those who are addressing the ROLE of nutrition in research, clinical care, or program development/evaluation.']	[('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 158), ('PROBABLE_UNDERSTANDING', 173), ('IMPORTANT_CONSIDERATION', 209), ('SUPERFICIAL_RELATIONSHIP', 257)]	5	[('CHEBI_33284', 'nutrient', 56, 'nutrients'), ('CHEBI_30751', 'formic acid', 79, 'folic acid'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 91, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 120, 'iodine')]
PMC4448820	5/2015	S162-PMC4448820	['the case study Nutrients covered in this review are Vitamin A, iron, zinc, Vitamin D, Folic Acid, and Selenium and were chosen on the basis of their PUBLIC HEALTH IMPORTANCE and BECAUSE they provide the MOST RELEVANT EVIDENCE with regard to their KNOWN EFFECT on Immunity.']	[('IMPORTANT_CONSIDERATION', 149), ('IMPORTANT_CONSIDERATION', 163), ('PROBABLE_UNDERSTANDING', 178), ('PROBABLE_UNDERSTANDING', 203), ('IMPORTANT_CONSIDERATION', 208), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 247), ('SUPERFICIAL_RELATIONSHIP', 253)]	8	[('CHEBI_33284', 'nutrient', 15, 'nutrients'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_30751', 'formic acid', 86, 'folic acid'), ('CHEBI_27568', 'selenium atom', 102, 'selenium'), ('GO_0007566', 'embryo implantation', 263, 'immunity')]
PMC4448820	5/2015	S185-PMC4448820	['AS a result of increased INTEREST in the activities of Vitamin D beyond the traditional FOCUS on bone/calcium, an IMPORTANT NEW UNDERSTANDING of Vitamin D’s ROLE in Immune function has EMERGED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 88), ('IMPORTANT_CONSIDERATION', 114), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 185)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0002405', 'immune system', 165, 'immune')]
PMC4448820	5/2015	S187-PMC4448820	['(113) DESCRIBED a Vitamin D–dependent pathogen-sensing axis in Human Macrophages that HIGHLIGHTS the IMPORTANCE of Vitamin D in Innate Immunity.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 86), ('IMPORTANT_CONSIDERATION', 101)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 63, 'human'), ('CL_0000235', 'macrophage', 69, 'macrophages'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('GO_0045087', 'innate immune response', 128, 'innate immunity')]
PMC4448820	5/2015	S239-PMC4448820	['in vivo data for Vitamin A– and Vitamin D–DEPENDENT induction of Tregs in Humans are EMERGING but are EXTREMELY DIFFICULT to establish methodologically BECAUSE of the LIKELY need to obtain biopsied materials (144–146).']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 102), ('DIFFICULT_TASK', 112), ('PROBLEM_COMPLICATION', 152), ('PROBABLE_UNDERSTANDING', 167)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 65, 'Tregs'), ('NCBITaxon_9606', 'Homo sapiens', 74, 'humans')]
PMC4448820	5/2015	S255-PMC4448820	['in particular, Nk T Cell Development in Mice is CRITICALLY DEPENDENT on Vitamin D (173).']	[('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('CL_0000213', 'lining cell', 15, 'NK T cell'), ('GO_0001822', 'kidney development', 15, 'NK T cell development'), ('GO_0005634', 'nucleus', 15, 'NK'), ('NCBITaxon_10088', 'Mus <genus>', 40, 'mice'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4448820	5/2015	S264-PMC4448820	['parenthetically, the IMPLICATIONS of the EFFECT of pem, Vitamin A, zinc, and Iron on Cd4+T Cell counts are IMPORTANT in the context of interpreting the IMPACT of nutritional interventions in conditions such as hiv in which Cd4+T Cell counts are used as a primary outcome.']	[('IMPORTANT_CONSIDERATION', 21), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 107), ('SUPERFICIAL_RELATIONSHIP', 152)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin A'), ('CHEBI_24870', 'ion', 77, 'iron'), ('CL_0000476', 'thyrotroph', 85, 'CD4 ...'), ('CL_0000084', 'T cell', 89, 'T cell'), ('CL_0000782', 'myeloid dendritic cell', 223, 'CD4+'), ('CL_0000084', 'T cell', 227, 'T cell')]
PMC4448820	5/2015	S379-PMC4448820	['the ESSENTIALITY of Vitamin D in Regulating invariant invariant Nk T Cell Development in Mice IS THOUGHT TO be via epigenetic mechanisms (173).']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 97)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0065007', 'biological regulation', 33, 'regulating'), ('CL_0000213', 'lining cell', 64, 'NK T cell'), ('GO_0001822', 'kidney development', 64, 'NK T cell development'), ('GO_0005634', 'nucleus', 64, 'NK'), ('NCBITaxon_10088', 'Mus <genus>', 89, 'mice')]
PMC4448820	5/2015	S471-PMC4448820	['ALTHOUGH Vitamin A is absolutely REQUIRED for mounting an effective Immune Response, it is TEMPTING to SPECULATE that temporarily inhibiting Plasma Delivery Of Vitamin A to Tissues is beneficial to the host by creating a favorable environment for inflammation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 103)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0006955', 'immune response', 68, 'immune response'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('GO_0070983', 'dendrite guidance', 148, 'delivery of vitamin A'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin A'), ('UBERON_0000479', 'tissue', 173, 'tissues')]
PMC4448820	5/2015	S527-PMC4448820	['● supplementation CAN have BENEFITS (e.g., reducing mortality and some types of morbidity in the case of Vitamin A and zinc) but MAY also increase risk of adverse outcomes in selected populations as HAS BEEN seen for both Vitamin A and iron.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 27), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 199)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin A')]
PMC4448820	5/2015	S552-PMC4448820	['● Serum Retinol and rbp also CORRELATE with Liver Vitamin A stores in subjects with or AT RISK of clinical deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 87)]	2	[('UBERON_0001977', 'blood serum', 2, 'Serum'), ('CHEBI_26536', 'retinoic acid', 8, 'retinol'), ('UBERON_0002107', 'liver', 44, 'liver'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin A')]
PMC4448820	5/2015	S574-PMC4448820	['the IMPORTANT EFFECTS of Vitamin A on Immune function are REFLECTED in the MANY community and clinical STUDIES that SHOWED that Vitamin A AFFECTS mortality and morbidity.']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 75), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 138)]	7	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('UBERON_0002405', 'immune system', 38, 'immune'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin A')]
PMC4448820	5/2015	S593-PMC4448820	['HOWEVER, the EFFECTS of Vitamin A supplementation on the Immune System MAY lead TO variable clinical outcomes, DEPENDING ON the nature of the Immune Response NEEDED to combat the infecting pathogens.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('GO_0006955', 'immune response', 142, 'immune response'), ('UBERON_0002405', 'immune system', 142, 'immune')]
PMC4448820	5/2015	S596-PMC4448820	['important EFFECT modifiers MAY BE population Vitamin A status, age, sex, vaccination status, season, pathogen prevalence, disease type, and disease BURDEN.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 27), ('IMPORTANT_CONSIDERATION', 148)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin A')]
PMC4448820	5/2015	S867-PMC4448820	['ANOTHER example is the observation that Vitamin A supplementation, which GENERALLY lowers mortality in children, increased the RISK of Mother-To-Child Hiv Transmission in pregnant and Postpartum hiv-infected women in tanzania (469), ALTHOUGH not in south africa (470) or malawi (471).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 73), ('IMPORTANT_CONSIDERATION', 127), ('ANOMALY_CURIOUS_FINDING', 233)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('GO_0007063', 'regulation of sister chromatid cohesion', 135, 'mother-to-child HIV transmission'), ('GO_0007565', 'female pregnancy', 184, 'postpartum')]
PMC4448820	5/2015	S1039-PMC4448820	['Vitamin D\n\n● POOR Prenatal Vitamin D status HAS BEEN IMPLICATED in increased asthma risk and severity in the offspring, ALTHOUGH EVIDENCE TO SUPPORT an IMPORTANT RELATION remains CONTROVERSIAL (577).']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 120), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 18, 'prenatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC4448820	5/2015	S1043-PMC4448820	['● EVIDENCE exists for a LINK between lower maternal Vitamin D intake and higher RISK of wheezing, allergic rhinitis, and eczema in childhood (591–595).']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 24), ('IMPORTANT_CONSIDERATION', 80)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC4448820	5/2015	S1044-PMC4448820	['● in a multicenter study in the united states, Vitamin D insufficiency (<30 μg/l) was PREDICTIVE of SEVERE asthma exacerbations (586).']	[('SUPERFICIAL_RELATIONSHIP', 86), ('IMPORTANT_CONSIDERATION', 100)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC4448820	5/2015	S1046-PMC4448820	['● five ONGOING clinical trials MAY provide FURTHER INSIGHTS into the ROLE of Vitamin D in the chronic inflammation RELATED to asthma (596).']	[('IMPORTANT_CONSIDERATION', 7), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 115)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC4448820	5/2015	S1193-PMC4448820	['THIS STUDY, which was followed by numerous others, HIGHLIGHTS an IMPORTANT and underappreciated ROLE for Vitamin D in Drug Metabolism through the induction of Gene Expression of key Drug-Metabolizing enzymes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 51), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 96)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_23888', 'drug', 118, 'drug'), ('GO_0042737', 'drug catabolic process', 118, 'drug metabolism'), ('GO_0010467', 'gene expression', 159, 'gene expression'), ('SO_0000704', 'gene', 159, 'gene'), ('CHEBI_23888', 'drug', 182, 'drug'), ('GO_0016540', 'protein autoprocessing', 182, 'drug-metabolizing')]
PMC4448820	5/2015	S1516-PMC4448820	['as outlined by wgs 1 and 2, an EXPANDING body of EVIDENCE ATTESTS to the IMPORTANCE of Vitamin D to Immune function and the inflammatory Response, with potential therapeutic applications for acute and chronic infectious and inflammatory diseases (790).']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 58), ('PROBABLE_UNDERSTANDING', 58), ('IMPORTANT_CONSIDERATION', 73)]	5	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('GO_0060033', 'anatomical structure regression', 137, 'response')]
PMC4452099	6/2015	S22-PMC4452099	['oral Intake MIGHT be further augmented by fortification and supplementation, which is especially IMPORTANT in order to maintain baseline Vitamin stores during winter in populations at northern latitudes, where the sun can initiate dermal Synthesis Of Vitamin D only from april to october [17,18].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 97)]	2	[('GO_0007631', 'feeding behavior', 5, 'intake'), ('CHEBI_33229', 'vitamin (role)', 137, 'vitamin'), ('GO_0030474', 'spindle pole body duplication', 238, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D')]
PMC4452099	6/2015	S80-PMC4452099	['on the background of the great NEED of Vitamin D in finland due to its high latitude, this COULD have CONTRIBUTED to the recent levelling-off of the otherwise very high t1d incidence in 0–15 year old children [25].']	[('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 102)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4466139	6/2015	S0-PMC4466139	['high prevalence of Vitamin D deficiency in native versus migrant mothers and newborns in the north of italy: a CALL TO act with a stronger prevention program\n\nabstract\n\nbackground\nVitamin D status during Pregnancy is RELATED to neonatal Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 111), ('SUPERFICIAL_RELATIONSHIP', 217)]	2	[('CHEBI_28384', 'vitamin K', 19, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 19, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 180, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC4466139	6/2015	S15-PMC4466139	['moreover, in RECENT YEARS, Vitamin D deficiency HAS BEEN CONSIDERED AS a POSSIBLE cause of several diseases, including Microbial infections, Cardiovascular and allergic diseases, cancers, type 1 diabetes, multiple sclerosis and other Autoimmune diseases [1–10].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 68), ('INCOMPLETE_EVIDENCE', 73)]	6	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 119, 'microbial'), ('UBERON_0004535', 'cardiovascular system', 141, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 234, 'autoimmune')]
PMC4466139	6/2015	S16-PMC4466139	['Vitamin D levels during fetal Life and the Neonatal Period MAY play a ROLE in the development of these conditions through epigenetic changes [11], THEREFORE, Vitamin D status during Pregnancy and in the newborn COULD provide IMPORTANT information.']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 147), ('INCOMPLETE_EVIDENCE', 211), ('IMPORTANT_CONSIDERATION', 225)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 30, 'life'), ('UBERON_0007221', 'neonate stage', 43, 'neonatal period'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy')]
PMC4466139	6/2015	S88-PMC4466139	['these two classifications of Vitamin D status are significantly DIVERGENT and the issue of DESIRABLE Vitamin D levels for a given age is a matter of great DEBATE, especially in the light of the Skeletal and Extraskeletal EFFECTS of Vitamin D (these were NOT BEEN INVESTIGATED in this study).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 64), ('IMPORTANT_CONSIDERATION', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 221), ('FULL_UNKNOWN', 254)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0004288', 'skeleton', 194, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 207, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]
PMC4466139	6/2015	S93-PMC4466139	['THESE STUDIES EVEN IF LIMITED to specific populations (caucasians [28], arab an asian [29], rural populations of south china [30]) SHOW a COMPLEX picture of Genetic FACTORS determining the level of 25Ohd and consequent risks of deficiency of Vitamin D. DESPITE this, the environmental COMPONENT is STILL preponderant ALTHOUGH LIMITED to 57–71% in determining the level of 25Ohd.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 131), ('DIFFICULT_TASK', 138), ('SUPERFICIAL_RELATIONSHIP', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253), ('ANOMALY_CURIOUS_FINDING', 253), ('SUPERFICIAL_RELATIONSHIP', 285), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 326)]	13	[('SO_0000704', 'gene', 157, 'genetic'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 198, '25OHD'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 372, '25OHD')]
PMC4466139	6/2015	S107-PMC4466139	['IN FACT, over the 50% of subjects who had declared taking Vitamin D, failed to achieve OPTIMAL Serum 25Ohd concentrations.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 87)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0001977', 'blood serum', 95, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 101, '25OHD')]
PMC4466139	6/2015	S108-PMC4466139	['Vitamin D deficiency in Pregnancy in spite of taking supplementation MAY BE AS a result of an INSUFFICIENT dose of Vitamin D contained in multivitamins in Prenatal supplements many of which contain only 400 iu or 500 iu, as PREVIOUSLY SHOWN in OTHER studies [33,34].']	[('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 76), ('IMPORTANT_CONSIDERATION', 94), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 244)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 24, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'prenatal')]
PMC4466139	6/2015	S112-PMC4466139	['RECENTLY, an increasing NUMBER OF STUDIES HAVE SHOWN that higher doses of Vitamin D supplementation are SAFE and EFFECTIVE in Pregnant women.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 104), ('SUPERFICIAL_RELATIONSHIP', 113)]	5	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'pregnant')]
PMC4466139	6/2015	S116-PMC4466139	['the RELATIONSHIP between 25Ohd levels, ethnicity and supplementation in Pregnancy SUGGESTS a ROLE for Genetic DETERMINANTS for Vitamin D status and STRESSES the IMPORTANCE of Vitamin D integration in preventative STRATEGIES.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 93), ('SUPERFICIAL_RELATIONSHIP', 110), ('IMPORTANT_CONSIDERATION', 148), ('IMPORTANT_CONSIDERATION', 161), ('FUTURE_WORK', 213)]	7	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 25, '25OHD'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('SO_0000704', 'gene', 102, 'genetic'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC4466139	6/2015	S117-PMC4466139	['OUR FINDINGS also underline the IMPORTANCE of certain RISK FACTORS in causing Vitamin D deficiency such as immigration, dark skin, and lack of Vitamin D supplementation during the Third Trimester of Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 54)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('GO_0042793', 'plastid transcription', 180, 'third trimester'), ('GO_0007565', 'female pregnancy', 199, 'pregnancy')]
PMC4466139	6/2015	S118-PMC4466139	['furthermore, AS maternal Vitamin D deficiency status AFFECTS the newborn, it MAY BE CONSIDERED as a risk FACTOR for other Vitamin D-related disorders in these newborns.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4466139	6/2015	S119-PMC4466139	['it is THEREFORE IMPORTANT to correct the deficiency in utero with higher doses in those AT RISK of SERIOUS deficiency and to closely follow these infants re the early detection of diseases RELATED to lack of Vitamin D.\nknowledge of a generalized Vitamin D deficiency and of RELATED RISK FACTORS MAY LEAD TO IMPROVING education and to more effective PUBLIC HEALTH initiatives.']	[('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 16), ('IMPORTANT_CONSIDERATION', 88), ('IMPORTANT_CONSIDERATION', 99), ('SUPERFICIAL_RELATIONSHIP', 189), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 295), ('PROBABLE_UNDERSTANDING', 299), ('FUTURE_WORK', 307), ('IMPORTANT_CONSIDERATION', 349)]	11	[('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
PMC4476607	1/2015	S147-PMC4476607	['ALTHOUGH antioxidant treatments in Animal MODELS are encouraging, researchers PREMATURELY terminated a clinical trial utilizing high doses of Vitamins C and E in women with Alcohol-exposed Pregnancies BECAUSE of SAFETY CONCERNS (goh et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 42), ('PROBLEM_COMPLICATION', 78), ('PROBLEM_COMPLICATION', 201), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 219), ('PROBLEM_COMPLICATION', 219)]	9	[('NCBITaxon_33208', 'Metazoa', 35, 'animal'), ('CHEBI_27300', 'vitamin D', 142, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 157, 'E'), ('CHEBI_30879', 'alcohol', 173, 'alcohol'), ('GO_0007565', 'female pregnancy', 189, 'pregnancies')]
PMC4488777	5/2015	S1-PMC4488777	['abstract\nin the last decade, Vitamin D was in the SPOTLIGHT in MANY fields of research.']	[('IMPORTANT_CONSIDERATION', 50), ('INCOMPLETE_EVIDENCE', 63)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC4488777	5/2015	S8-PMC4488777	['MOST experts agree that Vitamin D supplementation is a necessity, PARTICULARLY in women suffering from obesity, Insulin resistance or small Ovarian reserve, as well as in men with oligo- and asthenozoospermia if Serum concentration should fall below 50 nmol/l (normal range up to 125 nmol/l).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 66)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('PR_000045358', 'insulin family protein', 112, 'insulin'), ('UBERON_0000992', 'ovary', 140, 'ovarian'), ('UBERON_0001977', 'blood serum', 212, 'serum')]
PMC4488777	5/2015	S9-PMC4488777	['high concentration of Vitamin D and its Metabolites in Decidua during the 1st trimester SUGGESTS its IMPORTANT ROLE in the Implantation process and a local immunological Embryo-protection.']	[('INCOMPLETE_EVIDENCE', 88), ('IMPORTANT_CONSIDERATION', 101), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 30, 'D'), ('CHEBI_25212', 'metabolite', 40, 'metabolites'), ('UBERON_0002450', 'decidua', 55, 'decidua'), ('GO_0007566', 'embryo implantation', 123, 'implantation'), ('UBERON_0000922', 'embryo', 170, 'embryo')]
PMC4488777	5/2015	S24-PMC4488777	['THEREFORE, a clinician MUST BE careful when prescribing Vitamin D preparations, ESPECIALLY in male patients.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 23), ('ANOMALY_CURIOUS_FINDING', 80)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC4488777	5/2015	S31-PMC4488777	['research on the ROLE of Vitamin D in Reproduction Process Modulation SEEMS ESPECIALLY INTERESTING; their CONCLUSIONS PRESUMABLY have a significant practical meaning in infertility treatment, a SERIOUS medical PROBLEM affecting up to 53 million people worldwide [8].']	[('SUPERFICIAL_RELATIONSHIP', 16), ('ANOMALY_CURIOUS_FINDING', 69), ('ANOMALY_CURIOUS_FINDING', 75), ('ANOMALY_CURIOUS_FINDING', 86), ('PROBABLE_UNDERSTANDING', 105), ('PROBABLE_UNDERSTANDING', 117), ('IMPORTANT_CONSIDERATION', 193), ('IMPORTANT_CONSIDERATION', 209)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0003301', 'physiological cardiac muscle hypertrophy', 37, 'reproduction process modulation')]
PMC4488777	5/2015	S36-PMC4488777	['an OPTIMAL level of Vitamin D concentration in Blood Serum SHOULD range between 50 and 125 nmol/l [10], EVEN THOUGH SOME environmental STUDIES IMPLY that the target level SHOULD BE set much higher—up to 250, or even at 300 nmol/l [11,12].']	[('IMPORTANT_CONSIDERATION', 3), ('IMPORTANT_CONSIDERATION', 59), ('ANOMALY_CURIOUS_FINDING', 104), ('INCOMPLETE_EVIDENCE', 116), ('PROBABLE_UNDERSTANDING', 143), ('IMPORTANT_CONSIDERATION', 171)]	6	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0001977', 'blood serum', 53, 'serum')]
PMC4488777	5/2015	S54-PMC4488777	['since our PREVIOUS REVIEW [2], two NEW ORIGINAL papers HAVE BEEN published, EXPLAINING the SIGNIFICANCE of Vitamin D in pcos pathogenesis.']	[('INCOMPLETE_EVIDENCE', 10), ('FULL_UNKNOWN', 35), ('FULL_UNKNOWN', 39), ('INCOMPLETE_EVIDENCE', 55), ('PROBABLE_UNDERSTANDING', 76), ('IMPORTANT_CONSIDERATION', 91)]	6	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC4488777	5/2015	S176-PMC4488777	['COMPLEX evaluation of Vitamin D activity mechanism on fertility REQUIRES FURTHER STUDIES.']	[('DIFFICULT_TASK', 0), ('IMPORTANT_CONSIDERATION', 64), ('FUTURE_WORK', 73)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4488777	5/2015	S179-PMC4488777	['this is why even during the most physiological Pregnancy Vitamin D supplementation in the amount of 800–1000 iu daily is HIGHLY RECOMMENDED [65].']	[('IMPORTANT_CONSIDERATION', 121)]	1	[('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4488777	5/2015	S187-PMC4488777	['conclusions\nCURRENT RESEARCH on the ROLE of Vitamin D in Fertility impairments, such as polycystic Ovary syndrome, Uterine fibroids, improper Semen parameters and in the case of in vitro treatments and Pregnancy failure, SUGGESTS it plays an IMPORTANT ROLE in Human Reproduction processes.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 221), ('IMPORTANT_CONSIDERATION', 242), ('SUPERFICIAL_RELATIONSHIP', 252)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0009566', 'fertilization', 57, 'fertility'), ('UBERON_0000992', 'ovary', 99, 'ovary'), ('UBERON_0000995', 'uterus', 115, 'uterine'), ('UBERON_0001968', 'semen', 142, 'semen'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy'), ('NCBITaxon_9606', 'Homo sapiens', 260, 'human'), ('GO_0000003', 'reproduction', 266, 'reproduction')]
PMC4488777	5/2015	S190-PMC4488777	['administration of Vitamin D is RECOMMENDED in the case of CONSIDERABLE deficiency, PARTICULARLY in obese, Insulin resistant women with low Amh levels, as well as in men with oligo- and asthenozoospermia.']	[('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 58), ('IMPORTANT_CONSIDERATION', 83)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('PR_000045358', 'insulin family protein', 106, 'insulin'), ('CHEBI_16027', "adenosine 5'-monophosphate", 139, 'AMH')]
PMC4490503	6/2015	S308-PMC4490503	['FURTHER rcts are CRUCIAL to determining WHETHER Vitamin D has a ROLE in pathophysiology of gdm and WHETHER supplementation has a ROLE in preventing gdm [129].']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 40), ('SUPERFICIAL_RELATIONSHIP', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('SUPERFICIAL_RELATIONSHIP', 129)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC4499946	7/2015	S1-PMC4499946	['SOME observational STUDIES have SUGGESTED that Prenatal Vitamin D deficiency increases the RISK of adverse Pregnancy and/or Birth outcomes; HOWEVER, there is SCANT EVIDENCE from controlled trials, leading the world health organization to advise against routine Vitamin D supplementation in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140), ('INCOMPLETE_EVIDENCE', 158)]	5	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 107, 'pregnancy ...'), ('GO_0007567', 'parturition', 124, 'birth'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('GO_0007565', 'female pregnancy', 290, 'pregnancy')]
PMC4499946	7/2015	S2-PMC4499946	['IMPORTANTLY, LITTLE IS KNOWN about the EFFECT of maternal Vitamin D status on infant linear growth in communities in south asia where stunting is highly prevalent and maternal-infant Vitamin D status is commonly SUBOPTIMAL.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 13), ('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 212)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC4499946	7/2015	S10-PMC4499946	['THIS TRIAL is expected to contribute unique INSIGHTS into the EFFECTS of improving maternal-infant Vitamin D status in a low-income setting where stunting and adverse Perinatal outcomes represent SIGNIFICANT PUBLIC HEALTH BURDENS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 196), ('IMPORTANT_CONSIDERATION', 208)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0036268', 'swimming', 167, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 167, 'perinatal')]
PMC4499946	7/2015	S20-PMC4499946	['children with SEVERE Vitamin D deficiency rickets have secondary hyperparathyroidism and demineralization of the Growing Skeleton, as well as impairment of bone elongation [11].']	[('IMPORTANT_CONSIDERATION', 14)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0040007', 'growth', 113, 'growing'), ('UBERON_0004288', 'skeleton', 121, 'skeleton')]
PMC4499946	7/2015	S23-PMC4499946	['Vitamin D status is THEREFORE a logical CANDIDATE AS a modifiable nutritional DETERMINANT of linear growth in communities where stunting is prevalent and Vitamin D status is commonly SUBOPTIMAL.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 40), ('PROBABLE_UNDERSTANDING', 50), ('SUPERFICIAL_RELATIONSHIP', 78), ('IMPORTANT_CONSIDERATION', 183)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC4499946	7/2015	S27-PMC4499946	['because maternal Vitamin D status is the PREDOMINANT DETERMINANT of fetal and neonatal Vitamin D stores [18], Prenatal Vitamin D supplementation represents the OPTIMAL approach to testing the EFFECT of improving maternal-infant Vitamin D status on fetal-infant growth and other health outcomes.']	[('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 160), ('SUPERFICIAL_RELATIONSHIP', 192)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'prenatal'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC4499946	7/2015	S30-PMC4499946	['in a study conducted in the 1970s in london, england, Prenatal Vitamin D supplementation reduced the RISK of small for Gestational age (sga) versus control, BUT there was no significant effect on Birth length [24]; however, the infants in the Vitamin D group had significantly greater mean length at 1 year of age [25].']	[('IMPORTANT_CONSIDERATION', 101), ('ANOMALY_CURIOUS_FINDING', 157)]	2	[('GO_0007565', 'female pregnancy', 54, 'prenatal'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'gestational'), ('GO_0007567', 'parturition', 196, 'birth'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4499946	7/2015	S39-PMC4499946	['some observational studies have SUGGESTED that Antenatal Vitamin D deficiency increases the RISK of adverse Pregnancy and Birth outcomes, including sga [30,31].']	[('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 92)]	2	[('GO_0007567', 'parturition', 47, 'antenatal'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'pregnancy'), ('GO_0007567', 'parturition', 122, 'birth')]
PMC4499946	7/2015	S298-PMC4499946	['longer-term surveillance of the infant cohort will IDEALLY enable the assessment of OTHER IMPORTANT clinical outcomes (e.g., asthma, Neurodevelopment) that MAY be INFLUENCED by the NON-CLASSICAL ROLE of Vitamin D in immunoregulation and Extraskeletal Cellular Proliferation and Differentiation.']	[('IMPORTANT_CONSIDERATION', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 163), ('PROBLEM_COMPLICATION', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('GO_0007399', 'nervous system development', 133, 'neurodevelopment'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 237, 'extraskeletal'), ('GO_0030154', 'cell differentiation', 251, 'cellular proliferation ... differentiation')]
PMC4514967	12/2014	S34-PMC4514967	['for example, subclinical Vitamin A deficiency is PREVALENT, AFFECTING an ESTIMATED one-third of children and 15% of Pregnant women,19and increases the risk of death from diarrhea (and measles).']	[('IMPORTANT_CONSIDERATION', 49), ('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 73)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('GO_0007565', 'female pregnancy', 116, 'pregnant')]
PMC4514967	12/2014	S74-PMC4514967	['first, ra can synergize with the activity of Tgf-Β to promote development of induced Foxp3+Tregcells,55,59–61ALTHOUGH it should be NOTED that neither the frequency nor number of Tregcells are reduced in Vitamin A–deficient Mice.62second, ra is REQUIRED to mount protective Immune Responses to infection by Organisms such as toxoplasma gondii .62third, Vitamin A–deficient Mice lack th17 cells63,64and display IMPAIRED th1 and th17 responses to t. gondii infection and oral administration of escherichia coli heat-labile enterotoxin.62vitamin A is also required for conditioning of Dcs and promoting the stereotypical phenotypic features of Intestinal Cd103+Dcs,58highlighting the fact that multiple cell types are Modulated by Vitamin A and underscoring the IMPORTANT ROLE it plays in Immunity.']	[('ANOMALY_CURIOUS_FINDING', 107), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 409), ('IMPORTANT_CONSIDERATION', 758), ('SUPERFICIAL_RELATIONSHIP', 768)]	6	[('PR_000000046', 'TGF-beta', 45, 'TGF-β'), ('PR_000017653', 'zinc finger protein ZFPM2', 85, 'FoxP3'), ('CL_0000960', 'T3 B cell', 91, 'Tregcells'), ('CL_0000960', 'T3 B cell', 178, 'Tregcells'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 223, 'mice'), ('GO_0006955', 'immune response', 273, 'immune responses'), ('UBERON_0002405', 'immune system', 273, 'immune'), ('NCBITaxon_1', 'root', 306, 'organisms'), ('CHEBI_27300', 'vitamin D', 352, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 372, 'mice'), ('PR_000004370', 'asialoglycoprotein receptor 2', 542, 'A'), ('CL_0000990', 'conventional dendritic cell', 581, 'DCs'), ('UBERON_0000160', 'intestine', 640, 'intestinal'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 651, 'CD103'), ('CL_0000990', 'conventional dendritic cell', 657, 'DCs'), ('GO_0065007', 'biological regulation', 714, 'modulated'), ('CHEBI_27300', 'vitamin D', 727, 'vitamin A'), ('GO_0007566', 'embryo implantation', 785, 'immunity')]
PMC4514967	12/2014	S87-PMC4514967	['low Cord Blood Vitamin D levels are a PREDICTOR of subsequent infant Respiratory infections.70,71HOWEVER, data from clinical trials are too LIMITED to draw conclusions about the efficacy and SAFETY of Vitamin D supplementation in Pregnancy.72meta-analyses have HIGHLIGHTED THE NEED to extend endpoints in intervention trials of multiple Micronutrients in Pregnancy.30the timing of Nutrient interventions during Pregnancy or before Conception is an IMPORTANT clinical study parameter to CONSIDER in any meta-analysis designed to evaluate the EFFECTS of an intervention or interventions and the OBSERVED effect size.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 273), ('FUTURE_WORK', 277), ('IMPORTANT_CONSIDERATION', 448), ('FUTURE_WORK', 486), ('SUPERFICIAL_RELATIONSHIP', 541), ('INCOMPLETE_EVIDENCE', 593)]	11	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 69, 'respiratory'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0007565', 'female pregnancy', 230, 'pregnancy'), ('CHEBI_33839', 'macromolecule', 337, 'micronutrients'), ('GO_0007565', 'female pregnancy', 355, 'pregnancy'), ('CHEBI_33284', 'nutrient', 381, 'nutrient'), ('GO_0007565', 'female pregnancy', 411, 'pregnancy'), ('GO_0007620', 'copulation', 431, 'conception')]
PMC4516109	5/2015	S20-PMC4516109	['clinical presentations include Abdominal pain, vomiting, lethargy, hallucinations, confusion, hypoglycemia, deafness, tinnitus, tachypnea, irritability, Metabolic acidosis, coma and death.15\nrisks of OTHER topical agents, such as Anthralin and Calcipotriol on Human studies are NOT KNOWN and THUS most authors CONTRAINDICATE these treatments.7,15calcipotriol is a by-product of Vitamin D3, OFTEN used in combination with topical Corticosteroids in order to increase their effectiveness and minimize irritation.12nevertheless, studies evidenced its systemic absorption in Humans after application on psoriasis plaques and the development of Vitamin D-induced toxicity after treatment with Calcipotriol TENDS to increase the risk of teratogenicity.12\nALTHOUGH the NUMBER OF cases is LIMITED, coal tar HAS BEEN ASSOCIATED with spontaneous Abortions and congenital disorders, and WAS CONSIDERED Teratogenic in Animal studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('FULL_UNKNOWN', 278), ('PROBABLE_UNDERSTANDING', 292), ('IMPORTANT_CONSIDERATION', 310), ('PROBABLE_UNDERSTANDING', 390), ('SUPERFICIAL_RELATIONSHIP', 701), ('ANOMALY_CURIOUS_FINDING', 749), ('INCOMPLETE_EVIDENCE', 762), ('INCOMPLETE_EVIDENCE', 781), ('INCOMPLETE_EVIDENCE', 799), ('SUPERFICIAL_RELATIONSHIP', 808), ('INCOMPLETE_EVIDENCE', 876)]	12	[('UBERON_0000916', 'abdomen', 31, 'abdominal'), ('GO_0008152', 'metabolic process', 153, 'metabolic'), ('CHEBI_37510', 'anthralin', 230, 'anthralin'), ('CHEBI_50749', 'calcipotriol', 244, 'calcipotriol'), ('NCBITaxon_9606', 'Homo sapiens', 260, 'human'), ('CHEBI_33279', 'vitamin D5', 378, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 378, 'vitamin D3'), ('CHEBI_50850', 'etabonate ester', 429, 'corticosteroids'), ('NCBITaxon_9606', 'Homo sapiens', 571, 'humans'), ('CHEBI_27300', 'vitamin D', 640, 'vitamin D'), ('CHEBI_50749', 'calcipotriol', 688, 'calcipotriol'), ('GO_0006915', 'apoptotic process', 836, 'abortions'), ('CHEBI_50905', 'teratogenic agent', 891, 'teratogenic'), ('NCBITaxon_33208', 'Metazoa', 906, 'animal')]
PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
PMC4516377	6/2015	S79-PMC4516377	['SOME STUDIES17,18,20that evaluated the ASSOCIATION of Calcium and Vitamin D with obesity SHOWED a cross-sectional design and it is IMPORTANT to CONSIDER the existence of SOME LIMITATIONS, especially REVERSE causality, AS the exposure and outcome are collected simultaneously.30moreover, it is IMPORTANT to TAKE INTO account that one of the STUDIES14DID not make adjustments for CONFOUNDING FACTORS in the statistical analyses, in addition to the SMALL sample size used by others,13,14which CAN lead to erroneous conclusions.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 131), ('IMPORTANT_CONSIDERATION', 144), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 175), ('PROBLEM_COMPLICATION', 199), ('PROBABLE_UNDERSTANDING', 218), ('IMPORTANT_CONSIDERATION', 293), ('IMPORTANT_CONSIDERATION', 306), ('INCOMPLETE_EVIDENCE', 340), ('PROBLEM_COMPLICATION', 378), ('INCOMPLETE_EVIDENCE', 446), ('INCOMPLETE_EVIDENCE', 490)]	15	[('CHEBI_22313', 'alkaline earth metal atom', 54, 'calcium'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4516377	6/2015	S82-PMC4516377	['final CONSIDERATIONS\nthe ASSOCIATION between Calcium and Vitamin D with obesity is COMPLEX and much REMAINS TO BE ELUCIDATED.']	[('IMPORTANT_CONSIDERATION', 6), ('SUPERFICIAL_RELATIONSHIP', 25), ('DIFFICULT_TASK', 83), ('FULL_UNKNOWN', 100)]	4	[('CHEBI_22313', 'alkaline earth metal atom', 45, 'calcium'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4555116	7/2015	S78-PMC4555116	['the KEY Nutrients selected for comparison were Long-Chain Omega-3 Fatty Acids, Folate, Vitamin B6, Vitamin B12, Calcium, Vitamin D and iron.']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_33284', 'nutrient', 8, 'nutrients'), ('CHEBI_15904', 'long-chain fatty acid', 47, 'long-chain omega-3 fatty acids'), ('CHEBI_30863', '5-azaorotic acid', 79, 'folate'), ('CHEBI_33237', 'vitamin D4', 87, 'vitamin B6'), ('CHEBI_33279', 'vitamin D5', 99, 'vitamin B12'), ('CHEBI_22313', 'alkaline earth metal atom', 112, 'calcium'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4581239	8/2015	S56-PMC4581239	['in a longitudinal cohort study researchers FOUND a dose-response RELATIONSHIP between Micronutrient nutrition deficiency (specifically deficiencies in zinc, iron, and Vitamin B) at 3 years of age, and Externalizing behavior PROBLEMS across childhood and into Adolescence [8].']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 224)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 86, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin B'), ('GO_0007530', 'sex determination', 201, 'externalizing'), ('GO_0048848', 'neurohypophysis morphogenesis', 259, 'adolescence')]
PMC4586450	10/2015	S247-PMC4586450	['these analyses HIGHLIGHT the IMPORTANCE of Feeding young children Foods that are rich in Nutrients in place of energy-dense, Nutrient-poor Foods.Vitamin D\na parallel analysis investigated Vitamin D and Calcium intakes and changes with age between 1.5 and 3.5 years.24overall, Vitamin D intakes were low; all children had intakes below the uk dietary recommendations at both ages.']	[('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 29)]	2	[('GO_0007631', 'feeding behavior', 43, 'feeding'), ('CHEBI_33290', 'food', 66, 'foods'), ('CHEBI_33284', 'nutrient', 89, 'nutrients'), ('CHEBI_33284', 'nutrient', 125, 'nutrient'), ('CHEBI_33290', 'food', 139, 'foods'), ('CHEBI_28384', 'vitamin K', 145, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 145, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 202, 'calcium'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D')]
PMC4586450	10/2015	S251-PMC4586450	['in ndns 2008–2012, young children obtained only a quarter of the Vitamin D intake RECOMMENDED to be obtained from diet and only 12% took dietary supplements102; thus, there is a continuing PROBLEM in the united kingdom.']	[('FUTURE_WORK', 82), ('IMPORTANT_CONSIDERATION', 189)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4586450	10/2015	S252-PMC4586450	['WHETHER fortification of Foods COULD BE the answer to THIS problem was EXAMINED; the THEORETICAL intakes from DIFFERENT fortification regimens tested SUGGESTED that milk fortified at 2 µg vitamin d/100 g would provide MOST preschool children with adequate but not excessive intakes.24later work in the alspac looking at Plasma concentrations in mid-childhood of Vitamin D (25-Hydroxyvitamin-D2And 25-Hydroxyvitamin-D3) in RELATION to Cortical bone measures FOUND positive ASSOCIATIONS with D3Only, SUGGESTING that in supplementation OR fortification, d3should be used in PREFERENCE to d2.25these 2 PAPERS give valuable INSIGHTS into HOW the lack of Vitamin D in the diets of the majority of uk residents COULD BE TACKLED.iron\niron is a Nutrient that is ESSENTIAL to a child’s growth and development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 71), ('INCOMPLETE_EVIDENCE', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('INCOMPLETE_EVIDENCE', 150), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 422), ('INCOMPLETE_EVIDENCE', 457), ('SUPERFICIAL_RELATIONSHIP', 472), ('INCOMPLETE_EVIDENCE', 498), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 533), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 571), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 619), ('EXPLICIT_QUESTION', 633), ('INCOMPLETE_EVIDENCE', 704), ('FUTURE_WORK', 713), ('IMPORTANT_CONSIDERATION', 753)]	20	[('CHEBI_33290', 'food', 25, 'foods'), ('UBERON_0001969', 'blood plasma', 320, 'plasma'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin D'), ('CHEBI_66469', 'senegin III', 373, '25-hydroxyvitamin-D2and'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 373, '25'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 390, '-D2and'), ('CHEBI_65129', '2-hydroxy-AMP', 397, '25-hydroxyvitamin-D3'), ('PR_000000037', 'BMP receptor type-2', 414, '-D3'), ('UBERON_0001851', 'cortex', 434, 'cortical'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 490, 'D3only'), ('CHEBI_27300', 'vitamin D', 649, 'vitamin D'), ('CHEBI_33284', 'nutrient', 736, 'nutrient')]
PMC4586450	10/2015	S545-PMC4586450	['it was also EVIDENT that relative intakes of OTHER IMPORTANT Nutrients such as Calcium and Vitamin A declined in the preschool years,23and this was DUE TO the children starting to Consume more energy-dense, Nutrient-poor Foods (table 6).']	[('PROBABLE_UNDERSTANDING', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('IMPORTANT_CONSIDERATION', 51), ('PROBLEM_COMPLICATION', 148)]	4	[('CHEBI_33284', 'nutrient', 61, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 79, 'calcium'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin A'), ('GO_0007631', 'feeding behavior', 180, 'consume'), ('CHEBI_33284', 'nutrient', 207, 'nutrient'), ('CHEBI_33290', 'food', 221, 'foods')]
PMC4586451	10/2015	S18-PMC4586451	['this has LED to dietary RECOMMENDATIONS for Pregnancy that limit concentrated sources of Vitamin A and stress the IMPORTANCE of periconceptional Folic Acid supplementation, which HAS BEEN SHOWN to be PROTECTIVE against Neural Tube defects.4\nTHERE IS EVIDENCE that optimal fetal Neurodevelopment is DEPENDENT on specific Nutrients supplied by the mother mainly from dietary sources; these MAY include Long-Chain polyunsaturated Fatty Acids (lc-pufas) such as Docosahexaenoic Acid (Dha), an N-3 Fatty Acid, and arachidonic acid, an N-6 Fatty Acid.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('FUTURE_WORK', 24), ('IMPORTANT_CONSIDERATION', 114), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 200), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 298), ('INCOMPLETE_EVIDENCE', 388)]	8	[('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_30751', 'formic acid', 145, 'folic acid'), ('UBERON_0001049', 'neural tube', 219, 'neural tube'), ('GO_0007399', 'nervous system development', 278, 'neurodevelopment'), ('CHEBI_33284', 'nutrient', 320, 'nutrients'), ('CHEBI_28911', 'cob(III)alamin', 400, 'long-chain'), ('CHEBI_35366', 'fatty acid', 427, 'fatty acids'), ('CHEBI_36003', 'decenoic acid', 458, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 480, 'DHA'), ('CHEBI_35245', 'GDP-galactose', 489, 'n-3 fatty acid'), ('CHEBI_18320', '1,4-dithiothreitol', 530, 'n-6'), ('CHEBI_35366', 'fatty acid', 534, 'fatty acid')]
PMC4586451	10/2015	S212-PMC4586451	['there was also no evidence of an association between maternal Vitamin D status during Pregnancy and offspring bone Mineral content (table 3).24the SUGGESTION that maternal body fat stores are IMPORTANT for fetal bone Mineral deposition was investigated in a further study.25there was NO evidence of an independent association between maternal Prepregnancy bmi and offspring bone mass at age 9 years once adjustments were made for Birth weight and the current height and weight of the child.25\nthese data SUGGEST it is UNLIKELY that Pregnancy diet has an IMPORTANT EFFECT on any of the outcomes investigated in this section, ALTHOUGH the ASSOCIATIONS that were FOUND were with Nutrients that are most LIKELY to be inadequate in the diet of this population.8\n\nNeurocognitive and behavioral development Of the offspring\nBrain Cell Membranes have a high content of n-3 lc-pufas, and the predominant sources of these Nutrients in the diets of uk residents are fish and seafood.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 284), ('INCOMPLETE_EVIDENCE', 504), ('PROBABLE_UNDERSTANDING', 518), ('IMPORTANT_CONSIDERATION', 554), ('SUPERFICIAL_RELATIONSHIP', 564), ('ANOMALY_CURIOUS_FINDING', 624), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 660), ('PROBABLE_UNDERSTANDING', 700)]	11	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('CHEBI_46662', 'mineral', 115, 'mineral'), ('CHEBI_46662', 'mineral', 217, 'mineral'), ('GO_0007565', 'female pregnancy', 343, 'prepregnancy'), ('GO_0007567', 'parturition', 430, 'birth'), ('GO_0007565', 'female pregnancy', 532, 'pregnancy'), ('CHEBI_33284', 'nutrient', 676, 'nutrients'), ('GO_0043102', 'amino acid salvage', 758, 'Neurocognitive ... of ...'), ('UBERON_0000955', 'brain', 817, 'Brain'), ('GO_0005886', 'plasma membrane', 823, 'cell membranes'), ('CHEBI_33284', 'nutrient', 912, 'nutrients')]
PMC4595656	10/2015	S0-PMC4595656	['Vitamin D and Hippocampal Development-the story so far\n\nabstract\nepidemiological studies SUGGEST that Vitamin D insufficiency MAY BE PREVALENT in young as well as older populations.']	[('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 126), ('IMPORTANT_CONSIDERATION', 133)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('GO_0003163', 'sinoatrial node development', 14, 'hippocampal development'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4595656	10/2015	S1-PMC4595656	['the pleiotropic EFFECTS of Vitamin D are now BEYOND DISPUTE and a GROWING NUMBER OF STUDIES provide ACCUMULATING EVIDENCE of a ROLE for Vitamin D in Brain Development and function.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 127)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0007420', 'brain development', 149, 'brain development'), ('UBERON_0000955', 'brain', 149, 'brain')]
PMC4595656	10/2015	S7-PMC4595656	['it also REMAINS TO BE ESTABLISHED IF there are CRITICAL developmental windows during which Vitamin D is REQUIRED.']	[('FULL_UNKNOWN', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('IMPORTANT_CONSIDERATION', 47), ('IMPORTANT_CONSIDERATION', 104)]	4	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4595656	10/2015	S8-PMC4595656	['IN LIGHT OF the IMPORTANCE of the hippocampus in ltp and spatial Learning, FURTHER INVESTIGATIONS on the early EFFECTS of Vitamin D deprivation on hippocampal development ARE WARRANTED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('FUTURE_WORK', 75), ('SUPERFICIAL_RELATIONSHIP', 111), ('FUTURE_WORK', 171)]	5	[('GO_0007612', 'learning', 65, 'learning'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4595656	10/2015	S10-PMC4595656	['HOWEVER in RECENT YEARS, myriad OTHER functions and ROLES for Vitamin D HAVE BEEN gradually POSTULATED and VERIFIED, and its pleiotropic EFFECTS are now BEYOND DISPUTE (kalueff and tuohimaa,2007; mccann and ames,2008; lai and fang,2013; schlogl and holick,2014).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 137), ('IMPORTANT_CONSIDERATION', 153), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160)]	11	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4595656	10/2015	S14-PMC4595656	['among the general population, Pregnant women are CONSIDERED to be AT RISK of Vitamin D deficiency (vd).']	[('IMPORTANT_CONSIDERATION', 49), ('IMPORTANT_CONSIDERATION', 66)]	2	[('GO_0007565', 'female pregnancy', 30, 'pregnant'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC4595656	10/2015	S19-PMC4595656	['the QUESTION of reduced Vitamin D concentrations on consequent neonatal, infant and child Development in RELATION to the hippocampus is THEREFORE HIGHLY PERTINENT.']	[('EXPLICIT_QUESTION', 4), ('SUPERFICIAL_RELATIONSHIP', 105), ('PROBABLE_UNDERSTANDING', 136), ('IMPORTANT_CONSIDERATION', 146)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0048513', 'animal organ development', 90, '... development')]
PMC4595656	10/2015	S25-PMC4595656	['since then the investigation of a neural ROLE for Vitamin D has gained SIGNIFICANT traction and a PLETHORA OF Animal STUDIES have SHED LIGHT both on its presence and its biological activity within the Cns independent of Transport via the Blood-Brain Barrier.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 71), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 130)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 110, 'animal'), ('UBERON_0001017', 'central nervous system', 201, 'CNS'), ('GO_0006809', 'nitric oxide biosynthetic process', 220, 'transport'), ('UBERON_0000178', 'blood', 238, 'blood'), ('UBERON_0000052', 'fornix of brain', 244, 'brain barrier')]
PMC4595656	10/2015	S68-PMC4595656	['it MUST BE BORNE IN MIND also, that Rats in the cited studies received SOME Vitamin D from their mothers from the time of Birth until weaning, and IT IS POSSIBLE that this COULD have resulted in a partial restoration of hippocampal structure and function.']	[('IMPORTANT_CONSIDERATION', 3), ('IMPORTANT_CONSIDERATION', 11), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 147), ('INCOMPLETE_EVIDENCE', 172)]	5	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 36, 'rats'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007567', 'parturition', 122, 'birth')]
PMC4595656	10/2015	S121-PMC4595656	['this constitutes a MAJOR lacuna in our overall understanding of the ROLE of Vitamin D in the early development of the hippocampus and is an AVENUE RIPE for EXPLORATION.']	[('IMPORTANT_CONSIDERATION', 19), ('SUPERFICIAL_RELATIONSHIP', 68), ('FUTURE_WORK', 140), ('IMPORTANT_CONSIDERATION', 147), ('QUESTION_ANSWERED_BY_THIS_WORK', 156)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4598849	10/2015	S9-PMC4598849	['WHETHER the common Vitamin D deficiency during Pregnancy CONTRIBUTES to any of the GLOBAL adverse fetal growth epidemic REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 83), ('FULL_UNKNOWN', 120)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy')]
PMC4598849	10/2015	S10-PMC4598849	['maternal Vitamin D deficiency during Pregnancy is a SIGNIFICANT PUBLIC HEALTH PROBLEM GLOBALLY78DUE to the combined EFFECTS of limited sunlight exposure, INADEQUATE intake, and additional growth NEEDS of the fetus.']	[('IMPORTANT_CONSIDERATION', 52), ('PROBLEM_COMPLICATION', 78), ('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 116), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 195)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 37, 'pregnancy')]
PMC4598849	10/2015	S13-PMC4598849	['EVIDENCES from SOME STUDIES SUPPORT the HYPOTHESIS that lower Vitamin D status causes adverse fetal growth in a linear way, more SEVERE deficiency would be expected to have a stronger EFFECT than less severe deficiency or sufficiency91012131416.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 40), ('IMPORTANT_CONSIDERATION', 129), ('SUPERFICIAL_RELATIONSHIP', 184)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4598849	10/2015	S54-PMC4598849	['another case-control study SUGGESTED that infants Born before 32 wks’ Gestation had an increased RISK of Vitamin D deficiency compared with mature infant, HOWEVER, there was no statistically significant difference in mean Cord Blood 25(Oh)D levels between sga and non-sga infants29.']	[('INCOMPLETE_EVIDENCE', 27), ('IMPORTANT_CONSIDERATION', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('ANOMALY_CURIOUS_FINDING', 155)]	4	[('GO_0007567', 'parturition', 50, 'born'), ('GO_0007565', 'female pregnancy', 70, 'gestation'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 222, 'cord'), ('UBERON_0000178', 'blood', 227, 'blood'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 233, '25(OH ... D')]
PMC4598849	10/2015	S56-PMC4598849	['in THIS STUDY with a large sample, adjustment for more confounders and using non-linear models, we FOUND that there was an inverted u-shaped RELATIONSHIP between Cord Blood 25(Oh)D and Birth weight, SUGGESTING that the newborn with low or high levels of fetal Vitamin D are both in INCREASED risk of growth restriction and higher levels of fetal Vitamin D HAVE not been shown to confer greater BENEFITS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 141), ('INCOMPLETE_EVIDENCE', 199), ('IMPORTANT_CONSIDERATION', 282), ('IMPORTANT_CONSIDERATION', 356), ('IMPORTANT_CONSIDERATION', 394)]	7	[('UBERON_0002240', 'spinal cord', 162, 'cord'), ('UBERON_0000178', 'blood', 167, 'blood'), ('CHEBI_71657', 'versiconol acetate', 173, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 173, '25(OH)D'), ('GO_0007567', 'parturition', 185, 'birth'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D')]
PMC4598849	10/2015	S59-PMC4598849	['the FINDING that Vitamin D levels in the upper range increased the health RISK in THIS STUDY was CONSISTENT with PREVIOUS STUDIES examining the risk of fetal growth restriction11, Allergic Response3031, lower-extremity function32, frailty status33, as well as Cardiovascular disease3435.']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 74), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0019267', 'asparagine biosynthetic process from cysteine', 180, 'allergic response3031'), ('UBERON_0004535', 'cardiovascular system', 260, 'cardiovascular')]
PMC4598849	10/2015	S60-PMC4598849	['ALTHOUGH the neonatal 25(Oh)D levels at Birth cannot fully represent the Vitamin D status during CRITICAL times of Gestation DUE TO a half-life of several weeks of 25(Oh)D34, IT was quite POSSIBLE that the neonates with lower or higher Cord Blood 25(Oh)D levels MAY also have lower or higher average levels of 25(Oh)D during the whole Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 97), ('PROBLEM_COMPLICATION', 125), ('ANOMALY_CURIOUS_FINDING', 175), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_71657', 'versiconol acetate', 22, '25(OH)D'), ('GO_0007567', 'parturition', 40, 'birth'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'gestation'), ('CHEBI_79189', 'D-ribofuranose-2,5-bisphosphate', 164, '25(OH)D34'), ('PR_000001177', 'D(2) dopamine receptor', 170, 'D34'), ('UBERON_0002240', 'spinal cord', 236, 'cord'), ('UBERON_0000178', 'blood', 241, 'blood'), ('CHEBI_71657', 'versiconol acetate', 247, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 253, 'D'), ('CHEBI_71657', 'versiconol acetate', 310, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 316, 'D'), ('GO_0007565', 'female pregnancy', 335, 'pregnancy')]
PMC4598849	10/2015	S74-PMC4598849	['THUS, FUTURE STUDIES of Vitamin D and growth restriction would BENEFIT from the CONSIDERATION of OTHER Vitamin D family members.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 6), ('IMPORTANT_CONSIDERATION', 63), ('FUTURE_WORK', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4600246	10/2015	S0-PMC4600246	['the health benefits of Vitamin K\n\nabstract\nvitamin K has IMPORTANT functions within the body, SOME of which are STILL being DISCOVERED.']	[('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 94), ('IMPORTANT_CONSIDERATION', 112), ('INCOMPLETE_EVIDENCE', 124)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin K'), ('CHEBI_52071', 'dextran', 51, 'K')]
PMC4600246	10/2015	S3-PMC4600246	['additionally, Vitamin K antagonists such as warfarin MAY cause DETRIMENTAL side EFFECTS, which MAY PARTLY be blunted through Vitamin K supplementation.']	[('INCOMPLETE_EVIDENCE', 53), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 95)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin K')]
PMC4600246	10/2015	S4-PMC4600246	['introduction\nVitamin K is a fat-soluble Vitamin, IMPORTANT for the function of numerous proteins within the body, such as the Coagulation factors (ii, vii, Ix, x and protein c and protein s), Osteocalcin (a bone-Forming Protein) and Matrix-Gla Protein (Mgp) (an anticalcification protein), to name a few.1–3vitamin K exists naturally as Vitamin K1(Phylloquinone) and Vitamin K2(Menaquinone, mk-4 through mk-10).2–5vitamin K1Is mainly found in green leafy vegetables as well as olive oil and soyabean oil, whereas Vitamin K2(Menaquinone) is found in small amounts in Chicken, butter, Egg Yolks, cheese and fermented soyabeans (BETTER KNOWN as natto).26–9\nVitamin K1And Vitamin K2Are REQUIRED for the γ-glutamyl carboxylation of all Vitamin K-dependent proteins.2DESPITE the fact that Mammalian bacterial Intestinal flora are able to produce Vitamin K2, the amount produced IS THOUGHT TO be negligible.2the adequate intake (ai) for Vitamin K HAS BEEN PROPOSED to be 90\u2005µg/day for women and 120\u2005µg/day for men.210HOWEVER, it HAS BEEN SPECULATED that the ai for Vitamin K (90–120\u2005µg/day) is not sufficient to induce complete carboxylation of all Vitamin K-dependent proteins.21112\n\nvitamin K deficiency\nthe measurement and treatment of Vitamin K deficiency based on Blood tests is not perfect.']	[('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 626), ('IMPORTANT_CONSIDERATION', 682), ('ANOMALY_CURIOUS_FINDING', 760), ('INCOMPLETE_EVIDENCE', 872), ('INCOMPLETE_EVIDENCE', 875), ('INCOMPLETE_EVIDENCE', 940), ('INCOMPLETE_EVIDENCE', 949), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1007), ('INCOMPLETE_EVIDENCE', 1022), ('INCOMPLETE_EVIDENCE', 1031)]	11	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin K'), ('CHEBI_33229', 'vitamin (role)', 40, 'vitamin'), ('GO_0050817', 'coagulation', 126, 'coagulation'), ('PR_000008875', 'islet amyloid polypeptide', 156, 'IX'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 192, 'osteocalcin'), ('PR_000004759', 'Bloom syndrome protein', 211, '-forming protein'), ('GO_0031012', 'extracellular matrix', 233, 'matrix'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 233, 'matrix-Gla protein'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 253, 'MGP'), ('CHEBI_52071', 'dextran', 315, 'K'), ('CHEBI_33229', 'vitamin (role)', 337, 'vitamin'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 337, 'vitamin K1'), ('CHEBI_26124', 'phytosteroid', 348, 'phylloquinone'), ('CHEBI_28934', 'vitamin D2', 367, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 367, 'vitamin K2'), ('CHEBI_18154', 'polysaccharide', 378, 'menaquinone'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 422, 'K1is'), ('CHEBI_28934', 'vitamin D2', 513, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 513, 'vitamin K2'), ('CHEBI_18154', 'polysaccharide', 524, 'menaquinone'), ('NCBITaxon_33208', 'Metazoa', 566, 'chicken'), ('UBERON_0005079', 'eggshell', 583, 'egg yolks'), ('CHEBI_33229', 'vitamin (role)', 654, 'Vitamin'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 654, 'Vitamin K1and'), ('PR_000017209', 'utrophin', 668, 'vitamin K2are'), ('CHEBI_27300', 'vitamin D', 731, 'vitamin K'), ('NCBITaxon_40674', 'Mammalia', 783, 'mammalian'), ('UBERON_0000160', 'intestine', 803, 'intestinal'), ('CHEBI_28934', 'vitamin D2', 840, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 840, 'vitamin K2'), ('CHEBI_27300', 'vitamin D', 930, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 1058, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 1142, 'vitamin K'), ('CHEBI_52071', 'dextran', 1186, 'K'), ('CHEBI_27300', 'vitamin D', 1232, 'vitamin K'), ('UBERON_0000178', 'blood', 1262, 'blood')]
PMC4600246	10/2015	S14-PMC4600246	['the benefit of Vitamin K on bone IS THOUGHT TO be UNRELATED to increasing bmd BUT RATHER increasing bone strength.19a RECENT meta-analysis HAS SHOWN that vitamin K2(45\u2005mg/day) significantly reduces Hip (77% reduction), vertebral (60% reduction) and all non-vertebral fractures (81% reduction).20whether the results of vitamin K2At a dose of 45\u2005mg CAN be translated to over the counter doses of Vitamin K1(such as 1–5\u2005mg) is STILL a matter of DEBATE, BUT Vitamin K1On its own HAS already BEEN SHOWN to reduce fractures and cancer in a clinical TRIAL, ALTHOUGH more DATA ARE NEEDED TO CONFIRM these benefits.']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 347), ('IMPORTANT_CONSIDERATION', 424), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 442), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 450), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 543), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 550), ('FUTURE_WORK', 564), ('INCOMPLETE_EVIDENCE', 583)]	16	[('CHEBI_27300', 'vitamin D', 15, 'vitamin K'), ('PR_000009450', 'keratin, type II cytoskeletal 1', 162, 'K2'), ('UBERON_0001464', 'hip', 198, 'hip'), ('CHEBI_34810', 'Lactitol dihydrate', 326, 'K2at'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 326, 'K2at'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 394, 'vitamin K1'), ('CHEBI_33227', '(E)-cinnamyl alcohol', 454, 'vitamin K1on'), ('PR_000009495', 'keratin, type II cytoskeletal 8', 462, 'K1on')]
PMC4600246	10/2015	S15-PMC4600246	['Vitamin K and vascular calcifications\nCoronary Artery calcium (cac) HAS BEEN SHOWN to have increasing prevalence as Kidney function declines.3indeed, cac prevalence HAS BEEN reported in 13% of ‘healthy’ patients without Renal disease,2140% of patients with chronic Kidney disease patients not on dialysis,2157% of patients starting dialysis22and 83% of patients on long-term dialysis.23diets lacking Vitamin K can PRECIPITATE the development of Vitamin K deficiency in as little as 7\u2005days.24additionally, subclinical Vitamin K deficiency is not UNCOMMON, especially in patients receiving warfarin.25cross-sectional and cohort data HAVE SHOWN a lower risk of Coronary Heart disease (chd), chd mortality, all-cause mortality and SEVERE Aortic calcifications with higher Vitamin K2(Menaquinone) intake526(box 1).']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 165), ('SUPERFICIAL_RELATIONSHIP', 414), ('INCOMPLETE_EVIDENCE', 545), ('INCOMPLETE_EVIDENCE', 631), ('IMPORTANT_CONSIDERATION', 727)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin K'), ('UBERON_0001621', 'coronary artery', 38, 'Coronary artery'), ('UBERON_0002113', 'kidney', 116, 'kidney'), ('UBERON_0002113', 'kidney', 220, 'renal'), ('UBERON_0002113', 'kidney', 265, 'kidney'), ('CHEBI_27300', 'vitamin D', 400, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 517, 'vitamin K'), ('UBERON_0004151', 'cardiac chamber', 658, 'coronary heart'), ('UBERON_0000947', 'aorta', 734, 'aortic'), ('CHEBI_28934', 'vitamin D2', 768, 'vitamin K2'), ('PR_000009450', 'keratin, type II cytoskeletal 1', 776, 'K2'), ('CHEBI_18154', 'polysaccharide', 779, 'menaquinone')]
PMC4600246	10/2015	S16-PMC4600246	['this was NOT SHOWN with vitamin k1intake (Phylloquinone, the major dietary source of Vitamin K.2627thus, dietary vitamin k1intake, without Vitamin K2, MAY not be sufficient to suppress Arterial calcifications and/or reduce RISK for subsequent Cardiovascular events and death.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 151), ('IMPORTANT_CONSIDERATION', 223)]	3	[('CHEBI_26124', 'phytosteroid', 42, 'phylloquinone'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin K'), ('CHEBI_28934', 'vitamin D2', 139, 'vitamin K2'), ('UBERON_0001637', 'artery', 185, 'arterial'), ('UBERON_0004535', 'cardiovascular system', 243, 'cardiovascular')]
PMC4600246	10/2015	S24-PMC4600246	['Coronary Heart disease (chd)\nMAY reduce the RISK of chd, chd mortality and all-cause mortality52676\nInsulin sensitivity\nMAY help improve Insulin sensitivity40\nwarfarin international normalised ratio (inr)\nMAY help to stabilise inr in patients on warfarin41\nlow Vitamin K status (indicated by undercarboxylated mgp) is ASSOCIATED with increased vascular calcifications, and these levels CAN be improved by effective Vitamin K supplementation28–32it was long BELIEVED that Vitamin K was ONLY INVOLVED in forming Coagulation factors (ie, maintaining Haemostasis).']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 44), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 318), ('INCOMPLETE_EVIDENCE', 386), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 485), ('SUPERFICIAL_RELATIONSHIP', 490)]	9	[('UBERON_0002949', 'tectospinal tract', 0, 'Coronary heart'), ('PR_000045358', 'insulin family protein', 100, 'Insulin'), ('PR_000045358', 'insulin family protein', 137, 'insulin'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 415, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin K'), ('GO_0050817', 'coagulation', 510, 'coagulation'), ('GO_0007599', 'hemostasis', 547, 'haemostasis')]
PMC4600246	10/2015	S27-PMC4600246	['low levels of Vitamin K impair activation of Osteocalcin and decrease the activity of Osteoblasts (cells IMPORTANT for building bone).3334thus, Vitamin K is VITAL to the functionality of proteins such as Osteocalcin (IMPORTANT for building bone), (mgp, the most potent Arterial Calcification Inhibitor known) and the growth-arrest sequence-6 protein (Gas6, INVOLVED in Cell Growth Regulation35\nVitamin K HAS BEEN SHOWN to significantly delay the development of cac in a 3-year, double-blind, randomised controlled trial of 452 patients (229 patients on Vitamin K1And 223 patients in the control group).36all patients were assigned to a multivitamin (containing 1.6\u2005mg Thiamine, 1.8\u2005mg riboflavin, 2.1\u2005mg Vitamin B-6, 3\u2005µg Vitamin B12, 75\u2005mg Vitamin C, 12\u2005mg Vitamin E, 6\u2005mg Pantothenic Acid, 20\u2005mg niacin, 160\u2005µg Folate and 30\u2005µg of Biotin) as well as calcium (600\u2005mg Calcium Carbonate) and Vitamin D (Cholecalciferol 400\u2005iu).']	[('IMPORTANT_CONSIDERATION', 105), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 217), ('SUPERFICIAL_RELATIONSHIP', 357), ('INCOMPLETE_EVIDENCE', 404)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin K'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 45, 'osteocalcin'), ('CL_0000062', 'osteoblast', 86, 'osteoblasts'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin K'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 204, 'osteocalcin'), ('UBERON_0001637', 'artery', 269, 'arterial'), ('GO_0051301', 'cell division', 278, 'calcification'), ('CHEBI_35222', 'inhibitor', 292, 'inhibitor'), ('PR_000008000', 'gap junction beta-4 protein', 351, 'Gas6'), ('GO_0071475', 'cellular hyperosmotic salinity response', 369, 'cell growth regulation35'), ('CHEBI_28384', 'vitamin K', 394, 'Vitamin K'), ('CHEBI_10124', 'zolmitriptan', 553, 'vitamin K1and'), ('PR_000017209', 'utrophin', 553, 'vitamin K1and'), ('CHEBI_26948', 'vitamin B1', 668, 'thiamine'), ('CHEBI_27300', 'vitamin D', 704, 'vitamin B'), ('CHEBI_33279', 'vitamin D5', 722, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 741, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 758, 'vitamin E'), ('CHEBI_7916', 'pantothenic acid', 774, 'pantothenic acid'), ('CHEBI_30863', '5-azaorotic acid', 813, 'folate'), ('CHEBI_15956', 'biotin', 833, 'biotin'), ('CHEBI_3311', 'calcium carbonate', 868, 'calcium carbonate'), ('CHEBI_27300', 'vitamin D', 891, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 902, 'cholecalciferol')]
PMC4600246	10/2015	S44-PMC4600246	['furthermore, most Individuals taking warfarin are counselled to avoid Vitamin K-containing foods, such as green leafy vegetables, which MAY lead to an EVEN further increase in cac.36vitamin k deficiency CAN be exacerbated further when Warfarin is initiated.38the negative IMPACT that warfarin CAN have on the body HAS LONG BEEN RECOGNISED.39\nwarfarin HAS BEEN SHOWN to cause SEVERE Arterial calcifications in the Aorta and the Carotid Arteries of Rats.']	[('INCOMPLETE_EVIDENCE', 136), ('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 272), ('INCOMPLETE_EVIDENCE', 293), ('INCOMPLETE_EVIDENCE', 314), ('PROBABLE_UNDERSTANDING', 318), ('PROBABLE_UNDERSTANDING', 328), ('INCOMPLETE_EVIDENCE', 351), ('IMPORTANT_CONSIDERATION', 375)]	10	[('NCBITaxon_1', 'root', 18, 'individuals'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin K'), ('CHEBI_10033', 'warfarin', 235, 'warfarin'), ('UBERON_0001637', 'artery', 382, 'arterial'), ('UBERON_0000947', 'aorta', 413, 'aorta'), ('UBERON_0005396', 'carotid artery segment', 427, 'carotid arteries'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 447, 'rats')]
PMC4600246	10/2015	S77-PMC4600246	['finally, in the RECENT vitamin k italian (viki) dialysis STUDY, 23.5% of patients were FOUND to be Vitamin K deficient, and this deficiency was FOUND TO BE the strongest PREDICTOR of vertebral fractures (or: 2.94; 95% ci 1.38 to 6.26).72other data HAVE SHOWN that vitamin K2May improve Bone Remodelling in patients with haemodialysis with low Serum Parathyroid hormone levels.73supplementing with at LEAST 200\u2005µg Menaquinone-7 (a form of Vitamin K2) daily MAY help to achieve near maximal protection from vascular calcification, osteoporosis and cancer (measured by maximal gamma carboxylation of Vitamin K dependent proteins).35\n\nconclusion\nVitamin K has a plethora of POTENTIAL IMPLICATIONS, including prevention and treatment of Arterial calcifications, Coronary Heart disease and cancer, improvements in bone strength and reduced risks of fractures as well as improvements in Insulin sensitivity.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 87), ('ANOMALY_CURIOUS_FINDING', 144), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 248), ('PROBABLE_UNDERSTANDING', 400), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 670), ('IMPORTANT_CONSIDERATION', 680)]	10	[('CHEBI_27300', 'vitamin D', 99, 'vitamin K'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 272, 'K2may'), ('GO_0046849', 'bone remodeling', 286, 'bone remodelling'), ('UBERON_0001977', 'blood serum', 343, 'serum'), ('UBERON_0001132', 'parathyroid gland', 349, 'parathyroid'), ('CHEBI_18154', 'polysaccharide', 413, 'menaquinone'), ('CHEBI_28934', 'vitamin D2', 438, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 438, 'vitamin K2'), ('CHEBI_27300', 'vitamin D', 597, 'vitamin K'), ('CHEBI_28384', 'vitamin K', 642, 'Vitamin K'), ('UBERON_0001637', 'artery', 732, 'arterial'), ('UBERON_0004151', 'cardiac chamber', 757, 'coronary heart'), ('PR_000045358', 'insulin family protein', 880, 'insulin')]
PMC4600246	10/2015	S78-PMC4600246	['additionally, Vitamin K MAY EVEN play a VITAL ROLE in the stabilisation of inr control for patients on warfarin.']	[('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 40), ('SUPERFICIAL_RELATIONSHIP', 46)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin K')]
PMC4624803	10/2015	S9-PMC4624803	['several HYPOTHESES concerning the IMPORTANCE of Vitamin D for Brain Development, ESPECIALLY Prenatally and during the early Neonatal Period, HAVE BEEN formulated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('IMPORTANT_CONSIDERATION', 34), ('IMPORTANT_CONSIDERATION', 81), ('INCOMPLETE_EVIDENCE', 141)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007420', 'brain development', 62, 'brain development'), ('UBERON_0000955', 'brain', 62, 'brain'), ('GO_0019230', 'proprioception', 92, 'prenatally'), ('UBERON_0007221', 'neonate stage', 124, 'neonatal period')]
PMC4624803	10/2015	S92-PMC4624803	['[16] who, in a large english study, FOUND no association between low levels of Vitamin D and behavioural PROBLEMS, including inattention and hyperactivity.']	[('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 105)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC4624803	10/2015	S95-PMC4624803	['Human studies have INDICATED that Vitamin D deficiency is ASSOCIATED with an INCREASED RISK of developing many diseases and disorders, like parkinson’s disease, epilepsy, depression, multiple sclerosis, schizophrenia, autism, and Autoimmune diseases like rheumatoid arthritis and type i diabetes mellitus [18–20].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 58), ('IMPORTANT_CONSIDERATION', 77)]	3	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 230, 'autoimmune')]
PMC4627942	10/2015	S61-PMC4627942	['a study in west kiang hdss, gambia, SHOWED that nutritional rickets, a disease caused largely by Vitamin D deficiency, the EFFECTS of which CAN include Cardiac failure and hypoglycaemic seizures, was more PREVALENT in infants whose mothers had poor Vitamin D status during Pregnancy (21).']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 123), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 205)]	4	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('UBERON_0000948', 'heart', 152, 'cardiac'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('GO_0007565', 'female pregnancy', 273, 'pregnancy')]
PMC4627942	10/2015	S221-PMC4627942	["caption (table-wrap): table 5\n\ntackling malnutrition – prevention EFFORTS: findings from indepth studieshdss siteyearauthorsmain findingsbandim hdss, guinea-bissau2004nielsen et al.during civil war, Vitamin A supplementation for children helped reduce mortality.bandim hdss, guinea-bissau2005nielsen et al.during civil war, supplementary Feeding programme helped reduce mortality in children.filabavi hdss, vietnam2009nga et al.fortification with multiple Micronutrients of biscuits provided in schools reduced risk of anaemia and of iron and zinc deficiencies by 40%.nouna hdss, burkina faso2003müller et al.no significant impact of Zinc supplementation for children on height-for-age, weight-for-age, and weight-for-height scores.kintampo hdss, ghana2007newton et al.no positive EFFECT of Vitamin A supplements in combination with vaccines during the first few months of Life.farafenni hdss, gambia2013van der merwe et al.fish oil supplementation had no effect on growth, Intestinal integrity, morbidity, or cognitive development.kilifi hdss, kenya2010akech et al.use of low-dose hypotonic Fluid resuscitation for children who develop shock AS a result of SEVERE malnutrition has poor outcomes in terms of persistent shock, oliguria, and high case fatality.agincourt hdss, south africa2003deen et al.introduction of who guidelines in two hospitals strengthened the management of malnutrition.kintampo hdss, ghana2006tchum et al.vitamin a supplementation increased Liver reserves of mothers during the Postpartum period, with EFFECTS persisting for at least five months.niakhar hdss, senegal2006ly et al.provision of high energy, Nutrient-dense Food supplements to infants aged between four and seven months contributed to decreased Postpartum weight loss in their mothers.west kiang hdss, gambia2011hawkesworth et al.Nutrient supplementation during Pregnancy had little effect on infants’ risk of cardiovascular disease.west kiang hdss, gambia2009hawkesworth et al.protein-energy supplementation of mothers during Pregnancy had no effect on the Blood pressure of their children in adolescence.west kiang hdss, gambia2009prentice et al.Calcium supplementation for Pregnant mothers had no effect on foetal and infant growth.west kiang hdss, gambia2010jarjou et al.women given Calcium Supplements while Pregnant had lower bone Mineral content, bone area and bone Mineral density at the Hip during the 12-month Lactation period than other women.dikgale hdss, south africa2002nthangeni et al.the majority of People with type 2 diabetes had poor Glycaemic Control and were obese or had high blood pressure and were given poor advice by health educators.africa centre hdss, south africa2002o'donnell et al.agencies working to tackle a flood disaster in bangladesh in 1998 achieved MIXED results in terms of meeting international disaster response standards."]	[('FUTURE_WORK', 66), ('SUPERFICIAL_RELATIONSHIP', 781), ('PROBABLE_UNDERSTANDING', 1143), ('IMPORTANT_CONSIDERATION', 1158), ('SUPERFICIAL_RELATIONSHIP', 1527), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2776)]	6	[('CHEBI_27300', 'vitamin D', 199, 'vitamin A'), ('GO_0007631', 'feeding behavior', 338, 'feeding'), ('CHEBI_33839', 'macromolecule', 456, 'micronutrients'), ('CHEBI_33340', 'zinc group element atom', 634, 'zinc'), ('CHEBI_27300', 'vitamin D', 791, 'vitamin A'), ('UBERON_0000104', 'life cycle', 873, 'life'), ('UBERON_0000160', 'intestine', 974, 'intestinal'), ('UBERON_0006314', 'bodily fluid', 1092, 'fluid'), ('UBERON_0002107', 'liver', 1466, 'liver'), ('GO_0007565', 'female pregnancy', 1503, 'postpartum'), ('CHEBI_33284', 'nutrient', 1631, 'nutrient'), ('CHEBI_33290', 'food', 1646, 'food'), ('GO_0007565', 'female pregnancy', 1734, 'postpartum'), ('CHEBI_33284', 'nutrient', 1819, 'Nutrient'), ('GO_0007565', 'female pregnancy', 1851, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2016, 'pregnancy'), ('UBERON_0000178', 'blood', 2047, 'blood'), ('CHEBI_31341', 'calcium dihydroxide', 2137, 'Calcium'), ('GO_0007565', 'female pregnancy', 2165, 'pregnant'), ('CHEBI_22313', 'alkaline earth metal atom', 2276, 'calcium'), ('CHEBI_33341', 'titanium atom', 2284, 'supplements'), ('GO_0007565', 'female pregnancy', 2302, 'pregnant'), ('CHEBI_46662', 'mineral', 2326, 'mineral'), ('CHEBI_46662', 'mineral', 2362, 'mineral'), ('UBERON_0001464', 'hip', 2385, 'hip'), ('GO_0007595', 'lactation', 2409, 'lactation'), ('NCBITaxon_10088', 'Mus <genus>', 2505, 'people'), ('GO_0051162', 'L-arabitol metabolic process', 2542, 'glycaemic control')]
PMC4632418	10/2015	S3-PMC4632418	['the meta-analysis of 20 studies including 9209 participants SHOWED that women with Vitamin D deficiency experienced a significantly INCREASED RISK for developing gdm (odds ratio (or) = 1.53; 95% confidence intervals (ci), 1.33, 1.75) with a little heterogeneity ( i2= 16.20%, p = 0.252).']	[('INCOMPLETE_EVIDENCE', 60), ('IMPORTANT_CONSIDERATION', 132)]	2	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC4632418	10/2015	S7-PMC4632418	['IN SUMMARY, the EVIDENCE from this meta-analysis INDICATES a CONSISTENT ASSOCIATION between Vitamin D deficiency and an INCREASED RISK of gdm.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 120)]	6	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4632418	10/2015	S14-PMC4632418	['HOWEVER, it is NOT CLEAR WHETHER a POOR Vitamin D status is ASSOCIATED with the RISK of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 80)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4632418	10/2015	S18-PMC4632418	['IN ACCORDANCE WITH these definitions, EVEN middle-age Adults are at equally high RISK with elder and children for Vitamin D deficiency and insufficiency worldwide [6].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 38), ('IMPORTANT_CONSIDERATION', 81)]	3	[('UBERON_0007023', 'adult organism', 54, 'adults'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4632418	10/2015	S19-PMC4632418	['furthermore, Pregnant and Lactating women who take a Prenatal Vitamin and a Calcium supplement with Vitamin D remain at HIGH RISK for Vitamin D deficiency.']	[('IMPORTANT_CONSIDERATION', 120)]	1	[('GO_0007565', 'female pregnancy', 13, 'pregnant'), ('GO_0007594', 'puparial adhesion', 26, 'lactating'), ('GO_0007565', 'female pregnancy', 53, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 62, 'vitamin'), ('CHEBI_22313', 'alkaline earth metal atom', 76, 'calcium'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4632418	10/2015	S22-PMC4632418	['the ROLE of Vitamin D on Gdm Development HAS been studied, and Vitamin D deficiency APPEARS TO BE ASSOCIATED with altered Glucose Homeostasis during Pregnancy [12,13].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 41), ('ANOMALY_CURIOUS_FINDING', 84), ('SUPERFICIAL_RELATIONSHIP', 98)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0072147', 'glomerular parietal epithelial cell fate commitment', 25, 'GDM development'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_17234', 'glucose', 122, 'glucose'), ('GO_0042593', 'glucose homeostasis', 122, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 149, 'pregnancy')]
PMC4632418	10/2015	S34-PMC4632418	['study selection\noriginal research evaluating the ASSOCIATIONS between Vitamin D status and Pregnancy outcomes were scrutinized and subsequently selected if they fulfilled the following inclusion criteria: a. study population was Pregnant women without pre-existing chronic disease; b. gdm as outcome and the control were women with normal Glucose tolerance (ngt); c. contained RELEVANT data to calculate the effect size and corresponding 95% confidence intervals (ci); d. met the predefined methodological quality assessment criteria for observational studies (supplementary data box 1) [18]; e. only studies published in english were considered.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 377)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('GO_0007565', 'female pregnancy', 229, 'pregnant'), ('CHEBI_17234', 'glucose', 339, 'glucose')]
PMC4632418	10/2015	S75-PMC4632418	['HOWEVER, this meta-analysis SHOWED that women with Vitamin D deficiency COMPARED TO the control group experienced a significantly INCREASED RISK for developing gdm (or = 1.53; 95% ci, 1.33, 1.75) on a fixed-effects model (figure 2).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('IMPORTANT_CONSIDERATION', 130)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC4632418	10/2015	S78-PMC4632418	['these results INDICATED that Vitamin D deficiency significantly increase the risk of gdm, and the higher degree of deficiency SHOWED higher TREND of gdm risk RELEVANCE.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 158)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC4632418	10/2015	S84-PMC4632418	['this result SHOWED Serum 25(Oh)D level was significant lower in participants with gdm than the control and also DEMONSTRATED that Vitamin D deficiency is significantly ASSOCIATED with an INCREASED RISK of gmd.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 187)]	4	[('UBERON_0001977', 'blood serum', 19, 'serum'), ('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC4632418	10/2015	S98-PMC4632418	['SIMILARLY, our meta-analysis of 20 independent observational studies provided STRONG EVIDENCE that Vitamin D deficiency was ASSOCIATED with an INCREASED RISK of Gestational diabetes.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 78), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 124), ('IMPORTANT_CONSIDERATION', 143)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'gestational')]
PMC4632418	10/2015	S116-PMC4632418	['there are MAJOR causes behind Vitamin D deficiency during Pregnancy, such as INADEQUATE exposure to sunlight, low Vitamin D intake and more REQUIREMENTS for Vitamin D. Vitamin D supplementation during Pregnancy has beneficial EFFECTS on glycaemia, Insulin sensitivity [45], Insulin resistance [46] and Metabolic profiles [47].']	[('IMPORTANT_CONSIDERATION', 10), ('IMPORTANT_CONSIDERATION', 77), ('IMPORTANT_CONSIDERATION', 140), ('SUPERFICIAL_RELATIONSHIP', 226)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 168, 'Vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 176, 'D'), ('GO_0007565', 'female pregnancy', 201, 'pregnancy'), ('PR_000045358', 'insulin family protein', 248, 'insulin'), ('PR_000045358', 'insulin family protein', 274, 'insulin'), ('GO_0008152', 'metabolic process', 302, 'metabolic')]
PMC4632418	10/2015	S118-PMC4632418	['apart from diet and Supplements, ANOTHER way of keeping OPTIMAL level of body Vitamin D is from skin exposure to sunlight, which is REMARKABLY INFLUENCED by geographical location, season, dark skin tone, sunscreen use and EVEN the air pollution [48].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('IMPORTANT_CONSIDERATION', 56), ('ANOMALY_CURIOUS_FINDING', 132), ('SUPERFICIAL_RELATIONSHIP', 143), ('ANOMALY_CURIOUS_FINDING', 222)]	5	[('CHEBI_33341', 'titanium atom', 20, 'supplements'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4632418	10/2015	S129-PMC4632418	['HOWEVER, the ASSOCIATION between Vitamin D deficiency and gdm STILL REMAINS (or = 1.67; 95% ci, 1.31, 2.13; i2= 25.6%, p = 0.251) EVEN after adjusting for maternal age, bmi and ethnicity (supplementary figure s4).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('ANOMALY_CURIOUS_FINDING', 62), ('IMPORTANT_CONSIDERATION', 62), ('INCOMPLETE_EVIDENCE', 68), ('ANOMALY_CURIOUS_FINDING', 130)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4632418	10/2015	S132-PMC4632418	['conclusions\nin CONCLUSION, the EVIDENCE from THIS ARTICLE INDICATES a CONSISTENT ASSOCIATION between Vitamin D deficiency and an INCREASED RISK of Gestational diabetes mellitus.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 129)]	7	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'gestational')]
PMC4632418	10/2015	S135-PMC4632418	['UNTIL then, screening women who are AT RISK of Vitamin D deficiency and supplementation with Vitamin D COULD BE CONSIDERED.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 103), ('INCOMPLETE_EVIDENCE', 103), ('FUTURE_WORK', 112)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4632423	10/2015	S100-PMC4632423	['both Folate and Vitamin D deficiencies HAVE BEEN ASSOCIATED with INCREASED RISKS of pre-eclampsia, Preterm Delivery, low Birth weight and fetal growth restriction [26,27].']	[('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 65)]	3	[('CHEBI_30863', '5-azaorotic acid', 5, 'folate'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 99, 'preterm'), ('GO_0007567', 'parturition', 107, 'delivery'), ('GO_0007567', 'parturition', 121, 'birth')]
PMC4645901	8/2014	S19-PMC4645901	['[2]\nHOWEVER, it is ESSENTIAL to APPRECIATE that RECOMMENDED doses of Vitamin D supplementation are arbitary, and the THRESHOLD for toxicity is far higher.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 32), ('FUTURE_WORK', 48), ('IMPORTANT_CONSIDERATION', 117)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4645901	8/2014	S36-PMC4645901	['[4]\nthose AT RISK of Vitamin D deficiency include: Pregnant mothers, babies who are exclusively Breastfed, those who have darker skin, those who cover up most of their body when outside, and patients with certain medical conditions AFFECTING Gut absorption or who suffer from long term Liver and Kidney disease.']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 232)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnant'), ('GO_0007567', 'parturition', 96, 'breastfed'), ('UBERON_0001555', 'digestive tract', 242, 'gut'), ('UBERON_0002107', 'liver', 286, 'liver'), ('UBERON_0002113', 'kidney', 296, 'kidney')]
PMC4645901	8/2014	S52-PMC4645901	['see supplementary file: ds2663.doc - “tables and figures”\n\ndesign\nfollowing discussions with the parents and the clinical team, we RECOGNISED that there was a LACK OF AWARENESS of the IMPORTANCE of Vitamin D for the health and Development Of Babies.']	[('PROBABLE_UNDERSTANDING', 131), ('PROBLEM_COMPLICATION', 159), ('IMPORTANT_CONSIDERATION', 167), ('IMPORTANT_CONSIDERATION', 184)]	4	[('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0048513', 'animal organ development', 227, 'development of babies')]
PMC4645901	8/2014	S73-PMC4645901	['this MAY BE due to the increased AWARENESS of Vitamin D deficiency by the general public, and THEREFORE an increased uptake of Vitamin supplements during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 33), ('PROBABLE_UNDERSTANDING', 94)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 127, 'vitamin'), ('GO_0007565', 'female pregnancy', 154, 'pregnancy')]
PMC4645901	8/2014	S91-PMC4645901	['the most DESIRABLE follow up would be to measure their Vitamin D levels in a few years time, BUT this was beyond the scope of this project.']	[('IMPORTANT_CONSIDERATION', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4673623	11/2015	S1-PMC4673623	['Folate, Choline, betaine and Vitamin B-12) during Pregnancy is ESSENTIAL for normal maternal and fetal Methionine Metabolism, and is CRITICAL for IMPORTANT Metabolic processes including those INVOLVED in developmental programming.']	[('IMPORTANT_CONSIDERATION', 63), ('IMPORTANT_CONSIDERATION', 133), ('IMPORTANT_CONSIDERATION', 146), ('SUPERFICIAL_RELATIONSHIP', 192)]	4	[('CHEBI_30863', '5-azaorotic acid', 0, 'folate'), ('CHEBI_15354', 'choline', 8, 'choline'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 29, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0006555', 'methionine metabolic process', 103, 'methionine metabolism'), ('GO_0008152', 'metabolic process', 156, 'metabolic')]
PMC4673623	11/2015	S15-PMC4673623	['Folate, Vitamin B-12, Choline, and betaine) to several IMPORTANT Metabolic Processes (kalhan and marczewski2012) including those INVOLVED in developmental programming.']	[('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 129)]	2	[('CHEBI_30863', '5-azaorotic acid', 0, 'folate'), ('CHEBI_27300', 'vitamin D', 8, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 8, 'vitamin B-12'), ('CHEBI_15354', 'choline', 22, 'choline'), ('GO_0008152', 'metabolic process', 65, 'metabolic processes')]
PMC4673623	11/2015	S23-PMC4673623	['Choline, betaine, Folate, and Vitamin B-12 have CRITICAL ROLES in Lipid Metabolism because they CONTRIBUTE to the Production Of Phosphatidylcholine (Pc) via the Phosphatidylethanolamine- n- methyltransferase (Pemt) pathway, which is necessary for the formation of very-low-density-lipoproteins (vldl) and the removal of Triglycerides (Tgs) from the Liver.']	[('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 96)]	3	[('CHEBI_15354', 'choline', 0, 'Choline'), ('CHEBI_30863', '5-azaorotic acid', 18, 'folate'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 30, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 40, '12'), ('CHEBI_18059', 'lipid', 66, 'lipid'), ('GO_0006629', 'lipid metabolic process', 66, 'lipid metabolism'), ('GO_0070273', 'phosphatidylinositol-4-phosphate binding', 114, 'production of phosphatidylcholine'), ('CHEBI_36710', 'interferon inducer', 128, 'phosphatidylcholine'), ('CHEBI_16199', 'urea', 149, 'PC'), ('CHEBI_16038', 'phosphatidylethanolamine', 161, 'phosphatidylethanolamine'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 209, 'PEMT'), ('CHEBI_17855', 'triglyceride', 320, 'triglycerides'), ('CL_0002488', 'trophoblast giant cell', 335, 'TGs'), ('UBERON_0002107', 'liver', 349, 'liver')]
PMC4673623	11/2015	S118-PMC4673623	['IN CONTRAST, ALTHOUGH absolute Vitamin B-12 Intake MAY HAVE been slightly lower among the hf-hed (vs. control) group, this modestly lower Intake would not be expected to cause the functional B-12 deficiency OBSERVED in the hf-hed moms.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 51), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 207)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 31, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 44, 'intake'), ('GO_0007631', 'feeding behavior', 138, 'intake'), ('PR_000004770', 'Polycomb complex protein BMI-1', 191, 'B-12')]
PMC4676908	12/2015	S111-PMC4676908	['the content of each anc visit is also IMPORTANT, AS SOME anc INTERVENTIONS MAY not be beneficial, such as high does concomitant supplementation with Vitamin C and Vitamin e to PREVENT pre-eclampsia in high-risk women (poston2006).']	[('IMPORTANT_CONSIDERATION', 38), ('PROBABLE_UNDERSTANDING', 49), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 149, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 163, 'vitamin')]
PMC4684854	12/2015	S1-PMC4684854	['at the same time, there has been a burgeoning PROBLEM with WIDESPREAD Vitamin D deficiency among populations of many developed nations.']	[('IMPORTANT_CONSIDERATION', 46), ('PROBLEM_COMPLICATION', 46), ('IMPORTANT_CONSIDERATION', 59)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4684854	12/2015	S3-PMC4684854	['ALTHOUGH immediate costs for obstetric COMPLICATIONS RELATED to Gestational Vitamin D insufficiency MAY BE modest, the short- and long-term costs for pediatric healthcare resulting from such Gestational COMPLICATIONS MAY BE enormous and present an enduring BURDEN on Healthcare systems.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBLEM_COMPLICATION', 39), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 203), ('INCOMPLETE_EVIDENCE', 217), ('IMPORTANT_CONSIDERATION', 257)]	7	[('GO_0007565', 'female pregnancy', 64, 'gestational'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'gestational'), ('UBERON_0004151', 'cardiac chamber', 267, 'healthcare')]
PMC4684854	12/2015	S4-PMC4684854	['with INCREASING EVIDENCE POINTING TO fetal origins of SOME later Life disease, securing Vitamin D sufficiency in Pregnancy APPEARS TO BE a simple, SAFE, and cost-EFFECTIVE measure that CAN be incorporated into routine Preconception and Prenatal Care in the offices of primary care clinicians.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 54), ('ANOMALY_CURIOUS_FINDING', 123), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 162), ('INCOMPLETE_EVIDENCE', 185)]	7	[('UBERON_0000104', 'life cycle', 65, 'life'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('GO_0007565', 'female pregnancy', 218, 'preconception'), ('GO_0008283', 'cell proliferation', 236, 'prenatal care')]
PMC4684854	12/2015	S48-PMC4684854	['clinical relevance of Vitamin D sufficiency in Reproductive healthcare\nthe widespread clinical IMPORTANCE of determining the CORRELATION between Vitamin D levels and Reproductive outcomes is evident.']	[('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 125)]	2	[('CHEBI_28384', 'vitamin K', 22, 'Vitamin D'), ('GO_0000003', 'reproduction', 47, 'Reproductive'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0000003', 'reproduction', 166, 'reproductive')]
PMC4684854	12/2015	S51-PMC4684854	['with such widespread deficiency, it is VITAL to determine WHETHER OR NOT low Gestational levels of Vitamin D are a SIGNIFICANT DETERMINANT of Reproductive and pediatric health outcomes.']	[('IMPORTANT_CONSIDERATION', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('IMPORTANT_CONSIDERATION', 115), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('GO_0007565', 'female pregnancy', 77, 'gestational'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0000003', 'reproduction', 142, 'reproductive')]
PMC4684854	12/2015	S54-PMC4684854	['these iom RECOMMENDATIONS for REQUIRED Vitamin D intake HAVE BEEN put into SERIOUS question [42], HOWEVER, AS a significant statistical ERROR HAS BEEN identified in the way their recommendations were arrived AT [43].']	[('FUTURE_WORK', 10), ('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('PROBABLE_UNDERSTANDING', 107), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 142), ('IMPORTANT_CONSIDERATION', 208)]	9	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4684854	12/2015	S55-PMC4684854	['ACCORDINGLY, exploration of consensus FINDINGS on the clinical BENEFITS of Vitamin D supplementation is in order in all medical disciplines including Reproductive healthcare.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 63)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0000003', 'reproduction', 150, 'reproductive')]
PMC4684854	12/2015	S58-PMC4684854	['specifically, supplementation of Vitamin D in Pregnancy in SOME studies APPEARS TO SUGGEST marked BENEFIT WHILE research in OTHER publications does NOT APPEAR TO confer significant improvement in maternal-fetal outcomes [44].']	[('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 72), ('INCOMPLETE_EVIDENCE', 83), ('IMPORTANT_CONSIDERATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('ANOMALY_CURIOUS_FINDING', 148), ('ANOMALY_CURIOUS_FINDING', 152)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'pregnancy')]
PMC4684854	12/2015	S61-PMC4684854	['the APPARENT DISPARITY between findings in VARIOUS STUDIES has caused SOME to reflexively CONCLUDE that Vitamin D status in Pregnancy is IRRELEVANT to maternal-fetal outcomes.']	[('ANOMALY_CURIOUS_FINDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('ANOMALY_CURIOUS_FINDING', 13), ('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 90), ('IMPORTANT_CONSIDERATION', 137)]	8	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy')]
PMC4684854	12/2015	S63-PMC4684854	['it is IMPORTANT TO REALIZE that Vitamin D status is very different from WHETHER OR not someone is consuming Vitamin D supplementation.']	[('IMPORTANT_CONSIDERATION', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4684854	12/2015	S70-PMC4684854	['(ii) commencement of supplementation at differing times during the Gestation MAY miss CRITICAL periods when Vitamin D MAY play a PIVOTAL ROLE.']	[('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 86), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 129), ('SUPERFICIAL_RELATIONSHIP', 137)]	5	[('GO_0007565', 'female pregnancy', 67, 'gestation'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4684854	12/2015	S74-PMC4684854	['accordingly, a CRITICAL appraisal of such meta-analyses is in order to achieve an accurate perspective on the efficacy of Gestational Vitamin D supplementation.']	[('IMPORTANT_CONSIDERATION', 15)]	1	[('GO_0007565', 'female pregnancy', 122, 'gestational'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4684854	12/2015	S77-PMC4684854	['early in Pregnancy, for example, an increased risk of First Trimester Miscarriage HAS BEEN LINKED to INADEQUATE maternal Vitamin D levels [49].']	[('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 91), ('IMPORTANT_CONSIDERATION', 101)]	3	[('GO_0007565', 'female pregnancy', 9, 'pregnancy'), ('GO_0042733', 'embryonic digit morphogenesis', 54, 'first trimester'), ('GO_0046660', 'female sex differentiation', 70, 'miscarriage'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4684854	12/2015	S81-PMC4684854	['a NUMBER OF papers have CONFIRMED an INCREASED RISK of developing Gestational diabetes in those with INADEQUATE Vitamin D levels [52,53].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 37), ('IMPORTANT_CONSIDERATION', 101)]	4	[('GO_0007565', 'female pregnancy', 66, 'gestational'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4684854	12/2015	S91-PMC4684854	['other Gestational ISSUES also APPEAR TO BE INFLUENCED by maternal Vitamin D levels.']	[('IMPORTANT_CONSIDERATION', 18), ('ANOMALY_CURIOUS_FINDING', 30), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('GO_0007565', 'female pregnancy', 6, 'gestational'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4684854	12/2015	S94-PMC4684854	['a systematic review and meta-analysis of 24 studies SUGGESTED that low maternal Vitamin D levels in Pregnancy MAY BE ASSOCIATED with an INCREASED RISK of small for Gestational age infants, as well as being LINKED to preeclampsia, Gestational diabetes, and Preterm Birth [66].']	[('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 117), ('IMPORTANT_CONSIDERATION', 136), ('SUPERFICIAL_RELATIONSHIP', 206)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('GO_0007565', 'female pregnancy', 164, 'gestational'), ('GO_0007565', 'female pregnancy', 230, 'gestational'), ('GO_0007565', 'female pregnancy', 256, 'preterm birth')]
PMC4684854	12/2015	S95-PMC4684854	['another systematic review and meta-analysis published in the british medical journal also LINKED Vitamin D insufficiency with an INCREASED RISK of Gestational diabetes, Preeclampsia, and small for Gestational age infants [65].']	[('SUPERFICIAL_RELATIONSHIP', 90), ('IMPORTANT_CONSIDERATION', 129)]	2	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'gestational'), ('GO_0007128', 'meiotic prophase I', 169, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 197, 'gestational')]
PMC4684854	12/2015	S98-PMC4684854	['in ONE STUDY, women with Vitamin D levels below 37.5\u2009nmol/l were almost four times as LIKELY to REQUIRE a primary Cesarean Delivery as women with higher levels [67].']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 86), ('IMPORTANT_CONSIDERATION', 96)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0044808', 'oncostatin M production', 114, 'cesarean'), ('GO_0007567', 'parturition', 123, 'delivery')]
PMC4684854	12/2015	S103-PMC4684854	['there is escalating EVIDENCE in general that low Vitamin D levels are CORRELATED with higher RISK for a variety of mental health PROBLEMS including depressive illness [70], as Vitamin D IS KNOWN to play an IMPORTANT ROLE in activating Genes that release Neurotransmitters such as Dopamine and Serotonin [70,71].']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 70), ('IMPORTANT_CONSIDERATION', 93), ('IMPORTANT_CONSIDERATION', 129), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 206), ('SUPERFICIAL_RELATIONSHIP', 216)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('SO_0000704', 'gene', 235, 'genes'), ('CHEBI_25512', 'neurotransmitter', 254, 'neurotransmitters'), ('CHEBI_18243', 'dopamine', 280, 'dopamine'), ('CHEBI_28790', 'serotonin', 293, 'serotonin')]
PMC4684854	12/2015	S116-PMC4684854	['the authors STATE that “Vitamin D MAY have an IMPORTANT, multifaceted ROLE in the Development Of fetal Lungs, Brain, and Bone” [93].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 46), ('SUPERFICIAL_RELATIONSHIP', 70)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0050887', 'determination of sensory modality', 82, 'development of ... lungs ... brain'), ('UBERON_0002048', 'lung', 103, 'lungs'), ('UBERON_0000955', 'brain', 110, 'brain'), ('GO_0007567', 'parturition', 121, 'bone')]
PMC4684854	12/2015	S120-PMC4684854	['furthermore, current appraisals TEND to UNDERESTIMATE the extent of the REQUIRED resource utilization for specific conditions ASSOCIATED with Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 32), ('IMPORTANT_CONSIDERATION', 40), ('IMPORTANT_CONSIDERATION', 72), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC4684854	12/2015	S127-PMC4684854	['with regard to economic challenges ASSOCIATED with Vitamin D insufficiency, SUFFICE it to say that there are CONSIDERABLE costs POTENTIALLY ASSOCIATED with Gestational Vitamin D insufficiency [99] as well as corresponding BENEFITS and cost savings resulting from inexpensive supplementation with this ESSENTIAL Nutrient [99].']	[('SUPERFICIAL_RELATIONSHIP', 35), ('IMPORTANT_CONSIDERATION', 76), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 140), ('IMPORTANT_CONSIDERATION', 222), ('IMPORTANT_CONSIDERATION', 301)]	7	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 156, 'gestational'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CHEBI_33284', 'nutrient', 311, 'nutrient')]
PMC4684854	12/2015	S132-PMC4684854	['it is APPARENT that training is REQUIRED to establish clinical competency in (i) understanding of the ROLE of various Nutrients in Human health, (ii) HOW TO ASSESS nutritional biochemistry in patients, and (iii) and HOW to intervene to secure Nutrient sufficiency for Individuals and population groups\nwith the MOUNTING EVIDENCE of several health sequelae ASSOCIATED with Gestational Vitamin D deficiency, the VALUE of Preconception education and care by health providers and PUBLIC HEALTH bodies to secure Vitamin D sufficiency throughout Gestation is EVIDENT.']	[('ANOMALY_CURIOUS_FINDING', 6), ('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 102), ('EXPLICIT_QUESTION', 150), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('EXPLICIT_QUESTION', 216), ('INCOMPLETE_EVIDENCE', 311), ('SUPERFICIAL_RELATIONSHIP', 356), ('IMPORTANT_CONSIDERATION', 410), ('IMPORTANT_CONSIDERATION', 476), ('PROBABLE_UNDERSTANDING', 553)]	12	[('CHEBI_33284', 'nutrient', 118, 'nutrients'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('CHEBI_33284', 'nutrient', 243, 'nutrient'), ('NCBITaxon_1', 'root', 268, 'individuals'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('GO_0007565', 'female pregnancy', 419, 'preconception'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('GO_0007565', 'female pregnancy', 540, 'gestation')]
PMC4684854	12/2015	S133-PMC4684854	['as Pregnant women [105], particularly those with dark skin [106], are at CONSIDERABLE RISK for experiencing Vitamin D insufficiency [39], it is IMPORTANT to have a HIGH INDEX OF SUSPICION and to EFFECTIVELY preclude, assess for, and manage Vitamin D inadequacy, as would be done with OTHER biochemical irregularities.']	[('IMPORTANT_CONSIDERATION', 73), ('IMPORTANT_CONSIDERATION', 144), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 195), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 284)]	5	[('GO_0007565', 'female pregnancy', 3, 'pregnant'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC4684854	12/2015	S136-PMC4684854	['one researcher has SUGGESTED that the dietary REQUIREMENT during Pregnancy and Lactation MAY actually be as high as 6000\u2009iu/day [108], BUT most researchers have concluded, with OUR CURRENT KNOWLEDGE, that a supplemental Vitamin D intake of 4000\u2009iu/day is OPTIMAL [30].']	[('INCOMPLETE_EVIDENCE', 19), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('INCOMPLETE_EVIDENCE', 181), ('FUTURE_WORK', 189), ('IMPORTANT_CONSIDERATION', 255)]	8	[('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('GO_0007595', 'lactation', 79, 'lactation'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D')]
PMC4684854	12/2015	S138-PMC4684854	['with EVIDENCE that a major proportion of the Adult population [38], particularly in northern climates [39], is POTENTIALLY deficient in Vitamin D, it APPEARS that, at minimum, one out of every few expectant mothers will have INADEQUATE levels of this ESSENTIAL Nutrient.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 111), ('ANOMALY_CURIOUS_FINDING', 150), ('IMPORTANT_CONSIDERATION', 225), ('IMPORTANT_CONSIDERATION', 251)]	5	[('UBERON_0007023', 'adult organism', 45, 'adult'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_33284', 'nutrient', 261, 'nutrient')]
PMC4684854	12/2015	S139-PMC4684854	['with the recognition that Vitamin D plays an ESSENTIAL ROLE in myriad Genes that encode for health and Well-Being in the offspring, it behooves the medical and PUBLIC HEALTH community to endeavor to secure Vitamin D adequacy in the Gestational period.']	[('IMPORTANT_CONSIDERATION', 45), ('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 160)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('SO_0000704', 'gene', 70, 'genes'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 103, 'well-being'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 232, 'gestational')]
PMC4684854	12/2015	S140-PMC4684854	['the ONGOING personal health BURDEN ASSOCIATED with Gestational Vitamin D insufficiency throughout many parts of the world has the POTENTIAL to be ameliorated CONSIDERABLY by straightforward educational and healthcare measures in the Preconception and Prenatal period to secure Vitamin D sufficiency throughout Pregnancy.']	[('IMPORTANT_CONSIDERATION', 4), ('IMPORTANT_CONSIDERATION', 28), ('PROBLEM_COMPLICATION', 28), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 130), ('ANOMALY_CURIOUS_FINDING', 158)]	6	[('GO_0007565', 'female pregnancy', 51, 'gestational'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 233, 'preconception'), ('GO_0007565', 'female pregnancy', 251, 'prenatal'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('GO_0007565', 'female pregnancy', 310, 'pregnancy')]
PMC4689556	12/2015	S16-PMC4689556	['SEVERAL STUDIES have LINKED low Vitamin D status to a number of resource intensive childhood health PROBLEMS including allergy and infection [2–7], in addition to the WELL-ESTABLISHED EFFECTS on bone Metabolism.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 100), ('PROBABLE_UNDERSTANDING', 167), ('SUPERFICIAL_RELATIONSHIP', 184)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0008152', 'metabolic process', 200, 'metabolism')]
PMC4689556	12/2015	S145-PMC4689556	['our NEW FINDINGS SUGGEST that Prenatal maternal Vitamin D levels MAY BE less IMPORTANT than Postnatal infant Vitamin D levels for determining infant health outcomes, AT LEAST within the insufficient/deficient range.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 65), ('IMPORTANT_CONSIDERATION', 77), ('PROBABLE_UNDERSTANDING', 166)]	5	[('GO_0007565', 'female pregnancy', 30, 'prenatal'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007567', 'parturition', 92, 'postnatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC4689556	12/2015	S151-PMC4689556	['the FINDINGS from our trial, the FIRST Prenatal Vitamin D intervention trial to report child health outcomes, SUGGEST that either the dosing regimen used in this study was INADEQUATE, OR that the RELATIONSHIP between Cord Blood 25(Oh) Vitamin D and child health SEEN in OBSERVATIONAL studies MAY BE RELATED to hidden CONFOUNDERS.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 172), ('PROBLEM_COMPLICATION', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('SUPERFICIAL_RELATIONSHIP', 196), ('INCOMPLETE_EVIDENCE', 262), ('INCOMPLETE_EVIDENCE', 270), ('INCOMPLETE_EVIDENCE', 292), ('SUPERFICIAL_RELATIONSHIP', 299), ('PROBLEM_COMPLICATION', 317)]	12	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0009472', 'axilla', 217, 'cord blood'), ('CHEBI_30778', 'gallic acid', 228, '25(OH)'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D')]
PMC4689556	12/2015	S159-PMC4689556	['HOWEVER, guidance from the national institute for clinical excellence and royal college of obstetricians and gynaecologists in the uk now acknowledge this as a minimum dose for all Pregnant or breastfeeding women and that higher dosing SHOULD BE CONSIDERED in those at high RISK of Vitamin D deficiency [41,42].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 236), ('FUTURE_WORK', 246), ('IMPORTANT_CONSIDERATION', 246), ('IMPORTANT_CONSIDERATION', 274)]	5	[('GO_0007565', 'female pregnancy', 181, 'pregnant'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC4689556	12/2015	S165-PMC4689556	['), there REMAINS an IMPORTANT QUESTION WHETHER Prenatal Vitamin D supplementation at doses which reliably achieve sufficiency in the target population, CAN improve healthcare outcomes for young children.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 20), ('EXPLICIT_QUESTION', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 39), ('EXPLICIT_QUESTION', 39), ('INCOMPLETE_EVIDENCE', 152)]	6	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC4690051	12/2015	S170-PMC4690051	['DUE TO phlebotomy limits in infants and THE BURDEN of other candle procedures, this candle sub-study lacks repeated measures of 25(Oh)D status for participants and lacks individual assessments of Parathyroid hormone status or Vitamin D receptor ( vdr ) genotype.']	[('PROBLEM_COMPLICATION', 0), ('IMPORTANT_CONSIDERATION', 40)]	2	[('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 128, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 196, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC4691762	12/2015	S1-PMC4691762	['countries in the northern hemisphere RECOMMEND universal infant Vitamin D supplementation to optimise early Vitamin D levels, DESPITE the absence of large TRIALS proving SAFETY or efficacy for any disease outcome.']	[('FUTURE_WORK', 37), ('ANOMALY_CURIOUS_FINDING', 126), ('FUTURE_WORK', 155), ('IMPORTANT_CONSIDERATION', 170)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4691762	12/2015	S17-PMC4691762	['RECENT EVIDENCE SUGGESTS that low Vitamin D at Birth or during Infancy is ASSOCIATED with an increased RISK of Food allergy6and eczema.7in addition Food allergy and eczema prevalence is higher the further from the equator a Person resides, LENDING SUPPORT to the HYPOTHESES that low Vitamin D (through low ultraviolet (uv) exposure) MAY play a ROLE in aberrant Immune Development in early Life and increase the risk of developing Food allergy and eczema.3food allergy is one of the earliest manifestations of the Immune deviation,8but also STRONGLY COASSOCIATES with eczema in infancy and asthma later in Life.9\nVitamin D supplementation in the first year of Life has also BEEN ASSOCIATED with a reduced risk of lris10and reduced recovery time in infants with acute bronchiolitis.11since early Life wheezy lris are also strongly ASSOCIATED with longer term respiratory outcomes including asthma12understanding the ROLE of Vitamin D in the RISK of early Life Respiratory diseases is also IMPORTANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 263), ('INCOMPLETE_EVIDENCE', 263), ('INCOMPLETE_EVIDENCE', 333), ('SUPERFICIAL_RELATIONSHIP', 344), ('PROBABLE_UNDERSTANDING', 540), ('SUPERFICIAL_RELATIONSHIP', 549), ('ANOMALY_CURIOUS_FINDING', 673), ('SUPERFICIAL_RELATIONSHIP', 678), ('SUPERFICIAL_RELATIONSHIP', 829), ('SUPERFICIAL_RELATIONSHIP', 914), ('IMPORTANT_CONSIDERATION', 939), ('IMPORTANT_CONSIDERATION', 987)]	18	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007567', 'parturition', 47, 'birth'), ('GO_0007631', 'feeding behavior', 63, 'infancy'), ('CHEBI_33290', 'food', 111, 'food'), ('CHEBI_33290', 'food', 148, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 224, 'person'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0001822', 'kidney development', 361, 'immune development'), ('UBERON_0002405', 'immune system', 361, 'immune'), ('UBERON_0000104', 'life cycle', 389, 'life'), ('CHEBI_33290', 'food', 430, 'food'), ('UBERON_0002405', 'immune system', 513, 'immune'), ('UBERON_0000104', 'life cycle', 605, 'life'), ('CHEBI_28384', 'vitamin K', 612, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 659, 'life'), ('UBERON_0000104', 'life cycle', 794, 'life'), ('CHEBI_27300', 'vitamin D', 922, 'vitamin D'), ('UBERON_0000104', 'life cycle', 953, 'life'), ('UBERON_0001004', 'respiratory system', 958, 'respiratory')]
PMC4691762	12/2015	S18-PMC4691762	['Vitamin D deficiency (currently defined as 25Ohd3<50\u2005nmol/l) has become MORE COMMON in modern communities over time, PRESUMABLY DUE TO INADEQUATE sun exposure resulting from indoor activities and skin cancer CONCERNS.13vitamin d deficiency is common in victoria, australia and also APPEARS TO BE increasing among Pregnant women14and infants.6in addition, the prevalence of infant Vitamin D deficiency was fourfold higher among fully Breastfed infants than fully formula Fed (p<0.001) EVEN at 12\u2005months after solid Food had been introduced.15\nUNLIKE OTHER countries in the northern hemisphere, australia does not RECOMMEND universal Vitamin D supplementation.']	[('PROBABLE_UNDERSTANDING', 72), ('PROBABLE_UNDERSTANDING', 117), ('PROBABLE_UNDERSTANDING', 128), ('IMPORTANT_CONSIDERATION', 135), ('IMPORTANT_CONSIDERATION', 208), ('ANOMALY_CURIOUS_FINDING', 282), ('ANOMALY_CURIOUS_FINDING', 484), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 542), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 549), ('FUTURE_WORK', 612)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_63058', '(2R,3S)-EHNA', 43, '25OHD3'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 43, '25OHD3'), ('GO_0007565', 'female pregnancy', 313, 'pregnant'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('GO_0007567', 'parturition', 433, 'breastfed'), ('GO_0007631', 'feeding behavior', 470, 'fed'), ('CHEBI_33290', 'food', 514, 'food'), ('CHEBI_27300', 'vitamin D', 632, 'vitamin D')]
PMC4691762	12/2015	S20-PMC4691762	['objectives\nwith the ultimate GOAL of developing improved PUBLIC HEALTH GUIDELINES for Vitamin D supplementation of infants, we AIM TO DETERMINE IF Vitamin D supplementation in infants from 6 to 8\u2005weeks of age LEADS to a reduction in the following during the first year of Life:\nchallenge-proven Food allergy\nlower Respiratory infections\nFood sensitisation\ndoctor diagnosed eczema\nvitamin D deficiency\n\nmethods and analysis\n\ndesign\nvitality is a double-blind, randomised, placebo-controlled trial of Vitamin D supplementation during the first year of Life.']	[('IMPORTANT_CONSIDERATION', 29), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 71), ('FUTURE_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144), ('SUPERFICIAL_RELATIONSHIP', 209)]	8	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0000104', 'life cycle', 272, 'life'), ('CHEBI_33290', 'food', 295, 'food'), ('UBERON_0001004', 'respiratory system', 314, 'respiratory'), ('CHEBI_33290', 'food', 337, 'Food'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 388, 'D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('UBERON_0000104', 'life cycle', 550, 'life')]
PMC4691762	12/2015	S94-PMC4691762	['a 30% reduction in the prevalence of Food allergy ATTRIBUTED to Vitamin D supplementation represents a clinically IMPORTANT reduction on a population level.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 114)]	2	[('CHEBI_33290', 'food', 37, 'food'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4691762	12/2015	S106-PMC4691762	['we will not be monitoring Serum 25(Oh)D for safety reasons nor considering the association between 25(Oh)D and outcome frequency given that 400\u2005Iu HAS BEEN SHOWN to be SAFE in term babies,1926preterm infants27and is the current RECOMMENDED dose in the usa, canada, the uk and europe.18\n\ndiscussion\nthe results of the vitality trial will determine WHETHER Vitamin D supplementation has a ROLE in optimising infant Immune health in the first year of Life, reducing the risk of allergic disease and Respiratory diseases.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 168), ('FUTURE_WORK', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('SUPERFICIAL_RELATIONSHIP', 387)]	5	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 32, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 99, '25(OH)D'), ('CHEBI_17883', 'hydrogen chloride', 144, 'IU'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin D'), ('UBERON_0002405', 'immune system', 413, 'immune'), ('UBERON_0000104', 'life cycle', 448, 'life'), ('UBERON_0001004', 'respiratory system', 496, 'respiratory')]
PMC4691762	12/2015	S118-PMC4691762	['it acts by inducing Antimicrobial peptides in Epithelial Cells, Neutrophils and Macrophages28And increases transcription of the innate Immune protein (hcap-18) which is capable of killing a wide variety of Viral and bacterial pathogens.29THESE FINDINGS are SUPPORTED by the observation that Vitamin D receptor polymorphisms (which decrease the bioavailability of Vitamin D to the cell) are ASSOCIATED with more SEVERE bronchiolitis30and that defective Control Of Vitamin D receptor-Mediated Cell Signalling PREDISPOSES to SEVERE Respiratory syncytial Virus bronchiolitis.31\n\nconclusions\ninternational enthusiasm for supplemental Vitamin D has OUTPACED AVAILABLE EVIDENCE on its EFFECTIVENESS32AND in fact ARGUMENT for routine supplementation is in equipoise.']	[('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 411), ('SUPERFICIAL_RELATIONSHIP', 507), ('IMPORTANT_CONSIDERATION', 522), ('ANOMALY_CURIOUS_FINDING', 643), ('ANOMALY_CURIOUS_FINDING', 643), ('INCOMPLETE_EVIDENCE', 652), ('SUPERFICIAL_RELATIONSHIP', 678), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 705)]	11	[('CHEBI_65381', 'albizoside C', 20, 'antimicrobial'), ('CL_0000066', 'epithelial cell', 46, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 46, 'epithelial'), ('CL_0000775', 'neutrophil', 64, 'neutrophils'), ('CL_0000091', 'Kupffer cell', 80, 'macrophages28and'), ('UBERON_0002405', 'immune system', 135, 'immune'), ('NCBITaxon_1', 'root', 206, 'viral'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('GO_0060070', 'canonical Wnt signaling pathway', 452, 'control of ... -mediated cell signalling'), ('CHEBI_27300', 'vitamin D', 463, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 529, 'respiratory'), ('NCBITaxon_1', 'root', 551, 'virus'), ('CHEBI_27300', 'vitamin D', 629, 'vitamin D')]
PMC4691762	12/2015	S119-PMC4691762	['if FOUND to be both efficacious and cost-effective, Vitamin D infant supplementation would provide a readily available, low harm INTERVENTION that would optimise infant Immune health in the first year of Life and significantly reduce the population BURDEN of allergic disease.']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 129), ('IMPORTANT_CONSIDERATION', 249)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002405', 'immune system', 169, 'immune'), ('UBERON_0000104', 'life cycle', 204, 'life')]
PMC4691762	12/2015	S120-PMC4691762	['the vitality trial will also enable a FUTURE evaluation of WHETHER Postnatal Vitamin D supplementation is ASSOCIATED with IMPROVED bone health in later childhood—the historical basis of widespread Postnatal Vitamin D supplementation, which REMAINS essentially UNTESTED.']	[('FUTURE_WORK', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('SUPERFICIAL_RELATIONSHIP', 106), ('IMPORTANT_CONSIDERATION', 122), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 260)]	6	[('GO_0007567', 'parturition', 67, 'postnatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007567', 'parturition', 197, 'postnatal'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC4714725	1/2016	S96-PMC4714725	['ab, a Micronutrients and Herbal supplements\nthere is NO CLEAR EVIDENCE that dietary supplementation with Vitamins, Minerals, herbs, or spices CAN improve diabetes, and there MAY BE safety CONCERNS regarding the long-term use of antioxidant supplements such as Vitamins E and C and Carotene.c Alcohol\nadults with diabetes who drink alcohol SHOULD do so in moderation (no more than one drink per day for Adult women and no more than two drinks per day for Adult men).c\nAlcohol Consumption MAY place People with diabetes at INCREASED risk for delayed hypoglycemia, ESPECIALLY IF taking Insulin or Insulin secretagogues.']	[('FULL_UNKNOWN', 53), ('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 174), ('PROBLEM_COMPLICATION', 188), ('FUTURE_WORK', 339), ('INCOMPLETE_EVIDENCE', 487), ('IMPORTANT_CONSIDERATION', 521), ('ANOMALY_CURIOUS_FINDING', 562), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 573)]	10	[('CHEBI_34850', 'milrinone lactate', 6, 'Micronutrients'), ('NCBITaxon_7955', 'Danio rerio', 25, 'herbal'), ('CHEBI_33277', 'gamma-tocotrienol', 105, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 115, 'minerals'), ('CHEBI_27300', 'vitamin D', 260, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 275, 'C'), ('PR_000004900', 'complement C3', 275, 'C'), ('CHEBI_23042', 'carotene', 281, 'carotene'), ('CHEBI_30879', 'alcohol', 292, 'Alcohol'), ('UBERON_0007023', 'adult organism', 402, 'adult'), ('UBERON_0007023', 'adult organism', 454, 'adult'), ('CHEBI_30879', 'alcohol', 467, 'Alcohol'), ('GO_0007631', 'feeding behavior', 475, 'consumption'), ('NCBITaxon_10088', 'Mus <genus>', 497, 'people'), ('PR_000045358', 'insulin family protein', 583, 'insulin'), ('PR_000045358', 'insulin family protein', 594, 'insulin')]
PMC4714725	1/2016	S282-PMC4714725	['management of ckd in diabetesgfr (ml/min/1.73 m2)recommended managementall patientsyearly measurement of creatinine, uacr, potassium45–60referral to a nephrologist IF POSSIBILITY for nondiabetic Kidney disease exists (duration of type 1 diabetes <10 years, persistent albuminuria, abnormal findings on Renal ultrasound, resistant hypertension, rapid fall in egfr, or active Urinary sediment on Urine microscopic examination)consider THE NEED for dose adjustment of Medicationsmonitor egfr every 6 monthsmonitor electrolytes, bicarbonate, hemoglobin, calcium, Phosphorus, and Parathyroid hormone at least yearlyassure Vitamin D sufficiencyconsider bone density testingreferral for dietary counseling30–44monitor egfr every 3 monthsmonitor electrolytes, bicarbonate, calcium, phosphorus, Parathyroid hormone, hemoglobin, albumin, and weight every 3–6 monthsconsider the need for dose adjustment of Medications<30referral to a nephrologist\n\ndiabetic retinopathy\n\nrecommendations\n\noptimize Glycemic Control to reduce the RISK or slow the progression of diabetic retinopathy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 164), ('INCOMPLETE_EVIDENCE', 167), ('INCOMPLETE_EVIDENCE', 433), ('IMPORTANT_CONSIDERATION', 1017)]	4	[('UBERON_0002113', 'kidney', 195, 'kidney'), ('UBERON_0002113', 'kidney', 302, 'renal'), ('UBERON_0001088', 'urine', 374, 'urinary'), ('UBERON_0001088', 'urine', 394, 'urine'), ('CHEBI_25354', 'mineralocorticoid', 465, 'medicationsMonitor'), ('CHEBI_35885', 'secondary phosphine', 559, 'phosphorus'), ('UBERON_0001132', 'parathyroid gland', 575, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 617, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 786, 'parathyroid'), ('CHEBI_25441', 'mycothiols', 896, 'medications'), ('GO_0006094', 'gluconeogenesis', 986, 'glycemic control')]
PMC4719746	1/2016	S13-PMC4719746	['in europe, Vitamin D deficiency is REPORTED to be PREVALENT among Pregnant ethnic minority women in the netherlands [2] and uk [3], but is also OBSERVED in the majority population [3–5].']	[('INCOMPLETE_EVIDENCE', 35), ('IMPORTANT_CONSIDERATION', 50), ('INCOMPLETE_EVIDENCE', 144)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnant')]
PMC4719746	1/2016	S38-PMC4719746	['in THIS PAPER, Vitamin D deficiency was DEFINED AS 25(Oh) D <50\xa0nmol/l, and severe Vitamin D deficiency was DEFINED as 25(Oh) D <25\xa0nmol/l, IN ACCORDANCE WITH RELEVANT LITERATURE [20].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('PROBABLE_UNDERSTANDING', 40), ('PROBABLE_UNDERSTANDING', 48), ('PROBABLE_UNDERSTANDING', 108), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 159), ('INCOMPLETE_EVIDENCE', 168)]	7	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 51, '25(OH) D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 121, '(OH) D')]
PMC4719746	1/2016	S131-PMC4719746	['INTERPRETATION\nOUR FINDINGS are IN LINE WITH others CONFIRMING widespread Vitamin D deficiency during Pregnancy among ethnic minorities [2,3,11,23,24], although SOME STUDIES from northern europe have FOUND a comparatively higher prevalence and more SEVERE deficiency THAN observed in OUR STUDY [6,25].']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 52), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 200), ('IMPORTANT_CONSIDERATION', 249), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 267), ('QUESTION_ANSWERED_BY_THIS_WORK', 284)]	9	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy')]
PMC4719746	1/2016	S132-PMC4719746	['RECENT STUDIES from the same part of oslo MAY have increased AWARENESS of Vitamin D deficiency among health personnel [26–28], which MAY have CONTRIBUTED to the SOMEWHAT lower prevalence of Vitamin D deficiency in ethnic minorities in OUR STUDY.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 61), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 161), ('QUESTION_ANSWERED_BY_THIS_WORK', 235)]	7	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC4719746	1/2016	S135-PMC4719746	['at high latitude, seasonal variance is an IMPORTANT EXPLANATORY FACTOR, AS the sun is not capable of producing Vitamin D by skin radiation during winter time [30].']	[('IMPORTANT_CONSIDERATION', 42), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 64), ('PROBABLE_UNDERSTANDING', 72)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC4719746	1/2016	S141-PMC4719746	['the DEBATE about the OPTIMAL dose of Vitamin D supplementation during Pregnancy is ONGOING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('IMPORTANT_CONSIDERATION', 21), ('IMPORTANT_CONSIDERATION', 83)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy')]
PMC4719746	1/2016	S155-PMC4719746	['HOWEVER, it SHOULD BE NOTED that severe Vitamin D deficiency was STILL FOUND in 15-20\xa0% of the high risk groups.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 12), ('ANOMALY_CURIOUS_FINDING', 22), ('IMPORTANT_CONSIDERATION', 65), ('INCOMPLETE_EVIDENCE', 71)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4719746	1/2016	S158-PMC4719746	['conclusion\nwe FOUND that Vitamin D deficiency was PREVALENT among south asian, middle eastern and african women in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 50)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 121, 'pregnancy')]
PMC4729160	1/2016	S0-PMC4729160	['prevalence and INFLUENCE FACTORS of Vitamin A deficiency of chinese Pregnant women\n\nabstract\n\nbackground\nvitamin a plays an IMPORTANT ROLE in the periods of rapid Cellular Growth and Differentiation, especially during Pregnancy, which is supplied by the mother to the fetus.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 25), ('IMPORTANT_CONSIDERATION', 124), ('SUPERFICIAL_RELATIONSHIP', 134)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin A'), ('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('GO_0001775', 'cell activation', 163, 'cellular growth ... differentiation'), ('GO_0007565', 'female pregnancy', 218, 'pregnancy')]
PMC4729160	1/2016	S129-PMC4729160	['conclusions\nIN SUMMARY, THE CURRENT STUDY REPORTED the prevalence of Vitamin A among chinese Pregnant women and the prevalence of vad was 5.3\xa0%, which was a MILD PUBLIC-HEALTH ISSUE in china.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 162), ('IMPORTANT_CONSIDERATION', 176)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin A'), ('GO_0007565', 'female pregnancy', 93, 'pregnant')]
PMC4729160	1/2016	S132-PMC4729160	['so in the FUTURE health public policy on Vitamin A SHOULD BE paid more ATTENTION on Pregnant women with pertinent INFLUENCE FACTORS of vad, accordingly, eliminate vad improve the nutritional status of chinese Pregnant women.']	[('FUTURE_WORK', 10), ('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 71), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 49, 'A'), ('GO_0007565', 'female pregnancy', 84, 'pregnant'), ('GO_0007565', 'female pregnancy', 209, 'pregnant')]
PMC4764019	1/2016	S14-PMC4764019	['the RELATION to Vitamin D inadequacy SHOULD BE understood simply as just one of the conditions that, when met, together LEAD TO expression of the diseases CONCERNED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FUTURE_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 155)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC4764019	1/2016	S17-PMC4764019	['autoimmune disorders\ntwo SERIOUS Autoimmune diseases HAVE BEEN LINKED to low Vitamin D status in early Life, type 1 diabetes mellitus (dm1) and multiple sclerosis (ms).']	[('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('UBERON_0001442', 'skeleton of manus', 33, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0000104', 'life cycle', 103, 'life')]
PMC4764019	1/2016	S39-PMC4764019	['the OBSERVED ASSOCIATION is so strong that mcgrath et al ESTIMATED that 50% of the BURDEN of schizophrenia in the entire country of denmark COULD PERHAPS be ATTRIBUTED to PROBLEMS produced by low Perinatal Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 157), ('IMPORTANT_CONSIDERATION', 171)]	8	[('GO_0036268', 'swimming', 196, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 196, 'perinatal'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D')]
PMC4764019	1/2016	S40-PMC4764019	['WHILE this ASSOCIATION MIGHT initially SEEM far-fetched, it is IMPORTANT TO NOTE that the great famine in china in 1958 to 1961 was ASSOCIATED with a subsequent rise in the incidence of schizophrenia in famine victims.2measured Vitamin D status values in these Individuals are NOT AVAILABLE, but it HAS long BEEN KNOWN that rickets was endemic in china and certainly was so at the time of the famine.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 39), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 132), ('INCOMPLETE_EVIDENCE', 277), ('INCOMPLETE_EVIDENCE', 299)]	8	[('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('NCBITaxon_1', 'root', 261, 'individuals')]
PMC4764019	1/2016	S42-PMC4764019	['mcgrath et al also POINT out that Rats reared on Vitamin D–deficient diets produce pups that have morphologically abnormal Brain structures.9–11schizophrenia is USUALLY considered more a functional disorder with morphological alterations THAN a primarily morphologic one, and the Rat data INDICATE that Vitamin D is ESSENTIAL for normal Brain Development and HENCE plausibly for normal Brain function.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('INCOMPLETE_EVIDENCE', 289), ('IMPORTANT_CONSIDERATION', 316), ('PROBABLE_UNDERSTANDING', 359)]	6	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 34, 'rats'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000955', 'brain', 123, 'brain'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 280, 'rat'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('GO_0007420', 'brain development', 337, 'brain development'), ('UBERON_0000955', 'brain', 337, 'brain'), ('UBERON_0000955', 'brain', 386, 'brain')]
PMC4764019	1/2016	S43-PMC4764019	['cognitive function and Learning disabilities\nwhitehouse et al12report on the prevalence of Learning disabilities in school-age children as a function of maternal Vitamin D status at the time when the children CONCERNED were Born.']	[('IMPORTANT_CONSIDERATION', 209)]	1	[('GO_0090232', 'positive regulation of spindle checkpoint', 23, 'LEARNING'), ('GO_0007612', 'learning', 91, 'learning'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007567', 'parturition', 224, 'born')]
PMC4764019	1/2016	S49-PMC4764019	['this is BECAUSE, EVEN IF there were no connection between the Vitamin D status and the observed Learning difficulty, the group of Pregnant women to be studied would HAVE TO BE placed and maintained on a Vitamin D status, which is recognized to be INADEQUATE on OTHER grounds (ie, <18 ng/ml) and THEREFORE productive of harmful outcomes.']	[('PROBLEM_COMPLICATION', 8), ('ANOMALY_CURIOUS_FINDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('IMPORTANT_CONSIDERATION', 165), ('IMPORTANT_CONSIDERATION', 247), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 261), ('PROBABLE_UNDERSTANDING', 295)]	7	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007612', 'learning', 96, 'learning'), ('GO_0007565', 'female pregnancy', 130, 'pregnant'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
PMC4764019	1/2016	S51-PMC4764019	['CAN it be that Vitamin D inadequacy CONTRIBUTES to the disease BURDEN of so many otherwise UNRELATED disorders?']	[('EXPLICIT_QUESTION', 0), ('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 91), ('EXPLICIT_QUESTION', 110)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC4764019	1/2016	S59-PMC4764019	['in the final analysis, the underlying HYPOTHESIS is not that Vitamin D supplementation will reduce the disease BURDEN of dm1, preeclampsia, ms, schizophrenia, or the OTHER disorders listed, RATHER, the RELEVANT HYPOTHESIS is, INSTEAD, that it is precisely Vitamin D inadequacy that increases or aggravates the disease BURDEN of these varied outcomes.']	[('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('IMPORTANT_CONSIDERATION', 202), ('INCOMPLETE_EVIDENCE', 211), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226), ('IMPORTANT_CONSIDERATION', 318)]	8	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
PMC4764019	1/2016	S82-PMC4764019	['in closing, it would SEEM IMPORTANT TO EMPHASIZE that the LIKELY Vitamin D status values (and the corresponding daily intakes) ASSOCIATED with protection from the delayed outcomes DISCUSSED HERE are entirely physiological, not Pharmacological (ie, in the range of 40–60 ng/ml).']	[('ANOMALY_CURIOUS_FINDING', 21), ('IMPORTANT_CONSIDERATION', 26), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 180), ('QUESTION_ANSWERED_BY_THIS_WORK', 190)]	6	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_52217', 'pharmaceutical', 227, 'pharmacological')]
PMC4770602	1/2016	S0-PMC4770602	['EFFECT of Vitamin D supplementation in the reduce RISK of Preeclampsia in nulliparous women\n\nabstract\n\nbackground:\nthe exact ROLE of Vitamin D in the development and severity of Preeclampsia is STILL UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 125), ('FULL_UNKNOWN', 194)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 58, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 178, 'preeclampsia')]
PMC4770602	1/2016	S16-PMC4770602	['[5] and an ASSOCIATION between low maternal Vitamin D and early-onset, SEVERE Preeclampsia is RECENTLY REPORTED.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('IMPORTANT_CONSIDERATION', 71), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 103)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 78, 'preeclampsia')]
PMC4770602	1/2016	S17-PMC4770602	['[9] WHEREAS, an INCREASED RISK for preeclampsia is REPORTED in an investigation when Serum Vitamin D levels decreased around 20 ng/ml after adjusting for CONFOUNDERS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 51), ('PROBLEM_COMPLICATION', 154)]	4	[('UBERON_0001977', 'blood serum', 85, 'serum'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4770602	1/2016	S18-PMC4770602	['[5] another data SUGGESTED with ONLY a 10ng/ml increase in maternal Vitamin D a POSSIBLE reduction of the RISK of Preeclampsia.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 80), ('IMPORTANT_CONSIDERATION', 106)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 114, 'preeclampsia')]
PMC4770602	1/2016	S20-PMC4770602	['[8]\na WIDESPREAD PUBLIC HEALTH PROBLEM is maternal Vitamin D deficiency.']	[('IMPORTANT_CONSIDERATION', 6), ('IMPORTANT_CONSIDERATION', 17)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC4770602	1/2016	S22-PMC4770602	['[14151617] lack of adequate sunlight exposure NEEDED to synthesize Vitamin D3 in the skin, and Oral intakes that are TOO low TO meet the increased demands of Pregnancy are REASONS of epidemic deficiency of Vitamin D during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 46), ('DIFFICULT_TASK', 117), ('PROBABLE_UNDERSTANDING', 172)]	3	[('CHEBI_33279', 'vitamin D5', 67, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 67, 'vitamin D3'), ('UBERON_0000165', 'mouth', 95, 'oral'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
PMC4770602	1/2016	S26-PMC4770602	['THUS, THIS STUDY was AIMED TO EXAMINE the IMPACT of Vitamin D supplementation in reduction of RISK of Preeclampsia in nulliparous women in a randomized controlled trial.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 94)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 102, 'preeclampsia')]
PMC4770602	1/2016	S63-PMC4770602	['Preeclampsia is one of the LEADING CAUSES of Maternal and Perinatal Morbidity and mortality which, Vitamin D HAS BEEN HYPOTHESIZED to INFLUENCE Preeclampsia RISK.']	[('IMPORTANT_CONSIDERATION', 27), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 134), ('IMPORTANT_CONSIDERATION', 157)]	5	[('GO_0007128', 'meiotic prophase I', 0, 'Preeclampsia'), ('GO_0007618', 'mating', 45, 'maternal ...'), ('GO_0019230', 'proprioception', 58, 'perinatal morbidity'), ('UBERON_0012101', 'perinatal stage', 58, 'perinatal'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 144, 'preeclampsia')]
PMC4770602	1/2016	S76-PMC4770602	['level of calcium in studied women was an IMPORTANT unmeasured covariate in OUR STUDY, WHEREAS, low calcium intake MAY BE ASSOCIATED with Vitamin D deficiency and MAY be a RISK FACTOR for Preeclampsia.']	[('IMPORTANT_CONSIDERATION', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 121), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 171)]	7	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 187, 'preeclampsia')]
PMC4770602	1/2016	S77-PMC4770602	['THEREFORE, Calcium intake MAY CONFOUND an ASSOCIATION between maternal Vitamin D deficiency and preeclampsia RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('PROBLEM_COMPLICATION', 30), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 109)]	5	[('CHEBI_22313', 'alkaline earth metal atom', 11, 'calcium'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4770602	1/2016	S79-PMC4770602	['in CONCLUSION, results of the PRESENT STUDY DEMONSTRATED that Vitamin D supplementation during the third Trimester of Pregnancy; reduce the RISK of Preeclampsia HOWEVER, this was not statistically significant.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 44), ('IMPORTANT_CONSIDERATION', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 161)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 105, 'trimester'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 148, 'preeclampsia')]
PMC4778858	3/2016	S23-PMC4778858	['HOWEVER, PREVIOUS STUDIES on Birth weight outcomes and RISK of gdm among Vitamin D deficient mothers DID NOT adequately address rates of maternal obesity, used an inaccurate vitamin d assay, or studied neonates of varying Gestational ages, thus CONFOUNDING interpretation of results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 101), ('PROBLEM_COMPLICATION', 245)]	5	[('GO_0007567', 'parturition', 29, 'birth'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 222, 'gestational')]
PMC4778858	3/2016	S101-PMC4778858	['the results of THIS STUDY INDICATE that mothers with higher bmi are AT RISK for lower Vitamin D levels, and CONSEQUENTLY, lower Vitamin D levels in their neonates.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 68), ('PROBABLE_UNDERSTANDING', 108)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC4778858	3/2016	S102-PMC4778858	['as addressed PREVIOUSLY by our group [12] and others [27], obese women MAY REQUIRE larger amounts of Vitamin D supplementation compared to normal weight women to provide their neonates with sufficient levels of Vitamin D. YET the definition of neonatal Vitamin D sufficiency has NOT BEEN DETERMINED.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 222), ('ANOMALY_CURIOUS_FINDING', 222), ('FULL_UNKNOWN', 279)]	6	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
PMC4778858	3/2016	S106-PMC4778858	['THUS, well-designed, interventional studies, with both neonatal and longitudinal follow up outcomes, are NECESSARY in order to provide improved RECOMMENDATIONS for Vitamin D supplementation in Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 105), ('FUTURE_WORK', 144)]	3	[('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy')]
PMC4778858	3/2016	S108-PMC4778858	['these results are IN CONTRAST TO OTHER reports SUGGESTING that Vitamin D levels INFLUENCE the RISK of gdm [15,32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 80), ('IMPORTANT_CONSIDERATION', 94)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC4778858	3/2016	S124-PMC4778858	['a MAJOR strength of THIS PLANNED STUDY was its design to reduce POTENTIAL CONFOUNDERS of ASSOCIATIONS between maternal and Cord Blood Vitamin D levels and maternal bmi.']	[('IMPORTANT_CONSIDERATION', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 64), ('PROBLEM_COMPLICATION', 74), ('SUPERFICIAL_RELATIONSHIP', 89)]	6	[('UBERON_0002240', 'spinal cord', 123, 'cord'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4784858	3/2016	S87-PMC4784858	['EVEN IF national GUIDELINES RECOMMEND the use of dietary supplements to meet REQUIREMENTS for some Nutrients (Folate, Vitamin D, iron or Iodine) during Pregnancy, Nutrient intakes from dietary supplements were not included in the pandiet calculation, like in other studies using diet quality indexes for Pregnancy [11–13].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 17), ('FUTURE_WORK', 28), ('IMPORTANT_CONSIDERATION', 77)]	5	[('CHEBI_33284', 'nutrient', 99, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 110, 'folate'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 137, 'iodine'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy'), ('CHEBI_33284', 'nutrient', 163, 'nutrient'), ('GO_0007565', 'female pregnancy', 304, 'pregnancy')]
PMC4784858	3/2016	S149-PMC4784858	['by focusing on Nutrients CONSIDERED as KEY during Pregnancy in french nutritional guidelines: Folate, Vitamin D, Calcium, Iodine and Iron (36) plus Dha, we NOTED that three snack additions (‘cereal bar and yogurt’, ‘toasts and egg’ and ‘pita bread filled with salad and Tuna’) and the proportional increase in Consumed Food weight increased probabilities of adequacy for four key Nutrient Intakes during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 39), ('ANOMALY_CURIOUS_FINDING', 156)]	3	[('CHEBI_33284', 'nutrient', 15, 'nutrients'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('CHEBI_30863', '5-azaorotic acid', 94, 'folate'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 113, 'calcium'), ('CHEBI_24859', 'iodine atom', 122, 'iodine'), ('CHEBI_24870', 'ion', 133, 'iron'), ('CHEBI_17874', 'dihydrozeatin', 148, 'DHA'), ('NCBITaxon_10088', 'Mus <genus>', 270, 'tuna'), ('GO_0007631', 'feeding behavior', 310, 'consumed'), ('CHEBI_33290', 'food', 319, 'food'), ('CHEBI_33284', 'nutrient', 380, 'nutrient'), ('GO_0007631', 'feeding behavior', 389, 'intakes'), ('GO_0007565', 'female pregnancy', 404, 'pregnancy')]
PMC4785305	3/2016	S3-PMC4785305	['our HYPOTHESIS is that in middle eastern Pregnant women, a Vitamin D dose of 3000\u2005iu/day is REQUIRED to reach a DESIRABLE maternal 25-Hydroxyvitamin D [25(Oh)D] level, and to positively IMPACT infant bone Mineral content (bmc).']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 92), ('IMPORTANT_CONSIDERATION', 112), ('SUPERFICIAL_RELATIONSHIP', 186)]	4	[('GO_0007565', 'female pregnancy', 41, 'pregnant'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 131, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 152, '25(OH)D'), ('CHEBI_46662', 'mineral', 205, 'mineral')]
PMC4785305	3/2016	S20-PMC4785305	['results derived from Nutrient rct, specifically Vitamin D supplementation, SUFFER from several CONFOUNDING FACTORS RELATED to the baseline status, intake of OTHER Nutrients, such as calcium and proteins, and sun exposure, which are DIFFICULT to quantify accurately.']	[('IMPORTANT_CONSIDERATION', 75), ('PROBLEM_COMPLICATION', 95), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('DIFFICULT_TASK', 232)]	5	[('CHEBI_33284', 'nutrient', 21, 'nutrient'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_33284', 'nutrient', 163, 'nutrients')]
PMC4785305	3/2016	S22-PMC4785305	['WHILE the total Calcitriol levels double in the first trimester, free Calcitriol levels do not increase until the third trimester and remain so until Lactation.24conversely, Parathyroid hormone (pth) levels decrease early on and increase back to mid-normal range by term.2the total calcium level decreases during Pregnancy, due to haemodilution, WHILE the ionised calcium level remains stable.2vitamin D binding proteins also increase during Pregnancy secondary to high Oestrogen levels,45but the 25-Hydroxyvitamin D (25(Oh)D) level, the single best nutritional INDICATOR of Vitamin D status,6remains stable.7the changes in Calcitriol levels led to the description of Pregnancy as a state of ‘absorptive hypercalciuria’.12the above Adaptive physiology is KEY to SAFETY CONSIDERATIONS when using Vitamin D supplementation during Pregnancy, as well as to determining key biochemical and hormonal parameters to be monitored.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 346), ('SUPERFICIAL_RELATIONSHIP', 562), ('IMPORTANT_CONSIDERATION', 755), ('IMPORTANT_CONSIDERATION', 762), ('IMPORTANT_CONSIDERATION', 769)]	6	[('CHEBI_17823', 'calcitriol', 16, 'calcitriol'), ('CHEBI_17823', 'calcitriol', 70, 'calcitriol'), ('GO_0007595', 'lactation', 150, 'lactation'), ('UBERON_0001132', 'parathyroid gland', 174, 'parathyroid'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy'), ('PR_000006444', 'diacylglycerol kinase delta', 402, 'D'), ('GO_0007565', 'female pregnancy', 442, 'pregnancy'), ('CHEBI_50114', 'estrogen', 470, 'oestrogen'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 497, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 518, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 575, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 624, 'calcitriol'), ('GO_0007565', 'female pregnancy', 668, 'pregnancy'), ('GO_0018888', '3-chloroacrylic acid metabolic process', 732, 'adaptive'), ('CHEBI_27300', 'vitamin D', 795, 'vitamin D'), ('GO_0007565', 'female pregnancy', 828, 'pregnancy')]
PMC4785305	3/2016	S23-PMC4785305	['maternal Vitamin D status during Pregnancy\nvitamin D deficiency during Pregnancy is PREVALENT worldwide, ESPECIALLY in developing countries.8in a systematic review of 18 studies conducted in western countries during the first Trimester, white caucasian Pregnant women were found to have a mean 25(Oh)D level between 29 and 73\u2005nmol/l.9mean 25(Oh)D levels were lower in non-caucasian Pregnant women, ranging between 15.2 and 43\u2005nmol/l.9in addition to ethnicity, higher latitude was a significant predisposing FACTOR for hypovitaminosis d.9similarly, in non-western countries, more than half of the Pregnant women who were beyond their first trimester had 25(Oh)D levels below 75\u2005nmol/l; these include countries such as india,10kuwait,11pakistan12and turkey.13even lower levels (<25\u2005nmol/l) HAVE BEEN REPORTED at Delivery in saudi arabia, iran and the united arab emirates.14furthermore, immigrant women were at PARTICULAR RISK.1516an OBSERVATIONAL study from the netherlands SHOWED significantly lower 25(Oh)D levels during the first Trimester in immigrant Pregnant women (turkish, moroccan and others), compared to western participants.17\n\nASSOCIATION between maternal Vitamin D status and maternal adverse outcomes\nVitamin D insufficiency during Pregnancy is ASSOCIATED with adverse maternal outcomes such as increased risk of Gestational diabetes mellitus (gdm), preeclampsia, caesarean-section Delivery and bacterial vaginosis.18in a recent meta-analysis of observational studies, the risk of gdm was FOUND TO BE increased by 40–84% in Pregnant women with low 25(Oh)D levels, defined as <50\u2005nmol/l or <75\u2005nmol/l, DEPENDING ON the studies.19–21while Preeclampsia risk was significantly increased in Vitamin D insufficient women,22c-section rates were INCONSISTENTLY AFFECTED by Vitamin D status.23HOWEVER, THESE FINDINGS REMAIN LIMITED by the inherent BIASES of OBSERVATIONAL studies, INCONSISTENT adjustment for CONFOUNDERS, in addition to the wide HETEROGENEITY in Vitamin D assays and Vitamin D cut-offs definition.']	[('IMPORTANT_CONSIDERATION', 84), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 507), ('INCOMPLETE_EVIDENCE', 788), ('IMPORTANT_CONSIDERATION', 909), ('INCOMPLETE_EVIDENCE', 932), ('INCOMPLETE_EVIDENCE', 973), ('SUPERFICIAL_RELATIONSHIP', 1139), ('SUPERFICIAL_RELATIONSHIP', 1259), ('ANOMALY_CURIOUS_FINDING', 1503), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1752), ('SUPERFICIAL_RELATIONSHIP', 1767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1796), ('INCOMPLETE_EVIDENCE', 1807), ('INCOMPLETE_EVIDENCE', 1822), ('INCOMPLETE_EVIDENCE', 1829), ('PROBLEM_COMPLICATION', 1853), ('INCOMPLETE_EVIDENCE', 1863), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1886), ('PROBLEM_COMPLICATION', 1914), ('DIFFICULT_TASK', 1951)]	22	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 51, 'D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 226, 'trimester'), ('GO_0007565', 'female pregnancy', 253, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 294, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 294, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 345, 'D'), ('GO_0007565', 'female pregnancy', 382, 'pregnant'), ('GO_0007565', 'female pregnancy', 596, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 653, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 653, '25(OH)D'), ('GO_0007567', 'parturition', 810, 'delivery'), ('CHEBI_71657', 'versiconol acetate', 1000, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1000, '25(OH)D'), ('GO_0009294', 'DNA mediated transformation', 1032, 'trimester'), ('GO_0007565', 'female pregnancy', 1055, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1168, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 1215, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1246, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1327, 'gestational'), ('GO_0007567', 'parturition', 1396, 'delivery'), ('GO_0007565', 'female pregnancy', 1538, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 1562, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 1651, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 1700, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1779, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1968, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1989, 'vitamin D')]
PMC4785305	3/2016	S24-PMC4785305	["ASSOCIATION between maternal Vitamin D level and neonatal adverse outcomes\nlow maternal 25(Oh)D levels were RECENTLY LINKED to fetal programming, and were found TO be ASSOCIATED with adverse events in neonates, resulting in small for Gestational age (sga) at Birth,1923and also later on during childhood, leading to reduced muscle and bone mass in offspring at 4 and 9\u2005years.2425this MAY BE EXPLAINED by the fact that maternal Vitamin D is ESSENTIAL for fetal Musculoskeletal integrity, as it Regulates neonatal bone accrual, POSSIBLY through specific proteins that are responsible for Placental Calcium Transport.26RECENTLY, data from the southampton women's survey (sws) SHOWED that maternal 25(Oh)D level is significantly CORRELATED with Placental Amino Acid transporters Expression, that mediate the Transport Of various Nutrients to the fetus.27furthermore, maternal Vitamin D MAY INFLUENCE the fetal muscle motor Unit size, and CONSEQUENTLY muscle mass and strength after Birth.25it is NOTEWORTHY that fetal bone development is one of the PREDICTORS of peak bone mass, Adult bone Mineral content and Hip geometry, THUS CORRELATING with fracture risk later in Life.2628\n\nVitamin d replacement guidelines during Pregnancy\nthe guidelines regarding Vitamin D replacement or supplementation during Pregnancy VARY substantially."]	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 161), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 384), ('ANOMALY_CURIOUS_FINDING', 388), ('PROBABLE_UNDERSTANDING', 391), ('IMPORTANT_CONSIDERATION', 440), ('INCOMPLETE_EVIDENCE', 526), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 614), ('INCOMPLETE_EVIDENCE', 673), ('SUPERFICIAL_RELATIONSHIP', 725), ('INCOMPLETE_EVIDENCE', 882), ('SUPERFICIAL_RELATIONSHIP', 886), ('PROBABLE_UNDERSTANDING', 934), ('ANOMALY_CURIOUS_FINDING', 992), ('SUPERFICIAL_RELATIONSHIP', 1045), ('PROBABLE_UNDERSTANDING', 1120), ('SUPERFICIAL_RELATIONSHIP', 1125), ('DIFFICULT_TASK', 1309)]	21	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('GO_0007565', 'female pregnancy', 234, 'gestational'), ('GO_0007567', 'parturition', 259, 'birth'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 460, 'musculoskeletal'), ('GO_0065007', 'biological regulation', 493, 'regulates'), ('UBERON_0001987', 'placenta', 586, 'placental'), ('GO_0006816', 'calcium ion transport', 596, 'calcium transport'), ('CHEBI_71657', 'versiconol acetate', 694, '25(OH)D'), ('UBERON_0001987', 'placenta', 741, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 751, 'amino acid'), ('GO_0010467', 'gene expression', 775, 'expression'), ('GO_0006415', 'translational termination', 804, 'transport of ... nutrients'), ('CHEBI_33284', 'nutrient', 825, 'nutrients'), ('CHEBI_27300', 'vitamin D', 872, 'vitamin D'), ('UBERON_0002105', 'vestibulo-auditory system', 919, 'unit'), ('GO_0007567', 'parturition', 978, 'birth'), ('UBERON_0007023', 'adult organism', 1075, 'adult'), ('CHEBI_46662', 'mineral', 1086, 'mineral'), ('UBERON_0001464', 'hip', 1106, 'hip'), ('UBERON_0000104', 'life cycle', 1165, 'life'), ('CHEBI_33229', 'vitamin (role)', 1176, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1216, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1251, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1299, 'pregnancy')]
PMC4785305	3/2016	S25-PMC4785305	['the 2010 institute of medicine (iom) report on dietary reference intakes for Calcium and Vitamin D RECOMMENDED 600\u2005iu to Pregnant women as the recommended daily allowance (rda), the rda being the dose that is projected to allow at least 97.5% of the Pregnant women population to reach the DESIRABLE target 25(Oh)D level ≥50\u2005nmol/l.29this RECOMMENDATION was BASED ON OBSERVATIONAL studies, NONE of which were conducted in the middle east.29CONVERSELY, the Endocrine society 2011 GUIDELINES RECOMMENDED that 1500–2000\u2005iu daily of Vitamin D is NEEDED to reach a target 25(Oh)D level ≥75\u2005nmol/l (a RECOMMENDATION that was graded as weak with moderate quality of evidence).30the american college of obstetricians and gynecologists (acog) does not RECOMMEND screening for Vitamin D level in Pregnancy, and abides by the iom RECOMMENDATIONS.31moreover, the who 2012 guidelines on Vitamin D replacement during Pregnancy DID NOT RECOMMEND vitamin D supplementation as part of Prenatal care.32this was based ON a meta-analysis of Vitamin D trials during Pregnancy, which IDENTIFIED a LIMITED NUMBER of high-quality studies DEMONSTRATING a beneficial EFFECT of supplementation on maternal and neonatal outcomes, and CONCLUDED that FURTHER randomised controlled trials (rcts) ARE NEEDED.33in the uk, HOWEVER, Pregnant women are CONSIDERED AT RISK of Vitamin D deficiency, and supplementation with 400\u2005iu daily is REQUIRED.34\nit is NOT CLEAR WHETHER any of the above RECOMMENDED doses are applicable to non-western populations, with lower baseline Vitamin D levels, such as in lebanon and other middle eastern countries.']	[('FUTURE_WORK', 99), ('IMPORTANT_CONSIDERATION', 289), ('FUTURE_WORK', 338), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 366), ('INCOMPLETE_EVIDENCE', 389), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 437), ('PROBABLE_UNDERSTANDING', 478), ('FUTURE_WORK', 489), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 541), ('FUTURE_WORK', 594), ('FUTURE_WORK', 742), ('FUTURE_WORK', 818), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 920), ('ANOMALY_CURIOUS_FINDING', 998), ('ANOMALY_CURIOUS_FINDING', 998), ('INCOMPLETE_EVIDENCE', 1061), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1113), ('SUPERFICIAL_RELATIONSHIP', 1140), ('INCOMPLETE_EVIDENCE', 1205), ('FUTURE_WORK', 1220), ('FUTURE_WORK', 1264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1288), ('IMPORTANT_CONSIDERATION', 1316), ('INCOMPLETE_EVIDENCE', 1316), ('IMPORTANT_CONSIDERATION', 1327), ('IMPORTANT_CONSIDERATION', 1401), ('FULL_UNKNOWN', 1419), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1429), ('FUTURE_WORK', 1454)]	33	[('CHEBI_31341', 'calcium dihydroxide', 77, 'Calcium'), ('CHEBI_28384', 'vitamin K', 89, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 89, 'Vitamin'), ('GO_0007565', 'female pregnancy', 121, 'pregnant'), ('GO_0007565', 'female pregnancy', 250, 'pregnant'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 309, 'OH)D'), ('PR_000013502', 'parvalbumin alpha', 311, ')D'), ('UBERON_0005063', 'left ventricular compact myocardium', 455, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 528, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 566, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 566, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 766, 'vitamin D'), ('GO_0007565', 'female pregnancy', 785, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin D'), ('GO_0007565', 'female pregnancy', 902, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 938, 'D'), ('GO_0007565', 'female pregnancy', 967, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1020, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1044, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1297, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1338, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1535, 'vitamin D')]
PMC4785305	3/2016	S26-PMC4785305	['indeed, the who Pregnancy guidelines clearly STATED that “Vitamin D supplementation will PROBABLY have the most BENEFIT in populations of poor countries, those with darker skin colour and in populations with a high prevalence of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 89), ('IMPORTANT_CONSIDERATION', 112)]	3	[('GO_0007565', 'female pregnancy', 16, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 58, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D')]
PMC4785305	3/2016	S30-PMC4785305	['ONE STUDY from india, comparing non-intervention to Vitamin D supplementation groups, with the dose being DEPENDENT on 25(Oh)D levels at 20\u2005weeks Gestation, SHOWED that Vitamin D supplementation resulted in a significant difference in the achieved 25(Oh)D level at Delivery (43.1 (81.3) nmol/l in the former group versus 56.8 (47.5) nmol/l in the latter group).37hollis et al 36and sablok et al 37SHOWED that Vitamin D supplementation decreased the RISK of Preterm labour, Gestational diabetes and hypertensive complications (all combined).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 157), ('INCOMPLETE_EVIDENCE', 395), ('IMPORTANT_CONSIDERATION', 449)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 125, 'D'), ('GO_0007565', 'female pregnancy', 146, 'gestation'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 248, '25(OH)D'), ('GO_0007567', 'parturition', 265, 'delivery'), ('CHEBI_27300', 'vitamin D', 409, 'vitamin D'), ('GO_0007565', 'female pregnancy', 457, 'preterm'), ('GO_0007565', 'female pregnancy', 473, 'gestational')]
PMC4785305	3/2016	S31-PMC4785305	['in the middle east and north africa region, there are FEW RECENT rcts that attempted to determine the OPTIMAL regimen of Vitamin D replacement in healthy Pregnant women.38–41WITH the exception of soheilykhah et al 40who ASSESSED the EFFECT of Vitamin D supplementation on Insulin resistance, the primary outcomes in THESE studies were MOSTLY maternal and neonatal 25(Oh)D levels (seeonline supplementary appendix1).']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 58), ('IMPORTANT_CONSIDERATION', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 233), ('INCOMPLETE_EVIDENCE', 316), ('PROBABLE_UNDERSTANDING', 335)]	8	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnant'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('PR_000045358', 'insulin family protein', 272, 'insulin'), ('CHEBI_71657', 'versiconol acetate', 364, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 364, '25 ... OH ... D')]
PMC4785305	3/2016	S32-PMC4785305	['none of the other clinically IMPORTANT outcomes, such as neonatal size and OTHER anthropometric measurements, neonatal bmc, gdm and c-section rates, were evaluated as primary outcomes in any of these trials (seeonline supplementary appendix1).10.1136/bmjopen-2015-010818.supp1\n\nwe therefore compiled a registry of all ongoing Vitamin D trials in Pregnancy, as captured by their registration on clinicaltrial.gov42(seeonline supplementary appendix2).']	[('IMPORTANT_CONSIDERATION', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 75)]	2	[('CHEBI_27300', 'vitamin D', 326, 'vitamin D'), ('GO_0007565', 'female pregnancy', 346, 'pregnancy')]
PMC4785305	3/2016	S34-PMC4785305	['ONLY two of the ONGOING trials are being conducted in the middle east, one in iran and one in israel, start supplementation in the third Trimester and use Vitamin D doses of 7000\u2005iu and 2000\u2005iu daily, respectively.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 16)]	2	[('GO_0009294', 'DNA mediated transformation', 137, 'trimester'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4785305	3/2016	S168-PMC4785305	['furthermore, GIVEN the LACK OF EVIDENCE-BASED guidelines that define the OPTIMAL rda for Vitamin D supplementation during Pregnancy in our population, and the LIMITED NUMBER of randomised clinical trials completed so far in our region, this trial will fill an IMPORTANT KNOWLEDGE GAP.']	[('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 73), ('INCOMPLETE_EVIDENCE', 159), ('IMPORTANT_CONSIDERATION', 260), ('FULL_UNKNOWN', 270)]	6	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy')]
PMC4785305	3/2016	S169-PMC4785305	['we will conduct this rct TO TEST the IMPACT of two different doses of Vitamin D replacement on clinically RELEVANT maternal and neonatal outcomes in middle eastern women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 37), ('IMPORTANT_CONSIDERATION', 106)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4785305	3/2016	S174-PMC4785305	['FINDINGS from our trial, and SIMILAR TO results derived from Nutrient rcts, are PRONE to the CONFOUNDING effect of several FACTORS.52indeed, the baseline 25(Oh)D level, the dietary Intake of Vitamin D and OTHER Nutrients, such as Calcium and proteins, sun exposure and others, REMAIN IMPORTANT PREDICTORS AFFECTING the response to Vitamin D supplementation, but are very DIFFICULT to quantify accurately.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 80), ('PROBLEM_COMPLICATION', 93), ('SUPERFICIAL_RELATIONSHIP', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205), ('INCOMPLETE_EVIDENCE', 277), ('IMPORTANT_CONSIDERATION', 284), ('SUPERFICIAL_RELATIONSHIP', 294), ('SUPERFICIAL_RELATIONSHIP', 305), ('DIFFICULT_TASK', 371)]	11	[('CHEBI_33284', 'nutrient', 61, 'nutrient'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 157, 'OH)D'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('CHEBI_33284', 'nutrient', 211, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 230, 'calcium'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D')]
PMC4800340	5/2016	S56-PMC4800340	['THIS STUDY SHOWED that Prenatal Vitamin D-mediated epigenetic Regulation in Tslp increased the RISK of wheezing in children.77more Human STUDIES ARE NEEDED to substantiate the ROLE of epigenetic Regulation by Nutrients in the growing epidemic of Food allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 95), ('FUTURE_WORK', 137), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('GO_0007565', 'female pregnancy', 23, 'prenatal'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 62, 'regulation'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 76, 'TSLP'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('GO_0065007', 'biological regulation', 195, 'regulation'), ('CHEBI_33284', 'nutrient', 209, 'nutrients'), ('CHEBI_33290', 'food', 246, 'food')]
PMC4811107	3/2016	S12-PMC4811107	['the BEST EVIDENCE for the ROLE of Vitamin D in health is RELATED to its IMPORTANCE to bone health [1,2].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 72)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC4811107	3/2016	S16-PMC4811107	['GIVEN the IMPORTANT ROLE of Vitamin D in health, there has BEEN much discussion about the best ways to prevent and treat Vitamin D deficiency [3,6].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 59)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4811107	3/2016	S20-PMC4811107	['these analyses COULD identify Pregnant women who NEED a Prenatal Vitamin D intervention tailored to them BASED ON the various characteristics, as well as identifying children who MAY have a lower level of 25(Oh)D at Birth and MAY BE prioritized for Vitamin D screening.']	[('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 49), ('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 226)]	5	[('GO_0007565', 'female pregnancy', 30, 'pregnant'), ('GO_0007565', 'female pregnancy', 56, 'prenatal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('GO_0007567', 'parturition', 216, 'birth'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC4811107	3/2016	S97-PMC4811107	['EXAMINED WHETHER Prepregnancy obesity PREDICTED POOR Vitamin D status in neonates in their study of 400 women in pittsburgh, pennsylvania [7].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 38), ('IMPORTANT_CONSIDERATION', 48)]	4	[('GO_0007565', 'female pregnancy', 17, 'prepregnancy'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4811107	3/2016	S111-PMC4811107	['furthermore, children who are black and not firstborn and those Born to women with very low 25(Oh)D MAY identify a PRIORITY group for Vitamin D deficiency screening.']	[('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 115)]	2	[('GO_0007567', 'parturition', 64, 'born'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4811107	3/2016	S116-PMC4811107	['children who are not firstborn, those who are black, and those Born to women with very low 25(Oh)D MAY identify a PRIORITY group for Vitamin D deficiency screening.']	[('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 114)]	2	[('GO_0007567', 'parturition', 63, 'born'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 91, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC4811441	3/2016	S26-PMC4811441	['during the past decade, Vitamin D status has been ATTRIBUTED health BENEFITS beyond its RECOGNIZED EFFECTS on bone health.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 68), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 99)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC4811441	3/2016	S29-PMC4811441	['poorer Vitamin D status (measured as 25-Hydroxyvitamin D (25(Oh)D) during Pregnancy HAS BEEN ASSOCIATED with INCREASED RISKS of pe and Gestational hypertension in SOME [11,12] BUT NOT ALL observational studies [13,14].']	[('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 93), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 176), ('ANOMALY_CURIOUS_FINDING', 180)]	6	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 37, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007565', 'female pregnancy', 135, 'gestational')]
PMC4811441	3/2016	S141-PMC4811441	['THEREFORE, IT IS POSSIBLE that Vitamin D status in early Pregnancy MIGHT not play a MAJOR ROLE in Placental Development, but that an increment during Gestation MAY prevent the Development Of Pe.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 160)]	6	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('GO_0001890', 'placenta development', 98, 'placental development'), ('UBERON_0001987', 'placenta', 98, 'placental'), ('GO_0007565', 'female pregnancy', 150, 'gestation'), ('GO_0042494', 'detection of bacterial lipoprotein', 176, 'development of PE')]
PMC4811441	3/2016	S167-PMC4811441	['another STRENGTH is that Blood samples were taken in both early and late Pregnancy, enabling INVESTIGATION of changes in Vitamin D status in RELATION to pe and bp.']	[('IMPORTANT_CONSIDERATION', 8), ('FUTURE_WORK', 93), ('SUPERFICIAL_RELATIONSHIP', 141)]	3	[('UBERON_0000178', 'blood', 25, 'blood'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4829940	5/2016	S12-PMC4829940	['the MAJOR circulating form and indicator of Vitamin D status, 25-Hydroxyvitamin D (25(Oh)D), is supplied by 25-hydroxylation of Vitamin D produced in the skin upon uvb radiation or Vitamin D from the diet[1].']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 62, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 83, '25(OH)D'), ('CHEBI_33229', 'vitamin (role)', 128, 'vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 136, 'D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4829940	5/2016	S19-PMC4829940	['ALTHOUGH a NUMBER OF STUDIES have REPORTED inverse ASSOCIATIONS between maternal Vitamin D status and Postnatal health outcomes, systematic reviews SHOW that there is STILL substantial heterogeneity between studies in terms of methodology and results, and FEW or NO randomized TRIALS HAVE BEEN performed[6],[8],[10],[11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 148), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 256), ('FULL_UNKNOWN', 263), ('INCOMPLETE_EVIDENCE', 284)]	10	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'postnatal')]
PMC4843009	4/2016	S38-PMC4843009	['thus, kl/kl Mice and wild-type Mice were treated with Nh4Cl (280\u2009mm in drinking Water) and with either control diet or Vitamin D deficient diet, which HAS PREVIOUSLY BEEN shown to normalize Plasma 1,25(Oh)2D3Levels in kl/kl Mice55.']	[('IMPORTANT_CONSIDERATION', 151), ('INCOMPLETE_EVIDENCE', 155)]	2	[('NCBITaxon_10088', 'Mus <genus>', 12, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 31, 'mice'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 54, 'NH4Cl'), ('CHEBI_15377', 'water', 80, 'water'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 190, 'plasma'), ('CHEBI_17996', 'chloride', 198, ','), ('CHEBI_51467', 'PicoGreen', 199, '25(OH)2D3levels'), ('NCBITaxon_10088', 'Mus <genus>', 224, 'mice55')]
PMC4843009	4/2016	S114-PMC4843009	['the difference is abrogated by Vitamin D deficient diet, INDICATING that the excessive 1,25(oh)2d3formation in kl/kl Mice ACCOUNTED for the observed differences between Nh4Cl treated kl/kl Mice and wild-type Mice.']	[('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 122)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'mice'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 169, 'NH4Cl'), ('NCBITaxon_10088', 'Mus <genus>', 189, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 208, 'mice')]
PMC4843009	4/2016	S124-PMC4843009	['CONVERSELY Vitamin D supplementation decreases the RISK to develop psychotic-like symptoms44.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 51)]	2	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC4843009	4/2016	S132-PMC4843009	['in the presence of Klotho and Fgf23, the diet becomes CRITICALLY IMPORTANT only during Vitamin D deficiency.']	[('IMPORTANT_CONSIDERATION', 54), ('IMPORTANT_CONSIDERATION', 65)]	2	[('PR_000009306', 'kinesin-like protein KIF26B', 19, 'klotho'), ('PR_000007483', 'fibroblast growth factor 13', 30, 'FGF23'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC4846845	4/2016	S173-PMC4846845	['ACCUMULATING DATA SUPPORT that Vitamin D deficiency plays a ROLE in DISPARITIES in Reproductive health outcomes [132,134].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 68)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0000003', 'reproduction', 83, 'reproductive')]
PMC4848664	4/2016	S15-PMC4848664	['the institute of medicine (iom) conducted a comprehensive review of Folic Acid SAFETY and CONCLUDED that progression of neuropathy among Vitamin B-12-deficient Individuals receiving Folic Acid doses ≥5000 µg/day was a POTENTIAL adverse EFFECT of Folic Acid.']	[('IMPORTANT_CONSIDERATION', 79), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 218), ('SUPERFICIAL_RELATIONSHIP', 236)]	4	[('CHEBI_30751', 'formic acid', 68, 'folic acid'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 137, 'vitamin B-12'), ('NCBITaxon_1', 'root', 160, 'individuals'), ('CHEBI_30751', 'formic acid', 182, 'folic acid'), ('CHEBI_30751', 'formic acid', 246, 'folic acid')]
PMC4848664	4/2016	S132-PMC4848664	['the Folic Acid ul MAY BE MISINTERPRETED as an “upper limit”, but SHOULD ONLY BE CONSIDERED a tolerable upper intake level for Individuals with a Vitamin B-12 deficiency.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 25), ('FUTURE_WORK', 65), ('INCOMPLETE_EVIDENCE', 72), ('ANOMALY_CURIOUS_FINDING', 77), ('INCOMPLETE_EVIDENCE', 80)]	9	[('CHEBI_30751', 'formic acid', 4, 'folic acid'), ('NCBITaxon_1', 'root', 126, 'individuals'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin B')]
PMC4861121	5/2016	S74-PMC4861121	['micronutrient analysis REVEALED that, regarding SOME of the KEY Nutrients NECESSARY for a healthy Pregnancy, only 26% of women reached Folate recommendations, 0.9% reached Vitamin D recommendations, 36% met calcium recommendations and 17.6% met iron recommendations, from Food.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 60), ('IMPORTANT_CONSIDERATION', 74)]	4	[('CHEBI_33284', 'nutrient', 64, 'nutrients'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('CHEBI_30863', '5-azaorotic acid', 135, 'folate'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('CHEBI_33290', 'food', 272, 'food')]
PMC4874157	5/2016	S115-PMC4874157	['several other STUDIES SUGGEST that, WHENEVER POSSIBLE, Interferon Β treatment SHOULD BE discontinued prior to Conception.21–28HOWEVER, SIMILAR women in OTHER STUDIES continued to receive treatment modalities throughout Pregnancy.1015–19\ninitially, Vitamin D was given as a supplement to address the paucity women MAY SUFFER from during Pregnancy,29and to attend to the Vitamin D deficiency in the general lebanese population.30more RECENT STUDIES have also SHOWN that maintaining adequate levels of Vitamin D during Pregnancy MIGHT have a PROTECTIVE EFFECT and lower the risk of developing Postpartum relapses.31\npsychological support was CRUCIAL in maintaining the mental well-Being of the mother.32some women exhibited signs of anxiety and depression.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('INCOMPLETE_EVIDENCE', 45), ('FUTURE_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 313), ('IMPORTANT_CONSIDERATION', 317), ('INCOMPLETE_EVIDENCE', 432), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 539), ('SUPERFICIAL_RELATIONSHIP', 550), ('IMPORTANT_CONSIDERATION', 639)]	16	[('CHEBI_76163', 'isoxicam', 55, 'interferon β'), ('PR_000008918', 'interferon alpha-5', 55, 'interferon β'), ('GO_0007620', 'copulation', 110, 'conception'), ('GO_0007565', 'female pregnancy', 219, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('GO_0007565', 'female pregnancy', 336, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('GO_0007565', 'female pregnancy', 516, 'pregnancy'), ('GO_0007565', 'female pregnancy', 590, 'postpartum'), ('GO_0016441', 'posttranscriptional gene silencing', 677, '-being')]
PMC4877864	6/2015	S6-PMC4877864	['autistic children suffered INADEQUATE intake of some Micronutrients such as Vitamin D and c, calcium, Folate, magnesium, phosphorus, zinc, and iron, some DEFICIENCIES were highly significant ESPECIALLY at older age.']	[('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 154), ('ANOMALY_CURIOUS_FINDING', 191)]	3	[('CHEBI_33839', 'macromolecule', 53, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 102, 'folate')]
PMC4877864	6/2015	S83-PMC4877864	['furthermore, SEVERE Gestational Vitamin D deficiency in Rats produces pups with increased Brain size and enlarged Ventricles [23], Anatomical abnormalities SIMILAR TO those FOUND in autism [24].']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 156), ('INCOMPLETE_EVIDENCE', 173)]	3	[('GO_0007565', 'female pregnancy', 20, 'gestational'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 56, 'rats'), ('UBERON_0000955', 'brain', 90, 'brain'), ('UBERON_0002082', 'cardiac ventricle', 114, 'ventricles'), ('UBERON_0001062', 'anatomical entity', 131, 'anatomical')]
PMC4877864	6/2015	S84-PMC4877864	['maintaining Vitamin D sufficiency in utero and during early Life, to satisfy the Vitamin D receptor transcriptional activity in the Brain, MAY BE IMPORTANT for Brain Development as well as for maintenance of mental function later in Life [25].']	[('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 146)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0000104', 'life cycle', 60, 'life'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0000955', 'brain', 132, 'brain'), ('GO_0007420', 'brain development', 160, 'brain development'), ('UBERON_0000955', 'brain', 160, 'brain'), ('UBERON_0000104', 'life cycle', 233, 'life')]
PMC4889866	5/2016	S15-PMC4889866	['GIVEN the IMPORTANT Immune Modulatory ROLE of Vitamin D, the LINK between toll-like receptors- (tlrs-) mediated Innate Immunity and Vitamin D DESERVES in-depth INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 61), ('IMPORTANT_CONSIDERATION', 142), ('FUTURE_WORK', 160)]	6	[('GO_0051452', 'intracellular pH reduction', 20, 'immune modulatory'), ('UBERON_0002405', 'immune system', 20, 'immune'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0045087', 'innate immune response', 112, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4889866	5/2016	S20-PMC4889866	['furthermore, VERY FEW STUDIES address the IMPACT of Prenatal Vitamin D status on tlr-RELATED Innate Immune Response in neonatal infants.']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 85)]	4	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0045087', 'innate immune response', 93, 'innate immune response'), ('UBERON_0002405', 'immune system', 100, 'immune')]
PMC4889866	5/2016	S21-PMC4889866	['because of the APPARENT IMPORTANCE of Vitamin D in Immune Development, we AIMED TO INVESTIGATE the EFFECT of maternal and/or cord Vitamin D level on tlr-triggered cytokine response in neonates at time of Birth and disease outcome in early childhood.']	[('ANOMALY_CURIOUS_FINDING', 15), ('IMPORTANT_CONSIDERATION', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 99)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0001822', 'kidney development', 51, 'immune development'), ('UBERON_0002405', 'immune system', 51, 'immune'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007567', 'parturition', 204, 'birth')]
PMC4889866	5/2016	S91-PMC4889866	['the REASONS for various CONFLICTING results MIGHT be DUE TO DIFFERENCES in the study designs, age of the study population, definition of clinical outcomes, and also DISPARITIES in the assessment of Vitamin D concentration (use of maternal Blood or Cord Blood).']	[('PROBABLE_UNDERSTANDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 44), ('PROBLEM_COMPLICATION', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('IMPORTANT_CONSIDERATION', 165)]	7	[('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0000178', 'blood', 239, 'blood'), ('UBERON_0002240', 'spinal cord', 248, 'cord'), ('UBERON_0000178', 'blood', 253, 'blood')]
PMC4889866	5/2016	S92-PMC4889866	['our result SUGGESTED that the latter MIGHT be an IMPORTANT ISSUE to CONSIDER, BECAUSE DESPITE a strong CORRELATION between maternal and Cord Vitamin D level, OUR study had OBSERVED a distinction between maternal and cord Vitamin D status in their ASSOCIATION with tlr-triggered cytokine response.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 49), ('PROBLEM_COMPLICATION', 59), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 68), ('PROBLEM_COMPLICATION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ANOMALY_CURIOUS_FINDING', 86), ('SUPERFICIAL_RELATIONSHIP', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 158), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 247)]	13	[('UBERON_0002240', 'spinal cord', 136, 'cord'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
PMC4889866	5/2016	S93-PMC4889866	['THUS, when addressing the IMPACT of Prenatal Vitamin D status on various outcomes, it MIGHT be IMPORTANT to CONSIDER that Vitamin D levels in the Pregnant mothers and Cord Blood MIGHT not always correspond uniformly.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 86), ('IMPORTANT_CONSIDERATION', 95), ('FUTURE_WORK', 108), ('IMPORTANT_CONSIDERATION', 108), ('INCOMPLETE_EVIDENCE', 178)]	7	[('GO_0007565', 'female pregnancy', 36, 'prenatal'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnant'), ('UBERON_0002240', 'spinal cord', 167, 'cord'), ('UBERON_0000178', 'blood', 172, 'blood')]
PMC4889866	5/2016	S111-PMC4889866	['HOWEVER, in present analyses, ALBEIT an ASSOCIATION between maternal Vitamin D level and Viral Tlr-Triggered Il-10 Response, there was no effect on the PREVALENCE of infectious diseases during the first 12 months of Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ANOMALY_CURIOUS_FINDING', 30), ('SUPERFICIAL_RELATIONSHIP', 40), ('IMPORTANT_CONSIDERATION', 152)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('NCBITaxon_1', 'root', 89, 'viral'), ('GO_0033153', 'T cell receptor V(D)J recombination', 95, 'TLR-triggered ... -10 response'), ('PR_000001470', 'interleukin-28B', 109, 'IL-10'), ('UBERON_0000104', 'life cycle', 216, 'life')]
PMC4889866	5/2016	S116-PMC4889866	['SINCE the MAJORITY of our participants were Vitamin D deficient, IT IS POSSIBLE that higher Serum levels MIGHT be REQUIRED to reach optimal PROTECTIVE EFFECT to result in significant clinical DIFFERENCES.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 105), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192)]	9	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0001977', 'blood serum', 92, 'serum')]
PMC4889866	5/2016	S122-PMC4889866	['it has also LIMITED the applicability of our result in representing the general population, ALTHOUGH INADEQUATE Vitamin D concentration SEEMS PARTICULARLY common among Pregnant woman [3,19].']	[('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 92), ('IMPORTANT_CONSIDERATION', 101), ('ANOMALY_CURIOUS_FINDING', 136), ('ANOMALY_CURIOUS_FINDING', 142)]	5	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007565', 'female pregnancy', 168, 'pregnant')]
PMC4889866	5/2016	S123-PMC4889866	['in addition, having a majority of population with SUBOPTIMAL Vitamin D level, we were unable to perform analysis with commonly used clinical cut-offs of Vitamin D (deficient < 20\u2009ng/ml, insufficient 20–29.9\u2009ng/ml, sufficient ≥ 30\u2009ng/ml).']	[('IMPORTANT_CONSIDERATION', 50)]	1	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4889866	5/2016	S127-PMC4889866	['finally, ALTHOUGH PRESENT STUDY had OBSERVED an ASSOCIATION between Prenatal Vitamin D status and Viral tlrs-triggered response (Tlr3 and Tlr7/8, both of which recognize Viral rna), the EFFECT of Vitamin D on cpg Double Stranded dna motif (Tlr9) of the Viral Genome also DEMANDS FURTHER EXPLORATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 186), ('IMPORTANT_CONSIDERATION', 271), ('FUTURE_WORK', 279)]	7	[('GO_0007565', 'female pregnancy', 68, 'prenatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('NCBITaxon_1', 'root', 98, 'viral'), ('PR_000001155', 'Toll-like receptor 4', 129, 'TLR3'), ('PR_000001155', 'Toll-like receptor 4', 138, 'TLR7'), ('NCBITaxon_1', 'root', 170, 'viral'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('SO_0000985', 'double', 213, 'double stranded'), ('PR_000001155', 'Toll-like receptor 4', 240, 'TLR9'), ('NCBITaxon_1', 'root', 253, 'viral'), ('SO_0001026', 'genome', 259, 'genome')]
PMC4889866	5/2016	S131-PMC4889866	['THIS STUDY EMPHASIZED that EVEN THOUGH Cord Vitamin D level was STRONGLY CORRELATED with maternal Vitamin D status, the extent of IMPACT on fetal Immune Cytokine Response MIGHT be distinctive.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 11), ('IMPORTANT_CONSIDERATION', 11), ('ANOMALY_CURIOUS_FINDING', 27), ('ANOMALY_CURIOUS_FINDING', 32), ('PROBABLE_UNDERSTANDING', 64), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 171)]	9	[('UBERON_0002240', 'spinal cord', 39, 'cord'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0002250', 'adaptive immune response', 146, 'immune cytokine response'), ('UBERON_0002405', 'immune system', 146, 'immune')]
PMC4896250	4/2016	S2791-PMC4896250	['the GROWING DATA SUGGESTS that Vitamin D deficiency plays an IMPORTANT ROLE in the development of childhood asthma.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 61), ('SUPERFICIAL_RELATIONSHIP', 71)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC4896250	4/2016	S3018-PMC4896250	['FURTHER INVESTIGATIONS are NECESSARY to identify the RELATIONSHIPS between fia and Vitamin D.\n\nA210 TRIGGERING factors of atopic dermatitis by severity\n\nyoon ha hwang\n\nbusan st.mary’s hospital, south korea\nbackground : atopic dermatitis is exacerbated by several triggering factors, which are Allergens, stress, infections climates and so on.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 27), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 100)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('PR_000004050', 'ankyrin repeat domain-containing protein 6', 95, 'A210'), ('CHEBI_33663', 'cyclic hydrocarbon', 293, 'allergens')]
PMC4896250	4/2016	S3548-PMC4896250	['exclusively breastfed infants are especially vulnerable to Vitamin D deficiency DUE to their dependence on previous trans-Placental transfer of Vitamin D from the mother, dietary Vitamin D from Breast Milk and cutaneous Synthesis Of Vitamin D on exposure to sunlight.']	[('IMPORTANT_CONSIDERATION', 80)]	1	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0001987', 'placenta', 122, 'placental'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 194, 'breast milk'), ('GO_0030474', 'spindle pole body duplication', 220, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D')]
PMC4896250	4/2016	S3549-PMC4896250	['the worldwide EPIDEMIC of Vitamin D deficiency in Pregnancy and the low content of Vitamin D in Breast Milk UNDERLIE the high RISK of deficiency in exclusively Breastfed infants.']	[('IMPORTANT_CONSIDERATION', 14), ('SUPERFICIAL_RELATIONSHIP', 108), ('IMPORTANT_CONSIDERATION', 126)]	3	[('CHEBI_28384', 'vitamin K', 26, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 96, 'breast milk'), ('GO_0007567', 'parturition', 160, 'breastfed')]
PMC4896250	4/2016	S4149-PMC4896250	['emerging EVIDENCE has IMPLICATED Vitamin D as a CRITICAL REGULATOR of Immunity, playing a ROLE in both the innate and cell-Mediated Immune Systems.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 22), ('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 90)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007566', 'embryo implantation', 70, 'immunity'), ('GO_0007127', 'meiosis I', 123, 'mediated immune'), ('UBERON_0002405', 'immune system', 132, 'immune systems')]
PMC4896250	4/2016	S4159-PMC4896250	['conclusions: our results DEMONSTRATE that low Vitamin D levels MAY LINK to high hdm sensitization in patients with the SEVERE ad.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 119)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4896250	4/2016	S4160-PMC4896250	['FURTHER ELUCIDATION of the ROLE of Vitamin D in hdm sensitization MAY hold PROFOUND IMPLICATIONS for the prevention and treatment of ad.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 66), ('IMPORTANT_CONSIDERATION', 75), ('IMPORTANT_CONSIDERATION', 84)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4896250	4/2016	S4493-PMC4896250	['for PREVENTION and treatment of asthma, an intervention study in asthmatic children with low serum Vitamin D level, and a Vitamin D study ASSESSED the OPTIMAL delivery and safety of its supplementation IS NEEDED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 138), ('IMPORTANT_CONSIDERATION', 151), ('FUTURE_WORK', 202)]	4	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4896250	4/2016	S7531-PMC4896250	['result: the overall PREVALENCE rates of Vitamin D insufficiency (20 to 29 ng/ml) and deficiency (<20 ng/ml) were 64.1% and 18.4%.']	[('IMPORTANT_CONSIDERATION', 20)]	1	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4896250	4/2016	S8292-PMC4896250	['objective\nwe AIMED TO INVESTIGATE WHETHER Vitamin D insufficiency in asthmatic Adults ASSOCIATES with atopy, poor asthma Control, and more frequent Respiratory Tract infections, and WHETHER these patients CAN BENEFIT from Vitamin D supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 205), ('IMPORTANT_CONSIDERATION', 209)]	7	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 79, 'adults'), ('GO_0065007', 'biological regulation', 121, 'control'), ('UBERON_0000065', 'respiratory tract', 148, 'respiratory tract'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]
PMC4897157	5/2016	S91-PMC4897157	['in addition to its EFFECT on Calcium Homeostasis, Vitamin D has MAJOR EFFECTS on Innate and Adaptive Immunity, such that the INFLUENCE of Vitamin D on allergic diseases represents an area of significant interest.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('IMPORTANT_CONSIDERATION', 64), ('SUPERFICIAL_RELATIONSHIP', 70), ('SUPERFICIAL_RELATIONSHIP', 125)]	4	[('GO_0055073', 'cadmium ion homeostasis', 29, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007631', 'feeding behavior', 81, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 92, 'adaptive immunity'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC4897157	5/2016	S92-PMC4897157	['ALTHOUGH results are EQUIVOCAL, a CONSIDERABLE body of EVIDENCE SUGGESTS that Vitamin D has an IMPORTANT IMPACT on the progression of allergic diseases11).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4897157	5/2016	S94-PMC4897157	['the PREVALENCE of Vitamin D deficiency continues to increase12)and is particularly SEVERE during winter months, in which ultraviolet b rays are reduced13).']	[('IMPORTANT_CONSIDERATION', 4), ('IMPORTANT_CONSIDERATION', 83)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC4897157	5/2016	S117-PMC4897157	['in a Birth cohort study cord Blood 25(Oh)-Vitamin D deficiency was ASSOCIATED with INCREASED RISK of recurrent troublesome Lung symptoms till age 7 years, BUT SHOWED no association with Respiratory infection, asthma, or rhinitis21).']	[('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 83), ('ANOMALY_CURIOUS_FINDING', 155), ('INCOMPLETE_EVIDENCE', 159)]	4	[('GO_0007567', 'parturition', 5, 'birth'), ('UBERON_0000178', 'blood', 29, 'blood'), ('CHEBI_63056', 'zinc cation', 35, '25(OH'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002048', 'lung', 123, 'lung'), ('UBERON_0001004', 'respiratory system', 186, 'respiratory')]
PMC4897157	5/2016	S153-PMC4897157	['to CONFIRM the EFFECT of sun exposure during infancy on the development of Allergic Diseases, FURTHER prospective INVESTIGATIONS that measure Serum Vitamin D levels ARE REQUIRED.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('FUTURE_WORK', 94), ('FUTURE_WORK', 165), ('IMPORTANT_CONSIDERATION', 169)]	5	[('GO_0000381', 'regulation of alternative mRNA splicing, via spliceosome', 75, 'allergic diseases'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4897523	10/2014	S109-PMC4897523	['ON THE OTHER HAND, the involvement of maternal Vitamin D during Pregnancy in autism REQUIRES PROPER INVESTIGATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 84), ('FUTURE_WORK', 93)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy')]
PMC4903143	5/2016	S87-PMC4903143	['Vitamin D\nthere is general CONSENSUS in the medical literature that the Vitamin D status of many Individuals and population groups throughout much of the world (as reflected by population measurements of Serum 25(Oh)D levels) is INSUFFICIENT for OPTIMAL health [74].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('PROBABLE_UNDERSTANDING', 27), ('PROBLEM_COMPLICATION', 229), ('IMPORTANT_CONSIDERATION', 246)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_1', 'root', 97, 'individuals'), ('UBERON_0001977', 'blood serum', 204, 'serum'), ('CHEBI_71657', 'versiconol acetate', 210, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 210, '25(OH ... D')]
PMC4903143	5/2016	S88-PMC4903143	['Pregnant women screened in ONE STUDY in western canada, for example, DEMONSTRATED that the majority of women in one city had clearly INADEQUATE Vitamin D levels [75].']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 69), ('IMPORTANT_CONSIDERATION', 133)]	3	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC4903143	5/2016	S91-PMC4903143	['recognition of THE BURDEN of health sequelae resulting from low maternal Vitamin D concentrations continues to expand (tables1and2).']	[('IMPORTANT_CONSIDERATION', 15)]	1	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4903143	5/2016	S99-PMC4903143	['with ABUNDANT EVIDENCE of myriad health sequelae ASSOCIATED with Gestational Vitamin D deficiency, there is POTENTIAL for CONSIDERABLE amelioration of maternal and fetal health outcomes by educational and healthcare measures in the Preconception and Prenatal period to secure Vitamin D sufficiency throughout Gestation [76].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 122)]	4	[('GO_0007565', 'female pregnancy', 65, 'gestational'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 232, 'preconception'), ('GO_0007565', 'female pregnancy', 250, 'prenatal'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('GO_0007565', 'female pregnancy', 309, 'gestation')]
PMC4903143	5/2016	S100-PMC4903143	['because of widespread Vitamin D INSUFFICIENCY in many population groups and INCONSISTENT response to fixed doses of Vitamin D supplementation, the authors RECOMMEND testing for 25(Oh)d levels and SUITABLE intervention as REQUIRED [76].']	[('IMPORTANT_CONSIDERATION', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('FUTURE_WORK', 155), ('IMPORTANT_CONSIDERATION', 196), ('IMPORTANT_CONSIDERATION', 221)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 177, '25(OH)')]
PMC4908484	6/2016	S14-PMC4908484	['moreover, Vitamin D is a regulator of Brain Cell Proliferation and Differentiation, and has an ESSENTIAL ROLE in the Brain Development (chopp et\xa0al.2007; stewart et\xa0al.2010) and Neurotransmitter Synthesis (tetich et\xa0al.2004).']	[('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CL_0000359', 'vascular associated smooth muscle cell', 38, 'brain cell'), ('UBERON_0000955', 'brain', 38, 'brain'), ('GO_0030154', 'cell differentiation', 44, 'cell proliferation ... differentiation'), ('GO_0007420', 'brain development', 117, 'brain development'), ('UBERON_0000955', 'brain', 117, 'brain'), ('CHEBI_25512', 'neurotransmitter', 178, 'neurotransmitter'), ('GO_0042136', 'neurotransmitter biosynthetic process', 178, 'neurotransmitter synthesis')]
PMC4910734	6/2015	S133-PMC4910734	['autistic children are NOTORIOUS picky eaters, leading to SOME DOCUMENTED DEFICIENCIES in individual case STUDIES, such as Vitamin A deficiencies.53nutritional status based on dietary record keeping, not surprisingly, gives CONFLICTING results,118in PART BECAUSE autistic children OFTEN SUFFER from Gastrointestinal mal-absorption PROBLEMS77OR BECAUSE Genetic factors MAY play a ROLE in nutritional deficiency.']	[('IMPORTANT_CONSIDERATION', 22), ('IMPORTANT_CONSIDERATION', 22), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 73), ('INCOMPLETE_EVIDENCE', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 223), ('SUPERFICIAL_RELATIONSHIP', 249), ('PROBABLE_UNDERSTANDING', 254), ('PROBABLE_UNDERSTANDING', 280), ('IMPORTANT_CONSIDERATION', 286), ('IMPORTANT_CONSIDERATION', 330), ('PROBABLE_UNDERSTANDING', 343), ('INCOMPLETE_EVIDENCE', 367), ('SUPERFICIAL_RELATIONSHIP', 378)]	15	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 298, 'gastrointestinal'), ('SO_0000704', 'gene', 351, 'genetic')]
PMC4910734	6/2015	S243-PMC4910734	['additionally, Sulfur-containing antioxidants, such as Taurine and Nac, are superior to Vitamin C and form the ESSENTIAL core of any supplementation plan to counteract Aldehyde toxicity or oxidative stress.L-Carnitine, BUT NOT Acetyl-Carnitine, is LIKELY beneficial for many and can be included.']	[('IMPORTANT_CONSIDERATION', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 218), ('PROBABLE_UNDERSTANDING', 247)]	3	[('CHEBI_36933', 'oxygen-19 atom', 14, 'sulfur'), ('CHEBI_15891', 'taurine', 54, 'taurine'), ('CHEBI_7421', 'NAC', 66, 'NAC'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin C'), ('CHEBI_17478', 'aldehyde', 167, 'aldehyde'), ('CHEBI_86085', '(Z)-p-coumaroylagmatine', 205, 'l-carnitine'), ('CHEBI_17387', 'O-acylcarnitine', 226, 'acetyl-carnitine')]
PMC4929134	8/2016	S100-PMC4929134	['DEFICIENCIES in Vitamin A (Retinol\xa0<\xa00.7\xa0μmol/l), Vitamin D (25(Oh)D\xa0<\xa050\xa0nmol/l), Folate (Folic Acid\xa0<\xa013.6\xa0nmol/l), Vitamin B12 (cobalamin\xa0<\xa0150\xa0pmol/l), and iron (Transferrin Receptor to ferritin ratio\xa0>\xa0500\xa0μg/μg) were present in 8.4, 18.5, 6.4, 20.1, and 11.6% of children using conventional cut-offs (schulze et al.']	[('IMPORTANT_CONSIDERATION', 0)]	1	[('CHEBI_27300', 'vitamin D', 16, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 27, 'retinol'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 61, '25(OH)D'), ('CHEBI_30863', '5-azaorotic acid', 83, 'folate'), ('CHEBI_30751', 'formic acid', 91, 'folic acid'), ('CHEBI_33279', 'vitamin D5', 118, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 118, 'vitamin B12'), ('PR_000001679', 'trace amine-associated receptor 5', 166, 'transferrin receptor')]
PMC4930210	7/2016	S8-PMC4930210	['conclusions\nwe DEMONSTRATED the current rda (600 iu/ day) MAY not be adequate to achieve Vitamin D status >75 nmol/l in SOME Pregnant women who are residing in higher latitudes (calgary, 51°n) in alberta, canada and the current Vitamin D RECOMMENDATIONS for canadian Pregnant women NEED TO be re-evaluated.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 120), ('FUTURE_WORK', 238), ('IMPORTANT_CONSIDERATION', 282)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('GO_0007565', 'female pregnancy', 267, 'pregnant')]
PMC4930210	7/2016	S9-PMC4930210	['introduction\nVitamin D plays an IMPORTANT ROLE in promoting healthy Pregnancy and Fetal Development, and POOR Vitamin D status HAS BEEN ASSOCIATED with adverse maternal and infant health [1].']	[('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 105), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 136)]	5	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0007608', 'sensory perception of smell', 68, 'pregnancy ...'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 82, 'fetal development'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4930210	7/2016	S10-PMC4930210	['there is also EVIDENCE that Pregnancy RISKS MAY BE mitigated by Vitamin D supplementation, ALTHOUGH the optimal daily dose is NOT CLEAR [2].']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 38), ('INCOMPLETE_EVIDENCE', 44), ('ANOMALY_CURIOUS_FINDING', 91), ('FULL_UNKNOWN', 126)]	5	[('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4930210	7/2016	S19-PMC4930210	['a combined analysis of two randomized clinical trials of 494 Pregnant women taking 400, 2000, and 4000 iu/day Vitamin D during Pregnancy SHOWED that Vitamin D supplementation of 4000 iu/day was more EFFECTIVE in achieving Serum concentrations ≥ 80 nmol/l than 400 and 2000 iu/day in all women and their neonates REGARDLESS OF race, SUGGESTING that the current dietary RECOMMENDATION in the absence of supplementation in Pregnancy MAY not be OPTIMAL [9].']	[('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 199), ('INCOMPLETE_EVIDENCE', 312), ('INCOMPLETE_EVIDENCE', 332), ('FUTURE_WORK', 368), ('INCOMPLETE_EVIDENCE', 430), ('IMPORTANT_CONSIDERATION', 441)]	7	[('GO_0007565', 'female pregnancy', 61, 'pregnant'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('GO_0007565', 'female pregnancy', 420, 'pregnancy')]
PMC4930210	7/2016	S23-PMC4930210	['the BEST clinical laboratory INDICATOR of Vitamin D status is the Blood concentration of 25(Oh)D [4].']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 29)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0000178', 'blood', 66, 'blood'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 95, 'D')]
PMC4930210	7/2016	S129-PMC4930210	['in northern countries such as canada, the latitude of the country further reduces the POTENTIAL CONTRIBUTION of dermal synthesis to the maintenance of appropriate Vitamin D concentrations, placing women at greater RISK for Vitamin D deficiency/ insufficiency [21,22].']	[('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 96), ('IMPORTANT_CONSIDERATION', 214)]	3	[('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D')]
PMC4930210	7/2016	S135-PMC4930210	['OUR FINDINGS are SUPPORTIVE of a GROWING body of LITERATURE SUGGESTING that the RECOMMENDED dose of Vitamin D during Pregnancy is INADEQUATE in preventing Vitamin D deficiency/insufficiency [26].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 60), ('FUTURE_WORK', 80), ('IMPORTANT_CONSIDERATION', 130), ('PROBLEM_COMPLICATION', 130)]	8	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4930210	7/2016	S139-PMC4930210	['one STRENGTH of THE CURRENT STUDY is its use of a quantification method capable of ACCURATELY measuring 25(Oh)D (separating epimer) and adding the potential CONTRIBUTION of dietary Vitamin D to the total intake ESTIMATE.']	[('IMPORTANT_CONSIDERATION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 83), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 211)]	5	[('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 104, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4930210	7/2016	S147-PMC4930210	['THESE FINDINGS EMPHASIZE THE NEED for FURTHER identification of the functional ROLE and clinical SIGNIFICANCE of 3-Epi-25(Oh)D3In the assessment of Vitamin D status in Pregnant women, given the fact that the cut-off for Vitamin D sufficiency in Pregnancy is UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 15), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 29), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 97), ('FULL_UNKNOWN', 258)]	8	[('CHEBI_15616', '(3S,5S)-3,5-diaminohexanoic acid', 113, '3-epi-25(OH)D3in'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 125, 'D3in'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('GO_0007565', 'female pregnancy', 168, 'pregnant'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy')]
PMC4930210	7/2016	S157-PMC4930210	['HOWEVER, given that Vitamin D from Foods in canada makes such a small overall CONTRIBUTION to Vitamin D dietary Intake (table 3), the accuracy of the 24-hour recalls is LESS CRITICAL in estimating women’s total Vitamin D intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 169), ('IMPORTANT_CONSIDERATION', 174)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_33290', 'food', 35, 'foods'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007631', 'feeding behavior', 112, 'intake'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC4930210	7/2016	S160-PMC4930210	['STUDIES [34,35] HAVE SHOWN that ultraviolet radiation (uvr)-derived Vitamin D is an IMPORTANT FACTOR in 25(Oh)D3Concentration.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 94)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 104, '25(OH)D3concentration'), ('PR_000006744', 'dual specificity protein phosphatase 18', 110, 'D3concentration')]
PMC4934634	11/2015	S8-PMC4934634	['introduction\nWHILE the beneficial EFFECTS of Vitamin D supplementation with respect to reducing the RISK of rickets HAS BEEN recognized for close to 100 years, there is increasing concern that rickets in young children is reemerging in numerous countries [1,2].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('SUPERFICIAL_RELATIONSHIP', 34), ('IMPORTANT_CONSIDERATION', 100), ('INCOMPLETE_EVIDENCE', 116)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC4934634	11/2015	S10-PMC4934634	['over the past two decades, it HAS BEEN WELL ACCEPTED that Vitamin D is a pro-hormone, and suboptimal Vitamin D status HAS been increasingly LINKED to a broad range of diseases including, cancer, diabetes, Cardiovascular disease, and Autoimmune disorders.']	[('INCOMPLETE_EVIDENCE', 30), ('FUTURE_WORK', 39), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 44), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 140)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 205, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 233, 'autoimmune')]
PMC4934634	11/2015	S19-PMC4934634	['rickets will not be discussed in this review (readers are referred to a review on this topic by elder and bishop, 2014 [5]) as this paper is FOCUSED on RECENT LITERATURE regarding the IMPORTANCE of maternal Vitamin D status on Pregnancy and infant outcomes, with an EMPHASIS on supplementation trials.healthcare-03-01097-t001_table 1\n\ncaption (table-wrap): table 1\n\ndesignation of Vitamin D status based on circulating Vitamin D levels by the u.s. institute of medicine (iom) and the Endocrine society.Vitamin D statusiomendocrine societydeficiency<12 ng/ml (30 nmol/l)<20 ng/ml (50 nmol/l)insufficiency12–20 ng/ml (30–50 nmol/l)21–29 ng/ml (52.5–72.5 nmol/l)sufficiency>20 ng/ml (50 nmol/l)>30 ng/ml (75 nmol/l)toxicity>50 ng/ml (125 nmol/l)>150 ng/ml (375 nmol/l)\n\n2.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 141), ('INCOMPLETE_EVIDENCE', 152), ('IMPORTANT_CONSIDERATION', 184), ('IMPORTANT_CONSIDERATION', 266)]	4	[('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('GO_0007565', 'female pregnancy', 227, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 419, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 484, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 502, 'Vitamin D')]
PMC4934634	11/2015	S30-PMC4934634	['GIVEN the above it HAS BEEN ARGUED that obese Individuals are a population that is at an INCREASED RISK for Vitamin D deficiency [3,8].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 89)]	4	[('NCBITaxon_1', 'root', 46, 'individuals'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4934634	11/2015	S33-PMC4934634	['there are two forms of Vitamin D that are IMPORTANT in Humans.']	[('IMPORTANT_CONSIDERATION', 42)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 55, 'humans')]
PMC4934634	11/2015	S53-PMC4934634	['vdr and enzymes NECESSARY for Vitamin D Metabolism HAVE BEEN FOUND in male Testis, mature Spermatozoa, and the Ejaculatory Tract SUGGESTING an IMPORTANT ROLE of this Vitamin in Male Fertility [19].']	[('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 143), ('SUPERFICIAL_RELATIONSHIP', 153)]	5	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 30, 'vitamin D metabolism'), ('UBERON_0000473', 'testis', 75, 'testis'), ('CL_0000019', 'sperm', 90, 'spermatozoa'), ('UBERON_0002649', 'dorsolateral fasciculus of medulla', 111, 'ejaculatory tract'), ('CHEBI_33229', 'vitamin (role)', 166, 'vitamin'), ('GO_0007141', 'male meiosis I', 177, 'male fertility')]
PMC4934634	11/2015	S81-PMC4934634	['this FINDING COULD IMPACT doctor’s RECOMMENDATION of what are CONSIDERED OPTIMAL Vitamin D levels when women of different ethnic groups undergo ivf.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 19), ('FUTURE_WORK', 35), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 73)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4934634	11/2015	S94-PMC4934634	['these data FURTHER ILLUSTRATE HOW DIFFERENT cut-offs used by the iom vs. endocrine society for defining Vitamin D status (table 1) INFLUENCES the reporting of Vitamin D deficiency PREVALENCE in the population.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('EXPLICIT_QUESTION', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 131), ('IMPORTANT_CONSIDERATION', 180)]	6	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4934634	11/2015	S109-PMC4934634	['Gestational diabetes\nthe IMPACT of Vitamin D on vascular health and Glucose Control CAN LIKEWISE TRANSLATE to adverse EFFECTS of Vitamin D deficiency on Pregnancy outcomes including an INCREASED risk for Gestational diabetes and Preeclampsia.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 97), ('SUPERFICIAL_RELATIONSHIP', 118), ('IMPORTANT_CONSIDERATION', 185)]	6	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_28384', 'vitamin K', 35, 'Vitamin D'), ('CHEBI_17234', 'glucose', 68, 'glucose'), ('GO_0046323', 'glucose import', 68, 'glucose control'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'gestational'), ('GO_0007128', 'meiotic prophase I', 229, 'preeclampsia')]
PMC4934634	11/2015	S142-PMC4934634	['it SHOULD BE NOTED that OTHER STUDIES have FAILED TO CONFIRM OBSERVATIONS that lower 25(Oh)D status is ASSOCIATED with the occurrence of Preeclampsia, and it is STILL UNCLEAR WHETHER suboptimal Vitamin D status is a cause, OR an EFFECT, of preeclampsia [55,56].']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('ANOMALY_CURIOUS_FINDING', 43), ('DIFFICULT_TASK', 43), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 103), ('FULL_UNKNOWN', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('SUPERFICIAL_RELATIONSHIP', 229)]	14	[('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 137, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4934634	11/2015	S163-PMC4934634	['WHILE Serum Vitamin D levels improved in the intervention group, ONLY 15% of the women obtained levels of ≥30 ng/ml (Endocrine society cut-off for Vitamin D sufficiency) DUE to severely low baseline 25(Oh)D levels in this population (3–9 ng/ml).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 65), ('IMPORTANT_CONSIDERATION', 170), ('IMPORTANT_CONSIDERATION', 170)]	4	[('UBERON_0001977', 'blood serum', 6, 'serum'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 117, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 199, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 199, '25(OH ... D')]
PMC4934634	11/2015	S177-PMC4934634	['THUS it COULD BE ARGUED that adequate Maternal-fetal transfer of Vitamin D in utero and early Infancy is IMPORTANT for Life-long optimal health.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 105)]	4	[('GO_0007618', 'mating', 38, 'maternal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0000023', 'wing', 94, 'infancy'), ('UBERON_0000104', 'life cycle', 119, 'life')]
PMC4934634	11/2015	S180-PMC4934634	['if women PLAN to exclusively Breast Feed their baby, it is IMPORTANT for mothers to have adequate Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('IMPORTANT_CONSIDERATION', 59)]	2	[('GO_0007596', 'blood coagulation', 29, 'breast feed'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4934634	11/2015	S234-PMC4934634	['STILL, SOME professionals fear that with the increase in supplementation rates, there COULD BE a rise in Vitamin D toxicity.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 86)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4934634	11/2015	S261-PMC4934634	['ALTHOUGH both single and daily doses of Vitamin D3Seem to be SAFE, CAUTION SHOULD BE CONSIDERED when supplementing at these high doses in Pregnant women, PARTICULARLY if baseline Vitamin D status is sufficient.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 61), ('FUTURE_WORK', 67), ('INCOMPLETE_EVIDENCE', 67), ('FUTURE_WORK', 75), ('FUTURE_WORK', 85), ('ANOMALY_CURIOUS_FINDING', 154), ('IMPORTANT_CONSIDERATION', 154)]	8	[('CHEBI_64387', 'thiosultap(1-)', 40, 'vitamin D3seem'), ('GO_0007565', 'female pregnancy', 138, 'pregnant'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4934634	11/2015	S265-PMC4934634	['it is not COMPLETELY known HOW large, acute increases in circulating 25(Oh)D levels immediately following supplementation CAN AFFECT a fetus/infant, who are VULNERABLE to Vitamin D toxicity at this time in development.']	[('PROBABLE_UNDERSTANDING', 10), ('EXPLICIT_QUESTION', 27), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 126), ('IMPORTANT_CONSIDERATION', 157)]	5	[('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 69, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC4934634	11/2015	S266-PMC4934634	['as PREVIOUSLY mentioned, short-term studies GENERALLY AGREE with its SAFETY BUT long-term STUDIES ARE NEEDED to address the QUESTION of WHETHER large bolus Vitamin D supplementation during Pregnancy is ASSOCIATED with any adverse health outcomes in the offspring later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 44), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('FUTURE_WORK', 90), ('EXPLICIT_QUESTION', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('EXPLICIT_QUESTION', 136), ('SUPERFICIAL_RELATIONSHIP', 202)]	10	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('UBERON_0000104', 'life cycle', 272, 'life')]
PMC4934634	11/2015	S291-PMC4934634	['with large percentages of Individuals having INSUFFICIENT Vitamin D levels, this RAISES the QUESTION of WHETHER fortification EFFORTS SHOULD BE increased.']	[('IMPORTANT_CONSIDERATION', 45), ('EXPLICIT_QUESTION', 81), ('EXPLICIT_QUESTION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104), ('EXPLICIT_QUESTION', 104), ('FUTURE_WORK', 126), ('FUTURE_WORK', 134)]	7	[('NCBITaxon_1', 'root', 26, 'individuals'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4934634	11/2015	S292-PMC4934634	['MANY countries currently mandate the fortification of certain Foods with Vitamin D, e.g., 100 iu/cup milk in the united states, 30–45 iu/ 100 ml Milk in canada, and edible oil spreads (Margarine) in australia, HOWEVER, a large proportion of dietary intakes are STILL below RECOMMENDED levels [100,101].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 210), ('IMPORTANT_CONSIDERATION', 261), ('FUTURE_WORK', 273)]	4	[('CHEBI_33290', 'food', 62, 'foods'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001913', 'milk', 145, 'milk'), ('CHEBI_6784', 'mestranol', 185, 'margarine')]
PMC4934634	11/2015	S302-PMC4934634	['among the changes, is the REQUIREMENT that manufacturers declare the amount of Vitamin D on the label, AS it is one of the new “Nutrients of public health significance” based on nhanes dietary intake data [106].']	[('IMPORTANT_CONSIDERATION', 26), ('PROBABLE_UNDERSTANDING', 103)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_33284', 'nutrient', 128, 'nutrients')]
PMC4934634	11/2015	S306-PMC4934634	['WHILE the ESSENTIALITY of adequate Vitamin D during Pregnancy is not DISPUTED, CONTROVERSY exists over the RECOMMENDED dietary intake levels, the mathematical approaches to calculating that level, and the endpoints used to determine REQUIREMENTS; the concentrations of circulating 25(Oh)D that denote deficiency, insufficiency and adequacy status; and WHETHER race, body weight or OTHER factors SHOULD BE TAKEN into account when making dietary RECOMMENDATIONS, similarly, it is NOT CLEAR WHAT Vitamin D supplementation regimens are most EFFECTIVE during Pregnancy; WHETHER mother, child OR both SHOULD BE supplemented; and WHETHER there are long-term CONSEQUENCES of supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 233), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 381), ('FUTURE_WORK', 395), ('IMPORTANT_CONSIDERATION', 405), ('FUTURE_WORK', 444), ('FULL_UNKNOWN', 478), ('EXPLICIT_QUESTION', 488), ('SUPERFICIAL_RELATIONSHIP', 537), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 565), ('FUTURE_WORK', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 623), ('PROBLEM_COMPLICATION', 651)]	18	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 281, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 281, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 493, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnancy')]
PMC4944244	7/2016	S0-PMC4944244	['risk factors for Antenatal hypovitaminosis d in an urban district in malaysia\n\nabstract\n\nbackground\nPregnant women form one of the HIGH RISK groups facing hypovitaminosis d. low level of Vitamin D will AFFECT directly OR indirectly both mother and fetus.']	[('IMPORTANT_CONSIDERATION', 131), ('SUPERFICIAL_RELATIONSHIP', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 218)]	3	[('GO_0007567', 'parturition', 17, 'antenatal'), ('GO_0007565', 'female pregnancy', 100, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC4944244	7/2016	S1-PMC4944244	['screening Vitamin D in the first Trimester of Pregnancy is IMPORTANT to determine the NECESSARY preventive action.']	[('IMPORTANT_CONSIDERATION', 59), ('IMPORTANT_CONSIDERATION', 86)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 33, 'trimester'), ('GO_0007565', 'female pregnancy', 46, 'pregnancy')]
PMC4944244	7/2016	S9-PMC4944244	['conclusion\nawareness SHOULD BE raised among malay and indian Pregnant women with secondary and tertiary education who consumed Vitamin D (ESPECIALLY milk) poorly in order to prevent adverse health outcomes.']	[('FUTURE_WORK', 21), ('IMPORTANT_CONSIDERATION', 138)]	2	[('GO_0007565', 'female pregnancy', 61, 'pregnant'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4944244	7/2016	S10-PMC4944244	['FURTHER STUDIES NEED TO BE conducted among health care workers to determine their level of knowledge RELATED to Vitamin D, AS they are front liner in detecting the hypovitaminosis d.\n\nbackground\nmalaysia is rich with sunshine, a MAJOR source of Vitamin D. HOWEVER, a study by moy [1] among a cohort of malays SHOWED that 67.9\xa0% had insufficient Vitamin D especially in women, with Serum mean concentration of 25(Oh)D of 36.2\u2009±\u200913.4\xa0nmol/l in women and 56.2\u2009±\u200918.9\xa0nmol/l in men.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 101), ('PROBABLE_UNDERSTANDING', 123), ('IMPORTANT_CONSIDERATION', 229), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('INCOMPLETE_EVIDENCE', 309)]	7	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0001977', 'blood serum', 381, 'serum'), ('CHEBI_71657', 'versiconol acetate', 409, '25(OH)D')]
PMC4944244	7/2016	S19-PMC4944244	['attention also MUST BE given to those who have dark skin, less skin exposed to sunlight and obese because they have a higher RISK of Vitamin D deficiency warranting Vitamin D supplement, mainly during Pregnancy and Lactation [11].']	[('IMPORTANT_CONSIDERATION', 15), ('IMPORTANT_CONSIDERATION', 125)]	2	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 201, 'pregnancy'), ('GO_0007595', 'lactation', 215, 'lactation')]
PMC4944244	7/2016	S24-PMC4944244	['three IMPORTANT sources of Vitamin D are sunlight, Vitamin D supplements and Food.']	[('IMPORTANT_CONSIDERATION', 6)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_33290', 'food', 77, 'food')]
PMC4944244	7/2016	S27-PMC4944244	['healthcare workers USUALLY ENCOURAGE Pregnant women to increase calcium intake BUT they are LESS AWARE that without sufficient Vitamin D, calcium intake will not have much EFFECT ESPECIALLY during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 97), ('SUPERFICIAL_RELATIONSHIP', 172), ('ANOMALY_CURIOUS_FINDING', 179)]	8	[('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 197, 'pregnancy')]
PMC4944244	7/2016	S28-PMC4944244	['THEREFORE, it is NECESSARY to determine the PREVALENCE of hypovitaminosis D among Pregnant women and assess its risk FACTORS to overcome the PROBLEMS caused by lack of Vitamin D.\n\nmethods\n\nsubjects and sampling\na cross-sectional study was conducted in petaling district, selangor.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 44), ('SUPERFICIAL_RELATIONSHIP', 117), ('IMPORTANT_CONSIDERATION', 141), ('PROBLEM_COMPLICATION', 141)]	6	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 74, 'D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4944244	7/2016	S100-PMC4944244	['this is IN LINE WITH OUR STUDY, where the PREVALENCE of hypovitaminosis D (25 (Oh) D Serum <50\xa0nmol/l) in the first trimester was high (90.4\xa0%) and only 11.1\xa0% took supplements containing Vitamin D. moreover, most of them had just started the Supplements and the results MAY not have AFFECTED their Vitamin D status yet.']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('IMPORTANT_CONSIDERATION', 42), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 284)]	5	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 72, 'D'), ('CHEBI_71657', 'versiconol acetate', 75, '25 (OH) D'), ('PR_000003010', 'moesin isoform 1', 78, '(OH ... D'), ('UBERON_0001977', 'blood serum', 85, 'serum'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 243, 'supplements'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC4944244	7/2016	S116-PMC4944244	['in the second Trimester, there were two FACTORS that PREDICT INADEQUATE Vitamin D, namely not taking Antenatal Vitamins (or 4.28; 95\xa0% ci: 1.33–13.75; p \u2009<\u20090.05) and inadequate Serum Vitamin D levels in the first Trimester (or 5.10; 95\xa0% ci: 1.93–13.47; p \u2009<\u20090.01).']	[('SUPERFICIAL_RELATIONSHIP', 40), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 61)]	3	[('GO_0009294', 'DNA mediated transformation', 14, 'trimester'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007567', 'parturition', 101, 'antenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 111, 'vitamins'), ('UBERON_0001977', 'blood serum', 177, 'serum'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 213, 'trimester')]
PMC4944244	7/2016	S119-PMC4944244	['HOWEVER, 20 Pregnant women who consumed Antenatal Vitamins with Vitamin D at least 400\xa0iu/day still had INADEQUATE Vitamin D levels in the third trimester [22].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 104)]	3	[('GO_0007565', 'female pregnancy', 12, 'pregnant'), ('GO_0007567', 'parturition', 40, 'antenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 50, 'vitamins'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4944244	7/2016	S212-PMC4944244	['certain Dress code and sun block had limited the ability of the skin to synthesize Vitamin D.\nVitamin D Intake from Food is one of the MODIFIABLE FACTORS that CAN reduce the RISK of hypovitaminosis d. a total of 55.1\xa0% of respondents have met the malaysian recommended Nutrient intakes (rni) for Vitamin D in Pregnant women which REQUIRE Intake of 5\xa0μg (200\xa0iu) per day [38,39] (table\xa01).']	[('IMPORTANT_CONSIDERATION', 135), ('SUPERFICIAL_RELATIONSHIP', 146), ('INCOMPLETE_EVIDENCE', 159), ('IMPORTANT_CONSIDERATION', 174), ('IMPORTANT_CONSIDERATION', 330)]	5	[('UBERON_0001348', 'brown adipose tissue', 8, 'dress'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('CHEBI_28384', 'vitamin K', 94, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 104, 'intake'), ('CHEBI_33290', 'food', 116, 'food'), ('CHEBI_33284', 'nutrient', 269, 'Nutrient'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D'), ('GO_0007565', 'female pregnancy', 309, 'pregnant'), ('GO_0007631', 'feeding behavior', 338, 'intake')]
PMC4944244	7/2016	S213-PMC4944244	['ALTHOUGH over half of respondents had met the rni for Vitamin D (≥200\xa0iu/day), many respondents STILL had Serum 25(Oh)D\u2009<\u200950\xa0nmol/l.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 96), ('IMPORTANT_CONSIDERATION', 96)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_71657', 'versiconol acetate', 112, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 112, '25(OH ... D')]
PMC4944244	7/2016	S225-PMC4944244	['finally, AWARENESS of high PREVALENCE and DANGERS of hypovitaminosis d during Pregnancy NEEDS TO be highlighted to health care workers so that they are better informed of FACTORS INFLUENCING Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 9), ('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 42), ('FUTURE_WORK', 88), ('SUPERFICIAL_RELATIONSHIP', 171), ('SUPERFICIAL_RELATIONSHIP', 179)]	6	[('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4944244	7/2016	S229-PMC4944244	['dietary Intake of Food containing Vitamin D was found to reduce hypovitaminosis D. nutrition education NEEDS TO BE EMPHASIZED among Pregnant women, ESPECIALLY those of malay and indian ethnicity, who Consume little or no milk, and those who work at desk jobs as INDICATED by high education levels.']	[('FUTURE_WORK', 103), ('IMPORTANT_CONSIDERATION', 109), ('IMPORTANT_CONSIDERATION', 148), ('INCOMPLETE_EVIDENCE', 262)]	4	[('GO_0007631', 'feeding behavior', 8, 'intake'), ('CHEBI_33290', 'food', 18, 'food'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 80, 'D'), ('GO_0007565', 'female pregnancy', 132, 'pregnant'), ('GO_0007631', 'feeding behavior', 200, 'consume')]
PMC4944244	7/2016	S230-PMC4944244	['FURTHER STUDIES NEED TO BE conducted among health care staff to assess the level of knowledge RELATED to Vitamin D. in addition, THIS RESEARCH AIMED to create the AWARENESS on the IMPORTANCE of Vitamin D to patient.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 129), ('QUESTION_ANSWERED_BY_THIS_WORK', 143), ('IMPORTANT_CONSIDERATION', 163), ('IMPORTANT_CONSIDERATION', 180)]	7	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4949006	7/2016	S138-PMC4949006	['Vitamin D\nadequate Vitamin D status during Pregnancy is NECESSARY to ensure appropriate maternal responses to the calcium demands of the fetus for bone Mineral accretion.']	[('IMPORTANT_CONSIDERATION', 56)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('CHEBI_46662', 'mineral', 152, 'mineral')]
PMC4949006	7/2016	S145-PMC4949006	['HOWEVER, when Vitamin D deficiency is identified during Pregnancy, supplementation with up to 1000 to 2000 iu/d is CONSIDERED SAFE by MOST EXPERTS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 115), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 134), ('PROBABLE_UNDERSTANDING', 139)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnancy')]
PMC4949006	7/2016	S147-PMC4949006	['it HAS BEEN IDENTIFIED as a Nutrient of PUBLIC HEALTH CONCERN by the us department of health and Human services.104\nNUMEROUS STUDIES HAVE SHOWN a prevalence of vitamin d levels of less than 50 nmol/l in 30% to 96% of Pregnant women, increasing with latitude and with nonwhite race.105–111a study done using archived samples of Cord Blood in denmark SHOWED an increased risk of developing schizophrenia with either elevated or low levels of Vitamin D. it was HYPOTHESIZED that IF all the infants COULD have been Born with normal levels there would have been a reduction of 43% in the incidence of schizophrenia among the Adults.112there is also an ASSOCIATION of Vitamin D deficiency and Insulin resistance,113which was reversed with a single injection of the vitamin114(not approved in the united states).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 133), ('INCOMPLETE_EVIDENCE', 349), ('INCOMPLETE_EVIDENCE', 458), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 476), ('INCOMPLETE_EVIDENCE', 495), ('SUPERFICIAL_RELATIONSHIP', 647)]	10	[('CHEBI_33284', 'nutrient', 28, 'nutrient'), ('NCBITaxon_10088', 'Mus <genus>', 97, 'Human'), ('GO_0007565', 'female pregnancy', 217, 'pregnant'), ('UBERON_0002240', 'spinal cord', 327, 'cord'), ('UBERON_0000178', 'blood', 332, 'blood'), ('CHEBI_28384', 'vitamin K', 440, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 440, 'Vitamin D'), ('GO_0007567', 'parturition', 511, 'born'), ('UBERON_0007023', 'adult organism', 620, 'adults'), ('CHEBI_27300', 'vitamin D', 662, 'vitamin D'), ('PR_000045358', 'insulin family protein', 687, 'insulin')]
PMC4969253	8/2016	S4-PMC4969253	['introduction: Retinoic Acid, a CRUCIAL signal for Formation Of the Embryonic Lung\nCLASSIC STUDIES in multiple species, including Hamsters, Rats, and Mice, HAVE SHOWN major pleiotropic EFFECTS of maternal dietary Vitamin A deprivation in Embryonic Development.']	[('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_26536', 'retinoic acid', 14, 'retinoic acid'), ('GO_0001703', 'gastrulation with mouth forming first', 50, 'formation of ... lung'), ('UBERON_0000922', 'embryo', 67, 'embryonic'), ('UBERON_0002048', 'lung', 77, 'lung'), ('NCBITaxon_33208', 'Metazoa', 129, 'hamsters'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 139, 'rats'), ('NCBITaxon_10088', 'Mus <genus>', 149, 'mice'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A'), ('GO_0009790', 'embryo development', 237, 'embryonic development'), ('UBERON_0000922', 'embryo', 237, 'embryonic')]
PMC4969253	8/2016	S11-PMC4969253	['disruption of Aldh1A2 , in Mouse mutants, reproduces the Lung agenesis phenotype REPORTED in the SEVERE Vitamin A deficiency MODELS.']	[('INCOMPLETE_EVIDENCE', 81), ('IMPORTANT_CONSIDERATION', 97), ('INCOMPLETE_EVIDENCE', 125)]	3	[('PR_000003920', 'retinal dehydrogenase 1', 14, 'Aldh1a2'), ('NCBITaxon_10088', 'Mus <genus>', 27, 'mouse'), ('UBERON_0002048', 'lung', 57, 'lung'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin A')]
PMC4969253	8/2016	S59-PMC4969253	['premature infants were shown to have lower concentrations of Plasma Vitamin A, raising the POSSIBILITY that Vitamin A deficiency in preterm infants MAY CONTRIBUTE to INCREASED RISK of developing chronic Lung disease.']	[('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 152), ('IMPORTANT_CONSIDERATION', 166)]	4	[('UBERON_0001969', 'blood plasma', 61, 'plasma'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin A'), ('UBERON_0002048', 'lung', 203, 'lung')]
PMC4969253	8/2016	S86-PMC4969253	['conclusions\noverall, the OBSERVATIONS HERE underscore the IMPORTANCE of dietary Vitamin A/Retinoids, a SIGNIFICANT challenge in developing countries.']	[('INCOMPLETE_EVIDENCE', 25), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('IMPORTANT_CONSIDERATION', 58), ('IMPORTANT_CONSIDERATION', 103)]	4	[('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('CHEBI_26537', 'retinoid', 90, 'retinoids')]
PMC4971719	8/2016	S12-PMC4971719	['conclusions\nin women AT RISK for depression, early Pregnancy low Vitamin D levels are ASSOCIATED with higher depressive symptom scores in early and late Pregnancy.']	[('IMPORTANT_CONSIDERATION', 21), ('SUPERFICIAL_RELATIONSHIP', 86)]	2	[('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy')]
PMC4971719	8/2016	S34-PMC4971719	['similarly, gur, et al., FOUND a significant ASSOCIATED between mid-Pregnancy Vitamin D levels and depression and depression screen scores measured longitudinally in the Postpartum period among healthy women who were not considered AT RISK for depression [27].']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 44), ('IMPORTANT_CONSIDERATION', 231)]	3	[('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 169, 'postpartum')]
PMC4971719	8/2016	S145-PMC4971719	['discussion\n\nmain findings\nTHIS STUDY presents EVIDENCE that low Vitamin D levels in early Pregnancy (12–20 weeks) are significantly ASSOCIATED with higher depression symptom scores at in early and late Pregnancy in a group of women AT RISK for depression.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 132), ('IMPORTANT_CONSIDERATION', 232)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy')]
PMC4971719	8/2016	S162-PMC4971719	['in the PUBLISHED LITERATURE, both low and high Vitamin D levels HAVE BEEN ASSOCIATED with Perinatal depression, a FINDING that others HAVE HYPOTHESIZED MAY BE due to a 24-hydroxylase-based degradation mechanism responding to abnormally high concentrations of Vitamin D [29].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 114), ('IMPORTANT_CONSIDERATION', 134), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 152)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0036268', 'swimming', 90, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 90, 'perinatal'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
PMC4971719	8/2016	S163-PMC4971719	['the main finding of OUR STUDY is that there exists a RELATIONSHIP between low early-Pregnancy Vitamin D levels and depression symptoms in early and late Pregnancy in women AT risk for depression.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 172)]	3	[('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy')]
PMC4971719	8/2016	S170-PMC4971719	['IMPORTANT FUTURE AREAS OF RESEARCH would INCLUDE randomized controlled trials of Vitamin D supplementation for women who are screen for depression RISK in early Pregnancy and who are found to have low Vitamin D levels.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 0), ('FUTURE_WORK', 10), ('FUTURE_WORK', 41), ('IMPORTANT_CONSIDERATION', 147)]	5	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC4973215	8/2016	S0-PMC4973215	['racial DISPARITIES in Cord Blood Vitamin D levels and its ASSOCIATION with small-for-Gestational-age infants\n\nabstract\n\nobjective:\nTO EXAMINE the RELATIONSHIP of race and maternal characteristics and their ASSOCIATION with Cord Blood Vitamin D levels and small-for-Gestational-age (sga) status.']	[('IMPORTANT_CONSIDERATION', 7), ('SUPERFICIAL_RELATIONSHIP', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 131), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 206)]	5	[('UBERON_0002240', 'spinal cord', 22, 'cord'), ('UBERON_0000178', 'blood', 27, 'blood'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'gestational'), ('UBERON_0002240', 'spinal cord', 223, 'cord'), ('UBERON_0000178', 'blood', 228, 'blood'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('GO_0007565', 'female pregnancy', 265, 'gestational')]
PMC4973215	8/2016	S10-PMC4973215	['THUS, levels of neonates at Birth depend entirely on that of the mother and, ACCORDINGLY, SEVERAL STUDIES have CONSISTENTLY CORRELATED Cord Blood 25(Oh)D levels to those of their mothers.1,2,3,4,5,6in addition, maternal Vitamin D deficiency HAS BEEN LINKED to decreased fetal growth and Birth size in OBSERVATIONAL studies.7,8,9\nmaternal Vitamin D deficiency is PREVALENT, the extent of which CAN be INFLUENCED by many variables including skin pigmentation, sun exposure, season, age, Vitamin supplementation and obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 90), ('PROBABLE_UNDERSTANDING', 111), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 250), ('INCOMPLETE_EVIDENCE', 301), ('IMPORTANT_CONSIDERATION', 362), ('INCOMPLETE_EVIDENCE', 393), ('SUPERFICIAL_RELATIONSHIP', 400)]	11	[('GO_0007567', 'parturition', 28, 'birth'), ('UBERON_0002240', 'spinal cord', 135, 'cord'), ('UBERON_0000178', 'blood', 140, 'blood'), ('CHEBI_71657', 'versiconol acetate', 146, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007567', 'parturition', 287, 'birth'), ('CHEBI_27300', 'vitamin D', 338, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 485, 'vitamin')]
PMC4973215	8/2016	S11-PMC4973215	['several large OBSERVATIONAL studies and meta-analyses have DESCRIBED the ASSOCIATION of maternal Vitamin D deficiency with Pregnancy COMPLICATIONS such as pre-eclampsia, Gestational diabetes and premature Birth.10,11,12,13racial DISPARITIES in maternal and neonatal Vitamin D deficiency HAVE BEEN DESCRIBED.1,14,15vitamin D deficiency is MORE COMMON and more SEVERE in black mothers.10,15,16,17,18,19racial DISPARITIES are also SEEN with Pregnancy COMPLICATIONS such as Preterm birth, pre-eclampsia and Gestational diabetes, as well as adverse neonatal outcomes including low Birth weight and small-for-Gestational-age (sga) status.15,17,20,21HOWEVER, the MAJORITY of studies EXAMINED maternal Vitamin D levels during the first and second Trimesters of Pregnancy7,8,22,23and CORRELATED these levels to neonatal outcomes.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBLEM_COMPLICATION', 133), ('IMPORTANT_CONSIDERATION', 229), ('INCOMPLETE_EVIDENCE', 287), ('INCOMPLETE_EVIDENCE', 297), ('PROBABLE_UNDERSTANDING', 338), ('IMPORTANT_CONSIDERATION', 359), ('IMPORTANT_CONSIDERATION', 407), ('INCOMPLETE_EVIDENCE', 428), ('PROBLEM_COMPLICATION', 448), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('PROBABLE_UNDERSTANDING', 656), ('INCOMPLETE_EVIDENCE', 676), ('SUPERFICIAL_RELATIONSHIP', 775)]	16	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy'), ('GO_0007565', 'female pregnancy', 170, 'gestational'), ('GO_0007567', 'parturition', 205, 'birth'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 322, 'D'), ('GO_0007565', 'female pregnancy', 438, 'pregnancy'), ('GO_0007565', 'female pregnancy', 470, 'preterm'), ('GO_0007565', 'female pregnancy', 503, 'gestational'), ('GO_0007567', 'parturition', 576, 'birth'), ('GO_0007565', 'female pregnancy', 603, 'gestational'), ('CHEBI_27300', 'vitamin D', 694, 'vitamin D'), ('GO_0043033', 'isoamylase complex', 739, 'trimesters'), ('GO_0007565', 'female pregnancy', 753, 'pregnancy7')]
PMC4973215	8/2016	S12-PMC4973215	['far FEWER STUDIES have EXAMINED the RELATIONSHIP between Cord Blood Vitamin D levels, which MAY more ACCURATELY REFLECT fetal levels of Vitamin D, and neonatal outcomes.14,24GIVEN the racial DISPARITIES SEEN in both Vitamin D deficiency and Perinatal outcomes, Vitamin D HAS BEEN PROPOSED as part of the EXPLANATION for this DISPARITY, PARTICULARLY with regard to fetal growth and sga.8\nINCREASED AWARENESS of the GROWING PREVALENCE of maternal Vitamin D deficiency has LED TO an URGENT NEED for CONSIDERATION of supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 92), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 112), ('PROBABLE_UNDERSTANDING', 174), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 271), ('INCOMPLETE_EVIDENCE', 280), ('PROBABLE_UNDERSTANDING', 304), ('IMPORTANT_CONSIDERATION', 325), ('IMPORTANT_CONSIDERATION', 336), ('IMPORTANT_CONSIDERATION', 387), ('INCOMPLETE_EVIDENCE', 414), ('IMPORTANT_CONSIDERATION', 422), ('SUPERFICIAL_RELATIONSHIP', 470), ('IMPORTANT_CONSIDERATION', 480), ('FUTURE_WORK', 487), ('FUTURE_WORK', 496)]	21	[('UBERON_0002240', 'spinal cord', 57, 'cord'), ('UBERON_0000178', 'blood', 62, 'blood'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0036268', 'swimming', 241, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 241, 'perinatal'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0007565', 'female pregnancy', 536, 'pregnancy')]
PMC4973215	8/2016	S17-PMC4973215	['our GOAL was TO IDENTIFY specific high-risk subsets of Pregnant women who MAY BENEFIT from Vitamin D supplementation IN ORDER TO mitigate adverse Perinatal outcomes such as sga.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 74), ('IMPORTANT_CONSIDERATION', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 117)]	5	[('GO_0007565', 'female pregnancy', 55, 'pregnant'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0036268', 'swimming', 146, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 146, 'perinatal')]
PMC4973215	8/2016	S62-PMC4973215	['ALTHOUGH the prevalence of Vitamin D deficiency in black mothers and neonates is WELL KNOWN, DEBATE exists as to the RELATIONSHIP between race, Vitamin D deficiency and sga.12,14,15,17,18we EXAMINED this RELATIONSHIP in conjunction with additional maternal characteristics in order TO IDENTIFY groups of Pregnant women who could BENEFIT MOST from Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 190), ('SUPERFICIAL_RELATIONSHIP', 204), ('QUESTION_ANSWERED_BY_THIS_WORK', 282), ('IMPORTANT_CONSIDERATION', 329), ('PROBABLE_UNDERSTANDING', 337)]	9	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 304, 'pregnant'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D')]
PMC4973215	8/2016	S67-PMC4973215	['Vitamin D MAY AFFECT fetal growth through its EFFECT on Calcium Metabolism, bone growth and Placental Development.32ALTHOUGH INITIAL STUDIES SHOWED CONFLICTING results, more RECENT STUDIES SUGGEST that Vitamin D deficiency MAY adversely AFFECT growth and LEAD TO low Birth weight or sga infants.7,9,11,12,18,22,23,33BECAUSE of a KNOWN RELATIONSHIP between race and Vitamin D status, ATTENTION then turned to investigation of the RELATIONSHIP between race, Vitamin D deficiency and sga.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 223), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 255), ('PROBABLE_UNDERSTANDING', 316), ('INCOMPLETE_EVIDENCE', 329), ('SUPERFICIAL_RELATIONSHIP', 335), ('IMPORTANT_CONSIDERATION', 383), ('SUPERFICIAL_RELATIONSHIP', 429)]	17	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 56, 'calcium metabolism'), ('GO_0001890', 'placenta development', 92, 'placental development'), ('UBERON_0001987', 'placenta', 92, 'placental'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('GO_0007567', 'parturition', 267, 'birth'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 456, 'vitamin D')]
PMC4973215	8/2016	S73-PMC4973215	['gernand et al.22also EXAMINED second-Trimester Vitamin D levels and risk of sga in a population AT RISK of pre-eclampsia.']	[('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 96)]	2	[('GO_0009294', 'DNA mediated transformation', 37, 'trimester'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC4973215	8/2016	S78-PMC4973215	['furthermore, this study was CONDUCTED in hamilton county, ohio, an area with worse Perinatal outcomes THAN national averages, including higher infant mortality, Preterm Birth and low Birth weight rates, as well as CONSIDERABLE racial DISPARITIES in infant mortality and Perinatal outcomes.34all of Cord Blood samples were collected over one winter season, THUS negating seasonal variations in Vitamin D levels that MAY have been SEEN in OTHER STUDIES.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('IMPORTANT_CONSIDERATION', 214), ('IMPORTANT_CONSIDERATION', 234), ('PROBABLE_UNDERSTANDING', 356), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 429), ('INCOMPLETE_EVIDENCE', 437)]	8	[('GO_0036268', 'swimming', 83, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 83, 'perinatal'), ('GO_0007565', 'female pregnancy', 161, 'preterm birth'), ('GO_0007567', 'parturition', 183, 'birth'), ('GO_0036268', 'swimming', 270, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 270, 'perinatal'), ('UBERON_0002240', 'spinal cord', 298, 'cord'), ('UBERON_0000178', 'blood', 303, 'blood'), ('CHEBI_27300', 'vitamin D', 393, 'vitamin D')]
PMC4973215	8/2016	S94-PMC4973215	['Vitamin D supplementation during Pregnancy HAS BEEN SHOWN to positively AFFECT Cord Blood Vitamin D levels at Birth.43,44studies of Vitamin D supplementation during Pregnancy THUS FAR HAVE SHOWN CONFLICTING results with respect to Birth weight and reduction of sga.43,45,46,47,48adequately powered and randomized controlled trials of vitamin d supplementation during Pregnancy ARE NEEDED TO ASSESS the IMPACT of supplementation on sga as well as the APPROPRIATE dose and timing of supplementation.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 195), ('FUTURE_WORK', 377), ('FUTURE_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 402), ('IMPORTANT_CONSIDERATION', 450)]	9	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 79, 'cord'), ('UBERON_0000178', 'blood', 84, 'blood'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007567', 'parturition', 110, 'birth'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy'), ('GO_0007567', 'parturition', 231, 'birth'), ('GO_0007565', 'female pregnancy', 367, 'pregnancy')]
PMC4973215	8/2016	S96-PMC4973215	['if Vitamin D supplementation does not occur during Pregnancy, it MAY BE IMPERATIVE to identify and offer additional supplementation beyond the routinely recommended 400\u2009iu per day for all infants.28\nthere were several LIMITATIONS to our study.']	[('FUTURE_WORK', 65), ('IMPORTANT_CONSIDERATION', 72), ('INCOMPLETE_EVIDENCE', 218)]	3	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy')]
PMC4973215	8/2016	S102-PMC4973215	['conclusion\nblack obese mothers on medicaid without Prenatal vitamin use were at the HIGHEST RISK of Delivering neonates with Vitamin D deficiency.']	[('IMPORTANT_CONSIDERATION', 84)]	1	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('GO_0006900', 'vesicle budding from membrane', 100, 'delivering'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4973215	8/2016	S103-PMC4973215	['furthermore, black race and Vitamin D deficiency were ASSOCIATED with an INCREASED RISK of sga.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 73)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4973215	8/2016	S104-PMC4973215	['we IDENTIFIED additive and modifiable maternal RISK FACTORS that WOULD BENEFIT MOST from risk reduction and targeted Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 47), ('FUTURE_PREDICTION', 65), ('IMPORTANT_CONSIDERATION', 71), ('PROBABLE_UNDERSTANDING', 79)]	5	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC4973215	8/2016	S105-PMC4973215	['a GREATER UNDERSTANDING of the variables that INFLUENCE Vitamin D status during Pregnancy CAN have an immense PUBLIC HEALTH IMPACT in the reduction of adverse Perinatal outcomes such as sga.']	[('IMPORTANT_CONSIDERATION', 2), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 110), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0036268', 'swimming', 159, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 159, 'perinatal')]
PMC4976416	7/2016	S5-PMC4976416	['the AIM of THIS ARTICLE is to review the cosmetic as well as clinical IMPLICATIONS of Vitamin E in dermatology.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('IMPORTANT_CONSIDERATION', 70)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin E')]
PMC4976416	7/2016	S16-PMC4976416	['[8]\nALTHOUGH many cosmeceuticals contain Vitamins C and e, VERY FEW are actually EFFECTIVE in topical application because the stability is COMPROMISED as soon as the product is opened and exposed to air and light.']	[('ANOMALY_CURIOUS_FINDING', 4), ('IMPORTANT_CONSIDERATION', 59), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 139)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamins C')]
PMC4976416	7/2016	S17-PMC4976416	['HOWEVER when a stable formulation delivers a high concentration of nonesterified, OPTIMAL isomer of the antioxidant, Vitamins C and E inhibit the acute uv damage as well as chronic uv photoaging and skin cancer.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 82)]	2	[('CHEBI_27300', 'vitamin D', 117, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 132, 'E')]
PMC4976416	7/2016	S73-PMC4976416	['HOWEVER, studies looking AT the efficacy of Vitamin E in the treatment of burns and scars HAVE BEEN DISAPPOINTING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 90), ('ANOMALY_CURIOUS_FINDING', 100)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin E')]
PMC4976416	7/2016	S82-PMC4976416	['Vitamin E being a fat-soluble Vitamin, administration of a dose higher than daily REQUIREMENT results in accumulation inside the body, resulting in hypervitaminosis e. healthy Adults taking Vitamin E daily at a dose of 100 mg for more than 1 year are LIKELY to get hypervitaminosis E, manifesting as reduced Platelet Aggregation and interference with Vitamin K Metabolism resulting in bleeding tendencies.']	[('IMPORTANT_CONSIDERATION', 82), ('PROBABLE_UNDERSTANDING', 251)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('PR_000017279', 'testis-specific basic protein Y 1', 0, 'Vitamin E'), ('CHEBI_33229', 'vitamin (role)', 30, 'vitamin'), ('UBERON_0007023', 'adult organism', 176, 'adults'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin E'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 282, 'E'), ('CL_0000233', 'platelet', 308, 'platelet'), ('GO_0070527', 'platelet aggregation', 308, 'platelet aggregation'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin K'), ('GO_0007601', 'visual perception', 351, 'vitamin K'), ('GO_0008152', 'metabolic process', 361, 'metabolism')]
PMC4976416	7/2016	S85-PMC4976416	['conclusion\nDESPITE development of new Formulations for use in cosmetics and skin care products, there is a LACK OF controlled clinical trials providing a rationale for well-defined dosages and clinical indications for oral and topical Vitamin E. after so MANY YEARS of RESEARCH on Vitamin E, it is STILL UNCLEAR as to WHETHER millions of dollars worth of Vitamin E products paid for by patients and consumers have been of any benefit.']	[('ANOMALY_CURIOUS_FINDING', 11), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 255), ('INCOMPLETE_EVIDENCE', 269), ('FULL_UNKNOWN', 298), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 318)]	7	[('CHEBI_38864', 'propetamphos', 38, 'formulations'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin E')]
PMC4979151	8/2016	S10-PMC4979151	['introduction\nthe IMPORTANCE of adequate Vitamin D status during Pregnancy HAS BEEN SUGGESTED by OBSERVATIONAL studies DEMONSTRATING ASSOCIATIONS between low 25(Oh)D3And adverse Birth outcomes, childhood infections, and atopy [1,2].']	[('IMPORTANT_CONSIDERATION', 17), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 132)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('CHEBI_76945', 'manool', 157, '25(OH)D3and'), ('PR_000036846', 'class II olfactory receptor', 157, '25(OH)D3and'), ('GO_0007567', 'parturition', 177, 'birth')]
PMC4979151	8/2016	S12-PMC4979151	['IN CONTRAST, no association [6,7] or negative EFFECTS of high Vitamin D intake in Pregnancy on the RISK of eczema, asthma and wheezing in the offspring HAVE also BEEN SHOWN [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 46), ('IMPORTANT_CONSIDERATION', 99), ('INCOMPLETE_EVIDENCE', 152)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy')]
PMC4979151	8/2016	S146-PMC4979151	['down-regulation of Genes in the Tcr Complex, T Cell co-stimulatory Molecules and Major Histocompatibility Complexes (T Cell Adaptive Immunity) in the vitd group SUGGESTS suppression of T Cell Signaling Pathway by Vitamin D. induction of Cd2, Cd40Lg and Il-12Rb2 Expression that are IMPORTANT in T and Nk Cell function and inflammatory responses, and down-regulation of receptors for these ligands SUGGEST balanced responses to in vivo vitd3supplementation that would be expected to mitigate MAJOR downstream effects.']	[('DIFFICULT_TASK', 36), ('INCOMPLETE_EVIDENCE', 161), ('IMPORTANT_CONSIDERATION', 282), ('INCOMPLETE_EVIDENCE', 397), ('IMPORTANT_CONSIDERATION', 491)]	5	[('SO_0000704', 'gene', 19, 'genes'), ('GO_0042101', 'T cell receptor complex', 32, 'TCR complex'), ('CL_0000084', 'T cell', 45, 'T cell'), ('CHEBI_36357', 'polyatomic entity', 67, 'molecules'), ('GO_0042611', 'MHC protein complex', 81, 'major histocompatibility complexes'), ('CL_0000084', 'T cell', 117, 'T cell'), ('GO_0002456', 'T cell mediated immunity', 117, 'T cell adaptive immunity'), ('CL_0000084', 'T cell', 185, 'T cell'), ('GO_0002770', 'T cell inhibitory signaling pathway', 185, 'T cell signaling pathway'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('PR_000001204', 'C-C chemokine receptor type 8', 237, 'CD2'), ('PR_000001309', 'CD70 molecule', 242, 'CD40LG'), ('PR_000008990', 'interleukin-1 family member 9', 253, 'IL-12RB2'), ('GO_0010467', 'gene expression', 262, 'expression'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 295, 'T ...'), ('CL_0000623', 'natural killer cell', 301, 'NK cell'), ('GO_0005634', 'nucleus', 301, 'NK')]
PMC4982007	8/2016	S69-PMC4982007	['n \u2009=\u20095832: age 4\xa0years \u2003n \u2009=\u20095191; age 8\xa0years \u2003n \u2009=\u20097339; age 16\xa0yearsmaternal Gestational weight gain (kg)3 categories of weight gain1: less than recommended2: as recommended3: more than recommendedpre-Pregnancy weight (kg)school entry assessment score-4\xa0yearsiq- wechsler intelligence scale for children -iii-8\xa0yearsadequate final exam results-16\xa0yearschildren of women gained weight\u2009<\u2009expected-↓ school entry assessment score (-0.075 sd) and adequate final-exam results (or\u2009=\u20090.88); ↑weight gain - early and mid Pregnancy -↑school entry assessment score (0.072 and 0.077 sd)↑ weight gain in all three periods of Pregnancy-↑ iq at 8\xa0years (0.070 to 0.078 sd) and ↑pre-Pregnancy weight-↓ school entry assessment score (-0.004 sd/kg), iq (-0.004 sd) and the odds (or\u2009=\u20090.99) of achieving adequate final exam resultsconfounders adjusted for: the child’s sex, current age, ma; me, parity, pre-Pregnancy bmi, smoking and mode of Delivery16 medium\nbmi body mass index, qs quality score, rb risk of bias, ga Gestational age, ma maternal age, bwt Birthweight, ses socio-economic status, me maternal education, pe paternal education, miq maternal intelligence, he home environment, ms maternal smoking, bf breast-feeding, dm maternal diabetes, pih Pregnancy induced hypertension\n\ncaption (table-wrap): table 3\n\nsummary of the studies examining ASSOCIATIONS of maternal Vitamin D status with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb20gale c; 2008 \u2003n \u2009=\u2009178\u2003age 9\xa0years\u2003uk\u2003prospective longitudinalserum Vitamin D concentrations assessed at 28-42 weeks Gestation21.2\xa0% had <27.5\xa0nmol/l28.3\xa0% had 27.5-50\xa0nmol/lwechsler abbreviated scale of intelligencefull-scale, verbal or performance iqno association between Vitamin D concentrations and offspring iq (full-scale, verbal or performance)confounders adjusted for: unadjusted16 medium21whitehouse ajo; 2012\u2003age 5\xa0years ( n \u2009=\u2009534)\u2003age 10\xa0years ( n \u2009=\u2009474)\u2003australia\u2003prospective longitudinalserum Vitamin D concentrations assessed at 18\xa0weeks Gestation25.2\xa0% mothers had insufficiency (≤46\xa0nmol/l)(lowest quartile)peabody picture vocabulary test Receptive Languagechildren of mothers with Vitamin D insufficiency (lowest quartile (≤46\xa0nmol/l) were at INCREASED RISK (or\u2009=\u20091.97) of Language impairment compared to children of mothers without insufficiency (highest quartile (≥72\xa0nmol/l; or\u2009=\u20091.00)confounders adjusted for: ma, ms, parity, family income, season of maternal Blood sampling13 medium22morales\xa0e; 2012 \u2003n \u2009=\u20091820\u2003age 11-23 months\u2003spain\u2003prospective population based\u2003cohort studyplasma Vitamin D concentrations assessed during 12-23 weeks Gestation19.5\xa0% mothers had deficiency (<20\xa0ng/ml)31.5\xa0% had insufficiency (20-30\xa0ng/ml)bayley scales of infant development (mental (mdi) and psychomotor (pdi) developmental score)a positive linear ASSOCIATION between Vitamin D concentrations and mdi and pdiper 10\xa0ng/ml increase in Vitamin D concentrations mdi and pdi score increased by β\u2009=\u20090.79 and β\u2009=\u20090.88 points respectivelycompared to infants of deficient mothers, infants of mothers with normal level scored higher mdi (β\u2009=\u20092.60) and pdi (β\u2009=\u20092.32) points respectivelyconfounders adjusted for: the child’s sex, bwt, area of study, maternal country of origin, ma, parity, Pre-Pregnancy bmi, ses, me, ms, Alcohol and season15 medium\nqs quality score, rb risk of bias, ma maternal age, bwt Birthweight, me Maternal education, ms maternal smoking, bmi body mass index, ses socio-economic status\n\ncaption (table-wrap): table 4\n\nsummary of the studies examining ASSOCIATIONS of maternal Folate status with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb23wu btf; 2012 \u2003n \u2009=\u2009154\u2003age 18 months\u2003canada\u2003prospectiveplasma Folate and thcy concentrations assessed at 16 and 36\xa0weeks Gestationno Folate deficiency (plasma Folate <6.8\xa0nmol/l)high thcy not reportedbayley scales of infant developmentreceptive language, expressive language, Cognitive skills, fine motor and gross motorno ASSOCIATION of Folate and thcy with Cognitive functionconfounders adjusted for: the child’s sex, bf, ethnicity, ma, miq, maternal Fatty Acid level13 medium24tamura t; 2005 \u2003n \u2009=\u2009355\u2003age 5\xa0years\u2003usa\u2003prospective\u2003mothers participated in zinc supplementation trial during Pregnancyred cell and Plasma Folate concentrations – 19, 26 and 37\xa0weeks Gestation and thcy concentrations-26 and 37\xa0weekslow Folate-(Plasma Folate <11\xa0nmol/l)19\xa0weeks- 7.4\xa0%; 26\xa0weeks- 8.2\xa0%; 37\xa0weeks- 14.0\xa0%Red Cell Folate <430\xa0nmol/l)19\xa0weeks- 7.2\xa0%; 26\xa0weeks- 3.8\xa0%; 37\xa0weeks- 3.3\xa0%high thcy (thcy\u2009>\u20097\xa0μmol/l)26\xa0weeks- 8.4\xa0%; 37\xa0weeks- 22.1\xa0%differential ability scale (verbal, nonverbal and general iq), Visual and Auditory sequential Memory (Visual and Auditory Memory span)knox cube (attention span and Short-Term Memory)gross motor scale (gross Motor Development and grooved pegboard (manipulative dexterity)no difference in the mental and psychomotor developmental scores between children of mothers with normal and deficient Folate and thcy groups.']	[('SUPERFICIAL_RELATIONSHIP', 1338), ('IMPORTANT_CONSIDERATION', 2306), ('SUPERFICIAL_RELATIONSHIP', 2901), ('SUPERFICIAL_RELATIONSHIP', 3617), ('SUPERFICIAL_RELATIONSHIP', 4142)]	5	[('GO_0007565', 'female pregnancy', 80, 'gestational'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('GO_0007565', 'female pregnancy', 516, 'pregnancy'), ('GO_0007565', 'female pregnancy', 616, 'pregnancy'), ('GO_0007565', 'female pregnancy', 671, 'pregnancy'), ('GO_0007565', 'female pregnancy', 892, 'pregnancy'), ('GO_0007567', 'parturition', 927, 'delivery16'), ('GO_0007565', 'female pregnancy', 1004, 'gestational'), ('GO_0007596', 'blood coagulation', 1042, 'birthweight'), ('GO_0007565', 'female pregnancy', 1242, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1363, 'vitamin D'), ('GO_0050890', 'cognition', 1395, 'cognitive'), ('CHEBI_27300', 'vitamin D', 1611, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1660, 'gestation21'), ('CHEBI_27300', 'vitamin D', 1818, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2052, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2098, 'gestation25'), ('GO_0000724', 'double-strand break repair via homologous recombination', 2201, 'Receptive languageChildren'), ('CHEBI_27300', 'vitamin D', 2244, 'vitamin D'), ('GO_0006266', 'DNA ligation', 2336, 'language'), ('UBERON_0000178', 'blood', 2527, 'blood'), ('CHEBI_27300', 'vitamin D', 2650, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2703, 'gestation19'), ('CHEBI_27300', 'vitamin D', 2921, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2986, 'vitamin D'), ('GO_0007568', 'aging', 3332, 'pre'), ('GO_0007565', 'female pregnancy', 3336, 'pregnancy'), ('CHEBI_30879', 'alcohol', 3364, 'alcohol'), ('GO_0007596', 'blood coagulation', 3448, 'birthweight'), ('GO_0007618', 'mating', 3464, 'maternal'), ('CHEBI_30863', '5-azaorotic acid', 3642, 'folate'), ('GO_0050890', 'cognition', 3671, 'cognitive'), ('CHEBI_30863', '5-azaorotic acid', 3881, 'folate'), ('GO_0007565', 'female pregnancy', 3940, 'gestationNo'), ('CHEBI_30863', '5-azaorotic acid', 3952, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 3978, 'folate'), ('GO_0050890', 'cognition', 4095, 'cognitive'), ('CHEBI_30863', '5-azaorotic acid', 4157, 'folate'), ('GO_0050890', 'cognition', 4178, 'cognitive'), ('CHEBI_35366', 'fatty acid', 4272, 'fatty acid'), ('GO_0007605', 'sensory perception of sound', 4410, 'pregnancyRed'), ('UBERON_0001969', 'blood plasma', 4432, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 4439, 'folate'), ('GO_0007565', 'female pregnancy', 4483, 'gestation'), ('CHEBI_30863', '5-azaorotic acid', 4536, 'folate'), ('UBERON_0001969', 'blood plasma', 4544, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 4551, 'folate'), ('CL_0000232', 'erythrocyte', 4619, 'Red cell'), ('CHEBI_30863', '5-azaorotic acid', 4628, 'folate'), ('GO_0007601', 'visual perception', 4819, 'Visual'), ('GO_0006754', 'ATP biosynthetic process', 4830, 'Auditory ...'), ('GO_0007613', 'memory', 4850, 'Memory'), ('GO_0007601', 'visual perception', 4858, 'visual'), ('GO_0007605', 'sensory perception of sound', 4869, 'auditory'), ('GO_0007613', 'memory', 4878, 'memory'), ('GO_0007608', 'sensory perception of smell', 4920, 'short-term memory'), ('GO_0009653', 'anatomical structure morphogenesis', 4963, 'motor development'), ('CHEBI_30863', '5-azaorotic acid', 5145, 'folate')]
PMC4982007	8/2016	S278-PMC4982007	['another LIMITATION was that maternal Vitamin D status was available ONLY during the second trimester; SINCE Vitamin D IS KNOWN to fluctuate with sunlight exposure, the timing of deficiency MAY BE CRUCIAL in determining Cognitive function.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 68), ('PROBABLE_UNDERSTANDING', 102), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 189), ('IMPORTANT_CONSIDERATION', 196)]	6	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0050890', 'cognition', 219, 'cognitive')]
PMC4982007	8/2016	S359-PMC4982007	['we FOUND SOME EVIDENCE LINKING maternal obesity and low Micronutrient status, in particular, that of Vitamin D, Folate and B12 during Pregnancy with poorer offspring Cognitive function, SUGGESTING that maternal nutrition is IMPORTANT for optimal offspring Neurodevelopment and Long-Term Cognition.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 224)]	5	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 56, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 112, 'folate'), ('CHEBI_27778', 'abequose', 123, 'B12'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('GO_0050890', 'cognition', 166, 'cognitive'), ('GO_0007399', 'nervous system development', 256, 'neurodevelopment'), ('GO_0007040', 'lysosome organization', 277, 'long-term cognition')]
PMC4988030	8/2016	S164-PMC4988030	['the three point increase in total hei-2010 score and improvements in Saturated fat, Cholesterol and Vitamin C intake in the pat arm SUGGESTS that simple nutrition messaging, when presented in the context of a more GLOBAL maternal and child health curriculum, MAY promote positive maternal dietary behaviors in the Gestational period.']	[('INCOMPLETE_EVIDENCE', 132), ('IMPORTANT_CONSIDERATION', 214), ('INCOMPLETE_EVIDENCE', 259)]	3	[('CHEBI_51247', 'texas red', 69, 'saturated'), ('CHEBI_16113', 'cholesterol', 84, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin C'), ('GO_0007565', 'female pregnancy', 314, 'gestational')]
PMC4989298	8/2016	S237-PMC4989298	['NUMEROUS STUDIES have also evaluated the Intake of Vitamins (vit a, e, c) and Minerals (Mg, zn, Ca, p) [please NOTE that except for this chapter the data on Vitamin D is treated in a special section], BUT these often include methodological ERRORS, starting with the DIFFICULTY of FINDING a correct quantification of dietary Intakes of various Foods.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 201), ('PROBLEM_COMPLICATION', 240), ('DIFFICULT_TASK', 266), ('INCOMPLETE_EVIDENCE', 280)]	6	[('GO_0007631', 'feeding behavior', 41, 'intake'), ('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 78, 'minerals'), ('CHEBI_34829', 'Medrysone', 88, 'Mg'), ('CHEBI_32588', 'potassium chloride', 96, 'Ca'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007631', 'feeding behavior', 324, 'intakes'), ('CHEBI_33290', 'food', 343, 'foods')]
PMC4989298	8/2016	S345-PMC4989298	['HOWEVER, SEVERAL STUDIES report SUBOPTIMAL Vitamin D status in large parts of the population of children and Adults.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 32)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0007023', 'adult organism', 109, 'adults')]
PMC4989298	8/2016	S362-PMC4989298	['the study conclusions were that there was not SUFFICIENT evidence to establish a causal CONNECTION; there were also NO RANDOMISED clinical trial (rct) on the effect of supplementation of Vitamin D and risk of asthma.']	[('IMPORTANT_CONSIDERATION', 46), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 116)]	3	[('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC4989298	8/2016	S367-PMC4989298	['in the cohort studied by rothers and colleagues, high and low Vitamin D levels are ASSOCIATED with an INCREASED RISK of Sensitisation [123].']	[('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 102)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 120, 'sensitisation')]
PMC4989298	8/2016	S376-PMC4989298	['the use of Vitamin D supplementation for the primary PREVENTION of allergic diseases REMAINS an attractive TOPIC of study, BUT CURRENT KNOWLEDGE and AVAILABLE EVIDENCE does not warrant its RECOMMENDATION [129].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 149), ('FUTURE_WORK', 189)]	7	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC4990268	8/2016	S39-PMC4990268	['the interventions considered by this review are outlined intable 1(numbered to correspond to the sections of the paper where they are addressed).10.1371/journal.pone.0160562.t001\n\ncaption (table-wrap): table 1\ninterventions addressed in THIS review.Nutritioninfectionobstetrical and other• immediate & exclusive breastfeeding• deworming• advance distribution of Misoprostol for use immediately after Childbirth for preventing post-Partum hemorrhage• antenatal Iron supplementation & anemia screening & treatment• intermittent presumptive treatment of malaria & use of Insecticide-treated nets• pre-eclampsia screening & treatment• multi-Micronutrient supplementation• Tetanus Toxoid• clean Delivery practices• Calcium supplementation• advance distribution of Chlorhexidine for application to the Umbilical Cord Stump• thermal care• antenatal Vitamin A supplementation• syphilis screening & treatment• Birth preparedness & complication readiness• advance distribution of Vitamin A for administration to the newborn• hiv screening/ pmtct• tobacco, alcohol use• Iodized Salt use• Family Planning• balanced protein-energy supplementation\n\neffects modified by context\nfor each of these INTERVENTIONS, the review addresses: 1) EVIDENCE on EFFECTS with regard to mortality and other IMPORTANT endpoints and 2) variation in expected EFFECTS by context.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 237), ('SUPERFICIAL_RELATIONSHIP', 1181), ('INCOMPLETE_EVIDENCE', 1221), ('SUPERFICIAL_RELATIONSHIP', 1233), ('IMPORTANT_CONSIDERATION', 1276), ('SUPERFICIAL_RELATIONSHIP', 1325)]	6	[('GO_0012501', 'programmed cell death', 249, 'NutritionInfectionObstetrical'), ('CHEBI_63610', 'misoprostol', 362, 'misoprostol'), ('GO_0007623', 'circadian rhythm', 400, 'childbirth'), ('GO_0007567', 'parturition', 431, 'partum'), ('UBERON_0001013', 'adipose tissue', 431, 'partum'), ('CHEBI_24870', 'ion', 460, 'iron'), ('CHEBI_24852', 'insecticide', 568, 'insecticide'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 637, 'micronutrient'), ('CHEBI_32848', 'serine residue', 668, 'Tetanus'), ('CHEBI_29238', 'tritium atom', 676, 'toxoid'), ('GO_0007567', 'parturition', 690, 'delivery'), ('CHEBI_31341', 'calcium dihydroxide', 710, 'Calcium'), ('CHEBI_3647', 'chlorpromazine', 759, 'chlorhexidine'), ('UBERON_0010270', 'filum terminale externum', 796, 'umbilical cord stump'), ('CHEBI_27300', 'vitamin D', 842, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 850, 'A'), ('GO_0007567', 'parturition', 901, 'Birth'), ('CHEBI_27300', 'vitamin D', 970, 'vitamin A'), ('CHEBI_31721', 'Irsogladine maleate', 1059, 'Iodized salt'), ('GO_0006437', 'tyrosyl-tRNA aminoacylation', 1077, 'Family Planning')]
PMC4990268	8/2016	S294-PMC4990268	['Pregnant women who are Vitamin A deficient and their infants CAN suffer SIGNIFICANT adverse consequences AS a result of this deficiency.']	[('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 72), ('PROBABLE_UNDERSTANDING', 105)]	3	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin A')]
PMC4990268	8/2016	S295-PMC4990268	['as with all supplementation STRATEGIES to prevent the COMPLICATIONS ASSOCIATED with Micronutrient deficiencies, the IMPACT of supplementation in the Antenatal Period will DEPEND ON the overall Vitamin A status of the population and the special demands that Pregnancy makes on Vitamin A reserves.']	[('FUTURE_WORK', 28), ('IMPORTANT_CONSIDERATION', 54), ('PROBLEM_COMPLICATION', 54), ('SUPERFICIAL_RELATIONSHIP', 68), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 84, 'micronutrient'), ('GO_0007567', 'parturition', 149, 'antenatal'), ('UBERON_0006721', 'alisphenoid bone', 149, 'antenatal period'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin A'), ('GO_0007565', 'female pregnancy', 257, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin A')]
PMC4990268	8/2016	S326-PMC4990268	['maternal hiv infection: there is NO CONSISTENT EVIDENCE that Antenatal Vitamin A supplementation reduces RISK of Mother-To-child-Transmission Of Hiv (mtct) BUT there is significant heterogeneity in trial results [101].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('INCOMPLETE_EVIDENCE', 33), ('IMPORTANT_CONSIDERATION', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	4	[('GO_0007567', 'parturition', 61, 'antenatal'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin A'), ('GO_0007533', 'mating type switching', 113, 'mother-to ... transmission of HIV')]
PMC4990268	8/2016	S332-PMC4990268	['newborn Vitamin A advance distribution\nas mentioned in the section on Antenatal Vitamin A supplementation, almost 20 million women are Vitamin A deficient, with PARTICULARLY high prevalence in south and southeast asia[101].']	[('ANOMALY_CURIOUS_FINDING', 161), ('IMPORTANT_CONSIDERATION', 161)]	2	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 8, 'Vitamin A'), ('GO_0007567', 'parturition', 70, 'antenatal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A')]
PMC4990268	8/2016	S333-PMC4990268	['all infants are Born with limited to modest Liver reserves of Vitamin A and depend on breastfeeding to provide this ESSENTIAL Nutrient for proper growth and development[115].']	[('IMPORTANT_CONSIDERATION', 116)]	1	[('GO_0007567', 'parturition', 16, 'born'), ('UBERON_0002107', 'liver', 44, 'liver'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('CHEBI_33284', 'nutrient', 126, 'nutrient')]
PMC4990268	8/2016	S334-PMC4990268	['women who are Vitamin A deficient have lower levels in Breastmilk THUS limiting the intake during this CRUCIAL age[115].']	[('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 103)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin A'), ('UBERON_0001348', 'brown adipose tissue', 55, 'breastmilk')]
PMC4990268	8/2016	S360-PMC4990268	['in settings with endemic Vitamin A deficiency there is an overall BENEFIT to newborn dosing with regard to early infant mortality WHEREAS in settings without deficiency there is no evidence of benefit.']	[('IMPORTANT_CONSIDERATION', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 130)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A')]
PMC4990268	8/2016	S363-PMC4990268	['prepositioning a single capsule of Vitamin A (50,000 iu) at the location of Delivery in those settings where BENEFIT can be expected (primarily poorer, south asian populations) is FEASIBLE.']	[('IMPORTANT_CONSIDERATION', 109), ('PROBABLE_UNDERSTANDING', 180)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin A'), ('GO_0007567', 'parturition', 76, 'delivery')]
PMC4990268	8/2016	S364-PMC4990268	['the expected reduction in mortality BURDEN achievable with this intervention will vary DEPENDING ON the population BURDEN of Vitamin A deficiency among women of Reproductive age.']	[('IMPORTANT_CONSIDERATION', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('IMPORTANT_CONSIDERATION', 115)]	3	[('CHEBI_27300', 'vitamin D', 125, 'vitamin A'), ('GO_0000003', 'reproduction', 161, 'reproductive')]
PMC4990268	8/2016	S1116-PMC4990268	['intable 6below, we have offered very brief comments on such implementation CONSIDERATIONS.10.1371/journal.pone.0160562.t006\n\ncaption (table-wrap): table 6\n“best buy” ratings for interventions reviewed.interventionpopulation impactease of Deliverycommentsbreastfeeding—early initiation ✓ ☺large magnitude EFFECT on newborn mortalityiron/ anemia ✓✓✓ ☺LIKELY a significant mortality EFFECT, BUT EVIDENCE is WEAK; clear benefit however for iugr multi-Micronutrient supplementation✓ ☺ ALTHOUGH iugr is reduced , in many low income settings there MAY BE no net benefit; under SOME conditions there MAY BE net harm Calcium ✓✓✓😐 large magnitude EFFECTS but significant logistical barriers at currently recommended dose antenatal Vitamin A ☺ no effects on our outcomes of interest Postnatal Vitamin A ✓ ☺EVIDENCE for IMPACT on early infant deaths in Vitamin-A deficient populationsiodine ✓ ☺major benefit in ↓’d burden of Cognitive disabilitybalanced protein-energy supplementation ✓✓✓😐 significant benefits, but cost & logistical challenges limit scalability deworming ☺ no effects on our outcomes of interest iptp/itns ✓✓✓✓ ☺large magnitude EFFECTS in malarious areastetanus Toxoid ✓ ☺in most settings, coverage is now relatively high; this NEEDS to be sustainedchlorhexidine advance distribution ✓ ☺large magnitude EFFECT on newborn mortality in high nmr populationssyphilis screening & treatment ✓✓✓ ☺relatively inexpensive and straightforward diagnostics and treatmentpmtct ✓😐 high population effective coverage REQUIRES robust services and systemsmisoprostol advance distribution ✓ ☺to ensure SAFETY, Delivery strategy NEEDS to reliably ensure counseling on correct timing of use (i.e.']	[('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 304), ('PROBABLE_UNDERSTANDING', 349), ('SUPERFICIAL_RELATIONSHIP', 380), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('INCOMPLETE_EVIDENCE', 392), ('INCOMPLETE_EVIDENCE', 404), ('ANOMALY_CURIOUS_FINDING', 480), ('INCOMPLETE_EVIDENCE', 541), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 592), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 795), ('SUPERFICIAL_RELATIONSHIP', 808), ('SUPERFICIAL_RELATIONSHIP', 1134), ('FUTURE_WORK', 1234), ('SUPERFICIAL_RELATIONSHIP', 1309), ('IMPORTANT_CONSIDERATION', 1508), ('IMPORTANT_CONSIDERATION', 1590), ('FUTURE_WORK', 1616), ('IMPORTANT_CONSIDERATION', 1616)]	21	[('GO_0031078', 'histone deacetylase activity (H3-K14 specific)', 238, 'DeliveryCommentsBreastfeeding'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 447, 'micronutrient'), ('CHEBI_31341', 'calcium dihydroxide', 608, 'Calcium'), ('CHEBI_77082', 'O-adipoylcarnitine(1-)', 616, '✓✓✓😐'), ('CHEBI_33233', 'fundamental particle', 721, 'vitamin A ☺'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 721, 'vitamin A ☺'), ('GO_0007567', 'parturition', 772, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 782, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 841, 'vitamin'), ('PR_000027594', 'histone H3', 841, 'vitamin-A'), ('GO_0050890', 'cognition', 913, 'cognitive'), ('CHEBI_29238', 'tritium atom', 1168, 'toxoid'), ('GO_0007567', 'parturition', 1598, 'delivery')]
PMC4990268	8/2016	S1153-PMC4990268	['DEPENDING ON the setting, this COULD BE supplemented by clinical preventive interventions that CAN be put into operation at the time of home Births, NOTABLY the use of Misoprostol for prevention of pph, application of Chlorhexidine to the Umbilical Cord Stump and newborn Vitamin A supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 95), ('IMPORTANT_CONSIDERATION', 149)]	4	[('GO_0007567', 'parturition', 141, 'births'), ('CHEBI_63610', 'misoprostol', 168, 'misoprostol'), ('CHEBI_3647', 'chlorpromazine', 218, 'chlorhexidine'), ('UBERON_0010270', 'filum terminale externum', 239, 'umbilical cord stump'), ('CHEBI_27300', 'vitamin D', 272, 'vitamin A')]
PMC4990268	8/2016	S1184-PMC4990268	['BUT current RECOMMENDED dose imposes IMPORTANT logistical DIFFICULTIES.antenatal vitamin aroutine supplementation not indicated BUT in Vitamin A deficient populations screening for night blindness and treating such cases with Vitamin A CAN be RECOMMENDED.Postnatal vitamin abenefit expected in Vitamin A deficient populations (e.g.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 12), ('IMPORTANT_CONSIDERATION', 37), ('DIFFICULT_TASK', 58), ('PROBLEM_COMPLICATION', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('INCOMPLETE_EVIDENCE', 236), ('FUTURE_WORK', 243)]	8	[('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A'), ('GO_0007567', 'parturition', 255, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 294, 'vitamin A')]
PMC4990280	8/2016	S150-PMC4990280	['the mm supplement of unicef/who/unu contained IMPORTANT antioxidants such as Vitamin E, Vitamin C and Selenium which are KNOWN to reduce inflammatory responses.']	[('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 121)]	2	[('CHEBI_27300', 'vitamin D', 77, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin C'), ('CHEBI_27568', 'selenium atom', 102, 'selenium')]
PMC4992225	8/2016	S0-PMC4992225	['a randomized controlled trial of Vitamin D supplementation on Perinatal depression: in iranian Pregnant mothers\n\nabstract\n\nbackground\nMood disorders in Pregnancy and Post-Partum Period are common and CONSIDERED as a PUBLIC HEALTH ISSUE.']	[('IMPORTANT_CONSIDERATION', 200), ('IMPORTANT_CONSIDERATION', 216), ('IMPORTANT_CONSIDERATION', 230)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0036268', 'swimming', 62, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 62, 'perinatal'), ('GO_0007565', 'female pregnancy', 95, 'pregnant'), ('GO_0065007', 'biological regulation', 134, 'Mood'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy'), ('GO_0007565', 'female pregnancy', 166, 'post-partum'), ('UBERON_0001699', 'sensory root of facial nerve', 171, 'partum period')]
PMC4992225	8/2016	S39-PMC4992225	['IN ACCORDANCE to a GUIDELINE by holick et al., 6–8 weeks Consumption of a high dose Vitamin D supplement are ESSENTIAL to obtain an adequate Blood reserves of Vitamin D [19].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 19), ('IMPORTANT_CONSIDERATION', 109)]	3	[('GO_0007631', 'feeding behavior', 57, 'consumption'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0000178', 'blood', 141, 'blood'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4992225	8/2016	S40-PMC4992225	['it SEEMS that in addition to Calcium Homeostasis and bone health, Vitamin D is also ESSENTIAL for Brain Development and function [20,21].']	[('ANOMALY_CURIOUS_FINDING', 3), ('IMPORTANT_CONSIDERATION', 84)]	2	[('GO_0055073', 'cadmium ion homeostasis', 29, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007420', 'brain development', 98, 'brain development'), ('UBERON_0000955', 'brain', 98, 'brain')]
PMC4992225	8/2016	S47-PMC4992225	['SUGGESTED that more accurate clinical trials are REQUIRED to reach a CONCLUSION about the effectiveness of Vitamin D on depression [31].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 69)]	3	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC4992225	8/2016	S88-PMC4992225	['we also CONSIDERED Vitamin D INSUFFICIENCY AS a Serum 25-Hydroxyvitamin D of 21–29\xa0ng/ml, and the participants who had Serum 25-Hydroxyvitamin d of\u2009≥\u200930\xa0ng/ml AS sufficient [19,46].']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 29), ('PROBABLE_UNDERSTANDING', 43), ('PROBABLE_UNDERSTANDING', 159)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 54, '25-hydroxyvitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_67376', 'dihydrooroxylin A', 125, '25-hydroxyvitamin')]
PMC4992225	8/2016	S184-PMC4992225	['CONSIDERING the FACTORS AFFECTING Vitamin D Production such as clothing type, skin color and the time of day being exposed to the sun [48–50], these results are JUSTIFIABLE.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 161)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 34, 'vitamin D production')]
PMC4993554	8/2016	S113-PMC4993554	['Vitamins and other supplements in Pregnancy\nwomen’s awareness about the RECOMMENDATIONS for Supplements in Pregnancy was explored, including vitamins and other RECOMMENDED supplements (Folic Acid and Iodine), as well as those Vitamins for which there were DANGERS ASSOCIATED with excessive doses (Vitamin A, Vitamin D, and Vitamin B6).']	[('FUTURE_WORK', 72), ('FUTURE_WORK', 160), ('IMPORTANT_CONSIDERATION', 256), ('SUPERFICIAL_RELATIONSHIP', 264)]	4	[('CHEBI_28371', 'vitamin K epoxide', 0, 'Vitamins'), ('GO_0007565', 'female pregnancy', 34, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 92, 'supplements'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy'), ('CHEBI_30751', 'formic acid', 185, 'folic acid'), ('CHEBI_24859', 'iodine atom', 200, 'iodine'), ('CHEBI_33277', 'gamma-tocotrienol', 226, 'vitamins'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 305, 'A'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 323, 'vitamin B6'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 331, 'B6')]
PMC4993554	8/2016	S175-PMC4993554	['although Liver is a rich source of key Nutrients such as Iron and Folate, avoiding it in Pregnancy is RECOMMENDED as it contains a high level of Vitamin A and the upper safer limit is UNCERTAIN.52a high dose of Vitamin A in Pregnancy poses a SERIOUS risk of Birth defects.53ALTHOUGH our study DID NOT provide information on HOW this low awareness of Vitamin A-rich source Food COULD AFFECT Pregnant women’s Food choices, written comments (open text sections of the survey) in the PRESENT STUDY INDICATED that SOME women MAY BE INFLUENCED by some of nonevidence-based information.']	[('FUTURE_WORK', 102), ('FULL_UNKNOWN', 184), ('IMPORTANT_CONSIDERATION', 242), ('ANOMALY_CURIOUS_FINDING', 272), ('INCOMPLETE_EVIDENCE', 293), ('EXPLICIT_QUESTION', 324), ('INCOMPLETE_EVIDENCE', 377), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 480), ('INCOMPLETE_EVIDENCE', 494), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 520), ('SUPERFICIAL_RELATIONSHIP', 527)]	13	[('UBERON_0002107', 'liver', 9, 'liver'), ('CHEBI_33284', 'nutrient', 39, 'nutrients'), ('CHEBI_24870', 'ion', 57, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 66, 'folate'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin A'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007567', 'parturition', 258, 'birth'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin A'), ('CHEBI_33290', 'food', 372, 'food'), ('GO_0007565', 'female pregnancy', 390, 'pregnant'), ('CHEBI_33290', 'food', 407, 'food')]
PMC4997421	8/2016	S1-PMC4997421	['BECAUSE maternal Tissue is progressively depleted of Vitamin A to supply fetal demands, women who become Pregnant while possessing marginal Vitamin A reserves are at INCREASED RISK of vitamin a inadequacy as Pregnancy progresses.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 166)]	2	[('UBERON_0000479', 'tissue', 17, 'tissue'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin A'), ('GO_0007565', 'female pregnancy', 105, 'pregnant'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin A'), ('GO_0007565', 'female pregnancy', 208, 'pregnancy')]
PMC4997421	8/2016	S11-PMC4997421	['conclusion there APPEAR TO BE DISPARITIES in Serum Vitamin A levels in women of Childbearing age RELATED to income and race in the united states.']	[('ANOMALY_CURIOUS_FINDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('IMPORTANT_CONSIDERATION', 30), ('SUPERFICIAL_RELATIONSHIP', 97)]	4	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 80, 'childbearing')]
PMC4997421	8/2016	S13-PMC4997421	['introduction\nvitamin a is an ESSENTIAL Nutrient throughout the Lifecycle; HOWEVER, its INFLUENCE is PARTICULARLY CRITICAL during periods when cells Proliferate rapidly and differentiate, such as during Pregnancy.adequate Vitamin A status in the mother is CRITICAL for fetal growth, Morphogenesis, and maturation of multiple Organ Systems, including the Immune System, Lungs, and Eyes [1,2].']	[('IMPORTANT_CONSIDERATION', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('SUPERFICIAL_RELATIONSHIP', 87), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 113), ('IMPORTANT_CONSIDERATION', 255)]	6	[('CHEBI_33284', 'nutrient', 39, 'nutrient'), ('UBERON_0000104', 'life cycle', 63, 'lifecycle'), ('GO_0008283', 'cell proliferation', 148, 'proliferate'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin A'), ('GO_0009653', 'anatomical structure morphogenesis', 282, 'morphogenesis'), ('UBERON_0000467', 'anatomical system', 324, 'organ systems'), ('UBERON_0002405', 'immune system', 353, 'immune system'), ('UBERON_0002048', 'lung', 368, 'lungs'), ('UBERON_0000970', 'eye', 379, 'eyes')]
PMC4997421	8/2016	S14-PMC4997421	['maternal Vitamin A deficiency increases the RISK of COMPLICATIONS during Pregnancy and in the Postpartum Period and HAS BEEN positively ASSOCIATED with Preterm Delivery [3], maternal infections, night blindness, anemia [4], and Birth defects [5].']	[('IMPORTANT_CONSIDERATION', 44), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('GO_0007565', 'female pregnancy', 94, 'postpartum'), ('UBERON_2001055', 'pronephric duct opening', 105, 'period'), ('GO_0007565', 'female pregnancy', 152, 'preterm'), ('GO_0007567', 'parturition', 160, 'delivery'), ('GO_0007567', 'parturition', 228, 'birth')]
PMC4997421	8/2016	S15-PMC4997421	['maternal Vitamin A deficiency also has SERIOUS repercussions for the newborn and is ASSOCIATED with depressed Immune function and higher morbidity and mortality due to infections [1], low Birth weight [6], Diaphragmatic hernia [7], bronchopulmonary dysplasia and other Respiratory disease [8,9,10].']	[('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 84)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('UBERON_0002405', 'immune system', 110, 'immune'), ('GO_0007567', 'parturition', 188, 'birth'), ('UBERON_0001103', 'diaphragm', 206, 'diaphragmatic'), ('UBERON_0001004', 'respiratory system', 269, 'respiratory')]
PMC4997421	8/2016	S21-PMC4997421	['since maternal stores will be rapidly depleted in order to provide Vitamin A to the developing fetus [14], it is CRITICAL that women of Childbearing age are sufficient in Vitamin A prior to Conception.']	[('IMPORTANT_CONSIDERATION', 113)]	1	[('CHEBI_27300', 'vitamin D', 67, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 136, 'childbearing'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin A'), ('GO_0007620', 'copulation', 190, 'conception')]
PMC4997421	8/2016	S32-PMC4997421	['we chose these categories based on evidence that maternal stores will be rapidly depleted by the developing fetus [14], therefore we deemed it IMPORTANT that a woman begins a Pregnancy with sufficient Vitamin A stores.']	[('IMPORTANT_CONSIDERATION', 143)]	1	[('GO_0007565', 'female pregnancy', 175, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin A')]
PMC4997421	8/2016	S91-PMC4997421	['BECAUSE maternal Tissues are progressively depleted of Vitamin A to supply fetal demands [14], women who initially possess marginal or EVEN adequate Vitamin A stores at the beginning of Pregnancy are at an INCREASED RISK of Vitamin A inadequacy as Pregnancy progresses.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 135), ('IMPORTANT_CONSIDERATION', 206)]	3	[('UBERON_0000479', 'tissue', 17, 'tissues'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin A'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin A'), ('GO_0007565', 'female pregnancy', 248, 'pregnancy')]
PMC4997421	8/2016	S93-PMC4997421	['FOUND a significantly increased RISK of spontaneous Preterm Delivery, maternal anemia, and Pregnancy-induced hypertension when Retinol levels were below 0.70 µmol/l, and BASED ON those functional EFFECTS RECOMMEND a level of 0.70 µmol/l to define Vitamin A deficiency in Pregnancy [3].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 32), ('INCOMPLETE_EVIDENCE', 170), ('QUESTION_ANSWERED_BY_THIS_WORK', 170), ('SUPERFICIAL_RELATIONSHIP', 196), ('FUTURE_WORK', 204)]	6	[('GO_0007565', 'female pregnancy', 52, 'preterm'), ('GO_0007567', 'parturition', 60, 'delivery'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('CHEBI_26536', 'retinoic acid', 127, 'retinol'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin A'), ('GO_0007565', 'female pregnancy', 271, 'pregnancy')]
PMC4997421	8/2016	S94-PMC4997421	['measurements of Vitamin A concentrations in Breast Milk, maternal Serum Vitamin A concentration, and maternal dietary intake SUGGEST that a maternal concentration of ≥1.05 µmol/l is NECESSARY in order to maintain a sufficient Vitamin A content in Breast Milk [26].']	[('INCOMPLETE_EVIDENCE', 125), ('IMPORTANT_CONSIDERATION', 182)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin A'), ('UBERON_0001348', 'brown adipose tissue', 44, 'breast milk'), ('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 80, 'A'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A'), ('UBERON_0000310', 'breast', 247, 'breast'), ('UBERON_0001913', 'milk', 254, 'milk')]
PMC4997421	8/2016	S95-PMC4997421	['THEREFORE, it is IMPERATIVE that women be Vitamin A sufficient prior to Becoming Pregnant in order to avoid depletion of Vitamin A stores DUE TO fetal and Lactation demands and subsequent ramifications to the mother or developing infant.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 17), ('PROBLEM_COMPLICATION', 138)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin A'), ('GO_0007567', 'parturition', 72, 'becoming'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin A'), ('GO_0007595', 'lactation', 155, 'lactation')]
PMC4997421	8/2016	S108-PMC4997421	['RECENT STUDIES have raised concerns regarding Nutrient intake in the united states, ESPECIALLY with regard to Vitamin A and Vitamin A precursors from fruits and vegetables.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 84)]	2	[('CHEBI_33284', 'nutrient', 46, 'nutrient'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin A')]
PMC4997421	8/2016	S136-PMC4997421	['our use of the who Retinol classifications, HOWEVER, does provide us with INFORMATION about the Vitamin A status of this IMPORTANT population [44], women of Childbearing age.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('INCOMPLETE_EVIDENCE', 74), ('IMPORTANT_CONSIDERATION', 121)]	3	[('CHEBI_26536', 'retinoic acid', 19, 'retinol'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 157, 'childbearing')]
PMC4997421	8/2016	S138-PMC4997421	['conclusions\nour results DEMONSTRATE IT IS POSSIBLE that Vitamin A deficiency is a PUBLIC HEALTH CONCERN in nutritionally disadvantaged populations of industrialized societies.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 82)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin A')]
PMC4997421	8/2016	S139-PMC4997421	['MORE RESEARCH IS NEEDED to determine WHAT type of INTERVENTIONS will be best for specific populations, ESPECIALLY the low-income and minority populations that bear a greater BURDEN of Vitamin A inadequacy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('EXPLICIT_QUESTION', 37), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 103), ('IMPORTANT_CONSIDERATION', 174)]	6	[('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 192, 'A')]
PMC4997567	8/2016	S15-PMC4997567	['the study was DESIGNED to compare affected versus unaffected children in egypt taking into CONSIDERATION the socioeconomic status, housing and nutritional history, clinical examination, laboratory biochemical serum calcium, phosphorus, alkaline phosphatase, and active Vitamin D 1,25(Oh)2D levels, and radiographic findings.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('IMPORTANT_CONSIDERATION', 91)]	2	[('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 281, '25(OH)2D')]
PMC4997567	8/2016	S68-PMC4997567	['discussion\nnutritional Vitamin D deficiency rickets STILL exists in egypt with an overall incidence rate of 13.1%; although the sun is shining all the year [1].']	[('IMPORTANT_CONSIDERATION', 52)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC4997567	8/2016	S94-PMC4997567	['hollis and wagner (2004) [21] NOTICED that ALTHOUGH Breast Milk is adequate for growth and bone mineralization in the first year of Life, it is lacking adequate concentration of Vitamin D. THEREFORE, Vitamin D supplementation MUST BE NECESSARY for Breast-Fed infants.']	[('ANOMALY_CURIOUS_FINDING', 30), ('ANOMALY_CURIOUS_FINDING', 43), ('PROBABLE_UNDERSTANDING', 189), ('IMPORTANT_CONSIDERATION', 226), ('IMPORTANT_CONSIDERATION', 234)]	5	[('UBERON_0000310', 'breast', 52, 'breast'), ('UBERON_0001913', 'milk', 59, 'milk'), ('UBERON_0000104', 'life cycle', 132, 'life'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0000310', 'breast', 248, 'breast'), ('GO_0007631', 'feeding behavior', 255, 'fed')]
PMC4997567	8/2016	S103-PMC4997567	['several RISK FACTORS had IMPORTANT CONTRIBUTIONS, including low socio-economic status represented by low family income, low standard of education, poor housing conditions, lack of exposure to sunlight, nutritional status of mother, and prolonged Breast-Feeding without Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 8), ('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('GO_0007567', 'parturition', 246, 'breast-'), ('UBERON_0000310', 'breast', 246, 'breast'), ('GO_0007631', 'feeding behavior', 253, 'feeding'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC4998950	4/2016	S10-PMC4998950	['environmental and Genetic FACTORS APPEAR equally IMPORTANT,1ALTHOUGH asd with and without intellectual disability MAY IN PART have DIFFERENT origins.2,3\nin high-latitude countries such as sweden, children of mothers with dark complexion are at PARTICULARLY elevated RISK of asd with intellectual disability.3because such women OFTEN have very low Vitamin d levels due to Melanin absorption of uvb radiation, maternal Vitamin D deficiency HAS BEEN SUGGESTED to CONTRIBUTE to asd risk in offspring.4,5indeed, experimentally induced Vitamin D deficiency in Pregnant dams is REPORTED to AFFECT foetal Neurodevelopment and behaviour in Adult offspring in Rats,4AND a RECENT STUDY DEMONSTRATED lower neonatal Vitamin D levels in children with asd compared with their siblings.6\nearly Life Vitamin D deficiency is THUS a POSSIBLE RISK FACTOR for asd, BUT direct SUPPORT of an ASSOCIATION IS LACKING.4maternal hypovitaminosis d is treatable, THUS INVESTIGATION of the matter IS WARRANTED.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 49), ('ANOMALY_CURIOUS_FINDING', 59), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('ANOMALY_CURIOUS_FINDING', 244), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 266), ('PROBABLE_UNDERSTANDING', 327), ('INCOMPLETE_EVIDENCE', 438), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 571), ('SUPERFICIAL_RELATIONSHIP', 583), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 655), ('INCOMPLETE_EVIDENCE', 662), ('INCOMPLETE_EVIDENCE', 675), ('PROBABLE_UNDERSTANDING', 807), ('INCOMPLETE_EVIDENCE', 814), ('SUPERFICIAL_RELATIONSHIP', 823), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 844), ('INCOMPLETE_EVIDENCE', 855), ('SUPERFICIAL_RELATIONSHIP', 869), ('INCOMPLETE_EVIDENCE', 881), ('FULL_UNKNOWN', 884), ('PROBABLE_UNDERSTANDING', 934), ('FUTURE_WORK', 939), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 347, 'vitamin'), ('CHEBI_25179', 'melanins', 371, 'melanin'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnant'), ('GO_0007399', 'nervous system development', 597, 'neurodevelopment'), ('UBERON_0007023', 'adult organism', 631, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 650, 'rats'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin D'), ('UBERON_0000104', 'life cycle', 778, 'life'), ('CHEBI_27300', 'vitamin D', 783, 'vitamin D')]
PMC4998950	4/2016	S33-PMC4998950	['discussion\nTHIS STUDY is, TO OUR KNOWLEDGE, the FIRST population-based study to ESTIMATE the RELATIONSHIP between maternal Vitamin D deficiency and the RISK of asd in a child.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 93), ('IMPORTANT_CONSIDERATION', 152)]	6	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4998950	4/2016	S38-PMC4998950	['indeed, diagnosed maternal Vitamin D deficiency CO-OCCURRED with such FACTORS including parental psychiatric histories10(including depression, a PROXY also for in utero exposure to Antidepressants, shown to, RATHER than the underlying disorder, increase the risk of asd),11immigration status3and disadvantageous social position.8hence, residual CONFOUNDING CANNOT BE ruled out.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 70), ('SUPERFICIAL_RELATIONSHIP', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('PROBLEM_COMPLICATION', 345), ('DIFFICULT_TASK', 357)]	8	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_35475', 'non-steroidal anti-inflammatory drug', 181, 'antidepressants')]
PMC4998950	4/2016	S43-PMC4998950	['our finding of a stronger ASSOCIATION between maternal hypovitaminosis d and asd with intellectual disability than without intellectual disability is IN LINE WITH migrant STUDIES, DEMONSTRATING that offspring risk of severe forms of asd – BUT NOT asperger’s syndrome or asd without intellectual disability – is increased in migrant populations where Vitamin D deficiency is highly prevalent.3–6,8there is also MOUNTING EVIDENCE that environmental FACTORS are more RELEVANT (THAN Genetic factors) for the development of lower-functioning asd.2we, as well as others,6FURTHER OBSERVED heterogeneity in the ASSOCIATIONS between Vitamin D deficiency and asd between children with and without maternal migrant history.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 150), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239), ('ANOMALY_CURIOUS_FINDING', 239), ('INCOMPLETE_EVIDENCE', 410), ('SUPERFICIAL_RELATIONSHIP', 447), ('IMPORTANT_CONSIDERATION', 464), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 474), ('INCOMPLETE_EVIDENCE', 564), ('INCOMPLETE_EVIDENCE', 573), ('SUPERFICIAL_RELATIONSHIP', 603)]	13	[('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('SO_0000704', 'gene', 479, 'genetic'), ('CHEBI_27300', 'vitamin D', 624, 'vitamin D')]
PMC4998950	4/2016	S45-PMC4998950	['there are, HOWEVER, biological UNDERPINNINGS of a TRUE ASSOCIATION AS experimental studies INDICATE CRITICAL ROLES of Vitamin D in the Development and functioning Of the Brain.4\nIN SUMMARY, our results SUPPORT, BUT DO NOT PROVE, the HYPOTHESIS that maternal Vitamin D status is IMPLICATED in the aetiology of asd with comorbid intellectual disability.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('PROBABLE_UNDERSTANDING', 50), ('SUPERFICIAL_RELATIONSHIP', 55), ('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('FULL_UNKNOWN', 215), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 278)]	14	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0050887', 'determination of sensory modality', 135, 'development ... of ... brain'), ('UBERON_0000955', 'brain', 170, 'brain'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC4998950	4/2016	S46-PMC4998950	['AS Vitamin D deficiency in Pregnancy is both PREVALENT and treatable, FURTHER INVESTIGATION of this ASSOCIATION IS NEEDED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 45), ('FUTURE_WORK', 70), ('FUTURE_WORK', 78), ('SUPERFICIAL_RELATIONSHIP', 100), ('FUTURE_WORK', 112)]	6	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007565', 'female pregnancy', 27, 'pregnancy')]
PMC5014971	8/2016	S4-PMC5014971	['a majority INDICATED that Vitamin D insufficiency was a PROBLEM in their patient population (68.4%) and that most of their Pregnant patients would BENEFIT from vitamin D supplementation (66.3%).']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 56), ('PROBLEM_COMPLICATION', 56), ('IMPORTANT_CONSIDERATION', 147)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnant'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 168, 'D')]
PMC5014971	8/2016	S7-PMC5014971	['physicians who indicated that Vitamin D status was a PROBLEM in their patient population were more LIKELY to screen routinely (32.8% versus 9.7%, p = 0.002) and believe their patients would BENEFIT from supplementation (91.2% versus 16.1%, p = 0.001).']	[('IMPORTANT_CONSIDERATION', 53), ('PROBABLE_UNDERSTANDING', 99), ('IMPORTANT_CONSIDERATION', 190)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC5014971	8/2016	S10-PMC5014971	['introduction\nit is ONLY relatively recently in Human history that Vitamin D became a REQUIRED Nutrient.']	[('INCOMPLETE_EVIDENCE', 19), ('IMPORTANT_CONSIDERATION', 85)]	2	[('NCBITaxon_9606', 'Homo sapiens', 47, 'human'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_33284', 'nutrient', 94, 'nutrient')]
PMC5014971	8/2016	S13-PMC5014971	['the geographic expansion of humanity, the modern environment, and medical CONCERNS over the sequela of extensive sun exposure (e.g., melanoma) have created conditions where for much of modern humanity Endogenous Vitamin D Production is LIKELY far below that of our ancestors.']	[('IMPORTANT_CONSIDERATION', 74), ('PROBABLE_UNDERSTANDING', 236)]	2	[('GO_0009790', 'embryo development', 201, 'endogenous'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 212, 'vitamin D production')]
PMC5014971	8/2016	S14-PMC5014971	['the IMPORTANCE of dietary Vitamin D, both naturally occurring in foods and via supplements added to foods (e.g., fortified Milk) or Consumed directly, has increased.']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0001913', 'milk', 123, 'milk'), ('GO_0007631', 'feeding behavior', 132, 'consumed')]
PMC5014971	8/2016	S16-PMC5014971	['POOR Vitamin D status is a RISK FACTOR for POOR Skeletal Development and fractures in newborns [3].']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('IMPORTANT_CONSIDERATION', 43)]	3	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('GO_0001501', 'skeletal system development', 48, 'skeletal development'), ('UBERON_0004288', 'skeleton', 48, 'skeletal')]
PMC5014971	8/2016	S19-PMC5014971	['as many as 30% of Pregnant women in the us MAY have INADEQUATE Vitamin D status [12].']	[('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 52)]	2	[('GO_0007565', 'female pregnancy', 18, 'pregnant'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC5014971	8/2016	S20-PMC5014971	['in SOME populations, especially during the winter months in higher latitudes, the proportion of Pregnant women with INADEQUATE Vitamin D status MAY exceed 50% [13], DEPENDING ON whose definition of INADEQUATE is used.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 116), ('INCOMPLETE_EVIDENCE', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('PROBLEM_COMPLICATION', 198)]	5	[('GO_0007565', 'female pregnancy', 96, 'pregnant'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC5014971	8/2016	S21-PMC5014971	['there is SOME uncertainty over the extent of the us population that has INADEQUATE Vitamin D status DUE TO DISAGREEMENTS between experts as to WHAT constitutes INADEQUATE status.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 72), ('PROBLEM_COMPLICATION', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('EXPLICIT_QUESTION', 143), ('IMPORTANT_CONSIDERATION', 160)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC5014971	8/2016	S22-PMC5014971	['the main storage form of Vitamin D in Blood is 25-Hydroxyvitamin D (25-Oh-D) which makes this vitamin d metabolite the BEST indicator of nutritional status [2].']	[('IMPORTANT_CONSIDERATION', 119)]	1	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000178', 'blood', 38, 'blood'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 47, '25-hydroxyvitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 68, '25-OH-D')]
PMC5014971	8/2016	S24-PMC5014971	['other researchers have QUESTIONED this FINDING, citing both a CONCERN that circulating levels of 25-Oh-D at 20\u2009ng/ml have not been shown to be sufficient for bone health for all populations and that OTHER nonskeletal functions of Vitamin D POTENTIALLY IMPORTANT for health, which the iom report DISCOUNTS BASED ON INADEQUATE evidence, MAY yet be shown to be IMPORTANT and REQUIRE higher circulating levels of 25-Oh-D [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 199), ('INCOMPLETE_EVIDENCE', 240), ('IMPORTANT_CONSIDERATION', 252), ('INCOMPLETE_EVIDENCE', 295), ('PROBABLE_UNDERSTANDING', 305), ('ANOMALY_CURIOUS_FINDING', 311), ('IMPORTANT_CONSIDERATION', 314), ('PROBLEM_COMPLICATION', 314), ('INCOMPLETE_EVIDENCE', 335), ('IMPORTANT_CONSIDERATION', 358), ('IMPORTANT_CONSIDERATION', 372)]	15	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 97, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 409, '25-OH-D')]
PMC5014971	8/2016	S29-PMC5014971	['OBSERVATIONAL studies have CONSISTENTLY FOUND an ASSOCIATION with low maternal Vitamin D status and INCREASED risk of neonatal infectious disease and later inflammatory and atopic disease in offspring [21].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 27), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 100)]	5	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5014971	8/2016	S33-PMC5014971	['Vitamin D supplementation during Pregnancy is GENERALLY CONSIDERED SAFE, THOUGH rigorous studies on high doses of Vitamin D supplementation are LACKING [25].']	[('PROBABLE_UNDERSTANDING', 46), ('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 67), ('ANOMALY_CURIOUS_FINDING', 73), ('INCOMPLETE_EVIDENCE', 144)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5014971	8/2016	S34-PMC5014971	['results from a RECENT STUDY INDICATE that Vitamin D supplementation during Pregnancy with up to 4,000\u2009iu/day is SAFE and EFFECTIVE [26].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 112), ('SUPERFICIAL_RELATIONSHIP', 121)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy')]
PMC5014971	8/2016	S35-PMC5014971	['HOWEVER, CONSENSUS on WHAT constitutes adequate Vitamin D status during Pregnancy and the most efficacious means to prevent and treat Vitamin D deficiency/insufficiency in Pregnant women has yet to be reached, leading to DIFFERING assessments of this PUBLIC HEALTH ISSUE [14,19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('EXPLICIT_QUESTION', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('IMPORTANT_CONSIDERATION', 251), ('IMPORTANT_CONSIDERATION', 265)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 172, 'pregnant')]
PMC5014971	8/2016	S43-PMC5014971	['the survey contained questions on physician and patient population demographics, physician opinion regarding health CONCERNS associated with Vitamin D deficiency/insufficiency, and practice patterns regarding screening and supplementing Pregnant women.']	[('IMPORTANT_CONSIDERATION', 116)]	1	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 237, 'pregnant')]
PMC5014971	8/2016	S64-PMC5014971	['a majority responded that Vitamin D insufficiency was a PROBLEM in their patient population (68.3%) and that most of their patients would BENEFIT from taking a Vitamin D supplement (66.3%).']	[('IMPORTANT_CONSIDERATION', 56), ('PROBLEM_COMPLICATION', 56), ('IMPORTANT_CONSIDERATION', 138)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC5014971	8/2016	S68-PMC5014971	['a majority of respondents considered Vitamin D supplementation during Pregnancy (82.1%) to be SAFE.']	[('IMPORTANT_CONSIDERATION', 94)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy')]
PMC5014971	8/2016	S69-PMC5014971	['respondents were CONCERNED about Vitamin D deficiency and osteoporosis (91.1%) and bone fractures (88.1%), but less CONCERNED about other POSSIBLE sequelae of Vitamin D deficiency such as a weakened Immune System (32.7%), Colon cancer (27.7%), Cardiovascular disease (23.8%), impaired glucose Metabolism (22.8%), vulnerability to preeclampsia (22.8%), increased risk of small-for-Gestational-age infant (21.8%), vulnerability to Preterm Labor (19.8%), Breast cancer (14.9%), hypertension (12.9%), and infertility (10.9%).']	[('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 116), ('INCOMPLETE_EVIDENCE', 138)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('UBERON_0002405', 'immune system', 199, 'immune system'), ('UBERON_0001155', 'colon', 222, 'colon'), ('UBERON_0004535', 'cardiovascular system', 244, 'cardiovascular'), ('GO_0008152', 'metabolic process', 293, 'metabolism'), ('GO_0007565', 'female pregnancy', 380, 'gestational'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 429, 'preterm labor'), ('UBERON_0000310', 'breast', 452, 'breast')]
PMC5014971	8/2016	S72-PMC5014971	['physicians that reported having read co 495 were more LIKELY to screen their Pregnant patients (36.9% always or often versus 17.0% that had not read co 495; p< 0.001) AS were physicians that reported that Vitamin D insufficiency was a PROBLEM in their patient population (32.8% always or often versus 9.7%; p = 0.004).']	[('PROBABLE_UNDERSTANDING', 54), ('PROBABLE_UNDERSTANDING', 167), ('IMPORTANT_CONSIDERATION', 235), ('PROBLEM_COMPLICATION', 235)]	4	[('GO_0007565', 'female pregnancy', 77, 'pregnant'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
PMC5014971	8/2016	S80-PMC5014971	['there was a LACK OF consensus of opinion among respondents regarding whether Pregnant women taking Prenatal Vitamins are at low RISK of Vitamin D deficiency, with equal proportions agreeing and disagreeing and the modal response being neutral.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('ANOMALY_CURIOUS_FINDING', 17), ('IMPORTANT_CONSIDERATION', 128)]	3	[('GO_0007565', 'female pregnancy', 77, 'pregnant'), ('GO_0007565', 'female pregnancy', 99, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 108, 'vitamins'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC5014971	8/2016	S83-PMC5014971	['physicians who considered Vitamin D insufficiency a PROBLEM among their patients were more LIKELY to think that most of their Pregnant patients would BENEFIT from taking Vitamin D supplements (91.2% versus 16.1%; p< 0.001).']	[('IMPORTANT_CONSIDERATION', 52), ('PROBABLE_UNDERSTANDING', 91), ('IMPORTANT_CONSIDERATION', 150)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'pregnant'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5014971	8/2016	S87-PMC5014971	['regarding the level of circulating 25-Hydroxyvitamin D below which there is CONCERN for Vitamin D deficiency, respondents were ROUGHLY split between below 20\u2009ng/ml (50\u2009nmol/l) and 32\u2009ng/ml (80\u2009nmol/l) AS the level at which they would RECOMMEND a higher supplementation dose of vitamin d (46.5% versus 40.6%).']	[('IMPORTANT_CONSIDERATION', 76), ('PROBABLE_UNDERSTANDING', 127), ('PROBABLE_UNDERSTANDING', 201), ('FUTURE_WORK', 234)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 35, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5014971	8/2016	S90-PMC5014971	['physicians who indicated that Vitamin D insufficiency is a PROBLEM in their patient population were more LIKELY to agree or strongly agree that Vitamin D supplementation during Pregnancy is safe and that all Pregnant women SHOULD BE screened.']	[('IMPORTANT_CONSIDERATION', 59), ('PROBABLE_UNDERSTANDING', 105), ('FUTURE_WORK', 223)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy'), ('GO_0007565', 'female pregnancy', 208, 'pregnant')]
PMC5014971	8/2016	S92-PMC5014971	['these physicians were also more LIKELY to disagree with the following statements: Vitamin D supplementation during Pregnancy is GENERALLY not NECESSARY, they are not CONCERNED about Vitamin D deficiency in their Pregnant patients, Pregnant women taking Prenatal Vitamins are at low RISK for Vitamin D deficiency, and most of my Pregnant patients will get enough vitamin d through sun exposure and diet (table 3).']	[('PROBABLE_UNDERSTANDING', 32), ('PROBABLE_UNDERSTANDING', 128), ('IMPORTANT_CONSIDERATION', 142), ('IMPORTANT_CONSIDERATION', 166), ('IMPORTANT_CONSIDERATION', 282)]	5	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('GO_0007565', 'female pregnancy', 212, 'pregnant'), ('GO_0007565', 'female pregnancy', 231, 'pregnant'), ('GO_0007565', 'female pregnancy', 253, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 262, 'vitamins'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('GO_0007565', 'female pregnancy', 328, 'pregnant')]
PMC5014971	8/2016	S94-PMC5014971	['discussion\nthe results of THIS STUDY SUGGEST that practicing obstetrician-gynecologists GENERALLY are SOMEWHAT CONCERNED about the Vitamin D status of their Pregnant patients and consider Vitamin D supplementation during Pregnancy to be SAFE.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 102), ('IMPORTANT_CONSIDERATION', 111), ('IMPORTANT_CONSIDERATION', 237)]	6	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnant'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy')]
PMC5014971	8/2016	S97-PMC5014971	['the responding physicians were GENERALLY not supportive of screening all Pregnant women for Vitamin D status; EVEN among physicians that expressed a CONCERN regarding their patient population, less than half would screen most Pregnant patients.']	[('PROBABLE_UNDERSTANDING', 31), ('ANOMALY_CURIOUS_FINDING', 110), ('IMPORTANT_CONSIDERATION', 149), ('PROBLEM_COMPLICATION', 149)]	4	[('GO_0007565', 'female pregnancy', 73, 'pregnant'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 226, 'pregnant')]
PMC5014971	8/2016	S98-PMC5014971	['there was a LACK OF CONSENSUS regarding the APPROPRIATE level of Vitamin D supplementation during Pregnancy and the value of circulating 25-Hydroxyvitamin D, below which there is CONCERN regarding Vitamin D insufficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 44), ('IMPORTANT_CONSIDERATION', 179), ('PROBLEM_COMPLICATION', 179)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 137, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC5014971	8/2016	S100-PMC5014971	['there is CONTINUING CONTROVERSY over the APPROPRIATE levels of Vitamin D supplementation and of the levels of circulating 25-Hydroxyvitamin D that represent good health.']	[('FUTURE_WORK', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('IMPORTANT_CONSIDERATION', 41)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 122, '25-hydroxyvitamin D')]
PMC5014971	8/2016	S101-PMC5014971	['the result has been CONFLICTING RECOMMENDATIONS from the iom [14,15] and the Endocrine society [19], ESPECIALLY CONCERNING Vitamin D supplementation and APPROPRIATE levels of circulating 25-Oh-D during Pregnancy (table 4).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('FUTURE_WORK', 32), ('IMPORTANT_CONSIDERATION', 101), ('IMPORTANT_CONSIDERATION', 112), ('IMPORTANT_CONSIDERATION', 153)]	5	[('UBERON_0005063', 'left ventricular compact myocardium', 77, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 187, '25-OH-D'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy')]
PMC5014971	8/2016	S108-PMC5014971	['EVEN researchers SKEPTICAL of the causality of Vitamin D EFFECTS on Pregnancy outcomes POINT to a knowledge deficit that NEEDS ADDRESSING, ESPECIALLY in areas such as maternal and neonatal infections (e.g., [21]).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 87), ('FUTURE_WORK', 121), ('IMPORTANT_CONSIDERATION', 121), ('FUTURE_WORK', 127), ('IMPORTANT_CONSIDERATION', 139)]	8	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy')]
PMC5014971	8/2016	S110-PMC5014971	['on a CAUTIONARY NOTE, the EVIDENCE for positive BENEFITS of circulating levels of 25-Oh-D and Vitamin D supplementation above those from iom can hardly be called definitive.']	[('IMPORTANT_CONSIDERATION', 5), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 48)]	4	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 82, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5014971	8/2016	S121-PMC5014971	['the Endocrine society CONSIDERS Pregnant and Lactating women AS HIGH-risk groups for Vitamin D insufficiency and RECOMMENDS universal screening [19].']	[('PROBABLE_UNDERSTANDING', 22), ('PROBABLE_UNDERSTANDING', 61), ('IMPORTANT_CONSIDERATION', 64), ('FUTURE_WORK', 113)]	4	[('UBERON_0005063', 'left ventricular compact myocardium', 4, 'Endocrine'), ('GO_0007565', 'female pregnancy', 32, 'pregnant'), ('GO_0007594', 'puparial adhesion', 45, 'lactating'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5014971	8/2016	S123-PMC5014971	['the majority of respondents would consider screening for specific patient conditions (e.g., Gastric bypass surgery); a lesser proportion would consider screening BECAUSE of obesity or for african american women DESPITE both of these patient characteristics being KNOWN RISK FACTORS for INADEQUATE Vitamin D status.']	[('PROBLEM_COMPLICATION', 162), ('ANOMALY_CURIOUS_FINDING', 211), ('INCOMPLETE_EVIDENCE', 263), ('SUPERFICIAL_RELATIONSHIP', 269), ('IMPORTANT_CONSIDERATION', 286)]	5	[('UBERON_0001844', 'cochlea', 92, 'gastric'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D')]
PMC5014971	8/2016	S130-PMC5014971	['conclusions\nus obstetricians APPEAR cognizant of the IMPORTANCE of maternal Vitamin D status during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 29), ('IMPORTANT_CONSIDERATION', 53)]	2	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy')]
PMC5017622	9/2016	S25-PMC5017622	['women of Reproductive age, ESPECIALLY Pregnant women, in low and middle income countries are AT RISK of several Micronutrient deficiencies, such as Iron, Folic Acid, Iodine, zinc, Vitamins A and d, riboflavin, b6 and b12, which COULD adversely AFFECT the mother and Pregnancy outcome [13,14,15].']	[('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 93), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 244)]	4	[('GO_0000003', 'reproduction', 9, 'reproductive'), ('GO_0007565', 'female pregnancy', 38, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 112, 'micronutrient'), ('CHEBI_24870', 'ion', 148, 'iron'), ('CHEBI_30751', 'formic acid', 154, 'folic acid'), ('CHEBI_24859', 'iodine atom', 166, 'iodine'), ('CHEBI_27300', 'vitamin D', 180, 'vitamins A'), ('GO_0007565', 'female pregnancy', 266, 'pregnancy')]
PMC5024513	9/2016	S127-PMC5024513	['the summary results SHOW that there MAY BE areas of CONCERN in adolescent’s nutritional intake during Pregnancy, PARTICULARLY COMPARED to us RECOMMENDATIONS, with regard to calcium, Vitamin D, Vitamin E, Folate, potassium and magnesium.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 36), ('PROBLEM_COMPLICATION', 52), ('IMPORTANT_CONSIDERATION', 113), ('ANOMALY_CURIOUS_FINDING', 126), ('FUTURE_WORK', 141)]	6	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin E'), ('CHEBI_30863', '5-azaorotic acid', 204, 'folate')]
PMC5028238	10/2016	S83-PMC5028238	['in addition, BENEFITS from Prenatal Vitamin D supplementation are also Modulated by geographic location and OTHER FACTORS.47THEREFORE biological mechanisms that maximize Vitamin D production and absorption would be selected for in the north.']	[('IMPORTANT_CONSIDERATION', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('SUPERFICIAL_RELATIONSHIP', 114), ('ANOMALY_CURIOUS_FINDING', 122), ('ANOMALY_CURIOUS_FINDING', 122), ('ANOMALY_CURIOUS_FINDING', 122)]	6	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0065007', 'biological regulation', 71, 'modulated'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5028238	10/2016	S93-PMC5028238	['however, Vitamin D levels in slos patients are REPORTED to be low.55this COULD BE DUE TO many lifestyle factors that occur when a patient is SERIOUSLY ill with slos.']	[('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 73), ('PROBABLE_UNDERSTANDING', 82), ('PROBLEM_COMPLICATION', 82), ('IMPORTANT_CONSIDERATION', 141)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC5028238	10/2016	S94-PMC5028238	['one POSSIBLE biological EXPLANATION that fits with the literature-derived mechanism (figure 3) is that slos patients spent less time outdoors thereby reducing their Ultraviolet b exposure (another CRITICAL REQUIREMENT for Vitamin D Synthesis).55\n\nGenetic understanding of slos-inducing Dhcr7 mutations: IMPLICATIONS for FUTURE WORK\n\nchanging our understanding of slos genetics using large-scale Genomics studies\nusing exac,24we were able to compare the frequencies of Dhcr7 slos-inducing mutations in the slos population (extracted from the literature) and the assumed-healthy exac population.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 24), ('IMPORTANT_CONSIDERATION', 197), ('IMPORTANT_CONSIDERATION', 206), ('IMPORTANT_CONSIDERATION', 303), ('FUTURE_WORK', 320)]	6	[('CHEBI_75275', 'tetradecyl sulfonic acid', 165, 'ultraviolet'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D'), ('GO_0031151', 'histone methyltransferase activity (H3-K79 specific)', 230, 'D synthesis'), ('SO_0000704', 'gene', 247, 'Genetic'), ('PR_000006474', 'ATP-dependent RNA helicase A', 286, 'DHCR7'), ('SO_0001026', 'genome', 395, 'genomics'), ('PR_000006474', 'ATP-dependent RNA helicase A', 468, 'DHCR7')]
PMC5028238	10/2016	S201-PMC5028238	["COMMENT on Vitamin D3's in-direct inhibition of Dhcr7\nOF NOTE, Vitamin D (Cholecalciferol) decreases the Dhcr7 activity through an indirect mechanism.54there HAS BEEN SOME SPECULATION on the POSSIBILITY of Teratogenic AFFECTS resulting from high doses of Vitamin D when taken as a Prenatal supplement.89HOWEVER, a RECENT REVIEW of Vitamin D supplementation among Pregnant women FOUND that Vitamin D supplementation MAY reduce the RISK of pre-eclampsia, low Birth weight, Preterm Birth90,91and adverse Kidney outcomes in offspring.92BECAUSE the mechanism of Vitamin D3's inhibition of Dhcr7 is indirect (UNLIKE our studied Pharmacological Dhcr7 Inhibitors) it is LIKELY to be MEDIATED through a COMPLEX pathway with many INTERACTING feedback loops."]	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 54), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 167), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 191), ('SUPERFICIAL_RELATIONSHIP', 218), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('INCOMPLETE_EVIDENCE', 314), ('INCOMPLETE_EVIDENCE', 378), ('INCOMPLETE_EVIDENCE', 415), ('IMPORTANT_CONSIDERATION', 430), ('PROBABLE_UNDERSTANDING', 530), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 603), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 675), ('DIFFICULT_TASK', 694), ('SUPERFICIAL_RELATIONSHIP', 720)]	18	[('CHEBI_33279', 'vitamin D5', 11, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 11, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 48, 'DHCR7'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 74, 'cholecalciferol'), ('PR_000006474', 'ATP-dependent RNA helicase A', 105, 'DHCR7'), ('CHEBI_50905', 'teratogenic agent', 206, 'teratogenic'), ('GO_0031649', 'heat generation', 206, 'teratogenic'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D'), ('GO_0007565', 'female pregnancy', 281, 'prenatal'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D'), ('GO_0007565', 'female pregnancy', 363, 'pregnant'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('GO_0007567', 'parturition', 457, 'birth'), ('GO_0007565', 'female pregnancy', 471, 'preterm'), ('GO_0042633', 'hair cycle', 479, 'birth90'), ('UBERON_0002113', 'kidney', 501, 'kidney'), ('CHEBI_33279', 'vitamin D5', 557, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 557, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 584, 'DHCR7'), ('CHEBI_52217', 'pharmaceutical', 622, 'pharmacological'), ('PR_000006474', 'ATP-dependent RNA helicase A', 638, 'DHCR7'), ('CHEBI_35222', 'inhibitor', 644, 'inhibitors')]
PMC5030591	9/2016	S80-PMC5030591	["caption (table-wrap): table 4\n\nthemes and elements relating to specific Conception and Pregnancy information for women with rheumatoid arthritis and their familiessaying : information that should be discussed by health professionals doing : actions that SHOULD BE undertaken by health professionals review of current Medications in relation to safety during Conception and Pregnancy (100%) prior to Conception and Pregnancy, review current Medication(s) and discuss:\nmedications vary with respect to their SAFETY during Pregnancy and RISKS related to Fertility, Ovulation, Conception and Miscarriage\nSOME Medicines used in ra care MAY have EFFECTS on Fertility, Conception and Pregnancy process, for example, regular Nsaids MAY impair fertility and ASSOCIATED RISKS with fetus\nit is IMPORTANT to time Conceptionprovide GUIDANCE as to WHERE to obtain reliable information about SAFETY of Medicines in Pregnancywhere current Medication(s) is (are) contraindicated for Conception/Pregnancy the following SHOULD BE discussed with the patient:\nthere are SAFE Medication options pre, during (including Delivery) and Postpregnancy (including Breast feeding)\ntiming is IMPORTANT in RELATION to ceasing or switching of current Medications and allowing for washout periods prior to Conception\nthere is a need for close supervision/monitoring by a rheumatologist when discontinuing current Medications prior to Pregnancy, including CONSIDERING POTENTIAL NEED for disease stabilisation on new treatment prior to Conception and Pregnancydiscuss IMPACT of ra pathology on Pregnancy and Pregnancy on ra (100%) there are DIFFERENT SCENARIOS regarding ra disease activity during Pregnancy (eg, POSSIBLE remission/low disease activity)discuss: ra-related pain management options during Pregnancyconception MAY take longer compared with women who do not have rathere is a need to balance disease Control with maternal and fetal health and safetyra MAY AFFECT Pregnancy and Pregnancy MAY AFFECT ra, and there are POSSIBLE adverse outcomes where risks are identified (eg, Prematurity)there are significant risks ASSOCIATED with active or uncontrolled ra for the mother and baby, ESPECIALLY irreversible Joint damage and functional impairmentpregnancy MAY change a patient’s health outlook in the futurethe size of the baby MAY BE smaller than women without ra and MAY also be Delivered pre-term discuss IMPORTANT elements of Preconception care RELEVANT to patient (97.1%) it is IMPORTANT to achieve optimal disease control prior to considering Pregnancy—Planning Conception is preferable after patients achieve and maintain low disease activityencourage and facilitate early discussions with all health practitioners involved in care about family planning to allow for adequate preparationthere is a CRITICAL need for a planned Pregnancy RATHER than an unplanned Pregnancyreview Prenatal nutrition, including need for dietary/vitamin supplements (ie, Folic Acid, calcium, Vitamin D, Iodine, iron)history of previous Attempts To Conceive/Pregnancies or Pregnancy-related complications (eg, Miscarriage) and other relevant patient history (such as smoking/Illicit Drug use history, family history of hereditary issues) MAY AFFECT Pregnancyundertake RELEVANT health checks such as immunisation status (eg, rubella, varicella, pertussis), Sexually Transmitted disease screening, pap test, screening for other Autoimmune disorders that MAY IMPACT on Pregnancyweight management and appropriate exercise are very IMPORTANTCONSIDER the NEED for review of diabetes or impaired Glucose tolerance if RISK factors are present (eg, on Steroid medication or overweight/obese)it is IMPORTANT to manage comorbid conditions, such as diabetes and hypertensionsome women MAY NEED to avoid Conception during a flarera disease activity MAY or MAY not improve with Pregnancy and there is a LIKELIHOOD of Postpartum flares importance of maintaining optimistic outlook and providing positive messages (97.1%) Pregnancy and Breast feeding success rates are near normal in women with mild to moderate ra nowadays (where appropriate for the patient's clinical status)ra is not a BARRIER to Pregnancystrategies to address anxiety, stress and depression (if relevant) are IMPORTANT, such as mindfulness meditation need for close monitoring of a patient prior to and during Pregnancy, where indicated (94.1%) it is IMPORTANCE to have a healthcare team with expertise in Autoimmune disorders for SOME women with radetermine THE NEED for high-level obstetric care during a Pregnancy (where indicated), including the need for Anaesthetic inputsome women REQUIRE closer monitoring of their Pregnancy and this is USUALLY proportional to disease activity, comorbidities and maternal historyassess the REQUIREMENTS for any extra treatment or monitoring prior to, or during, Pregnancyit is IMPORTANT to develop a Pregnancy plan, which includes different options for management of ra and support for different scenariosvaginal Delivery MAY NOT always BE POSSIBLE, depending on condition of the patient's Hips."]	[('FUTURE_WORK', 254), ('IMPORTANT_CONSIDERATION', 506), ('IMPORTANT_CONSIDERATION', 534), ('INCOMPLETE_EVIDENCE', 600), ('INCOMPLETE_EVIDENCE', 631), ('SUPERFICIAL_RELATIONSHIP', 640), ('INCOMPLETE_EVIDENCE', 724), ('SUPERFICIAL_RELATIONSHIP', 749), ('IMPORTANT_CONSIDERATION', 760), ('IMPORTANT_CONSIDERATION', 783), ('FUTURE_WORK', 819), ('EXPLICIT_QUESTION', 834), ('IMPORTANT_CONSIDERATION', 877), ('FUTURE_WORK', 1001), ('IMPORTANT_CONSIDERATION', 1049), ('IMPORTANT_CONSIDERATION', 1161), ('SUPERFICIAL_RELATIONSHIP', 1174), ('FUTURE_WORK', 1421), ('IMPORTANT_CONSIDERATION', 1421), ('INCOMPLETE_EVIDENCE', 1433), ('SUPERFICIAL_RELATIONSHIP', 1532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1605), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('INCOMPLETE_EVIDENCE', 1677), ('INCOMPLETE_EVIDENCE', 1788), ('INCOMPLETE_EVIDENCE', 1929), ('SUPERFICIAL_RELATIONSHIP', 1933), ('INCOMPLETE_EVIDENCE', 1964), ('SUPERFICIAL_RELATIONSHIP', 1968), ('INCOMPLETE_EVIDENCE', 1993), ('SUPERFICIAL_RELATIONSHIP', 2091), ('IMPORTANT_CONSIDERATION', 2158), ('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2302), ('INCOMPLETE_EVIDENCE', 2343), ('IMPORTANT_CONSIDERATION', 2382), ('SUPERFICIAL_RELATIONSHIP', 2423), ('IMPORTANT_CONSIDERATION', 2457), ('IMPORTANT_CONSIDERATION', 2779), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2817), ('INCOMPLETE_EVIDENCE', 3196), ('SUPERFICIAL_RELATIONSHIP', 3200), ('IMPORTANT_CONSIDERATION', 3226), ('INCOMPLETE_EVIDENCE', 3410), ('SUPERFICIAL_RELATIONSHIP', 3414), ('IMPORTANT_CONSIDERATION', 3485), ('INCOMPLETE_EVIDENCE', 3507), ('SUPERFICIAL_RELATIONSHIP', 3568), ('IMPORTANT_CONSIDERATION', 3646), ('INCOMPLETE_EVIDENCE', 3731), ('FUTURE_WORK', 3735), ('IMPORTANT_CONSIDERATION', 3735), ('INCOMPLETE_EVIDENCE', 3794), ('INCOMPLETE_EVIDENCE', 3801), ('PROBABLE_UNDERSTANDING', 3847), ('DIFFICULT_TASK', 4131), ('IMPORTANT_CONSIDERATION', 4222), ('IMPORTANT_CONSIDERATION', 4364), ('INCOMPLETE_EVIDENCE', 4444), ('INCOMPLETE_EVIDENCE', 4472), ('IMPORTANT_CONSIDERATION', 4600), ('INCOMPLETE_EVIDENCE', 4657), ('IMPORTANT_CONSIDERATION', 4744), ('IMPORTANT_CONSIDERATION', 4831), ('INCOMPLETE_EVIDENCE', 4976), ('DIFFICULT_TASK', 4980)]	66	[('GO_0007631', 'feeding behavior', 72, 'conception ...'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_25441', 'mycothiols', 317, 'medications'), ('GO_0007620', 'copulation', 358, 'conception'), ('GO_0007565', 'female pregnancy', 373, 'pregnancy'), ('GO_0007620', 'copulation', 399, 'conception'), ('GO_0007565', 'female pregnancy', 414, 'pregnancy'), ('CHEBI_60211', 'compound Z', 440, 'medication'), ('GO_0007565', 'female pregnancy', 520, 'pregnancy'), ('GO_0009566', 'fertilization', 551, 'fertility'), ('GO_0030728', 'ovulation', 562, 'ovulation'), ('GO_0007620', 'copulation', 573, 'conception'), ('GO_0046660', 'female sex differentiation', 588, 'miscarriage'), ('CHEBI_25179', 'melanins', 605, 'medicines'), ('GO_0009566', 'fertilization', 651, 'fertility'), ('GO_0007620', 'copulation', 662, 'conception'), ('GO_0007565', 'female pregnancy', 677, 'pregnancy'), ('CHEBI_16039', 'ITP', 717, 'NSAIDs'), ('GO_0070268', 'cornification', 801, 'conceptionProvide'), ('CHEBI_25179', 'melanins', 887, 'medicines'), ('GO_0000712', 'resolution of meiotic recombination intermediates', 900, 'pregnancyWhere'), ('CHEBI_60211', 'compound Z', 923, 'medication'), ('GO_0007620', 'copulation', 966, 'conception'), ('GO_0007565', 'female pregnancy', 977, 'pregnancy'), ('CHEBI_60211', 'compound Z', 1054, 'medication'), ('GO_0007567', 'parturition', 1096, 'delivery'), ('GO_0007565', 'female pregnancy', 1110, 'postpregnancy'), ('UBERON_0000310', 'breast', 1135, 'breast'), ('CHEBI_25441', 'mycothiols', 1218, 'medications'), ('GO_0007620', 'copulation', 1272, 'conception'), ('CHEBI_25441', 'mycothiols', 1379, 'medications'), ('GO_0007565', 'female pregnancy', 1400, 'pregnancy'), ('GO_0007620', 'copulation', 1500, 'conception'), ('GO_0006915', 'apoptotic process', 1515, 'pregnancyDiscuss'), ('GO_0007565', 'female pregnancy', 1558, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1572, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1662, 'pregnancy'), ('GO_0007602', 'phototransduction', 1768, 'pregnancyConception'), ('GO_0065007', 'biological regulation', 1877, 'control'), ('GO_0007565', 'female pregnancy', 1940, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1954, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2051, 'prematurity'), ('UBERON_0004905', 'articulation', 2182, 'joint'), ('GO_0007567', 'parturition', 2355, 'delivered'), ('GO_0007565', 'female pregnancy', 2404, 'preconception'), ('GO_0007565', 'female pregnancy', 2523, 'pregnancy'), ('GO_0006260', 'DNA replication', 2533, 'planning'), ('GO_0007620', 'copulation', 2542, 'conception'), ('GO_0007565', 'female pregnancy', 2807, 'pregnancy'), ('GO_0006412', 'translation', 2842, 'pregnancyReview'), ('GO_0007565', 'female pregnancy', 2858, 'prenatal'), ('CHEBI_30751', 'formic acid', 2930, 'folic acid'), ('CHEBI_27300', 'vitamin D', 2951, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 2962, 'iodine'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 2995, 'attempts to conceive'), ('GO_0007565', 'female pregnancy', 3016, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3031, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3068, 'miscarriage'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 3133, 'illicit drug'), ('GO_0051610', 'serotonin uptake', 3207, 'pregnancyUndertake'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 3314, 'sexually transmitted'), ('UBERON_0001442', 'skeleton of manus', 3384, 'autoimmune'), ('GO_0006412', 'translation', 3424, 'pregnancyWeight'), ('CHEBI_17234', 'glucose', 3547, 'glucose'), ('CHEBI_35341', 'steroid', 3601, 'steroid'), ('GO_0007620', 'copulation', 3749, 'conception'), ('GO_0007565', 'female pregnancy', 3822, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3861, 'postpartum'), ('GO_0007565', 'female pregnancy', 3964, 'Pregnancy'), ('UBERON_0000310', 'breast', 3978, 'breast'), ('GO_0006915', 'apoptotic process', 4142, 'pregnancyStrategies'), ('GO_0007565', 'female pregnancy', 4323, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 4419, 'autoimmune'), ('GO_0007565', 'female pregnancy', 4520, 'pregnancy'), ('CHEBI_38867', 'anaesthetic', 4572, 'anaesthetic'), ('GO_0007565', 'female pregnancy', 4635, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4816, 'pregnancyIt'), ('GO_0007565', 'female pregnancy', 4854, 'pregnancy'), ('GO_0007567', 'parturition', 4967, 'delivery'), ('UBERON_0000988', 'pons', 5044, 'hips')]
PMC5035678	4/2016	S9-PMC5035678	['conclusions\nALTHOUGH the high Vitamin D supplementation dose in the PRESENT STUDY (compared to the 400 iu/day dose USUALLY recommended for Pregnancy) SAFELY increases the Serum 25Ohd, in gdm cases, the higher dose does not affect the plasma Glucose level or Insulin resistance at short term follow-up after Delivery.']	[('ANOMALY_CURIOUS_FINDING', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('INCOMPLETE_EVIDENCE', 115), ('IMPORTANT_CONSIDERATION', 150)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 139, 'pregnancy'), ('UBERON_0001977', 'blood serum', 171, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD'), ('CHEBI_17234', 'glucose', 241, 'glucose'), ('PR_000045358', 'insulin family protein', 258, 'insulin'), ('GO_0007567', 'parturition', 307, 'delivery')]
PMC5035678	4/2016	S112-PMC5035678	['fifty eight percent of group c remained Vitamin D deficient, which INDICATES that the usual multivitamin that is prescribed for a majority of Pregnant women (containing 400 iu Vitamin D3) is not adequate to correct hypovitaminosis D. THEREFORE, Pregnant women NEED a higher dose of Vitamin D than that typically consumed.']	[('INCOMPLETE_EVIDENCE', 67), ('PROBABLE_UNDERSTANDING', 234), ('IMPORTANT_CONSIDERATION', 260)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 142, 'pregnant'), ('CHEBI_33279', 'vitamin D5', 176, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 176, 'vitamin D3'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 231, 'D'), ('GO_0007565', 'female pregnancy', 245, 'pregnant'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC5035678	4/2016	S132-PMC5035678	['they FOUND that high dose supplementation for a mean of 14 weeks during Pregnancy was not beneficial to the patients’ plasma Glucose level or Insulin resistance during Pregnancy, BUT that their babies BENEFITTED from the supplementation with decreased neonatal hypovitaminosis D. the authors CONCLUDED that the commencement of Vitamin D supplementation MAY HAVE been too late to cause any observable EFFECTS on Β-Cell function, and they SUGGESTED that earlier supplementation, EVEN before Pregnancy, MIGHT be EFFECTIVE.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('IMPORTANT_CONSIDERATION', 201), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 353), ('IMPORTANT_CONSIDERATION', 357), ('SUPERFICIAL_RELATIONSHIP', 400), ('INCOMPLETE_EVIDENCE', 437), ('ANOMALY_CURIOUS_FINDING', 477), ('INCOMPLETE_EVIDENCE', 500), ('SUPERFICIAL_RELATIONSHIP', 509)]	11	[('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('CHEBI_17234', 'glucose', 125, 'glucose'), ('PR_000045358', 'insulin family protein', 142, 'insulin'), ('GO_0007565', 'female pregnancy', 168, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 277, 'D'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D'), ('CL_0000623', 'natural killer cell', 411, 'β-cell'), ('GO_0007565', 'female pregnancy', 489, 'pregnancy')]
PMC5035678	4/2016	S151-PMC5035678	['in addition, maternal and neonatal outcomes were assessed at Delivery, and we administered a reasonable dose of Vitamin D sufficient to achieve the NECESSARY Serum Vitamin D levels in group i.']	[('IMPORTANT_CONSIDERATION', 148)]	1	[('GO_0007567', 'parturition', 61, 'delivery'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0001977', 'blood serum', 158, 'serum'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC5035678	4/2016	S161-PMC5035678	['in conclusion, Prenatal Vitamin D supplementation in patients with gdm and hypovitaminosis D SAFELY and significantly increases maternal and neonatal Serum 25Ohd.']	[('IMPORTANT_CONSIDERATION', 93)]	1	[('GO_0007565', 'female pregnancy', 15, 'prenatal'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 91, 'D'), ('UBERON_0001977', 'blood serum', 150, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 156, '25OHD')]
PMC5039809	10/2016	S17-PMC5039809	['THERE IS EVIDENCE in Adults that Vitamin A intake is ASSOCIATED with measures of bone health, BUT NOTABLY, the DIFFERENT forms of dietary Vitamin A HAVE BEEN demonstrated to have OPPOSING ASSOCIATIONS with fracture risk (6).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 94), ('ANOMALY_CURIOUS_FINDING', 98), ('IMPORTANT_CONSIDERATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 148), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('SUPERFICIAL_RELATIONSHIP', 188)]	9	[('UBERON_0007023', 'adult organism', 21, 'adults'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A')]
PMC5039809	10/2016	S118-PMC5039809	['Animal studies HAVE SHOWN that both high and low intakes of Vitamin A CAN be DETRIMENTAL to the bone.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 70), ('IMPORTANT_CONSIDERATION', 77)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A')]
PMC5042197	9/2016	S0-PMC5042197	['prevalence and RISK FACTORS for low Vitamin D status among breastfeeding mother–infant dyads in an environment with abundant sunshine\n\nabstract\n\npurpose\nevaluation of Vitamin D (vd) status and RISK FACTORS for low vd among breastfeeding mother–infant dyads in a population at high RISK for vd deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 193), ('IMPORTANT_CONSIDERATION', 281)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC5045149	9/2016	S143-PMC5045149	['it is PRUDENT at this time to CONSIDER diverse combinations of Nutrients from a variety of natural Food sources, although SOME specific Nutrients, such as Omega-3 Fatty Acids or Vitamin C, as treatment modalities [45,46].']	[('FUTURE_WORK', 6), ('IMPORTANT_CONSIDERATION', 6), ('FUTURE_WORK', 30), ('INCOMPLETE_EVIDENCE', 122)]	4	[('CHEBI_33284', 'nutrient', 63, 'nutrients'), ('CHEBI_33290', 'food', 99, 'food'), ('CHEBI_33284', 'nutrient', 136, 'nutrients'), ('CHEBI_30823', 'oleate', 155, 'omega'), ('CHEBI_35366', 'fatty acid', 163, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin C')]
PMC5045784	10/2016	S13-PMC5045784	['introduction\nbronchopulmonary dysplasia (bpd) is the MOST PREVALENT long-term morbidity among surviving EXTREMELY preterm infants and has a MULTIFACTORIAL etiology.1bpd is ASSOCIATED with later risk of reactive Airways disease, such as asthma,2post neonatal mortality and adverse Neurodevelopmental outcomes.1bpd AFFECTS ~20% of preterm infants, and up to 60% of extremely preterm infants who are Born before 26 completed weeks of Gestation.2an ESTIMATED 10\u2009000 to 15\u2009000 infants are affected in the united states each year and this has substantial medical and socioeconomic IMPLICATIONS.2,3\nACCUMULATING epidemiologic EVIDENCE SUGGESTS that Vitamin D deficiency or insufficiency is ASSOCIATED with Respiratory disease in children.']	[('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 104), ('DIFFICULT_TASK', 140), ('SUPERFICIAL_RELATIONSHIP', 172), ('SUPERFICIAL_RELATIONSHIP', 313), ('INCOMPLETE_EVIDENCE', 445), ('IMPORTANT_CONSIDERATION', 575), ('INCOMPLETE_EVIDENCE', 592), ('INCOMPLETE_EVIDENCE', 628), ('SUPERFICIAL_RELATIONSHIP', 683)]	10	[('UBERON_0001005', 'respiratory airway', 211, 'airways'), ('GO_0007399', 'nervous system development', 280, 'neurodevelopmental'), ('GO_0007567', 'parturition', 397, 'born'), ('GO_0007565', 'female pregnancy', 431, 'gestation'), ('CHEBI_27300', 'vitamin D', 642, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 699, 'respiratory')]
PMC5045784	10/2016	S17-PMC5045784	['in addition, Animal studies SUPPORT the HYPOTHESIS that Vitamin D status MIGHT AFFECT the RISK of bpd GIVEN that both Vitamin D and the Vitamin D receptor (vdr) have IMPORTANT ROLES in Perinatal Lung Development.7,8thus, we SPECULATED that Vitamin D deficiency MIGHT predispose to and/or have a ROLE in the pathogenesis of bpd.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 90), ('PROBABLE_UNDERSTANDING', 102), ('IMPORTANT_CONSIDERATION', 166), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 261), ('SUPERFICIAL_RELATIONSHIP', 295)]	11	[('NCBITaxon_33208', 'Metazoa', 13, 'animal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0036268', 'swimming', 185, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 185, 'perinatal'), ('GO_0030324', 'lung development', 195, 'lung development'), ('UBERON_0002048', 'lung', 195, 'lung'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC5045784	10/2016	S59-PMC5045784	['SIMILARLY, a RECENT interventional TRIAL of three dosing regimens for Vitamin D supplementation in extremely preterm infants FOUND no association between Vitamin D status and Respiratory outcomes.17\nthe IMPORTANCE of Vitamin D status in pediatric Respiratory health is SUPPORTED by large epidemiologic studies of term infants SHOWING an ASSOCIATION between suboptimal Vitamin D status and wheezing.4,18in addition, Animal studies demonstrate an IMPORTANT biologic ROLE for Vitamin D in Lung Development and Maturation, including Differentiation Of Type Ii Pneumocytes, Surfactant Phospholipid synthesis and secretion,19as well as an immunomodulatory ROLE in Epithelial Cells, Neutrophils and Macrophages.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 125), ('IMPORTANT_CONSIDERATION', 203), ('INCOMPLETE_EVIDENCE', 269), ('INCOMPLETE_EVIDENCE', 326), ('SUPERFICIAL_RELATIONSHIP', 337), ('IMPORTANT_CONSIDERATION', 445), ('SUPERFICIAL_RELATIONSHIP', 464), ('SUPERFICIAL_RELATIONSHIP', 650)]	10	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 175, 'respiratory'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 247, 'respiratory'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 415, 'animal'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D'), ('GO_0035180', 'larval wandering behavior', 486, 'lung development ... maturation'), ('UBERON_0002048', 'lung', 486, 'lung'), ('GO_0007620', 'copulation', 529, 'differentiation of ...'), ('CL_0002063', 'type II pneumocyte', 548, 'type II pneumocytes'), ('CHEBI_53015', 'N(6)-carboxymethyl-L-lysine residue', 569, 'surfactant phospholipid'), ('CL_0000066', 'epithelial cell', 658, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 658, 'epithelial'), ('CL_0000775', 'neutrophil', 676, 'neutrophils'), ('CL_0000235', 'macrophage', 692, 'macrophages')]
PMC5045784	10/2016	S66-PMC5045784	['given that Vitamin D has IMPORTANT ROLES in early Lung Development and Innate Immunity, the LACK OF ASSOCIATION between Vitamin D status and development of bpd SUPPORTS the multifactorial etiology of and POSSIBLE Genetic predisposition to bpd.']	[('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 204)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0030324', 'lung development', 50, 'lung development'), ('UBERON_0002048', 'lung', 50, 'lung'), ('GO_0045087', 'innate immune response', 71, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('SO_0000704', 'gene', 213, 'genetic')]
PMC5045784	10/2016	S74-PMC5045784	['fetal and newborn concentrations of 25(Oh)D DEPEND ON and CORRELATE with maternal Serum levels AS the fetus has no endogenous production of 25(Oh)d and DEPENDS on transplacental transfer.28THIS occurs MAINLY in the third trimester and THEREFORE, as we and others PREVIOUSLY REPORTED, preterm infants are at INCREASED RISK of Vitamin D deficiency.10,29our PRIOR STUDY DEMONSTRATED that Birth before 32 completed weeks of Gestation is an INDEPENDENT RISK FACTOR for low 25(Oh)d levels at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 152), ('PROBABLE_UNDERSTANDING', 187), ('PROBABLE_UNDERSTANDING', 201), ('PROBABLE_UNDERSTANDING', 235), ('INCOMPLETE_EVIDENCE', 263), ('IMPORTANT_CONSIDERATION', 307), ('INCOMPLETE_EVIDENCE', 355), ('INCOMPLETE_EVIDENCE', 367), ('SUPERFICIAL_RELATIONSHIP', 436), ('SUPERFICIAL_RELATIONSHIP', 448)]	13	[('CHEBI_71657', 'versiconol acetate', 36, '25(OH)D'), ('UBERON_0001977', 'blood serum', 82, 'serum'), ('CHEBI_63056', 'zinc cation', 140, '25(OH'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('GO_0007567', 'parturition', 385, 'birth'), ('GO_0007565', 'female pregnancy', 420, 'gestation'), ('CHEBI_30778', 'gallic acid', 468, '25(OH)'), ('GO_0007567', 'parturition', 486, 'birth')]
PMC5045784	10/2016	S86-PMC5045784	['mccarthy et al.29REPORTED that in a cohort of 274 preterm infants (<32 weeks) in ireland, levels of 25(Oh)D REMAINED under 20\u2009ng\u2009ml−1in 78% of subjects DESPITE 18 days on average of enteral Feeding and Vitamin D supplementation.29a RECENT intervention TRIAL by fort et al.17DEMONSTRATED that biochemical Vitamin D deficiency among EXTREMELY preterm infants CAN be reduced by additional supplementation with 200 units of Vitamin D daily, and PREVENTED by additional supplementation with 800 units of Vitamin D daily17and these two regimens were FOUND TO BE SAFE.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 108), ('ANOMALY_CURIOUS_FINDING', 152), ('INCOMPLETE_EVIDENCE', 232), ('PROBABLE_UNDERSTANDING', 272), ('PROBABLE_UNDERSTANDING', 272), ('IMPORTANT_CONSIDERATION', 331), ('INCOMPLETE_EVIDENCE', 357), ('SUPERFICIAL_RELATIONSHIP', 441), ('ANOMALY_CURIOUS_FINDING', 544), ('IMPORTANT_CONSIDERATION', 556)]	11	[('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 106, 'D'), ('GO_0007631', 'feeding behavior', 190, 'feeding'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 420, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D')]
PMC5045784	10/2016	S91-PMC5045784	['in CONCLUSION, we FOUND that low 25(Oh)D levels (<30\u2009ng\u2009ml−1) are frequent and MODIFIABLE among preterm infants at Birth, HOWEVER, in our study samples we did not detect any association between Vitamin D status and Pulmonary or other morbidities of prematurity.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	4	[('CHEBI_71657', 'versiconol acetate', 33, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 39, 'D'), ('GO_0007567', 'parturition', 115, 'birth'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('UBERON_0002048', 'lung', 215, 'pulmonary')]
PMC5051327	9/2016	S11-PMC5051327	['IF OUR FINDINGS are SUPPORTED by FURTHER STUDIES, PREFERABLY on SEVERE Birth asphyxia, Vitamin D supplementation/sun exposure in Pregnancy MAY lower the risk of subsequent Birth asphyxia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 20), ('FUTURE_WORK', 33), ('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 64), ('INCOMPLETE_EVIDENCE', 139)]	7	[('GO_0007567', 'parturition', 71, 'birth'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007567', 'parturition', 172, 'birth')]
PMC5051327	9/2016	S17-PMC5051327	['introduction\nVitamin D is NECESSARY for optimal Skeletal function and deficiency is RELATED to rachitis.1\nit is, HOWEVER, IMPORTANT for bone Metabolism, as well as for optimal function of Striated and Smooth Muscle strength including Heart Muscle, and is RELATED to Postnatal muscle strength.2vitamin D supplementation has a positive IMPACT on muscle strength on Individuals with Vitamin D deficiency.134THE institute of medicine (iom), usa RECOMMENDS daily nutritional intake of Vitamin D of 600\u2005u, BUT OTHERS RECOMMEND higher doses.56a RECENT swedish STUDY SHOWED that the mean nutritional intake of Vitamin D was <200\u2005u/day.7ALTHOUGH Vitamin D is found in low amounts in the diet, mainly in oily fish and egg, the primary source of Vitamin D for Humans is skin conversion to Vitamin D from solar ultraviolet radiation.1pregnant women residing at high latitudes are AT RISK of Vitamin D deficiency BECAUSE of low solar intensity, especially during the winter months.18vitamin D deficiency is common in the nordic countries, ESPECIALLY among those not exposing themselves to the sun.8since fetal Vitamin D levels are directly RELATED to that of their mothers there is also a high LIKELIHOOD of fetal Vitamin D deficiency in our population.9\nBirth asphyxia is ASSOCIATED with Cardiovascular dysfunction, including low Ventricular output, lower left Ventricular Ejection fraction and increased troponin levels.1011congestive Heart failure MAY occur in severe cases of asphyxia.12intrauterine fetal distress is RELATED to an increase in Blood pressure, redistribution and a change in fetal Heart rate pattern.']	[('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('IMPORTANT_CONSIDERATION', 122), ('SUPERFICIAL_RELATIONSHIP', 255), ('SUPERFICIAL_RELATIONSHIP', 334), ('INCOMPLETE_EVIDENCE', 401), ('FUTURE_WORK', 441), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 500), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504), ('FUTURE_WORK', 511), ('INCOMPLETE_EVIDENCE', 538), ('INCOMPLETE_EVIDENCE', 559), ('ANOMALY_CURIOUS_FINDING', 627), ('IMPORTANT_CONSIDERATION', 868), ('PROBABLE_UNDERSTANDING', 900), ('ANOMALY_CURIOUS_FINDING', 1026), ('SUPERFICIAL_RELATIONSHIP', 1127), ('PROBABLE_UNDERSTANDING', 1181), ('SUPERFICIAL_RELATIONSHIP', 1260), ('INCOMPLETE_EVIDENCE', 1438), ('SUPERFICIAL_RELATIONSHIP', 1509)]	22	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0004288', 'skeleton', 48, 'skeletal'), ('GO_0008152', 'metabolic process', 141, 'metabolism'), ('UBERON_0002435', 'striatum', 188, 'striated'), ('UBERON_0001135', 'smooth muscle tissue', 201, 'smooth muscle'), ('UBERON_0001133', 'cardiac muscle tissue', 234, 'heart muscle'), ('GO_0007567', 'parturition', 266, 'postnatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 301, 'D'), ('NCBITaxon_1', 'root', 363, 'individuals'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 480, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 637, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 735, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'humans'), ('CHEBI_27300', 'vitamin D', 778, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 879, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 978, 'D'), ('CHEBI_27300', 'vitamin D', 1097, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1201, 'vitamin D'), ('GO_0007567', 'parturition', 1242, 'Birth'), ('UBERON_0004535', 'cardiovascular system', 1276, 'cardiovascular'), ('UBERON_0002082', 'cardiac ventricle', 1318, 'ventricular'), ('UBERON_0002082', 'cardiac ventricle', 1349, 'ventricular'), ('UBERON_0000970', 'eye', 1361, 'ejection'), ('UBERON_0000948', 'heart', 1424, 'heart'), ('UBERON_0000178', 'blood', 1535, 'blood'), ('UBERON_0000948', 'heart', 1588, 'heart')]
PMC5051327	9/2016	S19-PMC5051327	['SEVERAL STUDIES HAVE REPORTED increased frequency of emergency caesarean Delivery in RELATION to low Vitamin D,1415but NO PREVIOUS STUDY HAS BEEN particularly designed to study the RELATION between low Vitamin D levels, measured as 25-Hydroxy\xa0(Oh) Vitamin D, in early Pregnancy and the RISK for fetal distress/Birth asphyxia.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 85), ('FULL_UNKNOWN', 119), ('INCOMPLETE_EVIDENCE', 131), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 181), ('IMPORTANT_CONSIDERATION', 286)]	8	[('GO_0007567', 'parturition', 73, 'delivery'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_29991', 'L-aspartate(1-)', 232, '25-hydroxy (OH)'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('GO_0007565', 'female pregnancy', 268, 'pregnancy'), ('GO_0007567', 'parturition', 310, 'birth')]
PMC5051327	9/2016	S20-PMC5051327	['the primary AIM of this PILOT STUDY was TO INVESTIGATE 25-Oh Vitamin D, the main MARKER of Vitamin D status, in women who underwent caesarean section DUE to suspected fetal distress COMPARED TO those who did not.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	6	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 55, '25-OH'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC5051327	9/2016	S51-PMC5051327	['in a stratified analysis including only lean women (≤25 in body mass index (bmi)), the SIGNIFICANCE of difference of Vitamin D levels among those Delivered by caesarean section due to fetal distress in crude and adjusted analysis (p=0.05 and p=0.03, respectively) and the risk of Birth asphyxia was more than doubled among those with Vitamin D deficiency (or=2.5, 95% ci 1.0\xa0to 6.1 and or=2.9, 95% ci 1.1\xa0to 7.5, respectively).']	[('IMPORTANT_CONSIDERATION', 87)]	1	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007567', 'parturition', 146, 'delivered'), ('GO_0007567', 'parturition', 280, 'birth'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin D')]
PMC5051327	9/2016	S56-PMC5051327	['Vitamin D deficiency was ASSOCIATED with a significantly shorter Gestational age at Delivery, which is IN LINE WITH OTHER DATA.23furthermore, there SEEMS TO be an inverse RELATION between low active Vitamin D (1,25-Dihydroxy Vitamin D) and meconium-stained Amniotic Fluid, a sign of fetal distress, in Pregnancies complicated by Intrahepatic cholestasis.24\nthe FINDINGS that more than two-third of mothers were Vitamin D deficient during winter/spring season and one-third at summer are CONSISTENT with PREVIOUS reports.2526in THIS STUDY, we used the LIMITS of 25-Oh Vitamin D SUGGESTED by the iom,17BUT the discussion of WHAT levels SHOULD BE CONSIDERED deficient is ONGOING.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 361), ('INCOMPLETE_EVIDENCE', 487), ('INCOMPLETE_EVIDENCE', 503), ('QUESTION_ANSWERED_BY_THIS_WORK', 527), ('INCOMPLETE_EVIDENCE', 551), ('INCOMPLETE_EVIDENCE', 577), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 598), ('EXPLICIT_QUESTION', 622), ('FUTURE_WORK', 634), ('FUTURE_WORK', 644), ('IMPORTANT_CONSIDERATION', 668)]	16	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational'), ('GO_0007567', 'parturition', 84, 'delivery'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 210, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0000173', 'amniotic fluid', 257, 'amniotic fluid'), ('GO_0007565', 'female pregnancy', 302, 'pregnancies'), ('UBERON_0001226', 'major calyx', 329, 'intrahepatic'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 561, '25-OH'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]
PMC5051327	9/2016	S57-PMC5051327	['the daily RECOMMENDED intake of Vitamin D is 600\u2005iu/day in the usa5since the late 1990s in france, there HAVE been official RECOMMENDATIONS of 1000\u2005u vitamin d/day from 32\u2005weeks of Gestation or 100\u2005000 or 200\u2005000\u2005iu as a single dose at 32\u2005weeks in order to lower COMPLICATIONS in newborns.27\nCalcium Homeostasis In the Heart is IMPORTANT for the Contractility and function of the Heart.']	[('FUTURE_WORK', 10), ('IMPORTANT_CONSIDERATION', 105), ('FUTURE_WORK', 124), ('PROBLEM_COMPLICATION', 263), ('IMPORTANT_CONSIDERATION', 328)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 181, 'gestation'), ('CHEBI_31341', 'calcium dihydroxide', 292, 'Calcium'), ('GO_0007605', 'sensory perception of sound', 292, 'Calcium'), ('GO_0042592', 'homeostatic process', 300, 'homeostasis in'), ('GO_0007605', 'sensory perception of sound', 319, 'heart'), ('UBERON_0000948', 'heart', 319, 'heart'), ('GO_0006936', 'muscle contraction', 346, 'contractility'), ('GO_0007605', 'sensory perception of sound', 380, 'heart'), ('UBERON_0000948', 'heart', 380, 'heart')]
PMC5051327	9/2016	S59-PMC5051327	['this was CONNECTED to the Cyclic Adenosine Monophosphate (Camp) pathway and RELATED to accelerated relaxation.2829this EFFECT was not seen in Vitamin D Receptor knockout Mice, which IMPLIES that the EFFECT is MEDIATED by the Vitamin D receptor which SEEMS IMPORTANT for Cardiac muscle function.2830using a state Cardiac diagram, asphyxia is slowing the Relaxation phase in the fetal Heart.3132pregnancy is a condition with increased Oestrogen levels.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 119), ('PROBABLE_UNDERSTANDING', 182), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 209), ('ANOMALY_CURIOUS_FINDING', 250), ('IMPORTANT_CONSIDERATION', 256)]	8	[('CHEBI_23447', 'cyclic nucleotide', 26, 'cyclic adenosine monophosphate'), ('CHEBI_17489', "3',5'-cyclic AMP", 58, 'cAMP'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 142, 'vitamin D receptor'), ('NCBITaxon_10088', 'Mus <genus>', 170, 'mice'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0000948', 'heart', 270, 'cardiac'), ('UBERON_0000948', 'heart', 312, 'cardiac'), ('GO_0032809', 'neuronal cell body membrane', 353, 'relaxation'), ('UBERON_0000948', 'heart', 383, 'heart'), ('CHEBI_50114', 'estrogen', 433, 'oestrogen')]
PMC5051327	9/2016	S60-PMC5051327	['both Oestrogenic Compounds and Parathyroid Hormone upregulate 1,25-Dihydroxy Vitamin D in Vascular Smooth Muscle Cells.33thus, there are several Vitamin D-RELATED mechanisms that COULD AFFECT the strained fetal Heart during the CRITICAL time of Birth.']	[('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 185), ('IMPORTANT_CONSIDERATION', 228)]	4	[('CHEBI_33838', 'nucleoside', 5, 'oestrogenic compounds'), ('GO_0001896', 'autolysis', 5, 'oestrogenic'), ('UBERON_0001132', 'parathyroid gland', 31, 'parathyroid'), ('CHEBI_33280', 'molecular messenger', 43, 'hormone'), ('CHEBI_50341', '1-hydroxyethyl group', 62, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CL_0000359', 'vascular associated smooth muscle cell', 90, 'vascular smooth muscle cells'), ('UBERON_0004237', 'blood vessel smooth muscle', 90, 'vascular smooth muscle'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0000948', 'heart', 211, 'heart'), ('GO_0007567', 'parturition', 245, 'birth')]
PMC5051327	9/2016	S70-PMC5051327	['SINCE PRIOR STUDIES had REPORTED on INCREASED RISK of emergency caesarean Delivery in RELATION to low Vitamin D, we used caesarean Delivery DUE TO suspected fetal distress AS a main outcome and Birth asphyxia as a secondary outcome.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 36), ('SUPERFICIAL_RELATIONSHIP', 86), ('PROBLEM_COMPLICATION', 140), ('PROBABLE_UNDERSTANDING', 172)]	7	[('GO_0007567', 'parturition', 74, 'delivery'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007567', 'parturition', 131, 'delivery'), ('GO_0007567', 'parturition', 194, 'birth')]
PMC5062906	10/2016	S16-PMC5062906	['WHILE the biological IMPORTANCE of these subtle changes REMAINS UNCLEAR, they WARRANT AN INVESTIGATION of epigenome-wide EFFECTS of maternal Vitamin D depletion.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 21), ('FULL_UNKNOWN', 56), ('FUTURE_WORK', 78), ('SUPERFICIAL_RELATIONSHIP', 121)]	6	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5062906	10/2016	S33-PMC5062906	['APPROXIMATELY 32\xa0% of americans are AT RISK for Vitamin D inadequacy, having less than 25\xa0ng/ml Serum 25-Hydroxyvitamin D [15].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 36)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0001977', 'blood serum', 96, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 102, '25-hydroxyvitamin D')]
PMC5062906	10/2016	S242-PMC5062906	['we also FIND that parent and grandparent of origin plays in an IMPORTANT ROLE in the direction and extent of Vitamin D-DEPENDENT developmental and epigenetic EFFECTS in the offspring.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 119), ('SUPERFICIAL_RELATIONSHIP', 158)]	5	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC5062906	10/2016	S249-PMC5062906	['THIS STUDY highlights the IMPORTANCE of maternal Vitamin D intake in determining molecular and phenotypic Birth outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 26)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 106, 'birth')]
PMC5062906	10/2016	S250-PMC5062906	['ALTHOUGH Vitamin D deficiency HAS BEEN LINKED to adverse Pregnancy/Birth outcomes [14,46–52], there is currently NO STANDARD practice of screening women for Vitamin D deficiency during Pregnancy nor are there standard RECOMMENDATIONS beyond Prenatal Vitamins for supplementation during this CRITICAL time [53,54].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 113), ('FUTURE_WORK', 218), ('IMPORTANT_CONSIDERATION', 291)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 57, 'pregnancy ...'), ('GO_0007567', 'parturition', 67, 'birth'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007565', 'female pregnancy', 185, 'pregnancy'), ('GO_0007565', 'female pregnancy', 241, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 250, 'vitamins')]
PMC5062906	10/2016	S254-PMC5062906	['this is MOST LIKELY the result of Genetic DIFFERENCES in Vitamin D Metabolism and STUDIES are ONGOING to identify and characterize the loci responsible.']	[('PROBABLE_UNDERSTANDING', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 82), ('IMPORTANT_CONSIDERATION', 94)]	4	[('SO_0000704', 'gene', 34, 'genetic'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 57, 'vitamin D metabolism')]
PMC5062906	10/2016	S313-PMC5062906	['STUDIES are ONGOING to characterize Genome-wide epigenetic EFFECTS of maternal Vitamin D depletion including the IMPACT of Genetic differences in determining epigenetic and phenotypic outcomes.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('SO_0001026', 'genome', 36, 'genome'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('SO_0000704', 'gene', 123, 'genetic')]
PMC5064894	10/2016	S0-PMC5064894	['maternal Vitamin D supplementation during Pregnancy and Lactation to prevent acute Respiratory infections in infancy in dhaka, bangladesh (mdari trial): protocol for a prospective cohort study nested within a randomized controlled trial\n\nabstract\n\nbackground\nearly Infancy is a HIGH-RISK period for SEVERE acute Respiratory infection (ari), PARTICULARLY in low-income countries with resource-limited Health Systems.']	[('IMPORTANT_CONSIDERATION', 278), ('IMPORTANT_CONSIDERATION', 299), ('IMPORTANT_CONSIDERATION', 341)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0007595', 'lactation', 56, 'lactation'), ('UBERON_0001004', 'respiratory system', 83, 'respiratory'), ('UBERON_0000023', 'wing', 265, 'infancy'), ('UBERON_0001004', 'respiratory system', 312, 'respiratory'), ('UBERON_0002423', 'hepatobiliary system', 400, 'health systems')]
PMC5064894	10/2016	S11-PMC5064894	['discussion\nIF SHOWN to reduce the RISK of viral ari in infancy, integration of maternal Prenatal/Postpartum Vitamin D supplementation into Antenatal Care programs in south asia may be a FEASIBLE primary preventive STRATEGY to reduce THE BURDEN of ari-ASSOCIATED morbidity and mortality in young infants.']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 34), ('PROBABLE_UNDERSTANDING', 186), ('FUTURE_WORK', 214), ('IMPORTANT_CONSIDERATION', 233), ('SUPERFICIAL_RELATIONSHIP', 251)]	6	[('GO_0007565', 'female pregnancy', 88, 'prenatal'), ('GO_0007565', 'female pregnancy', 97, 'postpartum'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 139, 'antenatal care')]
PMC5064894	10/2016	S19-PMC5064894	['it HAS BEEN POSTULATED that lower Vitamin D levels MAY explain the seasonal variation in influenza and studies HAVE SHOWN that children with rickets are at INCREASED RISK of lower Respiratory Tract disease or pneumonia [2–4].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 111), ('IMPORTANT_CONSIDERATION', 156)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 180, 'respiratory tract')]
PMC5064894	10/2016	S28-PMC5064894	['DESPITE these SUGGESTIVE results from observational studies, there HAVE BEEN FEW prospective randomized controlled trials examining the IMPACT of Vitamin D supplementation on RISK of ari in children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 136), ('IMPORTANT_CONSIDERATION', 175)]	7	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC5064894	10/2016	S36-PMC5064894	['the maternal Vitamin D for ari (mdari) study addresses IMPORTANT gaps in the Vitamin D and Respiratory Tract infection literature.']	[('IMPORTANT_CONSIDERATION', 55)]	1	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 91, 'respiratory tract')]
PMC5064894	10/2016	S39-PMC5064894	['third, THERE HAVE BEEN NO STUDIES assessing the ASSOCIATION between Vitamin D supplementation and quantitative Nasal carriage of streptococcus pneumoniae (pneumococcus), the most IMPORTANT cause of bacterial lrti in young children worldwide.']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 179)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0000004', 'nose', 111, 'nasal')]
PMC5064894	10/2016	S163-PMC5064894	['THIS will TEST the core mechanistic HYPOTHESIS that IMPROVEMENTS in Vitamin D status via maternal Vitamin D supplementation reduce the RISK of ari among infants in dhaka.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 52), ('IMPORTANT_CONSIDERATION', 135)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC5064894	10/2016	S193-PMC5064894	['discussion\nthe mdari study in dhaka, bangladesh leverages the infrastructure of a large randomized placebo controlled, dose-ranging trial of maternal Vitamin D supplementation during Pregnancy and Lactation in bangladesh TO TEST the HYPOTHESIS that maternal Vitamin D supplementation CAN decrease infant Respiratory infections during the HIGH RISK first 6\xa0months of infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 221), ('INCOMPLETE_EVIDENCE', 233), ('INCOMPLETE_EVIDENCE', 284), ('IMPORTANT_CONSIDERATION', 338)]	4	[('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'pregnancy'), ('GO_0007595', 'lactation', 197, 'lactation'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 304, 'respiratory')]
PMC5064894	10/2016	S194-PMC5064894	['IF SHOWN to reduce the RISK of ari in infancy, integration of maternal Prenatal/Postpartum Vitamin D supplementation into Antenatal Care programs in south asia MAY BE a FEASIBLE primary preventive STRATEGY to reduce THE BURDEN of ari-associated morbidity and mortality in young infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 160), ('PROBABLE_UNDERSTANDING', 169), ('FUTURE_WORK', 197), ('IMPORTANT_CONSIDERATION', 216)]	7	[('GO_0007565', 'female pregnancy', 71, 'prenatal'), ('GO_0007565', 'female pregnancy', 80, 'postpartum'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 122, 'antenatal care')]
PMC5084016	10/2016	S93-PMC5084016	['Calcium metabolism also REQUIRES Vitamin D, the lack of which CAN also be due to calcium deficiency: in both cases, the result is a reduced mineralization of the bone matrix.']	[('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 62)]	2	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5084016	10/2016	S128-PMC5084016	['HOWEVER, Vitamin D deficiency is very common during Pregnancy EVEN in countries with sunny climates and is ASSOCIATED with an INCREASED RISK of developing pre-eclampsia and Gestational diabetes mellitus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 62), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 126)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('GO_0007565', 'female pregnancy', 173, 'gestational')]
PMC5084016	10/2016	S130-PMC5084016	['low Birth weight, impaired Skeletal Development, and Respiratory infections and allergic diseases in the early years of Life are OFTEN ASSOCIATED with INADEQUATE CONTRIBUTION of Vitamin D from the mother’s diet.']	[('PROBABLE_UNDERSTANDING', 129), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 151), ('SUPERFICIAL_RELATIONSHIP', 162)]	4	[('GO_0007567', 'parturition', 4, 'birth'), ('GO_0001501', 'skeletal system development', 27, 'skeletal development'), ('UBERON_0004288', 'skeleton', 27, 'skeletal'), ('UBERON_0001004', 'respiratory system', 53, 'respiratory'), ('UBERON_0000104', 'life cycle', 120, 'life'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC5084016	10/2016	S133-PMC5084016	['in women AT RISK for Vitamin D deficiency, the RECOMMENDATIONS SHOULD BE reach 1000–2000 iu/day.']	[('IMPORTANT_CONSIDERATION', 9), ('FUTURE_WORK', 47), ('IMPORTANT_CONSIDERATION', 47), ('FUTURE_WORK', 63), ('IMPORTANT_CONSIDERATION', 63)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5084016	10/2016	S134-PMC5084016	['prophylaxis with Vitamin D SHOULD BE planned from the beginning and throughout the Pregnancy, as underlined also in the recent consensus document from the italian pediatric societies [61].']	[('FUTURE_WORK', 27), ('IMPORTANT_CONSIDERATION', 27)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC5084016	10/2016	S135-PMC5084016	['GIVEN the INFLUENCE of sunlight exposure on Vitamin D Metabolism, ATTENTION to ethnic groups with hyper-Pigmented skin or with little exposure to sunlight SHOULD BE paid also during Lactation.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 66), ('FUTURE_WORK', 155)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 44, 'vitamin D metabolism'), ('CHEBI_26130', 'biological pigment', 104, 'pigmented'), ('GO_0007595', 'lactation', 182, 'lactation')]
PMC5084016	10/2016	S136-PMC5084016	['moreover, the habitual dietary Intake of Vitamin D MAY BE limited in specific conditions of higher REQUIREMENTS and in areas and/or countries with little availability of food sources [62].']	[('INCOMPLETE_EVIDENCE', 51), ('IMPORTANT_CONSIDERATION', 99)]	2	[('GO_0007631', 'feeding behavior', 31, 'intake'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5084016	10/2016	S170-PMC5084016	['a systematic review of the literature HIGHLIGHTED an INCREASED RISK of iron and Vitamin B 12 deficiency and low Birth weight in ASSOCIATION with vegetarian or strictly vegan diets, DESPITE the absence of adverse EFFECTS for the fetus [79].']	[('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 53), ('SUPERFICIAL_RELATIONSHIP', 128), ('ANOMALY_CURIOUS_FINDING', 181), ('SUPERFICIAL_RELATIONSHIP', 212)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin B'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 80, 'vitamin B 12'), ('GO_0007567', 'parturition', 112, 'birth')]
PMC5084041	10/2016	S14-PMC5084041	['introduction\nduring the past decade, Vitamin D has received INCREASING ATTENTION and has been ASSOCIATED with health BENEFITS in addition to its RECOGNIZED EFFECTS on bone health.']	[('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 94), ('IMPORTANT_CONSIDERATION', 117), ('PROBABLE_UNDERSTANDING', 145), ('SUPERFICIAL_RELATIONSHIP', 156)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5084041	10/2016	S17-PMC5084041	['POOR maternal Vitamin D status during Pregnancy is ASSOCIATED with lower bone Mineral density and muscle strength in the infant [2].']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 51)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('CHEBI_46662', 'mineral', 78, 'mineral')]
PMC5084041	10/2016	S18-PMC5084041	['POOR maternal Vitamin D status HAS also BEEN ASSOCIATED with Pregnancy COMPLICATIONS such as Preeclampsia [3], premature Birth [4] and infants Born small for Gestational age [5].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 45), ('PROBLEM_COMPLICATION', 71)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 93, 'preeclampsia'), ('GO_0007567', 'parturition', 121, 'birth'), ('GO_0007567', 'parturition', 143, 'born'), ('GO_0007565', 'female pregnancy', 158, 'gestational')]
PMC5084041	10/2016	S26-PMC5084041	['data from other studies SHOW that immigrant women in sweden are at higher RISK of Vitamin D deficiency than women of swedish origin [14,15].']	[('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 74)]	2	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC5084041	10/2016	S31-PMC5084041	['population-representative data on Vitamin D status during Pregnancy IS NEEDED to evaluate the POTENTIAL NEED for new PUBLIC-HEALTH policies and to provide reliable data on potential RISK groups for Vitamin D deficiency.']	[('FUTURE_WORK', 68), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 104), ('IMPORTANT_CONSIDERATION', 117), ('IMPORTANT_CONSIDERATION', 124), ('SUPERFICIAL_RELATIONSHIP', 182)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC5084041	10/2016	S35-PMC5084041	['subgroup analyses were performed in groups identified to be at higher RISK of Vitamin D deficiency.']	[('IMPORTANT_CONSIDERATION', 70)]	1	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5084041	10/2016	S157-PMC5084041	['these results SUGGEST that TARGETED PUBLIC HEALTH INTERVENTION to treat and prevent Vitamin D deficiency in these RISK groups IS WARRANTED.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 27), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 50), ('IMPORTANT_CONSIDERATION', 114), ('FUTURE_WORK', 126)]	6	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC5085625	9/2016	S16-PMC5085625	['the active form of Vitamin D, i.e., 1,25(Oh)2D, is now recognized as an IMPORTANT hormone playing a CRUCIAL role in Skeletal Homeostasis (classical effects) and exerting NON-CLASSICAL EFFECTS in various pathological and physiological conditions, such as cancer, Arterial hypertension, Cardiovascular diseases, Brain Development and Immunomodulation [3,4,5,6].']	[('IMPORTANT_CONSIDERATION', 72), ('IMPORTANT_CONSIDERATION', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 38, '25(OH)2D'), ('GO_0043276', 'anoikis', 116, 'skeletal homeostasis'), ('UBERON_0004288', 'skeleton', 116, 'skeletal'), ('UBERON_0001637', 'artery', 262, 'arterial'), ('UBERON_0004535', 'cardiovascular system', 285, 'cardiovascular'), ('GO_0007420', 'brain development', 310, 'brain development'), ('UBERON_0000955', 'brain', 310, 'brain'), ('GO_0050900', 'leukocyte migration', 332, 'immunomodulation')]
PMC5085625	9/2016	S24-PMC5085625	['DEFICIENCY of Vitamin D is commonly diagnosed among Pregnant women worldwide, and WAS SHOWN to be ASSOCIATED with an INCREASED RISK of Pregnancy-related complications [1].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 98), ('IMPORTANT_CONSIDERATION', 117)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnant'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy')]
PMC5085625	9/2016	S62-PMC5085625	['DESPITE widespread deficiency of Vitamin D among Pregnant women worldwide, its ROLE in Pregnancy has LARGELY BEEN IGNORED [25,26,27].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 114)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 49, 'pregnant'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy')]
PMC5085625	9/2016	S95-PMC5085625	['CONSEQUENTLY, Vitamin D level in early Pregnancy is less LIKELY to play a MAJOR ROLE in Placental Development, and it is later increased in this parameter which may PREVENT the development of pe [13].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 57), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 80), ('SUPERFICIAL_RELATIONSHIP', 165)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('GO_0001890', 'placenta development', 88, 'placental development'), ('UBERON_0001987', 'placenta', 88, 'placental')]
PMC5085625	9/2016	S100-PMC5085625	['both a RECENT meta-analysis and several OBSERVATIONAL studies SHOWED a significant ASSOCIATION between Vitamin D deficiency and INCREASED RISK for Preeclampsia [39,40,41].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 128)]	5	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 147, 'preeclampsia')]
PMC5085625	9/2016	S105-PMC5085625	['SOME EVIDENCE SUGGESTS that Preeclampsia MAY BE ASSOCIATED with a decrease in Placental and fetal concentrations of Vitamin D, and Placental dysfunction plays an IMPORTANT ROLE in the pathogenesis of pe [44].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 162), ('SUPERFICIAL_RELATIONSHIP', 172)]	6	[('GO_0007128', 'meiotic prophase I', 28, 'preeclampsia'), ('UBERON_0001987', 'placenta', 78, 'placental'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0001987', 'placenta', 131, 'placental')]
PMC5085625	9/2016	S109-PMC5085625	['ALTHOUGH preeclampsia HAS BEEN LINKED to maternal Vitamin D insufficiency/deficiency, STILL LITTLE IS KNOWN on POTENTIAL differences in Placental Metabolism Of this Vitamin in uncomplicated and preeclamptic Pregnancies [32].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 86), ('IMPORTANT_CONSIDERATION', 86), ('FULL_UNKNOWN', 92), ('INCOMPLETE_EVIDENCE', 111)]	7	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'placental'), ('UBERON_0001987', 'placenta', 136, 'placental'), ('GO_0006583', 'melanin biosynthetic process from tyrosine', 146, 'metabolism of ... vitamin'), ('CHEBI_33229', 'vitamin (role)', 165, 'vitamin'), ('GO_0007565', 'female pregnancy', 207, 'pregnancies')]
PMC5085625	9/2016	S126-PMC5085625	['to summarize, the LINK between Vitamin D and Glucose Metabolism REQUIRES FURTHER STUDIES on larger populations of Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('IMPORTANT_CONSIDERATION', 64), ('FUTURE_WORK', 73)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_17234', 'glucose', 45, 'glucose'), ('GO_0006006', 'glucose metabolic process', 45, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 114, 'pregnant')]
PMC5085625	9/2016	S169-PMC5085625	['conclusions\nin CONCLUSION, both the results of PREVIOUS STUDIES and OUR FINDINGS PRESENTED HERE, documenting the LINK between Maternal deficiency of Vitamin D and the INCREASED RISK of Preeclampsia, POINT TO the IMPORTANT ROLE of an appropriate level and adequate Metabolism Of this Vitamin in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 91), ('SUPERFICIAL_RELATIONSHIP', 113), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 199), ('IMPORTANT_CONSIDERATION', 212), ('SUPERFICIAL_RELATIONSHIP', 222)]	10	[('GO_0007618', 'mating', 126, 'maternal'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 185, 'preeclampsia'), ('GO_0006583', 'melanin biosynthetic process from tyrosine', 264, 'metabolism of ... vitamin'), ('CHEBI_33229', 'vitamin (role)', 283, 'vitamin'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy')]
PMC5085625	9/2016	S174-PMC5085625	['AVAILABLE EVIDENCE is STILL INSUFFICIENT to CONFIRM a causative LINK between Vitamin D and Pregnancy disorders IN LINE WITH hill’s criteria.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 22), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 64), ('INCOMPLETE_EVIDENCE', 111)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy')]
PMC5095257	11/2016	S85-PMC5095257	['FURTHER STUDIES ARE REQUIRED to investigate the ASSOCIATION of Perinatal Vitamin D status and the RISK for aad.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('IMPORTANT_CONSIDERATION', 20), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 98)]	5	[('GO_0036268', 'swimming', 63, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 63, 'perinatal'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC5095257	11/2016	S97-PMC5095257	['exposure to seasonal Viral infections in the Perinatal Period coupled with Vitamin D deficiency leading to dysregulation of innate immunity COULD BE the POTENTIAL initial triggers for the eventual development of aad, ALTHOUGH this REQUIRES FURTHER EXPLORATION.']	[('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 153), ('ANOMALY_CURIOUS_FINDING', 217), ('IMPORTANT_CONSIDERATION', 231), ('FUTURE_WORK', 240)]	5	[('NCBITaxon_1', 'root', 21, 'viral'), ('GO_0036268', 'swimming', 45, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 45, 'perinatal period'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5115165	1/2016	S14-PMC5115165	['introduction\npotatoes are the third most commonly Consumed Food crop in the world, after rice and wheat.1in the united states, about 35% of women of Reproductive Age (that is, aged 19-50) Consume potatoes daily, accounting FOR 8% of daily total energy intake.2the health EFFECTS of potatoes are INCONCLUSIVE,13and there HAVE BEEN longstanding DEBATES on the appropriate placement of potatoes in dietary guidance.456nonetheless, the dietary guidelines for americans continue to include potatoes in the vegetable Food group and encourage Consumption.7THOUGH potatoes are rich in Vitamin C, Potassium, dietary fiber, and some Phytochemicals,6unlike other vegetables they CAN have DETRIMENTAL EFFECTS on Glucose Metabolism because they contain large amounts of rapidly absorbable Starch.3indeed, SEVERAL epidemiologic STUDIES have LINKED higher potato Consumption to increased concentrations of fasting Plasma Glucose,8insulin resistance,8and an increased risk of type 2 diabetes mellitus.910\nGestational diabetes mellitus (gdm) is a common COMPLICATION of Pregnancy characterized by Glucose intolerance with onset or first recognition during Pregnancy.11gdm is not only ASSOCIATED with adverse Perinatal outcomes,12it is also RELATED to increased long term Cardiometabolic risk in both mothers and their offspring.1113it is THEREFORE CRUCIAL to identify modifiable RISK FACTORS that COULD CONTRIBUTE to the PREVENTION of gdm.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 223), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 320), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('ANOMALY_CURIOUS_FINDING', 548), ('INCOMPLETE_EVIDENCE', 668), ('IMPORTANT_CONSIDERATION', 677), ('SUPERFICIAL_RELATIONSHIP', 689), ('INCOMPLETE_EVIDENCE', 792), ('SUPERFICIAL_RELATIONSHIP', 827), ('PROBLEM_COMPLICATION', 1037), ('SUPERFICIAL_RELATIONSHIP', 1167), ('SUPERFICIAL_RELATIONSHIP', 1223), ('PROBABLE_UNDERSTANDING', 1321), ('IMPORTANT_CONSIDERATION', 1331), ('SUPERFICIAL_RELATIONSHIP', 1362), ('INCOMPLETE_EVIDENCE', 1380), ('SUPERFICIAL_RELATIONSHIP', 1386), ('SUPERFICIAL_RELATIONSHIP', 1404)]	20	[('GO_0007631', 'feeding behavior', 50, 'consumed'), ('CHEBI_33290', 'food', 59, 'food'), ('GO_0000003', 'reproduction', 149, 'reproductive age'), ('GO_0007631', 'feeding behavior', 188, 'consume'), ('CHEBI_33290', 'food', 511, 'food'), ('GO_0007631', 'feeding behavior', 536, 'consumption'), ('CHEBI_27300', 'vitamin D', 577, 'vitamin C'), ('CHEBI_22314', 'alkali metal atom', 588, 'potassium'), ('CHEBI_26254', 'prenylnaphthoquinone', 623, 'phytochemicals'), ('CHEBI_17234', 'glucose', 700, 'glucose'), ('GO_0006006', 'glucose metabolic process', 700, 'glucose metabolism'), ('CHEBI_28017', 'starch', 776, 'starch'), ('GO_0007631', 'feeding behavior', 848, 'consumption'), ('UBERON_0001969', 'blood plasma', 899, 'plasma'), ('CHEBI_17234', 'glucose', 906, 'glucose'), ('GO_0007565', 'female pregnancy', 989, 'Gestational'), ('GO_0007565', 'female pregnancy', 1053, 'pregnancy'), ('CHEBI_17234', 'glucose', 1080, 'glucose'), ('GO_0007565', 'female pregnancy', 1139, 'pregnancy'), ('GO_0036268', 'swimming', 1191, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1191, 'perinatal'), ('GO_0007599', 'hemostasis', 1254, 'cardiometabolic')]
PMC5118763	12/2016	S203-PMC5118763	['in conclusion, women assigned to the mmn regimen had a higher concentration of Plasma Vitamin B-12, ALTHOUGH the PUBLIC HEALTH SIGNIFICANCE of the size of the EFFECT is UNCERTAIN.']	[('ANOMALY_CURIOUS_FINDING', 100), ('IMPORTANT_CONSIDERATION', 113), ('IMPORTANT_CONSIDERATION', 127), ('SUPERFICIAL_RELATIONSHIP', 159), ('FULL_UNKNOWN', 169)]	5	[('UBERON_0001969', 'blood plasma', 79, 'plasma'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 86, 'vitamin B-12')]
PMC5129897	10/2016	S0-PMC5129897	['estimated economic BENEFIT of increasing 25-Hydroxyvitamin D concentrations of canadians to or above 100\xa0nmol/l\n\nabstractabstract\nMOUNTING EVIDENCE from observational and clinical TRIALS INDICATES that optimal Vitamin D reduces the RISK of many diseases.']	[('IMPORTANT_CONSIDERATION', 19), ('INCOMPLETE_EVIDENCE', 130), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 187), ('IMPORTANT_CONSIDERATION', 232)]	5	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 41, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC5129897	10/2016	S4-PMC5129897	['we used 25(Oh)D concentration–health outcome RELATIONS for Breast cancer and Cardiovascular disease and results of clinical trials with Vitamin D for Respiratory infections and Musculoskeletal disorders to ESTIMATE the reductions in disease BURDEN for increased 25(Oh)D concentrations.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 206), ('IMPORTANT_CONSIDERATION', 241)]	3	[('CHEBI_71657', 'versiconol acetate', 8, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 14, 'D'), ('UBERON_0000310', 'breast', 59, 'breast'), ('UBERON_0004535', 'cardiovascular system', 77, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 150, 'respiratory'), ('UBERON_0002204', 'musculoskeletal system', 177, 'musculoskeletal'), ('CHEBI_71657', 'versiconol acetate', 262, '25(OH)D')]
PMC5129897	10/2016	S6-PMC5129897	['HOWEVER, the EFFECTS on disease incidence, economic BURDEN, and mortality rate would be phased in gradually over several years PRIMARILY because once a chronic disease is established, Vitamin D AFFECTS its progression ONLY modestly.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 52), ('PROBABLE_UNDERSTANDING', 127), ('SUPERFICIAL_RELATIONSHIP', 194), ('ANOMALY_CURIOUS_FINDING', 218), ('INCOMPLETE_EVIDENCE', 218)]	7	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC5129897	10/2016	S7-PMC5129897	['NEVERTHELESS, national policy changes are JUSTIFIED to improve Vitamin D status of canadians through promotion of SAFE sun exposure messages, Vitamin D supplement use, and/or facilitation of Food fortification.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 42), ('IMPORTANT_CONSIDERATION', 42), ('IMPORTANT_CONSIDERATION', 114)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_33290', 'food', 191, 'food')]
PMC5129897	10/2016	S8-PMC5129897	['introduction\nduring the past 15\xa0years, CONSIDERABLE INTEREST in the health BENEFITS of Vitamin D has emerged BECAUSE People with higher ultraviolet-b (uvb) exposure and/or 25-Hydroxyvitamin D [25(Oh)D] concentrations have lower RISK of many diseases and conditions.1our analysis is LIMITED to the diseases with the greatest economic EFFECT and the STRONGEST evidence of PROTECTIVE ROLES of Vitamin D—namely, cancer, Cardiovascular disease (cvd), dementia, diabetes mellitus (dm), falls and fractures, multiple sclerosis (ms), and Respiratory Tract infections.']	[('ANOMALY_CURIOUS_FINDING', 39), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 52), ('IMPORTANT_CONSIDERATION', 75), ('PROBABLE_UNDERSTANDING', 109), ('IMPORTANT_CONSIDERATION', 228), ('INCOMPLETE_EVIDENCE', 282), ('SUPERFICIAL_RELATIONSHIP', 333), ('INCOMPLETE_EVIDENCE', 348), ('SUPERFICIAL_RELATIONSHIP', 370), ('SUPERFICIAL_RELATIONSHIP', 381)]	11	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'people'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 172, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 193, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 390, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 416, 'cardiovascular'), ('UBERON_0000065', 'respiratory tract', 530, 'respiratory tract')]
PMC5129897	10/2016	S9-PMC5129897	['table\xa01outlines information SUPPORTING the ROLE of Vitamin D in reducing RISK of those diseases.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 43), ('IMPORTANT_CONSIDERATION', 73)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC5129897	10/2016	S16-PMC5129897	['NEITHER ASSUMPTION holds for Vitamin D. robert heaney OUTLINED the GUIDELINES for Nutrient studies including Vitamin D. the most RELEVANT features are that one SHOULD start with an understanding of the 25(Oh)D concentration–health outcome RELATION, 25(Oh)D concentrations SHOULD BE measured in prospective participants, ONLY those with low concentrations SHOULD BE enrolled, sufficient Vitamin D SHOULD BE given to raise 25(Oh)D concentrations to where a significant beneficial EFFECT is expected, and achieved 25(Oh)D concentrations SHOULD BE measured.2until those steps are followed routinely, FEW Vitamin D clinical TRIALS will report beneficial EFFECTS.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 67), ('PROBABLE_UNDERSTANDING', 67), ('IMPORTANT_CONSIDERATION', 129), ('FUTURE_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 239), ('FUTURE_WORK', 272), ('INCOMPLETE_EVIDENCE', 320), ('FUTURE_WORK', 355), ('FUTURE_WORK', 396), ('SUPERFICIAL_RELATIONSHIP', 478), ('FUTURE_WORK', 534), ('INCOMPLETE_EVIDENCE', 596), ('FUTURE_WORK', 619), ('SUPERFICIAL_RELATIONSHIP', 649)]	17	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_33284', 'nutrient', 82, 'nutrient'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 249, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 386, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 421, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 427, 'D'), ('CHEBI_71657', 'versiconol acetate', 511, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 517, 'D'), ('CHEBI_27300', 'vitamin D', 600, 'vitamin D')]
PMC5129897	10/2016	S17-PMC5129897	['a review of clinical trials of Vitamin D with respect to biomarkers of inflammation SHOWS WHY following those guidelines is IMPORTANT.']	[('INCOMPLETE_EVIDENCE', 84), ('EXPLICIT_QUESTION', 90), ('IMPORTANT_CONSIDERATION', 124)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5129897	10/2016	S20-PMC5129897	['the criteria most RELEVANT for Vitamin D are strength of ASSOCIATION, CONSISTENT findings in DIFFERENT populations, temporality, biological gradient, plausibility (e.g., mechanisms), coherence with known facts, and experiments (e.g., clinical trials).5not all criteria NEED be satisfied, BUT the more that are, the stronger the case.']	[('IMPORTANT_CONSIDERATION', 18), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('IMPORTANT_CONSIDERATION', 269), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 288)]	6	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5129897	10/2016	S23-PMC5129897	['the PURPOSE of THIS NEW STUDY is to revisit Vitamin D concentrations of canadians and to ESTIMATE the economic BENEFIT of increasing 25(Oh)D concentrations, with the knowledge that overall 25(Oh)D concentrations have gone down since our PREVIOUS STUDY.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('FULL_UNKNOWN', 20), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 111), ('INCOMPLETE_EVIDENCE', 237)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 139, 'D'), ('CHEBI_71657', 'versiconol acetate', 189, '25(OH)D')]
PMC5129897	10/2016	S27-PMC5129897	['materials and methods\npublications on the RELATIONS between 25(Oh)D concentrations and health outcomes were obtained LARGELY by searchingpubmed.govandscholar.google.comfor terms such as Vitamin D, 25-Hydroxyvitamin D, meta-analysis, Back and Spine disorders, cancer, Cardiovascular disease, Immune System, osteoporosis, Respiratory infection, economic BURDEN, canada, cost, season, mortality, incidence , and risk .']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 352)]	3	[('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 60, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 197, '25-hydroxyvitamin D'), ('UBERON_0001137', 'dorsum', 233, 'back'), ('UBERON_0001013', 'adipose tissue', 242, 'spine'), ('UBERON_0004535', 'cardiovascular system', 267, 'cardiovascular'), ('UBERON_0002405', 'immune system', 291, 'immune system'), ('UBERON_0001004', 'respiratory system', 320, 'respiratory')]
PMC5129897	10/2016	S74-PMC5129897	["based on data from the us for 2004–2013, using the national cancer institute's surveillance, epidemiology, and end results (seer) program, cancer incidence rates for those aged 20–49\xa0y is 2% of that for those aged >50\xa0y.53\n\nrespiratory infections\ninfluenza and pneumonia accounted for 5,694 deaths of canadians in 2012.54the total economic impact for Respiratory infections was $5.4\xa0billion in 2008.55the ESTIMATED economic BURDEN in 2016 is$5.4\xa0billion\u2009×\u2009(1.033)2\u2009×\u2009(0.994)6\u2009×\u2009(36.3\xa0million/33.3\xa0million)\xa0=\xa0$6.1\xa0billion\nclinical trials SUPPORT the ROLE of Vitamin D in reducing RISK of influenza."]	[('INCOMPLETE_EVIDENCE', 405), ('IMPORTANT_CONSIDERATION', 424), ('INCOMPLETE_EVIDENCE', 537), ('SUPERFICIAL_RELATIONSHIP', 549), ('IMPORTANT_CONSIDERATION', 579)]	5	[('UBERON_0001004', 'respiratory system', 351, 'respiratory'), ('CHEBI_27300', 'vitamin D', 557, 'vitamin D')]
PMC5129897	10/2016	S86-PMC5129897	['OBSERVATIONAL STUDIES offer GOOD EVIDENCE that Vitamin D AFFECTS RISK of dm.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 28), ('PROBABLE_UNDERSTANDING', 28), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 65)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5129897	10/2016	S93-PMC5129897	['a RECENT PAPER by EXPERTS in ms ESTIMATED that Vitamin D supplementation COULD PREVENT 40% of ms cases.63using that value, the total economic BURDEN of ms in canada could eventually be reduced by $1.5\xa0billion.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 18), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 142)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5129897	10/2016	S117-PMC5129897	["the annual economic BURDEN of crohn's disease in canada is $1.7\xa0billion, WHEREAS that of ulcerative colitis is $1.2\xa0billion.78several papers HAVE REPORTED inverse CORRELATIONS between Vitamin D status and incidence, prevalence, and/or severity of Inflammatory Bowel disease.79,80\nEVIDENCE is mounting that higher 25(Oh)D concentrations are ASSOCIATED with BETTER Pregnancy and Birth outcomes."]	[('IMPORTANT_CONSIDERATION', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 280), ('SUPERFICIAL_RELATIONSHIP', 340), ('IMPORTANT_CONSIDERATION', 356)]	7	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0001782', 'pigmented layer of retina', 247, 'inflammatory bowel'), ('CHEBI_71657', 'versiconol acetate', 313, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 319, 'D'), ('GO_0007565', 'female pregnancy', 363, 'pregnancy'), ('GO_0007567', 'parturition', 377, 'birth')]
PMC5129897	10/2016	S118-PMC5129897	["“the CURRENTLY AVAILABLE results INDICATE that Vitamin D supplementation during Pregnancy reduces the RISK of Preterm Birth, low Birth weight, Dental caries of infancy, and neonatal infectious diseases such as Respiratory infections and sepsis.”81furthermore, with UNFOLDING RESEARCH into fetal origins of pediatric and Adult disease, EVIDENCE increasingly INDICATES that Gestational Vitamin D indices MAY determine health in later Life.82for example, an INTERESTING cohort study CORRELATING maternal Vitamin D levels at 18\xa0weeks' Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency was ASSOCIATED with a higher risk of impaired Lung Development in 6-year-old offspring, Neurocognitive difficulties at age 10\xa0years, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20\xa0y.83\na RECENT STUDY CONCLUDED that Vitamin D is reduces exacerbations of asthma.84\n\nall-cause mortality rate\ngarland and colleagues85presented a meta-analysis of 32 prospective observational studies that investigated all-cause mortality rate with respect to 25(Oh)D concentration at time of enrollment."]	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 33), ('IMPORTANT_CONSIDERATION', 102), ('INCOMPLETE_EVIDENCE', 265), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 402), ('ANOMALY_CURIOUS_FINDING', 455), ('SUPERFICIAL_RELATIONSHIP', 480), ('INCOMPLETE_EVIDENCE', 572), ('SUPERFICIAL_RELATIONSHIP', 620), ('INCOMPLETE_EVIDENCE', 838), ('INCOMPLETE_EVIDENCE', 851)]	13	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'preterm'), ('GO_0007567', 'parturition', 118, 'birth'), ('GO_0007567', 'parturition', 129, 'birth'), ('UBERON_0001091', 'calcareous tooth', 143, 'dental'), ('UBERON_0001004', 'respiratory system', 210, 'respiratory'), ('UBERON_0007023', 'adult organism', 320, 'adult'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('UBERON_0000104', 'life cycle', 432, 'life'), ('CHEBI_27300', 'vitamin D', 501, 'vitamin D'), ('GO_0007565', 'female pregnancy', 531, 'pregnancy'), ('GO_0007565', 'female pregnancy', 583, 'gestational'), ('CHEBI_27300', 'vitamin D', 595, 'vitamin D'), ('GO_0030324', 'lung development', 662, 'lung development'), ('UBERON_0002048', 'lung', 662, 'lung'), ('GO_0050905', 'neuromuscular process', 704, 'neurocognitive'), ('GO_0051318', 'G1 phase', 767, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 787, 'adolescence'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1089, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1089, '25(OH ... D')]
PMC5129897	10/2016	S134-PMC5129897	['the total economic BURDEN of the Vitamin D–sensitive diseases CONSIDERED HERE is ESTIMATED at $79.1\xa0billion in 2016 (table\xa08).']	[('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 73), ('INCOMPLETE_EVIDENCE', 81)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5129897	10/2016	S150-PMC5129897	['estimate of reduction in economic BURDEN in canada if all inhabitants had 25(Oh)D concentrations >100\xa0nmol/l after several years.outcometotal economic burden in 2016 ($b)reduction due to improving Vitamin D status (%)reduction in economic BURDEN due to improving Vitamin D status ($b)deaths in canada in 201139reduction in deaths, using deaths for 2011cancer7.3151.172,47610,870cvd24.6143.460,9108530dementia16.271.110,000700dm15.7182.871941290ms3.7401.5500 ref.92200osteoporosis (Hip fractures)5.0221.1\xa0\xa0respiratory infections6.1251.557671440total78.615.912.5156,84723,030\nnote: total deaths in canada in 2011 were 242,07488\n$b, billions of dollars; cvd, cardiovascular disease; dm, diabetes mellitus; ms, multiple sclerosis.']	[('IMPORTANT_CONSIDERATION', 34), ('IMPORTANT_CONSIDERATION', 239)]	2	[('CHEBI_71657', 'versiconol acetate', 74, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 74, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 263, 'vitamin D'), ('UBERON_0001464', 'hip', 481, 'hip')]
PMC5129897	10/2016	S151-PMC5129897	['as with all ESTIMATES, these have uncertainties, including the 25(Oh)D concentration–health outcome RELATIONS used; the ESTIMATES of economic BURDENS; whether reducing risk of specific diseases would translate into the same fraction of economic BURDEN; the extent to which changing risk-modifying risk factors such as smoking, alcohol Consumption, diet, and obesity modify the relative reduction due to higher 25(Oh)D concentration; and that the analysis omitted several Vitamin D–sensitive diseases and conditions BECAUSE of LIMITED UNDERSTANDING of the EFFECTS.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 120), ('IMPORTANT_CONSIDERATION', 142), ('IMPORTANT_CONSIDERATION', 245), ('PROBLEM_COMPLICATION', 515), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 555)]	8	[('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 63, '25(OH)D'), ('GO_0007631', 'feeding behavior', 335, 'consumption'), ('CHEBI_71657', 'versiconol acetate', 410, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin D')]
PMC5129897	10/2016	S158-PMC5129897	['the ESTIMATES intable\xa09SHOW a POTENTIAL large BENEFIT of improving Vitamin D status in terms of reduction in economic BURDEN ($12.5billion) and premature deaths (23,000/yr) ON THE BASIS OF the types of disease for which EVIDENCE IS STRONG that higher 25(Oh)D concentrations have beneficial EFFECTS.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 46), ('IMPORTANT_CONSIDERATION', 118), ('INCOMPLETE_EVIDENCE', 173), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 290)]	8	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 251, '25(OH)D')]
PMC5129897	10/2016	S161-PMC5129897	['those ESTIMATES are SIMILAR TO those in the PREVIOUS PAPER on THIS topic, which ESTIMATED that if the 25(Oh)D concentration of all canadians were raised from a mean value of 67\xa0nmol/l to 105\xa0nmol/l, the death rate could fall by 37,000 (22,300–52,300 deaths), REPRESENTING 16.1% (9.7%–22.7%) of annual deaths, and the economic BURDEN could fall by 6.9% (3.8%–10.0%), or $14.4\xa0billion ($8.0\xa0billion–$20.1\xa0billion).89that paper CONSIDERED HOW Vitamin D AFFECTS cancer, cvd, dm, falls and fractures, Heart disease, influenza and pneumonia, ms, and septicemia as well as Pregnancy and Birth outcomes.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('INCOMPLETE_EVIDENCE', 80), ('PROBABLE_UNDERSTANDING', 259), ('IMPORTANT_CONSIDERATION', 326), ('INCOMPLETE_EVIDENCE', 425), ('EXPLICIT_QUESTION', 436), ('SUPERFICIAL_RELATIONSHIP', 450)]	11	[('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 440, 'vitamin D'), ('UBERON_0000948', 'heart', 496, 'heart'), ('GO_0007565', 'female pregnancy', 566, 'pregnancy'), ('GO_0007567', 'parturition', 580, 'birth')]
PMC5129897	10/2016	S176-PMC5129897	['the results of observational studies are GENERALLY not well-SUPPORTED by clinical trials of Vitamin D supplementation.94the primary REASON for that lack OF support SEEMS TO be that the trials were NOT WELL DESIGNED, being based LARGELY on the guidelines for Pharmaceutical Drugs RATHER than for Nutrients.2another WORRISOME POINT is that clinical trials have BEEN much more successful when baseline 25(Oh)D concentrations were low.']	[('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 60), ('PROBABLE_UNDERSTANDING', 132), ('ANOMALY_CURIOUS_FINDING', 153), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 279), ('IMPORTANT_CONSIDERATION', 314), ('IMPORTANT_CONSIDERATION', 324), ('ANOMALY_CURIOUS_FINDING', 359)]	11	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_52217', 'pharmaceutical', 258, 'pharmaceutical'), ('CHEBI_23888', 'drug', 273, 'drugs'), ('CHEBI_33284', 'nutrient', 295, 'nutrients'), ('CHEBI_71657', 'versiconol acetate', 399, '25(OH)D')]
PMC5129897	10/2016	S177-PMC5129897	['for example, 50% of the clinical trials with baseline 25(Oh)D concentration <50\xa0nmol/l FOUND beneficial EFFECTS of Vitamin D on BIOMARKERS of inflammation, WHEREAS ONLY 26% of those with higher baseline 25(Oh)D concentrations did.3the DIFFERENT results with respect to baseline 25(Oh)D concentration MAY BE DUE TO the LIMITED accuracy of clinical trials but COULD also be DUE TO CONSIDERABLY less BENEFIT for those with 25(Oh)D concentrations above 50\xa0nmol/l.']	[('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156), ('ANOMALY_CURIOUS_FINDING', 156), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235), ('INCOMPLETE_EVIDENCE', 300), ('PROBLEM_COMPLICATION', 307), ('INCOMPLETE_EVIDENCE', 318), ('INCOMPLETE_EVIDENCE', 358), ('PROBLEM_COMPLICATION', 372), ('ANOMALY_CURIOUS_FINDING', 379), ('IMPORTANT_CONSIDERATION', 397)]	15	[('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 203, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 203, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 278, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 284, 'D'), ('CHEBI_71657', 'versiconol acetate', 420, '25(OH)D')]
PMC5129897	10/2016	S187-PMC5129897	['the institute FOUND no EVIDENCE of adverse health EFFECTS for the general population for intakes as high as 10,000 iu/d.96given the latitudes of canada, sun exposure is a good source of Vitamin D primarily in the summer and then best near solar noon.97\nmore than12 million canadians do not meet the minimum Vitamin D GUIDELINES of 50\xa0nmol/l put forth by health canada.98sun exposure HAS BEEN RECOGNIZED AS a KEY FACTOR INFLUENCING Vitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 317), ('PROBABLE_UNDERSTANDING', 317), ('INCOMPLETE_EVIDENCE', 383), ('PROBABLE_UNDERSTANDING', 392), ('PROBABLE_UNDERSTANDING', 403), ('IMPORTANT_CONSIDERATION', 408), ('SUPERFICIAL_RELATIONSHIP', 412), ('SUPERFICIAL_RELATIONSHIP', 419)]	11	[('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 307, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 431, 'vitamin D')]
PMC5129897	10/2016	S189-PMC5129897	['artificial sources of uvb COULD substitute when appropriate solar uvb doses are not available.100\nuv exposure confers health BENEFITS beyond Vitamin D production.']	[('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 125)]	2	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5129897	10/2016	S190-PMC5129897	['one is reduction in Blood pressure through liberating Nitric Oxide from subcutaneous Nitrogen stores.101another is that uv MAY Modulate the Immune Response to psoriasis, asthma, ms, and infection through mechanisms independent of Vitamin D.102uvb exposure APPARENTLY reduces the risk of ms through both Vitamin D–DEPENDENT and –INDEPENDENT mechanisms.103\nthe CONCERNS regarding RISK of skin cancer and melanoma are OFTEN overstated in comparison with the benefits of non burning, moderate uv exposure.']	[('INCOMPLETE_EVIDENCE', 123), ('ANOMALY_CURIOUS_FINDING', 256), ('SUPERFICIAL_RELATIONSHIP', 313), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBLEM_COMPLICATION', 359), ('IMPORTANT_CONSIDERATION', 378), ('PROBABLE_UNDERSTANDING', 415)]	7	[('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_16480', 'nitric oxide', 54, 'nitric oxide'), ('CHEBI_33300', 'pnictogen', 85, 'nitrogen'), ('GO_0065007', 'biological regulation', 127, 'modulate'), ('GO_0006955', 'immune response', 140, 'immune response'), ('UBERON_0002405', 'immune system', 140, 'immune'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]
PMC5129897	10/2016	S192-PMC5129897	['one was a meta-analysis of observational studies.104the OTHER was a study of cancer incidence by occupation in nordic countries.49\n\nconclusions\nmany People living in canada do not have OPTIMAL 25(Oh)D concentrations AS a result of limited solar uvb exposure and/or not obtaining enough Vitamin D from Food or supplements.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('IMPORTANT_CONSIDERATION', 185), ('PROBABLE_UNDERSTANDING', 216)]	3	[('NCBITaxon_10088', 'Mus <genus>', 149, 'people'), ('CHEBI_71657', 'versiconol acetate', 193, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 193, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 294, 'D'), ('CHEBI_33290', 'food', 301, 'food')]
PMC5133057	10/2016	S12-PMC5133057	['during Pregnancy, Vitamin A is IMPORTANT for Cell Division, growth, and maturation of Fetal Organ and Skeletal Systems.']	[('IMPORTANT_CONSIDERATION', 31)]	1	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin A'), ('GO_0051301', 'cell division', 45, 'cell division'), ('UBERON_0000922', 'embryo', 86, 'fetal'), ('UBERON_0000062', 'organ', 92, 'organ'), ('UBERON_0004755', 'skeletal tissue', 102, 'skeletal systems')]
PMC5133057	10/2016	S18-PMC5133057	['in brazil, vad HAS BEEN DOCUMENTED in the northeast and in SOME parts of the southeast [16]; HOWEVER, there are STILL ONLY a FEW STUDIES that evaluate the Consumption of Vitamin A by Pregnant women [17], and there are EVEN FEWER STUDIES investigating the occurrence of vad among Pregnant teenagers.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('IMPORTANT_CONSIDERATION', 112), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 125), ('ANOMALY_CURIOUS_FINDING', 218), ('INCOMPLETE_EVIDENCE', 223)]	9	[('GO_0007631', 'feeding behavior', 155, 'consumption'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin A'), ('GO_0007565', 'female pregnancy', 183, 'pregnant'), ('GO_0007565', 'female pregnancy', 279, 'pregnant')]
PMC5133057	10/2016	S108-PMC5133057	['it is IMPORTANT TO NOTE that EVEN IF the reduction occurs with more intensity in the second and third quarter due to Plasma volume expansion and increased Vitamin A transfer from the mother to the fetus, special ATTENTION throughout Pregnancy is NECESSARY, PARTICULARLY in the first trimester, when the major changes in the Fetal Development occur.']	[('IMPORTANT_CONSIDERATION', 6), ('ANOMALY_CURIOUS_FINDING', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('FUTURE_WORK', 212), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 246), ('IMPORTANT_CONSIDERATION', 257)]	7	[('UBERON_0001969', 'blood plasma', 117, 'plasma'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin A'), ('GO_0007565', 'female pregnancy', 233, 'pregnancy'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 324, 'fetal development')]
PMC5137891	12/2016	S140-PMC5137891	['many women were not meeting the ESTIMATED average REQUIREMENT for key Micronutrients (percent below ESTIMATED average requirement- ear: 25% for iron, 16% for zinc, 54% for Folate, 64% for Vitamin B12 and 27% for Vitamin A) [43].']	[('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 50), ('INCOMPLETE_EVIDENCE', 100)]	3	[('CHEBI_33839', 'macromolecule', 70, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 172, 'folate'), ('CHEBI_33279', 'vitamin D5', 188, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A')]
PMC5146866	12/2016	S10-PMC5146866	['OUR FINDINGS RAISE a QUESTION regarding the adequacy of the aap RECOMMENDED Vitamin D supplementation REQUIREMENTS without knowing the infant’s Vitamin D status at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('EXPLICIT_QUESTION', 13), ('EXPLICIT_QUESTION', 21), ('FUTURE_WORK', 64), ('IMPORTANT_CONSIDERATION', 102)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007567', 'parturition', 164, 'birth')]
PMC5146866	12/2016	S11-PMC5146866	['background\ncharacterization of the Vitamin D status in the maternal-fetal-neonatal interface is clinically IMPORTANT BECAUSE of the increased rates of detection of Vitamin D insufficiency in Cord Blood (Cb) and the ASSOCIATED RISK for health COMPLICATIONS in infants and children [1,2], including but not limited to rickets [3], infectious and allergic diseases, and type 1 diabetes [4–6].']	[('IMPORTANT_CONSIDERATION', 107), ('PROBABLE_UNDERSTANDING', 117), ('PROBLEM_COMPLICATION', 117), ('SUPERFICIAL_RELATIONSHIP', 215), ('IMPORTANT_CONSIDERATION', 226), ('IMPORTANT_CONSIDERATION', 242)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('UBERON_0009472', 'axilla', 191, 'cord blood'), ('UBERON_2005013', 'concurrent branch afferent branchial artery', 203, 'CB')]
PMC5146866	12/2016	S12-PMC5146866	['assessing Vitamin D status using cb is a CHALLENGE AS the OPTIMAL level of Vitamin D in children is STILL the subject of discussion [7].']	[('DIFFICULT_TASK', 41), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 58), ('IMPORTANT_CONSIDERATION', 100)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5146866	12/2016	S15-PMC5146866	['HOWEVER, the clinical practice guidelines published by the Endocrine society RECOMMENDS that 30\xa0ng/ml of Vitamin D in children and Adults SHOULD BE CONSIDERED sufficient and classifies levels below 20\xa0ng/ml (50\xa0nmol/l) and 21–29\xa0ng/ml (55–75\xa0nmol/l) as deficient and insufficient, respectively [10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 77), ('FUTURE_WORK', 138), ('IMPORTANT_CONSIDERATION', 148)]	4	[('UBERON_0005063', 'left ventricular compact myocardium', 59, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 131, 'adults')]
PMC5146866	12/2016	S24-PMC5146866	['DESPITE numerous publications that explored Vitamin D status in cb, FURTHER RESEARCH is REQUIRED to determine the LIKELIHOOD for detection of Vitamin D insufficiency in cb of infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 88), ('PROBABLE_UNDERSTANDING', 114)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC5146866	12/2016	S78-PMC5146866	['caption (table-wrap): table 3\n\ncharacteristics of neonates during Birth hospitalization with respect to their cb Vitamin D statusparametricvitamin D satus p valuedeficiency n \u2009=\u200995insufficiency n \u2009=\u200979sufficiency n \u2009=\u200991gestational age (weeks)38.8(38.6–39.1)39.2(38.9–39.5)38.9(38.7–39.3)0.65birth weight (g)3301(3215–3387)3433(3322–3544)3306(3305–3406)0.35birth length (cm)48.8(48.1–49.6)49.5(49.0–50.0)48.3(47.2–49.5)0.53apgar 1\xa0min <72.1%(0.6–7.0)2.6%(0.7–8.9)6.5%(2.4–12.2)0.21nicu admission6.3%(0.87–11.7)5.1%(0–10.6)8.9%(2.4–15.3)0.62hypoglycemia (%)01.3%(0–4.4)1.1%(0–3.6)0.56neonatal jaundice (%)21.1%(12.6–29.6)13.9%(5.3–22.5)13.9%(6.4–21.4)0.27phototherapy (%)5.3%(0.3–10.3)1.3%(0–4.4)1.1%(0–3.6)0.13\ndata presented as mean or proportion (%) with 95% confidence intervals of mean or %\n\ndiscussion\nwe FOUND that up to 45% infants are AT RISK for deficient and 35% for INSUFFICIENT levels of Vitamin D. the APPROXIMATED probability of an infant being Born with a sufficient Vitamin D level as defined by the aap for children [8] is less than 40%.']	[('INCOMPLETE_EVIDENCE', 810), ('IMPORTANT_CONSIDERATION', 843), ('IMPORTANT_CONSIDERATION', 877), ('INCOMPLETE_EVIDENCE', 915)]	4	[('GO_0007567', 'parturition', 66, 'birth'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 147, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 147, 'D'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin D'), ('GO_0007567', 'parturition', 959, 'born'), ('CHEBI_27300', 'vitamin D', 982, 'vitamin D')]
PMC5146866	12/2016	S79-PMC5146866	['IMPORTANTLY, the upper limit of Vitamin D that is defined as sufficient [8] COULD BE SUBOPTIMAL BECAUSE Vitamin D levels of <30\xa0ng/ml have been ASSOCIATED with increased secretion of intact Parathyroid hormone and reduced Intestinal calcium absorption in healthy Adults [22,23].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 85), ('PROBABLE_UNDERSTANDING', 96), ('SUPERFICIAL_RELATIONSHIP', 144)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 190, 'parathyroid'), ('UBERON_0000160', 'intestine', 222, 'intestinal'), ('UBERON_0007023', 'adult organism', 263, 'adults')]
PMC5146866	12/2016	S80-PMC5146866	['WHILE a Vitamin D level of 20\xa0ng/ml IS CONSIDERED sufficient, maintenance of 30\xa0ng/ml is RECOMMENDED for better health in children and Adults [24] DESPITE the LACK OF CLEAR EVIDENCE of an OPTIMAL concentration of Vitamin D for bone and general health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 89), ('ANOMALY_CURIOUS_FINDING', 147), ('INCOMPLETE_EVIDENCE', 159), ('IMPORTANT_CONSIDERATION', 188)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0007023', 'adult organism', 135, 'adults'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC5146866	12/2016	S82-PMC5146866	['OUR FINDINGS confirmed PREVIOUS reports SHOWING an INCREASED RISK for Vitamin D deficiency in infants Born to mothers of non-white race/ethnicity [11,14,15,28].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 40), ('IMPORTANT_CONSIDERATION', 51)]	4	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'born')]
PMC5146866	12/2016	S85-PMC5146866	['moreover, the internal VALIDITY of the EXISTING STUDIES is a subject for discussion because the INDEPENDENT EFFECT of maternal race/ethnicity on the Vitamin D status was not controlled for and other maternal FACTORS MAY also have an ASSOCIATION with the development of Vitamin D deficiency/insufficiency in infants at Birth.']	[('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 208), ('INCOMPLETE_EVIDENCE', 216), ('SUPERFICIAL_RELATIONSHIP', 233)]	7	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('GO_0007567', 'parturition', 318, 'birth')]
PMC5146866	12/2016	S106-PMC5146866	['conclusions\na significant number of infants, especially those Born to mothers of non-white race/ethnicity, younger age, and with a history of multiple Pregnancies, are AT RISK for having insufficient and deficient levels of Vitamin D in cb.']	[('IMPORTANT_CONSIDERATION', 168)]	1	[('GO_0007567', 'parturition', 62, 'born'), ('GO_0007565', 'female pregnancy', 151, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D')]
PMC5146866	12/2016	S107-PMC5146866	['our data SHOULD ENCOURAGE pediatricians to supplement infants with Vitamin D ESPECIALLY CONSIDERING the REPORTED POOR COMPLIANCE with the aap’s RECOMMENDATIONS by both, pediatricians and parents [38].']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 16), ('IMPORTANT_CONSIDERATION', 77), ('IMPORTANT_CONSIDERATION', 88), ('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 113), ('PROBLEM_COMPLICATION', 113), ('PROBLEM_COMPLICATION', 118), ('FUTURE_WORK', 144)]	10	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC5146866	12/2016	S108-PMC5146866	['moreover, DUE TO the high LIKELIHOOD of Vitamin D insufficiency/deficiency at Birth, FURTHER STUDIES MAY be REQUIRED to determine the ROLE of implementing Vitamin D supplementation with respect to the cb Vitamin D status.']	[('PROBLEM_COMPLICATION', 10), ('PROBABLE_UNDERSTANDING', 26), ('FUTURE_WORK', 85), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 108), ('SUPERFICIAL_RELATIONSHIP', 134)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 78, 'birth'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC5155676	12/2016	S14-PMC5155676	['maternal Vitamin D INSUFFICIENCY during Pregnancy is common (1,2), and THERE IS EVIDENCE that this MIGHT have DETRIMENTAL EFFECTS on maternal health, Fetal Development (3,4) and the long-term Skeletal health of children (1,3).']	[('IMPORTANT_CONSIDERATION', 19), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 110), ('SUPERFICIAL_RELATIONSHIP', 122)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 150, 'fetal development'), ('UBERON_0004288', 'skeleton', 192, 'skeletal')]
PMC5155676	12/2016	S15-PMC5155676	['SEVERE maternal Vitamin D deficiency during Pregnancy CAN result in symptomatic hypocalcaemia in the neonate (3).']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 54)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy')]
PMC5155676	12/2016	S18-PMC5155676	['indeed MANY national GUIDELINES RECOMMEND universal Antenatal Vitamin D supplementation to prevent Vitamin D INSUFFICIENCY (7–9).']	[('INCOMPLETE_EVIDENCE', 7), ('PROBABLE_UNDERSTANDING', 21), ('FUTURE_WORK', 32), ('IMPORTANT_CONSIDERATION', 109)]	4	[('GO_0007567', 'parturition', 52, 'antenatal'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC5155676	12/2016	S21-PMC5155676	['in nonpregnant Adults, baseline 25(Oh)D concentration, body weight/adiposity and age are IMPORTANT DETERMINANTS of the incremental rise in 25(Oh)D after Vitamin D supplementation (13,14).']	[('IMPORTANT_CONSIDERATION', 89), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('UBERON_0007023', 'adult organism', 15, 'adults'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 32, '25(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 38, 'D'), ('CHEBI_30778', 'gallic acid', 139, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 145, 'D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC5155676	12/2016	S23-PMC5155676	['clinically, understanding HOW Individuals respond COULD LEAD to individualized Antenatal counseling regarding Vitamin D supplementation to ensure Vitamin D repletion is achieved without increasing the RISK of Vitamin D toxicity.']	[('EXPLICIT_QUESTION', 26), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 201)]	4	[('NCBITaxon_1', 'root', 30, 'individuals'), ('GO_0007567', 'parturition', 79, 'antenatal'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC5155676	12/2016	S99-PMC5155676	['THUS, those women who are AT RISK of Vitamin D insufficiency in early Pregnancy, gain greater weight, and Deliver in winter MIGHT NEED supplementation with a higher dose of Cholecalciferol to achieve SIMILAR 25(Oh)D concentrations.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 26), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 130), ('SUPERFICIAL_RELATIONSHIP', 200)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0007567', 'parturition', 106, 'deliver'), ('CHEBI_52550', 'theopalauamide', 173, 'cholecalciferol'), ('CHEBI_71657', 'versiconol acetate', 208, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 214, 'D')]
PMC5155676	12/2016	S103-PMC5155676	['it is WELL RECOGNIZED that Individuals who are overweight or obese are at higher RISK of Vitamin D insufficiency, and this is SIMILARLY OBSERVED in Pregnancy (2,22).']	[('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 11), ('IMPORTANT_CONSIDERATION', 81), ('SUPERFICIAL_RELATIONSHIP', 126), ('INCOMPLETE_EVIDENCE', 136)]	5	[('NCBITaxon_1', 'root', 27, 'individuals'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy')]
PMC5155676	12/2016	S108-PMC5155676	['weight gain in Pregnancy REPRESENTS NOT ONLY increased fat mass BUT ALSO Feto-Placental Tissues and hemodilution (16); our data, THEREFORE, SUGGEST that overall volume of dilution, and not just adiposity, MAY BE IMPORTANT for response to Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('ANOMALY_CURIOUS_FINDING', 36), ('ANOMALY_CURIOUS_FINDING', 64), ('PROBABLE_UNDERSTANDING', 129), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 205), ('IMPORTANT_CONSIDERATION', 212)]	7	[('GO_0007565', 'female pregnancy', 15, 'pregnancy'), ('UBERON_0000981', 'femur', 73, 'feto'), ('UBERON_0002483', 'trabecular bone tissue', 78, 'placental tissues'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC5155676	12/2016	S115-PMC5155676	['this mechanism MIGHT be IMPORTANT in preventing hypervitaminosis D. HOWEVER, studies comparing the effectiveness of DIFFERING doses of Vitamin D in Pregnancy HAVE SHOWN that 4000 iu/d CAN achieve a higher 25(Oh)D than 400 iu/d (10,28), BUT WHETHER these higher doses are of clinical benefit is YET to be DEMONSTRATED (4,29) and at the general population level, lower doses would be compatible with keeping 25(Oh)D below a concentration which MIGHT be concerning.']	[('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 240), ('ANOMALY_CURIOUS_FINDING', 294), ('INCOMPLETE_EVIDENCE', 304), ('INCOMPLETE_EVIDENCE', 442)]	11	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 65, 'D'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 205, '25(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 211, 'D'), ('CHEBI_71657', 'versiconol acetate', 406, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 412, 'D')]
PMC5155676	12/2016	S124-PMC5155676	['AS such, young Pregnant women MIGHT PARTICULARLY REQUIRE ADVICE on the need for, and compliance with, Vitamin D supplementation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('ANOMALY_CURIOUS_FINDING', 36), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 49), ('IMPORTANT_CONSIDERATION', 49), ('FUTURE_WORK', 57)]	7	[('GO_0007565', 'female pregnancy', 15, 'pregnant'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5167470	12/2016	S100-PMC5167470	['in this regard, the most FREQUENTLY DESCRIBED maternal Micronutrient deficiency is that of Folic Acid, which entails a high risk of fetal Neural Tube defects.68moreover, there HAVE BEEN case reports of maternal and fetal hypercoagulability due to Vitamin K deficiency following bpd, Ophthalmic and Renal malformations due to SEVERE maternal and fetal Vitamin a deficiency, and megaloblastic anemia due to Vitamin B12 deficiency.69–71\n\nconclusion\nPregnancy after bs is SAFE, both for the mother and for the fetus.']	[('ANOMALY_CURIOUS_FINDING', 25), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 176), ('IMPORTANT_CONSIDERATION', 325), ('IMPORTANT_CONSIDERATION', 468)]	5	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 55, 'micronutrient'), ('CHEBI_30751', 'formic acid', 91, 'folic acid'), ('UBERON_0001049', 'neural tube', 138, 'neural tube'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin K'), ('UBERON_0000970', 'eye', 283, 'ophthalmic'), ('UBERON_0002113', 'kidney', 298, 'renal'), ('CHEBI_33229', 'vitamin (role)', 351, 'vitamin'), ('CHEBI_33279', 'vitamin D5', 405, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 405, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 446, 'Pregnancy')]
PMC5240436	1/2017	S114-PMC5240436	['a PREVIOUS STUDY that provided combined Vitamin A and zinc supplementation to children in ghana LED TO a reduction in the RISK of clinical malaria episodes [46] possibly DUE TO the synergistic EFFECTS of Vitamin A and zinc on Immune function [47].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 96), ('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 170), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin A'), ('UBERON_0002405', 'immune system', 226, 'immune')]
PMC5240436	1/2017	S116-PMC5240436	['the LACK OF treatment response DESPITE the provision of adequate doses of Vitamin A and zinc in mmn and sq-lns and reasonable adherence to supplementation [24] COULD HAVE been due to dietary factors inhibiting zinc absorption [48] or haemodilution in the latter half of Pregnancy lowering levels of Retinol binding protein resulting in functional Vitamin A deficiency [49].']	[('INCOMPLETE_EVIDENCE', 4), ('ANOMALY_CURIOUS_FINDING', 31), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 166)]	4	[('CHEBI_27300', 'vitamin D', 74, 'vitamin A'), ('GO_0007565', 'female pregnancy', 270, 'pregnancy'), ('CHEBI_26536', 'retinoic acid', 299, 'retinol'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin A')]
PMC5240436	1/2017	S120-PMC5240436	['FURTHER clinical TRIALS supplementing single Nutrients (efas, Vitamin A or zinc) MAY BE CRUCIAL in isolating the IMPACT of each Nutrient on maternal infections.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 81), ('IMPORTANT_CONSIDERATION', 88), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('CHEBI_33284', 'nutrient', 45, 'nutrients'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('CHEBI_33284', 'nutrient', 128, 'nutrient')]
PMC5241768	1/2017	S324-PMC5241768	['management of ckd in diabetesegfr (ml/min/1.73 m2)recommended managementall patients• yearly measurement of uacr, serum creatinine, and potassium45–60• refer to a nephrologist IF POSSIBILITY for nondiabetic Kidney disease exists (duration of type 1 diabetes <10 years, persistent albuminuria, abnormal findings on Renal ultrasound, resistant hypertension, rapid fall in egfr, or active Urinary sediment on Urine microscopic examination)• consider the need for dose adjustment of Medications• monitor egfr every 6 months• monitor electrolytes, bicarbonate, hemoglobin, calcium, Phosphorus, and Parathyroid hormone at least yearly• assure Vitamin D sufficiency• vaccinate against hepatitis b Virus• consider bone density testing• refer for dietary counseling30–44• monitor egfr every 3 months• monitor electrolytes, bicarbonate, calcium, phosphorus, Parathyroid hormone, hemoglobin, albumin, and weight every 3–6 months• consider THE NEED for dose adjustment of Medications<30• refer to a nephrologist\n\ndiabetic retinopathy\nrecommendations\noptimize Glycemic Control to reduce the RISK or slow the progression of diabetic retinopathy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 176), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 928), ('IMPORTANT_CONSIDERATION', 1078)]	4	[('UBERON_0002113', 'kidney', 207, 'kidney'), ('UBERON_0002113', 'kidney', 314, 'renal'), ('UBERON_0001088', 'urine', 386, 'urinary'), ('UBERON_0001088', 'urine', 406, 'urine'), ('CHEBI_25441', 'mycothiols', 479, 'medications'), ('CHEBI_35885', 'secondary phosphine', 577, 'phosphorus'), ('UBERON_0001132', 'parathyroid gland', 593, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 637, 'vitamin D'), ('NCBITaxon_1', 'root', 690, 'virus'), ('UBERON_0001132', 'parathyroid gland', 848, 'parathyroid'), ('CHEBI_25441', 'mycothiols', 960, 'medications'), ('GO_0006094', 'gluconeogenesis', 1047, 'glycemic control')]
PMC5264377	7/2016	S18-PMC5264377	['the ROLE of Vitamin D in fertility and Ovarian function is STILL LARGELY UNEXPLORED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 59), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 73)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0000992', 'ovary', 39, 'ovarian')]
PMC5264377	7/2016	S21-PMC5264377	['in Humans, the ROLE of Vitamin D in Fertilization, Embryo quality and Implantation is STILL CONTROVERSIAL (terushkin et al ., 2010;aleyasin et al ., 2011;rudick et al ., 2012;aflatoonian et al ., 2014;paffoni et al ., 2014;polyzos et al ., 2014).']	[('SUPERFICIAL_RELATIONSHIP', 15), ('IMPORTANT_CONSIDERATION', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92)]	3	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0009566', 'fertilization', 36, 'fertilization'), ('UBERON_0000922', 'embryo', 51, 'embryo'), ('GO_0007566', 'embryo implantation', 70, 'implantation')]
PMC5273824	1/2017	S0-PMC5273824	['investigation of the Vitamin D nutritional status in women with Gestational diabetes mellitus in beijing\n\nabstract\n\nbackground\nVitamin D deficiency is a common ISSUE, which has RELATION with gdm, during the Pregnant period.']	[('IMPORTANT_CONSIDERATION', 160), ('SUPERFICIAL_RELATIONSHIP', 177)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'gestational'), ('CHEBI_28384', 'vitamin K', 127, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 207, 'pregnant')]
PMC5310660	1/2017	S43-PMC5310660	['during Pregnancy, when a higher amount of Vitamin D is REQUIRED, many Pregnant women CAN develop a Vitamin D deficiency.']	[('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 85)]	2	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnant'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC5310660	1/2017	S48-PMC5310660	['Gestational Vitamin D concentration IS CONSIDERED IMPORTANT for the Development Of the Immune System.']	[('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 50)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0002020', 'protease binding', 68, 'development of ... immune system'), ('UBERON_0002405', 'immune system', 87, 'immune system')]
PMC5318550	2/2017	S19-PMC5318550	['HOWEVER, an integral test of these POSSIBLE explanations for the RISK of POOR Neurodevelopmental outcomes is LACKING and newer HYPOTHESES, such as variation in Vitamin D levels, HAVE NOT BEEN INVESTIGATED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 35), ('IMPORTANT_CONSIDERATION', 65), ('IMPORTANT_CONSIDERATION', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('FULL_UNKNOWN', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 178), ('IMPORTANT_CONSIDERATION', 178)]	10	[('GO_0007399', 'nervous system development', 78, 'neurodevelopmental'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC5322422	2/2017	S121-PMC5322422	['our case also LED to an educational opportunity on the CRITICAL IMPORTANCE of Vitamin K prophylaxis at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 64)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin K'), ('GO_0007567', 'parturition', 103, 'birth')]
PMC5325195	2/2017	S93-PMC5325195	['cbhvs also actively promoted facility-based delivery.10.1371/journal.pone.0170739.t001\n\ncaption (table-wrap): table 1\ncbhv messages to Pregnant women transmitted through pictorial counselling cards.1 importance of Antenatal clinic attendance for Pregnant women 2 importance of screening tests, including hiv in Pregnancy 3 importance of intermittent preventive therapy for malaria in Pregnancy using Sulphadoxine-Pyrimethamine tablets 4 importance of skilled attendance in Labor and Postpartum care 5 importance of an Insecticide-treated net and HOW to use it at home 6 types of Food, importance of an adequate and balanced diet in Pregnancy, and Vitamin A supplementation for children 7 the IMPORTANCE of iron and Folic Acid during Pregnancy 8 importance of using Misoprostol tablets after Delivery Of the Baby and HOW to use it 9 the IMPORTANCE of Chlorhexidine gel for Cord care and HOW to apply it on the Cord; avoiding use of POTENTIALLY harmful substances to the Cord 10 the care for low Birth weight babies with kangaroo care 11 HOW to prepare the Oral rehydration Solution (ors) for diarrheal diseases in children under 5 years, and the IMPORTANCE of ors.']	[('EXPLICIT_QUESTION', 546), ('IMPORTANT_CONSIDERATION', 692), ('EXPLICIT_QUESTION', 816), ('IMPORTANT_CONSIDERATION', 836), ('EXPLICIT_QUESTION', 886), ('INCOMPLETE_EVIDENCE', 931), ('EXPLICIT_QUESTION', 1036), ('IMPORTANT_CONSIDERATION', 1145)]	8	[('GO_0007565', 'female pregnancy', 135, 'pregnant'), ('GO_0007567', 'parturition', 214, 'antenatal'), ('GO_0007565', 'female pregnancy', 246, 'pregnant'), ('GO_0007565', 'female pregnancy', 311, 'pregnancy'), ('GO_0007565', 'female pregnancy', 384, 'pregnancy'), ('CHEBI_9329', 'sulfadoxine', 400, 'Sulphadoxine'), ('CHEBI_16610', 'spermidine', 413, 'pyrimethamine'), ('GO_0007612', 'learning', 473, 'labor'), ('GO_0007565', 'female pregnancy', 483, 'postpartum'), ('CHEBI_24852', 'insecticide', 518, 'insecticide'), ('CHEBI_33290', 'food', 579, 'food'), ('GO_0007565', 'female pregnancy', 632, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 647, 'vitamin A'), ('CHEBI_30751', 'formic acid', 715, 'folic acid'), ('GO_0007565', 'female pregnancy', 733, 'pregnancy'), ('CHEBI_63610', 'misoprostol', 765, 'misoprostol'), ('GO_0046697', 'decidualization', 791, 'delivery of ... baby'), ('CHEBI_3647', 'chlorpromazine', 850, 'chlorhexidine'), ('UBERON_0002240', 'spinal cord', 872, 'cord'), ('UBERON_0002240', 'spinal cord', 909, 'cord'), ('UBERON_0002240', 'spinal cord', 969, 'cord'), ('GO_0007567', 'parturition', 994, 'birth'), ('UBERON_0000978', 'leg', 1055, 'Oral'), ('CHEBI_75958', 'solution', 1072, 'Solution')]
PMC5340372	3/2017	S0-PMC5340372	['low Cord-Serum 25-Hydroxyvitamin D levels are ASSOCIATED with poor Lung function performance and increased Respiratory infection in infancy\n\nabstract\n\nbackground\nPerinatal Vitamin D deficiency is ASSOCIATED with a higher RISK of wheezing in childhood.']	[('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 196), ('IMPORTANT_CONSIDERATION', 221)]	3	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 15, '25-hydroxyvitamin D'), ('UBERON_0002048', 'lung', 67, 'lung'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory'), ('GO_0036268', 'swimming', 162, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 162, 'Perinatal'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC5340372	3/2017	S13-PMC5340372	['since the discovery that MOST Tissues and cells have Vitamin D receptors, there has been great INTEREST in its ROLE in the development of many diseases, such as cancer [1], Cardiovascular diseases [2], infectious diseases [3], and Autoimmune disease [4].']	[('PROBABLE_UNDERSTANDING', 25), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('UBERON_0000479', 'tissue', 30, 'tissues'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 173, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 231, 'autoimmune')]
PMC5340372	3/2017	S19-PMC5340372	['have RECENTLY SHOWN that infants with low Cord Serum Vitamin D levels have a higher RISK of childhood wheezing [7,11].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 84)]	3	[('UBERON_0002240', 'spinal cord', 42, 'cord'), ('UBERON_0001977', 'blood serum', 47, 'serum'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC5340372	3/2017	S92-PMC5340372	['infants who were exclusively Breastfed or had high levels of skin pigmentation, INADEQUATE sunlight exposure, or INADEQUATE Vitamin supplement are AT RISK of a Vitamin D deficiency [26].']	[('IMPORTANT_CONSIDERATION', 80), ('IMPORTANT_CONSIDERATION', 113), ('IMPORTANT_CONSIDERATION', 147)]	3	[('GO_0007567', 'parturition', 29, 'breastfed'), ('CHEBI_33229', 'vitamin (role)', 124, 'vitamin'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC5340372	3/2017	S103-PMC5340372	['HOWEVER, in CONTRARY to these REPORTS, a survey in canadian children SHOWED that both low and high Vitamin D levels were RELATED to INCREASED RISK of wheeze and reduced performance of Lung function [35].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 121), ('IMPORTANT_CONSIDERATION', 132)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0002048', 'lung', 184, 'lung')]
PMC5340372	3/2017	S126-PMC5340372	['in a randomized control TRIAL, a Vitamin D supplement CAN EVEN decrease the RISK of seasonal flu in children [50].']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 54), ('ANOMALY_CURIOUS_FINDING', 58), ('IMPORTANT_CONSIDERATION', 76)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5340372	3/2017	S131-PMC5340372	['more INVESTIGATION is REQUIRED to FURTHER understand the ROLE of Vitamin D for the PREVENTION of Respiratory Tract infection in infancy.']	[('FUTURE_WORK', 5), ('IMPORTANT_CONSIDERATION', 22), ('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 83)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 97, 'respiratory tract')]
PMC5340372	3/2017	S137-PMC5340372	['the MAJORITY of the participants lived in keelung, a rainy city whose inhabitants have a higher RISK of Vitamin D deficiency than elsewhere DUE TO lack of sun exposure [52].']	[('PROBABLE_UNDERSTANDING', 4), ('IMPORTANT_CONSIDERATION', 96), ('PROBABLE_UNDERSTANDING', 140)]	3	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC5340372	3/2017	S143-PMC5340372	['last, the sample size was rather SMALL, and the Vitamin D levels of the participants were GENERALLY SUBOPTIMAL in OUR STUDY.']	[('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 90), ('IMPORTANT_CONSIDERATION', 100), ('QUESTION_ANSWERED_BY_THIS_WORK', 114)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5340372	3/2017	S144-PMC5340372	['ALTHOUGH poor Lung function performance and an INCREASED RISK of Respiratory Tract infection were RELATED to relatively low cord Serum Vitamin D levels, FURTHER extrapolating the EFFECTS of Vitamin d on the Respiratory function of the general infant population MIGHT STILL BE DIFFICULT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 153), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 261), ('FUTURE_WORK', 267), ('DIFFICULT_TASK', 276)]	8	[('UBERON_0002048', 'lung', 14, 'lung'), ('UBERON_0000065', 'respiratory tract', 65, 'respiratory tract'), ('UBERON_0001977', 'blood serum', 129, 'serum'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 190, 'vitamin'), ('UBERON_0001004', 'respiratory system', 207, 'respiratory')]
PMC5351212	3/2017	S9-PMC5351212	['HOWEVER, Prenatal administration of Vitamin D had no effect on pro-inflammatory cytokine levels in dams or in fetal Brains SUGGESTING the anti-inflammatory actions of Vitamin d are not the CRITICAL mechanism for its preventive actions in this asd Animal MODEL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 123), ('IMPORTANT_CONSIDERATION', 189), ('INCOMPLETE_EVIDENCE', 254)]	5	[('GO_0007565', 'female pregnancy', 9, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000955', 'brain', 116, 'brains'), ('CHEBI_33229', 'vitamin (role)', 167, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 247, 'animal')]
PMC5351212	3/2017	S30-PMC5351212	['in addition to its classical ROLE in calcium and Bone Homeostasis, Vitamin D has MAJOR immunomodulatory ROLES ASSOCIATED with inflammation [28].']	[('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 81), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('GO_0055064', 'chloride ion homeostasis', 49, 'bone homeostasis'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC5351212	3/2017	S235-PMC5351212	['finally, in the context of this study, an EVEN more IMPORTANT finding was that maternal treatment with the active Vitamin D hormone 1,25Ohd was capable of preventing this altered social behavior in juvenile mia offspring.']	[('ANOMALY_CURIOUS_FINDING', 42), ('IMPORTANT_CONSIDERATION', 52)]	2	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 134, '25OHD')]
PMC5351212	3/2017	S262-PMC5351212	['HOWEVER, the fact that mia with poly(I:c) has induced abnormalities in Social Interaction and Cognition at a more translationally RELEVANT age, i.e., juveniles, together with the presence of behavioral abnormalities not normally associated with schizophrenia such as altered digging behavior SUGGEST to us that this Animal MODEL MAY have greater relevance to asd\n\nvitddoes not alter maternal or fetal inflammatory Cytokine Production\nin VIEW OF the KNOWN immunomodulatory EFFECTS of Vitamin D, an obvious neuroprotective mechanism explored HERE was the POSSIBILITY that vitdameliorates the inflammatory response induced by Poly(I:c).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 323), ('INCOMPLETE_EVIDENCE', 329), ('INCOMPLETE_EVIDENCE', 437), ('INCOMPLETE_EVIDENCE', 449), ('SUPERFICIAL_RELATIONSHIP', 472), ('QUESTION_ANSWERED_BY_THIS_WORK', 540), ('INCOMPLETE_EVIDENCE', 553)]	10	[('CHEBI_51686', 'haematoxylin', 37, 'I'), ('GO_0019417', 'sulfur oxidation', 71, 'social interaction'), ('GO_0050890', 'cognition', 94, 'cognition'), ('NCBITaxon_33208', 'Metazoa', 316, 'animal'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 414, 'cytokine production'), ('CHEBI_27300', 'vitamin D', 483, 'vitamin D'), ('CHEBI_37311', 'einsteinium molecular entity', 623, 'poly'), ('CHEBI_51686', 'haematoxylin', 628, 'I')]
PMC5359891	3/2017	S7-PMC5359891	['the additional Micronutrients seek to address DEFICIENCIES of SOME b-group Vitamins and Vitamin D that are both common during Pregnancy and that HAVE BEEN ASSOCIATED with maternal dysglycaemia, epigenetic changes and greater offspring adiposity.']	[('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 155)]	4	[('CHEBI_33839', 'macromolecule', 15, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 75, 'vitamins'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy')]
PMC5359891	3/2017	S92-PMC5359891	['the intervention\nthe nutritional intervention Preconception and during Pregnancy to maintain healthy Glucose Metabolism and offspring health (nipper) intervention comprises: (1) a Micronutrient-enriched nutritional drink containing myo-inositol, Vitamin D, riboflavin, Vitamin B6, Vitamin B12And zinc together with standard Folic Acid, Iodine, calcium, β-Carotene and iron; the quantities PROPOSED are either standard amounts (Myo-Inositol [54]), enhanced amounts that are available in over-the-counter products (Vitamins b6, b12, riboflavin), RECOMMENDED daily allowance amounts in uk for Pregnant women (Vitamin D, zinc, Folic Acid, Iodine) or minimal amounts for Micronutrients LINKED with POTENTIAL DETRIMENTAL EFFECTS at higher doses (Iron, Β-Carotene, Calcium) and (2) Probiotics (containing lactobacillus rhamnosus ncc 4007 (cgmcc 1.3724) also known as lpr and bifidobacterium animalis Sp.']	[('INCOMPLETE_EVIDENCE', 389), ('FUTURE_WORK', 544), ('SUPERFICIAL_RELATIONSHIP', 681), ('INCOMPLETE_EVIDENCE', 693), ('IMPORTANT_CONSIDERATION', 703), ('SUPERFICIAL_RELATIONSHIP', 715)]	6	[('GO_0007565', 'female pregnancy', 46, 'Preconception'), ('GO_0007565', 'female pregnancy', 71, 'Pregnancy'), ('CHEBI_17234', 'glucose', 101, 'Glucose'), ('GO_0006006', 'glucose metabolic process', 101, 'Glucose Metabolism'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 180, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 269, 'vitamin B6'), ('CHEBI_10124', 'zolmitriptan', 281, 'vitamin B12and'), ('CHEBI_30751', 'formic acid', 324, 'folic acid'), ('CHEBI_24859', 'iodine atom', 336, 'iodine'), ('CHEBI_23042', 'carotene', 355, 'carotene'), ('CHEBI_25435', 'mutagen', 427, 'myo-inositol'), ('CHEBI_33277', 'gamma-tocotrienol', 513, 'vitamins'), ('GO_0007565', 'female pregnancy', 590, 'pregnant'), ('CHEBI_27300', 'vitamin D', 606, 'vitamin D'), ('CHEBI_30751', 'formic acid', 623, 'folic acid'), ('CHEBI_24859', 'iodine atom', 635, 'iodine'), ('CHEBI_33839', 'macromolecule', 666, 'micronutrients'), ('CHEBI_24870', 'ion', 740, 'iron'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 746, 'β-carotene'), ('CHEBI_22313', 'alkaline earth metal atom', 758, 'calcium'), ('CHEBI_26346', 'prostaglandins J', 775, 'probiotics'), ('NCBITaxon_10088', 'Mus <genus>', 893, 'sp')]
PMC5359891	3/2017	S108-PMC5359891	['omission from control group SUPPORTED by usual clinical practiceβ-Carotene720\xa0μg (15% of Vitamin A REQUIREMENTS, as Retinol equivalents)required in Pregnancy in some jurisdictionsfolic acid400\xa0μgstandard Preconception RECOMMENDATIONIRON12\xa0mgiron is routinely prescribed and taken before/during Pregnancy, THOUGH WITHOUT CONVINCING EVIDENCE of benefit; low dose included to lessen LIKELIHOOD of additionally receiving a high-dose iron product, which HAS BEEN LINKED with Glucose Metabolism in Pregnancycalcium150\xa0mga low dose of Calcium is commonly taken before/during Pregnancy; provision of this will lessen the LIKELIHOOD of additional products being takeniodine150\xa0μgstandard preconception recommendationprobiotictaking a combination of two Probiotics HAS BEEN LINKED with maintenance of healthy Glucose Metabolism in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 99), ('FUTURE_WORK', 218), ('ANOMALY_CURIOUS_FINDING', 305), ('INCOMPLETE_EVIDENCE', 312), ('PROBABLE_UNDERSTANDING', 380), ('INCOMPLETE_EVIDENCE', 449), ('SUPERFICIAL_RELATIONSHIP', 458), ('PROBABLE_UNDERSTANDING', 613), ('INCOMPLETE_EVIDENCE', 755), ('SUPERFICIAL_RELATIONSHIP', 764)]	11	[('CHEBI_85000', '1-octadecenoyl-2-icosatetraenoyl-sn-glycero-3-phosphoethanolamine', 65, '-carotene720'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 116, 'retinol'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'preconception'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy'), ('CHEBI_17234', 'glucose', 470, 'glucose'), ('GO_0006006', 'glucose metabolic process', 470, 'glucose metabolism'), ('GO_0051561', 'positive regulation of mitochondrial calcium ion concentration', 492, 'pregnancyCalcium150'), ('CHEBI_22313', 'alkaline earth metal atom', 528, 'calcium'), ('GO_0007565', 'female pregnancy', 568, 'pregnancy'), ('CHEBI_26346', 'prostaglandins J', 744, 'probiotics'), ('CHEBI_17234', 'glucose', 799, 'glucose'), ('GO_0006006', 'glucose metabolic process', 799, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 821, 'pregnancy')]
PMC5359891	3/2017	S110-PMC5359891	['lactis ncc 2818 (cncm i-3446) also known as bl818control groupfolic Acid400\xa0μgstandard Preconception recommendationiron12\xa0mgiron is routinely prescribed and taken before/during Pregnancy, though WITHOUT CONVINCING EVIDENCE of benefit; low dose included to lessen LIKELIHOOD of additionally receiving a high-dose Iron product, which HAS BEEN LINKED with Glucose Metabolism in Pregnancycalcium150\xa0mga low dose of Calcium is commonly taken before/during Pregnancy; provision of this will lessen the LIKELIHOOD of additional products being takeniodine150\xa0μgstandard Preconception recommendationhttp://www.cdc.gov/Preconception/documents/clinical-content_womensnutritionfactsheet3.pdfβ-Carotene720\xa0μg (15% of Vitamin A REQUIREMENTS, as Retinol equivalents)required in Pregnancy in some jurisdictions\n\noutcome measurements\nthe primary analysis will adjust for site, ethnicity and Preconception glycaemia to account for POTENTIAL imbalance between treatment arms amongst Pregnancies which reach 28\xa0weeks’ Gestation, examining for differences in means between the control and intervention groups for the primary endpoint, specifically the fasting and/or 60-min and/or 2-h Glucose concentrations following a 75-g ogtt at 28\xa0weeks’ Gestation.']	[('INCOMPLETE_EVIDENCE', 195), ('PROBABLE_UNDERSTANDING', 263), ('INCOMPLETE_EVIDENCE', 332), ('SUPERFICIAL_RELATIONSHIP', 341), ('PROBABLE_UNDERSTANDING', 496), ('IMPORTANT_CONSIDERATION', 714), ('INCOMPLETE_EVIDENCE', 913)]	7	[('CHEBI_82451', "3,3'-Dimethoxybenzidine-4,4'-diisocyanate", 68, 'acid400'), ('GO_0007565', 'female pregnancy', 87, 'preconception'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy'), ('CHEBI_24870', 'ion', 312, 'iron'), ('CHEBI_17234', 'glucose', 353, 'glucose'), ('GO_0006006', 'glucose metabolic process', 353, 'glucose metabolism'), ('GO_0051561', 'positive regulation of mitochondrial calcium ion concentration', 375, 'pregnancyCalcium150'), ('CHEBI_22313', 'alkaline earth metal atom', 411, 'calcium'), ('GO_0007565', 'female pregnancy', 451, 'pregnancy'), ('GO_0007565', 'female pregnancy', 562, 'preconception'), ('GO_0007565', 'female pregnancy', 609, 'preconception'), ('CHEBI_52743', 'bromine-79 atom', 681, 'carotene720'), ('CHEBI_27300', 'vitamin D', 704, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 731, 'retinol'), ('GO_0007565', 'female pregnancy', 763, 'pregnancy'), ('GO_0007565', 'female pregnancy', 874, 'preconception'), ('GO_0007565', 'female pregnancy', 964, 'pregnancies'), ('GO_0007565', 'female pregnancy', 998, 'gestation'), ('CHEBI_17234', 'glucose', 1164, 'glucose'), ('GO_0007565', 'female pregnancy', 1222, 'gestation')]
PMC5368580	4/2017	S30-PMC5368580	['samples were analyzed for Retinol (Vitamin A), Tocopherol (Vitamin E), Thiamin (Vitamin B-1), riboflavin (Vitamin B-2), Nicotinamide (Vitamin B-3), Vitamin B-6, and Vitamin B-12 to examine 1 ) within-Feeding variation, 2 ) Circadian variation and contributions DUE TO subject variability, 3 ) acute short-term EFFECTS of maternal supplementation on milk Vitamin concentrations, and 4 ) the OPTIMAL time for collection to determine which Milk samples best represented the daily median Vitamin concentrations in Milk.']	[('PROBLEM_COMPLICATION', 261), ('SUPERFICIAL_RELATIONSHIP', 310), ('IMPORTANT_CONSIDERATION', 390)]	3	[('CHEBI_26536', 'retinoic acid', 26, 'retinol'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin A'), ('CHEBI_27013', 'tocopherol', 47, 'tocopherol'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin E'), ('CHEBI_26948', 'vitamin B1', 71, 'thiamin'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin B'), ('PR_000000037', 'BMP receptor type-2', 88, 'B'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 90, '1'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin B'), ('CHEBI_17154', 'nicotinamide', 120, 'nicotinamide'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 134, 'vitamin B-3'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 148, 'vitamin B-6'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 165, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 200, 'feeding'), ('GO_0051216', 'cartilage development', 223, 'circadian'), ('CHEBI_33229', 'vitamin (role)', 354, 'vitamin'), ('UBERON_0001913', 'milk', 437, 'milk'), ('CHEBI_33229', 'vitamin (role)', 484, 'vitamin'), ('UBERON_0001913', 'milk', 510, 'milk')]
PMC5371920	3/2017	S137-PMC5371920	['Vitamin D supplementation APPEARED SAFE; THESE FINDINGS SUPPORT current RECOMMENDATIONS in uk and elsewhere, and MAY SUGGEST the basis for more stratified approaches to Vitamin D supplementation in Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 26), ('IMPORTANT_CONSIDERATION', 35), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 56), ('FUTURE_WORK', 72), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 117)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy')]
PMC5372327	3/2017	S0-PMC5372327	['towards EVIDENCE-BASED Vitamin D supplementation in infants: Vitamin D intervention in infants (vidi) — study design and methods of a randomised controlled double-blinded intervention study\n\nabstract\n\nbackground\nVitamin D is IMPORTANT for bone mass accrual during growth.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 225)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 212, 'Vitamin D')]
PMC5372327	3/2017	S12-PMC5372327	['Paracrine Conversion Of 25-Ohd to Calcitriol occurs in many Tissues, such as Dendritic and Endothelial Cells, Brain, Placenta and Parathyroids, underscoring the IMPORTANCE of Vitamin D for these Organs [2].']	[('IMPORTANT_CONSIDERATION', 161)]	1	[('GO_0036518', 'chemorepulsion of dopaminergic neuron axon', 0, 'Paracrine conversion of 25-OHD'), ('CHEBI_72765', 'verruculogen', 24, '25-OHD'), ('CHEBI_17823', 'calcitriol', 34, 'calcitriol'), ('UBERON_0000479', 'tissue', 60, 'tissues'), ('CL_0000451', 'dendritic cell', 77, 'dendritic ...'), ('GO_0030425', 'dendrite', 77, 'dendritic'), ('CL_0000115', 'endothelial cell', 91, 'endothelial cells'), ('UBERON_0001986', 'endothelium', 91, 'endothelial'), ('UBERON_0000955', 'brain', 110, 'brain'), ('UBERON_0001987', 'placenta', 117, 'placenta'), ('UBERON_0001132', 'parathyroid gland', 130, 'parathyroids'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('UBERON_0000062', 'organ', 195, 'organs')]
PMC5372327	3/2017	S41-PMC5372327	['in Adults, Vitamin D insufficiency increases the RISK of SEVERE infections [28], BUT the results from intervention trials are CONFLICTING [29].']	[('IMPORTANT_CONSIDERATION', 49), ('IMPORTANT_CONSIDERATION', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126)]	4	[('UBERON_0007023', 'adult organism', 3, 'adults'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC5372327	3/2017	S57-PMC5372327	['ALTHOUGH PRELIMINARY results POINT to IMPORTANCE of early Life exposure, the ROLE of Vitamin D in Cognitive Development during childhood and Adolescence REMAINS LARGELY UNSTUDIED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 38), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 169)]	8	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0050787', 'detoxification of mercury ion', 98, 'cognitive development'), ('GO_0048848', 'neurohypophysis morphogenesis', 141, 'adolescence')]
PMC5372327	3/2017	S100-PMC5372327	['PREVIOUS intervention STUDIES have evaluated the SAFETY of substitution doses of up to 50\xa0μg Vitamin D in infants [61].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 49)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC5385921	4/2017	S1-PMC5385921	['the ASSOCIATION between Vitamin D deficiency during Gestation, a CRITICAL period in Neurodevelopment, and asd is NOT WELL UNDERSTOOD.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 65), ('FULL_UNKNOWN', 113)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'gestation'), ('GO_0007399', 'nervous system development', 84, 'neurodevelopment')]
PMC5385921	4/2017	S6-PMC5385921	['conclusions\nmid-Gestational Vitamin D deficiency was ASSOCIATED with an INCREASED RISK of asd.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 72)]	2	[('GO_0007565', 'female pregnancy', 16, 'gestational'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5385921	4/2017	S7-PMC5385921	['because Gestational Vitamin D deficiency is readily preventable with SAFE, inexpensive and readily available supplementation, this RISK FACTOR WARRANTS CLOSER SCRUTINY.']	[('IMPORTANT_CONSIDERATION', 69), ('SUPERFICIAL_RELATIONSHIP', 131), ('FUTURE_WORK', 143), ('FUTURE_WORK', 152)]	4	[('GO_0007565', 'female pregnancy', 8, 'gestational'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC5385921	4/2017	S13-PMC5385921	['within the domain of nutritional exposures, there is GROWING INTEREST in the POSSIBLE LINKS between Gestational Vitamin D deficiency and an INCREASED RISK of asd.3–6this research HAS BEEN inspired BY Birth cohort studies, which have provided EVIDENCE that Prenatal Vitamin D deficiency (as assessed in maternal Sera) is ASSOCIATED with a range of later Brain-related outcomes including impaired Language Development7,8and Cognitive Development in offspring.9,10ALTHOUGH SEVERAL STUDIES HAVE REPORTED that Vitamin D deficiency or insufficiency is MORE COMMON in children with asd compared with controls,11few STUDIES addressed the specific HYPOTHESIS that Vitamin D deficiency during Gestation, a CRUCIAL time point in Neurodevelopment, is RELATED to the risk of subsequent asd.']	[('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 86), ('IMPORTANT_CONSIDERATION', 140), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 197), ('INCOMPLETE_EVIDENCE', 242), ('SUPERFICIAL_RELATIONSHIP', 320), ('ANOMALY_CURIOUS_FINDING', 459), ('INCOMPLETE_EVIDENCE', 470), ('INCOMPLETE_EVIDENCE', 486), ('PROBABLE_UNDERSTANDING', 546), ('INCOMPLETE_EVIDENCE', 608), ('INCOMPLETE_EVIDENCE', 639), ('IMPORTANT_CONSIDERATION', 696), ('SUPERFICIAL_RELATIONSHIP', 739)]	16	[('GO_0007565', 'female pregnancy', 100, 'gestational'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007567', 'parturition', 200, 'birth'), ('GO_0007565', 'female pregnancy', 256, 'prenatal'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('UBERON_0001977', 'blood serum', 311, 'sera'), ('UBERON_0000955', 'brain', 353, 'brain'), ('GO_0001763', 'morphogenesis of a branching structure', 395, 'language development7'), ('GO_0050787', 'detoxification of mercury ion', 422, 'cognitive development'), ('CHEBI_27300', 'vitamin D', 505, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 655, 'vitamin D'), ('GO_0007565', 'female pregnancy', 683, 'gestation'), ('GO_0007399', 'nervous system development', 718, 'neurodevelopment')]
PMC5385921	4/2017	S124-PMC5385921	['furthermore, neonatal Vitamin D deficiency HAS been PREVIOUSLY ASSOCIATED with an increased risk of schizophrenia.36asd and schizophrenia are KNOWN to share Genetic risk variants;37our findings provide ADDITIONAL EVIDENCE of the shared risk ARCHITECTURE between these two Neurodevelopmental disorders.']	[('IMPORTANT_CONSIDERATION', 43), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 142), ('FUTURE_WORK', 202), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 241)]	7	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('SO_0000704', 'gene', 157, 'genetic'), ('GO_0007399', 'nervous system development', 272, 'neurodevelopmental')]
PMC5385921	4/2017	S131-PMC5385921	['in FUTURE STUDIES, it will be OF INTEREST to explore the CRITICAL window during which low Vitamin D MAY CONTRIBUTE to asd RISK – it is FEASIBLE that exposure in the first few years of Life MAY also CONTRIBUTE to adverse Brain outcomes.']	[('FUTURE_WORK', 3), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 104), ('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 135), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 198)]	9	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('UBERON_0000104', 'life cycle', 184, 'life'), ('UBERON_0000955', 'brain', 220, 'brain')]
PMC5385921	4/2017	S132-PMC5385921	['DEFINING the precise CRITICAL window during which developmental Vitamin D deficiency adversely AFFECTS Brain Development at this stage would be premature.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 21), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007420', 'brain development', 103, 'brain development'), ('UBERON_0000955', 'brain', 103, 'brain')]
PMC5385921	4/2017	S141-PMC5385921	['the ASSOCIATION between developmental Vitamin D deficiency and asd MAY have IMPORTANT IMPLICATIONS from a PUBLIC HEALTH perspective.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 76), ('IMPORTANT_CONSIDERATION', 86), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC5385921	4/2017	S142-PMC5385921	['it is FEASIBLE that a SAFE, inexpensive and PUBLICALLY acceptable Vitamin D supplementation in AT-RISK groups MAY reduce the PREVALENCE of this RISK FACTOR.']	[('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 22), ('IMPORTANT_CONSIDERATION', 44), ('IMPORTANT_CONSIDERATION', 95), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 125), ('SUPERFICIAL_RELATIONSHIP', 144)]	7	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5387760	11/2016	S188-PMC5387760	['the advantage of Ca Intake to the Human body also DEPENDS ON OPTIMAL levels of Vitamin D. OUR STUDY’s ability TO DETERMINE multiple INTERACTION EFFECTS among different Micronutrients and Vitamins in RELATION to Birth outcomes and early child survival was LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 61), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('QUESTION_ANSWERED_BY_THIS_WORK', 110), ('SUPERFICIAL_RELATIONSHIP', 132), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 199), ('INCOMPLETE_EVIDENCE', 255)]	8	[('CHEBI_32588', 'potassium chloride', 17, 'Ca'), ('GO_0007631', 'feeding behavior', 20, 'intake'), ('NCBITaxon_9606', 'Homo sapiens', 34, 'human'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_33839', 'macromolecule', 168, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 187, 'vitamins'), ('GO_0007567', 'parturition', 211, 'birth')]
PMC5405075	4/2017	S1-PMC5405075	['abstract\nthe worldwide increase in asthma PREVALENCE during the last decades and the re-emergence of Vitamin D deficiency in many populations HINTED toward an UNDERLYING ASSOCIATION between these two conditions.']	[('IMPORTANT_CONSIDERATION', 42), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 159), ('SUPERFICIAL_RELATIONSHIP', 170)]	4	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC5405075	4/2017	S4-PMC5405075	['in the randomized controlled clinical trials (rcts) that followed, increased doses of Vitamin D were tested in Pregnant women being at high RISK of having an asthmatic child.']	[('IMPORTANT_CONSIDERATION', 140)]	1	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 111, 'pregnant')]
PMC5405075	4/2017	S5-PMC5405075	['ALTHOUGH, the results of rcts SHOWED a POTENTIAL ASSOCIATION with asthma-RELATED phenotypes RATHER than asthma per se , the low toxicity of Vitamin D supplements make it TEMPTING to SPECULATE that Pregnant women at a high RISK of obtaining a child with asthma MAY BE benefited, ESPECIALLY if they are Vitamin D deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 182), ('IMPORTANT_CONSIDERATION', 222), ('INCOMPLETE_EVIDENCE', 260), ('ANOMALY_CURIOUS_FINDING', 278)]	12	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007565', 'female pregnancy', 197, 'pregnant'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D')]
PMC5405075	4/2017	S7-PMC5405075	['RECENTLY, randomized clinical trials HAVE BEEN conducted to determine OPTIMAL Serum concentrations and optimal intake of Vitamin D that MIGHT be beneficial to Human health (3–5).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 70), ('INCOMPLETE_EVIDENCE', 136)]	4	[('UBERON_0001977', 'blood serum', 78, 'serum'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 159, 'human')]
PMC5405075	4/2017	S10-PMC5405075	['besides, Pregnant women and infants are in high RISK of Vitamin D insufficiency (7–11).']	[('IMPORTANT_CONSIDERATION', 48)]	1	[('GO_0007565', 'female pregnancy', 9, 'pregnant'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC5405075	4/2017	S19-PMC5405075	['it SHOULD BE NOTICED that high Maternal Intake of 25(Oh)D or exceeding Vitamin D Serum levels during Pregnancy is not COMPLICATED from either hypercalcemia or hypercalciuria (16).']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 13), ('DIFFICULT_TASK', 118)]	3	[('GO_0007618', 'mating', 31, 'maternal'), ('GO_0007631', 'feeding behavior', 40, 'intake'), ('CHEBI_71657', 'versiconol acetate', 50, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0001977', 'blood serum', 81, 'serum'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC5405075	4/2017	S28-PMC5405075	['AS a result, Vitamin D deficiency during Pregnancy exerts SIGNIFICANT IMPACT on Vitamin D status of newborns and subsequently on early Childhood (9,28).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0013628', 'pollical pad', 135, 'childhood')]
PMC5405075	4/2017	S29-PMC5405075	['the IMPACT of Vitamin D exposure in utero\nthe DEPENDENCE of the developing fetus on maternal Vitamin D status TOGETHER with the REPORTED extra Skeletal function of the hormone and Vitamin D deficiency EPIDEMIC during the last years led to FURTHER INVESTIGATION of the CONSEQUENCES of maternal Vitamin D insufficiency on Pregnancy outcomes (6,29,30).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 128), ('IMPORTANT_CONSIDERATION', 201), ('FUTURE_WORK', 239), ('PROBLEM_COMPLICATION', 268)]	7	[('CHEBI_28384', 'vitamin K', 14, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('UBERON_0004288', 'skeleton', 143, 'skeletal'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('GO_0007565', 'female pregnancy', 320, 'pregnancy')]
PMC5405075	4/2017	S31-PMC5405075	['the most cited adverse outcome of maternal Vitamin D deficiency is neonatal rickets, WHILE mild hypovitaminosis D COULD BE more pronounced in exclusively Breast-Fed infants, on the BASIS that Breast Milk constitutes a POOR source of Vitamin D compared with formulas (34–36).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('ANOMALY_CURIOUS_FINDING', 85), ('INCOMPLETE_EVIDENCE', 114), ('PROBABLE_UNDERSTANDING', 181), ('IMPORTANT_CONSIDERATION', 218)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 112, 'D'), ('GO_0007567', 'parturition', 154, 'breast'), ('UBERON_0000310', 'breast', 154, 'breast'), ('GO_0007631', 'feeding behavior', 161, 'fed'), ('UBERON_0001348', 'brown adipose tissue', 192, 'breast milk'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D')]
PMC5405075	4/2017	S45-PMC5405075	['the INCONSISTENT body of EVIDENCE with glimmer of positivity from observational prospective cohorts, the RATHER low toxicity of Vitamin D, which is a relative inexpensive CANDIDATE in the attenuation of the asthma’s EPIDEMIC BURDEN on PUBLIC HEALTH, were clearly INDICATIVE of THE NEED to proceed to clinical trials.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('INCOMPLETE_EVIDENCE', 171), ('IMPORTANT_CONSIDERATION', 216), ('IMPORTANT_CONSIDERATION', 235), ('PROBABLE_UNDERSTANDING', 263), ('INCOMPLETE_EVIDENCE', 277)]	8	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5405075	4/2017	S54-PMC5405075	['HOWEVER, these clinical trials were BIASED by many LIMITATIONS, such as SMALL SIZE, Vitamin D administration ONLY in the last Trimester of Pregnancy, POSSIBLY INADEQUATE maternal dose administration, WHILE authors also acknowledged that they were NOT PRIMARY designed to assess the specific outcome.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('PROBLEM_COMPLICATION', 36), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 150), ('IMPORTANT_CONSIDERATION', 159), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('INCOMPLETE_EVIDENCE', 247)]	10	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 126, 'trimester'), ('GO_0007565', 'female pregnancy', 139, 'pregnancy')]
PMC5405075	4/2017	S73-PMC5405075	['Pregnant women on HIGH RISK to obtain children with asthma were randomized to either an interventional arm receiving 4,400\u2009iu of Vitamin D or to a control arm receiving 400\u2009iu, as usual care, from 10 to 18\u2009weeks of Gestation until Delivery.']	[('IMPORTANT_CONSIDERATION', 18)]	1	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007565', 'female pregnancy', 215, 'gestation'), ('GO_0007567', 'parturition', 231, 'delivery')]
PMC5405075	4/2017	S89-PMC5405075	['moreover, it HAS BEEN PROPOSED that studies SHOULD focus on Vitamin D status in early Pregnancy and supplementary administration SHOULD BE initiated from the first Trimester of Gestation in order to observe the OPTIMAL EFFECT on RISK of childhood asthma, THOUGH EVIDENCE from chawes et al.’s clinical trial DID NOT CONFIRM this NOTION (75).']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 22), ('FUTURE_WORK', 44), ('FUTURE_WORK', 129), ('IMPORTANT_CONSIDERATION', 211), ('SUPERFICIAL_RELATIONSHIP', 219), ('IMPORTANT_CONSIDERATION', 229), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255), ('ANOMALY_CURIOUS_FINDING', 255), ('INCOMPLETE_EVIDENCE', 262), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 307), ('INCOMPLETE_EVIDENCE', 328)]	12	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 164, 'trimester'), ('GO_0007565', 'female pregnancy', 177, 'gestation')]
PMC5405075	4/2017	S90-PMC5405075	['in addition, an INTERESTING REMARK is that study designs and analyses do not take into CONSIDERATION the starting maternal Vitamin D status and dose adequacy for the different body systems.']	[('ANOMALY_CURIOUS_FINDING', 16), ('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 87)]	3	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC5410409	4/2017	S62-PMC5410409	['SOME REPORTED that high maternal Vitamin D intake during Pregnancy was ASSOCIATED with reduced RISK of wheezing in the child, WHILE SOME SHOWED no effect.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 71), ('IMPORTANT_CONSIDERATION', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 137)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy')]
PMC5417583	5/2017	S53-PMC5417583	['similarly, iron, zinc, and Vitamin A are BEST sourced from meat, but not much is enough to satisfy REQUIREMENTS.']	[('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 99)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin A')]
PMC5418719	5/2017	S0-PMC5418719	['efficacy and SAFETY of early supplementation with 800\xa0iu of Vitamin D in very preterm infants followed by underlying levels of Vitamin D at Birth\n\nabstract\n\nbackground\nto determine the EFFICACY and SAFETY of early supplementation with 800\xa0iu of Vitamin D in very low Birth weight (vlbw) infants.']	[('IMPORTANT_CONSIDERATION', 13), ('SUPERFICIAL_RELATIONSHIP', 185), ('IMPORTANT_CONSIDERATION', 198)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007567', 'parturition', 140, 'birth'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('GO_0007567', 'parturition', 267, 'birth')]
PMC5418719	5/2017	S5-PMC5418719	['Vitamin D intake of 800\xa0iu/day SAFELY achieved an 88% PROBABILITY of Vitamin D sufficiency at 36\xa0weeks Postmenstrual age in vlbw infants with Cord-blood levels of 25(Oh)D\u2009≥\u200910\xa0ng/ml, and 65% PROBABILITY of Vitamin D sufficiency was OBSERVED in infants with 25 Ohd concentrations\u2009<\u200910\xa0ng/ml at Birth.']	[('IMPORTANT_CONSIDERATION', 31), ('PROBABLE_UNDERSTANDING', 54), ('PROBABLE_UNDERSTANDING', 191), ('INCOMPLETE_EVIDENCE', 232)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0008283', 'cell proliferation', 103, 'postmenstrual'), ('UBERON_0002240', 'spinal cord', 142, 'cord'), ('CHEBI_71657', 'versiconol acetate', 163, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 163, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 257, '25 OHD'), ('GO_0007567', 'parturition', 293, 'birth')]
PMC5418719	5/2017	S6-PMC5418719	['conclusion\nCONSIDERING the EFFICACY and SAFETY of Vitamin D supplementation in THIS STUDY, Vitamin D intake of 800\xa0iu/day MAY enhance Vitamin D status during early hospitalization in vlbw infants with 25 Ohd concentrations\u2009<\u200910\xa0ng/ml at Birth.']	[('PROBABLE_UNDERSTANDING', 11), ('SUPERFICIAL_RELATIONSHIP', 27), ('IMPORTANT_CONSIDERATION', 40), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('INCOMPLETE_EVIDENCE', 122)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 201, '25 OHD'), ('GO_0007567', 'parturition', 237, 'birth')]
PMC5418719	5/2017	S7-PMC5418719	['the clinical SIGNIFICANCE of optimal Vitamin D intake in vlbw infants NEEDS TO BE studied in larger controlled STUDIES.']	[('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 70), ('FUTURE_WORK', 111)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5418719	5/2017	S9-PMC5418719	['furthermore, very low Birth weight (vlbw) infants OFTEN have less time to store Vitamin D from mother due to a decreased trans-Placental transfer and may also have an increased Vitamin D REQUIREMENT.']	[('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 187)]	2	[('GO_0007567', 'parturition', 22, 'birth'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0001987', 'placenta', 127, 'placental'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC5418719	5/2017	S11-PMC5418719	['[1] EMPHASIZED the FUNDAMENTAL BENEFITS of Vitamin D treatment for multiple developmental abnormalities, REFERRING to the high percentage of preterm infants with Blood Vitamin D levels\u2009<\u200920\xa0ng/ml [2].']	[('IMPORTANT_CONSIDERATION', 4), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 105)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0000178', 'blood', 162, 'blood'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC5418719	5/2017	S15-PMC5418719	['CONSIDERING the high incidence of Vitamin D deficiency/insufficiency in preterm infants that miss the late Gestation period, which builds Vitamin D stores from mother to fetus, a Vitamin D supply MIGHT be NECESSARY and URGENT to compensate the sufficient Vitamin D level.']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 196), ('IMPORTANT_CONSIDERATION', 205), ('IMPORTANT_CONSIDERATION', 219)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'gestation'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
PMC5418719	5/2017	S16-PMC5418719	['WHILE Breast Milk Feeding is currently RECOMMENDED as a source of early nutrition in full and preterm infants, an infant diet with Breast Milk alone does not contain enough Vitamin D. the definition of Vitamin D sufficiency in preterm infants is STILL CONTROVERSIAL; optimal Vitamin D status is BASED ON the Vitamin D concentrations for multiple health outcomes in Adults with a target value for 25(Oh)D levels >30\xa0ng/ml [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 39), ('IMPORTANT_CONSIDERATION', 246), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('QUESTION_ANSWERED_BY_THIS_WORK', 295), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('UBERON_0001348', 'brown adipose tissue', 6, 'breast milk'), ('GO_0007614', 'short-term memory', 13, 'milk'), ('GO_0007631', 'feeding behavior', 18, 'feeding'), ('UBERON_0001348', 'brown adipose tissue', 131, 'breast milk'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('UBERON_0007023', 'adult organism', 365, 'adults'), ('CHEBI_71657', 'versiconol acetate', 396, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 396, '25(OH ... D')]
PMC5418719	5/2017	S18-PMC5418719	['NEVERTHELESS, the APPROPRIATE amount of Vitamin D REQUIRED for optimal growth in vlbw is STILL IMPORTANT ISSUE to address.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 18), ('IMPORTANT_CONSIDERATION', 50), ('IMPORTANT_CONSIDERATION', 89), ('IMPORTANT_CONSIDERATION', 95), ('PROBLEM_COMPLICATION', 105)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC5418719	5/2017	S19-PMC5418719	['the AIM of THIS STUDY was TO DETERMINE WHETHER daily Vitamin D supplementation with a high dose of 800\xa0iu is SAFE and EFFECTIVE to increase the proportion of vlbw infants with 25(Oh)D\u2009>\u200930\xa0ng/ml, from 2\xa0weeks of age until hospital discharge.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 39), ('IMPORTANT_CONSIDERATION', 109), ('SUPERFICIAL_RELATIONSHIP', 118)]	6	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 176, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 176, '25(OH)D')]
PMC5418719	5/2017	S33-PMC5418719	['we determined the efficacy and SAFETY of early supplementation with 800\xa0iu Vitamin D.\n\noutcome measures\nthe primary outcome measured the proportion of Vitamin D sufficiency (>30\xa0ng/ml) at 32 and 36\xa0weeks pma and was analyzed by Cord Blood 25(Oh)D levels (<10\xa0ng/ml versus\u2009≥\u200910\xa0ng/ml) at Birth.']	[('IMPORTANT_CONSIDERATION', 31)]	1	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('UBERON_0009472', 'axilla', 228, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 239, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 239, '25(OH)D'), ('GO_0007567', 'parturition', 287, 'birth')]
PMC5418719	5/2017	S89-PMC5418719	['discussion\nTHIS PROSPECTIVE STUDY was PLANNED TO DETERMINE WHETHER 800\xa0iu Vitamin D supplementation from 2\xa0weeks of age is SAFE and EFFECTIVE to reach sufficient Vitamin D levels at 36\xa0weeks pma in vlbw infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('IMPORTANT_CONSIDERATION', 123), ('SUPERFICIAL_RELATIONSHIP', 132)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC5418719	5/2017	S92-PMC5418719	['WHILE the use of 800\xa0iu/d of Vitamin D achieved Serum 25(Oh)D concentrations to the ADEQUATE range of 30–80\xa0ng/ml without toxicity at 36\xa0weeks pma, this dose MAY STILL be too low to restore Vitamin D stores for the MAJORITY of infants with 25(Oh)D concentrations\u2009<\u200910\xa0ng/ml at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 84), ('INCOMPLETE_EVIDENCE', 158), ('IMPORTANT_CONSIDERATION', 162), ('PROBABLE_UNDERSTANDING', 215)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 240, '25(OH)D'), ('GO_0007567', 'parturition', 277, 'birth')]
PMC5418719	5/2017	S94-PMC5418719	['RECENT STUDIES DEMONSTRATED that low Vitamin D PREDISPOSE to increased RISK of rickets, Immune dysfunction, asthma, type 1 diabetes and Viral Respiratory Tract infections during infancy [14–17].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 71)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0002405', 'immune system', 88, 'immune'), ('NCBITaxon_1', 'root', 136, 'viral'), ('UBERON_0000065', 'respiratory tract', 142, 'respiratory tract')]
PMC5418719	5/2017	S96-PMC5418719	['moreover, INADEQUATE Vitamin D levels in Cord Blood are ASSOCIATED with Immune status and the prevalence of SEVERE Respiratory Tract infections in the first year of Life, as well as reduced bone density during childhood [18–20].']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 108)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0009472', 'axilla', 41, 'cord blood'), ('UBERON_0002405', 'immune system', 72, 'immune'), ('UBERON_0000065', 'respiratory tract', 115, 'respiratory tract'), ('UBERON_0000104', 'life cycle', 165, 'life')]
PMC5418719	5/2017	S97-PMC5418719	['serial measurements of Serum 25(Oh)D to evaluate Vitamin D status during hospitalization MAY HELP to identify preterm infants AT RISK of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 93), ('IMPORTANT_CONSIDERATION', 126)]	3	[('UBERON_0001977', 'blood serum', 23, 'serum'), ('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 29, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC5418719	5/2017	S98-PMC5418719	['CONSIDERING the high prevalence of Vitamin D deficiency in Pregnant mothers, sufficient Vitamin D supply in preterm infants COULD BE IMPORTANT to quickly correct the fetal low Plasma levels of Vitamin D. a Vitamin D intake of 800\xa0iu to 1000\xa0iu per day during first Months Of Life is RECOMMENDED BASED ON european GUIDELINES [21].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 133), ('FUTURE_WORK', 283), ('PROBABLE_UNDERSTANDING', 295), ('ANOMALY_CURIOUS_FINDING', 301), ('PROBABLE_UNDERSTANDING', 313)]	8	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnant'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 176, 'plasma'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('UBERON_0005445', 'segment of pes', 265, 'months of life')]
PMC5418719	5/2017	S119-PMC5418719	['a RECENT STUDY REVEALING a high prevalence of SEVERE Vitamin D deficiency in the middle east prompted us TO INVESTIGATE the OPTIMAL Vitamin D REQUIREMENT of preterm infants in different geographical locations [7].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 105), ('IMPORTANT_CONSIDERATION', 124), ('IMPORTANT_CONSIDERATION', 142)]	6	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC5418719	5/2017	S125-PMC5418719	['SIMILAR TO PREVIOUS REPORTS [34,35], in the PRESENT STUDY, women with gdm had a significantly INCREASED RISK of deficient Vitamin D status with cord 25(Oh)D concentrations\u2009≤\u200910\xa0ng/ml.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 20), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('IMPORTANT_CONSIDERATION', 94)]	5	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 151, '(OH)D')]
PMC5418719	5/2017	S128-PMC5418719	['[36] RECENTLY CONFIRMED that women who had Vitamin D insufficiency during Pregnancy were AT RISK of developing Gestational diabetes and Delivering small for Gestational age infants in a systematic review.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 89)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007565', 'female pregnancy', 111, 'gestational'), ('GO_0006900', 'vesicle budding from membrane', 136, 'delivering'), ('GO_0007565', 'female pregnancy', 157, 'gestational')]
PMC5418719	5/2017	S132-PMC5418719	['during Vitamin D supplementation, preterm infants REQUIRE close monitoring of Serum calcium, Phosphorus, Urinary Calcium Excretion, Urinary P Excretion and Renal Calcification, frequently detected by ultrasonography.']	[('IMPORTANT_CONSIDERATION', 50)]	1	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('UBERON_0001977', 'blood serum', 78, 'serum'), ('CHEBI_35885', 'secondary phosphine', 93, 'phosphorus'), ('GO_0060073', 'micturition', 105, 'urinary'), ('UBERON_0001088', 'urine', 105, 'urinary'), ('GO_0036161', 'calcitonin secretion', 113, 'calcium excretion'), ('GO_0060073', 'micturition', 132, 'urinary'), ('UBERON_0001088', 'urine', 132, 'urinary'), ('GO_0007568', 'aging', 140, 'P excretion'), ('UBERON_0002113', 'kidney', 156, 'renal'), ('GO_0051301', 'cell division', 162, 'calcification')]
PMC5418719	5/2017	S137-PMC5418719	['conclusion\nTHIS STUDY FOCUSED on SAFETY and response to the early initiation of oral Vitamin D supplementation followed by underlying level of Vitamin D at Birth in vlbw infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('IMPORTANT_CONSIDERATION', 33)]	3	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('GO_0007567', 'parturition', 156, 'birth')]
PMC5418719	5/2017	S138-PMC5418719	['CONSIDERING the EFFICACY and SAFETY of Vitamin D supplementation in THIS STUDY, Vitamin D intake of 800\xa0iu per day MAY optimize Vitamin D levels during early hospitalization in vlbw infants.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('INCOMPLETE_EVIDENCE', 115)]	7	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5418719	5/2017	S140-PMC5418719	['longitudinal extension of this study and randomized controlled STUDIES ARE REQUIRED to explore the efficacy and clinical benefits of daily supplementation of Vitamin D in dose of 800\xa0iu in a larger cohort.']	[('FUTURE_WORK', 63), ('FUTURE_WORK', 71), ('IMPORTANT_CONSIDERATION', 75)]	3	[('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC5421133	5/2017	S0-PMC5421133	['marginal vitamin a deficiency EXACERBATES Memory deficits following aβ1-42injection in Rats\n\nabstract\n\nbackground:\nALTHOUGH clinical Vitamin A deficiency (vad), which is a PUBLIC HEALTH PROBLEM developing throughout the world, has been well controlled, marginal Vitamin A deficiency (mvad) is far more PREVALENT, especially among Pregnant women and preschool children in china.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('ANOMALY_CURIOUS_FINDING', 115), ('IMPORTANT_CONSIDERATION', 172), ('IMPORTANT_CONSIDERATION', 302)]	4	[('GO_0007613', 'memory', 42, 'Memory'), ('NCBITaxon_10088', 'Mus <genus>', 87, 'Rats'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin A'), ('GO_0007565', 'female pregnancy', 330, 'pregnant')]
PMC5426325	4/2017	S0-PMC5426325	['Prenatal exposure to Vitamin D from fortified Margarine and risk of fractures in late childhood: period and cohort results from 222 000 subjects in the d-tect observational study\n\nabstract:normal\nPrenatal low Vitamin D MAY have CONSEQUENCES for bone health.']	[('INCOMPLETE_EVIDENCE', 219), ('IMPORTANT_CONSIDERATION', 228)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_6784', 'mestranol', 46, 'margarine'), ('GO_0007565', 'female pregnancy', 196, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC5426325	4/2017	S16-PMC5426325	['until 1 june 1985, Vitamin D fortification of Margarine was MANDATORY in denmark, BUT fortification was abolished, RELATED to an UNSUPPORTED ASSUMPTION that the amounts added to Margarine were too small to IMPACT the dietary NEEDS of Vitamin D in the danish population(3).']	[('IMPORTANT_CONSIDERATION', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 206), ('IMPORTANT_CONSIDERATION', 225)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_6784', 'mestranol', 46, 'margarine'), ('CHEBI_6784', 'mestranol', 178, 'margarine'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D')]
PMC5426325	4/2017	S20-PMC5426325	['GIVEN that low bone Mineral density (bmd) is PREDICTIVE of increased fracture risk, AS SHOWN in both case–control and prospective studies – THOUGH principally in Adults(13–20)– maternal Vitamin D insufficiency MAY POTENTIALLY also INFLUENCE fracture RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 84), ('ANOMALY_CURIOUS_FINDING', 140), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 231), ('IMPORTANT_CONSIDERATION', 250)]	8	[('CHEBI_46662', 'mineral', 20, 'mineral'), ('UBERON_0007023', 'adult organism', 162, 'adults'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC5426325	4/2017	S143-PMC5426325	['intervention studies with supplementation of Vitamin D in Pregnancy are currently ONGOING(9,55).']	[('IMPORTANT_CONSIDERATION', 82)]	1	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy')]
PMC5426325	4/2017	S152-PMC5426325	['UNFORTUNATELY, we LACK INFORMATION on Vitamin D status among danish women in the Reproductive age during the fortification period, BUT for comparision, a study SHOWED that among 850 Pregnant women recruited from the second-largest city in denmark in 1988–1989 (the period without fortification), only 6·3 of the Pregnant women had a Serum 25(Oh)D concentration ≤25 nmol/l(12); the median concentrations of 76·2 (95 % ci 23·0, 152·1) nmol/l were also above the ‘OPTIMAL level’ as STATED by the us Endocrine society(62,63).']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 461), ('INCOMPLETE_EVIDENCE', 479)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0000003', 'reproduction', 81, 'reproductive'), ('GO_0007565', 'female pregnancy', 182, 'pregnant'), ('GO_0007565', 'female pregnancy', 312, 'pregnant'), ('UBERON_0001977', 'blood serum', 333, 'serum'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 339, '25(OH)D'), ('UBERON_0005063', 'left ventricular compact myocardium', 496, 'Endocrine')]
PMC5436890	5/2017	S30-PMC5436890	['the KEY STRATEGIES of the nns includes growth monitoring and promotion, ENCOURAGING behaviour change to improve good nutritional practices, Vitamin A supplementation, zinc supplementation during treatment of diarrhoea and Iron/Folic Acid supplementation for Pregnant women.']	[('IMPORTANT_CONSIDERATION', 4), ('FUTURE_WORK', 8), ('FUTURE_WORK', 72)]	3	[('CHEBI_27300', 'vitamin D', 140, 'vitamin A'), ('CHEBI_24870', 'ion', 222, 'iron'), ('CHEBI_30751', 'formic acid', 227, 'folic acid'), ('GO_0007565', 'female pregnancy', 258, 'pregnant')]
PMC5452160	4/2017	S237-PMC5452160	['CONSIDERING the high prevalence of iron, zinc, Vitamin A, b12, and Folate deficiencies, and PREVIOUSLY presented results on Iodine deficiency in this study population [63], INTERVENTIONS to promote the strengthening of anc, and access and adherence to nutrition and health interventions are URGENTLY NEEDED [64,65].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 173), ('IMPORTANT_CONSIDERATION', 291), ('FUTURE_WORK', 300)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 67, 'folate'), ('CHEBI_24859', 'iodine atom', 124, 'iodine')]
PMC5473979	6/2017	S118-PMC5473979	['various Micronutrients, such as Vitamin D, Selenium, zinc, Vitamin B12, Folates and OTHER b Vitamins, HAVE BEEN SUGGESTED as IMPORTANT for the PREVENTION of maternal depression [36].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('INCOMPLETE_EVIDENCE', 102), ('IMPORTANT_CONSIDERATION', 125), ('SUPERFICIAL_RELATIONSHIP', 143)]	4	[('CHEBI_33839', 'macromolecule', 8, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27568', 'selenium atom', 43, 'selenium'), ('CHEBI_33279', 'vitamin D5', 59, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 67, 'B12'), ('CHEBI_72469', 'alpha-Neup5Gc-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc', 72, 'folates'), ('CHEBI_33277', 'gamma-tocotrienol', 92, 'vitamins')]
PMC5474873	6/2017	S0-PMC5474873	['sun exposure and psychotic experiences\n\nabstract:executive-summary\n\nobjective\nsun exposure IS CONSIDERED the single most IMPORTANT source of Vitamin D. Vitamin D deficiency HAS BEEN SUGGESTED to play a ROLE in the etiology of psychotic disorders.']	[('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 121), ('INCOMPLETE_EVIDENCE', 173), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 202)]	5	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 152, 'Vitamin D')]
PMC5474873	6/2017	S17-PMC5474873	['EVIDENCE now LINKS low Vitamin D levels with reduced Cognitive performance (8), INCREASED RISK for cancer, diabetes, Cardiovascular disease, and premature death (9,10).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 80)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0050890', 'cognition', 53, 'cognitive'), ('UBERON_0004535', 'cardiovascular system', 117, 'cardiovascular')]
PMC5474873	6/2017	S22-PMC5474873	['moreover, it HAS BEEN ARGUED that prolonged exposure CAN break down Vitamin D, reducing health BENEFITS and increasing risk of skin cancer (13).']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 53), ('IMPORTANT_CONSIDERATION', 95)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5474873	6/2017	S27-PMC5474873	['mcgrath and colleagues REPORTED that “both low and high concentrations of neonatal Vitamin D were ASSOCIATED with INCREASED RISK of schizophrenia.” SIMILARLY, absence of supplementation with Vitamin d before the age of one was FOUND TO BE ASSOCIATED with later schizophrenia in males (19).']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 98), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 148), ('ANOMALY_CURIOUS_FINDING', 227), ('SUPERFICIAL_RELATIONSHIP', 239)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 191, 'vitamin')]
PMC5474873	6/2017	S29-PMC5474873	['WHILE there are MANY STUDIES reporting the ASSOCIATION between Vitamin D levels in the Blood samples (18,19), there is STILL a LACK OF STUDIES on sun exposure, the main source of Vitamin D in most countries.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 43), ('IMPORTANT_CONSIDERATION', 119), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 127)]	6	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0000178', 'blood', 87, 'blood'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC5474873	6/2017	S138-PMC5474873	['discussion\nin the nordic countries, as elsewhere, sun exposure is by far the most IMPORTANT source of Vitamin D. in a population-based cohort of over 30,000 women, we FOUND an ASSOCIATION between cumulative measures of sun exposure at ages 10–39\u2009years and positive pes later in Life.']	[('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 176)]	3	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0000104', 'life cycle', 278, 'life')]
PMC5474873	6/2017	S161-PMC5474873	['we had NO biological DATA on Vitamin D levels, which COULD have established a clear LINK to Vitamin D, ALTHOUGH it is WELL KNOWN that sun exposure is the MOST IMPORTANT DETERMINANT of Vitamin D status (9,13).']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 84), ('ANOMALY_CURIOUS_FINDING', 103), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 154), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 169)]	8	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC5474873	6/2017	S185-PMC5474873	['PREVIOUS STUDIES HAVE REPORTED ASSOCIATIONS between Vitamin D and INCREASED RISK for health PROBLEMS, such as schizophrenia, as well as clinical symptoms in patients with mental health problems.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 66), ('IMPORTANT_CONSIDERATION', 92)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC5487839	3/2016	S201-PMC5487839	['the data obtained in a relatively SMALL group of patients are IN LINE WITH REPORTS on the advantages of vegetal proteins in reducing Kidney disease progression in non-Pregnant Humans, with a systematic review on vegan-vegetarian diets in Pregnancy, and with the position of the american dietary association, provided that b12, iron and Vitamin D are Controlled and supplied upon NEED [170–178].']	[('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 379)]	4	[('UBERON_0002113', 'kidney', 133, 'kidney'), ('GO_0007565', 'female pregnancy', 167, 'pregnant'), ('NCBITaxon_9606', 'Homo sapiens', 176, 'humans'), ('GO_0007565', 'female pregnancy', 238, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D'), ('GO_0065007', 'biological regulation', 350, 'controlled')]
PMC5489519	6/2017	S8-PMC5489519	['our results INDICATE that Vitamin D status in mothers Modulates Trail Expression in Breast Milk, which MAY have IMPLICATIONS for both mother and infant health.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 103), ('IMPORTANT_CONSIDERATION', 112)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0065007', 'biological regulation', 54, 'modulates'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 64, 'TRAIL'), ('GO_0010467', 'gene expression', 70, 'expression'), ('UBERON_0001348', 'brown adipose tissue', 84, 'breast milk')]
PMC5489519	6/2017	S31-PMC5489519	['results\n\nVitamin D deficiency in mothers increases Trail Expression in Breast Milk\nphysiologic levels of Vitamin D HAS BEEN IMPLICATED as an IMPORTANT stimulant for Innate Immunity and Bone Remodeling.']	[('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 124), ('IMPORTANT_CONSIDERATION', 141)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 51, 'TRAIL'), ('GO_0010467', 'gene expression', 57, 'expression'), ('UBERON_0000310', 'breast', 71, 'breast'), ('UBERON_0001913', 'milk', 78, 'milk'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0045087', 'innate immune response', 165, 'innate immunity'), ('GO_0046849', 'bone remodeling', 185, 'bone remodeling')]
PMC5489519	6/2017	S91-PMC5489519	['THUS, OUR FINDINGS that Vitamin D is ASSOCIATED with altered Trail Expression in Breast Milk MAY BE an IMPORTANT LINK to the mother and infant Immune System.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 93), ('IMPORTANT_CONSIDERATION', 103), ('SUPERFICIAL_RELATIONSHIP', 113)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 61, 'TRAIL'), ('GO_0010467', 'gene expression', 67, 'expression'), ('UBERON_0001348', 'brown adipose tissue', 81, 'breast milk'), ('UBERON_0002405', 'immune system', 143, 'immune system')]
PMC5489519	6/2017	S103-PMC5489519	['PREVIOUSLY, it HAS BEEN SHOWN that Vitamin D deficiency during Pregnancy increases genotoxic RISKS in newborns40.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 93)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy')]
PMC5489519	6/2017	S106-PMC5489519	['this evidence SUGGESTS that Vitamin D and Trail Expression in Mammalian cells play a MAJOR ROLE in both mother and infant Immune health.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 85), ('SUPERFICIAL_RELATIONSHIP', 91)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 42, 'TRAIL'), ('GO_0010467', 'gene expression', 48, 'expression'), ('NCBITaxon_40674', 'Mammalia', 62, 'mammalian'), ('UBERON_0002405', 'immune system', 122, 'immune')]
PMC5489519	6/2017	S108-PMC5489519	['also, these studies MAY have IMPLICATIONS regarding Vitamin D supplemention during Lactation.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 29)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007595', 'lactation', 83, 'lactation')]
PMC5489519	6/2017	S113-PMC5489519	['high dose Vitamin D decreased Trail Expression COMPARED TO basal levels, SUGGESTING that low levels of Vitamin D MAY BE REQUIRED to stimulate Trail Expression in Mammary Epithelial Cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 113), ('IMPORTANT_CONSIDERATION', 120)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 30, 'TRAIL'), ('GO_0010467', 'gene expression', 36, 'expression'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 142, 'TRAIL'), ('GO_0010467', 'gene expression', 148, 'expression'), ('CL_0002327', 'mammary gland epithelial cell', 162, 'mammary epithelial cells'), ('UBERON_0006954', 'mammary gland myoepithelium', 162, 'mammary epithelial')]
PMC5489519	6/2017	S115-PMC5489519	['THUS, our results SUGGEST that the Vitamin D modulation of Trail expression in Mammary Epithelial Cells MAY CONTRIBUTE to Trail protein levels in Human Milk, which MAY have IMPLICATIONS for both mother and infant health under Vitamin D deficient and sufficient conditions.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 173)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 59, 'TRAIL'), ('CL_0002327', 'mammary gland epithelial cell', 79, 'mammary epithelial cells'), ('UBERON_0006954', 'mammary gland myoepithelium', 79, 'mammary epithelial'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 122, 'TRAIL'), ('NCBITaxon_9606', 'Homo sapiens', 146, 'human'), ('UBERON_0001913', 'milk', 152, 'milk'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC5510234	7/2017	S73-PMC5510234	['this finding SUGGESTS then a LINK between Vitamin A deficiency and an INCREASED RISK of infant exposure to hiv during Vaginal Delivery.48,57later on, this was NOT CONFIRMED by other studies from the developped countries.61,62a cochrane review on Vitamin A supplementation and mtct of hiv was published in 2011, by wiysonge et al .']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin A'), ('UBERON_0001987', 'placenta', 118, 'vaginal'), ('GO_0007567', 'parturition', 126, 'delivery'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin A')]
PMC5510234	7/2017	S78-PMC5510234	['the authors REPORTED that EVEN in regions where Vitamin A deficiency is a PUBLIC HEALTH CONCERN, Vitamin A supplementation for PREVENTION of Prenatal mtct is not RECOMMENDED.58finally a RECENT REVIEW done on the vitamin a supplementation for the reduction of the RISK of mother-to-child transmission of hiv, REPORTED that early observational studies FOUND an ASSOCIATION between Vitamin A deficiency and increased rates of mtct of hiv.']	[('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 26), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 127), ('FUTURE_WORK', 162), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 263), ('INCOMPLETE_EVIDENCE', 308), ('INCOMPLETE_EVIDENCE', 350), ('SUPERFICIAL_RELATIONSHIP', 359)]	10	[('CHEBI_27300', 'vitamin D', 48, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('GO_0007565', 'female pregnancy', 141, 'prenatal'), ('CHEBI_27300', 'vitamin D', 379, 'vitamin A')]
PMC5513133	7/2017	S6-PMC5513133	['conclusions\nthe included clinical trials do not show an independent effect of Vitamin D supplementation in PREVENTING pe; HOWEVER, ISSUES with dose, timing, and duration of supplementation HAVE NOT BEEN COMPLETELY ADDRESSED.']	[('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('PROBLEM_COMPLICATION', 131), ('IMPORTANT_CONSIDERATION', 189), ('INCOMPLETE_EVIDENCE', 194)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5513133	7/2017	S39-PMC5513133	['in the past decade, maternal Vitamin D insufficiency and deficiency have increasingly been recognized as a PUBLIC HEALTH CONCERN.']	[('IMPORTANT_CONSIDERATION', 107)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5513133	7/2017	S44-PMC5513133	['african american women of Reproductive age HAVE BEEN FOUND TO BE at PARTICULARLY high RISK for Vitamin D deficiency in the united states [18].']	[('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 59), ('ANOMALY_CURIOUS_FINDING', 68), ('IMPORTANT_CONSIDERATION', 86)]	4	[('GO_0000003', 'reproduction', 26, 'reproductive'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5513133	7/2017	S45-PMC5513133	['clothing with minimal skin exposure [38,39], increased urbanization, skin pigmentation [40], and Vegetarian diets [35] are all BELIEVED to have contributed to a Vitamin D deficiency EPIDEMIC worldwide.']	[('INCOMPLETE_EVIDENCE', 127), ('IMPORTANT_CONSIDERATION', 182)]	2	[('NCBITaxon_7955', 'Danio rerio', 97, 'vegetarian'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC5513133	7/2017	S52-PMC5513133	['additionally, Vitamin D LIKELY plays a KEY ROLE in the pathology of pre-eclamptic conditions by AFFECTING Blood pressure through Calcium Homeostasis and/or Modulating inflammation and Immunity, which are examined further in THIS review.']	[('PROBABLE_UNDERSTANDING', 24), ('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 96), ('QUESTION_ANSWERED_BY_THIS_WORK', 224)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000178', 'blood', 106, 'blood'), ('GO_0055073', 'cadmium ion homeostasis', 129, 'calcium homeostasis'), ('GO_0065007', 'biological regulation', 156, 'modulating'), ('GO_0007566', 'embryo implantation', 184, 'immunity')]
PMC5513133	7/2017	S118-PMC5513133	['HOWEVER, when CONSIDERING total Vitamin D intake (diet + supplement) of 15–20\xa0μg/d compared to less than 5\xa0μg/d, there was an adjusted or of 0.76 (95% ci 0.60–0.95) for diagnosis with pe [77].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 14)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC5513133	7/2017	S178-PMC5513133	['after controlling for smoking, the study SHOWED that in the first trimester (mean 11\xa0weeks), Vitamin D deficiency was not significantly associated with an INCREASED RISK of pe (aor\xa0=\xa01.24 95% ci: 0.58–2.67; p \xa0=\xa00.58) [60].']	[('INCOMPLETE_EVIDENCE', 41), ('IMPORTANT_CONSIDERATION', 155)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC5513133	7/2017	S199-PMC5513133	['discussion\nOBSERVATIONAL studies evaluating the ASSOCIATION between Vitamin D and pe HAVE SHOWN INCONSISTENT results and MUST BE interpreted CAUTIOUSLY.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('IMPORTANT_CONSIDERATION', 121), ('INCOMPLETE_EVIDENCE', 141)]	6	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5513133	7/2017	S200-PMC5513133	['this MAY BE a result of ISSUES with study design and methodology, including LACK OF adjustment of KEY CONFOUNDING variables and methods of measuring Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBLEM_COMPLICATION', 24), ('PROBLEM_COMPLICATION', 76), ('IMPORTANT_CONSIDERATION', 98), ('PROBLEM_COMPLICATION', 102)]	5	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC5513133	7/2017	S210-PMC5513133	['smoking MAY BE an IMPORTANT CONFOUNDER and SHOULD BE CONSIDERED in studies LINKING Vitamin D to pe.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 18), ('PROBLEM_COMPLICATION', 28), ('FUTURE_WORK', 43), ('FUTURE_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 75)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC5513133	7/2017	S229-PMC5513133	['in a cochrane review of Vitamin D supplementation for women during Pregnancy, women who received Vitamin D and Calcium supplementation had a lower RISK of pre-eclampsia than those not receiving any intervention (rr 0.51; 95% ci 0.32 to 0.80; three trials, 1114 women, moderate quality), YET an increased risk for Preterm Birth (rr\xa0=\xa01.57; 95% ci: 1.02–2.43; three studies, 798 women, moderate quality).']	[('IMPORTANT_CONSIDERATION', 147), ('ANOMALY_CURIOUS_FINDING', 287)]	2	[('CHEBI_28384', 'vitamin K', 24, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 111, 'calcium'), ('GO_0007565', 'female pregnancy', 313, 'preterm birth')]
PMC5513133	7/2017	S233-PMC5513133	['studies MUST ALSO BE interpreted according to HOW Vitamin D exposure is defined and measured.']	[('IMPORTANT_CONSIDERATION', 8), ('EXPLICIT_QUESTION', 46)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC5513133	7/2017	S236-PMC5513133	['FUTURE INVESTIGATIONS SHOULD CONSIDER concurrently measuring Vdbp levels and calculated free Vitamin D levels when CONSIDERING the ROLE of Vitamin D in pe [18].']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('FUTURE_WORK', 29), ('IMPORTANT_CONSIDERATION', 115), ('SUPERFICIAL_RELATIONSHIP', 131)]	5	[('PR_000017279', 'testis-specific basic protein Y 1', 61, 'VDBP'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC5513133	7/2017	S240-PMC5513133	['DESPITE EVIDENCE that low Vitamin D levels increase RISK for pe early in Pregnancy, VERY FEW STUDIES have tried TO RELATE this EFFECT with the Regulation Of Angiogenic or anti-Angiogenic factors.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 84), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 127), ('SUPERFICIAL_RELATIONSHIP', 143)]	9	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('GO_0006110', 'regulation of glycolytic process', 143, 'regulation of angiogenic'), ('GO_0001525', 'angiogenesis', 176, 'angiogenic')]
PMC5513133	7/2017	S249-PMC5513133	['SUGGESTS a POTENTIAL for a ROLE for the frequency and timing of Vitamin D supplementation and risk for pe, given that the total intake greater than 800\xa0iu/day did not reduce RISK.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 27), ('IMPORTANT_CONSIDERATION', 174)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5513133	7/2017	S253-PMC5513133	['HOWEVER, women with a Serum Vitamin D status of ≥75\xa0nmol/l that was maintained from enrollment through late Pregnancy had a significantly lower RISK of pe versus women who had <75\xa0nmol/l ( p \xa0=\xa00.04).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 144)]	3	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'pregnancy')]
PMC5513133	7/2017	S254-PMC5513133	['BUT this Vitamin D level was maintained in ONLY 74% of Pregnancies in the supplementation group by weeks 32 to 38 of Gestation, SUGGESTING that supplementation at EVEN earlier time-points or before Pregnancy MAY BE NECESSARY to maintain sufficient Vitamin D levels that are PROTECTIVE against pe.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 43), ('INCOMPLETE_EVIDENCE', 128), ('ANOMALY_CURIOUS_FINDING', 163), ('INCOMPLETE_EVIDENCE', 208), ('IMPORTANT_CONSIDERATION', 215), ('SUPERFICIAL_RELATIONSHIP', 274)]	8	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 55, 'pregnancies'), ('GO_0007565', 'female pregnancy', 117, 'gestation'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D')]
PMC5513133	7/2017	S264-PMC5513133	['WHILE SOME STUDIES HAVE BEEN able to capture an adequate representation of african american women [96], there is a NEED FOR FURTHER RESEARCH on populations with very low Vitamin D levels to understand THIS OBSERVATION and IDENTIFY FACTORS that PREDISPOSE high-risk groups to pe and its more THREATENING clinical subtypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 115), ('FUTURE_WORK', 124), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('INCOMPLETE_EVIDENCE', 206), ('QUESTION_ANSWERED_BY_THIS_WORK', 222), ('SUPERFICIAL_RELATIONSHIP', 231), ('SUPERFICIAL_RELATIONSHIP', 244), ('IMPORTANT_CONSIDERATION', 291)]	11	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5513133	7/2017	S265-PMC5513133	['DESPITE the clear ASSOCIATION of Serum deficiency with pe, a better understanding of the variable IMPACT of supplementation IS NEEDED to identify POTENTIAL of Genetic and environmental INTERACTIONS, as well as pre-Conception data TO IDENTIFY the CRITICAL time window for therapeutic potential of Vitamin D, if any.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 124), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 230), ('IMPORTANT_CONSIDERATION', 246)]	8	[('UBERON_0001977', 'blood serum', 33, 'serum'), ('SO_0000704', 'gene', 159, 'genetic'), ('GO_0007620', 'copulation', 214, 'conception'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D')]
PMC5513133	7/2017	S267-PMC5513133	['results from Vitamin D supplementation during Pregnancy did not show a statistically significant independent EFFECT of Vitamin D on the RISK of pe and pih.']	[('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 136)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC5513133	7/2017	S268-PMC5513133	['at this time, our UNDERSTANDING of an IDEAL supplementation dose of Vitamin D to reduce pih REMAINS INCOMPLETE.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 38), ('INCOMPLETE_EVIDENCE', 92)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5521778	7/2017	S24-PMC5521778	['in Mammals, preformed Vitamin A MUST BE Ingested from dietary sources or produced by Metabolism Of provitamin a Carotenoids, principally Β-Carotene, by the action of the bco1 [18,19].']	[('IMPORTANT_CONSIDERATION', 32)]	1	[('NCBITaxon_40674', 'Mammalia', 3, 'mammals'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('GO_0007631', 'feeding behavior', 40, 'ingested'), ('GO_0019386', 'methanogenesis, from carbon dioxide', 85, 'metabolism of ... carotenoids'), ('CHEBI_50815', 'norgestimate', 112, 'carotenoids'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 137, 'β-carotene')]
PMC5524288	7/2017	S0-PMC5524288	['maternal 25(Oh)D concentrations ≥40 ng/ml ASSOCIATED with 60% lower Preterm Birth RISK among general obstetrical patients at an urban medical center\n\nabstract\n\nbackground\nGIVEN the HIGH RATE of Preterm Birth (ptb) nationwide and data from rcts DEMONSTRATING risk reduction with Vitamin D supplementation, the medical university of south carolina (musc) implemented a NEW standard of care for Pregnant women to receive Vitamin D testing and supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 171), ('IMPORTANT_CONSIDERATION', 181), ('INCOMPLETE_EVIDENCE', 244), ('FULL_UNKNOWN', 367)]	6	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 9, '25(OH)D'), ('GO_0007565', 'female pregnancy', 68, 'preterm birth'), ('GO_0007565', 'female pregnancy', 194, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D'), ('GO_0007565', 'female pregnancy', 392, 'pregnant'), ('CHEBI_27300', 'vitamin D', 418, 'vitamin D')]
PMC5524288	7/2017	S17-PMC5524288	['multiple epidemiologic STUDIES have FOUND an ASSOCIATION between higher maternal Serum 25-Hydroxyvitamin D [25(Oh)D] concentration, the physiological measure of Vitamin D status, and lower ptb RISK [4–10].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 45), ('IMPORTANT_CONSIDERATION', 193)]	4	[('UBERON_0001977', 'blood serum', 81, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 87, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 108, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC5524288	7/2017	S21-PMC5524288	['in those clinical trials, 4000 iu/day of Vitamin D was FOUND to SAFELY achieve a concentration of at least 32 ng/ml by early in the second Trimester in a diverse group of Pregnant women [13–15].']	[('INCOMPLETE_EVIDENCE', 55), ('IMPORTANT_CONSIDERATION', 64)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 139, 'trimester'), ('GO_0007565', 'female pregnancy', 171, 'pregnant')]
PMC5524288	7/2017	S111-PMC5524288	['THESE FINDINGS SHOW that higher Vitamin D status is significantly ASSOCIATED with lower ptb RISK for both ptb subtypes and that Vitamin D plays an IMPORTANT ROLE in the UNDERLYING causes of indicated ptb including maternal hypertension, pre-existing diabetes, and non-reassuring fetal status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 92), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 157), ('SUPERFICIAL_RELATIONSHIP', 169)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5524288	7/2017	S116-PMC5524288	['THESE FINDINGS SUGGEST that IMPROVEMENTS in Vitamin D status MAY decrease the DISPARITY in ptb rates between race/ethnic groups.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('FUTURE_WORK', 28), ('FUTURE_PREDICTION', 61), ('IMPORTANT_CONSIDERATION', 78)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC5524288	7/2017	S117-PMC5524288	['additionally, for women with a prior ptb, the substantial decrease in recurrent ptb RISK (80%) for ≥40 ng/ml vs. <20 ng/ml INDICATES that IMPROVING Vitamin D status in this HIGH RISK subgroup COULD sizably reduce ptb rates.']	[('IMPORTANT_CONSIDERATION', 84), ('INCOMPLETE_EVIDENCE', 123), ('FUTURE_WORK', 138), ('IMPORTANT_CONSIDERATION', 173), ('FUTURE_PREDICTION', 192)]	5	[('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC5524288	7/2017	S118-PMC5524288	['among women with initial 25(Oh)D concentrations <40 ng/ml, the significantly lower ptb rate (60%) for those who achieved ≥40 ng/ml COMPARED TO those who did not reach the target concentration on a follow-up test SUGGESTS that maternal Vitamin D status is a MODIFIABLE RISK FACTOR that CAN be addressed during the Prenatal period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 268), ('INCOMPLETE_EVIDENCE', 285)]	5	[('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 25, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007565', 'female pregnancy', 313, 'prenatal')]
PMC5524288	7/2017	S120-PMC5524288	['this INDICATES that IMPROVING the Vitamin D status of non-white women, who are known to have PARTICULARLY low Vitamin D concentrations, COULD DRAMATICALLY decrease racial DISPARITIES in ptb rates.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 20), ('IMPORTANT_CONSIDERATION', 93), ('FUTURE_PREDICTION', 136), ('ANOMALY_CURIOUS_FINDING', 142), ('IMPORTANT_CONSIDERATION', 171)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC5524288	7/2017	S127-PMC5524288	['a LIMITATION of THIS STUDY was that nearly two-thirds of the women (63%) had ONLY one 25(Oh)D test during Pregnancy, which PROHIBITED assessment by Trimester and a more thorough analysis of Vitamin D BENEFIT among those with low initial levels.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 77), ('DIFFICULT_TASK', 123), ('IMPORTANT_CONSIDERATION', 200)]	5	[('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 86, '25(OH)D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 148, 'trimester'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC5537884	7/2017	S106-PMC5537884	['further IMPORTANT points are the avoidance of nutritional deficits, in particular of Vitamin B12, Vitamin D, and iron, all of which are regularly Controlled in our on-diet patients [26,27,28].']	[('IMPORTANT_CONSIDERATION', 8)]	1	[('CHEBI_33279', 'vitamin D5', 85, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 93, 'B12'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0065007', 'biological regulation', 146, 'controlled')]
PMC5537904	7/2017	S20-PMC5537904	['there is also a notable LACK OF study on body composition during infancy, a time in which Postnatal exposures (infant Vitamin D supplementation, Vitamin D-fortified formula use) MAY also play a PIVOTAL ROLE in Adiposity Development.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 178), ('IMPORTANT_CONSIDERATION', 194), ('SUPERFICIAL_RELATIONSHIP', 202)]	4	[('GO_0007567', 'parturition', 90, 'postnatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 210, 'adiposity development')]
PMC5537904	7/2017	S21-PMC5537904	['PRIOR STUDIES VARY strongly in methodology, PARTICULARLY in regard to assessment of Prenatal Vitamin D intake, timing and source of 25(Oh)D measurements, a method for assessing neonatal adiposity, and CONSIDERATION of OTHER contributing factors such as maternal obesity.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('IMPORTANT_CONSIDERATION', 44), ('FUTURE_WORK', 201), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 218)]	5	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 138, 'D')]
PMC5537904	7/2017	S61-PMC5537904	['this variable was used as PROXY for offspring Vitamin D intake from Food, given that Breastmilk contains little-to-no Vitamin D and all infant formulas in the united states are REQUIRED to contain at least 400 iu/l [40].']	[('SUPERFICIAL_RELATIONSHIP', 26), ('IMPORTANT_CONSIDERATION', 177)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_33290', 'food', 68, 'food'), ('UBERON_0001348', 'brown adipose tissue', 85, 'breastmilk'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC5537904	7/2017	S151-PMC5537904	['OUR finding that the ASSOCIATION between Cord Blood 25(Oh)D and Birthweight varies according to maternal bmi MUST BE REPLICATED in OTHER studies, including intervention trials, TO DETERMINE IF Vitamin D supplementation RECOMMENDATIONS to modify Birthweight SHOULD BE bmi-specific.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 117), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('FUTURE_WORK', 219), ('FUTURE_WORK', 257)]	9	[('UBERON_0009472', 'axilla', 41, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 52, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 52, '25(OH)D'), ('GO_0007596', 'blood coagulation', 64, 'birthweight'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007596', 'blood coagulation', 245, 'birthweight')]
PMC5537904	7/2017	S155-PMC5537904	['these data underscore the INCREASED RISK for both early Life Vitamin D deficiency and increased adiposity conferred to offspring by women with obesity.']	[('IMPORTANT_CONSIDERATION', 26)]	1	[('UBERON_0000104', 'life cycle', 56, 'life'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC5537904	7/2017	S173-PMC5537904	['continued RESEARCH into the IMPLICATIONS of Cord Blood 25(Oh)D status IS NEEDED to guide RECOMMENDATIONS for Prenatal Vitamin D intake.']	[('FUTURE_WORK', 10), ('IMPORTANT_CONSIDERATION', 28), ('FUTURE_WORK', 70), ('FUTURE_WORK', 89)]	4	[('UBERON_0002240', 'spinal cord', 44, 'cord'), ('UBERON_0000178', 'blood', 49, 'blood'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('GO_0007565', 'female pregnancy', 109, 'prenatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC5537904	7/2017	S181-PMC5537904	['the ethnically-diverse cohort, validated measures of 25(Oh)D and body composition, and detailed data on maternal Vitamin D intake during Pregnancy are all STRENGTHS of our study.']	[('IMPORTANT_CONSIDERATION', 155)]	1	[('CHEBI_71657', 'versiconol acetate', 53, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 53, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy')]
PMC5539754	8/2017	S18-PMC5539754	['HOWEVER, the MAJORITY of Vitamin D supplementation intervention trials in Pregnancy have not had a SIGNIFICANT IMPACT on maternal and offspring health [10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('IMPORTANT_CONSIDERATION', 99)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy')]
PMC5539754	8/2017	S30-PMC5539754	['due to the seasonal nature of 25Ohd concentrations in many parts of the world [32], and the OBSERVED ASSOCIATIONS between Vitamin D and Insulin resistance, it WOULD seem PRUDENT to HYPOTHESISE that seasonal variation of Glucose Homeostasis MAY BE MEDIATED through 25Ohd.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 101), ('FUTURE_PREDICTION', 159), ('IMPORTANT_CONSIDERATION', 170), ('FUTURE_WORK', 181), ('INCOMPLETE_EVIDENCE', 240), ('SUPERFICIAL_RELATIONSHIP', 247)]	7	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 30, '25OHD'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('PR_000045358', 'insulin family protein', 136, 'insulin'), ('CHEBI_17234', 'glucose', 220, 'glucose'), ('GO_0042593', 'glucose homeostasis', 220, 'glucose homeostasis'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 264, '25OHD')]
PMC5539754	8/2017	S153-PMC5539754	['a recent meta-analysis of OBSERVATIONAL studies REPORTED that Vitamin D\xa0<\xa050\xa0nmol/l was ASSOCIATED with an INCREASED RISK (or\xa0=\xa01.53) of developing Gestational diabetes [9].']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 107)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'gestational')]
PMC5539754	8/2017	S154-PMC5539754	['many women who Gestate through a typical winter in the northern hemisphere are AT RISK of Vitamin D deficiency [4,5].']	[('IMPORTANT_CONSIDERATION', 79)]	1	[('GO_0007565', 'female pregnancy', 15, 'gestate'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC5539754	8/2017	S155-PMC5539754	['POOR Vitamin D intakes HAVE BEEN REPORTED among Pregnant women living in ireland [5].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 23)]	2	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'pregnant')]
PMC5546866	8/2017	S14-PMC5546866	['antenatal Vitamin D supplementation is now RECOMMENDED for all Pregnant women in many national GUIDELINES (1–3) AS SEVERE maternal Vitamin D deficiency CAN result in symptomatic neonatal hypocalcemia (4).']	[('FUTURE_WORK', 43), ('PROBABLE_UNDERSTANDING', 95), ('PROBABLE_UNDERSTANDING', 112), ('IMPORTANT_CONSIDERATION', 115), ('INCOMPLETE_EVIDENCE', 152)]	5	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnant'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5546866	8/2017	S19-PMC5546866	['in a PREVIOUS Genome-wide association study (gwas), we DEMONSTRATED that a NUMBER OF Single-Nucleotide Polymorphisms (Snps) in or near to Genes encoding KEY components of the Vitamin D Metabolism pathway are ASSOCIATED with Serum 25(Oh)D level (8).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 153), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	[('SO_0001026', 'genome', 14, 'genome'), ('SO_0000694', 'SNP', 85, 'single-nucleotide polymorphisms'), ('SO_0000694', 'SNP', 118, 'SNPs'), ('SO_0000704', 'gene', 138, 'genes'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 175, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 224, 'serum'), ('CHEBI_71657', 'versiconol acetate', 230, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 233, 'OH ... D')]
PMC5546866	8/2017	S130-PMC5546866	['Cyp2R1 encodes a 25-hydroxylase, a KEY enzyme INVOLVED in the conversion of Vitamin D to 25(Oh)D (23).']	[('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 0, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D')]
PMC5546866	8/2017	S151-PMC5546866	['OUR FINDINGS SUGGEST that analysis of Snps MAY have an IMPORTANT ROLE in identifying high-risk categories of Individuals who are LIKELY to REQUIRE higher doses of Vitamin D to achieve repletion, and STUDIES ARE NEEDED to establish clinical approaches to Vitamin D supplementation that are centered on individual characteristics.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 129), ('IMPORTANT_CONSIDERATION', 139), ('FUTURE_WORK', 199)]	8	[('SO_0000694', 'SNP', 38, 'SNPs'), ('NCBITaxon_1', 'root', 109, 'individuals'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC555773	9/2004	S218-PMC555773	['IN GENERAL, it IS REPORTED that patients with UNCONTROLLED ESSENTIAL hypertension have elevated concentrations of Superoxide Anion (o2−⋅), H2O2, Lipid Peroxides, endothelin, and transforming Growth Factor-Beta (Tgf-Beta) with a simultaneous decrease in Endothelial No (eno), sod, Vitamin E, and Long-Chain polyunsaturated Fatty Acids (lcpufas).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 46), ('IMPORTANT_CONSIDERATION', 59)]	5	[('CHEBI_62945', 'thromboxane anion', 114, 'superoxide anion'), ('CHEBI_16240', 'hydrogen peroxide', 139, 'H2O2'), ('CHEBI_48155', 'tetrahydrofurancarboxylic acid', 145, 'lipid peroxides'), ('PR_000008020', 'glucocorticoid-induced transcript 1 protein', 191, 'growth factor-beta'), ('PR_000000046', 'TGF-beta', 211, 'TGF-beta'), ('UBERON_0001986', 'endothelium', 253, 'endothelial'), ('CHEBI_16382', 'iodide', 265, 'NO'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin E'), ('CHEBI_28911', 'cob(III)alamin', 295, 'long-chain'), ('CHEBI_33250', 'atom', 322, 'fatty'), ('CHEBI_37527', 'acid', 328, 'acids')]
PMC5579643	8/2017	S63-PMC5579643	['when specifically CONSIDERING a POTENTIAL ROLE for Vitamins in Food allergy, Vitamin D HAS BEEN SHOWN to AFFECT several mechanisms that promote immunologic tolerance, including T Regulatory Cell function and the induction of tolerogenic Dendritic Cells.']	[('IMPORTANT_CONSIDERATION', 18), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('CHEBI_33290', 'food', 63, 'food'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CL_0000902', 'induced T-regulatory cell', 177, 'T regulatory cell'), ('GO_0065007', 'biological regulation', 179, 'regulatory'), ('CL_0000451', 'dendritic cell', 237, 'dendritic cells')]
PMC5623264	9/2017	S8-PMC5623264	['six interventions were ASSOCIATED with a decreased RISK of lbw: oral supplementation with (1) Vitamin A, (2) low-dose Calcium, (3) zinc, (4) multiple Micronutrients (mmn), nutritional education and provision of preventive Antimalarials.']	[('SUPERFICIAL_RELATIONSHIP', 23), ('IMPORTANT_CONSIDERATION', 51)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin A'), ('CHEBI_22313', 'alkaline earth metal atom', 118, 'calcium'), ('CHEBI_33839', 'macromolecule', 150, 'micronutrients'), ('CHEBI_22580', 'anthraquinone', 222, 'antimalarials')]
PMC5623264	9/2017	S121-PMC5623264	['piso et al FOUND that Vitamin C supplementation during Pregnancy increased the RISK of ptb and magnesium supplementation decreased the RISK of ptb, lbw and sga.15HOWEVER, the cochrane reviews from which data were extracted had previously been updated and new studies had been added resulting in changed conclusions.']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 79), ('IMPORTANT_CONSIDERATION', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin C'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy')]
PMC5623264	9/2017	S122-PMC5623264	['currently, there is NO EVIDENCE that magnesium or Vitamin C supplementation during Pregnancy positively or negatively AFFECT the RISK of ptb, lbw or sga.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 118), ('IMPORTANT_CONSIDERATION', 129)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin C'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC5634602	10/2017	S25-PMC5634602	['*formula Fed infants taking <1 liter of formula2008[5]aap—committee on nutrition preterm infants vlbw200–400 iu>50 nmol/l (targeting bone health)discharge Vitamin D RECOMMENDED for breastfed infants 400 iu, for formula Fed 200–400 iu2013[6]aap—committee on nutrition preterm infants>1500g400–1000 iu>50 nmol/l (targeting bone health)tolerating full enteral feeds2013[6]world health organization Preterm infants400–1000 iulow and middle-income countrieswho[7]institute of medicine infants 0–6 months400 iu>50 nmol/l (targeting bone health)under assumption of minimal sunlight2011[8]esphagan preterm infants800–1000 iu>80 nmol/lstable Growing, 1000 to 1800 grams2010[4]pediatric Endocrine society breastfed infants, or those taking <1lformula/day400 iu>50 nmol/l (desire ADDITIONAL STUDIES to determine IF >80 nmol/l is OPTIMAL)800 iu for high risk populations i.e.']	[('FUTURE_WORK', 165), ('FUTURE_WORK', 769), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 801), ('IMPORTANT_CONSIDERATION', 818)]	4	[('GO_0007631', 'feeding behavior', 9, 'fed'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007631', 'feeding behavior', 219, 'fed'), ('GO_0007128', 'meiotic prophase I', 395, 'Preterm'), ('GO_0001947', 'heart looping', 633, 'Growing'), ('UBERON_0005063', 'left ventricular compact myocardium', 677, 'Endocrine')]
PMC5634602	10/2017	S26-PMC5634602	['preterm infants2008[2]Endocrine society healthy infants 0–1 year400–1000 iu>75 nmol/l (for non-Skeletal benefits)0–1 Vitamin D deficient (<50 nmol/l) 2000 iu/D for 6 weeks followed by maintenance dosing2011[9]\nvery LITTLE data is available regarding response to Vitamin D supplementation in the smallest and youngest infants (<1200 grams at Birth), a population that MIGHT see the most BENEFIT from normalized Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 215), ('INCOMPLETE_EVIDENCE', 367), ('IMPORTANT_CONSIDERATION', 386)]	3	[('UBERON_0005063', 'left ventricular compact myocardium', 22, 'Endocrine'), ('UBERON_0004288', 'skeleton', 95, 'skeletal'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D'), ('GO_0007567', 'parturition', 341, 'birth'), ('CHEBI_27300', 'vitamin D', 410, 'vitamin D')]
PMC5634602	10/2017	S30-PMC5634602	['as the ROLE of Vitamin D in Immune function, Respiratory health, allergy and atopic disease, and many other Tissue and Organ functions becomes apparent, adjustments have BEEN SUGGESTED in OPTIMAL Serum level of 25(Oh)D [12–14].']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 170), ('IMPORTANT_CONSIDERATION', 188)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0002405', 'immune system', 28, 'immune'), ('UBERON_0001004', 'respiratory system', 45, 'respiratory'), ('UBERON_0000479', 'tissue', 108, 'tissue'), ('UBERON_0000062', 'organ', 119, 'organ'), ('UBERON_0001977', 'blood serum', 196, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 217, 'D')]
PMC5634602	10/2017	S33-PMC5634602	['MANY STUDIES in the united states and abroad have DOCUMENTED maternal status to be SUBOPTIMAL and have CALLED for national programs to improve maternal Vitamin D status with increased supplementation dose and frequency [18–26].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 50), ('IMPORTANT_CONSIDERATION', 83), ('IMPORTANT_CONSIDERATION', 103), ('IMPORTANT_CONSIDERATION', 103)]	5	[('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
PMC5634602	10/2017	S97-PMC5634602	['the preterm population of patients is at high RISK for bone disease of prematurity, and improving Delivery of Vitamin D MAY have a positive IMPACT on bone health.']	[('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 140)]	3	[('GO_0007567', 'parturition', 98, 'delivery'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC5634602	10/2017	S98-PMC5634602	['improving Vitamin D ALONE is not adequate to prevent POOR bone mineralization; this physiology is also DEPENDENT on delivery of appropriate amounts and ratios of Calcium and Phosphorus in the parenteral and enteral diet, as well as a patient’s over all nutrition status [21].']	[('ANOMALY_CURIOUS_FINDING', 20), ('IMPORTANT_CONSIDERATION', 53), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 162, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 174, 'phosphorus')]
PMC5634602	10/2017	S105-PMC5634602	['using this 10thpercentile standard, a significantly higher proportion of infants in the 400 iu Vitamin D group were AT RISK for low bone density than their peers in the 800 Iu dosing group (56% vs 16% p = 0.04 n = 16).']	[('IMPORTANT_CONSIDERATION', 116)]	1	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_17883', 'hydrogen chloride', 173, 'IU')]
PMC5634602	10/2017	S125-PMC5634602	['supplementation of these patients with Vitamin D would NOT BE ADVISABLE.']	[('IMPORTANT_CONSIDERATION', 55), ('FUTURE_WORK', 62)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC5634602	10/2017	S131-PMC5634602	['these infants are the HIGHEST RISK infants and are in need of additional evaluation of Vitamin D status and response to supplementation.']	[('IMPORTANT_CONSIDERATION', 22)]	1	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC5634602	10/2017	S132-PMC5634602	['our dexa scan evaluation of these infants at term corrected age is an IMPORTANT INDICATOR of both short term and long-term benefits of improvement in Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 70), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC5634602	10/2017	S147-PMC5634602	['IN FACT, SOME authors, including heaney, have ARGUED that a physiological reference for optimal Vitamin D status would be between 100 and 130 nmol/l stating that BASED ON physiological outcomes such as normalization of pth and adequate Vitamin D supply in Breast Milk this level is SAFE for disease prevention without ASSOCIATION of toxicity [56].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 162), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 282), ('SUPERFICIAL_RELATIONSHIP', 318)]	7	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 256, 'breast milk')]
PMC5634602	10/2017	S148-PMC5634602	['OTHER authors have RECOMMENDED loading doses to more quickly improve Vitamin D status in AT RISK populations, a STRATEGY that MERITS FURTHER INVESTIGATION [57].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 19), ('IMPORTANT_CONSIDERATION', 89), ('FUTURE_WORK', 112), ('IMPORTANT_CONSIDERATION', 126), ('FUTURE_WORK', 133)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC5634602	10/2017	S150-PMC5634602	['the OPTIMAL dose of Vitamin D supplementation for preterm infants during the early Neonatal Period WARRANTS FURTHER INVESTIGATION, but it is REASONABLE and SAFE to RECOMMEND daily supplementation in addition to dietary intake with 800 iu of Vitamin D to high-risk preterm infants while hospitalized in the nicu in order to TARGET a level of 25(Oh)D that is >75 nmol/l, AS we HAVE SHOWN this to improve bone health defined by dexa in this AT-RISK population.']	[('IMPORTANT_CONSIDERATION', 4), ('FUTURE_WORK', 99), ('PROBABLE_UNDERSTANDING', 141), ('IMPORTANT_CONSIDERATION', 156), ('FUTURE_WORK', 164), ('FUTURE_WORK', 323), ('PROBABLE_UNDERSTANDING', 369), ('INCOMPLETE_EVIDENCE', 375), ('IMPORTANT_CONSIDERATION', 438)]	9	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0007221', 'neonate stage', 83, 'neonatal period'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 344, 'OH)D')]
PMC5638722	8/2017	S0-PMC5638722	['EFFECTS of Cord Blood Vitamin D levels on the RISK of neonatal sepsis in premature infants\n\nabstract\n\npurpose\nVitamin D plays a KEY ROLE in Immune function.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 46), ('IMPORTANT_CONSIDERATION', 128), ('SUPERFICIAL_RELATIONSHIP', 132)]	4	[('UBERON_0002240', 'spinal cord', 11, 'cord'), ('UBERON_0000178', 'blood', 16, 'blood'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 110, 'Vitamin D'), ('UBERON_0002405', 'immune system', 140, 'immune')]
PMC5638722	8/2017	S7-PMC5638722	['conclusion\nthere was no significant relationship between the Cord Blood Vitamin D levels and the RISK of neonatal sepsis in premature infants.']	[('IMPORTANT_CONSIDERATION', 97)]	1	[('UBERON_0002240', 'spinal cord', 61, 'cord'), ('UBERON_0000178', 'blood', 66, 'blood'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5638722	8/2017	S14-PMC5638722	['specifically, Vitamin D and its receptor exhibit KEY anti-inflammatory, Membrane-stabilizing and Antimicrobial properties at barrier sites such as the Gut, Lung and skin.']	[('IMPORTANT_CONSIDERATION', 49)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0016020', 'membrane', 72, 'membrane'), ('CHEBI_65381', 'albizoside C', 97, 'antimicrobial'), ('UBERON_0001555', 'digestive tract', 151, 'gut'), ('UBERON_0002048', 'lung', 156, 'lung')]
PMC5638722	8/2017	S28-PMC5638722	['moreover, there is a preponderance of epidemiological EVIDENCE INDICATING that lower Vitamin D concentrations from Cord Blood CORRELATE with INCREASED susceptibility to infections in newborns11).']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 126), ('IMPORTANT_CONSIDERATION', 141)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0009472', 'axilla', 115, 'cord blood')]
PMC5638722	8/2017	S95-PMC5638722	['cizmeci at al.91011), SIMILARLY, EMPHASIZED that the maternal and Cord Blood Vitamin D levels are significantly low in the babies who have eos.']	[('SUPERFICIAL_RELATIONSHIP', 22), ('IMPORTANT_CONSIDERATION', 33)]	2	[('UBERON_0002240', 'spinal cord', 66, 'cord'), ('UBERON_0000178', 'blood', 71, 'blood'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC5638722	8/2017	S107-PMC5638722	['SEVERE preeclampsia is FOUND TO BE 5.4 fold more in the 15- to 20-week Pregnant who have Vitamin D levels <20 ng/ml19).']	[('IMPORTANT_CONSIDERATION', 0), ('ANOMALY_CURIOUS_FINDING', 23)]	2	[('GO_0007565', 'female pregnancy', 71, 'pregnant'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5640793	9/2017	S44-PMC5640793	["the lancet 's 2013 maternal and child nutrition series RECOMMENDS ten nutrition-specific INTERVENTIONS, including sufficient and diverse Foods for adolescent girls and women; iron, Folic Acid, and Calcium supplementation in Pregnancy; good infant and young child Feeding practices; Vitamin A, iron, and preventive zinc supplementation for children; and treatment for moderate and severe acute malnutrition.5strikingly HOWEVER, expanding the coverage of these nutrition-specific INTERVENTIONS to 90% of mothers and children would only reduce stunting by an ESTIMATED 20%.5larger reductions than these REQUIRE increasing access to family Planning, health services for Pregnant women and children, investments in Water and sanitation, social safety nets, girls' education, and women's empowerment.6a pragmatic approach to design community STRATEGIES for stunting reduction MIGHT THEREFORE be to prioritise action on immediate determinants (infection control, nutrition, and care in the first 1000 days) while providing an enabling social environment for changes in more distal determinants, for example by sharing information about health, nutrition, and sanitation entitlements, and bolstering women's agency."]	[('FUTURE_WORK', 55), ('SUPERFICIAL_RELATIONSHIP', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 418), ('ANOMALY_CURIOUS_FINDING', 418), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 556), ('FUTURE_WORK', 600), ('IMPORTANT_CONSIDERATION', 600), ('FUTURE_WORK', 836), ('INCOMPLETE_EVIDENCE', 870), ('PROBABLE_UNDERSTANDING', 876)]	11	[('CHEBI_33290', 'food', 137, 'foods'), ('CHEBI_30751', 'formic acid', 181, 'folic acid'), ('CHEBI_22313', 'alkaline earth metal atom', 197, 'calcium'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007631', 'feeding behavior', 263, 'feeding'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin A'), ('GO_0006260', 'DNA replication', 636, 'planning'), ('GO_0007565', 'female pregnancy', 666, 'pregnant'), ('CHEBI_15377', 'water', 710, 'water')]
PMC5659607	10/2017	S0-PMC5659607	['Prenatal Vitamin D supplementation reduces RISK of asthma/recurrent wheeze in early childhood: a combined analysis of two randomized controlled trials\n\nabstract\n\nbackground\nwe RECENTLY published two independent randomized controlled trials of Vitamin D supplementation during Pregnancy, both INDICATING a >20% reduced risk of asthma/recurrent wheeze in the offspring by 3 years of age.']	[('IMPORTANT_CONSIDERATION', 43), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 292)]	3	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('GO_0007565', 'female pregnancy', 276, 'pregnancy')]
PMC5659607	10/2017	S113-PMC5659607	['Lower Respiratory Tract infections (lrti) are analyzed by poisson regression model.Vitamin D vs.placeboipdor (95% ci)asthma/ recurrent wheeze0.75 (0.57–0.97)p = 0.03total Ige > median0.93 (0.73–1.18)p = 0.43specific Ige > 0.35ku/l1.05 (0.77–1.43)p = 0.78eczema0.91 (0.71–1.18)p = 0.47lrti0.92 (0.75–1.14)p = 0.44\n\ndiscussion\nin THIS combined analysis of the two largest rcts to date of Vitamin D supplementation during Pregnancy, we SHOWED that the supplementation resulted in a significant and clinically IMPORTANT 26% reduced risk of asthma/recurrent wheeze in the offspring until age 3, with a more pronounced 46% reduced risk if the women had 25(Oh)d level ≥30ng/ml at trial entry.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 328), ('INCOMPLETE_EVIDENCE', 433), ('IMPORTANT_CONSIDERATION', 506)]	3	[('UBERON_0004905', 'articulation', 0, 'Lower respiratory tract'), ('CHEBI_28384', 'vitamin K', 83, 'Vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 171, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 216, 'IgE'), ('CHEBI_27300', 'vitamin D', 386, 'vitamin D'), ('GO_0007565', 'female pregnancy', 419, 'pregnancy'), ('CHEBI_63056', 'zinc cation', 647, '25(OH')]
PMC5659607	10/2017	S114-PMC5659607	['these results UNDERLINE that Vitamin D supplementation during Pregnancy MAY BE an IMPORTANT FACTOR in the PREVENTION of childhood asthma.']	[('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 72), ('IMPORTANT_CONSIDERATION', 82), ('SUPERFICIAL_RELATIONSHIP', 92), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy')]
PMC5659607	10/2017	S118-PMC5659607	['this resulted in more power to detect TRUE EFFECTS of the Vitamin D supplementation than the individual intent-to-treat analyses, illustrated by a similar overall effect estimate in the analyses, which now reached statistical SIGNIFICANCE.']	[('PROBABLE_UNDERSTANDING', 38), ('SUPERFICIAL_RELATIONSHIP', 43), ('IMPORTANT_CONSIDERATION', 226)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5659607	10/2017	S125-PMC5659607	['finally, vdaart included a large group of african-american women in the trial, who are WELL-KNOWN to have a higher RISK of developing asthma and allergy[25] and had lower Vitamin D levels at randomization COMPARED to the OTHER ethnic groups[12].']	[('FUTURE_WORK', 87), ('PROBABLE_UNDERSTANDING', 92), ('IMPORTANT_CONSIDERATION', 115), ('ANOMALY_CURIOUS_FINDING', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	5	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC5659607	10/2017	S135-PMC5659607	['to explore that ISSUE, we performed the combined analyses stratified for the women’s 25(Oh)D level at trial entry, which SHOWED that the Vitamin D supplement resulted in a significantly reduced RISK of asthma/recurrent wheeze in the offspring of women with 25(Oh)D ≥ 30 ng/ml, BUT a much SMALLER and statistically non-significant EFFECT among women with 25(Oh)D < 30 ng/ml.']	[('PROBLEM_COMPLICATION', 16), ('INCOMPLETE_EVIDENCE', 121), ('IMPORTANT_CONSIDERATION', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 277), ('INCOMPLETE_EVIDENCE', 288), ('SUPERFICIAL_RELATIONSHIP', 330)]	6	[('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 257, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 257, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 354, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 354, '25(OH)D')]
PMC5659607	10/2017	S136-PMC5659607	['this FINDING is CONTRARY to what MANY have SUGGESTED that ONLY those who are deficient in Vitamin D would BENEFIT from supplementation.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 58), ('IMPORTANT_CONSIDERATION', 106)]	6	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC5659607	10/2017	S142-PMC5659607	['our combined analysis also SUGGESTS that we MAY have used an INSUFFICIENT dosage of Vitamin D in both the trials.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 44), ('IMPORTANT_CONSIDERATION', 61), ('PROBLEM_COMPLICATION', 61)]	4	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC5659607	10/2017	S152-PMC5659607	['FUTURE STUDIES SHOULD explore the OPTIMAL timing and level of Vitamin D supplementation during Pregnancy.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 15), ('IMPORTANT_CONSIDERATION', 34)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy')]
PMC5659607	10/2017	S153-PMC5659607	['conclusion\nthis combined analysis SHOWS a significant and clinically IMPORTANT 26% PROTECTIVE EFFECT of Vitamin D supplementation during Pregnancy on the RISK of asthma/recurrent wheeze in the offspring, with a more pronounced risk reduction of 46% in women with 25(Oh)D level ≥ 30 ng/ml at trial entry.']	[('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 69), ('SUPERFICIAL_RELATIONSHIP', 83), ('SUPERFICIAL_RELATIONSHIP', 94), ('IMPORTANT_CONSIDERATION', 154)]	5	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 263, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 263, '25(OH)D')]
PMC5664622	9/2017	S6-PMC5664622	['THEREFORE, summer improves the levels of Vitamin D in the body but does not guarantee the RECOMMENDED concentration and supplementation throughout the whole year is ESSENTIAL.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 90), ('IMPORTANT_CONSIDERATION', 165)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5664622	9/2017	S8-PMC5664622	['introduction\nthe last decade has witnessed a steady stream of REPORTS from all over the world about Vitamin D INSUFFICIENCY in the general population, EVEN in regions with high year-round sun exposure (the so-CALLED “mediterranean paradox”) [1,2].']	[('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 110), ('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 208)]	4	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5664622	9/2017	S9-PMC5664622	['the FIRST REPORTS on Vitamin D insufficiency appeared in the 80s of the previous century but it was not until recently that the PROBLEM gained significant ATTENTION DUE TO the GROWING TENDENCY to stay indoors, avoid sun exposure, and use of sunscreen [2,3].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 10), ('IMPORTANT_CONSIDERATION', 128), ('INCOMPLETE_EVIDENCE', 155), ('PROBLEM_COMPLICATION', 165), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 184)]	7	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5664622	9/2017	S13-PMC5664622	['IN LIGHT OF the ONGOING DEBATE on the OPTIMAL Vitamin D concentration in Pregnant women, MOST EXPERTS are of the OPINION that the 25(Oh)D concentration in maternal Blood SHOULD exceed 30 ng/ml [2,8,9].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('IMPORTANT_CONSIDERATION', 38), ('PROBABLE_UNDERSTANDING', 89), ('PROBABLE_UNDERSTANDING', 94), ('INCOMPLETE_EVIDENCE', 113), ('FUTURE_WORK', 170), ('IMPORTANT_CONSIDERATION', 170)]	9	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC5664622	9/2017	S14-PMC5664622	['HOWEVER, OTHER authors CLAIM that maternal concentration that fully normalizes Vitamin D Metabolism and Calcium Homeostasis is AT LEAST 40 ng/ml [10], and still others that >20 ng/ml is NECESSARY to prevent Vitamin D deficiency in the newborn [11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 127), ('IMPORTANT_CONSIDERATION', 186)]	5	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 79, 'vitamin D metabolism'), ('GO_0055073', 'cadmium ion homeostasis', 104, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5664622	9/2017	S16-PMC5664622	['in CONSEQUENCE, season of the year, geographic location and lifestyle have become the KEY FACTORS as far as sources of Vitamin D are concerned.']	[('PROBABLE_UNDERSTANDING', 3), ('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 90)]	3	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC5664622	9/2017	S63-PMC5664622	['all neonates with Cord Blood Vitamin D deficiency were Born to mothers with <15.3 ng/ml Venous Blood concentration, WHILE 67 (93%) infants with OPTIMAL levels of Vitamin D were Born to mothers with ≥15.3 ng/ml Venous Blood concentration of that Vitamin, INDICATING that the sensitivity and specificity of the predicted normal Cord Blood levels were 93% and 100%, respectively at the maternal concentration of ≥15.3 ng/ml.']	[('ANOMALY_CURIOUS_FINDING', 116), ('IMPORTANT_CONSIDERATION', 144), ('INCOMPLETE_EVIDENCE', 254)]	3	[('UBERON_0002240', 'spinal cord', 18, 'cord'), ('UBERON_0000178', 'blood', 23, 'blood'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007567', 'parturition', 55, 'born'), ('UBERON_0001638', 'vein', 88, 'venous'), ('UBERON_0000178', 'blood', 95, 'blood'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007567', 'parturition', 177, 'born'), ('UBERON_0001638', 'vein', 210, 'venous'), ('UBERON_0000178', 'blood', 217, 'blood'), ('CHEBI_33229', 'vitamin (role)', 245, 'vitamin'), ('UBERON_0002240', 'spinal cord', 326, 'cord'), ('UBERON_0000178', 'blood', 331, 'blood')]
PMC5664622	9/2017	S92-PMC5664622	['a study conducted in belgium FOUND that Pregnant women who avoid sun exposure are at a 2-fold higher RISK for severe Vitamin D deficiency [25].']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 101)]	2	[('GO_0007565', 'female pregnancy', 40, 'pregnant'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5664622	9/2017	S93-PMC5664622	['DUE TO the fact that weather conditions, including the increasingly common heat waves which prevent exposure to sun, remain beyond Human control, supplementation SEEMS TO BE the BEST method of preventing Vitamin D insufficiency.']	[('PROBLEM_COMPLICATION', 0), ('ANOMALY_CURIOUS_FINDING', 162), ('IMPORTANT_CONSIDERATION', 178)]	3	[('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC5664622	9/2017	S95-PMC5664622	['small doses of Vitamin D do not meet the REQUIREMENTS of the body, and remain ineffective as preventive measures [23,26,27,28].']	[('IMPORTANT_CONSIDERATION', 41)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC5664622	9/2017	S98-PMC5664622	['the PROBLEM of low doses of Vitamin D in preparations for Pregnant women APPEARS TO BE GLOBAL.']	[('IMPORTANT_CONSIDERATION', 4), ('PROBLEM_COMPLICATION', 4), ('ANOMALY_CURIOUS_FINDING', 73), ('IMPORTANT_CONSIDERATION', 87)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnant')]
PMC5664622	9/2017	S107-PMC5664622	['in OUR STUDY, we FOUND that maternal Vitamin D concentration of >15.3 ng/ml, i.e., half the recommended dose, would be sufficient to meet the DEMANDS of the developing fetus.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 142)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5664622	9/2017	S109-PMC5664622	['DECLARED that maternal Vitamin D concentration which is NECESSARY for the fetus OUGHT to be >20 ng/ml [11].']	[('IMPORTANT_CONSIDERATION', 0), ('IMPORTANT_CONSIDERATION', 0), ('IMPORTANT_CONSIDERATION', 56), ('IMPORTANT_CONSIDERATION', 80)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC5664622	9/2017	S110-PMC5664622	['in OUR STUDY, we CONFIRMED DETRIMENTAL EFFECTS of excessive weight gain in Pregnancy which results in diminished Vitamin D concentration.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 27), ('SUPERFICIAL_RELATIONSHIP', 39)]	4	[('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC5664622	9/2017	S118-PMC5664622	['it SEEMS that the ESTIMATED Vitamin D consumption is a RELIABLE result AS it is CONSISTENT with OTHER REPORTS, which for years have INDICATED a consistently low amount of Vitamin D in the diet of polish Pregnant women (2.6–2.8 µg/day) [13,35].']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 55), ('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 132)]	8	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnant')]
PMC5664622	9/2017	S126-PMC5664622	['it is CONSISTENT with the national studies, on a representative sample, which have determined the EFFECT of the geographic latitude on Serum Vitamin D concentration to be of minimal IMPORTANCE [37].']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 98), ('IMPORTANT_CONSIDERATION', 182)]	3	[('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5664622	9/2017	S129-PMC5664622	['also, it is VITAL TO BEAR IN MIND that in OUR STUDY the analysis of Vitamin D level was conducted on the day of the Delivery, which does not signify that the concentration was typical for the entire course of Pregnancy or at least its significant part.']	[('IMPORTANT_CONSIDERATION', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 42)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007567', 'parturition', 116, 'delivery'), ('GO_0007565', 'female pregnancy', 209, 'pregnancy')]
PMC5664622	9/2017	S132-PMC5664622	['conclusions\nON THE BASIS OF the FINDINGS of OUR STUDY, conducted among polish Pregnant women, it SEEMS SAFE to conclude that significantly low levels of Vitamin D concentration among Pregnant women in poland MAY in FACT be a common occurrence.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('ANOMALY_CURIOUS_FINDING', 97), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 208), ('ANOMALY_CURIOUS_FINDING', 215)]	7	[('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'pregnant')]
PMC5664622	9/2017	S133-PMC5664622	['during the summer season, EVEN DESPITE visible improvement, a large group of women STILL REMAINS AT RISK for Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 26), ('ANOMALY_CURIOUS_FINDING', 31), ('ANOMALY_CURIOUS_FINDING', 83), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 97)]	6	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC5679631	11/2017	S15-PMC5679631	['given that Intestinal Microbiotic Homeostasis MAY BE an IMPORTANT FACTOR in the PREVENTION of Immune mediated diseases and that Vitamin D status is a MODIFIABLE FACTOR, FURTHER INVESTIGATION of the IMPACT of Postnatal Vitamin D supplementation SHOULD BE conducted in older infants.']	[('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 80), ('IMPORTANT_CONSIDERATION', 150), ('SUPERFICIAL_RELATIONSHIP', 161), ('FUTURE_WORK', 169), ('SUPERFICIAL_RELATIONSHIP', 198), ('FUTURE_WORK', 244)]	9	[('UBERON_0000160', 'intestine', 11, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 22, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 22, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 94, 'immune'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007567', 'parturition', 208, 'postnatal'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC5679631	11/2017	S26-PMC5679631	['GIVEN that Vitamin D status is a MODIFIABLE FACTOR which MAY INFLUENCE Intestinal Microbiotic Homeostasis, which in turn is INDICATED to be IMPORTANT in the prevention of Immune mediated diseases, we INVESTIGATED WHETHER maternal use of multivitamin supplements containing Vitamin D, maternal Vitamin D status (25 Hydroxyvitamin D (25(Oh)D), OR administration of Vitamin D supplement to the baby INFLUENCES the presence and abundance of several key bacterial taxa of the infant Gut microbiota.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 140), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 342), ('SUPERFICIAL_RELATIONSHIP', 396)]	11	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000160', 'intestine', 71, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 82, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 82, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 171, 'immune'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 311, '25 hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 332, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 478, 'gut')]
PMC5679631	11/2017	S128-PMC5679631	['a state of Vitamin D deficiency resulting in a pro-inflammatory state and INCREASED susceptibility to Intestinal infections, THEREFORE, MAY lead to altered microbial colonization known as Dysbiosis or disturbance of the balance between beneficial commensal and pathogenic species [24].']	[('IMPORTANT_CONSIDERATION', 74), ('PROBABLE_UNDERSTANDING', 125), ('INCOMPLETE_EVIDENCE', 136)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000160', 'intestine', 102, 'intestinal'), ('GO_0046067', 'dGDP catabolic process', 188, 'dysbiosis')]
PMC5679631	11/2017	S142-PMC5679631	['g ., health ISSUES leading to the choice of an alternative lifestyle, COULD BE modifying the EFFECT of Vitamin D on the Intestinal bacteria and, THEREFORE, recruitment group was adjusted for in the multivariable analyses.']	[('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 93), ('PROBABLE_UNDERSTANDING', 145)]	4	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0000160', 'intestine', 120, 'intestinal')]
PMC5679631	11/2017	S159-PMC5679631	['TO OUR KNOWLEDGE, THIS is the FIRST report of a large scale observational study INDICATING that Prenatal Vitamin D exposure, AS measured either by maternal use of multivitamin supplements containing Vitamin D, or 25(Oh)D quintiles, INFLUENCES several IMPORTANT bacterial taxa within the infant Gut.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 80), ('PROBABLE_UNDERSTANDING', 125), ('SUPERFICIAL_RELATIONSHIP', 232), ('IMPORTANT_CONSIDERATION', 251)]	7	[('GO_0007565', 'female pregnancy', 96, 'prenatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D'), ('UBERON_0001555', 'digestive tract', 294, 'gut')]
PMC5679631	11/2017	S161-PMC5679631	['the INFLUENCE of Postnatal Vitamin D supplementation MERITS to BE analyzed in a larger group of older infants and with extensive microbial profiling approach.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FUTURE_WORK', 53), ('IMPORTANT_CONSIDERATION', 53), ('ANOMALY_CURIOUS_FINDING', 63)]	4	[('GO_0007567', 'parturition', 17, 'postnatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC5682869	11/2017	S24-PMC5682869	['supplementation of Vitamin A is SUGGESTED to be restricted only to areas where Vitamin A deficiency is a substantial PUBLIC HEALTH PROBLEM.']	[('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 117), ('IMPORTANT_CONSIDERATION', 131), ('PROBLEM_COMPLICATION', 131)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A')]
PMC5685050	10/2014	S0-PMC5685050	['vitamin D deficiency in thailand☆\nvitamin D deficiency has received INCREASED ATTENTION over the past several years since Vitamin D MAY play an IMPORTANT ROLE not ONLY in bone Metabolism but also in a variety of non-Skeletal diseases such as diabetes mellitus, Autoimmune diseases, infectious diseases, Cardiovascular diseases and cancer1,2,3.']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 132), ('IMPORTANT_CONSIDERATION', 144), ('SUPERFICIAL_RELATIONSHIP', 154), ('INCOMPLETE_EVIDENCE', 163)]	5	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 8, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 42, 'D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0008152', 'metabolic process', 176, 'metabolism'), ('UBERON_0004288', 'skeleton', 216, 'skeletal'), ('UBERON_0001442', 'skeleton of manus', 261, 'autoimmune'), ('UBERON_0004535', 'cardiovascular system', 303, 'cardiovascular')]
PMC5685050	10/2014	S7-PMC5685050	["latitude is an IMPORTANT determinant of Vitamin D status since the amount of uvb that penetrates the earth's surface decreases markedly with increasing latitude[8]."]	[('IMPORTANT_CONSIDERATION', 15)]	1	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC5685050	10/2014	S49-PMC5685050	['the relatively high prevalence of Vitamin D insufficiency MAY have IMPORTANT health IMPLICATIONS for thai People as the science of Vitamin D continues to be UNRAVELED.']	[('INCOMPLETE_EVIDENCE', 58), ('IMPORTANT_CONSIDERATION', 67), ('IMPORTANT_CONSIDERATION', 84), ('INCOMPLETE_EVIDENCE', 157)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 106, 'people'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5706533	11/2017	S18-PMC5706533	['beyond its established INFLUENCE on bone growth and Calcium Homeostasis,1vitamin D and its RELATED Metabolites have HYPOTHESISED EFFECTS on the risk of Cardiovascular diseases,2cancer,3respiratory infections,4asthma,5conditions RELATED to Pregnancy (such as pre-eclampsia, Gestational diabetes), and Birth outcomes.6concern that Vitamin D deficiency is a global PUBLIC HEALTH PROBLEM HAS BEEN sparked by numerous REPORTS of the high proportion of Individuals in studies throughout the world who have relatively low Serum/Plasma concentrations of 25-hydroxyvitamin d (25(Oh)D),7the conventional circulating BIOMARKER of Vitamin D status.8there HAS BEEN particular ATTENTION to the high prevalence of vitamin d deficiency in Pregnant women and newborns.7\nin 2010, dietary reference intakes for Vitamin D for canada and the us from the institute of medicine were based solely on bone health—particularly in young children (for instance, rickets) and older Adults (for instance, osteoporosis).1considerable SKEPTICISM was cast onto the LINK between Vitamin D and Extraskeletal health conditions or the POTENTIAL benefits (versus risks) of intakes larger than the recommended dietary allowance (600 iu/day for MOST children and Adults).1THE institute’s report DID NOT RECOMMEND higher intakes during Pregnancy and Lactation.1a 2016 update of the cochrane collaboration systematic review and meta-analysis of trials of Vitamin D in Pregnancy (versus placebo or no Supplement), HOWEVER, TENTATIVELY CONCLUDED that Prenatal Vitamin D supplementation “MAY reduce the risk of pre-eclampsia, low birthweight and Preterm Birth.”6other RECENT systematic reviews that included trials with active control arms (in which participants received Vitamin D) ACKNOWLEDGED the POTENTIAL EFFECT of Vitamin D on fetal growth910but DID NOT FIND evidence of EFFECTS on OTHER maternal, fetal, or infant outcomes.91011citing the 2016 cochrane review,6the world health organization guidelines for Antenatal care ADVISE against routine Vitamin D supplementation in Pregnancy.12dietary and supplementation RECOMMENDATIONS, HOWEVER, vary widely across other professional organisations (appendix 1), and there REMAINS a LACK OF CONSENSUS on target health outcomes, indications for Prenatal supplementation, or EVIDENCE BASED regimens for supplement dose (or fortification STRATEGIES).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 129), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 362), ('IMPORTANT_CONSIDERATION', 376), ('PROBLEM_COMPLICATION', 376), ('INCOMPLETE_EVIDENCE', 384), ('INCOMPLETE_EVIDENCE', 413), ('SUPERFICIAL_RELATIONSHIP', 606), ('INCOMPLETE_EVIDENCE', 643), ('IMPORTANT_CONSIDERATION', 663), ('INCOMPLETE_EVIDENCE', 663), ('IMPORTANT_CONSIDERATION', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1098), ('PROBABLE_UNDERSTANDING', 1205), ('INCOMPLETE_EVIDENCE', 1231), ('INCOMPLETE_EVIDENCE', 1255), ('FUTURE_WORK', 1263), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1471), ('INCOMPLETE_EVIDENCE', 1480), ('INCOMPLETE_EVIDENCE', 1492), ('INCOMPLETE_EVIDENCE', 1543), ('INCOMPLETE_EVIDENCE', 1623), ('INCOMPLETE_EVIDENCE', 1738), ('PROBABLE_UNDERSTANDING', 1738), ('INCOMPLETE_EVIDENCE', 1755), ('SUPERFICIAL_RELATIONSHIP', 1765), ('INCOMPLETE_EVIDENCE', 1807), ('SUPERFICIAL_RELATIONSHIP', 1832), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1843), ('FUTURE_WORK', 1983), ('FUTURE_WORK', 2075), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2092), ('ANOMALY_CURIOUS_FINDING', 2092), ('INCOMPLETE_EVIDENCE', 2177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2187), ('INCOMPLETE_EVIDENCE', 2187), ('INCOMPLETE_EVIDENCE', 2277), ('FUTURE_WORK', 2339)]	42	[('GO_0055073', 'cadmium ion homeostasis', 52, 'calcium homeostasis'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 81, 'D'), ('CHEBI_25212', 'metabolite', 99, 'metabolites'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'gestational'), ('GO_0007567', 'parturition', 300, 'birth'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('NCBITaxon_1', 'root', 447, 'individuals'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('UBERON_0001969', 'blood plasma', 521, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 619, 'vitamin D'), ('GO_0007565', 'female pregnancy', 723, 'pregnant'), ('CHEBI_27300', 'vitamin D', 792, 'vitamin D'), ('UBERON_0007023', 'adult organism', 953, 'adults'), ('CHEBI_27300', 'vitamin D', 1045, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 1059, 'extraskeletal'), ('UBERON_0007023', 'adult organism', 1223, 'adults'), ('GO_0007565', 'female pregnancy', 1295, 'pregnancy'), ('GO_0007595', 'lactation', 1309, 'lactation'), ('CHEBI_27300', 'vitamin D', 1413, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1426, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 1458, 'supplement'), ('GO_0007565', 'female pregnancy', 1507, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1516, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1601, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 1727, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1775, 'vitamin D'), ('GO_0007567', 'parturition', 1968, 'antenatal'), ('CHEBI_27300', 'vitamin D', 2006, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2035, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2248, 'prenatal')]
PMC5706533	11/2017	S20-PMC5706533	['we SPECIFICALLY AIMED to estimate the EFFECTS of Vitamin D supplementation during Pregnancy on maternal, neonatal, and infant outcomes, taking into consideration the quality of AVAILABLE evidence and heterogeneity across studies; determine frequencies at which relevant outcome variable data were missing, unreported, or inconsistently reported among trials that were otherwise eligible for inclusion; and IDENTIFY ONGOING or PLANNED STUDIES of Vitamin D supplementation during Pregnancy to project the state of EVIDENCE that COULD accrue in the next decade.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 177), ('FUTURE_WORK', 406), ('IMPORTANT_CONSIDERATION', 415), ('FUTURE_WORK', 426), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 512), ('INCOMPLETE_EVIDENCE', 526)]	10	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0007565', 'female pregnancy', 478, 'pregnancy')]
PMC5706533	11/2017	S107-PMC5706533	['biochemical safety outcomes (hypercalcaemia, hypercalciuria, hypocalcaemia) were RARE; ONLY four trials met our minimum criteria for case definitions and methods of ascertainment based on routine monitoring of maternal Serum calcium (table 2; tables s9-s11in appendix 10), YET ignoring the these criteria did not change the inference that there was no significant EFFECT of Vitamin D supplementation on the RISK of hypercalcaemia, which is a primary INDICATOR of toxicity of Vitamin D supplementation (table s9 and fig s18 in Appendix 10).']	[('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 87), ('ANOMALY_CURIOUS_FINDING', 273), ('SUPERFICIAL_RELATIONSHIP', 364), ('IMPORTANT_CONSIDERATION', 407), ('SUPERFICIAL_RELATIONSHIP', 450)]	6	[('UBERON_0001977', 'blood serum', 219, 'serum'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin D'), ('UBERON_0001154', 'vermiform appendix', 526, 'appendix')]
PMC5706533	11/2017	S121-PMC5706533	['the pooled estimate from two high quality regular dose trials in high income countries (total 1387 participants) INDICATED that Prenatal Vitamin D supplementation significantly decreased the RISK of persistent/recurrent wheeze in offspring by age 3 years (table 2; fig s51 in appendix 10).']	[('INCOMPLETE_EVIDENCE', 113), ('IMPORTANT_CONSIDERATION', 191)]	2	[('GO_0007565', 'female pregnancy', 128, 'prenatal'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC5706533	11/2017	S145-PMC5706533	['discussion\nthough trials of Prenatal Vitamin D supplementation are being published at an ACCELERATING pace, randomised controlled trials published up to 2017 were GENERALLY SMALL, low quality, and RARELY designed to examine clinical outcomes.']	[('IMPORTANT_CONSIDERATION', 89), ('PROBABLE_UNDERSTANDING', 163), ('INCOMPLETE_EVIDENCE', 173), ('INCOMPLETE_EVIDENCE', 197)]	4	[('GO_0007565', 'female pregnancy', 28, 'prenatal'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5706533	11/2017	S157-PMC5706533	['one of the most ROBUST FINDINGS in our systematic review—which has been PREVIOUSLY REPORTED32—was the beneficial EFFECT of Prenatal Vitamin D on RISK of persistent/recurrent wheeze (or asthma) in offspring, BASED ON data from two large well conducted trials in which wheeze/asthma was the primary outcome.3334this is broadly CONSISTENT with the POSSIBLY positive EFFECT of Vitamin D on severity of illness in Adults with asthma.5before Prenatal Vitamin D CAN be RECOMMENDED as a routine preventive measure against childhood asthma, HOWEVER, FURTHER WORK IS REQUIRED to CLARIFY the minimum effective dose and longer term follow-up to determine IF OBSERVED early EFFECTS on symptoms TRANSLATE into reductions in the incidence of asthma and improvements in Pulmonary function.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 113), ('IMPORTANT_CONSIDERATION', 145), ('INCOMPLETE_EVIDENCE', 207), ('ANOMALY_CURIOUS_FINDING', 213), ('INCOMPLETE_EVIDENCE', 325), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 363), ('INCOMPLETE_EVIDENCE', 455), ('FUTURE_WORK', 462), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 532), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 557), ('FUTURE_WORK', 569), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('INCOMPLETE_EVIDENCE', 646), ('SUPERFICIAL_RELATIONSHIP', 661), ('SUPERFICIAL_RELATIONSHIP', 681)]	21	[('GO_0007565', 'female pregnancy', 123, 'prenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('UBERON_0007023', 'adult organism', 409, 'adults'), ('GO_0007565', 'female pregnancy', 436, 'prenatal'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('UBERON_0002048', 'lung', 754, 'pulmonary')]
PMC5706533	11/2017	S160-PMC5706533	['populations without Vitamin D deficiency MIGHT have little to gain from any dose, BUT deficient populations MIGHT require relatively high doses to raise Vitamin D status to an optimal range ASSOCIATED with clinical BENEFITS.35in this FRAMEWORK, the DISTINCTION between placebo versus active control trials is ONLY INFORMATIVE insofar as an active control dose increases the baseline status to which the intervention dose is compared (as such, we considered a “modified” baseline status to be reflected by the mean 25(Oh)d at Delivery in the control group).']	[('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 190), ('IMPORTANT_CONSIDERATION', 215), ('INCOMPLETE_EVIDENCE', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('INCOMPLETE_EVIDENCE', 309), ('INCOMPLETE_EVIDENCE', 314)]	9	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 514, '25(OH)'), ('GO_0007567', 'parturition', 525, 'delivery')]
PMC5706533	11/2017	S167-PMC5706533	['for example, for the EFFECT of Vitamin D on pre-eclampsia, de-regil and colleagues REPORTED a pooled risk ratio of 0.52 (95% confidence interval 0.25 to 1.05) based on two trials that we included in our review, but neither of which met our minimum criteria for case definitions and methods of ascertainment: one trial ONLY mentioned the exclusion of a participant for “severe pre-eclampsia,”38AND the other REPORTED frequencies of pre-eclampsia but DID NOT mention any screening or diagnostic procedures.39de-regil and colleagues also REPORTED that Vitamin D reduced the RISK of Preterm Birth based on thee trials,6but the current meta-analysis based on 15 comparisons produced REASONABLY strong evidence of a null effect.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 318), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 391), ('INCOMPLETE_EVIDENCE', 407), ('INCOMPLETE_EVIDENCE', 449), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 571), ('PROBABLE_UNDERSTANDING', 678)]	9	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 549, 'vitamin D'), ('GO_0007565', 'female pregnancy', 579, 'preterm birth')]
PMC5706533	11/2017	S176-PMC5706533	['in the meantime, we ENDORSE the NOTION that WHENEVER feasible, investigators SHOULD report all clinically IMPORTANT outcomes, EVEN in SMALL trials that are individually UNDERPOWERED to detect EFFECTS on such outcomes.45\njohn ioannidis RECENTLY REMARKED that “systematic reviews MAY SOMETIMES be most helpful IF, INSTEAD of focusing on the summary of the evidence, HIGHLIGHT the BIASES that are INVOLVED and what NEEDS to be done to remedy the state-of-the-EVIDENCE in the given field.”46we conclude that there is currently INSUFFICIENT EVIDENCE to guide RECOMMENDATIONS for Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('FUTURE_WORK', 77), ('IMPORTANT_CONSIDERATION', 106), ('ANOMALY_CURIOUS_FINDING', 126), ('INCOMPLETE_EVIDENCE', 134), ('PROBLEM_COMPLICATION', 169), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 235), ('ANOMALY_CURIOUS_FINDING', 244), ('ANOMALY_CURIOUS_FINDING', 244), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 282), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 312), ('INCOMPLETE_EVIDENCE', 364), ('PROBLEM_COMPLICATION', 378), ('SUPERFICIAL_RELATIONSHIP', 394), ('FUTURE_WORK', 412), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 523), ('FUTURE_WORK', 554)]	23	[('GO_0007565', 'female pregnancy', 574, 'prenatal'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D')]
PMC5706533	11/2017	S177-PMC5706533	['cautious PROJECTIONS for the next decade SUGGEST that we will eventually know more about Vitamin D in Pregnancy THAN we do now, BUT in the absence of a coordinated effort and funding to conduct large new trials, SOME of the most CRITICAL QUESTIONS about the effectiveness of Prenatal Vitamin D supplementation will PROBABLY REMAIN unanswered in the foreseeable FUTURE.']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 229), ('EXPLICIT_QUESTION', 238), ('PROBABLE_UNDERSTANDING', 315), ('INCOMPLETE_EVIDENCE', 324), ('FUTURE_WORK', 361)]	11	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('GO_0007565', 'female pregnancy', 275, 'prenatal'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC5706533	11/2017	S178-PMC5706533	['what is already known on THIS topic\nnumerous randomised trials and systematic reviews of Vitamin D supplementation during Pregnancy HAVE BEEN published, with CONFLICTING results and conclusions\nrecommendations regarding Vitamin D supplementation vary widely among medical and professional organisations, and who currently RECOMMENDS against routine Prenatal Vitamin D supplementation\n\nwhat THIS STUDY adds\nsystematic review and meta-analyses of 43 trials including 8406 participants SHOWED that Prenatal Vitamin D supplementation was ASSOCIATED with increased maternal and cord Serum 25-Hydroxyvitamin D concentrations, increased mean birth weight, reduced the risk of small for Gestational age, reduced the risk of wheeze in offspring, and increased infant length at one year of age\nthere was a LACK OF EVIDENCE OF benefits of Prenatal Vitamin D supplementation for maternal health conditions RELATED to Pregnancy, no effect on other Birth outcomes of PUBLIC HEALTH IMPORTANCE such as Preterm Birth, and SCANT EVIDENCE on safety outcomes\nFEW of the trials were designed to test the EFFECT of Vitamin D on clinical or functional outcomes, and most trials were SMALL and at overall high or UNCERTAIN risk of bias\nthirty five planned or ongoing Prenatal Vitamin D trials COULD contribute an additional 12\u2009530 participants to FUTURE systematic reviews\n\npubmed central:']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('FUTURE_WORK', 322), ('QUESTION_ANSWERED_BY_THIS_WORK', 390), ('INCOMPLETE_EVIDENCE', 483), ('SUPERFICIAL_RELATIONSHIP', 534), ('INCOMPLETE_EVIDENCE', 796), ('SUPERFICIAL_RELATIONSHIP', 894), ('IMPORTANT_CONSIDERATION', 953), ('IMPORTANT_CONSIDERATION', 967), ('INCOMPLETE_EVIDENCE', 1005), ('INCOMPLETE_EVIDENCE', 1039), ('SUPERFICIAL_RELATIONSHIP', 1083), ('INCOMPLETE_EVIDENCE', 1160), ('FULL_UNKNOWN', 1189), ('INCOMPLETE_EVIDENCE', 1269), ('FUTURE_WORK', 1323)]	18	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 228, 'D'), ('GO_0007565', 'female pregnancy', 349, 'prenatal'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0007565', 'female pregnancy', 495, 'prenatal'), ('CHEBI_27300', 'vitamin D', 504, 'vitamin D'), ('UBERON_0001977', 'blood serum', 578, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 584, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 679, 'gestational'), ('GO_0007565', 'female pregnancy', 828, 'prenatal'), ('CHEBI_27300', 'vitamin D', 837, 'vitamin D'), ('GO_0007565', 'female pregnancy', 905, 'pregnancy'), ('GO_0007567', 'parturition', 935, 'birth'), ('GO_0007565', 'female pregnancy', 986, 'preterm'), ('GO_0007567', 'parturition', 994, 'birth'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1243, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1252, 'vitamin D')]
PMC5707701	11/2017	S15-PMC5707701	['Vitamin A and Vitamin E are REQUIRED in many ESSENTIAL Metabolic functions for the growing infant [7,8].']	[('IMPORTANT_CONSIDERATION', 28), ('IMPORTANT_CONSIDERATION', 45)]	2	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin A'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin E'), ('GO_0008152', 'metabolic process', 55, 'metabolic')]
PMC5707701	11/2017	S165-PMC5707701	['OUR FINDINGS SUGGESTED that only Colostrum reached an ai proposal for the infant aged less than six months; therefore, the implementation of procedures to increase Vitamin E concentrations in milk would be IMPORTANT.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 206)]	3	[('UBERON_0001914', 'colostrum', 33, 'colostrum'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin E')]
PMC5707701	11/2017	S187-PMC5707701	['indeed, our results SHOWED that all of these milks, except for colostrum, did not meet an infant’s nutritional REQUIREMENT of Vitamin E. HOWEVER, we COULD NOT ESTIMATE the POSSIBLE supply of Vitamin A to the infant in the present study, DUE TO the LACKING detection of Retinol in Human milk.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('DIFFICULT_TASK', 149), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 172), ('PROBLEM_COMPLICATION', 237), ('FULL_UNKNOWN', 248)]	8	[('CHEBI_27300', 'vitamin D', 126, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 269, 'retinol'), ('NCBITaxon_9606', 'Homo sapiens', 280, 'human')]
PMC5716389	9/2017	S31-PMC5716389	['Micronutrients\nseveral Micronutrients (Minerals or Vitamins) are KNOWN to be IMPORTANT in Fetal Immune System Development and child Immune Response to vaccines.table 1summarizes findings relevant to Immune functioning (zinc, Vitamin A, d, Folate, Iodine and Iron).']	[('INCOMPLETE_EVIDENCE', 65), ('IMPORTANT_CONSIDERATION', 77)]	2	[('CHEBI_34850', 'milrinone lactate', 0, 'Micronutrients'), ('CHEBI_33839', 'macromolecule', 23, 'micronutrients'), ('CHEBI_46751', 'quinolizidine', 39, 'minerals'), ('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('UBERON_0000922', 'embryo', 90, 'fetal'), ('GO_0002520', 'immune system development', 96, 'immune system development'), ('UBERON_0002405', 'immune system', 96, 'immune system'), ('GO_0006955', 'immune response', 132, 'immune response'), ('UBERON_0002405', 'immune system', 132, 'immune'), ('UBERON_0002405', 'immune system', 199, 'immune'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 239, 'folate'), ('CHEBI_24859', 'iodine atom', 247, 'iodine'), ('CHEBI_24870', 'ion', 258, 'iron')]
PMC5732382	12/2017	S22-PMC5732382	['Pregnant women are among the MOST VULNERABLE, with a high risk of iron deficiency (60% among Pregnant woman) and Vitamin A deficiency (39%) [7].']	[('IMPORTANT_CONSIDERATION', 29), ('IMPORTANT_CONSIDERATION', 34)]	2	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('GO_0007565', 'female pregnancy', 93, 'pregnant'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin A')]
PMC5732505	12/2017	S15-PMC5732505	['a sufficient maternal Vitamin D status, specified AS 25(Oh)D above 50\xa0nmol/l, MAY BE a threshold above which the physiological REQUIREMENTS of Pregnancy are achieved.']	[('PROBABLE_UNDERSTANDING', 50), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 127)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 53, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 59, 'D'), ('GO_0007565', 'female pregnancy', 143, 'pregnancy')]
PMC5732505	12/2017	S26-PMC5732505	['POOR maternal Vitamin D status HAS BEEN RELATED to fetal growth restriction [15] BUT it is UNKNOWN WHETHER maternal Vitamin D status ASSOCIATES with Birth size in infants with normal Birth weight.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 81), ('FULL_UNKNOWN', 91), ('EXPLICIT_QUESTION', 99), ('SUPERFICIAL_RELATIONSHIP', 133)]	7	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 149, 'birth'), ('GO_0007567', 'parturition', 183, 'birth')]
PMC5732505	12/2017	S28-PMC5732505	['case-control STUDIES OFTEN focus on HIGH-RISK groups, for example women who are overweight and sedentary, which are INDEPENDENT RISK FACTORS for Vitamin D deficiency as well (for example [16]).']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 21), ('IMPORTANT_CONSIDERATION', 36), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 128)]	5	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5732505	12/2017	S117-PMC5732505	['the PREVALENCE of Vitamin D deficiency [25(Oh)D\u2009<\u200950\xa0nmol/l] during Pregnancy was SIMILAR between mothers with or without gdm [4.9% (4/81) vs 3.3% (21/642), p \u2009=\u20090.51].']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 46, 'D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy')]
PMC5732505	12/2017	S138-PMC5732505	['(2016) CONCLUDED in their meta-analysis that maternal Vitamin D insufficiency (< 50\xa0nmol/l or <75\xa0nmol/l) was ASSOCIATED with greater RISK of gdm [6].']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 110), ('IMPORTANT_CONSIDERATION', 134)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5732505	12/2017	S141-PMC5732505	['HOWEVER, we OBSERVED that Vitamin D deficiency at Delivery was more PREVALENT in mothers with gdm compared with non-gdm mothers, BUT this was not marked during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 68), ('ANOMALY_CURIOUS_FINDING', 129)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 50, 'delivery'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy')]
PMC5732505	12/2017	S148-PMC5732505	['furthermore, SOME of these FACTORS are RELATED to or CO-EXIST with POOR Vitamin D status [24,25], which further increases the CHALLENGE when dissecting INDEPENDENT EFFECT.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 67), ('DIFFICULT_TASK', 126), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 164)]	8	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5732505	12/2017	S151-PMC5732505	['ALTHOUGH a biological mechanism between low Vitamin D status and diabetes is PLAUSIBLE [29], ONLY a FEW INTERVENTIONS have been conducted, and these HAVE NOT proved an EFFECT of Vitamin D supplementation on RISK of gdm [30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 149), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 207)]	8	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC5732505	12/2017	S155-PMC5732505	['SOME earlier STUDIES HAVE SHOWN that SEVERE maternal Vitamin D deficiency ASSOCIATES with smaller Head circumference at Birth [32,33], YET SOME HAVE NOT [34,35].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 37), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 144)]	7	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0000033', 'head', 98, 'head'), ('GO_0007567', 'parturition', 120, 'birth')]
PMC5732505	12/2017	S157-PMC5732505	['HOWEVER, the clinical RELEVANCE, if any, of the inverse RELATIONSHIP between maternal Vitamin D status and Head circumference at Birth REMAINS UNEXPLAINED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 143)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000033', 'head', 107, 'head'), ('GO_0007567', 'parturition', 129, 'birth')]
PMC5732505	12/2017	S163-PMC5732505	['in MANY previous STUDIES, participants had various ethnic backgrounds which COULD AFFECT both Vitamin D status and their RISK of gdm [7,38].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 82), ('IMPORTANT_CONSIDERATION', 121)]	4	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5732505	12/2017	S166-PMC5732505	['a CHALLENGE in PREVIOUS STUDIES on Vitamin D status and gdm HAS BEEN the LACK OF RELEVANT adjustments, for example adjustments for bmi and smoking status [6].']	[('DIFFICULT_TASK', 2), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 60), ('PROBLEM_COMPLICATION', 73), ('IMPORTANT_CONSIDERATION', 81)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC5732505	12/2017	S176-PMC5732505	['sufficient maternal Vitamin D status, specified AS 25(Oh)D above 50\xa0nmol/l, SEEMS a threshold value, above which the physiological REQUIREMENTS of Pregnancy are achieved.']	[('PROBABLE_UNDERSTANDING', 48), ('PROBABLE_UNDERSTANDING', 76), ('IMPORTANT_CONSIDERATION', 131)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 51, '25(OH)D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy')]
PMC5732505	12/2017	S178-PMC5732505	['HOWEVER, randomised controlled TRIALS ARE REQUIRED in specific RISK groups of Vitamin D deficiency TO CLARIFY if Vitamin D supplementation AFFECTS the RISK of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 63), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 139), ('IMPORTANT_CONSIDERATION', 151)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC5758521	1/2018	S21-PMC5758521	['to fill this IMPORTANT research data gap, we SOUGHT TO EVALUATE WHETHER Vitamin A and e nutritional status in neonates are ASSOCIATED with circulating concentrations of leptin, adiponectin, Igf-I and Igf-Ii which are IMPORTANT BIOMARKERS of fetal growth and Metabolic health15,16.']	[('IMPORTANT_CONSIDERATION', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 64), ('SUPERFICIAL_RELATIONSHIP', 123), ('IMPORTANT_CONSIDERATION', 217), ('SUPERFICIAL_RELATIONSHIP', 227)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin A'), ('PR_000008919', 'interferon alpha-6', 190, 'IGF-I'), ('PR_000002046', 'interferon regulatory factor 4', 200, 'IGF-II'), ('GO_0008152', 'metabolic process', 258, 'metabolic')]
PMC5758521	1/2018	S155-PMC5758521	['it SHOULD be NOTED that the normal reference values for Vitamins A and E in Cord Blood are NOT AVAILABLE, and our OBSERVED ASSOCIATIONS were MOSTLY moderate.']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 123), ('PROBABLE_UNDERSTANDING', 141)]	6	[('CHEBI_27300', 'vitamin D', 56, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 56, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 71, 'E'), ('UBERON_0009472', 'axilla', 76, 'cord blood')]
PMC5784894	1/2018	S191-PMC5784894	['THIS work THUS establishes Early Life Vitamin D deficiency as a FACTOR that CAN CONTRIBUTE to Adult osteoporosis; offers a POTENTIAL Solution–supplementation of Vitamin D during Pregnancy and infancy; and presents a MODEL system TO IDENTIFY pathways that COULD BE TARGETED in Adult Life to prevent or treat osteoporosis, a GLOBAL health PROBLEM.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 10), ('SUPERFICIAL_RELATIONSHIP', 64), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 216), ('QUESTION_ANSWERED_BY_THIS_WORK', 229), ('INCOMPLETE_EVIDENCE', 255), ('FUTURE_WORK', 264), ('IMPORTANT_CONSIDERATION', 323), ('IMPORTANT_CONSIDERATION', 337)]	12	[('UBERON_0001847', 'lobule of pinna', 27, 'early life'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 94, 'adult'), ('CHEBI_75958', 'solution', 133, 'solution'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('UBERON_0000113', 'post-juvenile adult stage', 276, 'adult life')]
PMC5827025	2/2018	S0-PMC5827025	['INFLUENT FACTORS of Gestational Vitamin D deficiency and its RELATION to an INCREASED RISK of Preterm Delivery in chinese population\n\nabstract\nGestational Vitamin D deficiency (vdd) HAS BEEN LINKED with adverse Pregnant outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 61), ('IMPORTANT_CONSIDERATION', 76), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 191)]	6	[('GO_0007565', 'female pregnancy', 20, 'gestational'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'preterm'), ('GO_0007567', 'parturition', 102, 'delivery'), ('GO_0007565', 'female pregnancy', 143, 'Gestational'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 211, 'pregnant')]
PMC5827025	2/2018	S94-PMC5827025	['NUMEROUS STUDIES SHOWED that season is a MAJOR INFLUENT FACTOR for Vitamin D status31,32.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 41), ('SUPERFICIAL_RELATIONSHIP', 47), ('SUPERFICIAL_RELATIONSHIP', 56)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC5827025	2/2018	S102-PMC5827025	['the INCONSISTENCY of PAST FINDINGS MAY BE RELATED to following REASONS: first, cohort among Pregnant women with relatively Vitamin D replete, with a history of Preterm Delivery or at high risk for Preeclampsia; second, Gestational Vitamin D status is a LINK to ethnic DISPARITIES in adverse Birth outcomes24.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 63), ('SUPERFICIAL_RELATIONSHIP', 253), ('IMPORTANT_CONSIDERATION', 268)]	9	[('GO_0007565', 'female pregnancy', 92, 'pregnant'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'preterm'), ('GO_0007567', 'parturition', 168, 'delivery'), ('GO_0007128', 'meiotic prophase I', 197, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 219, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('GO_0007567', 'parturition', 291, 'birth')]
PMC5827025	2/2018	S103-PMC5827025	['ALTHOUGH a RECENT STUDY in northeast china DEMONSTRATED that vdd was more PREVALENT in the SEVERE preterm group than in the mildly preterm group and the in-term group, they DID NOT analyze the ASSOCIATION between vdd and an INCREASED RISK of Preterm Delivery BECAUSE Vitamin D status at prior to labor cannot be used to assess risk of Preterm Delivery39.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 74), ('IMPORTANT_CONSIDERATION', 91), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 193), ('IMPORTANT_CONSIDERATION', 224), ('PROBLEM_COMPLICATION', 259)]	10	[('GO_0007565', 'female pregnancy', 242, 'preterm'), ('GO_0007567', 'parturition', 250, 'delivery'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('GO_0007565', 'female pregnancy', 335, 'preterm'), ('GO_0007567', 'parturition', 343, 'delivery39')]
PMC5838372	3/2018	S11-PMC5838372	['conclusion:\nVitamin D deficiency in Pregnant women and their infants is STILL a SERIOUS health PROBLEM in turkey, although a Vitamin D support programme during Pregnancy has been launched by the department of health.']	[('IMPORTANT_CONSIDERATION', 72), ('IMPORTANT_CONSIDERATION', 80), ('IMPORTANT_CONSIDERATION', 95)]	3	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 36, 'pregnant'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy')]
PMC5838372	3/2018	S13-PMC5838372	['DESPITE improvement in the socio-economic level of the population, Vitamin D deficiency is STILL a SERIOUS health PROBLEM in turkey.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 91), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 114)]	4	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC5838372	3/2018	S16-PMC5838372	['DESPITE the launch of a Vitamin D support programme for Pregnant women by the ministry of health, Vitamin D deficiency in Pregnant women and their infants continues to be a SERIOUS health PROBLEM in turkey.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 173), ('IMPORTANT_CONSIDERATION', 188)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnant'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnant')]
PMC5838372	3/2018	S20-PMC5838372	['the lack of Vitamin D during Pregnancy is the MOST IMPORTANT RISK FACTOR for infantile rickets and MAY also result in POOR fetal growth and Neonatal Development (8,9,10,11).']	[('PROBABLE_UNDERSTANDING', 46), ('IMPORTANT_CONSIDERATION', 51), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 118)]	5	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 29, 'pregnancy'), ('GO_0021985', 'neurohypophysis development', 140, 'neonatal development')]
PMC5838372	3/2018	S78-PMC5838372	['discussion\nvitamin D deficiency LEADS TO IMPORTANT health PROBLEMS, NOT ONLY in mothers BUT ALSO in their infants, BECAUSE the Vitamin D store of the mother is the MAJOR source of Vitamin D for the fetus (9).']	[('PROBABLE_UNDERSTANDING', 32), ('SUPERFICIAL_RELATIONSHIP', 32), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 58), ('ANOMALY_CURIOUS_FINDING', 68), ('ANOMALY_CURIOUS_FINDING', 88), ('PROBABLE_UNDERSTANDING', 115), ('IMPORTANT_CONSIDERATION', 164)]	8	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 19, 'D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D')]
PMC5838372	3/2018	S82-PMC5838372	['the SAFETY dose during Pregnancy is NOT CLEAR, but hollis et al (20) SHOWED that Vitamin D supplementation of 4000 iu/day for achieving adequate levels was SAFE and EFFECTIVE in Pregnant women.']	[('IMPORTANT_CONSIDERATION', 4), ('FULL_UNKNOWN', 36), ('INCOMPLETE_EVIDENCE', 69), ('IMPORTANT_CONSIDERATION', 156), ('SUPERFICIAL_RELATIONSHIP', 165)]	5	[('GO_0007565', 'female pregnancy', 23, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnant')]
PMC5838372	3/2018	S84-PMC5838372	['HOWEVER, the levels of Vitamin D insufficiency and deficiency are NOT CLEARLY defined and the discussion about the prevalence Vitamin D deficiency is ONGOING (22,23).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 66), ('IMPORTANT_CONSIDERATION', 150)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC5838372	3/2018	S101-PMC5838372	['all these data CONFIRM that Vitamin D deficiency continues to be a PROBLEM in Pregnant women and their infants in turkey, DESPITE the introduction of the supplementation programme.']	[('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 67), ('PROBLEM_COMPLICATION', 67), ('ANOMALY_CURIOUS_FINDING', 122)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnant')]
PMC5838372	3/2018	S105-PMC5838372	['these results SHOW that high dose Vitamin D support is NECESSARY during Pregnancy and that the support program SHOULD BE continued.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 55), ('FUTURE_WORK', 111)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy')]
PMC5838372	3/2018	S112-PMC5838372	['THESE FINDINGS SHOW that covered clothing style is an IMPORTANT factor for Vitamin D deficiency in Pregnant women in turkey.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 54)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 99, 'pregnant')]
PMC5838372	3/2018	S116-PMC5838372	['ergur et al (31) SUGGESTED that maternal deficiency was the most IMPORTANT FACTOR for Vitamin D deficiency in newborns.']	[('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 75)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5838372	3/2018	S125-PMC5838372	['conclusion\nalthough a Vitamin D support programme was launched for Pregnant women by the ministry of health in 2011, Vitamin D deficiency in Pregnant women and their infants is STILL a SERIOUS health PROBLEM in turkey in 2016.']	[('IMPORTANT_CONSIDERATION', 177), ('IMPORTANT_CONSIDERATION', 185), ('IMPORTANT_CONSIDERATION', 200)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 67, 'pregnant'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'pregnant')]
PMC5841533	2/2018	S17-PMC5841533	['introduction\nan ESTIMATED 250\u2009million children GLOBALLY are denied the opportunity to reach their full developmental potential DUE TO the combined EFFECTS of poverty and undernutrition.1poor nutrition during Pregnancy CONTRIBUTES to maternal morbidity and mortality, increases the risks of low Birth weight and poor development, and exacerbates the risk of chronic disease in Adulthood.2 3many Pregnant women face Micronutrient deficiencies: an ESTIMATED 15.3% globally lack Vitamin A, 28.5% lack Iodine and 38% have iron-deficiency anaemia.1 4nutritional deprivation in Pregnancy CAN alter neural growth in the fetus and AFFECT Cognitive functioning, hindering children’s chances in school and CONTRIBUTING to the intergenerational transmission of poverty.5–9\nthe world health organisation (who) currently RECOMMENDS Iron and Folic Acid (ifa) supplementation in Pregnancy to improve maternal and Perinatal outcomes, BUT NOT multiple Micronutrient (mmn)supplementation.10–12could Antenatal Micronutrient supplementation improve children’s long-term Cognitive functioning?']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 47), ('PROBLEM_COMPLICATION', 127), ('SUPERFICIAL_RELATIONSHIP', 147), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 445), ('INCOMPLETE_EVIDENCE', 581), ('SUPERFICIAL_RELATIONSHIP', 622), ('SUPERFICIAL_RELATIONSHIP', 695), ('FUTURE_WORK', 807), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 917), ('ANOMALY_CURIOUS_FINDING', 917), ('EXPLICIT_QUESTION', 1070)]	13	[('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('GO_0007567', 'parturition', 294, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 376, 'adulthood'), ('GO_0007565', 'female pregnancy', 394, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 414, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 497, 'iodine'), ('GO_0007565', 'female pregnancy', 571, 'pregnancy'), ('GO_0050890', 'cognition', 629, 'cognitive'), ('CHEBI_24870', 'ion', 818, 'Iron'), ('CHEBI_30751', 'formic acid', 827, 'Folic Acid'), ('GO_0007565', 'female pregnancy', 863, 'pregnancy'), ('GO_0036268', 'swimming', 897, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 897, 'perinatal'), ('CHEBI_6956', 'Mitragynine', 934, 'Micronutrient'), ('GO_0007567', 'parturition', 980, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 990, 'micronutrient'), ('GO_0050890', 'cognition', 1049, 'cognitive')]
PMC5941617	5/2018	S20-PMC5941617	['the main OBJECTIVE is to give RECOMMENDATIONS regarding the PREVENTION and treatment of Vitamin D deficiency in italian children and adolescents (0–18\xa0years), CONSIDERING both the Skeletal and Extra-Skeletal EFFECTS of Vitamin D and POTENTIAL RISK FACTORS in specific subgroups of children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('FUTURE_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 208), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 243)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0004288', 'skeleton', 180, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 193, 'extra-skeletal'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D')]
PMC5941617	5/2018	S27-PMC5941617	['Vitamin D deficiency: ranges, analytic methods, and epidemiology\nthe MAJOR circulating form of Vitamin D is 25(Oh)D, having a half-life of 2–3\xa0weeks.']	[('IMPORTANT_CONSIDERATION', 69)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 108, '25(OH)D')]
PMC5941617	5/2018	S28-PMC5941617	['it is the BEST MARKER to monitor for Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 15)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5941617	5/2018	S29-PMC5941617	['in literature, several cut-offs HAVE BEEN PROPOSED for Vitamin D deficiency with respect to Serum 25(Oh)D levels measured with a RELIABLE assay.']	[('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 129)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0001977', 'blood serum', 92, 'serum'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 98, '25(OH)D')]
PMC5941617	5/2018	S40-PMC5941617	['this COULD BE DUE by an age-dependent more efficient calcium absorption, a compensatory absorption Vitamin D-independent and a higher conversion to Calcitriol [44,51,52].']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 14)]	2	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 148, 'calcitriol')]
PMC5941617	5/2018	S44-PMC5941617	['based ON the above CONSIDERATIONS, we SUGGEST to define Vitamin D status as reported in table\xa03.']	[('ANOMALY_CURIOUS_FINDING', 6), ('IMPORTANT_CONSIDERATION', 19), ('INCOMPLETE_EVIDENCE', 38)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC5941617	5/2018	S59-PMC5941617	['hypovitaminosis D and Vitamin D deficiency, independently from cut-off definitions, have a higher PREVALENCE worldwide in any age.']	[('IMPORTANT_CONSIDERATION', 98)]	1	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 16, 'D'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC5941617	5/2018	S90-PMC5941617	['children REQUIRE less sunlight exposure than Adults to produce sufficient quantities of Vitamin D, both BECAUSE of their higher body surface-area-to-volume ratio and of their increased capacity to produce Vitamin D [85].']	[('IMPORTANT_CONSIDERATION', 9), ('PROBABLE_UNDERSTANDING', 104)]	2	[('UBERON_0007023', 'adult organism', 45, 'adults'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
PMC5941617	5/2018	S93-PMC5941617	['Breast Milk represents the BEST Food to satisfy children’s nutritional NEEDS, ALTHOUGH it contains insufficient amount of Vitamin D (<\u200950\xa0iu/l) [86].']	[('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 71), ('ANOMALY_CURIOUS_FINDING', 78)]	3	[('UBERON_0013538', 'Brodmann (1909) area 7', 0, 'Breast milk'), ('CHEBI_33290', 'food', 32, 'food'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC5941617	5/2018	S95-PMC5941617	['CONSIDERING Water REQUIREMENTS, formula Fed infants MAY receive 400\xa0iu/day of Vitamin D, which is adequate for the first year of Life [10], only when they come to weigh 5 to 6 kg.']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 18), ('INCOMPLETE_EVIDENCE', 52)]	4	[('CHEBI_15377', 'water', 12, 'water'), ('GO_0007631', 'feeding behavior', 40, 'fed'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000104', 'life cycle', 129, 'life')]
PMC5941617	5/2018	S104-PMC5941617	['assuming minimal sunshine exposure, sacn RECOMMENDED a SAFE intake of 340–400\xa0iu/day of Vitamin D for infants under 1\xa0year of Life, a SAFE intake of 400\xa0iu/day for age 1 up to 4\xa0years, and a reference Nutrient intake of 400\xa0iu/day for the united kingdom population aged 4\xa0years and above [25].']	[('FUTURE_WORK', 41), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 134)]	3	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0000104', 'life cycle', 126, 'life'), ('CHEBI_33284', 'nutrient', 201, 'nutrient')]
PMC5941617	5/2018	S105-PMC5941617	['in 2016 also the european Food safety authority (efsa) revised dietary reference values for Vitamin D. CONSIDERING a Serum 25(Oh)D levels of 20\xa0ng/ml AS a SUITABLE target value, under conditions of minimal cutaneous Vitamin D synthesis efsa RECOMMENDED an adequate intake of 400\xa0iu/day for infants aged 7–11\xa0months and of 600\xa0iu/day for children aged 1–17\xa0years [26].']	[('PROBABLE_UNDERSTANDING', 103), ('PROBABLE_UNDERSTANDING', 150), ('IMPORTANT_CONSIDERATION', 155), ('FUTURE_WORK', 241)]	4	[('CHEBI_33290', 'food', 26, 'Food'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 100, 'D'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 123, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC5941617	5/2018	S108-PMC5941617	['particularly, the Endocrine society guidelines focused on patients AT RISK for Vitamin D deficiency, RECOMMENDING a Vitamin D daily REQUIREMENT of 400–1000\xa0iu in the first years of Life and of 600–1000\xa0iu from 1 up to 18\xa0years [11].']	[('IMPORTANT_CONSIDERATION', 67), ('FUTURE_WORK', 101), ('IMPORTANT_CONSIDERATION', 132)]	3	[('UBERON_0005063', 'left ventricular compact myocardium', 18, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0000104', 'life cycle', 181, 'life')]
PMC5941617	5/2018	S109-PMC5941617	['caption (table-wrap): table 5\n\ndietary reference values of Vitamin D in infants, children, and adolescents as PROPOSED by various organizations and societiesorganization/societyyearcountry/countriesdietary reference value for Vitamin D0–12\xa0months, iu/day1–18\xa0years, iu/dayeuropean Food safety authority [26]2016europeai400 (7–11\xa0months)600 (1–17\xa0years)scientific advisory committee on nutrition [25]2016united kingdomsafe intake (<\u20094\xa0years)340–400400rni (4–18\xa0years)nordic nutrition recommendations [16]2012denmark, finland, iceland, norway, sweden, faroe islands, greenland, åland islandsri400400german nutrition society [17]2012germany, austria, switzerlandai400 (infants)800a(children)health council of the netherlands [18]2012the netherlandsai400400italian society of nutrition [89]2012italyai (<\u2009 12\xa0months)400 (6–12\xa0months)600pri (1–18\xa0years)institute of medicine [10]2011north america, canadaai (<\u2009 12\xa0months)400600rda (1–18\xa0years)the Endocrine society [11]2011worldwidedaily requirementb400–1000600–1000\nai adequate intake, the average observed daily level of Intake by a population group of apparently healthy People that is ASSUMED to be adequate\nsafe intake , a level or range of intakes considered to pose no risk of deficiency and below a level where there is a risk of undesirable EFFECTS\nrni reference Nutrient intake, the amount of a Nutrient that is LIKELY to meet the needs of 97.5% of the population\nri recommended intake, the amount of a Nutrient that meets the known REQUIREMENT and maintains good nutritional status among practically all (97–98%) healthy Individuals in a particular Life Stage or gender group\npri population reference intake, the level of Nutrient intake sufficient to satisfy the needs of ALMOST all (97.5%) healthy subjects in one specific population group\nrda recommended dietary allowance, the estimated intake capable of satisfying the needs of 97.5% of the population\naadequate intake with missing Endogenous Synthesis Of Vitamin D\nbrecommended REQUIREMENTS for subjects at risk of Vitamin D deficiency\nin accordance with the european society for paediatric gastroenterology hepatology and nutrition [espghan] [19] and the european academy of pediatrics [30], we endorsed tolerable upper intake levels of Vitamin D proposed by efsa in 2012 (1000\xa0iu/day for infants: 2000\xa0iu/day for children ages 1 to 10\xa0years; 4000\xa0iu/day for children and adolescents ages 11 to 17\xa0years) [90].']	[('INCOMPLETE_EVIDENCE', 110), ('PROBABLE_UNDERSTANDING', 1134), ('SUPERFICIAL_RELATIONSHIP', 1295), ('PROBABLE_UNDERSTANDING', 1367), ('IMPORTANT_CONSIDERATION', 1488), ('ANOMALY_CURIOUS_FINDING', 1729), ('IMPORTANT_CONSIDERATION', 1990)]	7	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 226, 'vitamin D0'), ('PR_000017299', 'VIP peptides', 226, 'vitamin D0'), ('CHEBI_33290', 'food', 281, 'Food'), ('UBERON_0005063', 'left ventricular compact myocardium', 942, 'Endocrine'), ('GO_0007631', 'feeding behavior', 1068, 'intake'), ('NCBITaxon_10088', 'Mus <genus>', 1119, 'people'), ('CHEBI_33284', 'nutrient', 1317, 'Nutrient'), ('CHEBI_33284', 'nutrient', 1350, 'nutrient'), ('CHEBI_33284', 'nutrient', 1458, 'nutrient'), ('NCBITaxon_1', 'root', 1577, 'individuals'), ('UBERON_0000105', 'life cycle stage', 1605, 'life stage'), ('CHEBI_33284', 'nutrient', 1678, 'nutrient'), ('GO_0009790', 'embryo development', 1943, 'endogenous'), ('GO_0030474', 'spindle pole body duplication', 1954, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1967, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 1975, 'D'), ('CHEBI_27300', 'vitamin D', 2027, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2250, 'vitamin D')]
PMC5941617	5/2018	S110-PMC5941617	['Vitamin D supplementation\n\n0–12\xa0months\nvitamin D supplementation in the first year of Life is ESSENTIAL to ensure an adequate Vitamin D status and to prevent nutritional rickets.']	[('IMPORTANT_CONSIDERATION', 94)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 47, 'D'), ('UBERON_0000104', 'life cycle', 86, 'life'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC5941617	5/2018	S113-PMC5941617	['moreover, newborns from deficient mothers are at INCREASED RISK for Vitamin D deficiency AS Cord Blood and neonatal 25(Oh)D levels highly CORRELATE with maternal Vitamin d status during Gestation [92,93].']	[('IMPORTANT_CONSIDERATION', 49), ('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 92, 'cord'), ('UBERON_0000178', 'blood', 97, 'blood'), ('CHEBI_71657', 'versiconol acetate', 116, '25(OH)D'), ('CHEBI_33229', 'vitamin (role)', 162, 'vitamin'), ('GO_0007565', 'female pregnancy', 186, 'gestation')]
PMC5941617	5/2018	S114-PMC5941617	['the IMPORTANCE of Vitamin D supplementation during the first year of Life HAS BEEN CONFIRMED by the FINDING that children not receiving supplementation have reduced Serum 25(Oh)d levels, PARTICULARLY if exclusively Breastfed and during winter season [94–96].']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 100), ('ANOMALY_CURIOUS_FINDING', 187)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000104', 'life cycle', 69, 'life'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('GO_0007567', 'parturition', 215, 'breastfed')]
PMC5941617	5/2018	S117-PMC5941617	['ON THE CONTRARY, Vitamin D supplementation at higher dosages SEEMED TO BE ASSOCIATED with increased RISK of hypervitaminosis D with hypercalciuria and hypercalcemia [62].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('ANOMALY_CURIOUS_FINDING', 7), ('ANOMALY_CURIOUS_FINDING', 61), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 100)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 125, 'D')]
PMC5941617	5/2018	S119-PMC5941617	['ONLY FEW STUDIES evaluated the EFFICACY and SAFETY of intermittent Vitamin D supplementation during the first year of Life, particularly in cases with low compliance [109–111], THUS AT PRESENT daily supplementation REMAINS PREFERRED.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 44), ('PROBABLE_UNDERSTANDING', 177), ('INCOMPLETE_EVIDENCE', 182), ('INCOMPLETE_EVIDENCE', 215), ('PROBABLE_UNDERSTANDING', 223)]	8	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0000104', 'life cycle', 118, 'life')]
PMC5941617	5/2018	S122-PMC5941617	['the same RECOMMENDATION HAS BEEN worldwide PROPOSED also by an expert position statement on Vitamin D in childhood [1], the department of nutrition for health and development of the world health organization [116], the espghan [19], the european academy of pediatrics [30], and the Vitamin D GUIDELINES for united arab emirates [27] and central europe [20].']	[('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 292)]	4	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC5941617	5/2018	S123-PMC5941617	['these societies also agree that the administration of 400\xa0iu/day is SAFE and effective to prevent rickets and ensure an adequate Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 68)]	1	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC5941617	5/2018	S124-PMC5941617	['the endocrine society RECOMMENDED a daily intake of 400–1000\xa0iu of Vitamin D in children under 1\xa0year of age at RISK for Vitamin D deficiency [11].']	[('FUTURE_WORK', 22), ('IMPORTANT_CONSIDERATION', 112)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC5941617	5/2018	S126-PMC5941617	['DESPITE this GLOBAL agreement on Vitamin D supplementation in the first year of Life, several barriers to adherence STILL exist, such as reluctance of mothers to give their children daily supplementation, lack OF knowledge about Vitamin D actions and the RISK of nutritional rickets, lack of awareness by health care professionals, ASSUMPTION that both breast milk and formula milk provide sufficient Vitamin D intake [116,117].']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 116), ('ANOMALY_CURIOUS_FINDING', 210), ('IMPORTANT_CONSIDERATION', 255), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 332)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0000104', 'life cycle', 80, 'life'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 401, 'vitamin D')]
PMC5941617	5/2018	S129-PMC5941617	['we RECOMMEND against using Vitamin D Metabolites and their analogs (Calcifediol, Alfacalcidol, Calcitriol, and Dihydrotachysterol) for the routine Vitamin D supplementation, as the administration of these Compounds increases the RISK of hypercalcemia and is NOT ABLE to maintain and/or restore Vitamin D stores [118,119].']	[('FUTURE_WORK', 3), ('IMPORTANT_CONSIDERATION', 229), ('DIFFICULT_TASK', 258)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_25212', 'metabolite', 37, 'metabolites'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 68, 'calcifediol'), ('CHEBI_31186', 'alfacalcidol', 81, 'alfacalcidol'), ('CHEBI_17823', 'calcitriol', 95, 'calcitriol'), ('CHEBI_4657', 'disopyramide', 111, 'dihydrotachysterol'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_36357', 'polyatomic entity', 205, 'compounds'), ('CHEBI_27300', 'vitamin D', 294, 'vitamin D')]
PMC5941617	5/2018	S134-PMC5941617	['Ketoconazole)• infants Born from mothers with multiple RISK FACTORS for Vitamin D deficiency, particularly in absence of Vitamin D supplementation during Pregnancy\n\npreterm\npreterm infants are AT RISK for Calcium-Phosphorus Metabolism alterations, with POSSIBLE development of osteopenia of prematurity [120].']	[('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 193), ('INCOMPLETE_EVIDENCE', 253)]	3	[('CHEBI_47519', 'ketoconazole', 0, 'ketoconazole'), ('GO_0007567', 'parturition', 23, 'born'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnancy'), ('CHEBI_30272', 'arsonium', 205, 'calcium-phosphorus'), ('GO_0050655', 'dermatan sulfate proteoglycan metabolic process', 205, 'calcium-phosphorus metabolism')]
PMC5941617	5/2018	S140-PMC5941617	['RELATIVELY few international scientific societies gave RECOMMENDATIONS on Vitamin D supplementation in preterm infants.']	[('IMPORTANT_CONSIDERATION', 0), ('FUTURE_WORK', 55)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5941617	5/2018	S159-PMC5941617	['1–18\xa0years\nthe promotion of an adequate Vitamin D status is IMPORTANT for older children and adolescents, AS nutritional rickets MAY develop during the entire pediatric age [28] and Vitamin D deficiency MAY negatively AFFECT bone health [25,26].']	[('IMPORTANT_CONSIDERATION', 60), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 218)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC5941617	5/2018	S163-PMC5941617	['a RECENT rct performed during winter SHOWED that a Vitamin D intake up to 800\xa0iu/day was REQUIRED by white danish children (4–8\xa0years) to maintain Serum 25(Oh)D\u2009>\u200920\xa0ng/ml.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 89)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('UBERON_0001977', 'blood serum', 147, 'serum'), ('CHEBI_71657', 'versiconol acetate', 153, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 153, '25(OH)D')]
PMC5941617	5/2018	S165-PMC5941617	['another rct DEMONSTRATED that white uk adolescents (14–18\xa0years) REQUIRED higher intake of Vitamin D (up to 1200\xa0iu/day) during winter to achieve 25(Oh)D concentration\u2009>\u200920\xa0ng/ml in 97.5% of cases.']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 65)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 146, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 146, '25(OH ... D')]
PMC5941617	5/2018	S171-PMC5941617	['moreover, pediatricians SHOULD periodically evaluate Vitamin D intake from diet and Supplements [23,28].']	[('FUTURE_WORK', 24), ('IMPORTANT_CONSIDERATION', 24)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 84, 'supplements')]
PMC5941617	5/2018	S176-PMC5941617	['adolescents are at INCREASED RISK for Vitamin D deficiency [79], THUS the society for adolescent health and medicine RECOMMENDED continuous Vitamin D supplementation (600\xa0iu daily for healthy adolescents, and at LEAST 1000\xa0iu daily for adolescents at risk for Vitamin D deficiency or insufficiency) in addition to Vitamin D received through the diet or via sun exposure [21].']	[('IMPORTANT_CONSIDERATION', 19), ('PROBABLE_UNDERSTANDING', 65), ('FUTURE_WORK', 117), ('PROBABLE_UNDERSTANDING', 212)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 314, 'vitamin D')]
PMC5941617	5/2018	S187-PMC5941617	['in cases of POOR compliance, supplementation with intermittent dosing (weekly or monthly doses for a cumulative monthly dose of 18000–30000\xa0iu of Vitamin D) can be CONSIDERED, starting from children aged 5–6\xa0years and PARTICULARLY during Adolescence.']	[('PROBLEM_COMPLICATION', 12), ('FUTURE_WORK', 164), ('IMPORTANT_CONSIDERATION', 218)]	3	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 238, 'adolescence')]
PMC5941617	5/2018	S190-PMC5941617	['individuals on Anticonvulsants, oral Corticosteroids, Antimicotics and Antiretroviral Drugs SHOULD receive AT LEAST 2–3 times more Vitamin D than the daily REQUIREMENT RECOMMENDED for age, in agreement with the endocrine society [11] and the aap [23].']	[('FUTURE_WORK', 92), ('PROBABLE_UNDERSTANDING', 107), ('IMPORTANT_CONSIDERATION', 156), ('FUTURE_WORK', 168)]	4	[('CHEBI_37540', 'arabinarate(2-)', 15, 'anticonvulsants'), ('CHEBI_50850', 'etabonate ester', 37, 'corticosteroids'), ('CHEBI_33282', 'antibacterial agent', 54, 'antimicotics'), ('CHEBI_33656', 'antiaromatic compound', 71, 'antiretroviral drugs'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5941617	5/2018	S197-PMC5941617	['indeed, Serum 25(Oh)D evaluation SHOULD BE reserved to subjects AT RISK for Vitamin D deficiency, BUT INDICATIONS for 25(Oh)D measurement significantly VARY among different societies (table\xa08) [9,11,13,15,20–23,27,30].']	[('FUTURE_WORK', 33), ('IMPORTANT_CONSIDERATION', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 102), ('DIFFICULT_TASK', 152)]	5	[('UBERON_0001977', 'blood serum', 8, 'serum'), ('CHEBI_71657', 'versiconol acetate', 14, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D')]
PMC5941617	5/2018	S199-PMC5941617	['particularly, Vitamin D status SHOULD BE monitored AT LEAST yearly in subjects that REQUIRE supplementation during the whole year BECAUSE AFFECTED from pathological conditions or receiving Drugs AFFECTING vitamin D Metabolism (table\xa07) (see “Extraskeletal actions of Vitamin D” for specific RECOMMENDATIONS).']	[('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 31), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 84), ('PROBABLE_UNDERSTANDING', 130), ('SUPERFICIAL_RELATIONSHIP', 138), ('SUPERFICIAL_RELATIONSHIP', 195), ('FUTURE_WORK', 291)]	8	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_23888', 'drug', 189, 'drugs'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 213, 'D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 213, 'D metabolism'), ('UBERON_0001431', 'distal carpal bone 2', 242, 'Extraskeletal'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D')]
PMC5941617	5/2018	S205-PMC5941617	['tuberculosis)xxxxamenorrheaxcancer (DIFFERENT types)xfxxxhepatitis cgxxrecurrent acute Lower Respiratory Tract infectionsgxxatopic dermatitisgxxatopic asthmagxxautoimmune diseaseshxxixcardiovascular diseases (especially hypertension)xxmetabolic syndrome, type 2 diabetesx\npes pediatric endocrine society, Es endocrine society, fcn federal commission for nutrition (switzerland), sahm society for adolescent health and medicine, aap american academy of pediatrics, eap european academy of pediatrics\nasuggested to guide Vitamin D prescription in Individuals with underlying RISKS requiring continuing supplementation all year long, if NECESSARY\nbgenetic conditions (Osteogenesis imperfecta, idiopathic juvenile osteoporosis, turner syndrome), Endocrine conditions (cushing syndrome, hypogonadism, hyperthyroidism, hyperparathyroidism, growth hormone deficiency, diabetes mellitus) ASSOCIATED with reduced bone mass\ncliving at higher latitudes in the winter and spring months\ndafrican-american and hispanic children\neobese children with additional RISK factors/symptoms for Vitamin D deficiency\nfsome lymphomas\ngpatients admitted to hospital\nhmultiple sclerosis, psoriasis, rheumatoid arthritis, dermatomyositis, systemic lupus erythematosus\nisystemic lupus erythematosus, juvenile idiopathic arthritis, juvenile dermatomyositis as associated with reduced bone mass\n\nSkeletal actions of Vitamin D\n\nnutritional rickets\nrickets is characterized by defective Mineralization Of developing Bone Tissue and reduced or absent Endochondral Ossification of the growth plate, with subsequent deformation [183,184].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('IMPORTANT_CONSIDERATION', 573), ('IMPORTANT_CONSIDERATION', 634), ('SUPERFICIAL_RELATIONSHIP', 880), ('SUPERFICIAL_RELATIONSHIP', 1046)]	5	[('UBERON_0004905', 'articulation', 87, 'lower respiratory tract'), ('CL_0002322', 'embryonic stem cell', 305, 'ES'), ('CHEBI_27300', 'vitamin D', 519, 'vitamin D'), ('NCBITaxon_1', 'root', 545, 'individuals'), ('GO_0001503', 'ossification', 665, 'osteogenesis'), ('GO_0006397', 'mRNA processing', 742, 'endocrine'), ('CHEBI_27300', 'vitamin D', 1072, 'vitamin D'), ('UBERON_0004288', 'skeleton', 1365, 'Skeletal'), ('CHEBI_27300', 'vitamin D', 1385, 'vitamin D'), ('GO_0051217', 'molybdenum incorporation via L-aspartyl molybdenum bis(molybdopterin guanine dinucleotide)', 1454, 'mineralization of ...'), ('UBERON_0002481', 'bone tissue', 1483, 'bone tissue'), ('GO_0042695', 'thelarche', 1488, 'tissue'), ('GO_0001958', 'endochondral ossification', 1517, 'endochondral ossification'), ('UBERON_0010363', 'endochondral element', 1517, 'endochondral')]
PMC5941617	5/2018	S208-PMC5941617	['children of immigrants living in industrialized countries are at INCREASED RISK of rickets BECAUSE they USUALLY present several RISK FACTORS for Vitamin D deficiency such as prolonged breastfeeding without vitamin d supplementation, increased skin pigmentation, reduced sun exposure due to cultural habits (i.e.']	[('IMPORTANT_CONSIDERATION', 65), ('PROBABLE_UNDERSTANDING', 91), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5941617	5/2018	S211-PMC5941617	['a RECENT GLOBAL CONSENSUS RECOMMENDATIONS on prevention and management of nutritional rickets DEFINED Vitamin D deficiency AS Serum 25(Oh)D\u2009<\u2009\xa012\xa0ng/ml, CONSIDERING the increased incidence of rickets with Serum 25(Oh)D levels under this THRESHOLD [28].']	[('INCOMPLETE_EVIDENCE', 2), ('IMPORTANT_CONSIDERATION', 9), ('PROBABLE_UNDERSTANDING', 16), ('FUTURE_WORK', 26), ('INCOMPLETE_EVIDENCE', 94), ('PROBABLE_UNDERSTANDING', 94), ('PROBABLE_UNDERSTANDING', 123), ('IMPORTANT_CONSIDERATION', 153), ('PROBABLE_UNDERSTANDING', 237)]	9	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0001977', 'blood serum', 126, 'serum'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('UBERON_0001977', 'blood serum', 205, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 211, '25(OH ... D')]
PMC5941617	5/2018	S234-PMC5941617	['besides Vitamin D, Calcium is also IMPORTANT to treat nutritional rickets, EVEN in absence of hypocalcemia.']	[('IMPORTANT_CONSIDERATION', 35), ('ANOMALY_CURIOUS_FINDING', 75)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 19, 'calcium')]
PMC5941617	5/2018	S239-PMC5941617	['Calcium supplementation is IMPORTANT to prevent “hungry-bone” syndrome (hypocalcemia secondary to an increase in Bone mineralization as pth levels normalize during Vitamin D treatment) [9].']	[('IMPORTANT_CONSIDERATION', 27)]	1	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('GO_0007567', 'parturition', 113, 'bone'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC5941617	5/2018	S249-PMC5941617	['as discussed before, Vitamin D supplementation during the first year of Life is ESSENTIAL to prevent nutritional rickets occurrence.']	[('IMPORTANT_CONSIDERATION', 80)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0000104', 'life cycle', 72, 'life')]
PMC5941617	5/2018	S251-PMC5941617	['among these, three italian STUDIES assessed bone Mineral status in infants using quantitative ultrasound [201–203], SUGGESTING that Vitamin D supplementation is IMPORTANT to provide an adequate Bone Development, PARTICULARLY in exclusively breastfed infants.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 116), ('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 212), ('IMPORTANT_CONSIDERATION', 212)]	5	[('CHEBI_46662', 'mineral', 49, 'mineral'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0048539', 'bone marrow development', 194, 'bone development')]
PMC5941617	5/2018	S255-PMC5941617	['THUS, Vitamin D supplementation during infancy is IMPORTANT to optimize bone mass acquisition and body composition, but high doses are not RECOMMENDED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 50), ('FUTURE_WORK', 139)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC5941617	5/2018	S269-PMC5941617	['in 2016, sacn and efsa revised dietary reference values for Vitamin D reporting an INCREASED RISK of adverse Musculoskeletal health outcomes at Serum 25(Oh)D levels in the range of deficiency, BUT with DIFFERENT THRESHOLDS (<\u200910\xa0ng/ml and\u2009<\u2009\xa020\xa0ng/ml, respectively) [25,26].']	[('IMPORTANT_CONSIDERATION', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('PROBABLE_UNDERSTANDING', 212)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 109, 'musculoskeletal'), ('UBERON_0001977', 'blood serum', 144, 'serum'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 150, '25 ... OH ... D')]
PMC5941617	5/2018	S271-PMC5941617	['at PRESENT, SOME UNANSWERED QUESTIONS REMAIN [CRITICAL times during which supplementation MAY BE most EFFECTIVE, regimen and length of supplementation (continuous or intermittent), gender difference] [227], THUS Vitamin D supplementation to optimize bone mass acquisition SHOULD BE reserved for children AT RISK for deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 17), ('EXPLICIT_QUESTION', 28), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 102), ('PROBABLE_UNDERSTANDING', 207), ('FUTURE_WORK', 272), ('IMPORTANT_CONSIDERATION', 304)]	11	[('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC5941617	5/2018	S283-PMC5941617	['HOWEVER, the most RECENT STUDY SUGGESTED that Vitamin D status during childhood MIGHT be more RELEVANT for bone health that maternal 25(Oh)D levels during fetal Life [237].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 80), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 94)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('UBERON_0000104', 'life cycle', 161, 'life')]
PMC5941617	5/2018	S287-PMC5941617	['the LINK between SEVERE Vitamin D deficiency and susceptibility to Respiratory infections is prototypically represented by the high Respiratory morbidity in children with rickets [243,244].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 17)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 67, 'respiratory'), ('UBERON_0001004', 'respiratory system', 132, 'respiratory')]
PMC5941617	5/2018	S297-PMC5941617	['OTHER STUDIES have FOUND an inverse ASSOCIATION between Vitamin D concentrations in Pregnancy and the RISK of Respiratory infections in newborns or children during the first 3\xa0years of life [253,254].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 102)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('UBERON_0001004', 'respiratory system', 110, 'respiratory')]
PMC5941617	5/2018	S300-PMC5941617	['taken TOGETHER, all these data INDICATE that Vitamin D status MIGHT have SOME INFLUENCE on conditioning the incidence and severity of SOME but not all type of Respiratory infections and that more information are REQUIRED before drawing any firm conclusion on THIS topic.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 134), ('FUTURE_WORK', 212), ('IMPORTANT_CONSIDERATION', 212), ('QUESTION_ANSWERED_BY_THIS_WORK', 259)]	9	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 159, 'respiratory')]
PMC5941617	5/2018	S301-PMC5941617	['a RECENT LITERATURE REVIEW SUPPORTS a ROLE for Vitamin D deficiency ONLY for tuberculosis, recurrent acute otitis media and SEVERE bronchiolitis [242].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 68), ('IMPORTANT_CONSIDERATION', 124)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5941617	5/2018	S308-PMC5941617	['HOWEVER, a well conducted study, not included in the above cited meta-analysis, on a selected population of otitis prone children, FOUND that Vitamin D administration (1000\xa0iu/day) reduces the RISK of uncomplicated acute otitis [267].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 131), ('IMPORTANT_CONSIDERATION', 193)]	3	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC5941617	5/2018	S309-PMC5941617	['a RECENT meta-analysis of 25 rcts (total 11,321 participants, aged 0–95\xa0years) SHOWED that Vitamin D supplementation was SAFE and protected against acute Respiratory Tract infections overall (adjusted odds ratio 0.88).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 79), ('IMPORTANT_CONSIDERATION', 121)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 154, 'respiratory tract')]
PMC5941617	5/2018	S313-PMC5941617	['finally, LIMITED DATA are available on Vitamin D supplementation in Pregnancy and the RISK of Respiratory infections in the offspring [272,273].']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 86)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('UBERON_0001004', 'respiratory system', 94, 'respiratory')]
PMC5941617	5/2018	S321-PMC5941617	['FEW REPORTS exist regarding the BENEFIT of Vitamin D supplementation in children with specific infections.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 32)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC5941617	5/2018	S336-PMC5941617	['in a pilot study in botswana, Vitamin D3Supplementation (4000–7000\xa0iu/day for 12\xa0weeks) was SAFE and improved Vitamin D status, growth and hiv status [289].']	[('IMPORTANT_CONSIDERATION', 92)]	1	[('CHEBI_52915', 'phosphatediyl group', 30, 'vitamin D3supplementation'), ('PR_000006649', 'zinc finger protein neuro-d4', 38, 'D3supplementation'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC5941617	5/2018	S370-PMC5941617	['in 966 children DEMONSTRATED that Vitamin D deficiency [Serum 25(Oh)D\u2009<\u2009\xa020\xa0ng/ml] was the MAJOR PREDICTIVE factor of asthma RISK [327], and gale et al.']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 91), ('SUPERFICIAL_RELATIONSHIP', 97), ('IMPORTANT_CONSIDERATION', 125)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001977', 'blood serum', 56, 'serum'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 62, '25(OH ... D')]
PMC5941617	5/2018	S386-PMC5941617	['two STUDIES in vitro SHOWED the IMPORTANCE of Vitamin D supplementation in patients affected by Corticosteroid-resistant asthma [315,343] BUT two other STUDIES DEMONSTRATED in vivo that lower 25(Oh)D levels were ASSOCIATED with an increase in Corticosteroids use and an IMPAIRED Lung function [344,345].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 138), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 160), ('SUPERFICIAL_RELATIONSHIP', 212), ('IMPORTANT_CONSIDERATION', 270)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_36916', 'cation', 96, 'corticosteroid'), ('CHEBI_71657', 'versiconol acetate', 192, '25(OH)D'), ('CHEBI_50850', 'etabonate ester', 243, 'corticosteroids'), ('UBERON_0002048', 'lung', 279, 'lung')]
PMC5941617	5/2018	S390-PMC5941617	['the EVIDENCES for a pathogenetic ROLE for Vitamin D in ad are STILL CONFLICTING EVEN THOUGH data in favour of such CORRELATION are increasingly stronger with MORE STUDIES in favour BUT OTHERS OPPOSING THIS HYPOTHESIS.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 115), ('FUTURE_WORK', 158), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('INCOMPLETE_EVIDENCE', 206)]	11	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5941617	5/2018	S393-PMC5941617	['it is STILL a matter for full DEBATE WHETHER supplementation with Vitamin D in pediatric ad is WORTH, PARTICULARLY in deficient patients.']	[('IMPORTANT_CONSIDERATION', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('ANOMALY_CURIOUS_FINDING', 95), ('IMPORTANT_CONSIDERATION', 102)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5941617	5/2018	S397-PMC5941617	['in pediatric population there is SOME EVIDENCE about a favourable EFFECT of administration of Vitamin D on several aspects of ad, but results are STILL CONFLICTING.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152)]	4	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5941617	5/2018	S400-PMC5941617	['HOWEVER, it HAS BEEN SUGGESTED that in patients with a more SEVERE ad, unresponsive to common therapy and with low Serum 25(Oh)D levels, a trial of Vitamin D supplementation CAN BE CONSIDERED [352].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 60), ('FUTURE_WORK', 174), ('FUTURE_WORK', 181)]	5	[('UBERON_0001977', 'blood serum', 115, 'serum'), ('CHEBI_71657', 'versiconol acetate', 121, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 127, 'D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC5941617	5/2018	S420-PMC5941617	['a meta-analysis of six case-control studies and two cohort-studies SHOWED a reduction of the RISK of t1dm in later Life (odds ratio: 0.71; 95% ci 0.51–0.98) in infants who were supplemented with Vitamin D compared with controls, ALTHOUGH the needed time of supplementation and the dose are STILL UNCLEAR [377–379].']	[('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 93), ('ANOMALY_CURIOUS_FINDING', 229), ('FULL_UNKNOWN', 290)]	4	[('UBERON_0000104', 'life cycle', 115, 'life'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC5941617	5/2018	S422-PMC5941617	['IF data of OBSERVATIONAL studies in general population in infancy are ENCOURAGING, in the daisy study, conducted in subjects at higher RISK, the Vitamin D nutritional intake in the first years of Life as well as the Serum 25(Oh)D levels at 9\xa0months of age were not associated with the development of Autoantibodies or with the progression to t1dm [381].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('FUTURE_WORK', 70), ('IMPORTANT_CONSIDERATION', 135)]	4	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0000104', 'life cycle', 196, 'life'), ('UBERON_0001977', 'blood serum', 216, 'serum'), ('CHEBI_71657', 'versiconol acetate', 222, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 222, '25 ... OH ... D'), ('GO_0044308', 'axonal spine', 300, 'autoantibodies')]
PMC5941617	5/2018	S423-PMC5941617	['CONVERSELY, neonatal Vitamin D status SEEMS TO BE ASSOCIATED to the RISK of t1dm in some [382] BUT NOT all the populations [383].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 38), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5941617	5/2018	S431-PMC5941617	['ALTHOUGH SOME SUGGESTIVE and encouraging data on epidemiological observational studies and pilot clinical studies of intervention, the LACK OF EVIDENCE deriving by rcts DOES NOT ALLOW to ENCOURAGE treatment with Cholecalciferol or other Vitamin D Metabolites in patients with t1dm or subjects at higher RISK.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 135), ('DIFFICULT_TASK', 169), ('FUTURE_WORK', 187), ('IMPORTANT_CONSIDERATION', 303)]	8	[('CHEBI_52550', 'theopalauamide', 212, 'cholecalciferol'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('CHEBI_25212', 'metabolite', 247, 'metabolites')]
PMC5941617	5/2018	S444-PMC5941617	['AT PRESENT the IDEAL dosing regimen to treat Vitamin D deficiency and to maintain sufficiency in ibd patients is STILL DEBATED [406].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 15), ('IMPORTANT_CONSIDERATION', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC5941617	5/2018	S449-PMC5941617	['FOUND that two regimens of weekly Vitamin D3Administration (5000\xa0iu/10 kg/week, maximum weekly dose of 25000\xa0iu and maximum cumulative dose of 150000\xa0iu vs. 10000\xa0iu/10 kg/week, maximum weekly dose of 50000\xa0iu and maximum cumulative dose of 300000\xa0iu) for 6\xa0weeks were SAFE and EFFECTIVE in normalizing Vitamin D status in ibd children and adolescents with hypovitaminosis D [411].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 269), ('SUPERFICIAL_RELATIONSHIP', 278)]	3	[('CHEBI_63455', 'tetronic acid derivative', 34, 'vitamin D3administration'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 34, 'vitamin D3administration'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 373, 'D')]
PMC5941617	5/2018	S450-PMC5941617	['finally, a single age DEPENDENT high-dose oral Vitamin D3(the SO-CALLED stoss therapy; <\u20093\xa0years: 200000\xa0iu; 4–12\xa0years 400000\xa0iu; >\u200912\xa0years 800000\xa0iu) was SAFE and efficacious in achieving and maintaining Serum 25(Oh)D levels >\u200920\xa0ng/ml during a 6-month period in ibd children with Vitamin D deficiency [412].']	[('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 157)]	3	[('CHEBI_33279', 'vitamin D5', 47, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 47, 'vitamin D3'), ('UBERON_0001977', 'blood serum', 207, 'serum'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 213, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC5941617	5/2018	S456-PMC5941617	['the ROLE of Vitamin D as a therapeutic agent in ibd is still UNDER investigation.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 61)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC5941617	5/2018	S472-PMC5941617	['AS Vitamin D is an IMPORTANT KEY DETERMINANT of bone mass acquisition, SOME authors RECOMMENDED Vitamin D supplementation during winter and spring in all cd children and adolescents to optimize bone recovery [432].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 71), ('FUTURE_WORK', 84)]	6	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC5941617	5/2018	S473-PMC5941617	['nice GUIDELINES ADVICE that People with cd MAY NEED to receive Calcium and Vitamin D supplementation if their dietary intake is insufficient [433].']	[('PROBABLE_UNDERSTANDING', 5), ('FUTURE_WORK', 16), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 47)]	4	[('NCBITaxon_10088', 'Mus <genus>', 28, 'people'), ('CHEBI_22313', 'alkaline earth metal atom', 63, 'calcium'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5941617	5/2018	S476-PMC5941617	['FUTURE RESEARCH will clarify the IDEAL Vitamin D dosing regimen to treat Vitamin D deficiency and to maintain Serum 25(Oh)D levels ≥30\xa0ng/ml in cd children and adolescents [406].']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 33)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001977', 'blood serum', 110, 'serum'), ('CHEBI_71657', 'versiconol acetate', 116, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 116, '25(OH ... D')]
PMC5941617	5/2018	S482-PMC5941617	['a RECENT meta-analysis of 4 rcts and 11 non-rcts, ONLY 1 enrolling children [442], SHOWED that weight loss marginally improved Vitamin D in comparison with weight maintenance under similar Vitamin D intake [443], CONFIRMING that increased adiposity causes SUBOPTIMAL Serum 25(Oh)D concentrations.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 83), ('PROBABLE_UNDERSTANDING', 213), ('IMPORTANT_CONSIDERATION', 256)]	5	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('UBERON_0001977', 'blood serum', 267, 'serum'), ('CHEBI_71657', 'versiconol acetate', 273, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 273, '25(OH ... D')]
PMC5941617	5/2018	S503-PMC5941617	['the Endocrine society [11], united arab emirates GUIDELINES [27] and the society for adolescent health and medicine [21] RECOMMENDED to screen all obese children and adolescents AS they are at INCREASED RISK for Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 49), ('FUTURE_WORK', 121), ('PROBABLE_UNDERSTANDING', 178), ('IMPORTANT_CONSIDERATION', 193)]	4	[('UBERON_0005063', 'left ventricular compact myocardium', 4, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC5941617	5/2018	S506-PMC5941617	['the Endocrine society clinical practice guideline SUGGESTED in obese children Vitamin D supplementation at doses 2–3 times higher than those recommended for age to satisfy their body’s Vitamin D REQUIREMENT.']	[('INCOMPLETE_EVIDENCE', 50), ('IMPORTANT_CONSIDERATION', 195)]	2	[('UBERON_0005063', 'left ventricular compact myocardium', 4, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC5941617	5/2018	S507-PMC5941617	['similarly, obese children with Vitamin D deficiency SHOULD BE treated with Vitamin D at doses 2–3 times higher than those RECOMMENDED for non-obese pediatric population for at least 6\xa0weeks [11].']	[('FUTURE_WORK', 52), ('IMPORTANT_CONSIDERATION', 52), ('FUTURE_WORK', 122)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5941617	5/2018	S511-PMC5941617	['DIFFERENTLY, sacn CONFIRMED that obese People are AT RISK of low Serum 25(Oh)D concentrations, but HIGHLIGHTED that CURRENTLY EVIDENCE is INSUFFICIENT to RECOMMEND for obese Individuals different reference Nutrient intake of Vitamin D from that PROPOSED for the general uk population [25].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 50), ('INCOMPLETE_EVIDENCE', 99), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 138), ('FUTURE_WORK', 154), ('INCOMPLETE_EVIDENCE', 245)]	9	[('NCBITaxon_10088', 'Mus <genus>', 39, 'people'), ('UBERON_0001977', 'blood serum', 65, 'serum'), ('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 71, '25(OH ... D'), ('NCBITaxon_1', 'root', 174, 'individuals'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC5941617	5/2018	S513-PMC5941617	['in CONCLUSION, obese children have higher RISK of Vitamin D deficiency and insufficiency.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 42)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC5941617	5/2018	S538-PMC5941617	['Pregnancy and breastfeeding\nthe high prevalence of Vitamin D deficiency in Pregnant women is a worldwide health PROBLEM REGARDLESS OF latitude, Food Intake or socio-economic status [93].']	[('IMPORTANT_CONSIDERATION', 112), ('INCOMPLETE_EVIDENCE', 120)]	2	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnant'), ('CHEBI_33290', 'food', 144, 'food'), ('GO_0007631', 'feeding behavior', 144, 'food intake')]
PMC5941617	5/2018	S545-PMC5941617	['during Pregnancy Vitamin D Metabolism changes so that maternal Serum 1,25(Oh)2D levels significantly rise to meet increased calcium REQUIREMENTS for Fetal Skeleton mineralization, WHEREAS fetal Vitamin D stores are exclusively DEPENDENT on maternal Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 180), ('SUPERFICIAL_RELATIONSHIP', 227)]	3	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 17, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_37958', 'dye', 69, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 71, '25(OH)2D'), ('UBERON_0000922', 'embryo', 149, 'fetal'), ('UBERON_0004288', 'skeleton', 155, 'skeleton'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC5941617	5/2018	S548-PMC5941617	['in addition, Vitamin D plays a KEY ROLE in the Immunological Adaptation NEEDED for the onset and maintenance of a normal Pregnancy [500].']	[('IMPORTANT_CONSIDERATION', 31), ('SUPERFICIAL_RELATIONSHIP', 35), ('IMPORTANT_CONSIDERATION', 72)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0002455', 'humoral immune response mediated by circulating immunoglobulin', 47, 'immunological adaptation'), ('GO_0007565', 'female pregnancy', 121, 'pregnancy')]
PMC5941617	5/2018	S551-PMC5941617	['moreover, maternal Vitamin D deficiency HAS BEEN ASSOCIATED with INCREASED risk of several obstetrics diseases (spontaneous Pregnancy Loss, Preterm and/or small-for-Gestational age Birth, Gestational diabetes pre-eclampsia) [502–506].']	[('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 65)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0006508', 'proteolysis', 124, 'pregnancy loss'), ('GO_0007565', 'female pregnancy', 140, 'preterm'), ('GO_0007565', 'female pregnancy', 165, 'gestational'), ('GO_0007567', 'parturition', 181, 'birth'), ('GO_0007565', 'female pregnancy', 188, 'gestational')]
PMC5941617	5/2018	S552-PMC5941617	['in addition, Vitamin D deficiency during Pregnancy MAY negatively AFFECT long-term offspring Extraskeletal health outcomes, with INCREASED risk of infant Respiratory Tract infections, asthma, wheeze, and eczema [273,380,507,508].']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 129)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('UBERON_0001431', 'distal carpal bone 2', 93, 'extraskeletal'), ('UBERON_0000065', 'respiratory tract', 154, 'respiratory tract')]
PMC5941617	5/2018	S554-PMC5941617	['supplementing Pregnant women with Vitamin D in a single or continued dose increases Serum 25(Oh)D at term and MAY reduce the RISK of Preeclampsia, low Birth weight and Preterm Birth.']	[('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 125)]	2	[('GO_0007565', 'female pregnancy', 14, 'pregnant'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001977', 'blood serum', 84, 'serum'), ('CHEBI_71657', 'versiconol acetate', 90, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 93, 'OH ... D'), ('GO_0007128', 'meiotic prophase I', 133, 'preeclampsia'), ('GO_0007567', 'parturition', 151, 'birth'), ('GO_0007565', 'female pregnancy', 168, 'preterm'), ('GO_0007567', 'parturition', 176, 'birth')]
PMC5941617	5/2018	S558-PMC5941617	['indeed, Vitamin D supplementation with 400\xa0iu/day HAS BEEN REPORTED insufficient in Pregnancy, PARTICULARLY for women at higher RISK of Vitamin D deficiency [512,513].']	[('INCOMPLETE_EVIDENCE', 50), ('ANOMALY_CURIOUS_FINDING', 95), ('IMPORTANT_CONSIDERATION', 128)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC5941617	5/2018	S561-PMC5941617	['screening for Vitamin D deficiency during Pregnancy is STILL DEBATED.']	[('IMPORTANT_CONSIDERATION', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy')]
PMC5941617	5/2018	S568-PMC5941617	['we do not RECOMMEND routine screening of Serum 25(Oh)D levels in all Pregnant and breastfeeding women, BUT we SUGGEST to CONSIDER Vitamin D testing in women with multiple RISK FACTORS for Vitamin D deficiency, PARTICULARLY if not receiving Vitamin D supplementation.']	[('FUTURE_WORK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 110), ('FUTURE_WORK', 121), ('SUPERFICIAL_RELATIONSHIP', 171), ('ANOMALY_CURIOUS_FINDING', 210), ('IMPORTANT_CONSIDERATION', 210)]	7	[('UBERON_0001977', 'blood serum', 41, 'serum'), ('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 47, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC5941617	5/2018	S588-PMC5941617	['two studies evaluated the efficacy of administering a bolus dose of Vitamin D2, 150000\xa0iu [225] or 300000\xa0iu [224], every 3\xa0months for 12\xa0months in adolescent females with SEVERE Vitamin D deficiency, with CONFLICTING results.']	[('IMPORTANT_CONSIDERATION', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 206)]	2	[('CHEBI_28934', 'vitamin D2', 68, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 68, 'vitamin D2'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC5941617	5/2018	S591-PMC5941617	['adolescents with SEVERE Vitamin D deficiency treated with an intramuscular injection of a megadose of Vitamin D3(10000\xa0iu/kg, maximum 600000\xa0iu) had insufficient serum 25(Oh)D after 3\xa0months [522].']	[('IMPORTANT_CONSIDERATION', 17)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 102, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 102, 'vitamin D3'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D')]
PMC5941617	5/2018	S593-PMC5941617	['on the CONTRARY a stoss therapy (Oral single-dose of 10000\xa0iu/kg or 300000\xa0iu of Vitamin D3) HAS BEEN DEMONSTRATED EFFECTIVE and SAFE in the treatment of Vitamin D deficiency in older children (mean age 10.6\u2009±\u20094.4\xa0years) without rickets [523].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 115), ('IMPORTANT_CONSIDERATION', 129)]	4	[('UBERON_0000165', 'mouth', 33, 'oral'), ('CHEBI_33279', 'vitamin D5', 81, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 81, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC5941617	5/2018	S598-PMC5941617	['FOUND that in children infected with hiv and Vitamin D insufficiency a daily intake ≥1600\xa0iu/day of Vitamin D3Vitamin D MAY BE REQUIRED to achieve Serum 25(Oh)D levels >\u200930\xa0ng/ml [524].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 120), ('IMPORTANT_CONSIDERATION', 127)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_70326', 'guttiferone A, (rel-(+))-', 100, 'vitamin D3vitamin D'), ('UBERON_0001977', 'blood serum', 147, 'serum'), ('CHEBI_33010', 'chromide(1-)', 155, '(OH)D')]
PMC5941617	5/2018	S606-PMC5941617	['in the case of Vitamin D insufficiency, particularly in subjects AT RISK for Vitamin D deficiency, we RECOMMENDED starting Vitamin D supplementation according to the modalities and REQUIREMENTS RECOMMENDED for age.']	[('IMPORTANT_CONSIDERATION', 65), ('FUTURE_WORK', 102), ('IMPORTANT_CONSIDERATION', 181), ('FUTURE_WORK', 194)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC5941617	5/2018	S608-PMC5941617	['nutritional rickets cases are STILL REPORTED in italy, THUS adequate national STRATEGIES to prevent Vitamin D deficiency ARE NEEDED.']	[('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 36), ('PROBABLE_UNDERSTANDING', 55), ('FUTURE_WORK', 78), ('FUTURE_WORK', 121)]	5	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5941617	5/2018	S613-PMC5941617	['MORE STUDIES, particularly rcts, ARE NEEDED to confirm the PROMISING ROLE of Vitamin D in the promotion of the GLOBAL health of children.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('FUTURE_WORK', 33), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 69), ('IMPORTANT_CONSIDERATION', 111)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC5941617	5/2018	S619-PMC5941617	['adolescents are PARTICULARLY AT RISK of hypovitaminosis d.\nVitamin D status of newborns is INFLUENCED by ethnicity, season of Birth, and maternal Vitamin D status during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 16), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 91)]	3	[('CHEBI_28384', 'vitamin K', 59, 'Vitamin D'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
PMC5941617	5/2018	S626-PMC5941617	['the administration of these Compounds increases the RISK of hypercalcemia and is NOT ABLE to maintain and/or restore Vitamin D stores.']	[('IMPORTANT_CONSIDERATION', 52), ('DIFFICULT_TASK', 81)]	2	[('CHEBI_36357', 'polyatomic entity', 28, 'compounds'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5941617	5/2018	S635-PMC5941617	['ensuring an adequate Vitamin D intake is particularly IMPORTANT during Adolescence.']	[('IMPORTANT_CONSIDERATION', 54)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 71, 'adolescence')]
PMC5941617	5/2018	S639-PMC5941617	['in cases of POOR compliance, supplementation with intermittent dosing (weekly or monthly doses for a cumulative monthly dose of 18000–30000\xa0iu of Vitamin D) can be CONSIDERED, starting from children aged 5–6\xa0years and PARTICULARLY during Adolescence.']	[('PROBLEM_COMPLICATION', 12), ('FUTURE_WORK', 164), ('IMPORTANT_CONSIDERATION', 218)]	3	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 238, 'adolescence')]
PMC5941617	5/2018	S642-PMC5941617	['individuals on Anticonvulsants, oral Corticosteroids, Antimicotics and Antiretroviral Drugs SHOULD receive AT LEAST 2–3 times more Vitamin D than the daily REQUIREMENT RECOMMENDED for age.']	[('FUTURE_WORK', 92), ('PROBABLE_UNDERSTANDING', 107), ('IMPORTANT_CONSIDERATION', 156), ('FUTURE_WORK', 168)]	4	[('CHEBI_37540', 'arabinarate(2-)', 15, 'anticonvulsants'), ('CHEBI_50850', 'etabonate ester', 37, 'corticosteroids'), ('CHEBI_33282', 'antibacterial agent', 54, 'antimicotics'), ('CHEBI_33656', 'antiaromatic compound', 71, 'antiretroviral drugs'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5941617	5/2018	S645-PMC5941617	['the administration of these Compounds increases the RISK of hypercalcemia and is NOT ABLE to maintain and/or restore Vitamin D stores.']	[('IMPORTANT_CONSIDERATION', 52), ('DIFFICULT_TASK', 81)]	2	[('CHEBI_36357', 'polyatomic entity', 28, 'compounds'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5941617	5/2018	S648-PMC5941617	['Vitamin D status SHOULD BE monitored AT LEAST yearly in subjects that REQUIRE supplementation during the whole year BECAUSE AFFECTED from pathological conditions or receiving Drugs AFFECTING Vitamin D Metabolism (table\xa07).']	[('FUTURE_WORK', 17), ('IMPORTANT_CONSIDERATION', 17), ('PROBABLE_UNDERSTANDING', 37), ('IMPORTANT_CONSIDERATION', 70), ('PROBABLE_UNDERSTANDING', 116), ('SUPERFICIAL_RELATIONSHIP', 124), ('SUPERFICIAL_RELATIONSHIP', 181)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_23888', 'drug', 175, 'drugs'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0008152', 'metabolic process', 201, 'metabolism')]
PMC5941617	5/2018	S649-PMC5941617	['Skeletal actions of Vitamin D\n\nnutritional rickets\n\nchildren of immigrants living in industrialized countries are at INCREASED RISK of nutritional rickets BECAUSE they USUALLY present several risk FACTORS for vitamin d deficiency such as prolonged breastfeeding without Vitamin D supplementation, increased skin pigmentation, reduced sun exposure due to cultural habits (i.e.']	[('IMPORTANT_CONSIDERATION', 117), ('PROBABLE_UNDERSTANDING', 155), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 197)]	4	[('UBERON_0004288', 'skeleton', 0, 'Skeletal'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC5941617	5/2018	S655-PMC5941617	['intermittent administration of Vitamin D MAY BE CONSIDERED in children and adolescents with POOR compliance with daily treatment (i.e.']	[('INCOMPLETE_EVIDENCE', 41), ('FUTURE_WORK', 48), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 92), ('PROBLEM_COMPLICATION', 92)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5941617	5/2018	S672-PMC5941617	['we SUGGEST the evaluation of Vitamin D status ONLY in patients affected by tuberculosis or hiv infection, AS they MAY BENEFIT from Vitamin D supplementation, in particular due to concomitant treatments that INFLUENCE Vitamin D Metabolism.']	[('FUTURE_WORK', 3), ('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 114), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 207)]	7	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0008152', 'metabolic process', 227, 'metabolism')]
PMC5941617	5/2018	S674-PMC5941617	['HOWEVER, as FEW STUDIES SHOWED that Vitamin D supplementation improves clinical parameters in patients with active tuberculosis or hiv infection, MORE rigorous and extensive STUDIES ARE NEEDED to EVALUATE the ROLE of Vitamin D supplementation in infectious diseases, CONSIDERING also the setting of care, children’s age and nutritional status, POTENTIAL co-infections and compliance with Anti-infective therapy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 146), ('FUTURE_WORK', 174), ('QUESTION_ANSWERED_BY_THIS_WORK', 196), ('SUPERFICIAL_RELATIONSHIP', 209), ('IMPORTANT_CONSIDERATION', 267), ('INCOMPLETE_EVIDENCE', 344)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('CHEBI_59132', 'antigen', 388, 'anti')]
PMC5941617	5/2018	S678-PMC5941617	['recent meta-analyses SUGGEST that supplementation with Vitamin D (500–2000\xa0iu/day) MAY reduce the RISK of asthma exacerbation.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 83), ('IMPORTANT_CONSIDERATION', 98)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5941617	5/2018	S683-PMC5941617	['Serum 25(Oh)D evaluation MAY BE CONSIDERED in children with SEVERE ad unresponsive to common therapy and multiple RISK FACTORS for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 32), ('IMPORTANT_CONSIDERATION', 32), ('IMPORTANT_CONSIDERATION', 60), ('SUPERFICIAL_RELATIONSHIP', 114)]	5	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5941617	5/2018	S685-PMC5941617	['a short trial of Vitamin D supplementation CAN be CONSIDERED in patients with SEVERE ad unresponsive to common therapy, especially in the late winter-early spring period.']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 50), ('IMPORTANT_CONSIDERATION', 78)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC5941617	5/2018	S688-PMC5941617	['type 1 diabetes mellitus\n\nchildren and adolescents with t1dm are AT RISK for Vitamin D deficiency.']	[('IMPORTANT_CONSIDERATION', 65)]	1	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC5941617	5/2018	S702-PMC5941617	['AS gluten-free diet restores normal Intestinal absorption, after treatment of deficiency we RECOMMEND Vitamin D supplementation according to the modalities and REQUIREMENTS for otherwise healthy children and adolescents.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 92), ('IMPORTANT_CONSIDERATION', 160)]	3	[('UBERON_0000160', 'intestine', 36, 'intestinal'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5941617	5/2018	S703-PMC5941617	['obesity and Metabolic syndrome\n\nepidemiological studies SHOWED that obese children and adolescents are at high RISK for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 111)]	2	[('GO_0008152', 'metabolic process', 12, 'metabolic'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC5941617	5/2018	S706-PMC5941617	['we SUGGEST against Vitamin D administration to improve obesity-related COMPLICATIONS, given INCONSISTENT results and the SMALL NUMBER OF STUDIES.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 121)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC5941617	5/2018	S711-PMC5941617	['if an obese Individual does not receive Vitamin D supplementation and has a sedentary indoor lifestyle with consequent reduced sun exposure, Serum 25(Oh)D evaluation MAY BE CONSIDERED to confirm Vitamin D deficiency and start adequate treatment.']	[('INCOMPLETE_EVIDENCE', 166), ('ANOMALY_CURIOUS_FINDING', 170), ('FUTURE_WORK', 173), ('IMPORTANT_CONSIDERATION', 173)]	4	[('NCBITaxon_1', 'root', 12, 'individual'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001977', 'blood serum', 141, 'serum'), ('CHEBI_71657', 'versiconol acetate', 147, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 147, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC5941617	5/2018	S720-PMC5941617	['we SUGGEST to CONSIDER serum 25(Oh)D testing in women with multiple RISK FACTORS for Vitamin D deficiency, PARTICULARLY if not receiving Vitamin D supplementation, and/or with specific conditions POSSIBLY AFFECTING Pregnancy course (table\xa09).']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 68), ('ANOMALY_CURIOUS_FINDING', 107), ('IMPORTANT_CONSIDERATION', 107), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 205)]	7	[('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 35, 'D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy')]
PMC5941617	5/2018	S729-PMC5941617	['CONSIDERING AVAILABLE EVIDENCE, PARTICULARLY the LACK OF italian studies, at PRESENT we DO NOT RECOMMEND OTHER modalities DIFFERENT from daily or weekly administration of Vitamin D to treat asymptomatic Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 32), ('INCOMPLETE_EVIDENCE', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 77), ('FULL_UNKNOWN', 88), ('FUTURE_WORK', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	10	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 211, 'D')]
PMC5941617	5/2018	S730-PMC5941617	['in case of detection of asymptomatic Vitamin D insufficiency [25(Oh)D between 20 and 29\xa0ng/ml], particularly in subjects AT RISK for vitamin d deficiency, we RECOMMENDED to start Vitamin D supplementation according to the modalities and REQUIREMENTS RECOMMENDED for age.']	[('IMPORTANT_CONSIDERATION', 121), ('FUTURE_WORK', 158), ('IMPORTANT_CONSIDERATION', 237), ('FUTURE_WORK', 250)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC5952272	5/2018	S16-PMC5952272	['there is also a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK for autism.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 119)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0000104', 'life cycle', 105, 'life')]
PMC5952272	5/2018	S24-PMC5952272	['for this purpose, 10 Micronutrients are added to the flour, including b1, b2, b6, b12, Folic Acid, niacin, iron, zinc, Vitamin A, and Vitamin D.4\nDESPITE all the above-mentioned actions, anaemia PREVALENCE is STILL high among Pregnant women, Lactating mothers, and children less than 5\u2009years of age.']	[('ANOMALY_CURIOUS_FINDING', 146), ('IMPORTANT_CONSIDERATION', 195), ('IMPORTANT_CONSIDERATION', 209)]	3	[('CHEBI_33839', 'macromolecule', 21, 'micronutrients'), ('CHEBI_30751', 'formic acid', 87, 'folic acid'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 226, 'pregnant'), ('GO_0007594', 'puparial adhesion', 242, 'lactating')]
PMC5952272	5/2018	S107-PMC5952272	['anaemia and intellectual abilities\niron, Folate, Vitamin B12, Vitamin A, zinc, and other Micronutrient deficiencies CAN CONTRIBUTE to anaemia.5iron-deficiency anaemia is a MAJOR PUBLIC HEALTH nutritional PROBLEM AFFECTING People of all ages.']	[('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 172), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 204), ('SUPERFICIAL_RELATIONSHIP', 212)]	6	[('CHEBI_30863', '5-azaorotic acid', 41, 'folate'), ('CHEBI_33279', 'vitamin D5', 49, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 89, 'micronutrient'), ('NCBITaxon_10088', 'Mus <genus>', 222, 'people')]
PMC5952272	5/2018	S112-PMC5952272	['while all Nutrients are IMPORTANT for Brain Development, certain Nutrients (eg, protein, Long-Chain polyunsaturated Fatty Acids, iron, copper, zinc, Iodine, Folate, Choline, and Vitamins A, B6, and B12) have particularly large EFFECTS early in Life and exhibit CRITICAL or sensitive periods for Neurodevelopment.8all highly Metabolic, rapidly developing Organs have high iron requirements BECAUSE iron supports fundamental Metabolic Processes.9early-Life id is PARTICULARLY DETRIMENTAL as this is a period of rapid Neurodevelopment.']	[('IMPORTANT_CONSIDERATION', 24), ('SUPERFICIAL_RELATIONSHIP', 227), ('IMPORTANT_CONSIDERATION', 261), ('PROBABLE_UNDERSTANDING', 389), ('ANOMALY_CURIOUS_FINDING', 461), ('IMPORTANT_CONSIDERATION', 474)]	6	[('CHEBI_33284', 'nutrient', 10, 'nutrients'), ('GO_0007420', 'brain development', 38, 'brain development'), ('UBERON_0000955', 'brain', 38, 'brain'), ('CHEBI_33284', 'nutrient', 65, 'nutrients'), ('CHEBI_28911', 'cob(III)alamin', 89, 'long-chain'), ('CHEBI_35366', 'fatty acid', 116, 'fatty acids'), ('CHEBI_24859', 'iodine atom', 149, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 157, 'folate'), ('CHEBI_15354', 'choline', 165, 'choline'), ('CHEBI_27300', 'vitamin D', 178, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 178, 'vitamins A'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 190, 'B6'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 198, 'B12'), ('UBERON_0000104', 'life cycle', 244, 'life'), ('GO_0007399', 'nervous system development', 295, 'neurodevelopment'), ('GO_0008152', 'metabolic process', 324, 'metabolic'), ('UBERON_0000062', 'organ', 354, 'organs'), ('GO_0008152', 'metabolic process', 423, 'metabolic processes'), ('UBERON_0000104', 'life cycle', 450, 'life'), ('GO_0007399', 'nervous system development', 515, 'neurodevelopment')]
PMC5952272	5/2018	S146-PMC5952272	['it is IMPORTANT TO MENTION in this context that the PREVALENCE of autism in somali children Born in sweden was FOUND TO BE 3 to 4 times higher than in the non-somali group (0.7% vs 0.19%).39as somalis have high levels of Melanin, during migration to northern latitudes, such as sweden, they would REQUIRE 5 to 10 times more uv-b exposure than light-skinned Individuals OR an ALTERNATIVE Vitamin D source, such as from the diet or supplementation.40moreover, saad et al41reported that 57% Vitamin D deficient and 30% insufficient patients who received Vitamin D3 (300\u2009iu/kg/day not to exceed 5000\u2009iu/day) for 3\u2009months SHOWED significant improved outcomes (80.72 %), which were MAINLY in the sections of the childhood autism rating scale (cars) and aberrant behaviour checklist subscales that measure behaviour, stereotypy, Eye contact, and attention span.']	[('IMPORTANT_CONSIDERATION', 6), ('IMPORTANT_CONSIDERATION', 52), ('ANOMALY_CURIOUS_FINDING', 111), ('FUTURE_WORK', 297), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 369), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 375), ('INCOMPLETE_EVIDENCE', 617), ('PROBABLE_UNDERSTANDING', 676)]	8	[('GO_0007567', 'parturition', 92, 'born'), ('CHEBI_25179', 'melanins', 221, 'melanin'), ('NCBITaxon_1', 'root', 357, 'individuals'), ('CHEBI_27300', 'vitamin D', 387, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 488, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 551, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 551, 'vitamin D3'), ('UBERON_0000970', 'eye', 822, 'eye')]
PMC5952272	5/2018	S151-PMC5952272	['on the community level, it was NOTICED that diet plays a MAJOR ROLE in the manifestation of anaemia and Vitamin E and D deficiency; HOWEVER, OTHER factors MAY interfere to make such a deficiency multifactorial.']	[('ANOMALY_CURIOUS_FINDING', 31), ('IMPORTANT_CONSIDERATION', 57), ('SUPERFICIAL_RELATIONSHIP', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 104, 'vitamin E'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 118, 'D')]
PMC5956785	5/2018	S6-PMC5956785	['conclusion\nthe data INDICATE SUBOPTIMAL Vitamin D status in children with chronic arthritis.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 29)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC5956785	5/2018	S62-PMC5956785	['defining Vitamin D status\nvitamin D deficiency is DEFINED AS a Serum 25(Oh)D concentration less than 30\xa0nmol/l, a 25(Oh)D concentration between 30 and 50\xa0nmol/l IS CONSIDERED insufficient, greater than 50\xa0nmol/l IS CONSIDERED sufficient and a 25(Oh)D status greater than 125\xa0nmol/l IS CONSIDERED AT RISK of adverse EFFECTS [19].']	[('PROBABLE_UNDERSTANDING', 50), ('PROBABLE_UNDERSTANDING', 58), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 212), ('INCOMPLETE_EVIDENCE', 282), ('IMPORTANT_CONSIDERATION', 296), ('SUPERFICIAL_RELATIONSHIP', 315)]	7	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 34, 'D'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 114, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 120, 'D'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D')]
PMC5956785	5/2018	S63-PMC5956785	['these values are based on the institute of medicine (iom) review of published research focused on determining the OPTIMAL Vitamin D concentration for maximal calcium absorption, prevention of rickets, reduction of fracture risk and PREVENTION of osteomalacia in healthy populations [19].']	[('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 232)]	2	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC5956785	5/2018	S64-PMC5956785	['in the most RECENT review of Vitamin D REQUIREMENTS, the iom CONCLUDED that there was INADEQUATE INFORMATION to make intake RECOMMENDATIONS in RELATION to OTHER biologic ROLES of vitamin d [19].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 86), ('PROBLEM_COMPLICATION', 86), ('INCOMPLETE_EVIDENCE', 97), ('FUTURE_WORK', 124), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 170)]	10	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5956785	5/2018	S66-PMC5956785	['the endocrine society has published clinical practice GUIDELINES for patients AT RISK of Vitamin D deficiency [20].']	[('PROBABLE_UNDERSTANDING', 54), ('IMPORTANT_CONSIDERATION', 78)]	2	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5956785	5/2018	S67-PMC5956785	['the society RECOMMENDS that AT-RISK populations, including “obese children and Adults and children and Adults on Anticonvulsant medications, Glucocorticoids, antifungals such as Ketoconazole, and medications for acquired immune deficiency syndrome be given at least two to three times more Vitamin D for their age group to satisfy their body’s Vitamin D REQUIREMENT” [20].']	[('FUTURE_WORK', 12), ('IMPORTANT_CONSIDERATION', 28), ('IMPORTANT_CONSIDERATION', 354)]	3	[('UBERON_0007023', 'adult organism', 79, 'adults'), ('UBERON_0007023', 'adult organism', 103, 'adults'), ('CHEBI_35624', 'azaspiro compound', 113, 'anticonvulsant'), ('CHEBI_36597', 'phthalazine', 141, 'glucocorticoids'), ('CHEBI_47519', 'ketoconazole', 178, 'ketoconazole'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D')]
PMC5956785	5/2018	S71-PMC5956785	['results of scoping review and discussion\nconsiderations when evaluating the ROLE of Vitamin D in jia include Vitamin D REQUIREMENTS for this population and the ROLE that Vitamin D plays in disease activity.']	[('SUPERFICIAL_RELATIONSHIP', 76), ('IMPORTANT_CONSIDERATION', 119), ('SUPERFICIAL_RELATIONSHIP', 160)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5956785	5/2018	S83-PMC5956785	['(10.9–18.0)70.1\u2009±\u200921.2children with rheumatic disease would BENEFIT from receiving Calcium and Vitamin D supplements.illinois, usa reed et al.']	[('IMPORTANT_CONSIDERATION', 60)]	1	[('CHEBI_22313', 'alkaline earth metal atom', 83, 'calcium'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5956785	5/2018	S165-PMC5956785	['map produced by the spatial initiative, university of saskatchewan, 2018\nthe MAJOR source of Vitamin D for most People is endogenous Vitamin D Synthesis induced by sunlight exposure [62].']	[('IMPORTANT_CONSIDERATION', 77)]	1	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 112, 'people'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 133, 'vitamin D synthesis')]
PMC5956785	5/2018	S189-PMC5956785	['the authors QUESTIONED WHETHER jia patients with more SEVERE disease REQUIRE higher supplementation of Vitamin D to maintain normal 25(Oh) D concentrations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('IMPORTANT_CONSIDERATION', 54), ('IMPORTANT_CONSIDERATION', 69)]	5	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH) D')]
PMC5956785	5/2018	S193-PMC5956785	['long-term, adequately powered randomized studies which control for CONFOUNDING variables (sun exposure, season, and Vitamin D intake) are REQUIRED to confirm a causative RELATIONSHIP between Vitamin D and disease activity.']	[('PROBLEM_COMPLICATION', 67), ('IMPORTANT_CONSIDERATION', 138), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC5956785	5/2018	S194-PMC5956785	['POTENTIAL REQUIREMENTS of Vitamin D intake\nVitamin D intake was ONLY measured in seven studies [23,26,31,37,38,43,44].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 10), ('INCOMPLETE_EVIDENCE', 64)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 43, 'Vitamin D')]
PMC5956785	5/2018	S199-PMC5956785	['two studies REPORTED Intake of Vitamin D supplements by study participants but neither had a mean 25(Oh)D that reached the OPTIMAL concentration [38,44].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 123)]	2	[('GO_0007631', 'feeding behavior', 21, 'intake'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 104, 'D')]
PMC5956785	5/2018	S208-PMC5956785	['ADDITIONAL STUDIES investigating Vitamin D intake from all sources (both Food and supplements) are REQUIRED to determine IF children with chronic arthritis REQUIRE additional Vitamin D to maintain Serum concentrations in comparison to healthy children.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('IMPORTANT_CONSIDERATION', 156)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_33290', 'food', 73, 'food'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('UBERON_0001977', 'blood serum', 197, 'serum')]
PMC5956785	5/2018	S209-PMC5956785	['understanding this RELATIONSHIP will be IMPORTANT in the use of Vitamin D as a POTENTIAL adjunct therapy.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 79)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5956785	5/2018	S210-PMC5956785	['additionally, IMPROVED UNDERSTANDING of Vitamin D NEEDS in children with chronic arthritis will HELP TO CLARIFY the ROLE of Vitamin D in the UNDERLYING disease processes so that therapies that target specific Vitamin D responsive Immune pathways CAN be developed.']	[('FUTURE_WORK', 14), ('FUTURE_WORK', 23), ('FUTURE_WORK', 50), ('IMPORTANT_CONSIDERATION', 50), ('FUTURE_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 141), ('FUTURE_WORK', 246), ('INCOMPLETE_EVIDENCE', 246)]	9	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('UBERON_0002405', 'immune system', 230, 'immune')]
PMC5956785	5/2018	S212-PMC5956785	['two articles have discussed Vitamin D REQUIREMENTS for children with rheumatic conditions not in the context of Corticosteroids.']	[('IMPORTANT_CONSIDERATION', 38)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_50850', 'etabonate ester', 112, 'corticosteroids')]
PMC5956785	5/2018	S214-PMC5956785	['the authors CAUTIONED that providing large doses of Vitamin D CAN result in providing “too much of a good thing” and that studies comparing children with rheumatic diseases to healthy children are REQUIRED.']	[('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 197)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC5956785	5/2018	S261-PMC5956785	['this first step is IMPORTANT for the development of FUTURE STUDIES leading to the exploration of POTENTIAL OPTIMAL target concentrations of Vitamin D for the reduction of inflammation in children with chronic arthritis.']	[('IMPORTANT_CONSIDERATION', 19), ('FUTURE_WORK', 52), ('INCOMPLETE_EVIDENCE', 97), ('IMPORTANT_CONSIDERATION', 107)]	4	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC5956785	5/2018	S284-PMC5956785	['being able to SUGGEST specific TARGETS for Vitamin D status AS a POTENTIAL adjunct therapy in the treatment of jia and understanding HOW Genetic variants increase the RISK of disease development will enhance the quality of Life of patients and their families.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 31), ('PROBABLE_UNDERSTANDING', 60), ('INCOMPLETE_EVIDENCE', 65), ('EXPLICIT_QUESTION', 133), ('IMPORTANT_CONSIDERATION', 167)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('SO_0000704', 'gene', 137, 'genetic'), ('UBERON_0000104', 'life cycle', 223, 'life')]
PMC5995352	6/2018	S19-PMC5995352	['SEVERE Vitamin D deficiency in children manifests clinically as rickets characterized by Mineralization failure of the Growth Plates and of the newly formed Osteoid at the bone Matrix [1].']	[('IMPORTANT_CONSIDERATION', 0)]	1	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('GO_0031214', 'biomineral tissue development', 89, 'mineralization'), ('UBERON_0002516', 'epiphyseal plate', 119, 'growth plates'), ('UBERON_0008883', 'osteoid', 157, 'osteoid'), ('GO_0031012', 'extracellular matrix', 177, 'matrix')]
PMC5995352	6/2018	S22-PMC5995352	['hypovitaminosis D MAY BE defined as Vitamin D deficiency or insufficiency (Serum-25-Hydroxyvitamin D (25Ohd) < 25 nmol/l and 25–50 nmol/l, respectively) [3], ALTHOUGH the most APPROPRIATE cut points are STILL UNDER DEBATE [4,5].']	[('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('IMPORTANT_CONSIDERATION', 176), ('IMPORTANT_CONSIDERATION', 203), ('IMPORTANT_CONSIDERATION', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 215)]	6	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 16, 'D'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 81, '25-hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 102, '25OHD')]
PMC5995352	6/2018	S29-PMC5995352	['inborn rickets due to Vitamin D deficiency, however, is very RARE, but MAY BE seen in children of mothers with SEVERE Vitamin D deficiency, osteomalacia and low s-calcium during Pregnancy [11].']	[('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 111)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy')]
PMC5995352	6/2018	S31-PMC5995352	['low foetal Vitamin D stores MAY THEREFORE further decrease to CRITICAL levels soon after Birth, in the absence of infant Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 28), ('PROBABLE_UNDERSTANDING', 32), ('IMPORTANT_CONSIDERATION', 62)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007567', 'parturition', 89, 'birth'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC5995352	6/2018	S38-PMC5995352	['IF low maternal or Cord 25Ohd is LINKED to diminished infant growth, especially of the Long Bones, DESPITE Vitamin D supplementation RECOMMENDATIONS, an IMPORTANT POTENTIAL for enforced PREVENTION STRATEGIES is SUGGESTED, EVEN in populations with low incidence of Vitamin D deficiency rickets.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('ANOMALY_CURIOUS_FINDING', 99), ('FUTURE_WORK', 133), ('IMPORTANT_CONSIDERATION', 153), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 186), ('FUTURE_WORK', 197), ('INCOMPLETE_EVIDENCE', 211), ('ANOMALY_CURIOUS_FINDING', 222)]	10	[('UBERON_0002240', 'spinal cord', 19, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 24, '25OHD'), ('UBERON_0002495', 'long bone', 87, 'long bones'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D')]
PMC5995352	6/2018	S64-PMC5995352	['dietary Intake of Calcium and Vitamin D intake were ESTIMATED by multiplying the frequency of self-reported Consumed Food with standard portion sizes [29] and information obtained from danish Food composition tables [30] the Intake of supplementary Vitamin D was calculated based on self-reported data on type and frequency of Supplements, and a database of all registered Supplements in denmark provided by the danish veterinary and Food administration [31].']	[('INCOMPLETE_EVIDENCE', 52), ('IMPORTANT_CONSIDERATION', 98)]	2	[('GO_0007631', 'feeding behavior', 8, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 18, 'calcium'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007631', 'feeding behavior', 108, 'consumed'), ('CHEBI_33290', 'food', 117, 'food'), ('CHEBI_33290', 'food', 192, 'food'), ('GO_0007631', 'feeding behavior', 225, 'intake'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 327, 'supplements'), ('CHEBI_33341', 'titanium atom', 373, 'supplements'), ('CHEBI_33290', 'food', 434, 'Food')]
PMC5995352	6/2018	S147-PMC5995352	['Breastfed infants MAY BE at a higher RISK of rickets [36], BUT this DID NOT apply to our cohort with a general high Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('INCOMPLETE_EVIDENCE', 68)]	4	[('UBERON_0001224', 'renal pelvis', 0, 'Breastfed'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5995352	6/2018	S187-PMC5995352	['in conclusion, early Life Vitamin D status had no clinically IMPORTANT associations with linear growth in a generally healthy population of infants.']	[('IMPORTANT_CONSIDERATION', 61)]	1	[('UBERON_0000104', 'life cycle', 21, 'life'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC6011374	6/2018	S0-PMC6011374	['Vitamin D levels in an australian and new zealand cohort and the ASSOCIATION with Pregnancy outcome\n\nabstract\n\nbackground\nPregnant women are at INCREASED SUSCEPTIBILITY to Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 144)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0007565', 'female pregnancy', 122, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC6011374	6/2018	S26-PMC6011374	['furthermore, the Gestation at which Vitamin D was measured is also IMPORTANT.']	[('IMPORTANT_CONSIDERATION', 67)]	1	[('GO_0007565', 'female pregnancy', 17, 'gestation'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC6011374	6/2018	S91-PMC6011374	['furthermore, there MAY BE POSSIBLE fetal sex specific DIFFERENCES in Vitamin D status WORTH CONSIDERING in FUTURE STUDIES.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54), ('IMPORTANT_CONSIDERATION', 86), ('FUTURE_WORK', 107)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC6011374	6/2018	S118-PMC6011374	['during Gestation, fetal demand for Calcium increases and it is IMPERATIVE that maternal Vitamin D status remain adequate to support increased Calcium absorption from the Gut [54].']	[('IMPORTANT_CONSIDERATION', 63)]	1	[('GO_0007565', 'female pregnancy', 7, 'gestation'), ('CHEBI_22313', 'alkaline earth metal atom', 35, 'calcium'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 142, 'calcium'), ('UBERON_0001555', 'digestive tract', 170, 'gut')]
PMC6011374	6/2018	S119-PMC6011374	['THEREFORE, Vitamin D status MAY BE IMPORTANT in populations where dietary Calcium intake is low which is UNLIKELY in the population of women studied HERE.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 35), ('PROBABLE_UNDERSTANDING', 105), ('QUESTION_ANSWERED_BY_THIS_WORK', 149)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 74, 'calcium')]
PMC6039335	7/2018	S7-PMC6039335	['nutritional factors, including Fat Metabolism, Digestion and Absorption Of Feed, Glucose/Starch availability, and Vitamin A, d, and c levels are IMPORTANT for imf deposition.']	[('IMPORTANT_CONSIDERATION', 145)]	1	[('GO_0006631', 'fatty acid metabolic process', 31, 'fat metabolism'), ('GO_0007586', 'digestion', 47, 'digestion ...'), ('GO_0030254', 'protein secretion by the type III secretion system', 61, 'absorption of feed'), ('CHEBI_17234', 'glucose', 81, 'glucose'), ('CHEBI_28017', 'starch', 89, 'starch'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin A')]
PMC6039335	7/2018	S260-PMC6039335	['the appropriate age for, and duration of, Vitamin A deple tion or supplementation have been SUGGESTED as IMPORTANT factors that AFFECT ms. oka et al [134] reported that restricting Vitamin A in 15-month-old cattle until the final finishing phase (29 months of age) increased ms, but not in 23-month-old cattle prior to finishing.']	[('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 128)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin A')]
PMC6039335	7/2018	S294-PMC6039335	['FURTHER STUDY is NECESSARY to clarify the EFFECTS of dietary Vitamin C on ms and qg in other breeds of beef cattle.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 17), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin C')]
PMC6043562	7/2018	S161-PMC6043562	['Prenatal exposure INTERACTIONS MAY play an IMPORTANT ROLE, AS EVIDENCED by the POTENTIAL synergy between Vitamin E and Pm2.5.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 43), ('SUPERFICIAL_RELATIONSHIP', 53), ('PROBABLE_UNDERSTANDING', 59), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 79)]	7	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin E'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 119, 'PM2')]
PMC6056931	7/2018	S22-PMC6056931	['HOWEVER, adequate maternal intakes of zinc and Vitamin A MAY also be IMPORTANT for optimal Pregnancy outcomes, as well as for maternal and offspring health [11–13].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 69)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin A'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy')]
